PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Scarborough, CL; Ferrari, J; Godfray, HCJ				Scarborough, CL; Ferrari, J; Godfray, HCJ			Aphid protected from pathogen by endosymbiont	SCIENCE			English	Editorial Material							HOST-PLANT SPECIALIZATION; RESISTANCE; SYMBIONTS		Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Ferrari, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	julia.ferrari@imperial.ac.uk	Ferrari, Julia/B-2376-2009	Ferrari, Julia/0000-0001-6519-4254	Biotechnology and Biological Sciences Research Council [D19263] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Ferrari J, 2003, ECOL LETT, V6, P111, DOI 10.1046/j.1461-0248.2003.00399.x; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	6	526	559	6	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1781	1781		10.1126/science.1120180	http://dx.doi.org/10.1126/science.1120180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357252				2022-12-28	WOS:000234093600036
J	Ferrara, N; Kerbel, RS				Ferrara, N; Kerbel, RS			Angiogenesis as a therapeutic target	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; ANTI-VEGF ANTIBODY; CANCER STEM-CELLS; TUMOR ANGIOGENESIS; ENDOGENOUS INHIBITORS; VASCULAR-PERMEABILITY; MONOCLONAL-ANTIBODY; PROGENITOR CELLS; IN-VIVO	Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration. Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries. Therapeutic angiogenesis ( promoting new vessel growth to treat ischaemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first.	Genentech Inc, San Francisco, CA 94080 USA; Univ Toronto, Toronto, ON M5G 2M9, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M5G 2M9, Canada	Roche Holding; Genentech; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Ferrara, N (corresponding author), Genentech Inc, 1DNA Way, San Francisco, CA 94080 USA.	nf@gene.com	Xiao, Yang/B-5668-2012; Yin, ming/F-3737-2012					ALGIRE GH, 1945, J NATL CANCER I, V6, P73, DOI 10.1093/jnci/6.1.73; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bender JG, 2004, DRUG RESIST UPDATE, V7, P289, DOI 10.1016/j.drup.2004.09.001; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bertolini F, 2003, CANCER RES, V63, P4342; Browder T, 2000, CANCER RES, V60, P1878; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; DIPIETRO LA, 1997, REGULATION ANGIOGENE, P295; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Garner Alec, 1994, P1625; GASPARINI G, 1912, J CLIN ONCOL, P23; Gerber HP, 2000, CANCER RES, V60, P6253; Gerber HP, 2005, CANCER RES, V65, P671; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Heinl-Green A, 2005, EUR HEART J, V26, P1327, DOI 10.1093/eurheartj/ehi223; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Herbst RS, 2002, J CLIN ONCOL, V20, P3792, DOI 10.1200/JCO.2002.11.061; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; IDE A. GORDON, 1939, AMER JOUR ROENTGENOL AND RADIUM THERAP, V42, P891; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prewett M, 1999, CANCER RES, V59, P5209; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RAK J, 1995, CANCER RES, V55, P4575; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Samson M, 2004, J CLIN ENDOCR METAB, V89, P4078, DOI 10.1210/jc.2003-032024; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Siemann DW, 2004, CANCER-AM CANCER SOC, V100, P2491, DOI 10.1002/cncr.20299; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Smith JK, 2004, ONCOL RES, V14, P175, DOI 10.3727/000000003772462298; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Sweeney CJ, 2001, CANCER RES, V61, P3369; Sweeney CJ, 2003, TRENDS MOL MED, V9, P24, DOI 10.1016/S1471-4914(02)00007-2; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Webb T, 2003, J NATL CANCER I, V95, P774, DOI 10.1093/jnci/95.11.774; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Wood JM, 2000, CANCER RES, V60, P2178; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	99	2089	2253	7	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					967	974		10.1038/nature04483	http://dx.doi.org/10.1038/nature04483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355214				2022-12-28	WOS:000233934600056
J	Yue, ZC; Jiang, TX; Widelitz, RB; Chuong, CM				Yue, ZC; Jiang, TX; Widelitz, RB; Chuong, CM			Mapping stem cell activities in the feather follicle	NATURE			English	Article							EVOLUTIONARY ORIGIN; EMBRYONIC INDUCTION; ADHESION MOLECULES; HAIR-FOLLICLES; MORPHOGENESIS; SKIN; EXPRESSION; GROWTH; NICHE	It is important to know how different organs 'manage' their stem cells. Both hair and feather follicles show robust regenerative powers that episodically renew the epithelial organ. However, the evolution of feathers ( from reptiles to birds) and hairs ( from reptiles to mammals) are independent events and their follicular structures result from convergent evolution. Because feathers do not have the anatomical equivalent of a hair follicle bulge, we are interested in determining where their stem cells are localized. By applying long-term label retention(1), transplantation(2) and DiI tracing to map stem cell activities, here we show that feather follicles contain slow-cycling long-term label-retaining cells (LRCs), transient amplifying cells and differentiating keratinocytes. Each population, located in anatomically distinct regions, undergoes dynamic homeostasis during the feather cycle. In the growing follicle, LRCs are enriched in a 'collar bulge' niche. In the moulting follicle, LRCs shift to populate a papillar ectoderm niche near the dermal papilla. On transplantation, LRCs show multipotentiality. In a three-dimensional view, LRCs are configured as a ring that is horizontally placed in radially symmetric feathers but tilted in bilaterally symmetric feathers. The changing topology of stem cell activities may contribute to the construction of complex feather forms.	Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA.	chuong@pathfinder.usc.edu	yue, zhicao/AAJ-4636-2020; Yue, ZhiCao/A-5075-2016	Yue, ZhiCao/0000-0001-5729-3842	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047364-03, R01 AR047364-01A2, R01 AR042177-08S1, R01 AR042177-09, R01 AR047364-02, R01 AR042177-08, R01 AR042177-11, R01 AR042177-10, R01 AR042177, R01 AR047364, R01 AR047364-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BronnerFraser M, 1996, METHOD CELL BIOL, V51, P61, DOI 10.1016/S0091-679X(08)60622-6; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; CHUONG CM, 1985, J CELL BIOL, V101, P1027, DOI 10.1083/jcb.101.3.1027; CHUONG CM, 1985, J CELL BIOL, V101, P1009, DOI 10.1083/jcb.101.3.1009; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P223; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dupin E, 1998, CURR TOP DEV BIOL, V36, P1; FIALA JC, 2002, MICROSC ANAL, V52, P5; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Koster MI, 2002, J INVEST DERM SYMP P, V7, P41, DOI 10.1046/j.1523-1747.2002.19639.x; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; Lillie Frank R., 1944, PHYSIOL ZOOL, V17, P1; Lucas A.M., 1972, AGR HDB, V362; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Potten CS, 2002, J CELL SCI, V115, P2381; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2001, J EXP ZOOL, V291, P30, DOI 10.1002/jez.4; TingBerreth SA, 1996, DEV DYNAM, V207, P157, DOI 10.1002/(SICI)1097-0177(199610)207:2<157::AID-AJA4>3.0.CO;2-G; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang Hsi, 1943, PHYSIOL ZOOL, V16, P325; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196	29	98	102	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1026	1029		10.1038/nature04222	http://dx.doi.org/10.1038/nature04222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355227	Green Accepted			2022-12-28	WOS:000233934600069
J	Feddema, JJ; Oleson, KW; Bonan, GB; Mearns, LO; Buja, LE; Meehl, GA; Washington, WM				Feddema, JJ; Oleson, KW; Bonan, GB; Mearns, LO; Buja, LE; Meehl, GA; Washington, WM			The importance of land-cover change in simulating future climates	SCIENCE			English	Article							GLOBAL CLIMATE; TROPICAL DEFORESTATION; UNITED-STATES; VEGETATION; SENSITIVITY; LANDSCAPE; DYNAMICS; IMPACTS	Adding the effects of changes in land cover to the A2 and B1 transient climate simulations described in the Special Report on Emissions Scenarios (SRES) by the Intergovernmental Panel on Climate Change leads to significantly different regional climates in 2100 as compared with climates resulting from atmospheric SRES forcings alone. Agricultural expansion in the A2 scenario results in significant additional warming over the Amazon and cooling of the upper air column and nearby oceans. These and other influences on the Hadley and monsoon circulations affect extratropical climates. Agricultural expansion in the mid-latitudes produces cooling and decreases in the mean daily temperature range over many areas. The A2 scenario results in more significant change, often of opposite sign, than does the B1 scenario.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Kansas, Dept Geog, Lawrence, KS 66045 USA	National Center Atmospheric Research (NCAR) - USA; University of Kansas	Feddema, JJ (corresponding author), Univ Kansas, Dept Geog, Lawrence, KS 66045 USA.	feddema@ku.edu	Feddema, Johannes/J-4400-2012; Oleson, Keith/A-9328-2008	Feddema, Johannes/0000-0002-0800-0908; Oleson, Keith/0000-0002-0057-9900				Alcamo J, 1998, GLOBAL CHANGE SCENAR; Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Betts RA, 2001, ATMOS SCI LETT, V2, P39, DOI 10.1006/asle.2001.0023; Bonan GB, 1999, ECOL APPL, V9, P1305, DOI 10.1890/1051-0761(1999)009[1305:FFTPIO]2.0.CO;2; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Chase TN, 2000, CLIM DYNAM, V16, P93, DOI 10.1007/s003820050007; Costa MH, 2000, J CLIMATE, V13, P18, DOI [10.1175/1520-0442(2000)013<0018:CEODAD>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2]; DeFries RS, 2002, GLOBAL CHANGE BIOL, V8, P438, DOI 10.1046/j.1365-2486.2002.00483.x; Feddema J, 2005, CLIM DYNAM, V25, P581, DOI 10.1007/s00382-005-0038-z; Gedney N, 2000, GEOPHYS RES LETT, V27, P3053, DOI 10.1029/2000GL011794; Hansen JE, 1998, P NATL ACAD SCI USA, V95, P12753, DOI 10.1073/pnas.95.22.12753; Hoerling MP, 2004, CLIM DYNAM, V23, P391, DOI 10.1007/s00382-004-0433-x; Houghton J, 2001, CLIMATE CHANGE 2000; Kabat P., 2002, VEGETATION WATER HUM; Karl TR, 1997, B AM METEOROL SOC, V78, P1107, DOI 10.1175/1520-0477(1997)078<1107:TCHWHL>2.0.CO;2; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; MCGUFFIE K, 1995, GLOBAL PLANET CHANGE, V10, P97, DOI 10.1016/0921-8181(94)00022-6; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; *RIJKS I VOLKSG MI, 2002, IMAGE 2 2 IMPL SRES; Schellnhuber H.J., 2004, GLOBAL CHANGE EARTH; SITCH S, 2004, GLOBAL BIOGEOCHEM CY, V19, DOI UNSP GB2013; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079	28	757	823	13	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1674	1678		10.1126/science.1118160	http://dx.doi.org/10.1126/science.1118160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339443				2022-12-28	WOS:000233961700043
J	Niemann, HB; Atreya, SK; Bauer, SJ; Carignan, GR; Demick, JE; Frost, RL; Gautier, D; Haberman, JA; Harpold, DN; Hunten, DM; Israel, G; Lunine, JI; Kasprzak, WT; Owen, TC; Paulkovich, M; Raulin, F; Raaen, E; Way, SH				Niemann, HB; Atreya, SK; Bauer, SJ; Carignan, GR; Demick, JE; Frost, RL; Gautier, D; Haberman, JA; Harpold, DN; Hunten, DM; Israel, G; Lunine, JI; Kasprzak, WT; Owen, TC; Paulkovich, M; Raulin, F; Raaen, E; Way, SH			The abundances of constituents of Titan's atmosphere from the GCMS instrument on the Huygens probe	NATURE			English	Article							HETERODYNE OBSERVATIONS; MASS-SPECTROMETER; ORIGIN; EVOLUTION; NITROGEN; METHANE; PHOTOCHEMISTRY; HYDROCARBONS; TEMPERATURES; MILLIMETER	Saturn's largest moon, Titan, remains an enigma, explored only by remote sensing from Earth, and by the Voyager and Cassini spacecraft. The most puzzling aspects include the origin of the molecular nitrogen and methane in its atmosphere, and the mechanism(s) by which methane is maintained in the face of rapid destruction by photolysis. The Huygens probe, launched from the Cassini spacecraft, has made the first direct observations of the satellite's surface and lower atmosphere. Here we report direct atmospheric measurements from the Gas Chromatograph Mass Spectrometer (GCMS), including altitude profiles of the constituents, isotopic ratios and trace species ( including organic compounds). The primary constituents were confirmed to be nitrogen and methane. Noble gases other than argon were not detected. The argon includes primordial Ar-36, and the radiogenic isotope Ar-40, providing an important constraint on the outgassing history of Titan. Trace organic species, including cyanogen and ethane, were found in surface measurements.	NASA, Greenbelt, MD 20771 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Graz Univ, Inst Meteorol & Geophys, A-8010 Graz, Austria; Observ Paris, LESIA, F-92195 Meudon, France; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85716 USA; CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Alabama Birmingham, CMC, Birmingham, AL 35205 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Paris 12, Lab Interuniv Syst Atmospher, F-94010 Creteil, France; Univ Paris 07, F-94010 Creteil, France	National Aeronautics & Space Administration (NASA); University of Michigan System; University of Michigan; University of Graz; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Arizona; Centre National de la Recherche Scientifique (CNRS); University of Alabama System; University of Alabama Birmingham; University of Hawaii System; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Niemann, HB (corresponding author), NASA, Greenbelt, MD 20771 USA.	Hasso.B.Niemann@nasa.gov	Harpold, Dan/I-3345-2013	Lunine, Jonathan/0000-0003-2279-4131; Bauer, Siegfried/0000-0003-4213-2047				ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Boetius A, 2005, SCIENCE, V307, P1420, DOI 10.1126/science.1109849; Chiodini G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019480; COUSTENIS A, 1989, ICARUS, V82, P67, DOI 10.1016/0019-1035(89)90024-9; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; DEBERGH C, 1986, ASTROPHYS J, V311, P501, DOI 10.1086/164790; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; ENGEL S, 1994, J GEOPHYS RES-PLANET, V99, P3745, DOI 10.1029/93JE03433; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Hersant F, 2004, PLANET SPACE SCI, V52, P623, DOI 10.1016/j.pss.2003.12.011; Hidayat T, 1997, ICARUS, V126, P170, DOI 10.1006/icar.1996.5640; HOLLAND H, 1984, CHEM EVOLUTION ATMOS, V39; Hunten D.M, 1984, SATURN, P671; Israel G, 2002, SPACE SCI REV, V104, P433, DOI 10.1023/A:1023640723915; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; KOUVARIS LC, 1991, ICARUS, V91, P112, DOI 10.1016/0019-1035(91)90131-C; KUNDE VG, 1981, NATURE, V292, P686, DOI 10.1038/292686a0; KURAMOTO K, 1994, J GEOPHYS RES-PLANET, V99, P21183, DOI 10.1029/94JE01864; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; Lorenz RD, 1997, SCIENCE, V275, P642, DOI 10.1126/science.275.5300.642; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; Lunine JI, 1999, PLANET SPACE SCI, V47, P1291, DOI 10.1016/S0032-0633(99)00052-5; MCKAY CP, 1988, NATURE, V332, P520, DOI 10.1038/332520a0; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Niemann HB, 1998, ADV SPACE RES, V21, P1455, DOI 10.1016/S0273-1177(98)00019-2; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; ORTON G, 1992, ESA SP, V338; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; Owen T, 2002, SPACE SCI REV, V104, P347, DOI 10.1023/A:1023684406168; OWEN T, 1982, PLANET SPACE SCI, V30, P833, DOI 10.1016/0032-0633(82)90115-5; Owen T., 1999, IAU CIRC, V7306, P3; SAGAN C, 1992, ACCOUNTS CHEM RES, V25, P286, DOI 10.1021/ar00019a003; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; STROBEL DF, 1974, ICARUS, V21, P466, DOI 10.1016/0019-1035(74)90149-3; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; Wilson EH, 2003, PLANET SPACE SCI, V51, P1017, DOI 10.1016/j.pss.2003.06.003; Wong AS, 2002, ICARUS, V155, P382, DOI 10.1006/icar.2001.6720; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	46	699	705	3	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					779	784		10.1038/nature04122	http://dx.doi.org/10.1038/nature04122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319830	Green Published			2022-12-28	WOS:000233777800038
J	Wood, J				Wood, J			Alastair Cameron (1925-2005) - Astrophysicist and planetary scientist. Obituary	NATURE			English	Biographical-Item									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Wood, J (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	jawood@alum.mit.edu						CAMERON A, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					752	752		10.1038/438752a	http://dx.doi.org/10.1038/438752a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341002	Bronze			2022-12-28	WOS:000233777800029
J	Brodie, MJ; Kwan, P				Brodie, MJ; Kwan, P			Epilepsy in elderly people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NEWLY-DIAGNOSED EPILEPSY; DOUBLE-BLIND; UNPROVOKED SEIZURES; DRUG-TREATMENT; ADULT-ONSET; CARBAMAZEPINE; OLDER; LAMOTRIGINE; POPULATION; MANAGEMENT		Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	University of Glasgow; Chinese University of Hong Kong; Prince of Wales Hospital	Brodie, MJ (corresponding author), Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland.	Martin.J.Brodie@clinmed.gla.ac.uk		Kwan, Patrick/0000-0001-7310-276X				Alsaadi TM, 2004, SEIZURE-EUR J EPILEP, V13, P58, DOI 10.1016/S1059-1311(03)00070-0; ANNEGERS JF, 1995, EPILEPSIA, V36, P327, DOI 10.1111/j.1528-1157.1995.tb01005.x; Arroyo S, 2001, DRUG SAFETY, V24, P991, DOI 10.2165/00002018-200124130-00006; Baker GA, 2001, SEIZURE-EUR J EPILEP, V10, P92, DOI 10.1053/seiz.2000.0465; Bergey GK, 2004, NEUROLOGY, V63, pS40, DOI 10.1212/WNL.63.10_suppl_4.S40; Bill PA, 1997, EPILEPSY RES, V27, P195, DOI 10.1016/S0920-1211(97)00024-7; Birnbaum A, 2003, NEUROLOGY, V60, P555, DOI 10.1212/01.WNL.0000052997.43492.E0; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; BRODIE MJ, 1995, LANCET, V345, P476, DOI 10.1016/S0140-6736(95)90581-2; Brodie MJ, 1999, EPILEPSY RES, V37, P81, DOI 10.1016/S0920-1211(99)00039-X; Brodie MJ, 2002, NEUROLOGY, V58, pS2, DOI 10.1212/WNL.58.8_suppl_5.S2; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Cleary P, 2004, LANCET, V363, P1184, DOI 10.1016/S0140-6736(04)15946-1; delaCourt A, 1996, EPILEPSIA, V37, P141; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Drezner MK, 2004, EPILEPSY BEHAV, V5, pS41, DOI 10.1016/j.yebeh.2003.11.028; Drury I, 1998, ELECTROEN CLIN NEURO, V106, P369, DOI 10.1016/S0013-4694(97)00158-2; Easterford K, 2004, NEUROLOGY, V62, P1435, DOI 10.1212/01.WNL.0000121228.32913.00; Ensrud KE, 2004, NEUROLOGY, V62, P2051, DOI 10.1212/01.WNL.0000125185.74276.D2; Faught E, 1999, DRUG AGING, V15, P255, DOI 10.2165/00002512-199915040-00002; Ferrendelli JA, 2003, EPILEPSY BEHAV, V4, P702, DOI 10.1016/j.yebeh.2003.09.007; FRANSON KL, 1995, DRUG AGING, V7, P38, DOI 10.2165/00002512-199507010-00005; Giorgi L, 2001, DRUG AGING, V18, P621, DOI 10.2165/00002512-200118080-00006; Granger AS, 2001, AGE AGEING, V30, P523, DOI 10.1093/ageing/30.6.523; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; HOPKINS A, 1988, LANCET, V1, P721; Kellinghaus C, 2004, J NEUROL, V251, P704, DOI 10.1007/s00415-004-0406-3; Kramer G, 2001, EPILEPSIA, V42, P55, DOI 10.1046/j.1528-1157.2001.042suppl.3055.x; Kutluay E, 2003, EPILEPSY BEHAV, V4, P175, DOI 10.1016/S1525-5050(03)00037-4; Kwan P, 2003, NEUROLOGY, V60, pS2, DOI 10.1212/WNL.60.11_suppl_4.S2; Kwan P, 2001, LANCET, V357, P216, DOI 10.1016/S0140-6736(00)03600-X; Lhatoo SD, 2001, ANN NEUROL, V49, P336; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; LUHDORF K, 1986, EPILEPSIA, V27, P458, DOI 10.1111/j.1528-1157.1986.tb03567.x; Marini C, 2003, J NEUROL NEUROSUR PS, V74, P192, DOI 10.1136/jnnp.74.2.192; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Marson AG, 2002, EPILEPSIA, V43, P505, DOI 10.1046/j.1528-1157.2002.20801.x; McBride AE, 2002, EPILEPSIA, V43, P165, DOI 10.1046/j.1528-1157.2002.24401.x; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; MOHANRAJ R, IN PRESS EUR J NEURO; Patsalos PN, 2002, EPILEPSIA, V43, P365, DOI 10.1046/j.1528-1157.2002.13001.x; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; Ranta A, 2004, EPILEPSIA, V45, P879, DOI 10.1111/j.0013-9580.2004.00604.x; ROBERTS RC, 1988, EPILEPSIA, V29, P190, DOI 10.1111/j.1528-1157.1988.tb04418.x; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Sato Y, 2001, NEUROLOGY, V57, P445, DOI 10.1212/WNL.57.3.445; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; Sirven JI, 2001, MAYO CLIN PROC, V76, P175; Stephen LJ, 2000, LANCET, V355, P1441, DOI 10.1016/S0140-6736(00)02149-8; Van Cott AC, 2002, EPILEPSIA, V43, P94, DOI 10.1046/j.1528-1157.43.s.3.10.x; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Wieshmann UC, 2003, J NEUROL NEUROSUR PS, V74, P466, DOI 10.1136/jnnp.74.4.466; Willmore LJ, 2000, DRUG AGING, V17, P441, DOI 10.2165/00002512-200017060-00002	55	112	116	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1317	1322		10.1136/bmj.331.7528.1317	http://dx.doi.org/10.1136/bmj.331.7528.1317			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322020	Green Published			2022-12-28	WOS:000233778500021
J	Fathalla, MF				Fathalla, MF			When home is no longer safe: intimate-partner violence	LANCET			English	Editorial Material							HEALTH; WOMEN		Univ Hosp, Dept Obstet & Gynaecol, Assiut, Egypt		Fathalla, MF (corresponding author), Univ Hosp, Dept Obstet & Gynaecol, Assiut, Egypt.	mfathall@intouch.com		Fathalla, Mahmoud/0000-0001-6955-1933				Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; COOK RJ, 2003, REPROD HLTH HUMAN RI, P385; FATHALLA MF, 1994, INT J GYNECOL OBSTET, V46, P105, DOI 10.1016/0020-7292(94)90225-9; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Krug E., 2002, WORLD REPORT VIOLENC; Moreno CG, 1999, LANCET, V354, P2075, DOI 10.1016/S0140-6736(05)76813-6; The World Bank, 1993, WORLD DEV REP 1993 I, P50; *UNIFEM, NOT MIN MOR CALL END; World Health Organization, 2005, WHO MULT STUD WOM HL; 2004, LANCET, V364, P1556	10	4	4	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1910	1911		10.1016/S0140-6736(05)67769-0	http://dx.doi.org/10.1016/S0140-6736(05)67769-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	990XY	16325684				2022-12-28	WOS:000233777900007
J	Hippisley-Cox, J; Coupland, C; Logan, R				Hippisley-Cox, J; Coupland, C; Logan, R			Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CROSS-SECTIONAL SURVEY; ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; DEPRIVATION; HEMORRHAGE; TRIAL; PREVALENCE; MORTALITY; HEALTH; NSAIDS	Objective To determine the risk of an adverse upper gastrointestinal event in patients taking different cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs. Design Nested case-control study. Setting 367 general practices contributing to the UK QRESEARCH database, spread throughout every strategic health authority and each health board in England, Wales, and Scotland. Participants Patients aged 25 or more with a first ever diagnosis of an adverse upper gastrointestinal event (peptic ulcer or haematemesis) between I August 2000 and 31 July 2004 and up to 10 controls per case matched for age, sex, calendar time, and practice. Main outcome measures Unadjusted and adjusted odds ratios for adverse upper gastrointestinal events associated with exposure to celecoxib, rofecoxib, ibuprofen, diclofenac, naproxen, other selective and non-selective non-steroidal anti-inflammatory drugs, and aspirin. Results The incidence of adverse upper gastrointestinal events was 1.36 per 1000 person years (95% confidence interval 1.34 to 1.39). We identified 9407 incident cases and 88 867 matched controls. Increased risks of adverse gastrointestinal events were associated with current use of cyclo-oxygenase-2 inhibitors and with conventional non-steroidal anti-inflammatory drugs. Risks were reduced after adjustment for confounders but remained significantly increased for naproxen (adjusted odds ratio 2.12, 95% confidence interval 1.73 to 2.58), diclofenac (1.96, 1.78 to 2.15), and rofecoxib (1.56, 1.30 to 1.87) but not for current use of celecoxib (1.11, 0.87 to 1.41). We found clinically important interactions with current use Of ulcer healing drugs that removed the increased risks for adverse gastrointestinal events for all groups of non-steroidal anti-inflammatory drugs except diclofenac, which still had an increased odds ratio (1.49, 1.26 to 1.76). Conclusion No consistent evidence was found of enhanced safety against gastrointestinal events with any of the new cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs. The use of ulcer healing drugs reduced the increased risk of adverse gastrointestinal outcomes with all groups of non-steroidal anti-inflammatory drugs, but for diclofenac the increased risk remained significant.	Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England; Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; EACHUS J, BMJ, V312, P287; Hammersley V, 2002, BRIT J GEN PRACT, V52, P463; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439; Hippisley-Cox J, 2004, HLTH INFORMATICS J, V10, P91, DOI 10.1177/1460458204042230; HIPPISLEYCOX J, 1998, BMJ, V316; HOOPER I, 2004, BRIT MED J, V329, P948; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jick H, 1997, EPIDEMIOLOGY, V8, P446, DOI 10.1097/00001648-199707000-00017; Jones R, 2002, BMJ-BRIT MED J, V325, P607, DOI 10.1136/bmj.325.7365.607; Juni P, 2002, BRIT MED J, V324, P1287, DOI 10.1136/bmj.324.7349.1287; MacDonald TM, 2003, GUT, V52, P1265, DOI 10.1136/gut.52.9.1265; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Micklewright R, 2003, ALIMENT PHARM THER, V17, P321, DOI 10.1046/j.1365-2036.2003.01454.x; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; *NAT I CLIN EXC, 2000, CLIN EFF COST EFF CE; Office for National Statistics, 1998, KEY HLTH STAT GEN PR; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; PEDERSEN TR, 1994, LANCET, V344, P1383; Pollock AM, 1998, BMJ-BRIT MED J, V317, P245, DOI 10.1136/bmj.317.7153.245; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, V1; Schlienger RG, 2002, BRIT J CLIN PHARMACO, V54, P327, DOI 10.1046/j.1365-2125.2002.01637.x; Wright JM, 2002, CAN MED ASSOC J, V167, P1131	33	176	180	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1310	1312B		10.1136/bmj.331.7528.1310	http://dx.doi.org/10.1136/bmj.331.7528.1310			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322018	Bronze, Green Published			2022-12-28	WOS:000233778500018
J	Garcia-Moreno, C; Heise, L; Jansen, HAFM; Ellsberg, M; Watts, C				Garcia-Moreno, C; Heise, L; Jansen, HAFM; Ellsberg, M; Watts, C			Public health - Violence against women	SCIENCE			English	Editorial Material									WHO, Dept Gender Women & Hlth, CH-1211 Geneva, Switzerland; PATH, Washington, DC USA; London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Garcia-Moreno, C (corresponding author), WHO, Dept Gender Women & Hlth, CH-1211 Geneva, Switzerland.	garciamorenoc@who.int	Heise, LORI/AAI-6251-2020					[Anonymous], 1995, 4 WORLD C WOM BEIJ C; [Anonymous], 1999, ENDING VIOLENCE WOME; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; FANSLOW J, 2004, J NZ MED ASS, V117, P341; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Hassan Fatma, 2004, Inj Control Saf Promot, V11, P111, DOI 10.1080/15660970412331292333; Heise L., 2002, WORLD REPORT VIOLENC; JOHNSON H, 1996, DANGEROUS DOMAINS VI; Kishor S., 2004, PROFILING DOMESTIC V; Plichta SB, 1996, AM J OBSTET GYNECOL, V174, P903, DOI 10.1016/S0002-9378(96)70323-X; Plichta SB, 2001, WOMEN HEALTH ISS, V11, P244, DOI 10.1016/S1049-3867(01)00085-8; Resnick HS, 1997, BEHAV MED, V23, P65, DOI 10.1080/08964289709596730; Tjaden P, 2000, EXTENT NATURE CONSEQ; *UN GEN ASS, 1993, ARES48104 UN GEN ASS; White House United States, 2022, FACT SHEET REAUTH VI; *WHO, 2005, MIL GLOB CAMP VIOL P; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2005, ADD VIOL WOM ACH MIL	18	370	374	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2005	310	5752					1282	1283		10.1126/science.1121400	http://dx.doi.org/10.1126/science.1121400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988KN	16311321				2022-12-28	WOS:000233600200026
J	Karp, X; Ambros, V				Karp, X; Ambros, V			Encountering microRNAs in cell fate signaling	SCIENCE			English	Editorial Material							ELEGANS VULVAL DEVELOPMENT		Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Karp, X (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	xantha.e.karp@dartmouth.edu; victor.r.ambros@dartmouth.edu	Karp, Xantha/AAU-9847-2021	Karp, Xantha/0000-0001-6602-5583				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Sternberg PW, 2005, WORMBOOK, DOI 10.1895/wormbook.1.6.1; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	10	262	277	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2005	310	5752					1288	1289		10.1126/science.1121566	http://dx.doi.org/10.1126/science.1121566			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311325				2022-12-28	WOS:000233600200030
J	Danaei, G; Vander Hoorn, S; Lopez, AD; Murray, CJL; Ezzati, M				Danaei, G; Vander Hoorn, S; Lopez, AD; Murray, CJL; Ezzati, M		Comparative Risk Assessment Collab	Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors	LANCET			English	Article							COLORECTAL-CANCER; PARTICLE VACCINE; CERVICAL-CANCER; BREAST-CANCER; YOUNG-WOMEN; MORTALITY; EFFICACY; TRENDS; PREVENTION; INFECTION	Introduction With respect to reducing mortality, advances in cancer treatment have not been as effective as those for other chronic diseases; effective screening methods are available for only a few cancers. Primary prevention through lifestyle and environmental interventions remains the main way to reduce the burden of cancers. In this report, we estimate mortality from 12 types of cancer attributable to nine risk factors in seven World Bank regions for 2001. Methods We analysed data from the Comparative Risk Assessment project and from new sources to assess exposure to risk factors and relative risk by age, sex, and region. We applied population attributable fractions for individual and multiple risk factors to site-specific cancer mortality from WHO. Findings of the 7 million deaths from cancer worldwide in 2001, an estimated 2.43 million (35%) were attributable to nine potentially modifiable risk factors. Of these, 0.76 million deaths were in high-income countries and 1.67 million in low-and-middle-income nations. Among low-and-middle-income regions, Europe and Central Asia had the highest proportion (39%) of deaths from cancer attributable to the risk factors studied. 1.6 million of the deaths attributable to these risk factors were in men and 0.83 million in women. Smoking, alcohol use, and low fruit and vegetable intake were the leading risk factors for death from cancer worldwide and in low-and-middle-income countries. In high-income countries, smoking, alcohol use, and overweight and obesity were the most important causes of cancer. Sexual transmission of human papilloma virus is a leading risk factor for cervical cancer in women in low-and-middle-income countries. interpretation Reduction of exposure to key behavioural and environmental risk factors would prevent a substantial proportion of deaths from cancer.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Auckland; University of Queensland	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu	Lopez, Alan D/F-1487-2010; Danaei, Goodarz/B-6085-2008; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; 	NIA NIH HHS [P01-AG17625] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANNIE YHJ, 2003, CANC TREAT REV, V29, P461; BULL FC, 2004, COMP QUANTIFICATION, P729; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; Concha-Barrientos M, 2004, COMP QUANTIFICATION, P1651; Dikshit RP, 2000, INT J EPIDEMIOL, V29, P609, DOI 10.1093/ije/29.4.609; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1990, EUR J CANCER, V26, P500; Early Breast Cancer Trialists' Collaborative Group, 2001, COCHRANE DB SYST REV, V1; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2004, COMP QUANTIFICATION; Ezzati M., 2004, COMP QUANTIFICATION; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Freedman DA, 2004, INT J EPIDEMIOL, V33, P43, DOI 10.1093/ije/dyg275; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Hackshaw A, 2003, ANN ONCOL, V14, P1193, DOI 10.1093/annonc/mdg321; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; HAURI AM, 2004, COMP QUANTIFICATION, P1803; Hirayama T, 1990, LIFE STYLE MORTALITY; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; James WPT, 2004, COMP QUANTIFICATION, P497; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Krzyzanowski M., 2004, COMP QUANTIFICATION, P1353; LAARA E, 1987, LANCET, V1, P1247; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; LOCK K, 2004, COMP QUANTIFICATION, P597; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Manser RL, 2004, COCHRANE DB SYST REV, V1; Mathers CD, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-36; Mezzetti M, 1998, J NATL CANCER I, V90, P389, DOI 10.1093/jnci/90.5.389; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; PRESTON SH, 2005, DEMOGRAPHY MEASURING; Rehm J, 2004, COMP QUANTIFICATION, P959; Ries LAG, SEER CANC STAT REV 1; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Slaymaker E., 2004, COMP QUANTIFICATION, P1177; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; STEWART BW, 2003, WORLD CANC REP; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	49	846	887	5	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1784	1793		10.1016/S0140-6736(05)67725-2	http://dx.doi.org/10.1016/S0140-6736(05)67725-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298215				2022-12-28	WOS:000233517200022
J	Schiffmann, R; Ries, M				Schiffmann, R; Ries, M			Fabry's disease - an important risk factor for stroke	LANCET			English	Editorial Material							ENZYME REPLACEMENT THERAPY; GALACTOSIDASE-A DEFICIENCY; CEREBRAL HYPERPERFUSION; DIALYSIS; REVERSAL		NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schiffmann, R (corresponding author), NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA.	RS4e@nih.gov	Ries, Markus/AAE-4934-2020	Ries, Markus/0000-0002-5054-5741	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altarescu G, 2001, STROKE, V32, P1559, DOI 10.1161/01.STR.32.7.1559; Altarescu G, 2005, NEUROLOGY, V64, P2148, DOI 10.1212/01.WNL.0000166000.24321.4F; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Hilz MJ, 2004, J NEUROL, V251, P564, DOI 10.1007/s00415-004-0364-9; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Linthorst GE, 2003, NEPHROL DIAL TRANSPL, V18, P1581, DOI 10.1093/ndt/gfg194; Moore DF, 2002, STROKE, V33, P525, DOI 10.1161/hs0202.102601; Moore DF, 2003, AM J NEURORADIOL, V24, P1096; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Schiffmann R, 2003, MUSCLE NERVE, V28, P703, DOI 10.1002/mus.10497; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366	17	20	23	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1754	1756		10.1016/S0140-6736(05)67636-2	http://dx.doi.org/10.1016/S0140-6736(05)67636-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298202				2022-12-28	WOS:000233517200005
J	Wallace, C; Leask, J; Trevena, LJ				Wallace, C; Leask, J; Trevena, LJ			Effects of a web based decision aid on parental attitudes to MMR vaccination: a before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZE	Objective To determine whether an evidence based decision aid on the measles, mumps, and rubella (MMR) vaccine changed parents' attitudes towards vaccination. Design Before and after study. Setting Website promoted through search engines and online parenting and health websites. Participants 158 people completing offline questions out of 1277 who accessed the website. Intervention Evidence based decision aid with text and graphical representation of the possible outcomes of measles, mumps, and rubella diseases compared with MMR vaccination. Main outcome measures Attitudes towards MMR vaccination. Results Significantly more participants indicated they were "leaning towards" vaccination after using the decision aid (39% before v 55% after, P<0.001). Compared with those who were undecided or "leaning away from" vaccination after using the decision aid, participants "leaning towards" it were more likely to strongly value its potential to protect their children from the serious side effects of disease (98% v 84%) and other children who could not be vaccinated for medical reasons (68% v 25%). Participants with an unfavourable attitude to vaccination were more likely to be very concerned about die rare side effects of vaccination (78% v 57%), have residual concerns about autism and bowel disease (78% v 27%), and anticipate guilt should their child have an adverse reaction (77% v 50%). Those with a positive attitude to vaccination after using the decision aid were also more likely to feel well informed (83% v 48%). Conclusions A web based decision aid significantly improved parental attitudes to MMR vaccination. Residual concerns about autism and bowel disease and the rare chance of serious complications remained as attitudinal barriers to some parents.	Univ Sydney, Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia; Univ Sydney, Sch Publ Hlth, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney	Leask, J (corresponding author), Univ Sydney, Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Locked Bag 4001, Westmead, NSW 2145, Australia.	JulieL3@chw.edu.au	Leask, Julie/ABE-2077-2020	Leask, Julie/0000-0001-5095-1443; Trevena, Lyndal/0000-0003-1419-1832				Davies P, 2002, ARCH DIS CHILD, V87, P22, DOI 10.1136/adc.87.1.22; Guillaume L., 2004, HEALTH INFORM J, V10, P522, DOI DOI 10.1177/1460458204040664; Hall S., 1980, CULTURE MEDIA LANGUA; McMurray R, 2004, BRIT J GEN PRACT, V54, P520; OConnor AM, 1996, J CLIN EPIDEMIOL, V49, P1271, DOI 10.1016/S0895-4356(96)00177-1; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; Payne D, 2000, BRIT MED J, V321, P197; Petts J, 2004, HEALTH RISK SOC, V6, P7, DOI 10.1080/13698570410001678284; Raithatha N, 2003, J PUBLIC HEALTH MED, V25, P161, DOI 10.1093/pubmed/fdg034; RITOV I, 1995, ORGAN BEHAV HUM DEC, V64, P119, DOI 10.1006/obhd.1995.1094; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Sporton RK, 2001, FAM PRACT, V18, P181, DOI 10.1093/fampra/18.2.181; STACEY D, 2001, MED DECIS MAKING, V21, P527; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245; Wroe AL, 2004, HEALTH PSYCHOL, V23, P33, DOI 10.1037/0278-6133.23.1.33; 2004, COMMUN DIS REP CDR W, V14	16	74	74	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					146	+		10.1136/bmj.38678.681840.68	http://dx.doi.org/10.1136/bmj.38678.681840.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16352657	Bronze, Green Published			2022-12-28	WOS:000234905800016
J	Hacker, H; Redecke, V; Blagoev, B; Kratchmarova, I; Hsu, LC; Wang, GG; Kamps, MP; Raz, E; Wagner, H; Hacker, G; Mann, M; Karin, M				Hacker, H; Redecke, V; Blagoev, B; Kratchmarova, I; Hsu, LC; Wang, GG; Kamps, MP; Raz, E; Wagner, H; Hacker, G; Mann, M; Karin, M			Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6	NATURE			English	Article							INTERFERON-ALPHA INDUCTION; KAPPA-B ACTIVATION; PATHWAY; KINASE; INTERLEUKIN-1; COMPLEX; CASCADE; CELLS; TANK; TBK1	Toll-like receptors (TLRs) are activated by pathogen-associated molecular patterns to induce innate immune responses and production of pro-inflammatory cytokines, interferons and anti-inflammatory cytokines(1). TLRs activate downstream effectors through adaptors that contain Toll/interleukin-1 receptor (TIR) domains(2), but the mechanisms accounting for diversification of TLR effector functions are unclear. To dissect biochemically TLR signalling, we established a system for isolating signalling complexes assembled by dimerized adaptors. Using MyD88 as a prototypical adaptor, we identified TNF receptor-associated factor 3 (TRAF3) as a new component of TIR signalling complexes that is recruited along with TRAF6. Using myeloid cells from TRAF3- and TRAF6-deficient mice, we show that TRAF3 is essential for the induction of type I interferons (IFN) and the anti-inflammatory cytokine interleukin-10 (IL-10), but is dispensable for expression of pro-inflammatory cytokines. In fact, TRAF3- deficient cells overproduce pro-inflammatory cytokines owing to defective IL-10 production. Despite their structural similarity, the functions of TRAF3 and TRAF6 are largely distinct. TRAF3 is also recruited to the adaptor TRIF (Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta) and is required for marshalling the protein kinase TBK1 ( also called NAK) into TIR signalling complexes, thereby explaining its unique role in activation of the IFN response.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense M, Denmark; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Southern Denmark; Technical University of Munich	Hacker, H (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	Hans.Haecker@stjude.org	Mann, Matthias/A-3454-2013; Wang, G Greg/L-6666-2014; Li, Chia Cheng/D-9906-2015; Haecker, Hans/F-6826-2013	Mann, Matthias/0000-0003-1292-4799; Wang, G Greg/0000-0002-7210-9940; Haecker, Hans/0000-0001-5971-0451; Hsu, Li-Chung/0000-0001-7206-5231; Kratchmarova, Irina/0000-0001-6613-7315; Blagoev, Blagoy/0000-0002-3596-0066				Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Knoepfler PS, 2001, ONCOGENE, V20, P5440, DOI 10.1038/sj.onc.1204710; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	25	700	761	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					204	207		10.1038/nature04369	http://dx.doi.org/10.1038/nature04369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16306937	Bronze			2022-12-28	WOS:000234538400040
J	Dupont, E; Hanganu, IL; Kilb, W; Hirsch, S; Luhmann, HJ				Dupont, E; Hanganu, IL; Kilb, W; Hirsch, S; Luhmann, HJ			Rapid developmental switch in the mechanisms driving early cortical columnar networks	NATURE			English	Article							RAT SOMATOSENSORY CORTEX; OCULAR DOMINANCE COLUMNS; SUBPLATE NEURONS; DEVELOPING NEOCORTEX; CEREBRAL-CORTEX; VISUAL-CORTEX; OSCILLATIONS; RECEPTORS; CIRCUITS; MOUSE	The immature cerebral cortex self-organizes into local neuronal clusters long before it is activated by patterned sensory inputs1. In the cortical anlage of newborn mammals, neurons coassemble through electrical or chemical synapses either spontaneously(2-4) or by activation of transmitter-gated receptors(5,6). The neuronal network and the cellular mechanisms underlying this cortical self-organization process during early development are not completely understood. Here we show in an intact in vitro preparation of the immature mouse cerebral cortex that neurons are functionally coupled in local clusters by means of propagating network oscillations in the beta frequency range. In the newborn mouse, this activity requires an intact subplate and is strongly synchronized within a cortical column by gap junctions. With the developmental disappearance of the subplate at the end of the first postnatal week(7), activation of NMDA (N-methyl-D-aspartate) receptors in the immature cortical network is essential to generate this columnar activity pattern. Our findings show that during a brief developmental period the cortical network switches from a subplate-driven, gap-junction-coupled syncytium to a synaptic network acting through NMDA receptors to generate synchronized oscillatory activity, which may function as an early functional template for the development of the cortical columnar architecture.	Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Luhmann, HJ (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Duesbergweg 6, D-55128 Mainz, Germany.	luhmann@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; Kilb, Werner/F-6675-2010	Luhmann, Heiko J./0000-0002-7934-8661; Dupont, Erwan/0000-0003-0777-9734				Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CONNORS BW, 1983, J NEUROSCI, V3, P773; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FRIAUF E, 1990, J NEUROSCI, V10, P2601; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Hanganu IL, 2004, J NEUROPHYSIOL, V92, P189, DOI 10.1152/jn.00010.2004; Hanganu IL, 2002, J NEUROSCI, V22, P7165; Hanganu IL, 2001, CEREB CORTEX, V11, P400, DOI 10.1093/cercor/11.5.400; Kandler K, 1998, J NEUROSCI, V18, P1419; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kilb W, 2003, CEREB CORTEX, V13, P409, DOI 10.1093/cercor/13.4.409; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Mechawar N, 2001, NEUROSCIENCE, V108, P555, DOI 10.1016/S0306-4522(01)00389-X; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; Peinado A, 2000, J NEUROSCI, V20; Price DJ, 1997, J COMP NEUROL, V377, P414; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	30	230	231	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					79	83		10.1038/nature04264	http://dx.doi.org/10.1038/nature04264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16327778				2022-12-28	WOS:000234378700038
J	Cymes, GD; Ni, Y; Grosman, C				Cymes, GD; Ni, Y; Grosman, C			Probing ion-channel pores one proton at a time	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR CHANNEL; SHAKER K+ CHANNEL; ELECTROSTATIC BASIS; CHARGE SELECTIVITY; TRANSITION-STATE; SODIUM-CHANNEL; M2 SEGMENT; PROTEINS; DYNAMICS; SUBUNIT	Although membrane proteins often rely on ionizable residues for structure and function, their ionization states under physiological conditions largely elude experimental estimation. To gain insight into the effect of the local microenvironment on the proton affinity of ionizable residues, we have engineered individual lysines, histidines and arginines along the alpha-helical lining of the transmembrane pore of the nicotinic acetylcholine receptor. We can detect individual proton binding - unbinding reactions electrophysiologically at the level of a single proton on a single side chain as brief blocking - unblocking events of the passing cation current. Kinetic analysis of these fluctuations yields the position-dependent rates of proton transfer, from which the corresponding pK(a) values and shifts in pK(a) can be calculated. Here we present a self-consistent, residue-by-residue description of the microenvironment around the pore-lining transmembrane alpha-helices (M2) in the open-channel conformation, in terms of the excess free energy that is required to keep the engineered basic side chains protonated relative to bulk water. A comparison with closed-channel data leads us to propose that the rotation of M2, which is frequently invoked as a hallmark of the gating mechanism of Cys-loop receptors, is minimal, if any.	Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	grosman@life.uiuc.edu		Cymes, Gisela/0000-0002-4155-585X; Grosman, Claudio/0000-0001-8093-8362	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042169] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adcock C, 1998, BIOPHYS J, V75, P1211, DOI 10.1016/S0006-3495(98)74040-8; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Corry B, 2005, BBA-BIOMEMBRANES, V1711, P72, DOI 10.1016/j.bbamem.2005.03.002; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DAVIS ME, 1990, CHEM REV, V90, P509, DOI 10.1021/cr00101a005; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grosman C, 2003, BIOCHEMISTRY-US, V42, P14977, DOI 10.1021/bi0354334; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Kim S, 2004, BIOPHYS J, V87, P792, DOI 10.1579/biophysj.103.039396; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Parzefall F, 1998, J PHYSIOL-LONDON, V512, P181, DOI 10.1111/j.1469-7793.1998.181bf.x; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Stopar D, 1996, BIOCHEMISTRY-US, V35, P15467, DOI 10.1021/bi961770j; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	43	134	136	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					975	980		10.1038/nature04293	http://dx.doi.org/10.1038/nature04293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355215	Green Accepted			2022-12-28	WOS:000233934600057
J	Loll, B; Kern, J; Saenger, W; Zouni, A; Biesiadka, J				Loll, B; Kern, J; Saenger, W; Zouni, A; Biesiadka, J			Towards complete cofactor arrangement in the 3.0 angstrom resolution structure of photosystem II	NATURE			English	Article							FTIR DIFFERENCE SPECTROSCOPY; CYTOCHROME B(6)F COMPLEX; AMINO-ACID-RESIDUES; MANGANESE CLUSTER; CRYSTAL-STRUCTURE; WATER-OXIDATION; D1 POLYPEPTIDE; MN-CLUSTER; ANGSTROM RESOLUTION; COORDINATION	Oxygenic photosynthesis in plants, algae and cyanobacteria is initiated at photosystem II, a homodimeric multisubunit protein cofactor complex embedded in the thylakoid membrane(1). Photosystem II captures sunlight and powers the unique photo-induced oxidation of water to atmospheric oxygen(1,2). Crystallographic investigations of cyanobacterial photosystem II have provided several medium-resolution structures (3.8 to 3.2 angstrom)(3-6) that explain the general arrangement of the protein matrix and cofactors, but do not give a full picture of the complex. Here we describe the most complete cyanobacterial photosystem II structure obtained so far, showing locations of and interactions between 20 protein subunits and 77 cofactors per monomer. Assignment of 11 beta-carotenes yields insights into electron and energy transfer and photoprotection mechanisms in the reaction centre and antenna subunits. The high number of 14 integrally bound lipids reflects the structural and functional importance of these molecules for flexibility within and assembly of photosystem II. A lipophilic pathway is proposed for the diffusion of secondary plastoquinone that transfers redox equivalents from photosystem II to the photosynthetic chain. The structure provides information about the Mn4Ca cluster, where oxidation of water takes place. Our study uncovers near-atomic details necessary to understand the processes that convert light to chemical energy.	Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Kristallog, Takustr 6, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; zouni@phosis1.chem.tu-berlin.de	Loll, Bernhard/J-4815-2019; Kern, Jan/G-2586-2013	Loll, Bernhard/0000-0001-7928-4488; Kern, Jan/0000-0002-7272-1603				Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Debus RJ, 2001, BBA-BIOENERGETICS, V1503, P164, DOI 10.1016/S0005-2728(00)00221-8; Diner BA, 2001, BBA-BIOENERGETICS, V1503, P147, DOI 10.1016/S0005-2728(00)00220-6; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Gombos Z, 2002, BIOCHEMISTRY-US, V41, P3796, DOI 10.1021/bi011884h; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Ke B, 2001, PHOTOSYNTHESIS PHOTO; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P7613, DOI 10.1021/bi048203d; Kimura Y, 2005, J BIOL CHEM, V280, P2078, DOI 10.1074/jbc.M410627200; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1099, P193; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Roelofs TA, 1996, P NATL ACAD SCI USA, V93, P3335, DOI 10.1073/pnas.93.8.3335; Sauer K, 2005, PHOTOSYNTH RES, V85, P73, DOI 10.1007/s11120-005-0638-9; Steffen R, 2005, BIOCHEMISTRY-US, V44, P3134, DOI 10.1021/bi048465f; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Telfer A, 2002, PHILOS T R SOC B, V357, P1431, DOI 10.1098/rstb.2002.1139; Wada H, 1998, LIPIDS PHOTOSYNTHESI, P65, DOI [10.1007/0-306-48087-5_4, DOI 10.1007/0-306-48087-5_4]; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	1550	1610	6	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1040	1044		10.1038/nature04224	http://dx.doi.org/10.1038/nature04224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355230				2022-12-28	WOS:000233934600072
J	Cane, P; Chrystie, I; Dunn, D; Evans, B; Geretti, AM; Green, H; Phillips, A; Pillay, D; Porter, K; Pozniak, A; Sabin, C; Smith, E; Weber, J; Zuckerman, M				Cane, P; Chrystie, I; Dunn, D; Evans, B; Geretti, AM; Green, H; Phillips, A; Pillay, D; Porter, K; Pozniak, A; Sabin, C; Smith, E; Weber, J; Zuckerman, M		UK Grp Transmitted HIV Drug Resist	Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIRETROVIRAL THERAPY; INDIVIDUALS; PREVALENCE; COHORT; UK; LONDON; HAART	Objective To examine whether the level of primary resistance to HIV drugs is increasing in the United Kingdom. Design Multicentre observational study. Setting All virology laboratories in the United Kingdom carrying out tests for HIV resistance as part Of routine clinical care. Participants 2357 people infected with HIV who were tested for resistance before receiving antiretroviral therapy. Main outcome measure Prevalence of drug resistance on basis of the Stanford genotypic interpretation system. Results Over the study period (February 1996 to May 2003),335 (14.2%,95% confidence interval 12.8% to 15.7%) samples had mutations that conferred resistance to one or more antiretroviral drugs (9.3% high level resistance, 5.9% medium level resistance). The prevalence of primary resistance has increased markedly over time, although patterns are specific to drug class; the largest increase was for non-nucleoside reverse transcriptase inhibitors. In 2002-3, the prevalence of resistance to any antiretroviral drug, to nucleoside or nucleotide reverse transcriptase inhibitors, to non-nucleoside reverse transcriptase inhibitors, or to protease inhibitors Was 19.2% (15.7% to 23.2%),12.4% (9.5% to 15.9%),8.1% (5.8% to 11.1%), and 6.6% (4.4% to 9.3% respectively. The risk of primary resistance was only Weakly related to most demographic and clinical factors, including ethnicity and viral subtype. Conclusions The United Kingdom has one of the highest reported rates of primary resistance to HIV drugs worldwide. Prevalence seems still to be increasing and is high in all demographic subgroups.	MRC, Clin Trials Unit, London NW1 2DA, England	Medical Research Council Clinical Trials Unit	Dunn, D (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	d.dunn@ctu.mrc.ac.uk	Phillips, Andrew N/B-4427-2008; Sabin, Caroline/C-2464-2008	Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; Dunn, David/0000-0003-1836-4446; Castro, Hannah/0000-0001-9086-8687; Geretti, Anna Maria/0000-0002-3670-6588; Porter, Kholoud/0000-0002-9226-6206	Medical Research Council [MC_U122886351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ammaranond P, 2003, AIDS, V17, P264, DOI 10.1097/00002030-200301240-00020; Bennett DE, 2003, ANTIVIR THER, V8, pS133; Beral V, 1998, AIDS, V12, P659; Blackham J, 2005, AIDS, V19, P487; Chaix M., 2003, ANTIVIR THER, V8, pS137, DOI 10.1097/01.qai.0000155201.51232.2e; De Luca A, 2004, ANTIVIR THER, V9, P743; ERON JJ, ROLE RESISTANCE TEST; Foley E, 2003, AIDS, V17, P2404, DOI 10.1097/00002030-200311070-00022; Gale CV, 2004, AIDS RES HUM RETROV, V20, P457, DOI 10.1089/088922204323087697; Geretti AM, 2001, AIDS, V15, P1082, DOI 10.1097/00002030-200105250-00028; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Johnson Victoria A, 2004, Top HIV Med, V12, P119; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Murphy G, 2004, AIDS, V18, P265, DOI 10.1097/00002030-200401230-00016; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Sabin C, 2004, HIV MED, V5, P115; Sabin CA, 2005, BMJ-BRIT MED J, V330, P695, DOI 10.1136/bmj.38369.669850.8F; Vandamme AM, 2004, ANTIVIR THER, V9, P829; VERLY S, 2001, AIDS, V15, P2287; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; 2005, COMMUN DIS REP CDR W, V15; RELEASE NOTES HIVSEQ	23	146	157	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1368	1371		10.1136/bmj.38665.534595.55	http://dx.doi.org/10.1136/bmj.38665.534595.55			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16299012	Bronze, Green Published			2022-12-28	WOS:000233999300017
J	Roche, JJW; Wenn, RT; Sahota, O; Moran, CG				Roche, JJW; Wenn, RT; Sahota, O; Moran, CG			Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGERY; NECK; FEMUR; CARE; POPULATION; PREDICTORS; MORBIDITY; TIME; AGE	Objectives To evaluate postoperative medical complications and the association between these complications and mortality at 30 days mid one year after surgery for hip fracture and to examine the association between preoperative comorbidity and the risk of postoperative complications and mortality Design Prospective observational cohort study Setting University teaching hospital. Participants 2448 consecutive patients admitted With an acute hip fracture over a four year period. We excluded 358 patients: all those aged < 60; those With periprosthetic fractures, pathological fractures, and fractures treated without surgery; and patients who died before surgery. Interventions Routine care for hip fractures. Main outcome measures Postoperative complications and mortality at 30 days and one year. Results Mortality Was 9.6% at 30 days and 33% at one year. The most common postoperative complications were chest infection (9%) and heart failure (5%). In patients Who developed postoperative heart failure mortality Was 65% at 30 days (hazard ratio 16.1, 95% confidence interval 12.2 to 21.3). Of these patients, 92% were dead by one year (11.3, 9.1 to 14.0). In patients Who developed a postoperative chest infection mortality at 30 days Was 43% (8.5, 6.6 to 11.1). Significant preoperative variables for increased mortality at 30 days included die presence of three or more comorbidities (2.5, 1.6 to 3.9), respiratory disease (1.8,1.3 to 2.5), and malignancy (1.5, 1.01 to 9.3). Conclusions In elderly people with hip fracture, the presence of three or more comorbidities is die strongest preoperative risk factor. Chest infection and heart failure are the most common postoperative complications and lead to increased mortality. These groups offer a clear target for specialist medical assessment.	Univ Nottingham Hosp, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Dept Care Elderly, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Moran, CG (corresponding author), Univ Nottingham Hosp, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England.	anne.hay@qmc.nhs.uk		Sahota, Opinder/0000-0003-0055-7637				[Anonymous], 1989, J R Coll Physicians Lond, V23, P8; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; *BRIT ORTH ASS, 2003, CAR FRAG FRACT PAT; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; *DEP HLTH, 2005, HOSP EP STAT; DIRKSEN A, 1988, BRIT MED J, V297, P1011, DOI 10.1136/bmj.297.6655.1011; DYSON A, 1988, ANAESTH INTENS CARE, V16, P405, DOI 10.1177/0310057X8801600404; EISKJAER S, 1991, CLIN ORTHOP RELAT R, P295; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; HEMPSALL VJ, 1990, J ROY COLL PHYS LOND, V24, P47; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Juelsgaard P, 1998, EUR J ANAESTH, V15, P656, DOI 10.1097/00003643-199811000-00006; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Khan R, 2002, ANN ROY COLL SURG, V84, P122; *LUND U HOSP, 1997, SAHFE STAND AUD HIP; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; Nettleman MD, 1996, J GEN INTERN MED, V11, P765, DOI 10.1007/BF02598997; PRICE JD, 2005, COCHRANE DB SYST REV; Roberts SE, 2003, BRIT MED J, V327, P771, DOI 10.1136/bmj.327.7418.771; Royal College of Physicians, 1999, OST CLIN GUID PREV T; *SCOTT INT GUID NE, 2002, PREV MAN HIP FRACT O; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904	24	849	899	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1374	1376A		10.1136/bmj.38643.663843.55	http://dx.doi.org/10.1136/bmj.38643.663843.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16299013	Bronze, Green Published			2022-12-28	WOS:000233999300019
J	Hales, TC; Abt, DL; Humphreys, ED; Roering, JJ				Hales, TC; Abt, DL; Humphreys, ED; Roering, JJ			A lithospheric instability origin for Columbia River flood basalts and Wallowa Mountains uplift in northeast Oregon	NATURE			English	Article							WAVE VELOCITY; MANTLE; PROVINCE; CASCADIA	Flood basalts appear to form during the initiation of hotspot magmatism. The Columbia River basalts (CRB) represent the largest volume of flood basalts associated with the Yellowstone hotspot, yet their source appears to be in the vicinity of the Wallowa Mountains(1), about 500 km north of the projected hotspot track. These mountains are composed of a large granitic pluton intruded into a region of oceanic lithosphere affinity(2). The elevation of the interface between Columbia River basalts and other geological formations indicates that mild pre-eruptive subsidence took place in the Wallowa Mountains, followed by syn-eruptive uplift of several hundred metres and a long-term uplift of about 2 km. The mapped surface uplift mimics regional topography, with the Wallowa Mountains in the centre of a 'bull's eye' pattern of valleys and low-elevation mountains. Here we present the seismic velocity structure of the mantle underlying this region and erosion-corrected elevation maps of lava flows, and show that an area of reduced mantle melt content coincides with the 200-km-wide topographic uplift. We conclude that convective downwelling and detachment of a compositionally dense plutonic root can explain the timing and magnitude of Columbia River basalt magmatism, as well as the surface uplift and existence of the observed melt-depleted mantle.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Hales, TC (corresponding author), Univ Oregon, Dept Geol Sci, 1272 Univ Oregon, Eugene, OR 97403 USA.	thales@uoregon.edu	Hales, TC/D-2769-2009	Hales, Tristram/0000-0002-3330-3302				ANDERSON DL, 1994, EARTH PLANET SC LETT, V123, P269, DOI 10.1016/0012-821X(94)90273-9; ANDERSON RS, 1994, J GEOPHYS RES-SOL EA, V99, P20161, DOI 10.1029/94JB00713; ARMSTRONG RL, 1977, GEOL SOC AM BULL, V88, P397, DOI 10.1130/0016-7606(1977)88<397:RAKGOM>2.0.CO;2; Camp VE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002838; CAMP VE, 1981, GEOL SOC AM BULL, V92, P669, DOI 10.1130/0016-7606(1981)92<669:GSOTCP>2.0.CO;2; Camp VE, 2003, GEOL SOC AM BULL, V115, P105, DOI 10.1130/0016-7606(2003)115<0105:GOFBAB>2.0.CO;2; CAMP VE, 1981, GEOL SOC AM BULL, V92, P659, DOI 10.1130/0016-7606(1981)92<659:GSOTCP>2.0.CO;2; Dodson A, 1997, EARTH PLANET SC LETT, V150, P443, DOI 10.1016/S0012-821X(97)00090-3; Elkins-Tanton LT, 2000, GEOPHYS RES LETT, V27, P3937, DOI 10.1029/2000GL011751; GOLES GG, 1986, J PETROL, V27, P495, DOI 10.1093/petrology/27.2.495; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Hooper P. R., 1989, GEOL SOC AM SPEC PAP, P293, DOI DOI 10.1130/SPE239-P293; HOOPER PR, 1981, GEOLOGY, V9, P323, DOI 10.1130/0091-7613(1981)9<323:DOTSPO>2.0.CO;2; HOOPER PR, 1985, WASHINGTON DIVISION; HOOPER PR, 1997, GEOPH MONOG SERIES, V100, P1; Jordan BT, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(30); LALLEMANT HG, 1994, USGS PROF PAP, V1438, P271; LAMBECK K, 1988, GEOPHYS GEODESY SLOW, pCH10; McCaffrey R, 2000, GEOPHYS RES LETT, V27, P3117, DOI 10.1029/2000GL011768; Reidel SP., 1989, GEOL SOC AM SPEC PAP, V239, P21, DOI DOI 10.1130/SPE239-P21; REIDEL SP, 1992, WASHINGTON DIVISION; Saleeby J, 2004, GEOLOGY, V32, P245, DOI 10.1130/G19958.1; Saltzer RL, 1997, J GEOPHYS RES-SOL EA, V102, P11829, DOI 10.1029/97JB00211; SCHUTT DL, IN PRESS J GEOPHYS R; Tolan TL, 1989, GEOL SOC AM SPEC PAP, V239, P1; WALKER GW, 1979, USGS MISC INVESTIG I, V1116; Wells RE, 1998, GEOLOGY, V26, P759, DOI 10.1130/0091-7613(1998)026<0759:FAMICA>2.3.CO;2	27	117	117	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					842	845		10.1038/nature04313	http://dx.doi.org/10.1038/nature04313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341011				2022-12-28	WOS:000233777800048
J	Markel, H				Markel, H			The medical detectives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA.							[Anonymous], 1890, REV REV, V2, P552; DOYLE AC, 1924, MEMORIES ADVENTURES, P82; DOYLE AC, 1890, LONDON DAILY TE 1120, P3; Koch R, 1891, Br Med J, V1, P125; KOCH R, 1890, BRIT MED J, V4, P1193	5	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2426	2428		10.1056/NEJMp048252	http://dx.doi.org/10.1056/NEJMp048252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339092				2022-12-28	WOS:000233754400003
J	Reichhardt, T				Reichhardt, T			Internet star shoots for a rocket revolution	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					736	737		10.1038/438736a	http://dx.doi.org/10.1038/438736a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16340985				2022-12-28	WOS:000233777800017
J	Sejvar, JJ; Labutta, RJ; Chapman, LE; Grabenstein, JD; Iskander, J; Lane, JM				Sejvar, JJ; Labutta, RJ; Chapman, LE; Grabenstein, JD; Iskander, J; Lane, JM			Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; VACCINIA VIRUS; BELLS-PALSY; COMPLICATIONS; IMMUNIZATION; SURVEILLANCE; ENCEPHALITIS; CHILDREN; RISK	Context Neurologic illness is an infrequent but severe adverse event associated with smallpox vaccination. The reinstatement of smallpox vaccination in the United States in response to possible bioterrorism renewed concerns about vaccine-related adverse neurologic events. Objective To determine rates and describe the clinical features of neurologic events associated with smallpox vaccination. Design and Setting We assessed reports of adverse events obtained through active case reporting and review of data reported to the Vaccine Adverse Event Reporting System among 665 000 persons vaccinated against smallpox by the Departments of Defense (n = 590 400) and Health and Human Services (n =64 600) during the 20022004 US Smallpox Vaccination Program. Main Outcome Measure Adverse neurologic events temporally associated with smallpox vaccination. Results Between December 16, 2002, and March 11, 2004, 214 neurologic adverse events temporally associated with smallpox vaccination were reported; 111 reports involved Department of Health and Human Services and 103 involved Department of Defense vaccinees. Fifty-four percent of these events occurred within 1 week of vaccination, and 53% were among primary vaccinees. The most common neurologic adverse event was headache (95 cases), followed by nonserious limb paresthesias (n = 17) or pain (n = 13) and dizziness or vertigo (n = 13). Serious neurologic adverse events included 13 cases of suspected meningitis, 3 cases of suspected encephalitis or myelitis, 11 cases of Bell palsy, 8 seizures (including 1 death), and 3 cases of Guillain-Barre syndrome. Among these 39 events, 27 (69%) occurred in primary vaccinees and all but 2 occurred within 12 days of vaccination. Conclusions During the 2002-2004 smallpox vaccination campaign, reported neurologic events were generally mild and self-limited, and no neurologic syndrome was identified at a rate above baseline estimates. Serious neurologic adverse events, such as postvaccinal encephalitis, Bell palsy, and Guillain-Barre syndrome, occurred in accordance with expected ranges.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Walter Reed Army Med Ctr, Dept Neurol, Washington, DC 20307 USA; USA Med Command, Mil Vaccine Agcy, Falls Church, VA USA; Ctr Dis Control & Prevent, Smallpox Eradicat Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Centers for Disease Control & Prevention - USA	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-39, Atlanta, GA 30333 USA.	zea3@cdc.gov	Grabenstein, John/Y-7322-2019					[Anonymous], 1989, PEDIATRICS, V84, P1110; BERGER K, 1973, S SERIES IMMUNOBIOLO, P199; BOE E, 1980, SCAND J INFECT DIS, V12, P231, DOI 10.3109/inf.1980.12.issue-3.12; BRANDENBURG NA, 1993, NEUROEPIDEMIOLOGY, V12, P313, DOI 10.1159/000110333; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; CHAPMAN LE, 2005, US SMALLPOX VACCINE; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; De Wals P, 2004, JAMA-J AM MED ASSOC, V292, P2491, DOI 10.1001/jama.292.20.2491; DEVRIES E, 1959, POSTVACCINIAL PERIVE; Fenichel GM, 1999, NEUROLOGY, V52, P1546, DOI 10.1212/WNL.52.8.1546; FENICHEL GM, 1989, PEDIATR NEUROL, V5, P287, DOI 10.1016/0887-8994(89)90019-2; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; GURVICH EB, 1975, ACTA VIROL, V19, P92; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; HERRLICH A, 1954, Munch Med Wochenschr, V96, P529; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; KHLIABICH G, 1977, ZH MIKROBIOL EPIDEMI, V10, P77; KIMFARLEY RJ, 1984, LANCET, V2, P1315; KISCH AL, 1958, NEW ENGL J MED, V258, P83, DOI 10.1056/NEJM195801092580207; KURATA T, 1977, JPN J MED SCI BIOL, V30, P137, DOI 10.7883/yoken1952.30.137; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; MARRENIKOVA SS, 1969, P S SMALLP ZAGR YUG, P65; MILLER H, 1957, BRIT MED J, V23, P668; MILLER HG, 1953, AMA ARCH NEUROL PSY, V69, P695, DOI 10.1001/archneurpsyc.1953.02320300028003; Naruse Hiroshi, 1993, Acta Paediatrica Japonica, V35, P345; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; Orovcanec K, 1974, Med Pregl, V27, P25; Plesner AM, 1998, EUR J NEUROL, V5, P479, DOI 10.1046/j.1468-1331.1998.550479.x; POLACK MF, 1973, S SERIES IMMUNOLOBIO, P235; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; RUBEN FL, 1970, ARCH OPHTHALMOL-CHIC, V84, P45, DOI 10.1001/archopht.1970.00990040047012; SEELEMANN K, 1960, DEUT MED WOCHENSCHR, V85, P1081, DOI 10.1055/s-0028-1112546; Sejvar J, 2005, HEADACHE, V45, P87, DOI 10.1111/j.1526-4610.2005.t01-5-05013.x; SHAW FE, 1988, AM J EPIDEMIOL, V127, P337, DOI 10.1093/oxfordjournals.aje.a114808; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; SPILLANE JD, 1964, BRAIN, V87, P1, DOI 10.1093/brain/87.1.1; Stratton K.R., 1994, ADVERSE EVENTS ASS C; Stuart G, 1948, Bull World Health Organ, V1, P36; THALASSI.NC, 1973, LANCET, V1, P1130; THOMPSON R., 1931, Arch. Pathol., V12, P601; Turnbull HM, 1926, BRIT J EXP PATHOL, V7, P181; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; 2003, MMWR MORB MORTAL WKL, V52, P99	49	52	56	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2744	2750		10.1001/jama.294.21.2744	http://dx.doi.org/10.1001/jama.294.21.2744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333010	Bronze			2022-12-28	WOS:000233726900023
J	Duffy, PE; Sibley, H				Duffy, PE; Sibley, H			Are we losing artemisinin combination therapy already?	LANCET			English	Editorial Material							CHLOROQUINE RESISTANCE; PLASMODIUM-FALCIPARUM; MALARIA		Seattle Biomed Res Inst, Malaria Antigen Discovery Program, Seattle, WA 98109 USA; Walter Reed Army Inst Res, Seattle, WA 98109 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Center for Infectious Disease Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle	Duffy, PE (corresponding author), Seattle Biomed Res Inst, Malaria Antigen Discovery Program, 4 Nickerson St, Seattle, WA 98109 USA.	pduffy@sbri.org						Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Durrani N, 2005, TROP MED INT HEALTH, V10, P521, DOI 10.1111/j.1365-3156.2005.01429.x; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nosten F, 1998, Med Trop (Mars), V58, P45; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Wongsrichanalai Chansuda, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P41; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; 2005, ROLL BACK MALARIA WO	13	23	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1908	1909		10.1016/S0140-6736(05)67768-9	http://dx.doi.org/10.1016/S0140-6736(05)67768-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325683				2022-12-28	WOS:000233777900006
J	Bowie, JU				Bowie, JU			Solving the membrane protein folding problem	NATURE			English	Review							TRANSMEMBRANE ALPHA-HELICES; INTERHELICAL HYDROGEN-BONDS; SIDE-CHAINS; LIPID-BILAYER; CONDUCTING CHANNEL; POLAR INTERACTIONS; 2-STAGE MODEL; PACKING; STABILITY; SEQUENCE	One of the great challenges for molecular biologists is to learn how a protein sequence defines its three-dimensional structure. For many years, the problem was even more difficult for membrane proteins because so little was known about what they looked like. The situation has improved markedly in recent years, and we now know over 90 unique structures. Our enhanced view of the structure universe, combined with an increasingly quantitative understanding of fold determination, engenders optimism that a solution to the folding problem for membrane proteins can be achieved.	Univ Calif Los Angeles, Inst Mol Biol, UCLA DOE Ctr Genom & Proteom, Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, UCLA DOE Ctr Genom & Proteom, Dept Chem & Biochem, Boyer Hall,611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu			NIGMS NIH HHS [R01 GM063919, R01 GM063919-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; AICHINGER I, 1956, ART TALE, P9; Allen SJ, 2004, J MOL BIOL, V342, P1293, DOI 10.1016/j.jmb.2004.07.041; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arbely E, 2004, J AM CHEM SOC, V126, P5362, DOI 10.1021/ja049826h; Bigelow HR, 2004, NUCLEIC ACIDS RES, V32, P2566, DOI 10.1093/nar/gkh580; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; Deupi X, 2004, BIOPHYS J, V86, P105, DOI 10.1016/S0006-3495(04)74088-6; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Fleishman SJ, 2002, J MOL BIOL, V321, P363, DOI 10.1016/S0022-2836(02)00590-9; Fleming KG, 2001, PROTEINS, V45, P313, DOI 10.1002/prot.1151; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; HUSCHILT JC, 1989, BIOCHIM BIOPHYS ACTA, V979, P139, DOI 10.1016/0005-2736(89)90534-8; Jiang SL, 2004, PROTEIN SCI, V13, P1426, DOI 10.1110/ps.03505804; Jiang SL, 2000, PROTEINS, V40, P429, DOI 10.1002/1097-0134(20000815)40:3<429::AID-PROT80>3.0.CO;2-2; Kim S, 2004, P NATL ACAD SCI USA, V101, P5988, DOI 10.1073/pnas.0308694101; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LENARD J, 1966, P NATL ACAD SCI USA, V56, P1828, DOI 10.1073/pnas.56.6.1828; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Lu H, 2000, J MOL BIOL, V299, P233, DOI 10.1006/jmbi.2000.3735; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 1996, J CHEM PHYS, V104, P9090, DOI 10.1063/1.471442; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mottamal M, 2005, BIOCHEMISTRY-US, V44, P1607, DOI 10.1021/bi048065s; Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n; O'Keeffe AH, 2000, BIOPHYS J, V79, P2066, DOI 10.1016/S0006-3495(00)76454-X; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Riek RP, 2001, J MOL BIOL, V306, P349, DOI 10.1006/jmbi.2000.4402; Rigoutsos I, 2003, NUCLEIC ACIDS RES, V31, P4625, DOI 10.1093/nar/gkg639; Sale K, 2004, PROTEIN SCI, V13, P2613, DOI 10.1110/ps.04781504; Schonbrun J, 2002, CURR OPIN STRUC BIOL, V12, P348, DOI 10.1016/S0959-440X(02)00336-6; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Tieleman DP, 1999, BIOPHYS J, V76, P40, DOI 10.1016/S0006-3495(99)77176-6; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vargas R, 2000, J AM CHEM SOC, V122, P4750, DOI 10.1021/ja993600a; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WIENER MC, 1992, BIOPHYS J, V61, P437; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yohannan S, 2004, J AM CHEM SOC, V126, P2284, DOI 10.1021/ja0317574; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	89	362	368	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					581	589		10.1038/nature04395	http://dx.doi.org/10.1038/nature04395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319877				2022-12-28	WOS:000233593100035
J	McLaughlin, S; Murray, D				McLaughlin, S; Murray, D			Plasma membrane phosphoinositide organization by protein electrostatics	NATURE			English	Review							C-KINASE SUBSTRATE; GROWTH-FACTOR RECEPTOR; PLECKSTRIN HOMOLOGY DOMAIN; CALMODULIN-BINDING DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EFFECTOR DOMAIN; PHOSPHOLIPASE-C; ACTIN DYNAMICS; MARCKS FAMILY; RICH	Phosphatidylinositol 4,5- bisphosphate ( PIP2), which comprises only about 1% of the phospholipids in the cytoplasmic leaflet of the plasma membrane, is the source of three second messengers, activates many ion channels and enzymes, is involved in both endocytosis and exocytosis, anchors proteins to the membrane through several structured domains and has other roles. How can a single lipid in a fluid bilayer regulate so many distinct physiological processes? Spatial organization might be the key to this. Recent studies suggest that membrane proteins concentrate PIP2 and, in response to local increases in intracellular calcium concentration, release it to interact with other biologically important molecules.	SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cornell University	McLaughlin, S (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	stuart.mclaughlin@stonybrook.edu						ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ellena JF, 2003, BIOPHYS J, V85, P2442, DOI 10.1016/S0006-3495(03)74667-0; Ferguson KM, 2004, BIOCHEM SOC T, V32, P742, DOI 10.1042/BST0320742; Gallagher K, 1998, BIOPHYS J, V75, P769, DOI 10.1016/S0006-3495(98)77566-6; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Hinchliffe KA, 1998, BBA-MOL CELL BIOL L, V1436, P87, DOI 10.1016/S0005-2760(98)00140-4; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; KIM JY, 1994, J BIOL CHEM, V269, P28214; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; Martikka H, 2002, HI PER STRUCT MAT, V4, P13; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Murray D, 2002, CURR TOP MEMBR, V52, P277; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; Swann K, 2004, REPRODUCTION, V127, P431, DOI 10.1530/rep.1.00169; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uyemura T, 2005, BIOPHYS J, V88, P3720, DOI 10.1529/biophysj.104.053330; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang JY, 2004, BIOPHYS J, V86, P1969, DOI 10.1016/S0006-3495(04)74260-5; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200	85	680	690	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					605	611		10.1038/nature04398	http://dx.doi.org/10.1038/nature04398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319880				2022-12-28	WOS:000233593100038
J	Yang, PM; Chen, DS				Yang, PM; Chen, DS			Caput medusae	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Taiwan Univ Hosp, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital	Yang, PM (corresponding author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.			CHEN, DING-SHINN/0000-0001-7791-6154; YANG, PEI-MING/0000-0003-3473-4611					0	4	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					E19	E19		10.1056/NEJMicm050651	http://dx.doi.org/10.1056/NEJMicm050651			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306514				2022-12-28	WOS:000233434500011
J	Thorsdottir, I				Thorsdottir, I			Supplement and stimulation for stunted children	LANCET			English	Editorial Material							NUTRITIONAL SUPPLEMENTATION; EARLY-CHILDHOOD; PSYCHOSOCIAL STIMULATION; GROWTH; COGNITION; BENEFITS		Landspitali Univ Hosp, Unit Nutr Res, IS-101 Reykjavik, Iceland; Univ Iceland, Landspitali, IS-101 Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland	Thorsdottir, I (corresponding author), Landspitali Univ Hosp, Unit Nutr Res, IS-101 Reykjavik, Iceland.	ingathor@landspitali.is	Thorsdottir, Inga/M-3260-2015	Thorsdottir, Inga/0000-0002-2946-287X				Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Pollitt E, 1997, AM J CLIN NUTR, V66, P1357, DOI 10.1093/ajcn/66.6.1357; Pollitt E, 1993, Monogr Soc Res Child Dev, V58, P1; *UN SYST STAND COM, 2004, 5 UN SYST STAND COMM; Walker SP, 1996, J NUTR, V126, P3017, DOI 10.1093/jn/126.12.3017; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227	11	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1756	1758		10.1016/S0140-6736(05)67538-1	http://dx.doi.org/10.1016/S0140-6736(05)67538-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298203				2022-12-28	WOS:000233517200006
J	Mossman, KD; Campi, G; Groves, JT; Dustin, ML				Mossman, KD; Campi, G; Groves, JT; Dustin, ML			Altered TCR signaling from geometrically repatterned immunological synapses	SCIENCE			English	Article							T-CELL-ACTIVATION; LIPID RAFTS; CYTOSKELETON; TRANSDUCTION; RECOGNITION; MEMBRANES; MOLECULES; BILAYERS; ACTIN	The immunological synapse is a specialized cell-cell junction that is defined by large-scale spatial patterns of receptors and signaling molecules yet remains largely enigmatic in terms of formation and function. We used supported bilayer membranes and nanometer-scale structures fabricated onto the underlying substrate to impose geometric constraints on immunological synapse formation. Analysis of the resulting alternatively patterned synapses revealed a causal relation between the radial position of T cell receptors (TCRs) and signaling activity, with prolonged signaling from TCR microclusters that had been mechanically trapped in the peripheral regions of the synapse. These results are consistent with a model of the synapse in which spatial translocation of TCRs represents a direct mechanism of signal regulation.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; New York University	Dustin, ML (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	JTGroves@lbl.gov; Dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064900] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64900] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Friedl P, 2004, TRENDS CELL BIOL, V14, P557, DOI 10.1016/j.tcb.2004.09.005; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jackson BL, 2004, J AM CHEM SOC, V126, P13878, DOI 10.1021/ja046040a; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; TSENG SY, IN PRESS J IMMUNOL; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	22	416	429	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1191	1193		10.1126/science.1119238	http://dx.doi.org/10.1126/science.1119238			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293763				2022-12-28	WOS:000233437300047
J	Kishore, S; Stamm, S				Kishore, S; Stamm, S			The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; PRADER-WILLI; IDENTIFICATION; PROTEIN; ORGANIZATION; SELECTION; GENE	The Prader-Willi syndrome is a congenital disease that is caused by the loss of paternal gene expression from a maternally imprinted region on chromosome 15. This region contains a small nucleolar RNA (snoRNA), HBII-52, that exhibits sequence complementarity, to the alternatively spliced exon Vb of the serotonin receptor 5-HT2CR. We found that HBII-52 regulates alternative splicing of 5-HT2CR by binding to a silencing element in exon Vb. Prader-Willi syndrome patients do not express HBII-52. They have different 5-HT2CR messenger RNA (mRNA) isoforms than healthy individuals. Our results show that a snoRNA regulates the processing of an mRNA expressed from a gene located on a different chromosome, and the results indicate that a defect in pre-mRNA processing contributes to the Prader-Willi syndrome.	Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Stamm, S (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	stefan@stamms-lab.net			NICHD NIH HHS [N01-HD-1-3138] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013138] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Dykens E, 2003, CNS DRUGS, V17, P167, DOI 10.2165/00023210-200317030-00003; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Stamm S, 1999, MOL BRAIN RES, V64, P108, DOI 10.1016/S0169-328X(98)00313-1; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Zhang L, 1996, RNA, V2, P682	16	481	507	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					230	232		10.1126/science.1118265	http://dx.doi.org/10.1126/science.1118265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16357227				2022-12-28	WOS:000234722200042
J	Dias, R; Cutts, S; Massoud, S				Dias, R; Cutts, S; Massoud, S			Frozen shoulder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADHESIVE CAPSULITIS; PERIARTHRITIS; MANIPULATION; ASSOCIATION; ANESTHESIA; PHYSIOTHERAPY; CYTOKINES; SURGERY		Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England	Royal Orthopaedic Hospital	Cutts, S (corresponding author), Royal Orthopaed Hosp, Bristol Rd S, Birmingham B31 2AP, W Midlands, England.	stevenfrcs@hotmail.com	Cutts, Steven/GVT-4673-2022					Andersen NH, 1998, J SHOULDER ELB SURG, V7, P218, DOI 10.1016/S1058-2746(98)90048-9; BINDER AI, 1984, ANN RHEUM DIS, V43, P365, DOI 10.1136/ard.43.3.365; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BOWMAN CA, 1988, BRIT J RHEUMATOL, V27, P62; Boyle-Walker K L, 1997, J Hand Ther, V10, P222; BRIDGMAN JF, 1972, ANN RHEUM DIS, V31, P69, DOI 10.1136/ard.31.1.69; BRUCKNER FE, 1981, Q J MED, V50, P191; Buchbinder R, 2004, ANN RHEUM DIS, V63, P1460, DOI 10.1136/ard.2003.018218; BUGLEN D, 1976, LANCET, V968, P1042; BUGLEN D, 1982, J RHEUMATOL, V9, P893; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Bunker TD, 2000, J BONE JOINT SURG BR, V82B, P768, DOI 10.1302/0301-620X.82B5.9888; Cameron RI, 2000, J SHOULDER ELB SURG, V9, P65, DOI 10.1016/S1058-2746(00)90011-9; Carette S, 2003, ARTHRITIS RHEUM, V48, P829, DOI 10.1002/art.10954; CHOY EHS, 1991, BRIT J RHEUMATOL, V30, P226; Codman E., 1934, TENDINITIS SHORT ROT; Dahan T. H., 2000, J RHEUMATOL, V27, P1329; de Jong BA, 1998, CLIN REHABIL, V12, P211, DOI 10.1191/026921598673772420; Diercks RL, 2004, J SHOULDER ELB SURG, V13, P499, DOI 10.1016/j.jse.2004.03.002; Dodenhoff RM, 2000, J SHOULDER ELB SURG, V9, P23, DOI 10.1016/S1058-2746(00)90005-3; Duplay, 1872, ARCH GEN MED, V20, P513; Fareed DO, 1989, CLIN ORTHOP RELAT R, V242, P177; Gam AN, 1998, SCAND J RHEUMATOL, V27, P425; Griggs SM, 2000, J BONE JOINT SURG AM, V82A, P1398, DOI 10.2106/00004623-200010000-00005; HAERI G, 1981, J RHEUMATOL, V20, P54; Haines J F, 1982, J R Coll Surg Edinb, V27, P271; Hamdan TA, 2003, INT ORTHOP, V27, P107, DOI 10.1007/s00264-002-0397-6; HANNAFIN JA, 2000, CLIN ORTHOP RELAT R, V372, P95, DOI DOI 10.1097/00003086-200003000-00012; HAZLEMAN B L, 1972, Rheumatology and Physical Medicine, V11, P413; Hutchinson JW, 1998, J BONE JOINT SURG BR, V80B, P907, DOI 10.1302/0301-620X.80B5.8464; JAYSON MIV, 1981, BMJ-BRIT MED J, V283, P1005, DOI 10.1136/bmj.283.6298.1005; LEQUESNE M, 1977, SCAND J RHEUMATOL, V6, P53; LIGHT KE, 1984, PHYS THER, V64, P330, DOI 10.1093/ptj/64.3.330; Loew M, 2005, J SHOULDER ELB SURG, V14, P16, DOI 10.1016/j.jse.2004.04.004; Lundberg B J, 1969, Acta Orthop Scand Suppl, V119, P1; Massoud SN, 2002, J SHOULDER ELB SURG, V11, P609, DOI 10.1067/mse.2002.127301; Mengiardi B, 2004, RADIOLOGY, V233, P486, DOI 10.1148/radiol.2332031219; MORENHYBBINETTE I, 1987, ACTA MED SCAND, V221, P73; Muller L P, 1998, Acta Orthop Belg, V64, P434; NEVIASER JS, 1945, J BONE JOINT SURG, V27, P211; NEVIASER RJ, 1987, CLIN ORTHOP RELAT R, P59; OGILVIEHARRIS DJ, 1995, CLIN ORTHOP RELAT R, P238; OGILVIEHARRIS DJ, 1986, J BONE JOINT SURG BR, V68, P201, DOI 10.1302/0301-620X.68B2.3958003; OZAKI J, 1989, J BONE JOINT SURG AM, V71A, P1511, DOI 10.2106/00004623-198971100-00009; PAL B, 1986, BRIT J RHEUMATOL, V25, P147; PATTEN C, 1993, ARCH OTOLARYNGOL, V119, P215; PINEDA C, 1994, AM J MED, V96, P90, DOI 10.1016/0002-9343(94)90121-X; POLLOCK RG, 1994, CLIN ORTHOP RELAT R, P30; REEVES B, 1975, SCAND J RHEUMATOL, V4, P193, DOI 10.3109/03009747509165255; RILEY D, 1989, J NEUROL NEUROSUR PS, V52, P63, DOI 10.1136/jnnp.52.1.63; RIZK TE, 1983, ARCH PHYS MED REHAB, V64, P29; RIZK TE, 1982, SEMIN ARTHRITIS RHEU, V11, P440, DOI 10.1016/0049-0172(82)90030-0; Rodeo SA, 1997, J ORTHOPAED RES, V15, P427, DOI 10.1002/jor.1100150316; SATTAR MA, 1985, DIABETES CARE, V8, P507, DOI 10.2337/diacare.8.5.507; SEIGNALET J, 1981, TISSUE ANTIGENS, V18, P364, DOI 10.1111/j.1399-0039.1981.tb01405.x; SHAFFER B, 1992, J BONE JOINT SURG AM, V74A, P738, DOI 10.2106/00004623-199274050-00013; Smith SP, 2001, J SHOULDER ELB SURG, V10, P149, DOI 10.1067/mse.2001.112883; Tuten HR, 2000, ORTHOPEDICS, V23, P693; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; WADSWORTH CT, 1986, PHYS THER, V66, P1878, DOI 10.1093/ptj/66.12.1878; Warner JJP, 1996, J BONE JOINT SURG AM, V78A, P1808, DOI 10.2106/00004623-199612000-00003; WOHLGETHAN JR, 1987, ARTHRITIS RHEUM, V30, P936, DOI 10.1002/art.1780300815; WRIGHT V, 1976, ANN RHEUM DIS, V35, P220, DOI 10.1136/ard.35.3.220	63	155	159	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1453	1456C		10.1136/bmj.331.7530.1453	http://dx.doi.org/10.1136/bmj.331.7530.1453			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356983	Green Published			2022-12-28	WOS:000234156400027
J	Hunter, A; Humphries, SE				Hunter, A; Humphries, SE			Family history of breast cancer and cost of life assurance: a test case comparison of current UK industry practice	BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, London IDEAS Genet Knowledge Pk, London WC1N 1EH, England; BHF Labs, Ctr Cardiovasc Genet, London WC1E 6JF, England	University of London; University College London; University of London; University College London	Hunter, A (corresponding author), Inst Child Hlth, London IDEAS Genet Knowledge Pk, 30 Guilford St, London WC1N 1EH, England.	a.hunter@ich.ucl.ac.uk	Humphries, Stephen E/C-5075-2008	Humphries, Stephen E/0000-0002-8221-6547				Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; *DEP HLTH ASS BRIT, 2005, CONC MOR GEN INS; *NAT I CLIN EXC, 2004, CLIN GUID CLASS CAR; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1	5	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1438	1439		10.1136/bmj.331.7530.1438	http://dx.doi.org/10.1136/bmj.331.7530.1438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356979	Green Published, Bronze			2022-12-28	WOS:000234156400020
J	Clift, PD; Blusztajn, J				Clift, PD; Blusztajn, J			Reorganization of the western Himalayan river system after five million years ago	NATURE			English	Article							EVOLUTION; PAKISTAN; CONSTRAINTS; TECTONICS; EROSION; CLIMATE; TIBET; RATES; ASIA; ND	Uplift of mountains driven by tectonic forces can influence regional climate(1,2) as well as regional drainage patterns, which in turn control the discharge of eroded sediment to the ocean(3,4). But the nature of the interactions between tectonic forces, climate and drainage evolution remains contested(5-7). Here we reconstruct the erosional discharge from the Indus river over the past 30 million years using seismic reflection data obtained from drill core samples from the Arabian Sea and neodymium isotope data. We find that the source of the Indus sediments was dominated by erosion within and north of the Indus suture zone until five million years ago; after that, the river began to receive more erosional products from Himalayan sources. We propose that this change in the erosional pattern is caused by a rerouting of the major rivers of the Punjab into the Indus, which flowed east into the Ganges river before that time. Seismic reflection profiles from the Indus fan suggest high mass accumulation rates during the Pleistocene epoch partly driven by increased drainage to the Indus river after five million years ago and partly by faster erosion linked to a stronger monsoon over the past four million years(1). Our isotope stratigraphy for the Indus fan provides strong evidence for a significant change in the geometry of western Himalayan river systems in the recent geologic past.	Univ Aberdeen, Dept Geol & Petr Geol, Aberdeen AB24 3UE, Scotland; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of Aberdeen; Woods Hole Oceanographic Institution	Clift, PD (corresponding author), Univ Aberdeen, Dept Geol & Petr Geol, Aberdeen AB24 3UE, Scotland.	p.clift@abdn.ac.uk	Clift, Peter D/A-8972-2012					An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Bouquillon A., 1990, P OCEAN DRILL PROGRA, V116, P43; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Burbank D. W., 1996, ASIAN TECTONICS, P149; Burbank D.W., 1989, GEOLOGICAL SOC AM SP, V232, P113; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Catlos EJ, 2001, J GEOPHYS RES-SOL EA, V106, P16177, DOI 10.1029/2000JB900375; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clift PD, 2002, EARTH PLANET SC LETT, V200, P91, DOI 10.1016/S0012-821X(02)00620-9; Clift PD, 2001, GEOL SOC AM BULL, V113, P1039, DOI 10.1130/0016-7606(2001)113<1039:DOTIFA>2.0.CO;2; DEBON F, 1986, J PETROL, V27, P219, DOI 10.1093/petrology/27.1.219; DEPAOLO DJ, 1976, GEOPHYS RES LETT, V3, P249, DOI 10.1029/GL003i005p00249; HARRISON TM, 1997, EARTH PLANET SC LETT, V146, P1; Hodges KV, 2000, GEOL SOC AM BULL, V112, P324, DOI 10.1130/0016-7606(2000)112<324:TOTHAS>2.0.CO;2; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; Metivier F, 1999, GEOPHYS J INT, V137, P280, DOI 10.1046/j.1365-246X.1999.00802.x; Molnar P, 2003, NATURE, V426, P612, DOI 10.1038/426612a; Najman Y, 2003, GEOL SOC AM BULL, V115, P1265, DOI 10.1130/B25165.1; PETTERSON MG, 1993, J GEOL SOC LONDON, V150, P125, DOI 10.1144/gsjgs.150.1.0125; Prell W.L., 1992, SYNTHESIS RESULTS SC, DOI [DOI 10.1029/GM070P0447, 10.1029/GM070p0447]; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; SEARLE MP, 1996, ASIAN TECTONICS, P110; SHUAIB SM, 1982, AAPG BULL, V66, P940; Walker CB, 2001, TECTONICS, V20, P810, DOI 10.1029/2000TC001249; Whittington A, 1999, GEOLOGY, V27, P585, DOI 10.1130/0091-7613(1999)027<0585:LCITWH>2.3.CO;2; Zhang PZ, 2001, NATURE, V410, P891, DOI 10.1038/35073504	27	125	134	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					1001	1003		10.1038/nature04379	http://dx.doi.org/10.1038/nature04379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355221				2022-12-28	WOS:000233934600063
J	Teasdale, S				Teasdale, S			Commentary: Trouble in paradise - learning from Hawaii	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Teasdale, S (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	sheila.teasdale@primis.nottingham.ac.uk						*NHS CONN HLTH, NAT PROGR IT NHS; Scott JT, 2005, BRIT MED J, V331, P1313, DOI 10.1136/bmj.38638.497477.68; Teasdale Sheila, 2005, Inform Prim Care, V13, P81	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2005	331	7528					1316	1316		10.1136/bmj.38651.528519.DE	http://dx.doi.org/10.1136/bmj.38651.528519.DE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322019	Green Published, Bronze			2022-12-28	WOS:000233778500020
J	Dhawan, J; Gokhale, RS; Verma, IM				Dhawan, J; Gokhale, RS; Verma, IM			Bioscience in India: Times are changing	CELL			English	Editorial Material								India has a unique opportunity to become a leader in biological sciences research. In this commentary, we address what India needs to do to achieve this goal.	Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; Natl Inst Immunol, New Delhi 110067, India; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Salk Institute	Dhawan, J (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	verma@salk.edu							0	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					743	745		10.1016/j.cell.2005.11.018	http://dx.doi.org/10.1016/j.cell.2005.11.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325565	Bronze			2022-12-28	WOS:000233814100004
J	Finger, TE; Danilova, V; Barrows, J; Bartel, DL; Vigers, AJ; Stone, L; Hellekant, G; Kinnamon, SC				Finger, TE; Danilova, V; Barrows, J; Bartel, DL; Vigers, AJ; Stone, L; Hellekant, G; Kinnamon, SC			ATP signaling is crucial for communication from taste buds to gustatory nerves	SCIENCE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; FOS-LIKE IMMUNOREACTIVITY; SUPERIOR LARYNGEAL NERVE; P2X(2) RECEPTOR SUBUNIT; SOLITARY TRACT; RAT; SEROTONIN; CELLS; LOCALIZATION; ORGANIZATION	Taste receptor cells detect chemicals in the oral cavity and transmit this information to taste nerves, but the neurotransmitter(s) have not been identified. We report that adenosine 5'-triphosphate (ATP) is the key neurotransmitter in this system. Genetic elimination of ionotropic purinergic receptors (P2X(2) and P2X(3)) eliminates taste responses in the taste nerves, although the nerves remain responsive to touch, temperature, and menthol. Similarly, P2X-knockout mice show greatly reduced behavioral responses to sweeteners, glutamate, and bitter substances. Finally, stimulation of taste buds in vitro evokes release of ATP. Thus, ATP fulfils the criteria for a neurotransmitter linking taste buds to the nervous system.,	Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Aurora, CO 80045 USA; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; Univ Minnesota, Dept Physiol, Duluth, MN 55812 USA; Univ Minnesota, Dept Pharmacol, Duluth, MN 55812 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; Colorado State University; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Kinnamon, SC (corresponding author), Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA.	sue.kinnamon@colostate.edu	Finger, Thomas/R-2974-2017	Finger, Thomas/0000-0001-5923-5099	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, R01DC000766, R01DC006070] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30 DC04657, R01 DC06070, R01 DC00766] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARRY MA, 1992, J HISTOCHEM CYTOCHEM, V40, P1919, DOI 10.1177/40.12.1453008; BARTEL DL, IN PRESS CHEM SENSES, P20601; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DICKMAN JD, 1988, BRAIN RES, V450, P25; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Harrer MI, 1996, BRAIN RES, V711, P125, DOI 10.1016/0006-8993(95)01410-1; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; IWAYAMA T, 1967, EXP CELL RES, V46, P607, DOI 10.1016/0014-4827(67)90388-6; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rong WF, 2003, J NEUROSCI, V23, P11315; Sbarbati A, 2004, J COMP NEUROL, V475, P188, DOI 10.1002/cne.20172; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; SMITH DV, 1991, J NEUROPHYSIOL, V65, P1098, DOI 10.1152/jn.1991.65.5.1098; Travers SP, 2002, AM J PHYSIOL-REG I, V282, pR1798, DOI 10.1152/ajpregu.00590.2001; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002	20	548	579	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1495	1499		10.1126/science.1118435	http://dx.doi.org/10.1126/science.1118435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322458				2022-12-28	WOS:000233756500045
J	Hunter, T; Schulman, H				Hunter, T; Schulman, H			CaMKII structure - An elegant design	CELL			English	Editorial Material							PROTEIN-KINASE-II; MOLECULAR TURNOVER; CALMODULIN; MEMORY; ALPHA	Crystal structures of protein kinases continue to reveal new mechanisms for the regulation of catalytic activity of these enzymes. In this issue of Cell, Rosenberg et al. (2005) report the structure of the catalytic and regulatory domains of CaMKII, a protein kinase important in the cellular response to changes in intracellular calcium ion concentration. This study provides new mechanistic insights into the workings of this finely tuned molecular machine.	Salk Inst Biol Studies, Mol Cell Biol Lab, La Jolla, CA 92037 USA; PPD Biomarker Discovery Sci, Menlo Pk, CA 94025 USA	Salk Institute	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu; hschulman@surromed.com						Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; ROSENBERG OS, 2005, CELL; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x	11	15	15	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					765	767		10.1016/j.cell.2005.11.017	http://dx.doi.org/10.1016/j.cell.2005.11.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325572	Bronze			2022-12-28	WOS:000233814100011
J	Frieden, TR; Das-Douglas, M; Kellerman, SE; Henning, KJ				Frieden, TR; Das-Douglas, M; Kellerman, SE; Henning, KJ			Applying public health principles to the HIV epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEXUAL-BEHAVIOR; PARTNER NOTIFICATION; COST-EFFECTIVENESS; UNITED-STATES; PREVENTION; INFECTION; PROGRAMS; AIDS; CARE		New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Frieden, TR (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.		Abrams, William R/A-5782-2008	Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P597; BAYER R, 1991, NEW ENGL J MED, V324, P1500, DOI 10.1056/NEJM199105233242111; Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Blake SM, 2003, AM J PUBLIC HEALTH, V93, P955, DOI 10.2105/AJPH.93.6.955; *CDCP, 2004, HIV AIDS SURV REP, V15; *CDCP, 2005, DIFF EFF BEH INT PRO; *CDCP, 2003, ADV HIV PREV 4 STRAT; Cohen DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1404, DOI 10.1097/01.qai.0000123271.76723.96; Golden MR, 2004, SEX TRANSM DIS, V31, P709, DOI 10.1097/01.olq.0000145847.65523.43; HOLTGRAVE DR, IN PRESS ANN REV PUB; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; LANDIS SE, 1992, NEW ENGL J MED, V326, P101, DOI 10.1056/NEJM199201093260205; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MARTIN JL, 1987, AM J PUBLIC HEALTH, V77, P578, DOI 10.2105/AJPH.77.5.578; Morin SF, 2004, JAIDS-J ACQ IMM DEF, V36, P960, DOI 10.1097/00126334-200408010-00010; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Remafedi G, 2001, AIDS PATIENT CARE ST, V15, P147, DOI 10.1089/108729101750123625; Schreibman T, 2003, CLIN INFECT DIS, V36, P1171, DOI 10.1086/374359; SHALALA D, 2000, EVIDENCE BASED FINDI; Shlay JC, 2004, SEX TRANSM DIS, V31, P154, DOI 10.1097/01.OLQ.0000114338.60980.12; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *SUBST AB MENT HLT, 2005, INJ DRUG US UPD 2002; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; 2003, MMWR MORB MORTAL WKL, V52, P329	30	112	115	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2397	2402		10.1056/NEJMsb053133	http://dx.doi.org/10.1056/NEJMsb053133			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988EO	16319391				2022-12-28	WOS:000233574600014
J	Picozzi, K; Fevre, EM; Odiit, M; Carrington, M; Eisler, MC; Maudlin, I; Welburn, SC				Picozzi, K; Fevre, EM; Odiit, M; Carrington, M; Eisler, MC; Maudlin, I; Welburn, SC			Sleeping sickness in Uganda: a thin line between two fatal diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRYPANOSOMA-BRUCEI-GAMBIENSE; RHODESIENSE; EPIDEMIC; COUNTY	Objective To determine, through the use of molecular diagnostic tools, whether the two species of parasite that cause human African trypanosomiasis have become sympatric. Design Blood sampling of all available patients between June 2001 and June 2005 in central Uganda and between July and September 2003 in northwest Uganda and analysis of subcounty sleeping sickness records in Uganda between 1985 and 2005. Setting Sleeping sickness treatment centres in central and northwest Uganda and in south Sudan. Participants Patients presenting at the treatment centres and diagnosed as having sleeping sickness. Main outcome measure Classification of parasites from patients from each disease focus as either Trypanosoma brucei rhodesiense (acute form) or T b gambiense (chronic form). Results Blood from 231 patients with sleeping sickness in central Uganda and from 91 patients with sleeping sickness in northwest Uganda and south Sudan were screened for T b rhodesiense (detection of SRA gene) and T b gambiense (detection of TgsGP gene). All samples from central Uganda were classified as T b rhodesiense, and all samples from northwest Uganda and south Sudan were identified as T b gambiense. Conclusions The two focuses of human African trypanosomiasis remain discrete, but the area of Uganda affected by the acute form of human sleeping sickness has increased 2.5-fold since 1985, spreading to three new districts within the past five years through movement of infected livestock. Without preventive action targeted at the livestock reservoir of this zoonotic disease, it is likely that the two disease focuses will converge. This will have a major impact on diagnosis and treatment of this neglected disease. Real time monitoring is recommended, using molecular diagnostic tools (at a regional surveillance centre, for example) targeted at both livestock and human patients.	Univ Edinburgh, Coll Med & Vet Med, Royal Dick Sch Vet Studies, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Minist Hlth Uganda, Kampala, Uganda; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Edinburgh; University of Cambridge	Welburn, SC (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Royal Dick Sch Vet Studies, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland.	sue.welburn@ed.ac.uk	Eisler, Mark/AAK-1119-2020; Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018	Eisler, Mark/0000-0001-6843-3345; Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086				ABARU DE, 1985, TROP MED PARASITOL, V36, P72; APTED FIC, 1980, PHARMACOL THERAPEUT, V11, P391, DOI 10.1016/0163-7258(80)90035-2; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; CATTAND P, 1994, B SOC PATHOL EXOT, V87, P307; COOK JH, 1901, J TROP MED, V4, P236; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; *GOV UG, 2005, 2002 UG POP HOUS CEN, P120; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Hutin YJF, 2004, AM J TROP MED HYG, V70, P390, DOI 10.4269/ajtmh.2004.70.390; Kioy D, 2005, LANCET, V366, P695, DOI 10.1016/S0140-6736(05)67153-X; Langlands BW, 1967, 1 MAK U COLL; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Moore A, 1999, AM J TROP MED HYG, V61, P315, DOI 10.4269/ajtmh.1999.61.315; Moore A, 2001, TROP MED INT HEALTH, V6, P342, DOI 10.1046/j.1365-3156.2001.00714.x; MORRIS K. R. S., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P384, DOI 10.1016/0035-9203(59)90039-2; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; Ochan Benjamin, 2004, BMJ, V328, P70, DOI 10.1136/bmj.328.7431.70-e; OKIRIA R, 1985, E AFR MED J, V62, P813; PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38; Picozzi K., 2002, African Journal of Biotechnology, V1, P39; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Rogers David J., 2004, P139, DOI 10.1079/9780851994758.0139; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Shaw APM, 2005, TRYPANOSOMIASES, P369, DOI 10.1079/9780851994758.0369; Solano P, 2003, Med Trop (Mars), V63, P577; Stich A, 2002, BRIT MED J, V325, P203, DOI 10.1136/bmj.325.7357.203; *UG FOR DEP, 1996, NAT BIOM STUD PHAS 3; Welburn SC, 2002, CURR OPIN INFECT DIS, V15, P477, DOI 10.1097/00001432-200210000-00004; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Wendo C, 2002, LANCET, V359, P239, DOI 10.1016/S0140-6736(02)07489-5	34	122	123	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1238	1241		10.1136/bmj.331.7527.1238	http://dx.doi.org/10.1136/bmj.331.7527.1238			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308383	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000233606800018
J	Wong, SSY; Yuen, KY				Wong, SSY; Yuen, KY			Commentary: Zoonotic potential of emerging animal diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONAVIRUS		Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.	hkumicro@hkucc.hku.hk	Yuen, Kwok Yung/C-4465-2009; Wong, Samson/C-4446-2009	Yuen, Kwok-yung/0000-0002-2083-1552				GAMBARYAN A, IN PRESS VIROLOGY; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Yi CE, 2005, J VIROL, V79, P11638, DOI 10.1128/JVI.79.18.11638-11646.2005	7	1	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1260	1260		10.1136/bmj.331.7527.1260	http://dx.doi.org/10.1136/bmj.331.7527.1260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308390	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000233606800026
J	Samejima, K; Ueda, Y; Doya, K; Kimura, M				Samejima, K; Ueda, Y; Doya, K; Kimura, M			Representation of action-specific reward values in the striatum	SCIENCE			English	Article							BASAL GANGLIA; PREFRONTAL CORTEX; DECISION-MAKING; NEURONS; PREDICTION; CEREBELLUM; DOPAMINE; SIGNALS; MONKEY; ROLES	The estimation of the reward an action will yield is critical in decision-making. To elucidate the role of the basal ganglia in this process, we recorded striatal neurons of monkeys who chose between left and right handle turns, based on the estimated reward probabilities of the actions. During a delay period before the choices, the activity of more than one-third of striatal projection neurons was selective to the values of one of the two actions. Fewer neurons were tuned to relative values or action choice. These results suggest representation of action values in the striatum, which can guide action selection in the basal ganglia circuit.	ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Kyoto Prefectural Univ Med, Dept Physiol, Kyoto 6028566, Japan; Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan	Kyoto Prefectural University of Medicine; Okinawa Institute of Science & Technology Graduate University	Samejima, K (corresponding author), Tamagawa Univ Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan.	samejima@tab.tamagawa.ac.jp; mkimura@koto.kpu-m.ac.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820				Arkadir D, 2004, J NEUROSCI, V24, P10047, DOI 10.1523/JNEUROSCI.2583-04.2004; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; HOUK J, 1995, MODELS INFORMATION P; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; LAU B, 2003, SOC NEUR ABSTR, V29; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; SAMEJIMA K, 2004, ADV NEURAL INFORMATI, V16; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Thorndike E, 1898, PSYCHOL REV SER MO S, V2, P1, DOI [DOI 10.1037/0003-066X.53.10.1125, DOI 10.1037/H0092987]; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013	26	632	640	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1337	1340		10.1126/science.1115270	http://dx.doi.org/10.1126/science.1115270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311337				2022-12-28	WOS:000233600200044
J	Spahni, R; Chappellaz, J; Stocker, TF; Loulergue, L; Hausammann, G; Kawamura, K; Fluckiger, J; Schwander, J; Raynaud, D; Masson-Delmotte, V; Jouzel, J				Spahni, R; Chappellaz, J; Stocker, TF; Loulergue, L; Hausammann, G; Kawamura, K; Fluckiger, J; Schwander, J; Raynaud, D; Masson-Delmotte, V; Jouzel, J			Atmospheric methane and nitrous oxide of the late Pleistocene from Antarctic ice cores	SCIENCE			English	Article							LAST GLACIAL PERIOD; GREENLAND CLIMATE; CH4 GRADIENT; RECORD; HOLOCENE; CO2; TEMPERATURE; CYCLES; SCALE	The European Project for Ice Coring in Antarctica Dome C ice core enables us to extend existing records of atmospheric methane (CH4) and nitrous oxide (N2O) back to 650,000 years before the present. A combined record of CH4 measured along the Dome C and the Vostok ice cores demonstrates, within the resolution of our measurements, that preindustrial concentrations over Antarctica have not exceeded 773 +/- 15 ppbv (parts per billion by volume) during the past 650,000 years. Before 420,000 years ago, when interglacials were cooler, maximum CH4 concentrations were only about 600 ppbv, similar to lower Holocene values. In contrast, the N2O record shows maximum concentrations of 278 +/- 7 ppbv, slightly higher than early Holocene values.	Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; UJF, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Ctr Etud Saclay, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, CEA CNRS 1572, F-91191 Gif Sur Yvette, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Stocker, TF (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Chappellaz, Jérôme A./A-4872-2011; raynaud, dominique/ABG-4718-2020; Masson-Delmotte, Valerie L/G-1995-2011; Kawamura, Kenji/C-7660-2011; Stocker, Thomas/B-1273-2013; Raynaud, Dominique/H-9626-2016; Fluckiger, Jacqueline/G-3457-2011	Masson-Delmotte, Valerie L/0000-0001-8296-381X; Kawamura, Kenji/0000-0003-1163-700X; 				Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; BLUNIER T, 1993, GEOPHYS RES LETT, V20, P2219, DOI 10.1029/93GL02414; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; CHAPPELLAZ JA, 1993, TELLUS B, V45, P228, DOI 10.1034/j.1600-0889.1993.t01-2-00002.x; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Fluckiger J, 1999, SCIENCE, V285, P227, DOI 10.1126/science.285.5425.227; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Fluckiger J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001417; JOUZEL J, UNPUB; KAWAMURA K, 2000, THESIS TOHOKU U TOHO; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; MASSONDELMOTE V, UNPUB; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Petit JR, 1997, NATURE, V387, P359, DOI 10.1038/387359a0; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Sarnthein M, 1990, PALEOCEANOGRAPHY, V5, P1041, DOI 10.1029/PA005i006p01041; Schwander J, 1997, J GEOPHYS RES-ATMOS, V102, P19483, DOI 10.1029/97JD01309; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sowers T, 2003, SCIENCE, V301, P945, DOI 10.1126/science.1085293; Sowers T, 2001, J GEOPHYS RES-ATMOS, V106, P31903, DOI 10.1029/2000JD900707; Spahni R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017093; Stauffer B, 2002, ANN GLACIOL-SER, V35, P202, DOI 10.3189/172756402781816861; STAUFFER B, 2003, MEM NATL I POLAR RES, V57, P139; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Valdes PJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021004	33	297	314	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1317	1321		10.1126/science.1120132	http://dx.doi.org/10.1126/science.1120132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311333				2022-12-28	WOS:000233600200038
J	Steinbrook, R				Steinbrook, R			Biomedical research and biosecurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*COMM GEN DAT BIOT, 2004, SEEK SEC PATH OP ACC; KURZWEIL R, 2005, NY TIMES        1017, pA23; National Research Council, 2004, BIOT RES AG TERR, DOI [10.17226/10827, DOI 10.17226/10827]; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; WEIN LM, 2005, NY TIMES        0530, pA15	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2212	2214		10.1056/NEJMp058278	http://dx.doi.org/10.1056/NEJMp058278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306516				2022-12-28	WOS:000233434500002
J	Menezes, AMB; Perez-Padilla, R; Jardim, JRB; Muino, A; Lopez, MV; Valdivia, G; de Oca, MM; Talamo, C; Hallal, PC; Victora, CG				Menezes, AMB; Perez-Padilla, R; Jardim, JRB; Muino, A; Lopez, MV; Valdivia, G; de Oca, MM; Talamo, C; Hallal, PC; Victora, CG		PLATINO Team	Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study	LANCET			English	Article							HIGH-ALTITUDE RESIDENTS; COPD; BURDEN; EPIDEMIOLOGY; IMPACT; SCOPE	Background Both the prevalence and mortality attributable to chronic obstructive pulmonary disease (COPD) seem to be increasing in low-income and middle-income countries, but few data are available. The aim of the PLATINO study, launched in 2002, was to describe the epidemiology of COPD in five major Latin American cities: Sao Paulo (Brazil), Santiago (Chile), Mexico City (Mexico), Montevideo (Uruguay), and Caracas (Venezuela). Methods A two-stage sampling strategy was used in the five areas to obtain probability samples of adults aged 40 years or older. These individuals were invited to answer a questionnaire and undergo anthropometry, followed by prebronchodilator and postbronchodilator spirometry. We defined COPD as a ratio less than 0.7 of postbronchodilator forced expiratory volume in the first second over forced vital capacity. Findings Complete information, including spirometry, was obtained from 963 people in Sao Paulo, 1173 in Santiago, 1000 in Mexico City, 885 in Montevideo, and 1294 in Caracas. Crude rates of COPD ranged from 7.8% (78 of 1000; 95% CI 5.9-9.7) in Mexico City to 19.7% (174 of 885; 17.2-22.2) in Montevideo. After adjustment for key risk factors, the prevalence of COPD in Mexico City remained significantly lower than that in other cities. Interpretation These results suggest that COPD is a greater health problem in Latin America than previously realised. Altitude may explain part of the difference in prevalence. Given the high rates of tobacco use in the region, increasing public awareness of the burden of COPD is important.	Univ Fed Pelotas, Fac Med, Duque Caxias,250-3 Piso, BR-96030002 Pelotas, RS, Brazil; Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; Univ Fed Sao Paulo, Sao Paulo, Brazil; Univ Republica, Montevideo, Uruguay; Pontificia Univ Catolica Chile, Santiago, Chile; Cent Univ Venezuela, Caracas, Venezuela	Universidade Federal de Pelotas; Universidade Federal de Sao Paulo (UNIFESP); Universidad de la Republica, Uruguay; Pontificia Universidad Catolica de Chile; University of Central Venezuela	Menezes, AMB (corresponding author), Univ Fed Pelotas, Fac Med, Duque Caxias,250-3 Piso, BR-96030002 Pelotas, RS, Brazil.	anamene@terra.com.br	Menezes, Ana MB/G-7266-2012; Hallal, Pedro C/A-3249-2011; Jardim, Jose R/E-3205-2016; de, Maria Montes/AAP-7687-2021; Victora, Cesar Gomes/Y-2455-2019	Menezes, Ana MB/0000-0002-2996-9427; Hallal, Pedro C/0000-0003-1470-6461; Victora, Cesar Gomes/0000-0002-2465-2180; Valdivia, Gonzalo/0000-0001-5368-6745				Ahmad OB, AGE STANDARDIZATION; *BC CANC RES CTR, 2004, LUNG HLTH STUD QUEST; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; *GLOB IN CHRON OBS, 2005, GUENT GOLD DOC RES; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Havryk AP, 2002, RESP PHYSIOL NEUROBI, V132, P223, DOI 10.1016/S1569-9048(02)00072-1; Hurd S, 2000, CHEST, V117, P1; *I NAC EST, 2004, GEOGR INF ENC NAC AD; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Keller S.D., 1995, SCORE SF12 PHYS MENT, VSecond; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Menezes Ana, 2004, COPD, V1, P173; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; *MIN SAUD, INF SAUD MORT; Pauwels R, 2000, CHEST, V117, p332S, DOI 10.1378/chest.117.5_suppl_2.332S; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Perez-Padilla R, 2003, PEDIATR PULM, V35, P177, DOI 10.1002/ppul.10232; Petty TL, 2000, CHEST, V117, p326S, DOI 10.1378/chest.117.5_suppl_2.326S; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Tzanakis N, 2004, CHEST, V125, P892, DOI 10.1378/chest.125.3.892; *WHO, TOB ATL; Wood S, 2003, HIGH ALT MED BIOL, V4, P445, DOI 10.1089/152702903322616191; World Bank Group, WORLD DEV IND	27	612	681	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1875	1881		10.1016/S0140-6736(05)67632-5	http://dx.doi.org/10.1016/S0140-6736(05)67632-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310554				2022-12-28	WOS:000233643200026
J	Moore, D; Montaner, J				Moore, D; Montaner, J			Total lymphocyte counts and ART in resource-limited settings	LANCET			English	Editorial Material							CD4 CELL COUNT; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; PREDICTOR; WORLD; WILL		British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; US Ctr Dis Control & Prevent, Global AIDS Program, Entebbe, Uganda	B.C. Centre for Excellence in HIV/AIDS	Montaner, J (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					Akinola NO, 2004, CLIN INFECT DIS, V39, P579, DOI 10.1086/422722; Badri M, 2003, AIDS, V17, P541, DOI 10.1097/00002030-200303070-00009; Bedell R, 2003, ANTIVIR THER, V8, P379; Dunn DT, 2005, LANCET, V366, P1868, DOI 10.1016/S0140-6736(05)67757-4; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jacobson MA, 2003, AIDS, V17, P917, DOI 10.1097/00002030-200304110-00019; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; KOTYLO PK, 1993, AM J CLIN PATHOL, V100, P111, DOI 10.1093/ajcp/100.2.111; Kumarasamy N, 2004, LANCET, V364, P3, DOI 10.1016/S0140-6736(04)16605-1; Kumarasamy N, 2002, JAIDS-J ACQ IMM DEF, V31, P378, DOI 10.1097/00126334-200212010-00002; Liotta G, 2004, AIDS, V18, P1082, DOI 10.1097/00002030-200404300-00023; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MARTINSON N, 2005, 3 INT AIDS SOC C HIV; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; SCHECHTER M, 1994, J ACQ IMMUN DEF SYND, V7, P163; Spacek LA, 2003, AIDS, V17, P1311, DOI 10.1097/00002030-200306130-00005	16	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1831	1832		10.1016/S0140-6736(05)67736-7	http://dx.doi.org/10.1016/S0140-6736(05)67736-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310537				2022-12-28	WOS:000233643200005
J	Kraft, S				Kraft, S			Fourth floor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												skraft@optonline.net							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2821	2822		10.1001/jama.294.22.2821	http://dx.doi.org/10.1001/jama.294.22.2821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352781				2022-12-28	WOS:000233826700001
J	Hsu, M; Bhatt, M; Adolphs, R; Tranel, D; Camerer, CF				Hsu, M; Bhatt, M; Adolphs, R; Tranel, D; Camerer, CF			Neural systems responding to degrees of uncertainty in human decision-making	SCIENCE			English	Article							EXPECTED UTILITY; SURPRISED FACES; AMYGDALA; AMBIGUITY; BRAIN; RESPONSES; FEAR	Much is known about how people make decisions under varying levels of probability (risk). Less is known about the neural basis of decision-making when probabilities are uncertain because of missing information (ambiguity). In decision theory, ambiguity about probabilities should not affect choices. Using functional brain imaging, we show that the level of ambiguity in choices correlates positively with activation in the amygdala and orbitofrontal cortex, and negatively with a striatal system. Moreover, striatal activity correlates positively with expected reward. Neurological subjects with orbitofrontal lesions were insensitive to the level of ambiguity and risk in behavioral choices. These data suggest a general neural circuit responding to degrees of uncertainty, contrary to decision theory.	CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Iowa, Sch Med, Iowa City, IA 52242 USA	California Institute of Technology; University of Iowa	Camerer, CF (corresponding author), CALTECH, Div Humanities & Social Sci, 228-77, Pasadena, CA 91125 USA.	camerer@hss.caltech.edu		Tranel, Daniel/0000-0002-1338-1389	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH067681] Funding Source: Medline; NINDS NIH HHS [P01 NS19632] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; AMARAL D G, 1992, P1; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; BECKER SW, 1964, J POLIT ECON, V72, P62, DOI 10.1086/258854; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; FOX CR, 1995, Q J ECON, V110, P585, DOI 10.2307/2946693; Frisch D., 1988, J BEHAVIORAL DECISIO, V1, P149, DOI [DOI 10.1002/BDM.3960010303, 10.1002/bdm.3960010303]; GAFFAN D, 1993, EUR J NEUROSCI, V5, P968, DOI 10.1111/j.1460-9568.1993.tb00948.x; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kuhberger A, 2003, J BEHAV DECIS MAKING, V16, P181, DOI 10.1002/bdm.441; MACCRIMMON KR, 1968, RISK UNCERTAINTY; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; SCHMEIDLER D, 1989, ECONOMETRICA, V57, P571, DOI 10.2307/1911053; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	27	844	860	5	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1680	1683		10.1126/science.1115327	http://dx.doi.org/10.1126/science.1115327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339445				2022-12-28	WOS:000233961700045
J	Pielke, RA				Pielke, RA			Land use and climate change	SCIENCE			English	Editorial Material							COVER CHANGE; IMPACTS		Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	Colorado State University	Pielke, RA (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	pielke@atmos.colostate.edu	Pielke, Roger A/A-5015-2009					[Anonymous], 1995, GLOBAL DISTRIBUTION; *AUSTR CONS FDN, AUSTR LAND CLEAR GLO; Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Chase TN, 2000, CLIM DYNAM, V16, P93, DOI 10.1007/s003820050007; Chung CE, 2003, J CLIMATE, V16, P1791, DOI 10.1175/1520-0442(2003)016<1791:SAHFRI>2.0.CO;2; *COMM RAD FORC EFF, 2005, RAD FORC CLIM CHANG; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Houghton J. T., 2001, CLIMATE CHANGE 2001; *IPCC WORK GROUP I, SUMM POL SCI CLIM CH; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Marshall CH, 2004, MON WEATHER REV, V132, P28, DOI 10.1175/1520-0493(2004)132<0028:TIOALC>2.0.CO;2; Matsui T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019287; *NASA NEWS FEAT, TROP DEF AFF RAINF U; Pielke RA, 2001, REV GEOPHYS, V39, P151, DOI 10.1029/1999RG000072; Riehl H., 1979, Contributions to Atmospheric Physics, V52, P287; Riehl H, 1958, GEOPHYSICA, V6, P503, DOI DOI 10.1016/0011-7471(64)90337-7; Wu ZX, 1998, CLIM DYNAM, V14, P275, DOI 10.1007/s003820050223; Zhao M, 2001, CLIM DYNAM, V17, P467, DOI 10.1007/PL00013740	20	424	452	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1625	1626		10.1126/science.1120529	http://dx.doi.org/10.1126/science.1120529			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339435				2022-12-28	WOS:000233961700030
J	Elinder, LS				Elinder, LS			Obesity, hunger, and agriculture: the damaging role of subsidies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEIGHT-GAIN		Swedish Natl Inst Publ Hlth, S-10352 Stockholm, Sweden		Elinder, LS (corresponding author), Swedish Natl Inst Publ Hlth, S-10352 Stockholm, Sweden.	liselotte.elinder@fhi.se	Elinder, Liselotte S/J-4677-2012; Elinder, Liselotte Schäfer/R-4500-2019	Elinder, Liselotte S/0000-0001-7270-1162; Elinder, Liselotte Schäfer/0000-0001-7270-1162				Chopra M, 2004, BMJ-BRIT MED J, V328, P1558, DOI 10.1136/bmj.328.7455.1558; Elinder L. S., 2003, Eurochoices, V2, P32, DOI 10.1111/j.1746-692X.2003.tb00050.x; *EUR COMM, 2004, 35 EUR COMM; FAO, 2002, WORLD AGR 2015 2030; Irz X., 2001, Development Policy Review, V19, P449, DOI 10.1111/1467-7679.00144; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Mulvihill C., 2003, MANAGEMENT OBESITY O; *ORG EC COOP DEV, 2004, AGR POL 2004 GLANC; Org. for Econ. Co-Operation and Dev, 2004, AN 2003 CAP REF; *OXF, 2002, MILK CAP EUR DAIR RE; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Putnam J., 2002, FoodReview, V25, P2; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; *UN FAO, 2004, WORLD FOOD SUMM 5 YE; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2003, DIET NUTR PREV CHRON, V916; World Health Organization, 2004, GLOB STRAT DIET PHYS	22	53	53	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1333	1336		10.1136/bmj.331.7528.1333	http://dx.doi.org/10.1136/bmj.331.7528.1333			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322026	Green Published			2022-12-28	WOS:000233778500030
J	Alberts, B				Alberts, B			A wakeup call for science faculty	CELL			English	Editorial Material								By changing the way we teach the introductory science courses in our colleges and universities, we can attract many more talented students to science careers. At the same time, we will be fostering positive public attitudes about science that are critical for a successful modern society.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Alberts, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	balberts@ucsf.edu						Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Amaral O.M., 2002, BILINGUAL RES J, V29, P213, DOI [DOI 10.1080/15235882.2002.10668709, 10.1080/15235882.2002.10668709]; Bronowski J., 1956, SCI HUMAN VALUES, DOI DOI 10.1111/J.1468-2273.1956.TB00909.X; DeHaan R. L., 2005, J SCI EDUC TECHNOL, V14, P253, DOI DOI 10.1007/S10956-005-4425-3; GLASS B, 1970, TIMELY TIMELESS; Gollub J. P., 2002, LEARN UND IMPR ADV S; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Moore J. A., 1993, SCI WAY KNOWING; *NAT RES COUNC, 1999, TRANSF UND ED SCI; *NAT RES COUNC, 1998, EV CHILD SCI; National Research Council, 2000, INQ NAT SCI ED STAND; National Research Council (NRC), 1996, NAT SCI ED STAND; SEYMOUR E, 1997, TALKING LEAVING UNDE; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934	14	37	38	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					739	741		10.1016/j.cell.2005.11.014	http://dx.doi.org/10.1016/j.cell.2005.11.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325564	Bronze			2022-12-28	WOS:000233814100003
J	Beaulieu, JM; Caron, MG				Beaulieu, JM; Caron, MG			beta-arrestin goes nuclear	CELL			English	Editorial Material							EXPORT SIGNAL; RECEPTOR; PROTEIN; INTERNALIZATION; BETA-ARRESTIN-2	Arrestins have important roles in the cytoplasm and at the plasma membrane, including the desensitization and internalization of G protein-coupled receptors (GPCRs). In this issue of Cell, Kang et al. (2005) provide evidence that beta-arrestin 1 moves to the nucleus in response to GPCR stimulation, where it regulates gene expression by facilitating histone acetylation at specific gene promoters.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Beaulieu, JM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Beaulieu, Jean-Martin/A-7598-2008	Beaulieu, Jean-Martin/0000-0002-0446-7447				Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; KANG J, 2005, CELL; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193	12	32	33	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					755	757		10.1016/j.cell.2005.11.010	http://dx.doi.org/10.1016/j.cell.2005.11.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325568	Bronze			2022-12-28	WOS:000233814100007
J	Hammond, WC				Hammond, WC			The ghost of an earthquake	SCIENCE			English	Editorial Material							LOWER CRUST; DEFORMATION; RATES; FLOW		Univ Nevada, Nevada Bur Mines & Geol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Hammond, WC (corresponding author), Univ Nevada, Nevada Bur Mines & Geol, Reno, NV 89557 USA.	whammond@unr.edu						Bell JW, 2004, B SEISMOL SOC AM, V94, P1229, DOI 10.1785/012003226; Bennett RA, 2004, GEOLOGY, V32, P961, DOI 10.1130/G20806.1; BILLS BG, 1987, J GEOPHYS RES, V92, P11; BLOCK L, 1990, TECTONICS, V9, P557, DOI 10.1029/TC009i004p00557; Cathles L.M., 1975, VISCOSITY EARTHS MAN, P390; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; Friedrich AM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000682; Gourmelen N, 2005, SCIENCE, V310, P1473, DOI 10.1126/science.1119798; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; NAKIBOGLU SM, 1983, J GEOPHYS RES, V88, P439, DOI 10.1029/JB088iB12p10439; NUR A, 1974, SCIENCE, V183, P204, DOI 10.1126/science.183.4121.204; Pollitz FF, 1997, J GEOPHYS RES-SOL EA, V102, P17921, DOI 10.1029/97JB01277; Thatcher W, 1999, SCIENCE, V283, P1714, DOI 10.1126/science.283.5408.1714	13	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1440	1442		10.1126/science.1121349	http://dx.doi.org/10.1126/science.1121349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322443				2022-12-28	WOS:000233756500029
J	Yokobayashi, S; Watanabe, Y				Yokobayashi, S; Watanabe, Y			The kinetochore protein Moa1 enables cohesion-mediated monopolar attachment at meiosis I	CELL			English	Article							SISTER-CHROMATID COHESION; REDUCTIONAL CHROMOSOME SEGREGATION; 1ST MEIOTIC DIVISION; FISSION YEAST; CENTROMERIC COHESION; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR-BIOLOGY; DNA-REPLICATION; AXIAL ELEMENTS; REC8	Meiosis resembles mitosis but employs a unique "reductional" nuclear division to allow the production of haploid gametes from diploid cells. The crucial ploidy reduction step requires that sister kinetochores attach to microtubules emanating from the same spindle pole, achieving "monopolar attachment," which ensures that maternal and paternal chromosomes are segregated. Here we screened for factors required to establish monopolar attachment in fission yeast and identified a novel protein, Moa1. Moa1 is meiosis specific and localizes exclusively to the central core of the centromere, a region that binds meiotic Rec8-containing cohesin complexes but not mitotic Rad21/Scc1-containing complexes. Enforced cleavage of Rec8 in the central core region led to the disruption of monopolar attachment, as in moa1 Delta cells, without diminishing Moa1 localization. Moa1 physically interacts with Rec8, implying that Moa1 functions only through Rec8, presumably to facilitate central core cohesion. These results prove that monoorientation of kinetochores is established in a cohesion-mediated manner.	Univ Tokyo, Grad Sch Sci, Lab Chromosome Dynam,SORST,Japan Sci & Technol Ag, Inst Mol & Cellular Biosci,Grad Sch Biophys & Bio, Tokyo 1130032, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Lab Chromosome Dynam,SORST,Japan Sci & Technol Ag, Inst Mol & Cellular Biosci,Grad Sch Biophys & Bio, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812				Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Chua G, 2000, Nucleic Acids Res, V28, pE53, DOI 10.1093/nar/28.11.e53; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1980, GENETICS, V96, P589; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee Y, 2000, MEAS SCI TECHNOL, V11, P51, DOI 10.1088/0957-0233/11/1/308; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; MOLNAR M, 1995, GENETICS, V141, P61; NAKASEKO Y, 1984, J BACTERIOL, V157, P334, DOI 10.1128/JB.157.1.334-336.1984; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; OSTERGREN G, 1951, HEREDITAS, V37, P85; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003	48	120	126	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					803	817		10.1016/j.cell.2005.09.013	http://dx.doi.org/10.1016/j.cell.2005.09.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325576	Bronze			2022-12-28	WOS:000233814100015
J	Zambrano, MM; Kolter, R				Zambrano, MM; Kolter, R			Mycobacterial biofilms: A greasy way to hold it together	CELL			English	Editorial Material								Microorganisms growing on surfaces can form biofilms under certain conditions. In this issue of Cell, Ojha et al. (2005) investigate biofilm formation in mycobacteria. They identify new cell-wall components that are required for the formation of architecturally complex mature biofilms in these bacteria and the surprising involvement of a chaperone protein in this process.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Corpogen Inst, Dept Mol Genet, Bogota, Colombia	Harvard University; Harvard Medical School	Zambrano, MM (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	rkolter@hms.harvard.edu	Zambrano, Maria Mercedes/AAD-2805-2019	Zambrano, Maria Mercedes/0000-0002-0796-4473				Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; OHJA A, 2005, CELL; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; STERNBERG N, 1973, J MOL BIOL, V76, P1, DOI 10.1016/0022-2836(73)90078-8	10	46	49	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					762	764		10.1016/j.cell.2005.11.011	http://dx.doi.org/10.1016/j.cell.2005.11.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325571	Bronze			2022-12-28	WOS:000233814100010
J	McMahon, HT; Gallop, JL				McMahon, HT; Gallop, JL			Membrane curvature and mechanisms of dynamic cell membrane remodelling	NATURE			English	Review							CLATHRIN-MEDIATED ENDOCYTOSIS; MULTIVESICULAR BODY; LIVING CELLS; PHOSPHOINOSITIDE METABOLISM; VESICLE ENDOCYTOSIS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; BAR DOMAINS; IN-VITRO; PROTEIN	Membrane curvature is no longer seen as a passive consequence of cellular activity but an active means to create membrane domains and to organize centres for membrane trafficking. Curvature can be dynamically modulated by changes in lipid composition, the oligomerization of curvature scaffolding proteins and the reversible insertion of protein regions that act like wedges in membranes. There is an interplay between curvature- generating and curvature- sensing proteins during vesicle budding. This is seen during vesicle budding and in the formation of microenvironments. On a larger scale, membrane curvature is a prime player in growth, division and movement.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ca.uk	Wunder, Stephanie L/B-5066-2012; Zdilla, Michael J/B-4145-2011	Gallop, Jennifer Louise/0000-0002-9978-1382				ALLAN V, 1994, J CELL SCI, V107, P1885; Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bettache N, 2003, J CELL SCI, V116, P2277, DOI 10.1242/jcs.00424; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HAMMOND K, 1984, BIOCHIM BIOPHYS ACTA, V774, P19, DOI 10.1016/0005-2736(84)90269-4; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kinuta M, 2002, P NATL ACAD SCI USA, V99, P2842, DOI 10.1073/pnas.261715599; Kirchhausen T, 2005, BIOCHEM SOC SYMP, V72, P71, DOI 10.1042/bss0720071; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Lee S, 2001, J BIOL CHEM, V276, P41224, DOI 10.1074/jbc.M104705200; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mashl RJ, 1998, BIOPHYS J, V74, P2862, DOI 10.1016/S0006-3495(98)77993-7; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Nossal R, 2001, TRAFFIC, V2, P138, DOI 10.1034/j.1600-0854.2001.020208.x; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; PERRY MM, 1979, J CELL SCI, V39, P257; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PETROU S, 1995, PROSTAG LEUKOTR ESS, V52, P173, DOI 10.1016/0952-3278(95)90018-7; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Richnau N, 2004, BIOCHEM BIOPH RES CO, V320, P1034, DOI 10.1016/j.bbrc.2004.05.221; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rothman JE, 1996, SCI AM, V274, P70, DOI 10.1038/scientificamerican0396-70; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Seaman MNJ, 1996, J BIOL CHEM, V271, P25446, DOI 10.1074/jbc.271.41.25446; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VALE RD, 1988, J CELL BIOL, V107, P2233, DOI 10.1083/jcb.107.6.2233; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	91	1533	1564	12	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					590	596		10.1038/nature04396	http://dx.doi.org/10.1038/nature04396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319878				2022-12-28	WOS:000233593100036
J	Poulet, F; Bibring, JP; Mustard, JF; Gendrin, A; Mangold, N; Langevin, Y; Arvidson, RE; Gondet, B; Gomez, C				Poulet, F; Bibring, JP; Mustard, JF; Gendrin, A; Mangold, N; Langevin, Y; Arvidson, RE; Gondet, B; Gomez, C		Omega Team	Phyllosilicates on Mars and implications for early martian climate	NATURE			English	Article							REFLECTANCE SPECTROSCOPY; SURFACE; REGION; WATER; DIVERSITY; MINERALS; OLIVINE; SPECTRA; ANALOG	The recent identification of large deposits of sulphates by remote sensing and in situ observations has been considered evidence of the past presence of liquid water on Mars. Here we report the unambiguous detection of diverse phyllosilicates, a family of aqueous alteration products, on the basis of observations by the OMEGA imaging spectrometer on board the Mars Express spacecraft. These minerals are mainly associated with Noachian outcrops, which is consistent with an early active hydrological system, sustaining the long- term contact of igneous minerals with liquid water. We infer that the two main families of hydrated alteration products detected - phyllosilicates and sulphates - result from different formation processes. These occurred during two distinct climatic episodes: an early Noachian Mars, resulting in the formation of hydrated silicates, followed by a more acidic environment, in which sulphates formed.	Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; CNRS, UMR 8617, F-91405 Orsay, France; Brown Univ, Providence, RI 02912 USA; Interact & Dynam Environm Surface, F-91405 Orsay, France; Washington Univ, St Louis, MO 63130 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Brown University; Washington University (WUSTL)	Poulet, F (corresponding author), Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France.	francois.poulet@ias.fr	Fouchet, Thierry/C-6374-2017; Gomez, cecile/Q-2526-2019; Hauber, Ernst/U-2521-2018; Gomez, Cécile/B-8473-2012; Korablev, Oleg/L-5083-2013	Fouchet, Thierry/0000-0001-9040-8285; Gomez, cecile/0000-0002-2986-430X; Hauber, Ernst/0000-0002-1375-304X; Gomez, Cécile/0000-0002-2986-430X; Korablev, Oleg/0000-0003-1115-0656; Altieri, Francesca/0000-0002-6338-8300; Erard, Stephane/0000-0002-9099-8366				ALLEN PA, 1997, EARTH SURFACE PROCES; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bishop J, 2002, CLAY MINER, V37, P607, DOI 10.1180/0009855023740063; Bishop J, 2002, CLAY MINER, V37, P617, DOI 10.1180/0009855023740064; BISHOP JL, 1995, J GEOPHYS RES-PLANET, V100, P5369, DOI 10.1029/94JE03331; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P14463, DOI 10.1029/JB095iB09p14463; Dickinson WW, 2003, GEOLOGY, V31, P199, DOI 10.1130/0091-7613(2003)031<0199:APAAFW>2.0.CO;2; Edgett KS, 1997, GEOPHYS RES LETT, V24, P2897, DOI 10.1029/97GL02840; Frost RL, 2002, SPECTROCHIM ACTA A, V58, P1657, DOI 10.1016/S1386-1425(01)00637-0; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; HAMILTON VE, 2005, IN PRESS GEOLOGY; Hiesinger H, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002143; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Keeling J. L., 2004, REGOLITH 2004, P166; Kraft MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018848; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Righi D., 1995, Origin and mineralogy of clays: clays and the environment., P43; Schiffman P, 2000, GEOCHEM GEOPHY GEOSY, V1; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; Velde B., 1995, Origin and mineralogy of clays: clays and the environment., P8; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a	32	712	721	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					623	627		10.1038/nature04274	http://dx.doi.org/10.1038/nature04274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319882				2022-12-28	WOS:000233593100040
J	Talkington, MWT; Siuzdak, G; Williamson, JR				Talkington, MWT; Siuzdak, G; Williamson, JR			An assembly landscape for the 30S ribosomal subunit	NATURE			English	Article							LASER-DESORPTION IONIZATION; DNAK CHAPERONE SYSTEM; ESCHERICHIA-COLI; MASS-SPECTROMETRY; BACTERIAL RIBOSOMES; PROTEIN EXPRESSION; CENTRAL DOMAIN; 16-S RNA; 30-S; RECONSTITUTION	Self- assembling macromolecular machines drive fundamental cellular processes, including transcription, messenger RNA processing, translation, DNA replication and cellular transport. The ribosome, which carries out protein synthesis, is one such machine, and the 30S subunit of the bacterial ribosome is the preeminent model system for biophysical analysis of large RNA - protein complexes. Our understanding of 30S assembly is incomplete, owing to the challenges of monitoring the association of many components simultaneously. Here we have developed a method involving pulse - chase monitored by quantitative mass spectrometry ( PC/ QMS) to follow the assembly of the 20 ribosomal proteins with 16S ribosomal RNA during formation of the functional particle. These data represent a detailed and quantitative kinetic characterization of the assembly of a large multicomponent macromolecular complex. By measuring the protein binding rates at a range of temperatures, we find that local transformations throughout the assembling subunit have similar but distinct activation energies. Thus, the prevailing view of 30S assembly as a pathway proceeding through a global rate-limiting conformational change must give way to one in which the assembly of the complex traverses a landscape dotted with various local conformational transitions.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Siuzdak, Gary/0000-0002-4749-0014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053757] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053757] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalarov SC, 2000, RNA, V6, P402, DOI 10.1017/S1355838200991945; ALIX JH, 1993, P NATL ACAD SCI USA, V90, P9725, DOI 10.1073/pnas.90.20.9725; Beavis RC, 1996, METHOD ENZYMOL, V270, P519; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HELD WA, 1974, J BIOL CHEM, V249, P3103; HELD WA, 1973, BIOCHEMISTRY-US, V12, P3273, DOI 10.1021/bi00741a020; HILLENKAMP F, 1990, METHOD ENZYMOL, V193, P280, DOI 10.1016/0076-6879(90)93420-P; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; JENNINGS KR, 1990, METHOD ENZYMOL, V193, P37, DOI 10.1016/0076-6879(90)93410-M; Maki JA, 2003, RNA, V9, P1418, DOI 10.1261/rna.5139703; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; MANGIARO.G, 1968, BIOCHEMISTRY-US, V7, P456, DOI 10.1021/bi00841a058; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Pasa-Tolic L, 1999, J AM CHEM SOC, V121, P7949, DOI 10.1021/ja991063o; PICHON J, 1975, J MOL BIOL, V96, P125, DOI 10.1016/0022-2836(75)90186-2; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; Recht MI, 2001, COLD SPRING HARB SYM, V66, P591, DOI 10.1101/sqb.2001.66.591; Rook MS, 1998, J MOL BIOL, V281, P609, DOI 10.1006/jmbi.1998.1960; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sechi S, 2003, CURR OPIN CHEM BIOL, V7, P70, DOI 10.1016/S1367-5931(02)00010-8; SERDYUK IN, 1983, J MOL BIOL, V169, P409, DOI 10.1016/S0022-2836(83)80058-8; SRIVASTAVA AK, 1990, RIBOSOME, P426; Stagg SM, 2003, J MOL BIOL, V328, P49, DOI 10.1016/S0022-2836(03)00174-8; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Thirumalai D, 1996, ACCOUNTS CHEM RES, V29, P433, DOI 10.1021/ar9500933; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	36	209	215	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					628	632		10.1038/nature04261	http://dx.doi.org/10.1038/nature04261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319883	Green Accepted			2022-12-28	WOS:000233593100041
J	Abraham, C; Cho, JH				Abraham, C; Cho, JH			Inducing intestinal growth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EPITHELIUM		Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Abraham, C (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521	3	4	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2297	2299		10.1056/NEJMcibr053367	http://dx.doi.org/10.1056/NEJMcibr053367			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306530				2022-12-28	WOS:000233434500017
J	Demedts, M; Behr, J; Buhl, R; Costabel, U; Dekhuijzen, R; Jansen, HM; MacNee, W; Thomeer, M; Wallaert, B; Laurent, F; Nicholson, AG; Verbeken, EK; Verschakelen, J; Flower, CDR; Capron, F; Petruzzelli, S; De Vuyst, P; van den Bosch, JMM; Rodriguez-Becerra, E; Corvasce, G; Lankhorst, I; Sardina, M; Montanari, M				Demedts, M; Behr, J; Buhl, R; Costabel, U; Dekhuijzen, R; Jansen, HM; MacNee, W; Thomeer, M; Wallaert, B; Laurent, F; Nicholson, AG; Verbeken, EK; Verschakelen, J; Flower, CDR; Capron, F; Petruzzelli, S; De Vuyst, P; van den Bosch, JMM; Rodriguez-Becerra, E; Corvasce, G; Lankhorst, I; Sardina, M; Montanari, M		IFIGENIA Study Grp	High-dose acetylcysteine in idiopathic pulmonary fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; N-ACETYLCYSTEINE; PROGNOSTIC-SIGNIFICANCE; INTERSTITIAL PNEUMONIA; LUNG GLUTATHIONE; DOUBLE-BLIND; WALK TEST; PREDNISONE; SURVIVAL; PATHOGENESIS	BACKGROUND Idiopathic pulmonary fibrosis is a chronic progressive disorder with a poor prognosis. METHODS We conducted a double-blind, randomized, placebo-controlled multicenter study that assessed the effectiveness over one year of a high oral dose of acetylcysteine (600 mg three times daily) added to standard therapy with prednisone plus azathioprine. The primary end points were changes between baseline and month 12 in vital capacity and in single-breath carbon monoxide diffusing capacity (DL(sub CO)). RESULTS A total of 182 patients were randomly assigned to treatment (92 to acetylcysteine and 90 to placebo). Of these patients, 155 (80 assigned to acetylcysteine and 75 to placebo) had usual interstitial pneumonia, as confirmed by high-resolution computed tomography and histologic findings reviewed by expert committees, and did not withdraw consent before the start of treatment. Fifty-seven of the 80 patients taking acetylcysteine (71 percent) and 51 of the 75 patients taking placebo (68 percent) completed one year of treatment. Acetylcysteine slowed the deterioration of vital capacity and DL(sub CO): at 12 months, the absolute differences in the change from baseline between patients taking acetylcysteine and those taking placebo were 0.18 liter (95 percent confidence interval, 0.03 to 0.32), or a relative difference of 9 percent, for vital capacity (P=0.02), and 0.75 mmol per minute per kilopascal (95 percent confidence interval, 0.27 to 1.23), or 24 percent, for DL(sub CO) (P=0.003). Mortality during the study was 9 percent among patients taking acetylcysteine and 11 percent among those taking placebo (P=0.69). There were no significant differences in the type or severity of adverse events between patients taking acetylcysteine and those taking placebo, except for a significantly lower rate of myelotoxic effects in the group taking acetylcysteine (P=0.03). CONCLUSIONS Therapy with acetylcysteine at a dose of 600 mg three times daily, added to prednisone and azathioprine, preserves vital capacity and DL(sub CO) in patients with idiopathic pulmonary fibrosis better than does standard therapy alone.	Katholieke Univ Leuven, Univ Hosp, Louvain, Belgium; Univ Munich, Klinikum Grosshadern, Med Klin 1, D-8000 Munich, Germany; Univ Mainz Klinikum, Med Klin 3, Mainz, Germany; Ruhrlandklin, Med Fac Essen, Essen, Germany; Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; Ctr Hosp Reg Univ Lille, Hop Calmette, Lille, France; Ctr Hosp Univ Bordeaux, Hop Cardiol, Bordeaux, France; Royal Brompton Hosp, London SW3 6LY, England; Evelyn Hosp, Cambridge, England; Hop Antoine Beclere, Clamart, France; Univ Pisa, Dipartimento Cardiotorac, Pisa, Italy; Univ Libre Bruxelles, Erasmus Hosp, Brussels, Belgium; St Antonius Hosp, Heart Lung Ctr Utrecht, Nieuwegein, Netherlands; Hosp Univ Virgen Rocio, Seville, Spain; Zambon Grp, Milan, Italy; Innopharma, Milan, Italy	KU Leuven; University of Munich; Johannes Gutenberg University of Mainz; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Edinburgh; Universite de Lille - ISITE; CHU Lille; CHU Bordeaux; Royal Brompton Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Pisa; Universite Libre de Bruxelles; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Virgen del Rocio University Hospital; Zambon	Demedts, M (corresponding author), Univ Hosp Gasthuisberg, Div Pneumol, Herestr 49, B-3000 Louvain, Belgium.	maurits.demedts@uz.kuleuven.ac.be	; Thomeer, Michiel/C-9544-2014	Verschakelen, Johny/0000-0001-9573-9614; Thomeer, Michiel/0000-0001-5627-0323; MacNee, William/0000-0002-3692-1448				Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], INT C HARM TECHN REQ; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Behr J, 1997, AM J RESP CRIT CARE, V156, P1897, DOI 10.1164/ajrccm.156.6.9706065; Behr J, 2002, EUR RESPIR J, V19, P906, DOI 10.1183/09031936.02.00204902; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Douglas WW, 1998, AM J RESP CRIT CARE, V158, P220, DOI 10.1164/ajrccm.158.1.9709089; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hallstrand TS, 2005, EUR RESPIR J, V25, P96, DOI 10.1183/09031936.04.00137203; JOHNSON MA, 1989, THORAX, V44, P280, DOI 10.1136/thx.44.4.280; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Liu RM, 2004, AM J PHYSIOL-LUNG C, V286, pL121, DOI 10.1152/ajplung.00231.2003; Mallinckrodt CH, 2004, PHARM STAT, V3, P161, DOI 10.1002/pst.124; Mallinckrodt CH, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-26; Menor C, 2004, J PHARMACOL EXP THER, V311, P668, DOI 10.1124/jpet.104.069286; MEYER A, 1994, EUR RESPIR J, V7, P431, DOI 10.1183/09031936.94.07030431; MEYER A, 1995, AM J RESP CRIT CARE, V152, P1055, DOI 10.1164/ajrccm.152.3.7663783; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213, DOI 10.1164/ajrccm.162.6.2003049; Official statement of the European Respiratory Society, 1993, EUR RESPIR J S16, V16, P1; Prasse A, 2003, EUR RESPIR J, V22, P906, DOI 10.1183/09031936.03.00091802; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Raza A, 2003, COMP BIOCHEM PHYS C, V134, P451, DOI 10.1016/S1532-0456(03)00022-X; Roca J, 1997, EUR RESPIR J, V10, P2662; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P450, DOI 10.1164/ajrccm.149.2.8306044; Selman M, 1998, CHEST, V114, P507, DOI 10.1378/chest.114.2.507; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thomeer MJ, 2004, RESP MED, V98, P567, DOI 10.1016/j.rmed.2003.10.015; WATTERS LC, 1986, AM REV RESPIR DIS, V133, P97, DOI 10.1164/arrd.1986.133.1.97; WELLS AU, 1993, AM REV RESPIR DIS, V148, P1076, DOI 10.1164/ajrccm/148.4_Pt_1.1076; Ziesche R, 2000, NEW ENGL J MED, V342, P975	50	695	753	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2229	2242		10.1056/NEJMoa042976	http://dx.doi.org/10.1056/NEJMoa042976			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306520	Green Published, Bronze			2022-12-28	WOS:000233434500006
J	Levskaya, A; Chevalier, AA; Tabor, JJ; Simpson, ZB; Lavery, LA; Levy, M; Davidson, EA; Scouras, A; Ellington, AD; Marcotte, EM; Voigt, CA				Levskaya, A; Chevalier, AA; Tabor, JJ; Simpson, ZB; Lavery, LA; Levy, M; Davidson, EA; Scouras, A; Ellington, AD; Marcotte, EM; Voigt, CA			Engineering Escherichia coli to see light - These smart bacteria 'photograph' a light pattern as a high-definition chemical image.	NATURE			English	Editorial Material							SYSTEM		Univ Calif San Francisco, Biophys Program, San Francisco, CA 94143 USA; Univ Texas, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Synthet Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Levskaya, A (corresponding author), Univ Calif San Francisco, Biophys Program, San Francisco, CA 94143 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361; Marcotte, Edward/0000-0001-8808-180X				Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	8	428	473	7	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					441	442		10.1038/nature04405	http://dx.doi.org/10.1038/nature04405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306980				2022-12-28	WOS:000233458200034
J	Rolfs, A; Bottcher, T; Zschiesche, M; Morris, P; Winchester, B; Bauer, P; Walter, U; Mix, E; Lohr, M; Harzer, K; Strauss, U; Pahnke, J; Grossmann, A; Benecke, R				Rolfs, A; Bottcher, T; Zschiesche, M; Morris, P; Winchester, B; Bauer, P; Walter, U; Mix, E; Lohr, M; Harzer, K; Strauss, U; Pahnke, J; Grossmann, A; Benecke, R			Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study	LANCET			English	Article							ISCHEMIC STROKE	Background Strokes are an important cause of morbidity and mortality in young adults. However, in most cases the cause of the stroke remains unclear. Anderson-Fabry disease is an X-linked recessive lysosomal storage disease resulting from the deficient alpha-galactosidase and causes an endothelial vasculopathy followed by cerebral ischaemia. To determine the importance of Fabry disease in young people with stroke, we measured the frequency of unrecognised Fabry disease in a cohort of acute stroke patients. Methods Between February, 2110, and December, 2004 721 German adults aged 18 to 55 years suffering from acute cryptogenic stroke were screened for Fabry disease. The plasma alpha-galactosidase activity in men was measured followed by sequencing of the entire alpha-GAL gene in those with low enzyme activity. By contrast, the entire alpha-GAL gene was genetically screened for mutations in women even if enzyme activity was normal. Findings 21 of 432 (4.9%) male stroke patients and seven of 2879 (2.4%) women had a biologically significant mutation within the alpha-GAL gene. The mean age of onset of symptomatic cerebrovascular disease was 38.4 years (SD 13.0) in the male stroke patients and 40.3 years (13.1) in the female group. The higher frequency of infarctions in the vertebrobasilar area correlated with more pronounced changes in the vertebrobasilar vessels like dolichoectatic pathology (42.9% vs 6.8%). Interpretation We have shown a high frequency of Fabry disease in a cohort of patients with cryptogenic stroke, which corresponds to about 1.2% in young stroke patients. Fabry disease must be considered in all cases of unexplained stroke in young patients, especially in those with the combination of infarction in the vertebrobasilar artery system and proteinuria.	Univ Rostock, Dept Neurol, D-18055 Rostock, Germany; Univ Rostock, Inst Diagnost & Intervent Radiol, Rostock, Germany; Univ Tubingen, Dept Med Genet, Tubingen, Germany; Univ Tubingen, Neurochem Lab, Tubingen, Germany; Inst Child Hlth, London, England; UCL, Great Ormond St Hosp Children NHS Trust, London, England; Univ Mannheim Heidelberg, Dept Gastroenterol, Mannheim, Germany; Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Rostock; University of Rostock; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Mannheim; University of Zurich; University Zurich Hospital	Rolfs, A (corresponding author), Univ Rostock, Dept Neurol, POB 100 888, D-18055 Rostock, Germany.	arndt.rolfs@med.uni-rostock.cle	Löhr, Matthias/A-3692-2012; Walter, Uwe/O-4591-2017; Pahnke, Jens/G-1757-2010; Strauss, Ulf/I-4146-2012	Löhr, Matthias/0000-0002-7647-198X; Walter, Uwe/0000-0002-6280-785X; Pahnke, Jens/0000-0001-7355-4213; Strauss, Ulf/0000-0002-1534-6624				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bauer P, 2002, HUM MUTAT, V19, P30, DOI 10.1002/humu.10016; BOGOUSSLAVSKY J, 1992, NEUROL CLIN, V10, P113, DOI 10.1016/S0733-8619(18)30236-6; Brady RO, 2000, JAMA-J AM MED ASSOC, V284, P2771, DOI 10.1001/jama.284.21.2771; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; Mills K, 2002, FEBS LETT, V515, P171, DOI 10.1016/S0014-5793(02)02491-2; Mogensen J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e59; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352	8	324	345	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1794	1796		10.1016/S0140-6736(05)67635-0	http://dx.doi.org/10.1016/S0140-6736(05)67635-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298216				2022-12-28	WOS:000233517200023
J	Oganesyan, G; Saha, SK; Guo, BC; He, JQ; Shahangian, A; Zarnegar, B; Perry, A; Cheng, GH				Oganesyan, G; Saha, SK; Guo, BC; He, JQ; Shahangian, A; Zarnegar, B; Perry, A; Cheng, GH			Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response	NATURE			English	Article							NF-KAPPA-B; INTERFERON-ALPHA INDUCTION; DOUBLE-STRANDED-RNA; SIGNALING PATHWAY; VIRAL-INFECTION; ESSENTIAL COMPONENTS; IMMUNE-RESPONSES; ACTIVATION; KINASE; CELLS	Type I interferon (IFN) production is a critical component of the innate defence against viral infections(1). Viral products induce strong type I IFN responses through the activation of Toll-like receptors (TLRs) and intracellular cytoplasmic receptors such as protein kinase R (PKR)(2-12). Here we demonstrate that cells lacking TRAF3, a member of the TNF receptor-associated factor family, are defective in type I IFN responses activated by several different TLRs. Furthermore, we show that TRAF3 associates with the TLR adaptors TRIF and IRAK1, as well as downstream IRF3/7 kinases TBK1 and IKK-epsilon, suggesting that TRAF3 serves as a critical link between TLR adaptors and downstream regulatory kinases important for IRF activation. In addition to TLR stimulation, we also show that TRAF3-deficient fibroblasts are defective in their type I IFN response to direct infection with vesicular stomatitis virus, indicating that TRAF3 is also an important component of TLR-independent viral recognition pathways. Our data demonstrate that TRAF3 is a major regulator of type I IFN production and the innate antiviral response.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Med Sci Training Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, 609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	genhongc@microbio.ucla.edu	Saha, Supriya/AAC-5365-2019	Saha, Supriya/0000-0003-3029-7995; Miyahira, Andrea/0000-0003-4976-002X				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	30	674	723	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					208	211		10.1038/nature04374	http://dx.doi.org/10.1038/nature04374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16306936				2022-12-28	WOS:000234538400041
J	Casarett, D; Kapo, J; Caplan, A				Casarett, D; Kapo, J; Caplan, A			Appropriate use of artificial nutrition and hydration - Fundamental principles and recommendations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ADJUVANT PARENTERAL-NUTRITION; NURSING-HOME RESIDENTS; ENTERAL NUTRITION; ADVANCED DEMENTIA; CARE; PREFERENCES; END; MANAGEMENT; PHYSICIANS											AHRONHEIM JC, 1990, LANCET, V335, P278, DOI 10.1016/0140-6736(90)90084-I; *AM AC HOSP PALL M, STAT US NUTR HYDR; *AM NURS ASS, 1992, ANA NURSING WOR 0402; [Anonymous], COMMUNICATION; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; BONE RC, 1990, CHEST, V97, P949, DOI 10.1378/chest.97.4.949; BRENNAN MF, 1994, ANN SURG, V220, P436, DOI 10.1097/00000658-199410000-00003; Brett AS, 2001, ARCH INTERN MED, V161, P745, DOI 10.1001/archinte.161.5.745; Buchanan Allen E., 1989, DECIDING OTHERS ETHI; Callahan CM, 2000, J AM GERIATR SOC, V48, P1048, DOI 10.1111/j.1532-5415.2000.tb04779.x; CALLAHAN D, 1983, HASTINGS CENT REP, V13, P22, DOI 10.2307/3560573; Casarett David J, 2002, J Palliat Med, V5, P3, DOI 10.1089/10966210252784962; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; Centers for Medicare and Medicaid Services, NURS HOM COMP; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; *COMM UN STAT LAWS, 1993, NAT C COMM UN STAT L; *CTR MED MED SERV, DESCR RUG3 CLASS SYS; DALY JM, 1995, ANN SURG, V221, P327, DOI 10.1097/00000658-199504000-00002; DALY JM, 1984, AM J SURG, V148, P514, DOI 10.1016/0002-9610(84)90379-9; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Happ MB, 2002, J AM GERIATR SOC, V50, P829, DOI 10.1046/j.1532-5415.2002.50207.x; Helman, 2000, CULTURE HLTH ILLNESS; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; *HOSP PALL NURS AS, POS STAT ART NUTR HY; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Lee JH, 1998, ARCH OTOLARYNGOL, V124, P871, DOI 10.1001/archotol.124.8.871; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; MAZZINI L, 1995, J NEUROL, V242, P695, DOI 10.1007/BF00866922; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Meisel A, 1995, AM J LAW MED, V21, P335; Meisel A, 2004, RIGHT DIE LAW END OF; MEISEL A, 1995, RIGHT TO DIE; Miller RG, 2001, AMYOTROPH LATERAL SC, V2, P3, DOI 10.1080/146608201300079355; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2003, J AM GERIATR SOC, V51, P129, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2001, J AM GERIATR SOC, V49, P313, DOI 10.1046/j.1532-5415.2001.4930313.x; Mitchell SL, 1998, J GERONTOL A-BIOL, V53, pM207, DOI 10.1093/gerona/53A.3.M207; Mitchell Susan L, 2004, J Am Med Dir Assoc, V5, pS22, DOI 10.1097/00130535-200403001-00010; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; Morrison RS, 1998, ARCH INTERN MED, V158, P2493, DOI 10.1001/archinte.158.22.2493; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; National Consensus Project for Quality Palliative Care, CLIN PRACT GUID QUAL; Odom SR, 2003, SURG ENDOSC, V17, P651, DOI 10.1007/s00464-002-8599-y; Pasman HRW, 2005, ARCH INTERN MED, V165, P1729, DOI 10.1001/archinte.165.15.1729; PATRICK DL, 1994, MED DECIS MAKING, V14, P9, DOI 10.1177/0272989X9401400102; POPP MB, 1981, SURGERY, V90, P195; Post SG, 2001, HASTINGS CENT REP, V31, P36, DOI 10.2307/3528732; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAK HLTH CAR DEC REP; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Scolapio JS, 1999, MAYO CLIN PROC, V74, P217, DOI 10.4065/74.3.217; Senkal M, 1999, ARCH SURG-CHICAGO, V134, P1309, DOI 10.1001/archsurg.134.12.1309; SHAMBERGER RC, 1984, SURGERY, V96, P1; Shannon TA, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3528689; Sieger CE, 2002, J AM GERIATR SOC, V50, P544, DOI 10.1046/j.1532-5415.2002.50124.x; *SOC CRIT CAR MED, 1990, CRIT CARE MED, V18, P1435; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Teno JM, 1997, J AM GERIATR SOC, V45, P939, DOI 10.1111/j.1532-5415.1997.tb02963.x; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Viola RA, 1997, J PALLIATIVE CARE, V13, P41, DOI 10.1177/082585979701300407; WANKLYN P, 1995, AGE AGEING, V24, P510, DOI 10.1093/ageing/24.6.510; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; World Health Organization, WHO DEF PALL CAR; YAMADA N, 1983, BRIT J SURG, V70, P267, DOI 10.1002/bjs.1800700508; 2005, PHYS ORDERS LIFE SUS	78	124	127	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2607	2612		10.1056/NEJMsb052907	http://dx.doi.org/10.1056/NEJMsb052907			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354899				2022-12-28	WOS:000233926500013
J	White, HD				White, HD			Adherence and outcomes: it's more than taking the pills	LANCET			English	Editorial Material							HEART-FAILURE; CONTROLLED-TRIAL; THERAPY; CARE; MORTALITY; PLACEBO; RISK		Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1001, New Zealand	Auckland City Hospital	White, HD (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1001, New Zealand.	HarveyW@adhb.govt.nz						Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bissell P, 2004, SOC SCI MED, V58, P851, DOI 10.1016/S0277-9536(03)00259-4; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; EKMAN I, 2005, PATIENT EDUC COUNS, DOI DOI 10.1016/JPEC.2005.04.005; Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lavie Carl J, 2004, Am J Geriatr Cardiol, V13, P29; McDonald K, 2001, EUR J HEART FAIL, V3, P209, DOI 10.1016/S1388-9842(00)00134-3; Miller NH, 1997, CIRCULATION, V95, P1085; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Roe CM, 1999, AM HEART J, V138, P818, DOI 10.1016/S0002-8703(99)70005-0; van der Wal MHL, 2005, EUR J HEART FAIL, V7, P5, DOI 10.1016/j.ejheart.2004.04.007	19	31	32	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					1989	1991		10.1016/S0140-6736(05)67761-6	http://dx.doi.org/10.1016/S0140-6736(05)67761-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338439				2022-12-28	WOS:000233826900006
J	Fulchignoni, M; Ferri, F; Angrilli, F; Ball, AJ; Bar-Nun, A; Barucci, MA; Bettanini, C; Bianchini, G; Borucki, W; Colombatti, G; Coradini, M; Coustenis, A; Debei, S; Falkner, P; Fanti, G; Flamini, E; Gaborit, V; Grard, R; Hamelin, M; Harri, AM; Hathi, B; Jernej, I; Leese, MR; Lehto, A; Stoppato, PFL; Lopez-Moreno, JJ; Makinen, T; McDonnell, JAM; McKay, CP; Molina-Cuberos, G; Neubauer, FM; Pirronello, V; Rodrigo, R; Saggin, B; Schwingenschuh, K; Seiff, A; Simoes, F; Svedhem, H; Tokano, T; Towner, MC; Trautner, R; Withers, P; Zarnecki, JC				Fulchignoni, M; Ferri, F; Angrilli, F; Ball, AJ; Bar-Nun, A; Barucci, MA; Bettanini, C; Bianchini, G; Borucki, W; Colombatti, G; Coradini, M; Coustenis, A; Debei, S; Falkner, P; Fanti, G; Flamini, E; Gaborit, V; Grard, R; Hamelin, M; Harri, AM; Hathi, B; Jernej, I; Leese, MR; Lehto, A; Stoppato, PFL; Lopez-Moreno, JJ; Makinen, T; McDonnell, JAM; McKay, CP; Molina-Cuberos, G; Neubauer, FM; Pirronello, V; Rodrigo, R; Saggin, B; Schwingenschuh, K; Seiff, A; Simoes, F; Svedhem, H; Tokano, T; Towner, MC; Trautner, R; Withers, P; Zarnecki, JC			In situ measurements of the physical characteristics of Titan's environment	NATURE			English	Article							VOYAGER-1 RADIO-OCCULTATION; HUYGENS PROBE; ELECTRICAL-CONDUCTIVITY; ELECTROMAGNETIC-WAVES; GRAVITY-WAVES; PWA-HASI; ATMOSPHERE; SURFACE; TEMPERATURES; PROPAGATION	On the basis of previous ground-based and fly-by information, we knew that Titan's atmosphere was mainly nitrogen, with some methane, but its temperature and pressure profiles were poorly constrained because of uncertainties in the detailed composition. The extent of atmospheric electricity ('lightning') was also hitherto unknown. Here we report the temperature and density profiles, as determined by the Huygens Atmospheric Structure Instrument (HASI), from an altitude of 1,400 km down to the surface. In the upper part of the atmosphere, the temperature and density were both higher than expected. There is a lower ionospheric layer between 140 km and 40 km, with electrical conductivity peaking near 60 km. We may also have seen the signature of lightning. At the surface, the temperature was 93.65 +/- 0.25 K, and the pressure was 1,467 +/- 1 hPa.	Univ Padua, CISAS G Colombo, I-35131 Padua, Italy; Observ Paris, LESIA, F-92195 Meudon, France; Univ Denis Diderot Paris 7, UFR Phys, F-75006 Paris, France; Open Univ, PSSRI, Milton Keynes MK7 6AA, Bucks, England; Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; ESA Headquarters, Sci Directorate, F-75015 Paris, France; European Space Agcy, Estec, ESA, NL-2200 AG Noordwijk, Netherlands; Agenzia Spaziale Italiana, I-00198 Rome, Italy; CETP IPSL, F-94107 St Maur, France; CNRS, LPCE, F-45071 Orleans, France; Finnish Meteorol Inst, Helsinki 00100, Finland; Austrian Acad Sci IWF, Space Res Inst, A-8042 Graz, Austria; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Univ Murcia, Dept Phys, Appl Electromagnet Grp, E-30100 Murcia, Spain; Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; Univ Catania, DMFCI, I-95125 Catania, Italy; Politecn Milan, Dipartimento Meccan, I-20133 Milan, Italy; Boston Univ, Ctr Space Phys, Boston, MA 02215 USA	University of Padua; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; UDICE-French Research Universities; Universite Paris Cite; Open University - UK; Tel Aviv University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; European Space Agency; European Space Agency; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); Finnish Meteorological Institute; Austrian Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Murcia; University of Cologne; University of Catania; Polytechnic University of Milan; Boston University	Ferri, F (corresponding author), Univ Padua, CISAS G Colombo, Via Venezia 15, I-35131 Padua, Italy.	francesca.ferri@unipd.it	Ball, Andrew/B-6747-2009; Harri, Ari-Matti/C-7142-2012; Simoes, Fernando/D-7731-2012; saggin, bortolino/G-2831-2018; Lopez-Moreno, Jose Juan/C-7976-2011; Moreno, Jose Juan Lopez/M-5537-2019; Withers, Paul/H-2241-2014; Molina-Cuberos, Gregorio/K-7522-2014; Colombatti, Giacomo/R-4974-2018	Ball, Andrew/0000-0003-1593-3279; Harri, Ari-Matti/0000-0001-8541-2802; saggin, bortolino/0000-0002-4033-3585; Lopez-Moreno, Jose Juan/0000-0002-7946-2624; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Molina-Cuberos, Gregorio/0000-0002-5664-7028; Colombatti, Giacomo/0000-0002-4169-9319; BETTANINI FECIA DI COSSATO, Carlo/0000-0001-5457-9108; Ferri, Francesca/0000-0003-2395-5275; Debei, Stefano/0000-0002-6757-6616				BORUCKI WJ, 1987, ICARUS, V72, P604, DOI 10.1016/0019-1035(87)90056-X; BORUCKI WJ, IN PRESS ICARUS; BOUCHEZ AH, 2002, B AM ASTRON SOC, V34, P881; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; BROWN RH, UNPUB ASTRON ASTROPH; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; Coustenis A, 2005, ICARUS, V177, P89, DOI 10.1016/j.icarus.2005.03.012; Desch SJ, 2002, REP PROG PHYS, V65, P955, DOI 10.1088/0034-4885/65/6/202; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; FRIEDSON AJ, 1994, ICARUS, V109, P40, DOI 10.1006/icar.1994.1076; Fulchignoni M, 2002, SPACE SCI REV, V104, P395, DOI 10.1023/A:1023688607077; GRARD R, 1995, J ATMOS TERR PHYS, V57, P575, DOI 10.1016/0021-9169(94)00082-Y; Hamelin M, 2000, ADV SPACE RES, V26, P1697, DOI 10.1016/S0273-1177(00)00113-7; Harri AM, 1998, PLANET SPACE SCI, V46, P1383, DOI 10.1016/S0032-0633(97)00185-2; HINSON DP, 1983, ICARUS, V54, P337, DOI 10.1016/0019-1035(83)90202-6; HUBBARD WB, 1990, NATURE, V343, P353, DOI 10.1038/343353a0; Kliore AJ, 2004, SPACE SCI REV, V115, P1, DOI 10.1007/s11214-004-1436-y; KSANFOMALITI LV, 1982, SOV ASTRON LETT+, V8, P227; Lebreton JP, 2002, SPACE SCI REV, V104, P59, DOI 10.1023/A:1023657127549; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LELLOUCH E, 1990, ICARUS, V83, P308, DOI 10.1016/0019-1035(90)90070-P; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; MAKINEN T, 1995, ADV SPACE RES, V17, P219; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Molina-Cuberos GJ, 1999, J GEOPHYS RES-PLANET, V104, P21997, DOI 10.1029/1998JE001001; Molina-Cuberos GJ, 2001, ADV SPACE RES, V28, P1511, DOI 10.1016/S0273-1177(01)00585-3; Morente JA, 2003, ICARUS, V162, P374, DOI 10.1016/S0019-1035(03)00025-3; Nickolaenko AP, 2003, PLANET SPACE SCI, V51, P853, DOI 10.1016/S0032-0633(03)00119-3; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Ruffino G, 1996, PLANET SPACE SCI, V44, P1149, DOI 10.1016/S0032-0633(96)00028-1; Schwingenschuh K, 2001, ADV SPACE RES, V28, P1505, DOI 10.1016/S0273-1177(01)00584-1; Sicardy B, 1999, ICARUS, V142, P357, DOI 10.1006/icar.1999.6219; SICARDY B, 2004, B AM ASTRON SOC, V36, P1119; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tokano T, 2001, PLANET SPACE SCI, V49, P539, DOI 10.1016/S0032-0633(00)00170-7; Tracadas PW, 2001, ICARUS, V153, P285, DOI 10.1006/icar.2001.6701; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796; YELLE RV, 1997, ESA SP PUBL, V1177, P243; ZARNECKI JC, 2004, ESA, P71	45	513	518	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					785	791		10.1038/nature04314	http://dx.doi.org/10.1038/nature04314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319827				2022-12-28	WOS:000233777800039
J	Lebreton, JP; Witasse, O; Sollazzo, C; Blancquaert, T; Couzin, P; Schipper, AM; Jones, JB; Matson, DL; Gurvits, LI; Atkinson, DH; Kazeminejad, B; Perez-Ayucar, M				Lebreton, JP; Witasse, O; Sollazzo, C; Blancquaert, T; Couzin, P; Schipper, AM; Jones, JB; Matson, DL; Gurvits, LI; Atkinson, DH; Kazeminejad, B; Perez-Ayucar, M			An overview of the descent and landing of the Huygens probe on Titan	NATURE			English	Article							SURFACE; ENTRY; TELESCOPE; MISSION; SCIENCE; SYSTEM	Titan, Saturn's largest moon, is the only Solar System planetary body other than Earth with a thick nitrogen atmosphere. The Voyager spacecraft confirmed that methane was the second-most abundant atmospheric constituent in Titan's atmosphere, and revealed a rich organic chemistry, but its cameras could not see through the thick organic haze. After a seven-year interplanetary journey on board the Cassini orbiter, the Huygens probe was released on 25 December 2004. It reached the upper layer of Titan's atmosphere on 14 January and landed softly after a parachute descent of almost 2.5 hours. Here we report an overview of the Huygens mission, which enabled studies of the atmosphere and surface, including in situ sampling of the organic chemistry, and revealed an Earth-like landscape. The probe descended over the boundary between a bright icy terrain eroded by fluvial activity - probably due to methane - and a darker area that looked like a river- or lake-bed. Post-landing images showed centimetre-sized surface details.	European Space Agcy, Estec, Sci Directorate, Res & Sci Support Dept, NL-2200 AG Noordwijk, Netherlands; European Space Agcy, Estec, Sci Directorate, Sci Project Dept, NL-2200 AG Noordwijk, Netherlands; ESOC, ESA Operat Directorate, D-64293 Darmstadt, Germany; Alcatel Alenia Space, F-06156 Cannes La Bocca, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands; Univ Idaho, Dept Elect & Comp Engn, Moscow, ID 83844 USA; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria	European Space Agency; European Space Agency; European Space Agency; Alcatel-Lucent; Thales Group; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Idaho; University of Idaho; Austrian Academy of Sciences	Lebreton, JP (corresponding author), European Space Agcy, Estec, Sci Directorate, Res & Sci Support Dept, NL-2200 AG Noordwijk, Netherlands.	jean-pierre.lebreton@esa.int	Witasse, Olivier/AGL-7805-2022	Witasse, Olivier/0000-0003-3461-5604; Gurvits, Leonid/0000-0002-0694-2459				Atkinson DH, 2005, PLANET SPACE SCI, V53, P586, DOI 10.1016/j.pss.2004.11.005; Bird MK, 2002, SPACE SCI REV, V104, P613, DOI 10.1023/A:1023683004351; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; Clausen KC, 2002, SPACE SCI REV, V104, P155, DOI 10.1023/A:1023648925732; Coustenis A, 2005, ICARUS, V177, P89, DOI 10.1016/j.icarus.2005.03.012; Fulchignoni M, 2002, SPACE SCI REV, V104, P395, DOI 10.1023/A:1023688607077; Gibbard SG, 1999, ICARUS, V139, P189, DOI 10.1006/icar.1999.6095; Israel G, 2002, SPACE SCI REV, V104, P433, DOI 10.1023/A:1023640723915; Kazeminejad B, 2004, PLANET SPACE SCI, V52, P799, DOI 10.1016/j.pss.2004.03.008; KAZEMINEJAD B, 2004, ESA, P137; KAZEMINEJAD B, 2005, THESIS K FRANZENS U; Lebreton JP, 2002, SPACE SCI REV, V104, P59, DOI 10.1023/A:1023657127549; Lorenz R. D., 2002, LIFTING TITANS VEIL; Matson DL, 2002, SPACE SCI REV, V104, P1, DOI 10.1023/A:1023609211620; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; POGREBENKO SV, 2004, ESA, P197; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Raulin F, 2002, SPACE SCI REV, V104, P377, DOI 10.1023/A:1023636623006; Schulze-Makuch D, 2005, ASTROBIOLOGY, V5, P560, DOI 10.1089/ast.2005.5.560; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Tomasko MG, 2002, SPACE SCI REV, V104, P469, DOI 10.1023/A:1023632422098; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Zarnecki JC, 2002, SPACE SCI REV, V104, P593, DOI 10.1023/A:1023628321189	24	162	163	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					758	764		10.1038/nature04347	http://dx.doi.org/10.1038/nature04347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319826				2022-12-28	WOS:000233777800036
J	Earnshaw, WC				Earnshaw, WC			Keeping survivin nimble at centromeres in mitosis	SCIENCE			English	Editorial Material							AURORA-B; KINASE-ACTIVITY; DYNAMICS; SPINDLE; INCENP		Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Earnshaw, WC (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	bill.earnshaw@ed.ac.uk	Earnshaw, William/AAY-7438-2020	Earnshaw, William/0000-0002-7191-0621	Wellcome Trust [073915] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Delacour-Larose M, 2004, CELL CYCLE, V3, P1418, DOI 10.4161/cc.3.11.1203; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160	10	8	9	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1443	1444		10.1126/science.1121952	http://dx.doi.org/10.1126/science.1121952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322445				2022-12-28	WOS:000233756500031
J	Ortiz-Barrientos, D; Noor, MAF				Ortiz-Barrientos, D; Noor, MAF			Evidence for a one-allele assortative mating locus	SCIENCE			English	Article							SPECIATION		Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ortiz-Barrientos, D (corresponding author), Indiana Univ, Dept Biol, 1001 E 3rd St, Bloomington, IN 47405 USA.	dortizba@indiana.edu	Ortiz-Barrientos, Daniel/B-2274-2010; Ortiz-Barrientos, Daniel/N-3294-2019	Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Noor, Mohamed/0000-0002-5400-4408				COYNE J, 2004, SPECIATION, P20601; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412	5	66	68	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1467	1467		10.1126/science.1121260	http://dx.doi.org/10.1126/science.1121260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322450				2022-12-28	WOS:000233756500036
J	Rosenberg, OS; Deindl, S; Sung, RJ; Nairn, AC; Kuriyan, J				Rosenberg, OS; Deindl, S; Sung, RJ; Nairn, AC; Kuriyan, J			Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CALMODULIN; AUTOPHOSPHORYLATION; SUBSTRATE; ALPHA; SUBUNIT; SITE	Ca2+/calmodulin-dependent protein kinase-II (CaMKII) is unique among protein kinases for its dodecameric assembly and its complex response to Ca2+. The crystal structure of the autoinhibited kinase domain of CaMKII, determined at 1.8 angstrom resolution, reveals an unexpected dimeric organization in which the calmodulin-responsive regulatory segments form a coiled-coil strut that blocks peptide and ATP binding to the otherwise intrinsically active kinase domains. A threonine residue in the regulatory segment, which when phosphorylated renders CaMKII calmodulin independent, is held apart from the catalytic sites by the organization of the dimer. This ensures a strict Ca2+ dependence for initial activation. The structure of the kinase dimer, when combined with small-angle X-ray scattering data for the holoenzyme, suggests that inactive CaMKII forms tightly packed autoinhibited assemblies that convert upon activation into clusters of loosely tethered and independent kinase domains.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06508 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Yale University; Yale University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		Nairn, Angus/0000-0002-7075-0195; Deindl, Sebastian/0000-0001-6807-8654				Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case D., 2004, AMBER; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DAVIESJM, 2005, STRUCTURE CAMB, V13, P183; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DeLano W.L, PYMOL MOL GRAPHICS S; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; HUANG CYF, 1995, J BIOL CHEM, V270, P7183, DOI 10.1074/jbc.270.13.7183; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; KING MM, 1988, ARCH BIOCHEM BIOPHYS, V267, P467, DOI 10.1016/0003-9861(88)90052-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KOVNAREV PV, 2003, J APPL CRYSTALLOGR, V36, P1277; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1989, J NEUROSCI, V9, P2020; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SHIELDS SM, 1984, J NEUROCHEM, V43, P1599, DOI 10.1111/j.1471-4159.1984.tb06084.x; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	54	222	231	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					849	860		10.1016/j.cell.2005.10.029	http://dx.doi.org/10.1016/j.cell.2005.10.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325579	Bronze			2022-12-28	WOS:000233814100018
J	Woof, JM				Woof, JM			Tipping the scales toward more effective antibodies	SCIENCE			English	Editorial Material									Univ Dundee, Sch Med, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland	University of Dundee	Woof, JM (corresponding author), Univ Dundee, Sch Med, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	j.m.woof@dundee.ac.uk						Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039	6	24	25	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1442	1443		10.1126/science.1122009	http://dx.doi.org/10.1126/science.1122009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322444				2022-12-28	WOS:000233756500030
J	Hegland, DD; Kunz, GA; Harrison, JK; Wang, A				Hegland, DD; Kunz, GA; Harrison, JK; Wang, A			Clinical problem-solving - A hole in the argument	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATENT FORAMEN OVALE; PERCUTANEOUS CLOSURE; PLATYPNEA-ORTHODEOXIA; CRYPTOGENIC STROKE; ECHOCARDIOGRAPHY; HYPOXEMIA; DEVICE; RISK		Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA	Duke University	Wang, A (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, DUMC Box 3428, Durham, NC 27710 USA.	a.wang@duke.edu		Wang, Andrew/0000-0001-8729-0933				DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; DUBOURG O, 1984, J AM COLL CARDIOL, V4, P587, DOI 10.1016/S0735-1097(84)80106-0; FISHER DC, 1995, CHEST, V107, P1504, DOI 10.1378/chest.107.6.1504; Godart F, 2000, EUR HEART J, V21, P483, DOI 10.1053/euhj.1999.1944; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; KRONIK G, 1982, AM J CARDIOL, V49, P1806, DOI 10.1016/0002-9149(82)90263-6; LAHAM RJ, 1994, AM J CARDIOL, V74, P824, DOI 10.1016/0002-9149(94)90447-2; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Popp G, 1997, CHEST, V112, P1682, DOI 10.1378/chest.112.6.1682; Rao PS, 2001, CATHETER CARDIO INTE, V54, P77, DOI 10.1002/ccd.1243; Savage EB, 1996, ANN THORAC SURG, V62, P582, DOI 10.1016/0003-4975(96)00386-4; VACEK JL, 1985, ANN THORAC SURG, V39, P576, DOI 10.1016/S0003-4975(10)62005-X; VALDESCRUZ LM, 1976, CIRCULATION, V54, P558, DOI 10.1161/01.CIR.54.4.558; Wang A, 1999, CATHETER CARDIO INTE, V46, P452, DOI 10.1002/(SICI)1522-726X(199904)46:4<452::AID-CCD15>3.3.CO;2-J; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; Windecker S, 2000, CIRCULATION, V101, P893, DOI 10.1161/01.CIR.101.8.893	16	18	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2385	2390		10.1056/NEJMcps050473	http://dx.doi.org/10.1056/NEJMcps050473			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319388				2022-12-28	WOS:000233574600011
J	Kizer, JR; Devereux, RB				Kizer, JR; Devereux, RB			Clinical practice - Patent foramen ovale in young adults with unexplained stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL SEPTAL ANEURYSM; CEREBRAL ISCHEMIC EVENTS; MITRAL-VALVE-PROLAPSE; CRYPTOGENIC STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PARADOXICAL EMBOLISM; CEREBROVASCULAR EVENTS; VENOUS THROMBOSIS; SURGICAL CLOSURE; MEDICAL THERAPY		Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY USA	Cornell University; Cornell University	Kizer, JR (corresponding author), New York Presbyterian Hosp, Box 222,525 E 68th St, New York, NY 10021 USA.	jok2007@med.cornell.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL070854] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23 HL070854] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agmon Y, 1999, CIRCULATION, V99, P1942, DOI 10.1161/01.CIR.99.15.1942; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Berthet K, 2000, STROKE, V31, P398, DOI 10.1161/01.STR.31.2.398; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Cramer SC, 2004, STROKE, V35, P46, DOI 10.1161/01.STR.0000106137.42649.AB; Cujec B, 1999, CAN J CARDIOL, V15, P57; DANIEL WG, 1991, CIRCULATION, V83, P817, DOI 10.1161/01.CIR.83.3.817; De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407; Dearani JA, 1999, CIRCULATION, V100, P171; Deeik RK, 2002, ANN THORAC SURG, V74, pS1326; DEROOK FA, 1992, ANN INTERN MED, V117, P922, DOI 10.7326/0003-4819-117-11-922; Devuyst G, 1996, NEUROLOGY, V47, P1162, DOI 10.1212/WNL.47.5.1162; DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020; Eggebrecht H, 2004, J AM SOC ECHOCARDIOG, V17, P1161, DOI 10.1016/j.echo.2004.06.024; FALK RH, 1991, AM HEART J, V121, P1264, DOI 10.1016/0002-8703(91)90695-E; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Gilon D, 1999, NEW ENGL J MED, V341, P8, DOI 10.1056/NEJM199907013410102; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HANLEY PC, 1985, J AM COLL CARDIOL, V6, P1370, DOI 10.1016/S0735-1097(85)80228-X; HIRSH J, 1990, AM J CARDIOL, V65, pC45, DOI 10.1016/0002-9149(90)90115-H; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 2004, STROKE, V35, P2145, DOI 10.1161/01.STR.0000135773.24116.18; Homma S, 2004, STROKE, V35, P1436, DOI 10.1161/01.STR.0000126100.53682.a0; Homma S, 2003, J AM COLL CARDIOL, V42, P1066, DOI 10.1016/S0735-1097(03)00907-0; Homma S, 1997, STROKE, V28, P2376, DOI 10.1161/01.STR.28.12.2376; KASNER S, 1997, NEUROLOGY NETWORK CO, V1, P127; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Kristensen B, 1997, STROKE, V28, P1702, DOI 10.1161/01.STR.28.9.1702; Laperche T, 1997, CIRCULATION, V96, P288; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Lock JE, 2000, CIRCULATION, V101, P838, DOI 10.1161/01.CIR.101.8.838; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P366, DOI 10.1001/jama.294.3.366; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; McAllister HA, 1978, ATLAS TUMOR PATHOL, V2nd; Meacham RR, 1998, ARCH INTERN MED, V158, P438, DOI 10.1001/archinte.158.5.438; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Messe SR, 2004, NEUROLOGY, V62, P1042, DOI 10.1212/01.WNL.0000119173.15878.F3; MOHR JP, 1988, NEW ENGL J MED, V318, P1197, DOI 10.1056/NEJM198805053181810; Moussouttas M, 2000, NEUROLOGY, V55, P959, DOI 10.1212/WNL.55.7.959; MUGGE A, 1995, CIRCULATION, V91, P2785, DOI 10.1161/01.CIR.91.11.2785; Nendaz MR, 1998, AM HEART J, V135, P532, DOI 10.1016/S0002-8703(98)70332-1; Orgera MA, 2001, SOUTHERN MED J, V94, P699; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Rahmatullah AF, 1999, CLIN CARDIOL, V22, P391, DOI 10.1002/clc.4960220605; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7; Schuchlenz HW, 2000, AM J MED, V109, P456, DOI 10.1016/S0002-9343(00)00530-1; Serena J, 1998, STROKE, V29, P1322, DOI 10.1161/01.STR.29.7.1322; SILVER MD, 1978, ARCH PATHOL LAB MED, V102, P62; STOLLBERGER C, 1993, ANN INTERN MED, V119, P461, DOI 10.7326/0003-4819-119-6-199309150-00003; STOLLBERGER C, 1994, ANN INTERN MED, V120, P347, DOI 10.7326/0003-4819-120-4-199402150-00031	56	133	141	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2361	2372		10.1056/NEJMcp043981	http://dx.doi.org/10.1056/NEJMcp043981			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319385				2022-12-28	WOS:000233574600008
J	Maxfield, FR; Tabas, I				Maxfield, FR; Tabas, I			Role of cholesterol and lipid organization in disease	NATURE			English	Review							UNFOLDED PROTEIN RESPONSE; ATHEROSCLEROTIC PLAQUE; MACROPHAGE APOPTOSIS; ENDOPLASMIC-RETICULUM; MEMBRANE CHOLESTEROL; ACYL-COENZYME; TRITON X-100; ACID; TRAFFICKING; MECHANISMS	Membrane lipids are essential for biological functions ranging from membrane trafficking to signal transduction. The composition of lipid membranes influences their organization and properties, so it is not surprising that disorders in lipid metabolism and transport have a role in human disease. Significant recent progress has enhanced our understanding of the molecular and cellular basis of lipid- associated disorders such as Tangier disease, Niemann - Pick disease type C and atherosclerosis. These insights have also led to improved understanding of normal physiology.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Cell Biol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Cornell University; Columbia University; Columbia University; Columbia University	Maxfield, FR (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	frmaxfie@med.cornell.edu	Maxfield, Fred/M-6747-2019; Maxfield, Fred/A-1718-2011; Duarte, Graziela Biude Silva/Q-7728-2016	Maxfield, Fred/0000-0003-4396-8866; 				Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317; Aikawa M, 2004, CARDIOVASC PATHOL, V13, P125, DOI 10.1016/S1054-8807(04)00004-3; Anitschkow N, 1913, ZENTRALBL ALLG PATHO, V24, P1; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Buton X, 1999, J BIOL CHEM, V274, P32112, DOI 10.1074/jbc.274.45.32112; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Corti R, 2004, J THROMB THROMBOLYS, V17, P35, DOI 10.1023/B:THRO.0000036027.39353.70; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; GERRITY RG, 1981, AM J PATHOL, V103, P181; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kockx MM, 1998, ARTERIOSCL THROM VAS, V18, P1519, DOI 10.1161/01.ATV.18.10.1519; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; *MEGH LOND, 2004, J BIOL CHEM, V279, P9997; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; Nhan TQ, 2005, ARTERIOSCL THROM VAS, V25, P895, DOI 10.1161/01.ATV.0000159519.07181.33; Oram JF, 2002, CURR OPIN LIPIDOL, V13, P373, DOI 10.1097/00041433-200208000-00004; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; QIN C, IN PRESS ARTERIOSCLE; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Sakr SW, 2001, J BIOL CHEM, V276, P37649, DOI 10.1074/jbc.M105129200; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; SCHROEDER F, 1984, BIOCHIM BIOPHYS ACTA, V776, P299, DOI 10.1016/0005-2736(84)90219-0; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shah Prediman K, 2005, Indian Heart J, V57, P21; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stefkova J, 2004, PHYSIOL RES, V53, P235; Strauss JF, 2003, MOL CELL ENDOCRINOL, V202, P59, DOI 10.1016/S0303-7207(03)00063-7; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Sun Y, 2003, J BIOL CHEM, V278, P5813, DOI 10.1074/jbc.M208687200; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 1999, ANNU REV NUTR, V19, P123, DOI 10.1146/annurev.nutr.19.1.123; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Twickler ThB, 2005, Curr Atheroscler Rep, V7, P140, DOI 10.1007/s11883-005-0037-x; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang TY, 2003, BIOPHYS J, V84, P367, DOI 10.1016/S0006-3495(03)74857-7; Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 2005, CURR OPIN CLIN NUTR, V8, P139, DOI 10.1097/00075197-200503000-00006; Wolozin B, 2004, CURR OPIN LIPIDOL, V15, P667, DOI 10.1097/00041433-200412000-00007; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Zhang Y, 2003, J BIOL CHEM, V278, P11642, DOI 10.1074/jbc.M211559200; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	100	933	957	5	170	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					612	621		10.1038/nature04399	http://dx.doi.org/10.1038/nature04399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319881				2022-12-28	WOS:000233593100039
J	Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, ND; Burroughs, AK; Planas, R; Escorsell, A; Garcia-Pagan, JC; Patch, D; Matloff, DS; Gao, H; Makuch, R				Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, ND; Burroughs, AK; Planas, R; Escorsell, A; Garcia-Pagan, JC; Patch, D; Matloff, DS; Gao, H; Makuch, R		Portal Hypertension Collaborative	Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORTAL PRESSURE RESPONSE; LARGE ESOPHAGEAL-VARICES; ISOSORBIDE MONONITRATE; PHARMACOLOGICAL-TREATMENT; HEMODYNAMIC-RESPONSE; PRIMARY PROPHYLAXIS; RANDOMIZED-TRIAL; PROPRANOLOL; NADOLOL; HYPERTENSION	BACKGROUND Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown. METHODS We randomly assigned 213 patients with cirrhosis and portal hypertension (minimal hepatic venous pressure gradient [HVPG] of 6 mm Hg) to receive timolol, a nonselective beta-blocker (108 patients), or placebo (105 patients). The primary end point was the development of gastroesophageal varices or variceal hemorrhage. Endoscopy and HVPG measurements were repeated yearly. RESULTS During a median follow-up of 54.9 months, the rate of the primary end point did not differ significantly between the timolol group and the placebo group (39 percent and 40 percent, respectively; P=0.89), nor were there significant differences in the rates of ascites, encephalopathy, liver transplantation, or death. Serious adverse events were more common among patients in the timolol group than among those in the placebo group (18 percent vs. 6 percent, P=0.006). Varices developed less frequently among patients with a baseline HVPG of less than 10 mm Hg and among those in whom the HVPG decreased by more than 10 percent at one year and more frequently among those in whom the HVPG increased by more than 10 percent at one year. CONCLUSIONS Nonselective beta-blockers are ineffective in preventing varices in unselected patients with cirrhosis and portal hypertension and are associated with an increased number of adverse events. (ClinicalTrials.gov number, NCT00006398.)	Yale Univ, Sch Med, VA CT Healthcare Syst, Digest Dis Sect 111H, West Haven, CT 06516 USA; Yale Univ, Sch Med, New Haven, CT USA; Hosp Clin Barcelona, Barcelona, Spain; Brigham & Womens Hosp, Boston, MA 02115 USA; Faulkner Hosp, Jamaica Plain, MA USA; Univ London Royal Free Hosp, London, England; Hosp Badalona Germans Trias & Pujol, Badalona, Spain	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; University of Barcelona; Hospital Clinic de Barcelona; Harvard University; Brigham & Women's Hospital; University of London; University College London; Hospital Germans Trias i Pujol	Groszmann, RJ (corresponding author), Yale Univ, Sch Med, VA CT Healthcare Syst, Digest Dis Sect 111H, 950 Campbell Ave, West Haven, CT 06516 USA.		Garcia-Tsao, Guadalupe/ABF-7374-2020; Burroughs, Andrew K/C-5645-2009; Garcia-Pagan, Juan-Carlos/P-6291-2015	Burroughs, Andrew K/0000-0001-6527-457X; Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954	PHS HHS [R01 46580] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abecasis R, 2003, HEPATOLOGY, V37, P359, DOI 10.1053/jhep.2003.50032; Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Angelico M, 1997, GASTROENTEROLOGY, V113, P1632, DOI 10.1053/gast.1997.v113.pm9352866; Aracil C, 2003, HEPATOLOGY, V38, p296A, DOI 10.1016/S0270-9139(03)80334-8; BENDSTEN F, 1991, HEPATOLOGY, V14, P1016; Borroni G, 2002, J HEPATOL, V37, P315, DOI 10.1016/S0168-8278(02)00174-5; CALES P, 1990, GUT, V31, P1298, DOI 10.1136/gut.31.11.1298; Cales P, 1999, EUR J GASTROEN HEPAT, V11, P741, DOI 10.1097/00042737-199907000-00011; CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944; D'Amico G, 2000, SEMIN LIVER DIS, V20, P399; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; DAMICO G, 2001, P 3 BAV INT CONS WOR, P36; Escorsell A, 1997, GASTROENTEROLOGY, V112, P2012, DOI 10.1053/gast.1997.v112.pm9178694; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; Garcia-Pagan JC, 2003, HEPATOLOGY, V37, P1260, DOI 10.1053/jhep.2003.50211; GARCIATSAO G, 1986, HEPATOLOGY, V6, P101, DOI 10.1002/hep.1840060119; Groszmann RJ, 2004, HEPATOLOGY, V39, P280, DOI 10.1002/hep.20062; GROSZMANN RJ, 1990, GASTROENTEROLOGY, V99, P1401, DOI 10.1016/0016-5085(90)91168-6; ISHIZAKI T, 1978, EUR J CLIN PHARMACOL, V14, P7, DOI 10.1007/BF00560252; JENNINGS G, 1979, MED J AUSTRALIA, V2, P263, DOI 10.5694/j.1326-5377.1979.tb127133.x; KROEGER RJ, 1985, HEPATOLOGY, V5, P97, DOI 10.1002/hep.1840050120; KROEGER RJ, 1985, GASTROENTEROLOGY, V88, P896, DOI 10.1016/S0016-5085(85)80005-6; LEBREC D, 1988, J HEPATOL, V7, P118, DOI 10.1016/S0168-8278(88)80515-4; Merkel C, 2004, HEPATOLOGY, V40, p627A; Merkel C, 2004, GASTROENTEROLOGY, V127, P476, DOI 10.1053/j.gastro.2004.05.004; Merkel C, 1996, LANCET, V348, P1677, DOI 10.1016/S0140-6736(96)05406-2; PASCAL JP, 1988, NEW ENGL J MED, V318, P994; PASTA L, 1989, J HEPATOL, V9, P75; SARIN SK, 1991, J CLIN INVEST, V87, P1032, DOI 10.1172/JCI115062; SHEEN IS, 1989, LIVER, V9, P1; Villanueva C, 1996, NEW ENGL J MED, V334, P1624, DOI 10.1056/NEJM199606203342502; Villanueva C, 2001, NEW ENGL J MED, V345, P647, DOI 10.1056/NEJMoa003223; Vorobioff J, 1996, GASTROENTEROLOGY, V111, P701, DOI 10.1053/gast.1996.v111.pm8780575; Wang T, 1996, BRIT J CLIN PHARMACO, V42, P217, DOI 10.1046/j.1365-2125.1996.39412.x; WEINER N, 1980, GOODMAN GILMANS PHAR, P176; WESTABY D, 1990, HEPATOLOGY, V11, P353, DOI 10.1002/hep.1840110304	36	616	661	4	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2254	2261		10.1056/NEJMoa044456	http://dx.doi.org/10.1056/NEJMoa044456			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306522	Green Published			2022-12-28	WOS:000233434500008
J	Rothwell, PM; Coull, AJ; Silver, LE; Fairhead, JF; Giles, MF; Lovelock, CE; Redgrave, JNE; Bull, LM; Welch, SJV; Cuthbertson, FC; Binney, LE; Gutnikov, SA; Anslow, P; Banning, AP; Mant, D; Mehta, Z				Rothwell, PM; Coull, AJ; Silver, LE; Fairhead, JF; Giles, MF; Lovelock, CE; Redgrave, JNE; Bull, LM; Welch, SJV; Cuthbertson, FC; Binney, LE; Gutnikov, SA; Anslow, P; Banning, AP; Mant, D; Mehta, Z		Oxford Vasc Study	Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)	LANCET			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; MONICA PROJECT; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR-DISEASE; EUROPEAN-SOCIETY; STROKE INCIDENCE; GLOBAL BURDEN; RISK-FACTORS	Background Acute coronary, cerebrovascular, and peripheral vascular events have common underlying arterial pathology, risk factors, and preventive treatments, but they are rarely studied concurrently. In the Oxford Vascular Study, we determined the comparative epidemiology of different acute vascular syndromes, their current burdens, and the potential effect of the ageing population on future rates. Methods We prospectively assessed all individuals presenting with an acute vascular event of any type in any arterial territory irrespective of age in a population of 91106 in Oxfordshire, UK, in 2002-05. Findings 2024 acute vascular events occurred in 1657 individuals: 918 (45%) cerebrovascular (618 stroke, 300 transient ischaernic attacks [TIA]); 856 (42%) coronary vascular (159 ST-elevation myocardial infarction, 316 non-ST-elevation myocardial infarction, 218 unstable angina, 163 sudden cardiac death); 188 (9%) peripheral vascular (43 aortic, 53 embolic visceral or limb ischaemia, 92 critical limb ischaemia); and 62 unclassifiable deaths. Relative incidence of cerebrovascular events compared with coronary events was 1.19 (95% CI 1.06-1.33) overall; 1.40 (1.23-1.59) for non-fatal events; and 1.21 (1.04-1.41) if TIA and unstable angina were further excluded. Event and incidence rates rose steeply with age in all arterial territories, with 735 (80%) cerebrovascular, 623 (73%) coronary, and 147 (78%) peripheral vascular events in 12 886 (14%) individuals aged 65 years or older; and 503 (54%), 402 (47%), and 105 (56%), respectively, in the 5919 (6%) aged 75 years or older. Although case-fatality rates increased with age, 736 (47%) of 1561 non-fatal events occurred at age 75 years or older. Interpretation The high rates of acute vascular events outside the coronary arterial territory and the steep rise in event rates with age in all territories have implications for prevention strategies, clinical trial design, and the targeting of funds for service provision and research.	Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Dept Neuroradiol, Oxford OX2 6HE, England; John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; Univ Oxford, Inst Hlth Sci, Dept Publ Hlth & Primary Care, Oxford, England	University of Oxford; Radcliffe Infirmary; University of Oxford; University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	banning, adrian p/AAF-7229-2021; Rothwell, Peter/ABE-5913-2020; Mant, David CA/C-7763-2009	Rothwell, Peter/0000-0001-9739-9211; Banning, Adrian/0000-0002-2842-7861	Medical Research Council [G0500987] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Shahi R, 2005, BRIT MED J, V331, P942, DOI 10.1136/bmj.38624.397569.68; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Asplund K, 2005, LANCET NEUROL, V4, P64, DOI 10.1016/S1474-4422(04)00967-6; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BONITA R, 1993, LANCET, V341, P1510, DOI 10.1016/0140-6736(93)90640-3; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Department of the Environment, 2000, IND DEPR; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferguson JL, 2002, HEART, V88, P343, DOI 10.1136/heart.88.4.343; Findlay IN, 2005, HEART, V91, P857, DOI 10.1136/hrt.2004.052795; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuster V, 1999, CIRCULATION, V99, P1132, DOI 10.1161/01.CIR.99.9.1132; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MELTON LJ, 1980, DIABETES CARE, V3, P650, DOI 10.2337/diacare.3.6.650; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarti C, 2003, STROKE, V34, P1833, DOI 10.1161/01.STR.0000081224.15480.52; *STAT OFF, 2001, 2001 CENS AR STAT; Thom T J, 1993, Ann Epidemiol, V3, P509; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	34	714	736	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1773	1783		10.1016/S0140-6736(05)67702-1	http://dx.doi.org/10.1016/S0140-6736(05)67702-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298214				2022-12-28	WOS:000233517200021
J	Ohlstein, B; Spradling, A				Ohlstein, B; Spradling, A			The adult Drosophila posterior midgut is maintained by pluripotent stem cells	NATURE			English	Article							MELANOGASTER; GUT; DIFFERENTIATION; EXPRESSION; OOGENESIS; NICHE	Vertebrate and invertebrate digestive systems show extensive similarities in their development, cellular makeup and genetic control(1). The Drosophila midgut is typical: enterocytes make up the majority of the intestinal epithelial monolayer, but are interspersed with hormone-producing enteroendocrine cells(2-4). Human ( and mouse) intestinal cells are continuously replenished by stem cells, the misregulation of which may underlie some common digestive diseases and cancer(5). In contrast, stem cells have not been described in the intestines of flies, and Drosophila intestinal cells have been thought to be relatively stable(6-7). Here we use lineage labelling to show that adult Drosophila posterior midgut cells are continuously replenished by a distinctive population of intestinal stem cells (ISCs). As in vertebrates, ISCs are multipotent, and Notch signalling is required to produce an appropriate fraction of enteroendocrine cells(8). Notch is also required for the differentiation of ISC daughter cells, a role that has not been addressed in vertebrates. Unlike previously characterized stem cells, which reside in niches containing a specific partner stromal cell(9,10), ISCs adjoin only the basement membrane, differentiated enterocytes and their most recent daughters. The identification of Drosophila intestinal stem cells with striking similarities to their vertebrate counterparts will facilitate the genetic analysis of normal and abnormal intestinal function.	Carnegie Inst Sci, Howard Hughes Med Inst Res Labs, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, A (corresponding author), Carnegie Inst Sci, Howard Hughes Med Inst Res Labs, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 BC010738-01] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Baumann O, 2001, EXP CELL RES, V270, P176, DOI 10.1006/excr.2001.5343; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DAY MF, 1949, AUST J SCI RES SER B, V2, P175, DOI 10.1071/BI9490175; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gartner L P, 1970, J Baltimore Coll Dent Surg, V25, P64; GARTNER LP, 1973, INT J RADIAT BIOL, V23, P23, DOI 10.1080/09553007314550031; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; MICCHELLI CA, 2005, NATURE          1207, DOI DOI 10.1038/NATURE04371; Miller A., 1950, BIOL DROSOPHILA, P420; Nassel DR, 1999, PEPTIDES, V20, P141, DOI 10.1016/S0196-9781(98)00142-9; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310	29	731	755	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					470	474		10.1038/nature04333	http://dx.doi.org/10.1038/nature04333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16340960				2022-12-28	WOS:000234859200046
J	Low, N; McCarthy, A; Roberts, TE; Huengsberg, M; Sanford, E; Sterne, JAC; Macleod, J; Salisbury, C; Pye, K; Holloway, A; Morcom, A; Patel, R; Robinson, SM; Horner, P; Barton, PM; Egger, M				Low, N; McCarthy, A; Roberts, TE; Huengsberg, M; Sanford, E; Sterne, JAC; Macleod, J; Salisbury, C; Pye, K; Holloway, A; Morcom, A; Patel, R; Robinson, SM; Horner, P; Barton, PM; Egger, M		ClaSS Project Grp	Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use	BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; TRACHOMATIS; ENGLAND; HEALTH	Objective To evaluate the effectiveness of a practice nurse led strategy to improve the notification and treatment of partners of people with chlamydia infection. Design Randomised controlled trial. Setting 27 general practices in the Bristol and Birmingham areas. Participants 140 men and women with chlamydia (index cases) diagnosed by screening of home collected urine sample or vulval swab specimen. Interventions Partner notification at the general practice immediately after diagnosis by trained practice nurses, with telephone follow-up by a health adviser; or referral to a specialist health adviser at a genitourinary medicine clinic. Main outcome measures Primary outcome was the proportion of index cases with at least one treated sexual partner. Specified secondary outcomes included the number of sexual contacts elicited during a sexual history, positive test result for chlamydia six weeks after treatment, and the cost of each strategy in 2003 pounds sterling prices. Results 65.3% (47/72) of participants receiving practice nurse led partner notification had at least one partner treated compared with 52.9% (39/68) of those referred to a genitourinary medicine clinic (risk difference 12.4%, 95% confidence interval - 1.8% to 26.5%). Of 68 participants referred to the clinic, 21 (31%) did not attend. The costs per index case were 32.55 pound for the practice nurse led strategy and 32.62 pound for the referral strategy. Conclusion Practice based partner notification by trained nurses with telephone follow-up by health advisers is at least as effective as referral to a specialist	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2TT, W Midlands, England; Heart Birmingham Teaching Primary Care Trust, Whittall St Clin, Dept Genitourinary Med, Birmingham B4 6DH, W Midlands, England; Milne Ctr Sexual Hlth, United Bristol Healthcare Trust, Dept Genitourinary Med, Bristol BS2 8EE, Avon, England; Univ Birmingham, Dept Gen Practice & Primary Care, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bern; University of Birmingham; University of Birmingham; University of Bristol; University of Bristol	Low, N (corresponding author), Univ Bern, Dept Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	low@ispm.unibe.ch	Low, Nicola/H-4718-2019; Salisbury, Chris/C-6724-2008; Sterne, Jonathan/Z-3106-2019; Roberts, Tracy/AAO-4610-2021; Robinson, Suzanne/B-6604-2013	Low, Nicola/0000-0003-4817-8986; Salisbury, Chris/0000-0002-4378-3960; Sterne, Jonathan/0000-0001-8496-6053; Roberts, Tracy/0000-0002-0624-0537; Horner, Paddy/0000-0003-0411-8332; Robinson, Suzanne/0000-0001-5703-6475; Egger, Matthias/0000-0001-7462-5132; Holloway, Aisha/0000-0003-3070-3703; Macleod, John/0000-0001-8202-1144				Adams EJ, 2004, SEX TRANSM INFECT, V80, P363, DOI 10.1136/sti.2004.009654; Adler M, 2003, BRIT MED J, V327, P62, DOI 10.1136/bmj.327.7406.62; CURTIS L, 2003, UNITS COSTS HLTH SOC; *DEP HLTH, 2003, CHLAMYDIA SCREENING; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; *HLTH PROT AG, 2004, ALL NEW EP SEEN GUM; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; LAMONTAGNE DS, 2005, 16 BIENN M INT SOC S; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; MATHEWS C, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002843; Niccolai LM, 2005, SEX TRANSM INFECT, V81, P271, DOI 10.1136/sti.2004.012872; Ross JDC, 1996, BRIT MED J, V313, P1192, DOI 10.1136/bmj.313.7066.1192a; Stokes T, 1999, INT J STD AIDS, V10, P17, DOI 10.1258/0956462991913024; *WHO JOINT UN PROG, SEX TRANSM DIS POL P	15	53	53	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					14	18		10.1136/bmj.38678.405370.7C	http://dx.doi.org/10.1136/bmj.38678.405370.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16356945	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000234684200014
J	Thorpe, RS				Thorpe, RS			Population evolution and island biogeography	SCIENCE			English	Editorial Material							LIZARD POPULATIONS; NATURAL-SELECTION		Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales	Bangor University	Thorpe, RS (corresponding author), Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	r.s.thorpe@bangor.ac.uk						Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; LOSOS JB, 2005, ADAPTIVE SPECIATION, P322; MALHOTRA A, 1991, NATURE, V353, P347, DOI 10.1038/353347a0; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Schoener TW, 2005, SCIENCE, V310, P1807, DOI 10.1126/science.1120165; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Thorpe RS, 2005, AM NAT, V165, P495, DOI 10.1086/428408; Thorpe RS, 2003, MOL ECOL, V12, P117, DOI 10.1046/j.1365-294X.2003.01704.x	10	9	9	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1778	1779		10.1126/science.1122457	http://dx.doi.org/10.1126/science.1122457			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357251				2022-12-28	WOS:000234093600035
J	Okie, S				Okie, S			Glimpses of Guantanamo - Medical ethics and the war on terror	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*DEP JUST IMM NAT, 1992, IMM ACT 1990 REP CRI, P3; Lewis Neil A, 2004, N Y Times Web, pA14; RUMSFELD D, 2003, COMMUNICATION   0416; WHITE J, 2005, WASHINGTON POST 0902, pA1	4	30	31	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2529	2534		10.1056/NEJMp058296	http://dx.doi.org/10.1056/NEJMp058296			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993BA	16354888				2022-12-28	WOS:000233926500001
J	Wu, HJ; Chen, YP; Liang, J; Shi, B; Wu, G; Zhang, Y; Wang, D; Li, RF; Yi, X; Zhang, H; Sun, LY; Shang, YF				Wu, HJ; Chen, YP; Liang, J; Shi, B; Wu, G; Zhang, Y; Wang, D; Li, RF; Yi, X; Zhang, H; Sun, LY; Shang, YF			Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis	NATURE			English	Article							ESTROGEN-RECEPTOR MODULATORS; CANCER-CELLS; BREAST-CANCER; GENE-EXPRESSION; ABERRANT EXPRESSION; PROMOTER CONTEXT; BINDING PROTEIN; TARGET GENES; ER-ALPHA; IN-VIVO	Tamoxifen, a selective oestrogen receptor modulator, has been used in the treatment of all stages of hormone-responsive breast cancer. However, tamoxifen shows partial oestrogenic activity in the uterus and its use has been associated with an increased incidence of endometrial cancer. The molecular explanation for these observations is not known. Here we show that tamoxifen and oestrogen have distinct but overlapping target gene profiles. Among the overlapping target genes, we identify a paired-box gene, PAX2, that is crucially involved in cell proliferation and carcinogenesis in the endometrium. Our experiments show that PAX2 is activated by oestrogen and tamoxifen in endometrial carcinomas but not in normal endometrium, and that this activation is associated with cancer-linked hypomethylation of the PAX2 promoter.	Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China.	jason@bjmu.edu.cn	Chen, Yupeng/T-5275-2019	Chen, Yupeng/0000-0001-8887-9547				Akhmedkhanov A, 2001, ANN NY ACAD SCI, V943, P296, DOI 10.1111/j.1749-6632.2001.tb03811.x; Bramlett KS, 2003, J STEROID BIOCHEM, V86, P27, DOI 10.1016/S0960-0760(03)00258-9; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro-Rivera E, 2003, J STEROID BIOCHEM, V84, P23, DOI 10.1016/S0960-0760(03)00010-4; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Dardes RC, 2002, GYNECOL ONCOL, V85, P498, DOI 10.1006/gyno.2002.6659; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Galien R, 1996, MOL ENDOCRINOL, V10, P713, DOI 10.1210/me.10.6.713; Ghosh MG, 2000, CANCER RES, V60, P6367; Gupta A, 2003, CANCER RES, V63, P664; Hague S, 2002, BRIT J CANCER, V86, P761, DOI 10.1038/sj.bjc.6600157; Hernandez E, 2001, OBSTET GYN CLIN N AM, V28, P743, DOI 10.1016/S0889-8545(05)70233-3; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jones PS, 1999, J BIOL CHEM, V274, P32008, DOI 10.1074/jbc.274.45.32008; Jordan VC, 2001, J NATL CANCER I, V93, P1449, DOI 10.1093/jnci/93.19.1449; KATZENELLENBOGEN BS, 1995, J STEROID BIOCHEM, V53, P387, DOI 10.1016/0960-0760(95)00084-D; Khoubehi B, 2001, J UROLOGY, V165, P2115, DOI 10.1016/S0022-5347(05)66304-5; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MONTANO MM, 1995, MOL ENDOCRINOL, V9, P814, DOI 10.1210/me.9.7.814; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; Robertson JA, 1998, J STEROID BIOCHEM, V67, P285, DOI 10.1016/S0960-0760(98)00121-6; Russo LA, 2001, J BIOL CHEM, V276, P686, DOI 10.1074/jbc.M004106200; Sakamoto T, 2002, MOL CELL ENDOCRINOL, V192, P93, DOI 10.1016/S0303-7207(02)00086-2; Sato N, 2003, CANCER RES, V63, P4158; Seth P, 2002, ONCOGENE, V21, P836, DOI 10.1038/sj.onc.1205113; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SHYAMALA G, 1992, P NATL ACAD SCI USA, V89, P10628, DOI 10.1073/pnas.89.22.10628; Silberstein GB, 2002, ONCOGENE, V21, P1009, DOI 10.1038/sj.onc.1205172; Stayner CK, 1998, J BIOL CHEM, V273, P25472, DOI 10.1074/jbc.273.39.25472; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Wang ZO, 2002, ONCOGENE, V21, P3517, DOI 10.1038/sj.onc.1205463; Watanabe T, 1997, BIOCHEM BIOPH RES CO, V236, P140, DOI 10.1006/bbrc.1997.6915; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704	47	212	234	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					981	987		10.1038/nature04225	http://dx.doi.org/10.1038/nature04225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355216				2022-12-28	WOS:000233934600058
J	Jain, A				Jain, A			Treating obesity in individuals and populations	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREVENTIVE-SERVICES; PHARMACOTHERAPY; INTERVENTIONS; TRIALS		BMJ Knowledge, London WC1H 9JR, England		Jain, A (corresponding author), BMJ Knowledge, BMA House, London WC1H 9JR, England.	ajain@bmjgroup.com						*AM OB ASS, OB RES; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Brownell K. D., 2004, FOOD FIGHT INSIDE ST; Campbell K, 2001, Obes Rev, V2, P149, DOI 10.1046/j.1467-789x.2001.00035.x; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; COLQUITT J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003641; Glenny AM, 1997, INT J OBESITY, V21, P715, DOI 10.1038/sj.ijo.0800495; Haddock CK, 2002, INT J OBESITY, V26, P262, DOI 10.1038/sj.ijo.0801889; HIDER P, 2001, 42 NZ HLTH TECHN; JADAD A, 1998, RANDOMISED CONTROLLE, P45; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; KATZ DL, 2005, MMWR, V54; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Lenz Thomas L, 2004, J Am Pharm Assoc (2003), V44, P59, DOI 10.1331/154434504322713246; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; Rychetnik L, 2004, J EPIDEMIOL COMMUN H, V58, P538, DOI 10.1136/jech.2003.011585; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Swinburn B, 2002, Obes Rev, V3, P289; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; *U YORK NHS CTR RE, 2002, EFFECTIVE HLTH CARE, V7, P1; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725	24	64	65	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1387	1390		10.1136/bmj.331.7529.1387	http://dx.doi.org/10.1136/bmj.331.7529.1387			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339251	Green Published			2022-12-28	WOS:000233999300024
J	Tomasko, MG; Archinal, B; Becker, T; Bezard, B; Bushroe, M; Combes, M; Cook, D; Coustenis, A; de Bergh, C; Dafoe, LE; Doose, L; Doute, S; Eibl, A; Engel, S; Gliem, F; Grieger, B; Holso, K; Howington-Kraus, E; Karkoschka, E; Keller, HU; Kirk, R; Kramm, R; Kuppers, M; Lanagan, P; Lellouch, E; Lemmon, M; Lunine, J; McFarlane, E; Moores, J; Prout, GM; Rizk, B; Rosiek, M; Rueffer, P; Schroder, SE; Schmitt, B; See, C; Smith, P; Soderblom, L; Thomas, N; West, R				Tomasko, MG; Archinal, B; Becker, T; Bezard, B; Bushroe, M; Combes, M; Cook, D; Coustenis, A; de Bergh, C; Dafoe, LE; Doose, L; Doute, S; Eibl, A; Engel, S; Gliem, F; Grieger, B; Holso, K; Howington-Kraus, E; Karkoschka, E; Keller, HU; Kirk, R; Kramm, R; Kuppers, M; Lanagan, P; Lellouch, E; Lemmon, M; Lunine, J; McFarlane, E; Moores, J; Prout, GM; Rizk, B; Rosiek, M; Rueffer, P; Schroder, SE; Schmitt, B; See, C; Smith, P; Soderblom, L; Thomas, N; West, R			Rain, winds and haze during the Huygens probe's descent to Titan's surface	NATURE			English	Article							AGGREGATE PARTICLES; ATMOSPHERE; AEROSOLS; SIMULATION; AMMONIA; ENTRY; MODEL; ICE	The irreversible conversion of methane into higher hydrocarbons in Titan's stratosphere implies a surface or subsurface methane reservoir. Recent measurements from the cameras aboard the Cassini orbiter fail to see a global reservoir, but the methane and smog in Titan's atmosphere impedes the search for hydrocarbons on the surface. Here we report spectra and high-resolution images obtained by the Huygens Probe Descent Imager/Spectral Radiometer instrument in Titan's atmosphere. Although these images do not show liquid hydrocarbon pools on the surface, they do reveal the traces of once flowing liquid. Surprisingly like Earth, the brighter highland regions show complex systems draining into flat, dark lowlands. Images taken after landing are of a dry riverbed. The infrared reflectance spectrum measured for the surface is unlike any other in the Solar System; there is a red slope in the optical range that is consistent with an organic material such as tholins, and absorption from water ice is seen. However, a blue slope in the near-infrared suggests another, unknown constituent. The number density of haze particles increases by a factor of just a few from an altitude of 150 km to the surface, with no clear space below the tropopause. The methane relative humidity near the surface is 50 per cent.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Observ Paris, LESIA, F-92195 Meudon, France; Univ Grenoble 1, CNRS, Lab Planetol Grenoble, F-38041 Grenoble, France; Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; Ist Fis Spazio Interplanetario, Ist Nazl Astrofis, ARTOV, I-00133 Rome, Italy; Univ Bern, Dept Phys, CH-3012 Bern, Switzerland; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Braunschweig University of Technology; Max Planck Society; Texas A&M University System; Texas A&M University College Station; Istituto Nazionale Astrofisica (INAF); University of Bern; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	See, C (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	csee@lpl.arizona.edu	Schmitt, Bernard/A-1064-2009; Lemmon, Mark/X-2333-2019; Lemmon, Mark T/E-9983-2010; Moores, John E./AAO-6622-2021; Schröder, Stefan/D-9709-2013; Thomas, Nicolas/G-4693-2015	Schmitt, Bernard/0000-0002-1230-6627; Lemmon, Mark/0000-0002-4504-5136; Lemmon, Mark T/0000-0002-4504-5136; Moores, John E./0000-0001-9435-1095; Schröder, Stefan/0000-0003-0323-8324; Bezard, Bruno/0000-0002-5433-5661; Thomas, Nicolas/0000-0002-0146-0071; Lunine, Jonathan/0000-0003-2279-4131				Bernard JM, 2003, PLANET SPACE SCI, V51, P1003, DOI 10.1016/j.pss.2003.05.009; BERNARD JM, UNPUB ICARUS; BOND NA, 1992, J CLIMATE, V5, P699, DOI 10.1175/1520-0442(1992)005<0699:OOPBLS>2.0.CO;2; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CABANE M, 1993, PLANET SPACE SCI, V41, P257, DOI 10.1016/0032-0633(93)90021-S; CABANE M, 1992, ICARUS, V96, P176, DOI 10.1016/0019-1035(92)90071-E; Coll P, 1999, PLANET SPACE SCI, V47, P1331, DOI 10.1016/S0032-0633(99)00054-9; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; Coustenis A, 2005, ICARUS, V177, P89, DOI 10.1016/j.icarus.2005.03.012; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; FLASAR FM, 1997, ESA SP PUBL, V1177, P287; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Ivanov BA, 1997, PLANET SPACE SCI, V45, P993, DOI 10.1016/S0032-0633(97)00044-5; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Lellouch E, 2004, ICARUS, V168, P209, DOI 10.1016/j.icarus.2003.12.001; LEMMON MT, 1994, THESIS U ARIZONA; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tomasko MG, 2002, SPACE SCI REV, V104, P469, DOI 10.1023/A:1023632422098; TOON OB, 1992, ICARUS, V95, P24, DOI 10.1016/0019-1035(92)90188-D; WEST RA, 1991, APPL OPTICS, V30, P5316, DOI 10.1364/AO.30.005316; WEST RA, 1991, ICARUS, V90, P330, DOI 10.1016/0019-1035(91)90113-8	31	415	420	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					765	778		10.1038/nature04126	http://dx.doi.org/10.1038/nature04126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319829				2022-12-28	WOS:000233777800037
J	Zeilinger, A				Zeilinger, A			The message of the quantum	NATURE			English	Editorial Material									Univ Vienna, Inst Expt Phys, A-1090 Vienna, Austria; Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria	University of Vienna; Austrian Academy of Sciences	Zeilinger, A (corresponding author), Univ Vienna, Inst Expt Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.		Zeilinger, Anton/A-1170-2011					SCHILPP PA, 1949, A EINSTEIN PHILOS SC; Zeilinger A, 2005, NATURE, V433, P230, DOI 10.1038/nature03280	2	72	74	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					743	743		10.1038/438743a	http://dx.doi.org/10.1038/438743a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16340995				2022-12-28	WOS:000233777800023
J	Goy, JJ; Urban, P				Goy, JJ; Urban, P			Life and limb: bypass versus angioplasty in the ischaemic limb	LANCET			English	Editorial Material							METAANALYSIS; SURGERY; DISEASE		Clin Cecil, Serv Cardiol, CH-1003 Lausanne, Switzerland		Goy, JJ (corresponding author), Clin Cecil, Serv Cardiol, CH-1003 Lausanne, Switzerland.	jjgoy@goyman.com						Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Burns P, 2003, BMJ-BRIT MED J, V326, P584, DOI 10.1136/bmj.326.7389.584; Duda SH, 2002, CIRCULATION, V106, P1505, DOI 10.1161/01.CIR.0000029746.10018.36; Holm J, 1991, Eur J Vasc Surg, V5, P517, DOI 10.1016/S0950-821X(05)80338-X; King SB, 2005, CIRCULATION, V112, P1500, DOI 10.1161/CIRCULATIONAHA.104.483339; Mercado N, 2005, J THORAC CARDIOV SUR, V130, P512, DOI 10.1016/j.jtcvs.2004.12.049; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; WILSON SE, 1989, J VASC SURG, V9, P1, DOI 10.1067/mva.1989.vs0090001; 2004, EUR J VASC ENDOVASC, V28, P132	9	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1905	1906		10.1016/S0140-6736(05)67705-7	http://dx.doi.org/10.1016/S0140-6736(05)67705-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325681				2022-12-28	WOS:000233777900004
J	Yamada, S; Pokutta, S; Drees, F; Weis, WI; Nelson, WJ				Yamada, S; Pokutta, S; Drees, F; Weis, WI; Nelson, WJ			Deconstructing the cadherin-catenin-actin complex	CELL			English	Article							CELL-CELL ADHESION; ALPHA-CATENIN; EPITHELIAL-CELLS; BETA-CATENIN; INTERCELLULAR-ADHESION; JUNCTIONAL COMPLEX; F-ACTIN; PROTEIN; MEMBRANE; BINDING	Spatial and functional organization of cells in tissues is determined by cell-cell adhesion, thought to be initiated through trans-interactions between extracellular domains of the cadherin family of adhesion proteins, and strengthened by linkage to the actin cytoskeleton. Prevailing dogma is that cadherins are linked to the actin cytoskeleton through beta-catenin and alpha-catenin, although the quaternary complex has never been demonstrated. We test this hypothesis and find that alpha-catenin does not interact with actin filaments and the E-cadherin-beta-catenin complex simultaneously, even in the presence of the actin binding proteins vinculin and alpha-actinin, either in solution or on isolated cadherin-containing membranes. Direct analysis in polarized cells shows that mobilities of E-cadherin, beta-catenin, and alpha-catenin are similar, regardless of the dynamic state of actin assembly, whereas actin and several actin binding proteins have higher mobilities. These results suggest that the linkage between the cadherin-catenin complex and actin filaments is more dynamic than previously appreciated.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	bill.weis@stanford.edu; wjnelson@stanford.edu	Weis, William I/G-1437-2011; Yamada, Soichiro/B-7360-2019	Weis, William I/0000-0002-5583-6150; Yamada, Soichiro/0000-0001-6413-0814	NIGMS NIH HHS [R01 GM035527, R01 GM56169, R01 GM35527, R01 GM056169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R01GM056169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERLE H, 1994, J CELL SCI, V107, P3655; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Drees Frauke, 2004, V294, P303; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	46	762	785	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					889	901		10.1016/j.cell.2005.09.020	http://dx.doi.org/10.1016/j.cell.2005.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325582	Bronze, Green Accepted			2022-12-28	WOS:000233814100021
J	Whyte, MA				Whyte, MA			A gigantic fossil arthropod trackway	NATURE			English	Editorial Material									Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Whyte, MA (corresponding author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.	m.a.whyte@sheffield.ac.uk						Almond J.E., 2002, GEOBULLETIN, V45, P28; Braddy SJ, 1998, CAN J EARTH SCI, V35, P1116, DOI 10.1139/e98-057; Braddy SJ, 1999, J AFR EARTH SCI, V29, P165, DOI 10.1016/S0899-5362(99)00087-1; BRIGGS DEG, 1983, J PALEONTOL, V57, P377; Draganits E, 2001, PALAIOS, V16, P126, DOI 10.2307/3515525; HANKEN N-M, 1975, Fossils and Strata, V4, P255; JERAM AJ, 1994, T ROY SOC EDIN-EARTH, V84, P301; Selden PA, 2005, BIOL LETT-UK, V1, P44, DOI 10.1098/rsbl.2004.0272; Waterston C.D., 1968, Transactions R Soc Edinburgh, V68, P1; WATERSTON CD, 1957, T R SOC EDINB, V61, P265	10	25	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					576	576		10.1038/438576a	http://dx.doi.org/10.1038/438576a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319874	Green Submitted, Bronze			2022-12-28	WOS:000233593100031
J	Kollmann, M; Lovdok, L; Bartholome, K; Timmer, J; Sourjik, V				Kollmann, M; Lovdok, L; Bartholome, K; Timmer, J; Sourjik, V			Design principles of a bacterial signalling network	NATURE			English	Article							GENE-EXPRESSION; CHEMOTAXIS; ROBUSTNESS; STOCHASTICITY; SENSITIVITY; PROTEIN; NOISE	Cellular biochemical networks have to function in a noisy environment using imperfect components. In particular, networks involved in gene regulation or signal transduction allow only for small output tolerances, and the underlying network structures can be expected to have undergone evolution for inherent robustness against perturbations(1). Here we combine theoretical and experimental analyses to investigate an optimal design for the signalling network of bacterial chemotaxis, one of the most thoroughly studied signalling networks in biology. We experimentally determine the extent of intercellular variations in the expression levels of chemotaxis proteins and use computer simulations to quantify the robustness of several hypothetical chemotaxis pathway topologies to such gene expression noise. We demonstrate that among these topologies the experimentally established chemotaxis network of Escherichia coli has the smallest sufficiently robust network structure, allowing accurate chemotactic response for almost all individuals within a population. Our results suggest that this pathway has evolved to show an optimal chemotactic performance while minimizing the cost of resources associated with high levels of protein expression. Moreover, the underlying topological design principles compensating for intercellular variations seem to be highly conserved among bacterial chemosensory systems(2).	Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany; Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany; Univ Freiburg, FDM, D-79104 Freiburg, Germany	University of Freiburg; Ruprecht Karls University Heidelberg; University of Freiburg	Kollmann, M (corresponding author), Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.	markus.kollmann@fdm.uni-freiburg.de; v.sourjik@zmbh.uni-heidelberg.de	Bartholome, Kilian/F-1691-2011; Bartholome, Kilian/A-9593-2013	Bartholome, Kilian/0000-0001-6525-777X; Bartholome, Kilian/0000-0001-6525-777X				Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Almogy G, 2001, BIOPHYS J, V81, P3016, DOI 10.1016/S0006-3495(01)75942-5; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; ROSENFELD N, 2005, NATURE, V307, P1962; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Webre DJ, 2003, CURR BIOL, V13, pR47, DOI 10.1016/S0960-9822(02)01424-0	30	229	243	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					504	507		10.1038/nature04228	http://dx.doi.org/10.1038/nature04228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306993				2022-12-28	WOS:000233458200051
J	Merano, M; Sonderegger, S; Crottini, A; Collin, S; Renucci, P; Pelucchi, E; Malko, A; Baier, MH; Kapon, E; Deveaud, B; Ganiere, JD				Merano, M; Sonderegger, S; Crottini, A; Collin, S; Renucci, P; Pelucchi, E; Malko, A; Baier, MH; Kapon, E; Deveaud, B; Ganiere, JD			Probing carrier dynamics in nanostructures by picosecond cathodoluminescence	NATURE			English	Article							QUANTUM DOTS; SINGLE; LUMINESCENCE; RELAXATION	Picosecond and femtosecond spectroscopy allow the detailed study of carrier dynamics in nanostructured materials(1). In such experiments, a laser pulse normally excites several nanostructures at once. However, spectroscopic information may also be acquired using pulses from an electron beam in a modern electron microscope, exploiting a phenomenon called cathodoluminescence. This approach offers several advantages. The multimode imaging capabilities of the electron microscope enable the correlation of optical properties (via cathodoluminescence) with surface morphology (secondary electron mode) at the nanometre scale(2). The broad energy range of the electrons can excite wide-bandgap materials, such as diamond- or gallium-nitride-based structures that are not easily excited by conventional optical means. But perhaps most intriguingly, the small beam can probe a single selected nanostructure. Here we apply an original time-resolved cathodoluminescence set-up to describe carrier dynamics within single gallium-arsenide-based pyramidal nanostructures(3) with a time resolution of 10 picoseconds and a spatial resolution of 50 nanometres. The behaviour of such charge carriers could be useful for evaluating elementary components in quantum computers(4,5), optical quantum gates6 or single photon sources(7-9) for quantum cryptography(10).	Ecole Polytech Fed Lausanne, Inst Quantum Elect & Photon, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Merano, M (corresponding author), Ecole Polytech Fed Lausanne, Inst Quantum Elect & Photon, CH-1015 Lausanne, Switzerland.	michele.merano@ensta.fr	Merano, Michele/G-8774-2016; Deveaud, Benoit/A-4782-2013; Collin, Stéphane/B-4118-2008; Deveaud, Benoit/N-1947-2014; Ganiere, Jean-Daniel JD/I-3881-2012; Pelucchi, Emanuele/B-2744-2009	Deveaud, Benoit/0000-0002-9776-6314; Collin, Stéphane/0000-0001-6176-1653; Deveaud, Benoit/0000-0002-9776-6314; Pelucchi, Emanuele/0000-0001-7682-0601; MERANO, MICHELE/0000-0001-7970-4200				Baier MH, 2004, APPL PHYS LETT, V84, P648, DOI 10.1063/1.1643533; Bell A, 2004, J APPL PHYS, V95, P4670, DOI 10.1063/1.1689736; Diaz-Guerra C, 2003, J APPL PHYS, V94, P2341, DOI 10.1063/1.1592296; ELSAYEDALI HE, 1990, REV SCI INSTRUM, V61, P1636, DOI 10.1063/1.1141126; Gerard JM, 1999, J LIGHTWAVE TECHNOL, V17, P2089, DOI 10.1109/50.802999; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Gustafsson A, 1998, J APPL PHYS, V84, P1715, DOI 10.1063/1.368613; Hartmann A, 2000, PHYS REV LETT, V84, P5648, DOI 10.1103/PhysRevLett.84.5648; Imamoglu A, 2003, PHYSICA E, V16, P47, DOI 10.1016/S1386-9477(02)00581-7; Kapon E, 2004, PHYSICA E, V25, P288, DOI 10.1016/j.physe.2004.06.033; KONG SH, 1995, NUCL INSTRUM METH A, V358, P284, DOI 10.1016/0168-9002(94)01407-8; Korovyanko OJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017403; Leifer K, 2000, APPL PHYS LETT, V77, P3923, DOI 10.1063/1.1332099; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MAY P, 1987, APPL PHYS LETT, V51, P145, DOI 10.1063/1.98596; Menniger J, 1996, PHYS REV B, V53, P1881, DOI 10.1103/PhysRevB.53.1881; Piermarocchi C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.167402; REIMER L, 1998, SCANNING ELECT MICRO, pCH1; SHAH J, 1999, ULTRAFAST SPECTROSCO, pCH8; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; STECKENBORN A, 1981, J LUMIN, V24-5, P351, DOI 10.1016/0022-2313(81)90288-X; Turck V, 2001, PHYS STATUS SOLIDI B, V224, P643, DOI 10.1002/(SICI)1521-3951(200104)224:3<643::AID-PSSB643>3.0.CO;2-L; Vetter U, 2004, APPL PHYS LETT, V84, P4286, DOI 10.1063/1.1753053; Warburton RJ, 2002, CONTEMP PHYS, V43, P351, DOI 10.1080/00107510210123845; Williamson JC, 1997, NATURE, V386, P159, DOI 10.1038/386159a0; Zhang X, 1998, APPL PHYS LETT, V73, P1430, DOI 10.1063/1.121966	28	122	124	5	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					479	482		10.1038/nature04298	http://dx.doi.org/10.1038/nature04298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306988				2022-12-28	WOS:000233458200045
J	Han, JK				Han, JK			Malignant neglect	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hanjk@upmc.edu						HIMMELSTEIN DU, 2005, HLTH AFF MILLWO 0202	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2546	2548		10.1001/jama.294.20.2546	http://dx.doi.org/10.1001/jama.294.20.2546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304062				2022-12-28	WOS:000233436200001
J	Locock, L				Locock, L			The parents' journey: continuing a pregnancy after a diagnosis of Patau's syndrome	BRITISH MEDICAL JOURNAL			English	Review									Univ Oxford, Dept Primary Care, DIPEx Res Grp, Oxford OX3 7LF, England	University of Oxford	Locock, L (corresponding author), Univ Oxford, Dept Primary Care, DIPEx Res Grp, Oxford OX3 7LF, England.	louise.locock@dphpc.ox.ac.uk						*CAMBR, 2001, FIN REP STUD 247 WOM; Chitty LS, 1996, BRIT MED J, V313, P478; Katz Rothman B., 1994, TENTATIVE PREGNANCY; *NAT EL LIB HLTH, SPEC LIB CLIN GEN; Redlinger-Grosse K, 2002, AM J MED GENET, V112, P369, DOI 10.1002/ajmg.10657; Sandelowski M, 1996, SOC SCI MED, V42, P353, DOI 10.1016/0277-9536(95)00102-6; STATHAM H, 2004, PRENATAL DIAGNOSIS H	7	16	16	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1186	1189		10.1136/bmj.331.7526.1186	http://dx.doi.org/10.1136/bmj.331.7526.1186			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293841	Green Published			2022-12-28	WOS:000233571000023
J	Marshall, M; Wilson, T				Marshall, M; Wilson, T			The NHS revolution: health care in the market place - Competition in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY; INEQUALITY; ENGLAND		Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Mill Stream Surg, Benson OX10 6RL, Oxon, England	University of Manchester	Marshall, M (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	martin.marshall@manchester.ac.uk						Baker R, 2002, BRIT J GEN PRACT, V52, pS2; Blendon RJ, 2002, HEALTH AFFAIR, V21, P182, DOI 10.1377/hlthaff.21.3.182; BOWER P, 2003, BRIT MED J, V236, pS25; Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680; CAMPBELL SM, 2003, IN PRESS BMJ; *COMM HEALTHC IMPR, 2003, LOC HLTH SERV PAT SU; De Maeseneer J, 2000, BRIT MED J, V320, P1616, DOI 10.1136/bmj.320.7250.1616; *DEP HLTH, 2005, MOR GPS DOCT AR; *DEP HLTH, 2003, BUILD BEST CHOIC RES; Dovey SM, 2002, QUAL SAF HEALTH CARE, V11, P233, DOI 10.1136/qhc.11.3.233; Freeman G, 1997, BRIT MED J, V314, P1870, DOI 10.1136/bmj.314.7098.1870; Gatrell A, 2002, HEALTH PLACE, V8, P147, DOI 10.1016/S1353-8292(01)00044-2; Grol R, 2000, BRIT J GEN PRACT, V50, P882; Hann M, 2004, BRIT J GEN PRACT, V54, P894; Haslam D, 2003, BRIT MED J, V326, P234, DOI 10.1136/bmj.326.7383.234; *HLTH SOC CAR INF, QUAL OUTC FRAM INF; Irvine D, 1975, J R Coll Gen Pract, V25, P399; Mainous AG, 2001, FAM MED, V33, P22; MARSHALL M, 2005, PRODUCING INFORMATIO; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; ROBINSON JC, 1988, JAMA-J AM MED ASSOC, V260, P2676, DOI 10.1001/jama.260.18.2676; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; SCHOEN C, 2004, HLTH AFF MILWOOD S; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Sheaff R, 2003, ORG FACTORS PERFORMA; Sheaff Rod, 2004, J Health Serv Res Policy, V9, P132, DOI 10.1258/1355819041403295; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Starfield B, 1998, PRIMARY CARE BALANCI; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; WEINER JP, 1983, AM J PUBLIC HEALTH, V73, P666, DOI 10.2105/AJPH.73.6.666	30	4	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2005	331	7526					1196	1199		10.1136/bmj.331.7526.1196	http://dx.doi.org/10.1136/bmj.331.7526.1196			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988DG	16293844	Green Published			2022-12-28	WOS:000233571000026
J	Dunn, DT; Gibb, DM; Duong, T; Babiker, AG; Aboulker, IP; Bulterys, M; Cortina-Borja, M; Gabiano, C; Galli, L; Giaquinto, C; Harris, DR; Hughes, M; McKinney, R; Moye, J; Newell, ML; Pahwa, S; Palumbo, P; Rudin, C; Sharland, M; Shearer, W; Thompson, B; Tookey, P				Dunn, DT; Gibb, DM; Duong, T; Babiker, AG; Aboulker, IP; Bulterys, M; Cortina-Borja, M; Gabiano, C; Galli, L; Giaquinto, C; Harris, DR; Hughes, M; McKinney, R; Moye, J; Newell, ML; Pahwa, S; Palumbo, P; Rudin, C; Sharland, M; Shearer, W; Thompson, B; Tookey, P		HIV Paediat Prognostic Markers Col	Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data	LANCET			English	Article							AFRICAN CHILDREN; CD4; MORTALITY; AGE; SUBSETS; BIRTH	Background Total lymphocyte count has been proposed as an alternative to the percentage of CD4+ T-cells to indicate when antiretroviral therapy should be started in children with HIV in resource-poor settings. We aimed to assess thresholds of total lymphocyte count at which antiretroviral therapy should be considered, and compared monitoring of total lymphocyte count with monitoring of CD4-cell percentage. Methods Longitudinal data on 3917 children with HIV infection were pooled from observational and randomised studies in Europe and the USA. The 12-month risks of death and AIDS by most recent total lymphocyte count and age were estimated by parametric survival models, based on measurements before antiretroviral therapy or during zidovudine monotherapy. Risks were derived and compared at thresholds of total lymphocyte count and CD4-cell percentage for starting antiretroviral therapy recommended in WHO 2003 guidelines. Findings Total lymphocyte count was a powerful predictor of the risk of disease progression despite a weak correlation with CD4-cell percentage (r=0.08-0.19 dependent on age). For children older than 2 years, the 12-month risk of death and AIDS increased sharply at values less than 1500-2000 cells per mu L, with little trend at higher values. Younger children had higher risks and total lymphocyte count was less prognostic. Mortality risk was substantially higher at thresholds of total lymphocyte count recommended by WHO than at corresponding thresholds of CD4-cell percentage. When the markers were compared at the threshold values at which mortality risks were about equal, total lymphocyte count was as effective as CD4-cell percentage for identifying children before death, but resulted in an earlier start of antiretroviral therapy. Interpretation In this population, total lymphocyte count was a strong predictor of short-term disease progression, being only marginally less predictive than CD4-cell percentage. Confirmatory studies in resource-poor settings are needed to identify the most cost-effective markers to guide initiation of antiretroviral therapy.	MRC, Clin Trials Unit, London NW1 2DA, England; INSERM, SC10, F-75654 Paris, France; Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; UCL, Inst Child Hlth, London, England; Univ Turin, Dept Paediat, Turin, Italy; Univ Florence, Dept Paediat, Florence, Italy; Univ Padua, Dept Paediat, Padua, Italy; Westat Corp, Rockville, MD 20850 USA; NICHD, Intravenous Immunoglobulin Study Grp, Bethesda, MD 20892 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Duke Univ, Med Ctr, Durham, NC USA; NICHD, NIH, Rockville, MD USA; NICHD, Women & Infants Transmiss Study, Bethesda, MD 20892 USA; N Shore LIJ Res Inst, Manhasset, NY USA; UMDNJ Med Sch, Newark, NJ USA; Univ Childrens Hosp, Basel, Switzerland; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Baylor Coll Med, Houston, TX 77030 USA; Clin Trials & Surveys Corp, Baltimore, MD USA	Medical Research Council Clinical Trials Unit; Institut National de la Sante et de la Recherche Medicale (Inserm); Centers for Disease Control & Prevention - USA; University of London; University College London; University of Turin; University of Florence; University of Padua; Westat; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; Duke University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Northwell Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; St Georges University London; Baylor College of Medicine	Dunn, DT (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	d.dunn@ctu.mrc.ac.uk	Tookey, Pat A/G-2732-2010; Borja, Mario Cortina/A-3847-2009; Newell, Marie-Louise/AAE-8222-2019; VALLET, Yannick/F-9979-2011; Giaquinto, Carlo/AAB-5016-2020; Pahwa, Savita/AAA-4900-2019	Tookey, Pat A/0000-0001-6258-0387; Borja, Mario Cortina/0000-0003-0627-2624; Newell, Marie-Louise/0000-0002-1074-7699; Pahwa, Savita/0000-0002-4470-4216; Dunn, David/0000-0003-1836-4446; sharland, mike/0000-0001-8626-8291	Medical Research Council [MC_U122886351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; Abrams EJ, 2003, LANCET, V362, P1595, DOI 10.1016/S0140-6736(03)14837-4; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; [Anonymous], GUIDELINES USE ANTIR; Bedell R, 2003, ANTIVIR THER, V8, P379; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; FISHER KA, 2004, 15 INT AIDS C BANGK; *FOR COLL HIV RES, QA QC CD4 VIR LOAD A; GAZZARD B, 2001, HIV MED, V2, P276; Gray L, 2003, JAIDS-J ACQ IMM DEF, V33, P635, DOI 10.1097/00126334-200308150-00013; Howden B, 2001, LAB HEMATOL, V7, P89; Jacobson MA, 2003, AIDS, V17, P917, DOI 10.1097/00002030-200304110-00019; KIEPIELA P, 1989, ANN TROP PAEDIATR, V9, P199, DOI 10.1080/02724936.1989.11748633; Kumarasamy N, 2002, JAIDS-J ACQ IMM DEF, V31, P378, DOI 10.1097/00126334-200212010-00002; Lisse IM, 1997, J PEDIATR-US, V130, P77, DOI 10.1016/S0022-3476(97)70313-5; Mekonnen Y, 2003, AIDS, V17, P815, DOI 10.1097/00002030-200304110-00006; Mofenson LM, 2003, LANCET, V362, P1625, DOI 10.1016/S0140-6736(03)14825-8; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Post FA, 1996, QJM-MON J ASSOC PHYS, V89, P505; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Schreibman T, 2004, CLIN INFECT DIS, V38, P257, DOI 10.1086/380792; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; SINYINZA F, 2004, 11 C RETR OPP INF SA; Spacek LA, 2003, AIDS, V17, P1311, DOI 10.1097/00002030-200306130-00005; Taha TE, 2000, AIDS, V14, P453, DOI 10.1097/00002030-200003100-00021; World Health Organization, 2004, SCAL ANT THER RES LT	29	36	36	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1868	1874						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310553				2022-12-28	WOS:000233643200025
J	Gallo, RC				Gallo, RC			The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years	LANCET			English	Editorial Material							REACTIVE NEUTRALIZING ANTIBODIES; GENOMIC DIVERSITY; INTERFERON-ALPHA; BETA-CHEMOKINES; PUBLIC-HEALTH; ELICIT; AIDS; IMMUNIZATION; COMPLEXES; MACAQUES		Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Gallo, RC (corresponding author), Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA.	gallo@umbi.umd.edu						AIDS Vaccine Advocacy Coalition, 2004, SCIENCE, V305, P177; Barouch DH, 2002, VACCINE, V20, pA66, DOI 10.1016/S0264-410X(02)00390-0; Belshe R, 2004, SCIENCE, V305, P177; Bower JF, 2004, VIROLOGY, V328, P292, DOI 10.1016/j.virol.2004.07.031; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen J, 2003, SCIENCE, V299, P1290, DOI 10.1126/science.299.5611.1290; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Devico A, 1996, VIROLOGY, V218, P258, DOI 10.1006/viro.1996.0188; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; Gallo RC, 2004, SCIENCE, V305, P179; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gringeri A, 1996, J ACQ IMMUN DEF SYND, V13, P55, DOI 10.1097/00042560-199609000-00009; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Hilleman MR, 2002, INTERVIROLOGY, V45, P199, DOI 10.1159/000067911; Hilleman MR, 2001, VACCINE, V19, P1837, DOI 10.1016/S0264-410X(00)00364-9; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Horton R, 2004, NEW YORK REV BOOKS, V51, P14; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KAHN JO, 1990, ANN INTERN MED, V112, P254, DOI 10.7326/0003-4819-112-4; KOUP R, 2004, 13 INT S HIV EM INF; Kuhmann SE, 2004, TRENDS PHARMACOL SCI, V25, P117, DOI 10.1016/j.tips.2004.01.005; Lehner T, 2000, IMMUNOLOGY, V99, P569, DOI 10.1046/j.1365-2567.2000.00993.x; Lockey TD, 2000, IMMUNOL RES, V21, P7, DOI 10.1385/IR:21:1:7; McCutchan FE, 2000, AIDS, V14, pS31; McNeil JG, 2004, SCIENCE, V303, P961, DOI 10.1126/science.1096161; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Srivastava Indresh K, 2004, Expert Rev Vaccines, V3, pS33, DOI 10.1586/14760584.3.4.S33; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; WONGSTAAL F, 1985, SCIENCE, V229, P759, DOI 10.1126/science.2992084; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; 2001, AIDSCIENCE, V1, P1	42	30	103	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1894	1898		10.1016/S0140-6736(05)67395-3	http://dx.doi.org/10.1016/S0140-6736(05)67395-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310557				2022-12-28	WOS:000233643200029
J	Black, N				Black, N			Rise and demise of the hospital: a reappraisal of nursing	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	nick.black@lshtm.ac.uk						Abel-Smith Brian, 1964, HOSP 1800 1948; *AUD COMM, 2001, AC HOSP PORTF DAY SU; Bodenheimer T, 2005, BRIT MED J, V330, P612, DOI 10.1136/bmj.330.7492.612; BOSELEY S, 2005, GUARDIAN        0207, P12; *BRIT MED ASS ROYA, 1998, PROV AC GEN HOSP SER; *DEP HLTH, 2004, MATR CHART; Department of Health, 2000, ORG MEM; GULL WW, 1896, COLLECTION PUBLISHES; HELMSTADTER C, 1993, B HIST MED, V67, P282; HOLLOWAY S W, 1959, Med Hist, V3, P146; *I MED, 1999, ERR IS HUM BUILD SAF; Lightfoot Thomas, 1850, LOND MED TIMES, V561, P463; Lloyd WEB, 1936, 100 YEARS MED; Nightingale F., 1859, NOTES NURSING WHAT I; Nightingale Florence, 1859, NOTES HOSP; *ROYAL COLL PHYS L, 2004, CLIN SERV COMM CHRON; SHRYOCK RH, 1959, HIST NURSING INTERPR; SIMPSON HM, 1964, EVOLUTION HOSP; SIMPSON JY, 1869, LANCET, V2, P475; Smith R, 2001, BRIT MED J, V323, P245, DOI 10.1136/bmj.323.7307.245; Strong P, 1990, NHS NEW MANAGEMENT; WADDINGTON K, 1995, SOC HIST MED, V8, P211, DOI 10.1093/shm/8.2.211; WHELDON J, 2005, DAILY MAIL      0225, P1; 1880, BMJ, V2, P97	24	16	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1394	1396		10.1136/bmj.331.7529.1394	http://dx.doi.org/10.1136/bmj.331.7529.1394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16339253	Green Published, Green Accepted			2022-12-28	WOS:000233999300029
J	Lamb, D; Erskine, PD; Parrotta, JA				Lamb, D; Erskine, PD; Parrotta, JA			Restoration of degraded tropical forest landscapes	SCIENCE			English	Review							ABANDONED PASTURES; COSTA-RICA; BIODIVERSITY; PLANTATIONS; CONSERVATION; REGENERATION; GROWTH	The current scale of deforestation in tropical regions and the large areas of degraded lands now present underscore the urgent need,for interventions to restore biodiversity, ecological functioning, and the supply of goods and ecological services previously used by poor rural communities. Traditional timber plantations have supplied some goods but have made only minor contributions to fulfilling most of these other objectives. New approaches to reforestation are now emerging, with potential for both overcoming forest degradation and addressing rural poverty.	Univ Queensland, Rainforest Cooperat Res Ctr, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; US Forest Serv, Res & Dev, USDA, Arlington, VA 22209 USA	University of Queensland; University of Queensland; United States Department of Agriculture (USDA); United States Forest Service	Lamb, D (corresponding author), Univ Queensland, Rainforest Cooperat Res Ctr, Brisbane, Qld 4072, Australia.	d.lamb@uq.edu.au	Erskine, Peter D/U-3136-2018	Erskine, Peter D/0000-0002-8298-2866; Parrotta, John/0000-0002-9283-6037				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Arroyo-Mora JP, 2005, AGR ECOSYST ENVIRON, V106, P27, DOI 10.1016/j.agee.2004.07.002; Ashton MS, 2001, FOREST ECOL MANAG, V154, P431, DOI 10.1016/S0378-1127(01)00513-8; BARROW E, 2002, FOREST LANDSCAPE RES; Corlett RT, 1999, FOREST ECOL MANAG, V116, P93, DOI 10.1016/S0378-1127(98)00443-5; du Toit JT, 2004, TRENDS ECOL EVOL, V19, P12, DOI 10.1016/j.tree.2003.09.018; Elliott S, 2003, FOREST ECOL MANAG, V184, P177, DOI 10.1016/S0378-1127(03)00211-1; Engel VL, 2001, FOREST ECOL MANAG, V152, P169, DOI 10.1016/S0378-1127(00)00600-9; Erskine PD, 2002, ECOL MANAG RESTOR, V3, P136; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; ITTO-International Tropical Timber Organization, 2002, POLICY DEV SERIES, V13; Lamb D., 2003, REHABILITATION RESTO; Leopold AC, 2001, FOREST ECOL MANAG, V142, P243, DOI 10.1016/S0378-1127(00)00354-6; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MacDonald GE, 2004, CRIT REV PLANT SCI, V23, P367, DOI 10.1080/07352680490505114; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin PH, 2004, BIOTROPICA, V36, P297; McNabb KL, 1999, NEW FOREST, V18, P5, DOI 10.1023/A:1006536105443; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Parrotta JA, 1999, RESTOR ECOL, V7, P103, DOI 10.1046/j.1526-100X.1999.72001.x; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P21, DOI 10.1016/S0378-1127(97)00192-8; Piotto D, 2004, FOREST ECOL MANAG, V190, P359, DOI 10.1016/j.foreco.2003.11.005; Piotto D, 2003, FOREST ECOL MANAG, V175, P195, DOI 10.1016/S0378-1127(02)00127-5; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; SCHERR S, 2004, SERVICES RENDERED; TEMPERTON V. M., 2004, ASSEMBLY RULES RESTO; Tucker NIJ, 1997, FOREST ECOL MANAG, V99, P133, DOI 10.1016/S0378-1127(97)00200-4; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566	30	866	935	20	539	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1628	1632		10.1126/science.1111773	http://dx.doi.org/10.1126/science.1111773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339437				2022-12-28	WOS:000233961700032
J	Naylor, R; Steinfeid, H; Falcon, W; Galloways, J; Smil, V; Bradford, E; Alder, J; Mooney, H				Naylor, R; Steinfeid, H; Falcon, W; Galloways, J; Smil, V; Bradford, E; Alder, J; Mooney, H			Losing the links between livestock and land	SCIENCE			English	Editorial Material									Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; FAO Headquarters, Anim Prod & Hlth Div, I-00100 Rome, Italy; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Univ Manitoba, Dept Geog, Winnipeg, MB R3T 2N2, Canada; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Stanford University; Stanford University; Food & Agriculture Organization of the United Nations (FAO); University of Virginia; University of Manitoba; University of California System; University of California Davis; University of British Columbia	Naylor, R (corresponding author), Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA.	roz@stanford.edu	Galloway, James N/C-2769-2013	Galloway, James N/0000-0001-7676-8698				Arthur J. A., 2003, POULTRY GENETICS BRE; Bruinsma J, 2003, WORLD AGR 2015 2030; *EPA, 2003, NAT POLL DISCH EL EF; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Herath DP, 2005, REV AGR ECON, V27, P49, DOI 10.1111/j.1467-9353.2004.00207.x; *NAT AC SCI, NUTR REQ DOM AN; OENERMA O, 2005, MANURE POLICY MINAS; Smil V, 2002, POPUL DEV REV, V28, P599, DOI 10.1111/j.1728-4457.2002.00599.x; Smil V., 2000, FEEDING WORLD CHALLE; *USDA, AM BRAZ FIN SOYB FRO	11	267	282	8	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1621	1622		10.1126/science.1117856	http://dx.doi.org/10.1126/science.1117856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339432				2022-12-28	WOS:000233961700027
J	Trinkle, DR; Woodward, C				Trinkle, DR; Woodward, C			The chemistry of deformation: How solutes soften pure metals	SCIENCE			English	Article							ALLOYS	Solutes have been added to strengthen elemental metals, generating usable materials for millennia; in the 1960s, solutes were found to also soften metals. Despite the empirical correlation between the "electron number" of the solute and the change in strength of the material to which it is added, the mechanism responsible for softening is poorly understood. Using state-of-the-art quantum-mechanical methods, we studied the direct interaction of transition-metal solutes with dislocations in molybdenum. The interaction increases dramatically with increasing electron number and strongly influences the mechanisms responsible for plasticity in these materials. Our quantitative model explains solution softening of metals by using changes in energy and stress scales of plasticity from solutes.	USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Trinkle, DR (corresponding author), USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.	dallas.trinkle@wpafb.af.mil	Trinkle, Dallas R/E-6609-2010	Trinkle, Dallas/0000-0002-6472-9840				Agricola, 1950, DE RE METALLICA; Argon AS, 2006, STRENGTHENING MECH C; Davidson DL, 2003, MAT SCI ENG A-STRUCT, V357, P203, DOI 10.1016/S0921-5093(03)00162-X; DAVIDSON DL, 1970, ACTA METALL MATER, V18, P463, DOI 10.1016/0001-6160(70)90132-X; Haasen P., 1996, PHYS METALLURGY, DOI [10.1017/CBO9781107295551, DOI 10.1017/CBO9781107295551]; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Li J, 2003, MODEL SIMUL MATER SC, V11, P173, DOI 10.1088/0965-0393/11/2/305; Medvedeva NI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.136402; Orowan E, 1940, P PHYS SOC, V52, P8, DOI 10.1088/0959-5309/52/1/303; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; PETUKHOV BV, 1983, PHYS MET METALLOGR, V56, P123; PINK E, 1979, PROG MATER SCI, V24, P1, DOI 10.1016/0079-6425(79)90010-0; SATO A, 1973, ACTA METALL MATER, V21, P753, DOI 10.1016/0001-6160(73)90040-0; STEPHENS JR, 1972, J LESS-COMMON MET, V29, P371, DOI 10.1016/0022-5088(72)90201-9; SUZUKI H, 1979, DISLOCATIONS SOLIDS, P193; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Woodward C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216402	18	162	163	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1665	1667		10.1126/science.1118616	http://dx.doi.org/10.1126/science.1118616			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339441				2022-12-28	WOS:000233961700040
J	Kirn, TJ; Jude, BA; Taylor, RK				Kirn, TJ; Jude, BA; Taylor, RK			A colonization factor links Vibrio cholerae environmental survival and human infection	NATURE			English	Article							TOXIN-COREGULATED PILUS; RECEPTOR PROTEIN; EPITHELIAL-CELLS; INTESTINAL-CELLS; BLOOD-GROUP; CHITIN; ZOOPLANKTON; ATTACHMENT; EXPRESSION; ADHERENCE	Many bacteria that cause diseases must be able to survive inside and outside the host. Attachment to and colonization of abiotic or biotic surfaces is a common mechanism by which various microorganisms enhance their ability to survive in diverse environments(1). Vibrio cholerae is a Gram-negative aquatic bacillus that is often found in the environment attached to the chitinous exo-skeletons of zooplankton(2,3). It has been suggested that attachment to zooplankton enhances environmental survival of Vibrio spp., probably by providing both an abundant source of carbon and nitrogen and protection from numerous environmental challenges(4). On ingestion by humans, some serogroups of V. cholerae cause the diarrhoeal disease cholera(5). The pathophysiology of cholera is a result of the effects of cholera toxin on intestinal epithelial cells. For sufficient quantities of cholera toxin to reach the intestinal epithelium and to produce clinical symptoms, colonization of the small bowel must occur. Because most V. cholerae do not colonize humans, but all probably require strategies for survival in the environment, we considered that colonization factors selected for in the environment may be the same as those required for intestinal colonization of humans. In support of this hypothesis, here we have identified a single protein required for efficient intestinal colonization that mediates attachment to both zooplankton and human epithelial cells by binding to a sugar present on both surfaces.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Taylor, RK (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Ronald.K.Taylor@dartmouth.edu		Jude, Brooke/0000-0003-0384-8173				Benitez JA, 1997, INFECT IMMUN, V65, P3474; BJORK S, 1987, J BIOL CHEM, V262, P6758; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cottingham KL, 2003, FRONT ECOL ENVIRON, V1, P80, DOI 10.1890/1540-9295(2003)001[0080:EMAHPT]2.0.CO;2; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; FINNE J, 1989, J BIOL CHEM, V264, P5720; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HUO A, 1996, APPL ENVIRON MICROB, V62, P2508; Huq A., 1984, VIBRIOS ENV, P521; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; SASMAL D, 1992, FEMS MICROBIOL LETT, V98, P217, DOI 10.1016/0378-1097(92)90159-L; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Skorupski K, 1997, GENE, V198, P297, DOI 10.1016/S0378-1119(97)00331-4; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Zampini M, 2005, FEMS MICROBIOL LETT, V244, P267, DOI 10.1016/j.femsle.2005.01.052	27	222	241	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					863	866		10.1038/nature04249	http://dx.doi.org/10.1038/nature04249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341015				2022-12-28	WOS:000233777800053
J	Lemaitre, JM; Danis, E; Pasero, P; Vassetzky, Y; Mechali, M				Lemaitre, JM; Danis, E; Pasero, P; Vassetzky, Y; Mechali, M			Mitotic remodeling of the replicon and chromosome structure	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; DNA TOPOISOMERASE-II; XENOPUS EGG EXTRACTS; NUCLEAR-MATRIX; REPLICATION ORIGINS; DEVELOPMENTAL CAPACITY; HISTONE DEACETYLASE; RIBOSOMAL DNA; STEM-CELLS; CHROMATIN	Animal cloning by nuclear-transfer experiments frequently fails due to the inability of transplanted nuclei to support normal embryonic development. We show here that the formation of mitotic chromosomes in the egg context is crucial for adapting differentiated nuclei for early development. Differentiated erythrocyte nuclei replicate inefficiently in Xenopus eggs but do so as rapidly as sperm nuclei if a prior single mitosis is permitted. This mitotic remodeling involves a topoisomerase II-dependent shortening of chromatin loop domains and an increased recruitment of replication initiation factors onto chromatin, leading to a short interorigin spacing characteristic of early developmental stages. It also occurs within each early embryonic cell cycle and dominantly regulates initiation of DNA replication for the subsequent S phase. These results indicate that mitotic conditioning is crucial to reset the chromatin structure of differentiated adult donor cells for embryonic DNA replication and suggest that it is an important step in nuclear cloning.	CNRS, Inst Human Genet, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	mechali@igh.cnrs.fr	Vassetzky, Yegor S/C-6447-2008; LEMAITRE, Jean-Marc/I-4989-2016; Pasero, Philippe/O-2340-2018; Vassetzky, Yegor/M-3383-2019	Vassetzky, Yegor S/0000-0003-3101-7043; Pasero, Philippe/0000-0001-5891-0822; Vassetzky, Yegor/0000-0003-3101-7043; LEMAITRE, Jean-Marc/0000-0002-6492-5219				ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Berezney R, 1995, INT REV CYTOL, V162A, P1; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; COOK PR, 1976, J CELL SCI, V22, P287; COOK PR, 1975, J CELL SCI, V19, P261; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; DIBERARDINO MA, 1983, SCIENCE, V219, P862, DOI 10.1126/science.6600520; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; FIRMBACHKRAFT I, 1995, J CELL BIOL, V129, P17, DOI 10.1083/jcb.129.1.17; Francon P, 2004, J CELL SCI, V117, P4909, DOI 10.1242/jcs.01361; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; GURDON JB, 1975, J EMBRYOL EXP MORPH, V34, P93; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1970, J EMBRYOL EXP MORPH, V24, P227; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; IAROVAIA OV, 1995, BIOCHEMISTRY-US, V34, P4133, DOI 10.1021/bi00012a032; JACKSON DA, 1990, BIOESSAYS, V12, P87, DOI 10.1002/bies.950120207; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; LEMAITRE JM, 1995, MOL CELL BIOL, V15, P5054; LENO GH, 1991, J CELL BIOL, V112, P557, DOI 10.1083/jcb.112.4.557; LEONARD RA, 1982, DEV BIOL, V92, P343, DOI 10.1016/0012-1606(82)90180-4; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lu ZH, 1999, MOL BIOL CELL, V10, P4091, DOI 10.1091/mbc.10.12.4091; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Menut S, 1999, ADV MOLEC BIOL, P196; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NERI LM, 1992, HISTOCHEMISTRY, V98, P19, DOI 10.1007/BF00716934; Oestergaard VH, 2004, J BIOL CHEM, V279, P28100, DOI 10.1074/jbc.M402119200; PARDOLL DM, 1980, EXP CELL RES, V128, P466, DOI 10.1016/0014-4827(80)90083-X; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Rowles A, 1999, J CELL SCI, V112, P2011; Ryan J, 1999, J CELL SCI, V112, P2441; Sato M, 1997, BIOCHEM BIOPH RES CO, V235, P571, DOI 10.1006/bbrc.1997.6851; TAKASUGA Y, 1995, EXP CELL RES, V217, P378, DOI 10.1006/excr.1995.1100; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Vassetzky Y, 2000, GENE DEV, V14, P1541; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wade PA, 1999, METHOD ENZYMOL, V304, P715; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; Wu JR, 1997, METHODS, V13, P313, DOI 10.1006/meth.1997.0530; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270	68	146	155	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					787	801		10.1016/j.cell.2005.08.045	http://dx.doi.org/10.1016/j.cell.2005.08.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325575	Bronze			2022-12-28	WOS:000233814100014
J	Volkov, I; Banavar, JR; He, FL; Hubbell, SP; Maritan, A				Volkov, I; Banavar, JR; He, FL; Hubbell, SP; Maritan, A			Density dependence explains tree species abundance and diversity in tropical forests	NATURE			English	Article							DISTANCE; NUMBER	The recurrent patterns in the commonness and rarity of species in ecological communities - the relative species abundance - have puzzled ecologists for more than half a century(1,2). Here we show that the framework of the current neutral theory in ecology(3 - 10) can easily be generalized to incorporate symmetric density dependence(11 - 14). We can calculate precisely the strength of the rare- species advantage that is needed to explain a given RSA distribution. Previously, we demonstrated that a mechanism of dispersal limitation also fits RSA data well(3,4). Here we compare fits of the dispersal and density- dependence mechanisms for empirical RSA data on tree species in six New and Old World tropical forests and show that both mechanisms offer sufficient and independent explanations. We suggest that RSA data cannot by themselves be used to discriminate among these explanations of RSA patterns(15) - empirical studies will be required to determine whether RSA patterns are due to one or the other mechanism, or to some combination of both.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Alberta; University System of Georgia; University of Georgia; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Padua	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Volkov, Igor/GVT-6571-2022	Maritan, Amos/0000-0002-3535-7873				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; CHESSON P, 1991, TRENDS ECOL EVOL, V6, P26, DOI 10.1016/0169-5347(91)90144-M; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; CONNELL J H, 1971, P298; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2004, ECOL LETT, V7, P170, DOI 10.1111/j.1461-0248.2004.00572.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hilborn Ray, 1997, V28; Houchmandzadeh B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061912; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; MORLEY RJ, 2000, ORIGIN EVOLUTION TRO, pCH5; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Vallade M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061902; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	224	249	4	122	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					658	661		10.1038/nature04030	http://dx.doi.org/10.1038/nature04030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319890				2022-12-28	WOS:000233593100048
J	Jannin, JG				Jannin, JG			Commentary: Sleeping sickness - a growing problem?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN AFRICAN TRYPANOSOMIASIS		WHO, Communicable Dis Neglected Trop Dis Control, Innovat & Intensified Dis Management, CH-121 Geneva, Switzerland	World Health Organization	Jannin, JG (corresponding author), WHO, Communicable Dis Neglected Trop Dis Control, Innovat & Intensified Dis Management, CH-121 Geneva, Switzerland.	janninj@who.int						Cox A, 2005, EXP PARASITOL, V111, P24, DOI 10.1016/j.exppara.2005.03.014; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Jannin J, 2004, CURR OPIN INFECT DIS, V17, P565, DOI 10.1097/00001432-200412000-00009; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238	5	13	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2005	331	7527					1242	1242		10.1136/bmj.331.7527.1242	http://dx.doi.org/10.1136/bmj.331.7527.1242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308384	Bronze, Green Published			2022-12-28	WOS:000233606800019
J	Cuddy, E; Robertson, S; Cross, S; Isles, C				Cuddy, E; Robertson, S; Cross, S; Isles, C			Risks of coronary angiography	LANCET			English	Editorial Material							CARDIAC-CATHETERIZATION		Dumfries & Galloway Royal Infirm, Renal Unit, Dumfries DG1 4AP, Scotland; Raigmore Hosp Inverness, Dept Cardiol, Inverness, Scotland		Isles, C (corresponding author), Dumfries & Galloway Royal Infirm, Renal Unit, Dumfries DG1 4AP, Scotland.	chris.isles@nhs.net						Fukumoto Y, 2003, J AM COLL CARDIOL, V42, P211, DOI 10.1016/S0735-1097(03)00579-5; JOHNSON LW, 1993, CATHETER CARDIO DIAG, V28, P219, DOI 10.1002/ccd.1810280305; JULIAN DG, 2000, CARDIOLOGY; Saklayen MG, 1997, ANGIOLOGY, V48, P609, DOI 10.1177/000331979704800707; Scolari F, 2000, AM J KIDNEY DIS, V36, P1089, DOI 10.1053/ajkd.2000.19809	5	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1825	1825		10.1016/S0140-6736(05)67729-X	http://dx.doi.org/10.1016/S0140-6736(05)67729-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298222				2022-12-28	WOS:000233517200029
J	Cote, AP; Benin, AI; Ockwig, NW; O'Keeffe, M; Matzger, AJ; Yaghi, OM				Cote, AP; Benin, AI; Ockwig, NW; O'Keeffe, M; Matzger, AJ; Yaghi, OM			Porous, crystalline, covalent organic frameworks	SCIENCE			English	Article							ADSORPTION	Covalent organic frameworks (COFs) have been designed and successfully synthesized by condensation reactions of phenyl diboronic acid {C6H4[B(OH)(2)](2)} and hexahydroxytriphenylene [C18H6(OH)(6)]. Powder x-ray diffraction studies of the highly crystalline products (C3H2BO)(6)center dot(C9H12)(1) (COF-1) and C9H4BO2 (COF-5) revealed expanded porous graphitic layers that are either staggered (COF-1, P6(3)/mmc) or eclipsed (COF-5, P6/mmm). Their crystal structures are entirely held by strong bonds between B, C, and O atoms to form rigid porous architectures with pore sizes ranging from 7 to 27 angstroms. COF-1 and COF-5 exhibit high thermal stability (to temperatures up to 500 degrees to 600 degrees C), permanent porosity, and high surface areas (711 and 1590 square meters per gram, respectively).	Univ Michigan, Dept Chem, Mat Design & Discovery Grp, Ann Arbor, MI 48105 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of Michigan System; University of Michigan; Arizona State University; Arizona State University-Tempe	Cote, AP (corresponding author), Univ Michigan, Dept Chem, Mat Design & Discovery Grp, 930 N Univ Ave, Ann Arbor, MI 48105 USA.	apcote@umich.edu; oyaghi@umich.edu	Matzger, Adam J/G-7497-2016; Yaghi, Omar M/C-6749-2013	Matzger, Adam J/0000-0002-4926-2752; Yaghi, Omar/0000-0002-5611-3325				BROCK CP, 1987, ACTA CRYSTALLOGR C, V43, P1775, DOI 10.1107/S010827018709022X; Brunet P, 2003, ANGEW CHEM INT EDIT, V42, P5303, DOI 10.1002/anie.200352252; Curtis SM, 2005, SUPRAMOL CHEM, V17, P31, DOI 10.1080/10610270412331328916; FLOREY PJ, 1953, PRINCIPLES POLYM CHE; Gervais C, 2002, J ORGANOMET CHEM, V657, P75, DOI 10.1016/S0022-328X(02)01586-3; Hoang T, 2002, J AM CHEM SOC, V124, P10656, DOI 10.1021/ja027444a; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Kruk M, 2000, CHEM MATER, V12, P222, DOI 10.1021/cm9905601; Kruk M, 1997, J PHYS CHEM B, V101, P583, DOI 10.1021/jp962000k; Larson A.C., 2004, 86748 LAUR GSAS; *MOL SIM, 1999, CER MOD ENV; Niu WJ, 2005, CHEM COMMUN, P4342, DOI 10.1039/b504634c; Ravikovitch PI, 2000, LANGMUIR, V16, P2311, DOI 10.1021/la991011c; ROUQUEROL F, 2002, ADSORPTION POWDERS P; SICHEL EK, 1976, PHYS REV B, V13, P4607, DOI 10.1103/PhysRevB.13.4607; Sonmez HB, 2005, MACROMOLECULES, V38, P1623, DOI 10.1021/ma048731x; TATAR RC, 1982, PHYS REV B, V25, P4126, DOI 10.1103/PhysRevB.25.4126; Thommes M, 2004, NANOPOROUS MAT SCI E; Vodak DT, 2002, J AM CHEM SOC, V124, P4942, DOI 10.1021/ja017683i; Xu ZT, 2001, ADV MATER, V13, P637, DOI 10.1002/1521-4095(200105)13:9<637::AID-ADMA637>3.0.CO;2-S; ZETTLER F, 1974, ACTA CRYSTALLOGR B, VB 30, P1876, DOI 10.1107/S0567740874010879	21	4201	4346	382	5486	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1166	1170		10.1126/science.1120411	http://dx.doi.org/10.1126/science.1120411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	986GE	16293756				2022-12-28	WOS:000233437300040
J	Kaeberlein, M; Powers, RW; Steffen, KK; Westman, EA; Hu, D; Dang, N; Kerr, EO; Kirkland, KT; Fields, S; Kennedy, BK				Kaeberlein, M; Powers, RW; Steffen, KK; Westman, EA; Hu, D; Dang, N; Kerr, EO; Kirkland, KT; Fields, S; Kennedy, BK			Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; CALORIE RESTRICTION; SIGNALING PATHWAY; KINASE; GENES; SIR2; EXPRESSION; LONGEVITY; EXTENSION	Calorie restriction increases life span in many organisms, including the budding yeast Saccharomyces cerevisiae. From a large-scale analysis of 564 single-gene-deletion strains of yeast, we identified 10 gene deletions that increase replicative life span. Six of these correspond to genes encoding components of the nutrient-responsive TOR and Sch9 pathways. Calorie restriction of tor1 Delta or sch9 Delta cells failed to further increase life span and, like calorie restriction, deletion of either SCH9 or TOR1 increased life span independent of the Sir2 histone deacetylase. We propose that the TOR and Sch9 kinases define a primary conduit through which excess nutrient intake limits longevity in yeast.	Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA.	kaeber@u.washington.edu; bkenn@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874	NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG013280] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Helliwell SB, 1998, GENETICS, V148, P99; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	23	957	998	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1193	1196		10.1126/science.1115535	http://dx.doi.org/10.1126/science.1115535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293764				2022-12-28	WOS:000233437300048
J	Gabellini, D; D'Antona, G; Moggio, M; Prelle, A; Zecca, C; Adami, R; Angeletti, B; Ciscato, P; Pellegrino, MA; Bottinelli, R; Green, MR; Tupler, R				Gabellini, D; D'Antona, G; Moggio, M; Prelle, A; Zecca, C; Adami, R; Angeletti, B; Ciscato, P; Pellegrino, MA; Bottinelli, R; Green, MR; Tupler, R			Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1	NATURE			English	Article							MOLECULAR DIAGNOSIS; MYOTONIC-DYSTROPHY; SKELETAL; GENE; COMPLEX; MUSCLE; MODEL; RNA; PATHOGENESIS; EXPRESSION	Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene(1,2). Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 ( ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing(5-7). We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, Dipartimento Med Sperimentale, Sez Fisiol Umana, I-27100 Pavia, Italy; Univ Milan, IRCCS, Fdn Osped Maggiore, UO Neurol, I-20122 Milan, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Tupler, R (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, I-41100 Modena, Italy.	rossella.tupler@umassmed.edu	Tupler, Rossella/C-9500-2015; Pellegrino, Maria Antonietta/AAC-4680-2022; Gabellini, Davide/I-4551-2018; Zecca, Chiara/L-3406-2013; canepari, Monica MC/D-7677-2015; Bottinelli, Roberto/AAC-1904-2020	Tupler, Rossella/0000-0002-3797-1789; Pellegrino, Maria Antonietta/0000-0002-1653-1266; Gabellini, Davide/0000-0002-3811-4121; Bottinelli, Roberto/0000-0002-4960-7490; Zecca, Chiara/0000-0002-9990-3431; prelle, alessandro/0000-0002-7019-5291; Adami, Raffaella/0000-0001-9656-3219; D'Antona, Giuseppe/0000-0002-0683-5565	Telethon [GGP05050] Funding Source: Medline	Telethon(Fondazione Telethon)		Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chaudhuri T, 2005, J MOL BIOL, V352, P58, DOI 10.1016/j.jmb.2005.06.066; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Flanigan KM, 2004, MYOLOGY, P1123; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KILMER DD, 1995, AM J PHYS MED REH  S, V74, P131; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Orrell RW, 1999, NEUROLOGY, V52, P1822, DOI 10.1212/WNL.52.9.1822; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Rogers MT, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P277; Tawil Rabi, 2004, Curr Neurol Neurosci Rep, V4, P51, DOI 10.1007/s11910-004-0012-x; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037	28	169	178	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					973	977		10.1038/nature04422	http://dx.doi.org/10.1038/nature04422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16341202				2022-12-28	WOS:000235486100047
J	Ueba, H; Wolf, M				Ueba, H; Wolf, M			Lateral hopping require molecular rocking	SCIENCE			English	Editorial Material							SINGLE-MOLECULE; DESORPTION; CHEMISTRY; MOTION; CO		Toyama Univ, Dept Elect, Toyama 9308555, Japan; Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	University of Toyama; Free University of Berlin	Ueba, H (corresponding author), Toyama Univ, Dept Elect, Toyama 9308555, Japan.	ueba@eng.toyama-u.ac.jp	Wolf, Martin/Q-3548-2016					Backus EHG, 2005, SCIENCE, V310, P1790, DOI 10.1126/science.1120693; Bartels L, 2004, SCIENCE, V305, P648, DOI 10.1126/science.1099770; Bonn M, 2000, PHYS REV LETT, V84, P4653, DOI 10.1103/PhysRevLett.84.4653; Bonn M, 1999, SCIENCE, V285, P1042, DOI 10.1126/science.285.5430.1042; Fournier F, 2004, J CHEM PHYS, V121, P4839, DOI 10.1063/1.1778138; Komeda T, 2002, SCIENCE, V295, P2055, DOI 10.1126/science.1069016; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Ranea VA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.136104; Stepan K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236103; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; ZEWAIL AH, 2003, NOBEL LECT CHEM 1996, P43004	12	19	19	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1774	1775		10.1126/science.1122123	http://dx.doi.org/10.1126/science.1122123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357248				2022-12-28	WOS:000234093600032
J	Greenberg, DA; Jin, KL				Greenberg, DA; Jin, KL			From angiogenesis to neuropathology	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; NEURAL STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; VEGF GENE-TRANSFER; IN-VIVO; RAT-BRAIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE	Angiogenesis - the growth of new blood vessels - is a crucial force for shaping the nervous system and protecting it from disease. Recent advances have improved our understanding of how the brain and other tissues grow new blood vessels under normal and pathological conditions. Angiogenesis factors, especially vascular endothelial growth factor, are now known to have roles in the birth of new neurons (neurogenesis), the prevention or mitigation of neuronal injury ( neuroprotection), and the pathogenesis of stroke, Alzheimer's disease and motor neuron disease. As our understanding of pathophysiology grows, these developments may point the way towards new molecular and cell-based therapies.	Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Greenberg, DA (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	dgreenberg@buckinstitute.org			NIA NIH HHS [AG21980] Funding Source: Medline; NINDS NIH HHS [NS44921] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021980] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bao WL, 1999, ACTA PHARMACOL SIN, V20, P313; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; BROADWELL RD, 1990, PROG BRAIN RES, V82, P95; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chattopadhyay M, 2005, GENE THER, V12, P1377, DOI 10.1038/sj.gt.3302533; CHEN HH, 1994, STROKE, V25, P1651, DOI 10.1161/01.STR.25.8.1651; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Del Bo R, 2005, ANN NEUROL, V57, P373, DOI 10.1002/ana.20390; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Eig J., 2005, LUCKIEST MAN LIFE DE; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; GENY C, 1994, J NEUROSCI, V14, P7553; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, J MOL NEUROSCI, V14, P197, DOI 10.1385/JMN:14:3:197; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2003, ANN NEUROL, V53, P405, DOI 10.1002/ana.10506; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; JIN KL, IN PRESS J NEUROBIOL; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu JL, 1998, J NEUROSCI, V18, P7768; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Ment LR, 1997, DEV BRAIN RES, V100, P52, DOI 10.1016/S0165-3806(97)00012-6; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2004, J CEREBR BLOOD F MET, V24, P1146, DOI 10.1097/01.WCB.0000134477.38980.38; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	99	413	428	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					954	959		10.1038/nature04481	http://dx.doi.org/10.1038/nature04481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355213				2022-12-28	WOS:000233934600054
J	Steiner, JF				Steiner, JF			The use of stories in clinical research and health policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITATIVE RESEARCH; MEDICINE; VACCINATION; AUTISM; SYSTEM; CARE		Univ Colorado, Hlth Sci Ctr, Dept Med, Colorado Hlth Outcomes Program, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Gen Internal Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Steiner, JF (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Colorado Hlth Outcomes Program, POB 6508,Mailstop F-443, Aurora, CO 80045 USA.	john.steiner@uchsc.edu						BORDIGA E, 1977, J APPL SOC PSYCHOL, V7, P258; Bruner J, 2002, MAKING STORIES; Charon R, 2004, NEW ENGL J MED, V350, P862, DOI 10.1056/NEJMp038249; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Elwyn GJ, 1997, BRIT MED J, V315, P1659, DOI 10.1136/bmj.315.7123.1659; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Hamm RM, 1996, J FAM PRACTICE, V43, P56; INUI TS, 1991, J GEN INTERN MED, V6, P485, DOI 10.1007/BF02598180; Kleinman A., 1988, ILLNESS NARRATIVES; Kleinman Arthur, 1995, WRITING MARGIN DISCO; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McDonough JE, 2001, HEALTH AFFAIR, V20, P207, DOI 10.1377/hlthaff.20.1.207; Mitchell W.J.T., 1981, NARRATIVE, V1st ed; Mullan F, 1999, HEALTH AFFAIR, V18, P118, DOI 10.1377/hlthaff.18.4.118; Newman TB, 2003, BRIT MED J, V327, P1424, DOI 10.1136/bmj.327.7429.1424; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; SCHOLES R, 1981, ON NARRATIVITY, P200; Sharf BF, 2001, HEALTH AFFAIR, V20, P213, DOI 10.1377/hlthaff.20.1.213; SMITH BH, 1981, ON NARRATIVE, P209; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; Woo EJ, 2004, AM J PUBLIC HEALTH, V94, P990, DOI 10.2105/AJPH.94.6.990	25	41	41	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2901	2904		10.1001/jama.294.22.2901	http://dx.doi.org/10.1001/jama.294.22.2901			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352799				2022-12-28	WOS:000233826700032
J	Tesmer, VM; Kawano, T; Shankaranarayanan, A; Kozasa, T; Tesmer, JJG				Tesmer, VM; Kawano, T; Shankaranarayanan, A; Kozasa, T; Tesmer, JJG			Snapshot of activated G proteins at the membrane: The G alpha(q)-GRK2-G beta gamma complex	SCIENCE			English	Article							COUPLED RECEPTOR KINASE-2; BETA-GAMMA-SUBUNITS; G-ALPHA-SUBUNITS; MUSCARINIC ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; STRUCTURAL DETERMINANTS; SELECTIVE REGULATION; BINDING-SITE; 2.0 ANGSTROM	G protein-coupled receptor kinase 2 (GRK2) plays a key role in the desensitization of G protein-coupled receptor signaling by phosphorylating activated heptahelical receptors and by sequestering heterotrimeric G proteins. We report the atomic structure of GRK2 in complex with G alpha(q) and G beta gamma, in which the activated G alpha subunit of G(q) is fully dissociated from G beta gamma and dramatically reoriented from its position in the inactive G alpha beta gamma heterotrimer. G alpha(q) forms an effector-like interaction with the GRK2 regulator of G protein signaling (RGS) homology domain that is distinct from and does not overlap with that used to bind RGS proteins such as RGS4.	Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tesmer, JJG (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, Austin, TX 78712 USA.	johntesmer@umich.edu		Tesmer, John/0000-0003-1125-3727	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006093] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071818] Funding Source: Medline; NIA NIH HHS [AG006093] Funding Source: Medline; NIGMS NIH HHS [GM61454] Funding Source: Medline; NINDS NIH HHS [NS41441] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARKINSTALL S, 1995, FEBS LETT, V364, P45, DOI 10.1016/0014-5793(95)00351-9; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gilchrist, 2002, SCI STKE; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; HAGA K, 1992, J BIOL CHEM, V267, P2222; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KREUTZ B, IN PRESS BIOCHEMISTR; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; NEER EJ, 1988, J BIOL CHEM, V263, P8996; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAO CS, 2002, SCI STKE, pPE42; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Usui K, 2000, INT J MOL MED, V5, P335; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	52	228	234	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1686	1690		10.1126/science.1118890	http://dx.doi.org/10.1126/science.1118890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339447				2022-12-28	WOS:000233961700047
J	Grogg, MW; Call, MK; Okamoto, M; Vergara, MN; Del Rio-Tsonis, K; Tsonis, PA				Grogg, MW; Call, MK; Okamoto, M; Vergara, MN; Del Rio-Tsonis, K; Tsonis, PA			BMP inhibition-driven regulation of six-3 underlies induction of newt lens regeneration	NATURE			English	Article							RETINOIC ACID; ADULT NEWT; IRIS; DORSAL; DIFFERENTIATION; CELLS; EYE	Lens regeneration in adult newts is a classic example of how cells can faithfully regenerate a complete organ through the process of transdifferentiation(1-6). After lens removal, the pigment epithelial cells of the dorsal, but not the ventral, iris dedifferentiate and then differentiate to form a new lens. Understanding how this process is regulated might provide clues about why lens regeneration does not occur in higher vertebrates. The genes six-3 and pax-6 are known to induce ectopic lenses during embryogenesis(7,8). Here we tested these genes, as well as members of the bone morphogenetic protein (BMP) pathway that regulate establishment of the dorsal ventral axis in embryos(9), for their ability to induce lens regeneration. We show that the lens can be regenerated from the ventral iris when the BMP pathway is inhibited and when the iris is transfected with six-3 and treated with retinoic acid. In intact irises, six-3 is expressed at higher levels in the ventral than in the dorsal iris. During regeneration, however, only expression in the dorsal iris is significantly increased. Such an increase is seen in ventral irises only when they are induced to transdifferentiate by six-3 and retinoic acid or by BMP inhibitors. These data suggest that lens regeneration can be achieved in noncompetent adult tissues and that this regeneration occurs through a gene regulatory mechanism that is more complex than the dorsal expression of lens regeneration-specific genes.	Univ Dayton, Dept Biol, Mol Biol Lab, Dayton, OH 45469 USA; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 464, Japan; Miami Univ, Dept Zool, Oxford, OH 45056 USA	University of Dayton; Nagoya University; University System of Ohio; Miami University	Tsonis, PA (corresponding author), Univ Dayton, Dept Biol, Mol Biol Lab, Dayton, OH 45469 USA.	panagiotis.tsonis@notes.udayton.edu	Vergara, Natalia/J-6722-2019	Vergara, Natalia/0000-0003-4545-8181	NEI NIH HHS [R01 EY010540] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573; Colucci VL, 1891, MEM R ACAD SCI I BOL, V1, P593; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; EGUCHI G, 1964, EMBRYOLOGIA, V8, P247, DOI 10.1111/j.1440-169X.1964.tb00202.x; EGUCHI G, 1963, EMBRYOLOGIA, V8, P45, DOI 10.1111/j.1440-169X.1963.tb00185.x; Hayashi T, 2001, DEV GROWTH DIFFER, V43, P361; Hayashi T, 2004, MECH DEVELOP, V121, P519, DOI 10.1016/j.mod.2004.04.010; Ito M, 1999, DEV GROWTH DIFFER, V41, P429; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Maden M, 2003, DEV DYNAM, V226, P237, DOI 10.1002/dvdy.10222; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Okamoto M, 1998, DEV GROWTH DIFFER, V40, P11; Oliver G, 1996, MECH DEVELOP, V60, P233, DOI 10.1016/S0925-4773(96)00632-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAWADA K, 1993, JPN J OPHTHALMOL, V37, P355; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Tsonis PA, 2000, DEV DYNAM, V219, P588, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1082>3.0.CO;2-H; Tsonis PA, 2004, DEV BIOL, V267, P450, DOI 10.1016/j.ydbio.2003.12.005; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Tsonis PA., 1996, LIMB REGENERATION; Wolff G., 1895, W ROUX ARCH ENTWICKL, V1, P380; Yamada T, 1977, Monogr Dev Biol, V13, P1; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	23	95	97	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					858	862		10.1038/nature04175	http://dx.doi.org/10.1038/nature04175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341014	Green Accepted			2022-12-28	WOS:000233777800052
J	Lerner, BH				Lerner, BH			Remembering Berton Roueche - Master of medical mysteries	NEW ENGLAND JOURNAL OF MEDICINE			English	Biographical-Item									Columbia Univ, New York, NY 10027 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, New York, NY 10027 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2428	2431		10.1056/NEJMp058147	http://dx.doi.org/10.1056/NEJMp058147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339093	Green Published			2022-12-28	WOS:000233754400004
J	Jackson, R; Broad, J; Connor, J; Wells, S				Jackson, R; Broad, J; Connor, J; Wells, S			Alcohol and ischaemic heart disease: probably no free lunch	LANCET			English	Editorial Material							MODERATE-DRINKING; CONSUMPTION; MORTALITY; RISK; METAANALYSIS; THERAPY; MEN		Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	University of Auckland	Jackson, R (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand.	rt.jackson@auckland.ac.nz	Broad, Joanna B/D-1194-2010	Broad, Joanna B/0000-0003-0157-7031; Connor, Jennie/0000-0002-3209-8693; Jackson, Rod/0000-0001-5914-6934				CONNOR J, 2005, ALCOHOL ADVISORY COU, V23; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Doll R, 1997, EUR HEART J, V18, P23, DOI 10.1093/oxfordjournals.eurheartj.a015112; Ellison R C, 1990, Epidemiology, V1, P337; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; MOORE RD, 1986, MEDICINE, V65, P242, DOI 10.1097/00005792-198607000-00004; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; SHAPER AG, 1988, LANCET, V2, P1267; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X	14	100	101	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1911	1912		10.1016/S0140-6736(05)67770-7	http://dx.doi.org/10.1016/S0140-6736(05)67770-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325685				2022-12-28	WOS:000233777900008
J	Bonetta, L				Bonetta, L			Going on a cancer gene hunt	CELL			English	Editorial Material								NIH is preparing to announce plans for the pilot phase of their proposed Human Cancer Genome Project. This initiative seeks to provide a complete list of the mutations that give rise to cancer.											0	9	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					735	737		10.1016/j.cell.2005.11.013	http://dx.doi.org/10.1016/j.cell.2005.11.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325563	Bronze			2022-12-28	WOS:000233814100002
J	Drees, F; Pokutta, S; Yamada, S; Nelson, WJ; Weis, WI				Drees, F; Pokutta, S; Yamada, S; Nelson, WJ; Weis, WI			alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly	CELL			English	Article							CELL-CELL ADHESION; INTERCELLULAR-ADHESION; JUNCTIONAL COMPLEX; CYTOPLASMIC DOMAIN; ARP2/3 COMPLEX; F-ACTIN; MECHANISM; VINCULIN; PROTEIN; DYNAMICS	Epithelial cell-cell junctions, organized by adhesion proteins and the underlying actin cytoskeleton, are considered to be stable structures maintaining the structural integrity of tissues. Contrary to the idea that alpha-catenin links the adhesion protein E-cadherin through beta-catenin to the actin cytoskeleton, in the accompanying paper we report that alpha-catenin does not bind simultaneously to both E-cadherin-beta-catenin and actin filaments. Here we demonstrate that alpha-catenin exists as a monomer or a homodimer with different binding properties. Monomeric alpha-catenin binds more strongly to E-cadherin-beta-catenin, whereas the dimer preferentially binds actin filaments. Different molecular conformations are associated with these different binding states, indicating that alpha-catenin is an allosteric protein. Significantly, alpha-catenin directly regulates actin-filament organization by suppressing Arp2/3-mediated actin polymerization, likely by competing with the Arp2/3 complex for binding to actin filaments. These results indicate a new role for alpha-catenin in local regulation of actin assembly and organization at sites of cadherin-mediated cell-cell adhesion.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu; bill.weis@stanford.edu	Yamada, Soichiro/B-7360-2019; Weis, William I/G-1437-2011	Yamada, Soichiro/0000-0001-6413-0814; Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [R01 GM35527, R01 GM056169, R01 GM035527, R01 GM56169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM035527] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; CHOI HJ, 2006, IN PRESS J BIOL CHEM; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; GESTSIOS S, 2004, NAT REV MOL CELL BIO, V5, P271; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIROKAWA N, 1983, J CELL BIOL, V96, P1325, DOI 10.1083/jcb.96.5.1325; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maeno Y, 1999, AM J PATHOL, V154, P1323, DOI 10.1016/S0002-9440(10)65385-0; MATSUZAKI F, 1990, J CELL BIOL, V110, P1239, DOI 10.1083/jcb.110.4.1239; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; vanHengel J, 1997, J CELL BIOL, V137, P1103, DOI 10.1083/jcb.137.5.1103; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	54	755	771	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					903	915		10.1016/j.cell.2005.09.021	http://dx.doi.org/10.1016/j.cell.2005.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325583	Bronze, Green Accepted			2022-12-28	WOS:000233814100022
J	Mayr, G; Pohl, B; Peters, DS				Mayr, G; Pohl, B; Peters, DS			A well-preserved Archaeopteryx specimen with theropod features	SCIENCE			English	Article							BIRDS; DINOSAURS; EVOLUTION; ORIGIN	A nearly complete skeleton of Archaeopteryx with excellent bone preservation shows that the osteology of the urvogel is similar to that of nonavian theropod dinosaurs..The new specimen confirms the presence of a hyper-extendible second toe as in dromaeosaurs and troodontids. Archaeoptelyx had a plesiomorphic tetraradiate palatine bone and no fully reversed first toe. These observations provide further evidence for the theropod ancestry of birds. in addition, the presence of a hyperextendible second toe blurs the distinction of archaeopterygids from basal deinonychosaurs (troodontids and dromaeosaurs) and challenges the monophyly of Aves.	Forschungsinst Senckenberg, Div Ornithol, D-60325 Frankfurt, Germany; Wyoming Dinosaur Ctr, Thermopolis, WY 82443 USA	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mayr, G (corresponding author), Forschungsinst Senckenberg, Div Ornithol, Senckenberganlage 25, D-60325 Frankfurt, Germany.	Gerald.Mayr@senckenberg.de						CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; de Beer G., 1954, CRAFTSMANS HDB; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Elzanowski A, 2001, NETH J ZOOL, V51, P207, DOI 10.1163/156854201X00279; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Elzanowski Andrzej, 1999, Acta Ornithologica (Warsaw), V34, P123; Elzanowski Andrzej, 2002, P129; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Goloboff PA., 1993, NONA VERSION 2 0 COM; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Martin L.D., 1985, P177; Martin L.D., 1991, P485; MARTIN LD, 1980, AUK, V97, P86; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Ostrom J.H., 1991, P467; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Paul G. S., 2002, DINOSAURS AIR EVOLUT; ROPER M, 2004, ARCHAEOPTERYX, V22, P1; Senter P, 2003, J VERTEBR PALEONTOL, V23, P961, DOI 10.1671/22; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Tarsitano S., 1991, P541; Weishampel DB., 2004, DINOSAURIA; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; WELLNHOFER P, 1992, LOS ANGELES CITY MUS, V36, P3; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wellnhofer Peter, 2004, Archaeopteryx, V22, P3; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342	29	97	105	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1483	1486		10.1126/science.1120331	http://dx.doi.org/10.1126/science.1120331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322455	Green Submitted			2022-12-28	WOS:000233756500041
J	Wickner, W; Schekman, R				Wickner, W; Schekman, R			Protein translocation across biological membranes	SCIENCE			English	Review							SIGNAL RECOGNITION PARTICLE; PEROXISOMAL TARGETING SIGNAL; MITOCHONDRIAL INNER MEMBRANE; ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL TRANSPORT; MISFOLDED GLYCOPROTEINS; CYTOPLASMIC MEMBRANE; RETRO-TRANSLOCATION; SECRETORY PROTEIN; PRECURSOR PROTEIN	Subcellular compartments have unique protein compositions, yet protein synthesis only occurs in the cytosol and in mitochondria and chloroplasts. How do proteins get where they need to go? The first steps are targeting to an organelle and efficient translocation across its limiting membrane. Given that most transport systems are exquisitely substrate specific, how are diverse protein sequences recognized for translocation? Are they translocated as linear polypeptide chains or after folding? During translocation, how are diverse amino acyl side chains accommodated? What are the proteins and the lipid environment that catalyze transport and couple it to energy? How is translocation coordinated with protein synthesis and folding, and how are partially translocated transmembrane proteins released into the lipid bilayer? We review here the marked progress of the past 35 years and salient questions for future work.	Dartmouth Coll Sch Med, Dept Biol Chem, Hanover, NH 03755 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Dartmouth College; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wickner, W (corresponding author), Dartmouth Coll Sch Med, Dept Biol Chem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@Dartmouth.edu; schekman@berkeley.edu						Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; BASSFORD P, 1979, NATURE, V277, P538, DOI 10.1038/277538a0; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; Clemons WM, 2004, CURR OPIN STRUC BIOL, V14, P390, DOI 10.1016/j.sbi.2004.07.006; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; GANOZA MC, 1969, P NATL ACAD SCI USA, V63, P1370, DOI 10.1073/pnas.63.4.1370; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HALLERMAYER G, 1976, GENETICS BIOGENESIS, P807; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; HANSEN W, 1988, J CELL BIOL, V106, P1075, DOI 10.1083/jcb.106.4.1075; HARMEY MA, 1977, EUR J BIOCHEM, V81, P533, DOI 10.1111/j.1432-1033.1977.tb11979.x; HARMEY MA, 1976, GENETICS BIOGENESIS, P813; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HICKS SJ, 1969, SCIENCE, V164, P584, DOI 10.1126/science.164.3879.584; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; ITO K, 1977, CELL, V11, P551, DOI 10.1016/0092-8674(77)90073-3; Jakob CA, 2001, EMBO REP, V2, P423; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; MORENO F, 1980, NATURE, V286, P356, DOI 10.1038/286356a0; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; RANDALL LL, 1983, CELL, V33, P231, DOI 10.1016/0092-8674(83)90352-5; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; REDMAN CM, 1969, J BIOL CHEM, V244, P4308; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SABATINI DD, 1970, J CELL BIOL, V45, P146, DOI 10.1083/jcb.45.1.146; SCHEELE GA, 1975, J CELL BIOL, V67, pA385; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; TOYN J, 1988, EMBO J, V7, P4347, DOI 10.1002/j.1460-2075.1988.tb03333.x; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; WOLFE PB, 1984, CELL, V36, P1067, DOI 10.1016/0092-8674(84)90056-4; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	95	327	337	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1452	1456		10.1126/science.1113752	http://dx.doi.org/10.1126/science.1113752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322447				2022-12-28	WOS:000233756500033
J	Raible, F; Tessmar-Raible, K; Osoegawa, K; Wincker, P; Jubin, C; Balavoine, G; Ferrier, D; Benes, V; de Jong, P; Weissenbach, J; Bork, P; Arendt, D				Raible, F; Tessmar-Raible, K; Osoegawa, K; Wincker, P; Jubin, C; Balavoine, G; Ferrier, D; Benes, V; de Jong, P; Weissenbach, J; Bork, P; Arendt, D			Vertebrate-type intron-rich genes in the marine annelid Platynereis dumerilii	SCIENCE			English	Article							CIONA-INTESTINALIS; EVOLUTION; CONSERVATION; ARTHROPODS; CHORDATE; ANIMALS; GENOME; PAX-6	Previous genome comparisons have suggested that one important trend in vertebrate evolution has been a sharp rise in intron abundance. By using genomic data and expressed sequence tags from the marine annelid Platynereis dumerilii, we provide direct evidence that about two-thirds of human introns predate the bilaterian radiation but were lost from insect and nematode genomes to a large extent. A comparison of coding exon sequences confirms the ancestral nature of Platynereis and human genes. Thus, the urbilaterian ancestor had complex, intron-rich genes that have been retained in Platynereis and human.	European Mol Biol Lab, Dev Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Computat Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Genom Core Facil, D-69117 Heidelberg, Germany; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Ctr Natl Sequencage, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Raible, F (corresponding author), European Mol Biol Lab, Dev Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	raible@embl.de; arendt@embl.de	Raible, Florian/G-6019-2011; Tessmar-Raible, Kristin/F-9642-2011; Bork, Peer/F-1813-2013; Ferrier, David E.K./D-7595-2013	Tessmar-Raible, Kristin/0000-0002-8038-1741; Bork, Peer/0000-0002-2627-833X; Ferrier, David E.K./0000-0003-3247-6233; Benes, Vladimir/0000-0002-0352-2547; Raible, Florian/0000-0002-4515-6485	Biotechnology and Biological Sciences Research Council [BBS/B/12067] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Glardon S, 1997, DEVELOPMENT, V124, P817; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8	16	179	183	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1325	1326		10.1126/science.1119089	http://dx.doi.org/10.1126/science.1119089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311335				2022-12-28	WOS:000233600200040
J	Holmes, W				Holmes, W			Seeking rational policy settings for PMTCT	LANCET			English	Editorial Material							HIV-1 TRANSMISSION; PREGNANCY; UGANDA; RAKAI; RISK		Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia	Burnet Institute	Holmes, W (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia.	holmes@burnet.edu.au						Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; McIntyre JA, 2005, LANCET, V366, P1141, DOI 10.1016/S0140-6736(05)67458-2; Nieburg P, 2005, EXPANDED HIV TESTING; TOOLE MJ, IN PRESS SEX TRANSM; *UN, 2001, UNGASS DECL COMM HIV; UNFPA, 2004, GLION CALL ACT FAM P; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	9	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1835	1836		10.1016/S0140-6736(05)67738-0	http://dx.doi.org/10.1016/S0140-6736(05)67738-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310540				2022-12-28	WOS:000233643200008
J	Stittelaar, KJ; Neyts, J; Naesens, L; van Amerongen, G; van Lavieren, RF; Holy, A; De Clercq, E; Niesters, HGM; Fries, E; Maas, C; Mulder, PGH; van der Zeijst, BAM; Osterhaus, ADME				Stittelaar, KJ; Neyts, J; Naesens, L; van Amerongen, G; van Lavieren, RF; Holy, A; De Clercq, E; Niesters, HGM; Fries, E; Maas, C; Mulder, PGH; van der Zeijst, BAM; Osterhaus, ADME			Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection	NATURE			English	Article							POXVIRUS INFECTIONS; PROTECTS MICE; CIDOFOVIR; EFFICACY; VACCINIA; ANALOGS; COWPOX; PROPHYLAXIS; INHIBITION; THERAPY	There is concern that variola virus, the aetiological agent of smallpox, may be used as a biological weapon. For this reason several countries are now stockpiling ( vaccinia virus-based) smallpox vaccine. Although the preventive use of smallpox vaccination has been well documented, little is known about its efficacy when used after exposure to the virus. Here we compare the effectiveness of ( 1) post-exposure smallpox vaccination and ( 2) antiviral treatment with either cidofovir ( also called HPMPC or Vistide) or with a related acyclic nucleoside phosphonate analogue (HPMPO-DAPy) after lethal intratracheal infection of cynomolgus monkeys ( Macaca fascicularis) with monkeypox virus (MPXV). MPXV causes a disease similar to human smallpox(1) and this animal model can be used to measure differences in the protective efficacies of classical and new-generation candidate smallpox vaccines(2). We show that initiation of antiviral treatment 24 h after lethal intratracheal MPXV infection, using either of the antiviral agents and applying various systemic treatment regimens, resulted in significantly reduced mortality and reduced numbers of cutaneous monkeypox lesions. In contrast, when monkeys were vaccinated 24 h after MPXV infection, using a standard human dose of a currently recommended smallpox vaccine (Elstree-RIVM), no significant reduction in mortality was observed. When antiviral therapy was terminated 13 days after infection, all surviving animals had virus-specific serum antibodies and antiviral T lymphocytes. These data show that adequate preparedness for a biological threat involving smallpox should include the possibility of treating exposed individuals with antiviral compounds such as cidofovir or other selective anti-poxvirus drugs.	Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; Netherlands Vaccine Inst, NL-3720 BA Bilthoven, Netherlands; ViroClin BV, NL-3000 DR Rotterdam, Netherlands; Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; KU Leuven; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Osterhaus, ADME (corresponding author), Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl	Naesens, Lieve/V-8725-2019; Neyts, Johan/U-8267-2017; Naesens, Lieve MJ/V-8581-2017; Niesters, Hubert/AAH-6808-2019; Van der Zeijst, Bernard B.A./A-3847-2013; Van der Zeijst, Bernard/AAH-1415-2020	Naesens, Lieve/0000-0001-9742-9302; Neyts, Johan/0000-0002-0033-7514; Naesens, Lieve MJ/0000-0001-9742-9302; Van der Zeijst, Bernard B.A./0000-0001-9316-2161; Van der Zeijst, Bernard/0000-0001-9316-2161; Niesters, Hubert/0000-0002-1758-0430; De Clercq, Erik/0000-0002-2985-8890; Osterhaus, Albert/0000-0002-6074-1172				Balzarini J, 2004, NUCLEOS NUCLEOT NUCL, V23, P1321, DOI 10.1081/NCN-200027573; Bray M, 2004, J ANTIMICROB CHEMOTH, V54, P1, DOI 10.1093/jac/dkh286; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; Bronze Michael S, 2003, Curr Opin Investig Drugs, V4, P172; Buller RM, 2004, VIROLOGY, V318, P474, DOI 10.1016/j.virol.2003.11.015; Cundy KC, 1999, CLIN PHARMACOKINET, V36, P127, DOI 10.2165/00003088-199936020-00004; De Clercq E, 2004, REV MED VIROL, V14, P289, DOI 10.1002/rmv.439; De Clercq E, 2002, TRENDS PHARMACOL SCI, V23, P456, DOI 10.1016/S0165-6147(02)02091-6; Finkel E, 2001, SCIENCE, V291, P585, DOI 10.1126/science.291.5504.585; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Massoudi MS, 2003, J INFECT DIS, V188, P973, DOI 10.1086/378357; McFadden G, 2005, NAT MED, V11, P711, DOI 10.1038/nm0705-711; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Neyts J, 2004, ANTIVIR RES, V62, pA71; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Prichard Mark N., 2005, Current Drug Targets - Infectious Disorders, V5, P17, DOI 10.2174/1568005053174627; Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rose E, 2002, EUR J ORAL SCI, V110, P99, DOI 10.1034/j.1600-0722.2002.11178.x; Roy CJ, 2003, ANTIMICROB AGENTS CH, V47, P2933, DOI 10.1128/AAC.47.9.2933-2937.2003; Smee DF, 2004, J INFECT DIS, V190, P1132, DOI 10.1086/422696; Smee DF, 2003, CHEMOTHERAPY, V49, P126, DOI 10.1159/000070618; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; Stanford MM, 2005, TRENDS IMMUNOL, V26, P339, DOI 10.1016/j.it.2005.04.001; STILLELAAR KJ, 2005, J VIROL, V79, P7845; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005; Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	30	122	124	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					745	748		10.1038/nature04295	http://dx.doi.org/10.1038/nature04295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16341204	Bronze			2022-12-28	WOS:000235193100049
J	Gessner, O; Lee, AMD; Shaffer, JP; Reisler, H; Levchenko, SV; Krylov, AI; Underwood, JG; Shi, H; East, ALL; Wardlaw, DM; Chrysostom, ET; Hayden, CC; Stolow, A				Gessner, O; Lee, AMD; Shaffer, JP; Reisler, H; Levchenko, SV; Krylov, AI; Underwood, JG; Shi, H; East, ALL; Wardlaw, DM; Chrysostom, ET; Hayden, CC; Stolow, A			Femtosecond multidimensional imaging of a molecular dissociation	SCIENCE			English	Article							PHOTOELECTRON ANGULAR-DISTRIBUTIONS; NITRIC-OXIDE DIMER; NO DIMER; ULTRAVIOLET PHOTODISSOCIATION; ELECTRONIC STATES; 193 NM; TIME; DYNAMICS; SPECTROSCOPY; PHOTOION	The coupled electronic and vibrational motions governing chemical processes are best viewed from the molecule's point of view-the molecular frame. Measurements made in the laboratory frame often conceal information because of the random orientations the molecule can take. We used a combination of time-resolved photoelectron spectroscopy, multidimensional coincidence imaging spectroscopy, and ab initio computation to trace a complete reactant-to-product pathway-the photodissociation of the nitric oxide dimer-from the molecule's point of view, on the femtosecond time scale. This method revealed an elusive photochemical process involving intermediate electronic configurations.	Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Open Univ, Dept Phys & Astron, Milton Keynes MK7 6AA, Bucks, England; Univ Regina, Dept Chem, Regina, SK S4S 0A2, Canada; Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA	National Research Council Canada; Queens University - Canada; University of Oklahoma System; University of Oklahoma - Norman; University of Southern California; Open University - UK; University of Regina; United States Department of Energy (DOE); Sandia National Laboratories	Stolow, A (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	albert.stolow@nrc.ca	Stolow, Albert/AAN-5609-2020; Levchenko, Sergey V/H-1977-2017	Levchenko, Sergey V/0000-0001-5813-8473; Krylov, Anna/0000-0001-6788-5016; Lee, Anthony/0000-0001-6327-2351				BILLINGSLEY J, 1971, T FARADAY SOC, V67, P589, DOI 10.1039/tf9716700589; Blanchet V, 1998, J CHEM PHYS, V108, P4371, DOI 10.1063/1.475848; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; CARNOVALE F, 1986, J CHEM PHYS, V84, P6526, DOI 10.1063/1.450702; Davies JA, 2000, PHYS REV LETT, V84, P5983, DOI 10.1103/PhysRevLett.84.5983; Davies JA, 1999, J CHEM PHYS, V111, P1, DOI 10.1063/1.479248; Demyanenko AV, 2002, J CHEM PHYS, V117, P2568, DOI 10.1063/1.1490599; Dribinski V, 2004, CHEM PHYS LETT, V385, P233, DOI 10.1016/j.cplett.2003.12.092; East ALL, 1998, J CHEM PHYS, V109, P2185, DOI 10.1063/1.476786; ELAND JHD, 1979, J CHEM PHYS, V70, P2926, DOI 10.1063/1.437831; FORTE E, 1978, CHEM PHYS, V30, P325, DOI 10.1016/0301-0104(78)87004-9; GESSNER O, UNPUB; KAJIMOTO O, 1985, J PHYS CHEM-US, V89, P2725, DOI 10.1021/j100259a004; Lochbrunner S, 2000, J ELECTRON SPECTROSC, V112, P183, DOI 10.1016/S0368-2048(00)00212-7; LOW KG, 1985, CHEM PHYS, V100, P401, DOI 10.1016/0301-0104(85)87066-X; NAITOH Y, 1993, CHEM PHYS LETT, V205, P423, DOI 10.1016/0009-2614(93)87145-S; NAITOH Y, 1995, J PHYS CHEM-US, V99, P13652, DOI 10.1021/j100037a012; Potter AB, 2003, J CHEM PHYS, V119, P7197, DOI 10.1063/1.1606442; Rakitzis TP, 2004, SCIENCE, V303, P1852, DOI 10.1126/science.1094186; Reid KL, 2000, J CHEM PHYS, V112, P3643, DOI 10.1063/1.480517; Reid KL, 2003, ANNU REV PHYS CHEM, V54, P397, DOI 10.1146/annurev.physchem.54.011002.103814; Sayos R, 2000, J CHEM PHYS, V112, P6608, DOI 10.1063/1.481234; Seideman T, 2002, ANNU REV PHYS CHEM, V53, P41, DOI 10.1146/annurev.physchem.53.082101.130051; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Stolow A, 2004, SCIENCE, V305, P1575, DOI 10.1126/science.1103195; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Stolow A, 2003, ANNU REV PHYS CHEM, V54, P89, DOI 10.1146/annurev.physchem.54.011002.103809; Tobita M, 2003, J CHEM PHYS, V119, P10713, DOI 10.1063/1.1619952; Tsubouchi M, 2005, J ELECTRON SPECTROSC, V142, P193, DOI 10.1016/j.elspec.2004.09.013; Tsubouchi M, 2003, CHEM PHYS LETT, V382, P418, DOI 10.1016/j.cplett.2003.10.078; Tsubouchi M, 2003, J CHEM PHYS, V119, P11728, DOI 10.1063/1.1624600; Underwood JG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143002; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587	33	154	154	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					219	222		10.1126/science.1120779	http://dx.doi.org/10.1126/science.1120779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16357226				2022-12-28	WOS:000234722200039
J	Mackay, D; Sutton, M; Watt, G				Mackay, D; Sutton, M; Watt, G			Deprivation and volunteering by general practices: cross sectional analysis of a national primary care system	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland; Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland	University of Glasgow; University of Aberdeen	Watt, G (corresponding author), Univ Glasgow, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland.	gcmw1j@clinmed.gla.ac.uk		Sutton, Matt/0000-0002-6635-2127				MCKEON AJ, 1997, PERSONAL MED SERVICE; Noble M., 2003, SCOTTISH INDICES DEP; Scottish Executive, 2000, OUR NAT HLTH PLAN AC; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7	4	23	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1449	1451		10.1136/bmj.331.7530.1449	http://dx.doi.org/10.1136/bmj.331.7530.1449			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356981	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000234156400025
J	Bartlett, DH; Azam, F				Bartlett, DH; Azam, F			Chitin, cholera, and competence	SCIENCE			English	Editorial Material							BIOFILM FORMATION; ESCHERICHIA-COLI; DNA; VIRULENCE		Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Bartlett, DH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu; fazam@ucsd.edu	Azam, Farooq/A-2306-2012					Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Castro-Rosas J, 2005, INT J FOOD MICROBIOL, V102, P195, DOI 10.1016/j.ijfoodmicro.2004.12.015; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Matsui K, 2003, APPL ENVIRON MICROB, V69, P2399, DOI 10.1128/AEM.69.4.2399-2404.2003; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Naviaux RK, 2005, MAR ECOL PROG SER, V301, P9, DOI 10.3354/meps301009; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wang YJ, 2005, APPL ENVIRON MICROB, V71, P1291, DOI 10.1128/AEM.71.3.1291-1299.2005; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960	19	69	77	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1775	1777		10.1126/science.1122396	http://dx.doi.org/10.1126/science.1122396			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357249				2022-12-28	WOS:000234093600033
J	Petri, M; Kim, MY; Kalunian, KC; Grossman, J; Hahn, BH; Sammaritano, LR; Lockshin, M; Merrill, JT; Belmont, HM; Askanase, AD; McCune, WJ; Hearth-Holmes, M; Dooley, MA; Von Feldt, J; Friedman, A; Tan, M; Davis, J; Cronin, M; Diamond, B; Mackay, M; Sigler, L; Fillius, M; Rupel, A; Licciardi, F; Buyon, JP				Petri, M; Kim, MY; Kalunian, KC; Grossman, J; Hahn, BH; Sammaritano, LR; Lockshin, M; Merrill, JT; Belmont, HM; Askanase, AD; McCune, WJ; Hearth-Holmes, M; Dooley, MA; Von Feldt, J; Friedman, A; Tan, M; Davis, J; Cronin, M; Diamond, B; Mackay, M; Sigler, L; Fillius, M; Rupel, A; Licciardi, F; Buyon, JP		OC-SELENA Trial	Combined oral contraceptives in women with systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE-ACTIVITY; UNITED-STATES; ESTROGEN; THERAPY; CLASSIFICATION; OSTEOPOROSIS; FREQUENCY; TRIAL; RISK; SLE	BACKGROUND: Oral contraceptives are rarely prescribed for women with systemic lupus erythematosus, because of concern about potential negative side effects. In this double-blind, randomized, noninferiority trial, we prospectively evaluated the effect of oral contraceptives on lupus activity in premenopausal women with systemic lupus erythematosus. METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were randomly assigned to receive either oral contraceptives (triphasic ethinyl estradiol at a dose of 35 microg plus norethindrone at a dose of 0.5 to 1 mg for 12 cycles of 28 days each; 91 women) or placebo (92 women) and were evaluated at months 1, 2, 3, 6, 9, and 12. Subjects were excluded if they had moderate or high levels of anticardiolipin antibodies, lupus anticoagulant, or a history of thrombosis. RESULTS: The primary end point, a severe lupus flare, occurred in 7 of 91 subjects receiving oral contraceptives (7.7 percent) as compared with 7 of 92 subjects receiving placebo (7.6 percent). The 12-month rates of severe flare were similar: 0.084 for the group receiving oral contraceptives and 0.087 for the placebo group (P=0.95; upper limit of the one-sided 95 percent confidence interval for this difference, 0.069, which is within the prespecified 9 percent margin for noninferiority). Rates of mild or moderate flares were 1.40 flares per person-year for subjects receiving oral contraceptives and 1.44 flares per person-year for subjects receiving placebo (relative risk, 0.98; P=0.86). In the group that was randomized to receive oral contraceptives, there was one deep venous thrombosis and one clotted graft; in the placebo group, there was one deep venous thrombosis, one ocular thrombosis, one superficial thrombophlebitis, and one death (after cessation of the trial). CONCLUSIONS: Our study indicates that oral contraceptives do not increase the risk of flare among women with systemic lupus erythematosus whose disease is stable.	NYU, Hosp Joint Dis, Sch Med, Dept Rheumatol, New York, NY 10003 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Hosp Special Surg, New York, NY 10021 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; NYU, Sch Med, Bellevue Hosp, New York, NY USA; Univ Michigan, Ann Arbor, MI 48109 USA; Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Texas, Houston, TX USA; Rheumatol Associates Long Isl, Port Jefferson Stn, NY USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Johns Hopkins University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles; Oklahoma Medical Research Foundation; Bellevue Hospital Center; New York University; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Texas System; University of California System; University of California San Francisco; Medical College of Wisconsin	Buyon, JP (corresponding author), NYU, Hosp Joint Dis, Sch Med, Dept Rheumatol, Rm 1608,301 E 17th St, New York, NY 10003 USA.	jill.buyon@nyumc.org	Kalunian, Kenneth/L-4471-2019; Kalunian, Kenneth/AAK-6424-2020	Belmont, Howard/0000-0003-3389-2976; Kalunian, Kenneth/0000-0003-0261-3102; Buyon, Jill/0000-0002-3852-7129; Licciardi, Frederick/0000-0002-2186-5981	NCRR NIH HHS [M01-RR 00096, M01-RR 00052] Funding Source: Medline; NIAID NIH HHS [R01 AI062069] Funding Source: Medline; NIAMS NIH HHS [U01 AR42540, AR 43727] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727, U01AR042540, R55AR043727] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Buyon J P, 1995, J Clin Rheumatol, V1, P205, DOI 10.1097/00124743-199508000-00002; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; FINE LG, 1981, ANN INTERN MED, V94, P667, DOI 10.7326/0003-4819-94-5-667; GALLAGHER JC, 1980, J CLIN ENDOCR METAB, V51, P1359, DOI 10.1210/jcem-51-6-1359; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; Hochberg MC, 1996, ARTHRITIS RHEUM-US, V39, P1791; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; JULKUNEN HA, 1991, SCAND J RHEUMATOL, V20, P427, DOI 10.3109/03009749109096822; JUNGERS P, 1982, ARTHRITIS RHEUM, V25, P618, DOI 10.1002/art.1780250603; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; LAHITA RG, 1982, ARTHRITIS RHEUM, V25, P843, DOI 10.1002/art.1780250726; MASI AT, 1978, ARTHRITIS RHEUM-US, V21, P480, DOI 10.1002/art.1780210413; PACIFICI R, 1989, P NATL ACAD SCI USA, V86, P2398, DOI 10.1073/pnas.86.7.2398; Petri M, 1997, ARTHRITIS RHEUM, V40, P797, DOI 10.1002/art.1780400504; Petri M, 1995, Arthritis Care Res, V8, P137, DOI 10.1002/art.1790080305; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Ramsey-Goldman R, 1999, ARTHRITIS RHEUM, V42, P882, DOI 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; ROUBINIAN J, 1979, ARTHRITIS RHEUM, V22, P1162; SanchezGuerrero J, 1997, ARTHRITIS RHEUM, V40, P804, DOI 10.1002/art.1780400505; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TRUSSELL J, 1987, STUD FAMILY PLANN, V18, P237, DOI 10.2307/1966856	25	721	756	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2550	2558		10.1056/NEJMoa051135	http://dx.doi.org/10.1056/NEJMoa051135			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354891	Green Published, Bronze			2022-12-28	WOS:000233926500004
J	Fan, E; Needham, DM; Stewart, TE				Fan, E; Needham, DM; Stewart, TE			Ventilatory management of acute lung injury and acute respiratory distress syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INHALED NITRIC-OXIDE; FREQUENCY OSCILLATORY VENTILATION; TIDAL VOLUME VENTILATION; QUALITY-OF-LIFE; MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; RECRUITMENT MANEUVERS; SYNDROME ARDS; GAS-EXCHANGE; TRIAL	Context The acute lung injury and acute respiratory distress syndrome are critical illnesses associated with significant morbidity and mortality. Mechanical ventilation is the cornerstone of supportive therapy. However, despite several important advances, the optimal strategy for ventilation and adjunctive therapies for patients with acute lung injury and acute respiratory distress syndrome is still evolving. Evidence Acquisition To identify reports of invasive ventilatory and adjunctive therapies in adult patients with acute lung injury and acute respiratory distress syndrome, we performed a systematic English-language literature search of MEDLINE (19662005) using the Medical Subject Heading respiratory distress syndrome, adult, and related text words, with emphasis on randomized controlled trials and meta-analyses. EMBASE and the Cochrane Central Register of Controlled Trials were similarly searched. The search yielded 1357 potential articles of which 53 were relevant to the study objectives and considered in this review. Evidence Synthesis There is strong evidence to support the use of volume- and pressure-limited lung-protective ventilation in adult patients with acute lung injury and acute respiratory distress syndrome. The benefit of increased levels of positive end-expiratory pressure and recruitment maneuvers is uncertain and is being further evaluated in ongoing trials. Existing randomized controlled trials of alternative ventilation modes, such as high-frequency oscillation and adjunctive therapies, including inhaled nitric oxide and prone positioning demonstrate no significant survival advantage. However, they may have a role as rescue therapy for patients with acute respiratory distress syndrome with refractory life-threatening hypoxemia. Conclusions Volume- and pressure-limited ventilation strategies should be used in managing adult acute lung injury and acute respiratory distress syndrome patients. Further research is needed to identify barriers to widespread adoption of this strategy, as well as the role of alternative ventilation modes and adjunctive therapies.	Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada; Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto; University of Toronto; Johns Hopkins University	Stewart, TE (corresponding author), Mt Sinai Hosp, Univ Hlth Network, 600 Univ Ave,Suite 18-206, Toronto, ON M5G 1X5, Canada.	tstewart@mtsinai.on.ca			NHLBI NIH HHS [P050 HL 73994-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073994] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; *AM THOR SOC, 1999, AM J RESP CRIT CARE, V160, P2118; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; ARDS Clinical Trials Network, 2003, CRIT CARE MED, V31, P2592, DOI 10.1097/01.CCM.0000090001.91640.45; ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2002, AM J RESP CRIT CARE, V166, P1515, DOI 10.1164/ajrccm.166.11.340; BROWER RG, 2004, AM J RESP CRIT CARE, V169, pA17; BRYAN AC, 1974, AM REV RESPIR DIS, V110, P143; Cakar N, 2002, CRIT CARE MED, V30, P2103, DOI 10.1097/00003246-200209000-00025; Crimi Ettore, 2004, Best Pract Res Clin Anaesthesiol, V18, P477, DOI 10.1016/S1521-6896(03)00121-6; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Dellinger RP, 1998, CRIT CARE MED, V26, P15, DOI 10.1097/00003246-199801000-00011; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Fan Eddy, 2005, Crit Care Med, V33, pS182, DOI 10.1097/01.CCM.0000155927.54034.34; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Ferguson ND, 2004, INTENS CARE MED, V30, P1111, DOI 10.1007/s00134-004-2163-2; Foti G, 2000, INTENS CARE MED, V26, P501, DOI 10.1007/s001340051196; Frutos-Vivar Fernando, 2004, Curr Opin Crit Care, V10, P1, DOI 10.1097/00075198-200402000-00001; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Gattinoni L., 1987, INTENSIVE CRIT CARE, V6, P1; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Imai Yumiko, 2005, Crit Care Med, V33, pS129, DOI 10.1097/01.CCM.0000156793.05936.81; Kahn JM, 2005, CRIT CARE MED, V33, P766, DOI 10.1097/01.CCM.0000157786.41506.24; Kallet RH, 2005, CRIT CARE MED, V33, P925, DOI 10.1097/01.CCM.0000162382.59289.9C; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Lapinsky SE, 1999, INTENS CARE MED, V25, P1297, DOI 10.1007/s001340051061; Lapinsky SE, 2005, CRIT CARE, V9, P60, DOI 10.1186/cc2934; Levy MM, 2004, NEW ENGL J MED, V351, P389, DOI 10.1056/NEJMe048103; Lim SC, 2004, CRIT CARE MED, V32, P2371, DOI 10.1097/01.CCM.0000147445.73344.3A; Lundin S, 1999, INTENS CARE MED, V25, P911, DOI 10.1007/s001340050982; Mancebo J, 2003, INTENS CARE MED, V29, pS64; Marini JJ, 2004, CRIT CARE MED, V32, P250, DOI 10.1097/01.CCM.0000104946.66723.A8; Meade MO, 2001, AM J RESP CRIT CARE, V165, pA683; Medoff BD, 2005, NEW ENGL J MED, V352, P2425, DOI 10.1056/NEJMcpc059012; Mehta S, 2004, CHEST, V126, P518, DOI 10.1378/chest.126.2.518; MEHTA S, 2001, J APPL RES, V1, P73; Michael JR, 1998, AM J RESP CRIT CARE, V157, P1372, DOI 10.1164/ajrccm.157.5.96-10089; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Moran JL, 2005, INTENS CARE MED, V31, P227, DOI 10.1007/s00134-004-2506-z; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Pelosi P, 1999, AM J RESP CRIT CARE, V159, P872, DOI 10.1164/ajrccm.159.3.9802090; Pelosi P, 2003, EUR RESPIR J, V22, p48S, DOI 10.1183/09031936.03.00420803; Pelosi P, 2002, EUR RESPIR J, V20, P1017, DOI 10.1183/09031936.02.00401702; Petrucci N, 2004, ANESTH ANALG, V99, P193, DOI 10.1213/01.ANE.0000118102.93688.97; PETTY TL, 1971, CHEST, V60, P233, DOI 10.1378/chest.60.3.233; Plotz FB, 2004, INTENS CARE MED, V30, P1865, DOI 10.1007/s00134-004-2363-9; Ritacca FV, 2003, CRIT CARE, V7, P385, DOI 10.1186/cc2182; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Rubenfeld GD, 1999, CHEST, V116, P1347, DOI 10.1378/chest.116.5.1347; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; Santos C, 2000, AM J RESP CRIT CARE, V161, P26, DOI 10.1164/ajrccm.161.1.9902084; SHAPIRO BA, 1980, CHEST, V77, P138, DOI 10.1378/chest.77.2.138; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Sokol J, 2003, ANESTH ANALG, V97, P989, DOI [10.1213/01.ANE.0000078819.48523.26, 10.1213/01.ANE.0000078819.45523.26]; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Troncy E, 1998, AM J RESP CRIT CARE, V157, P1483, DOI 10.1164/ajrccm.157.5.9707090; Weinert CR, 2003, AM J RESP CRIT CARE, V167, P1304, DOI 10.1164/rccm.200205-478OC; Young MP, 2004, CRIT CARE MED, V32, P1260, DOI 10.1097/01.CCM.0000127784.54727.56	79	131	142	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2889	2896		10.1001/jama.294.22.2889	http://dx.doi.org/10.1001/jama.294.22.2889			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352797	Bronze			2022-12-28	WOS:000233826700030
J	Kleine, T; Palme, H; Mezger, K; Halliday, AN				Kleine, T; Palme, H; Mezger, K; Halliday, AN			Hf-W chronometry of lunar metals and the age and early differentiation of the Moon	SCIENCE			English	Article							COSMIC-RAY PRODUCTION; CORE FORMATION; ORIGIN; EARTH; CONSTRAINTS; EVOLUTION; METEORITES; ACCRETION; KREEP; EUCRITES	The use of hafnium-tungsten chronometry to date the Moon is hampered by cosmogenic tungsten-182 production mainly by neutron capture of tantalum-181 at the lunar surface. We report tungsten isotope data for lunar metals, which contain no (181)Ta-derived cosmogenic (182)W. The data reveal differences in indigenous (182)W/(184)W of lunar mantle reservoirs, indicating crystallization of the lunar magma ocean 4.527 +/- 0.010 billion years ago. This age is consistent with the giant impact hypothesis and defines the completion of the major stage of Earth's accretion.	Inst Mineral, Zent Lab Geochronol, D-48149 Munster, Germany; ETH Zentrum NO, Dept Erdwissensch, Inst Isotopengeol & Mineral Rohstoffe, CH-8092 Zurich, Switzerland; Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne; University of Oxford	Kleine, T (corresponding author), Inst Mineral, Zent Lab Geochronol, Corrensstr 24, D-48149 Munster, Germany.	kleine@erdw.ethz.ch	Mezger, Klaus/D-9502-2011; Kleine, Thorsten/S-2792-2017	Mezger, Klaus/0000-0002-2443-8539; Kleine, Thorsten/0000-0003-4657-5961				ALIBERT C, 1994, GEOCHIM COSMOCHIM AC, V58, P2921, DOI 10.1016/0016-7037(94)90125-2; Borg L, 1999, GEOCHIM COSMOCHIM AC, V63, P2679, DOI 10.1016/S0016-7037(99)00130-1; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; CARLSON RW, 1979, EARTH PLANET SC LETT, V45, P123, DOI 10.1016/0012-821X(79)90114-6; Elkins-Tanton LT, 2002, EARTH PLANET SC LETT, V196, P239, DOI 10.1016/S0012-821X(01)00613-6; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Jones J. H., 2000, ORIGIN EARTH MOON, P197, DOI DOI 10.1016/0016-7037(83)90024-8.; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Kleine T, 2005, EARTH PLANET SC LETT, V231, P41, DOI 10.1016/j.epsl.2004.12.016; Kleine T, 2004, EARTH PLANET SC LETT, V228, P109, DOI 10.1016/j.epsl.2004.09.023; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; KLEINE T, IN PRESS GEOCHIM COS; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Leya I, 2000, EARTH PLANET SC LETT, V175, P1, DOI 10.1016/S0012-821X(99)00295-2; Leya I, 2003, GEOCHIM COSMOCHIM AC, V67, P529, DOI 10.1016/S0016-7037(02)01091-8; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; PALME H, 1977, GEOCHIM COSMOCHIM AC, V41, P1791, DOI 10.1016/0016-7037(77)90211-3; Palme H., 1975, P LUN SCI C, V6, P1179; Palme H., 1981, LUNAR PLANET SCI, VXII, P796; Righter K, 2003, GEOCHIM COSMOCHIM AC, V67, P2497, DOI 10.1016/S0016-7037(02)01349-2; Shearer CK, 2000, GEOCHIM COSMOCHIM AC, V64, P3599, DOI 10.1016/S0016-7037(00)00442-7; Shearer CK, 1999, AM MINERAL, V84, P1469; Solomon S. C., 1977, P LUNAR PLANET SCI C, P583; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; Wunke H., 1971, P 2 LUN SCI C, P1187; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	29	108	118	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1671	1674		10.1126/science.1118842	http://dx.doi.org/10.1126/science.1118842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16308422				2022-12-28	WOS:000233961700042
J	Parsonnet, J				Parsonnet, J			Clinician-discoverers - Marshall, Warren, and H-Pylori	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Parsonnet, J (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Parsonnet, Julie/0000-0001-7342-5366				BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; *LIT NET, ANC MED HIPP; Marshall B. J., 2002, HELICOBACTER PIONEER; SIURALA M, 1974, MED WELT, V25, P498	4	19	21	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2421	2423		10.1056/NEJMp058270	http://dx.doi.org/10.1056/NEJMp058270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339090				2022-12-28	WOS:000233754400001
J	Izurieta, HS; Haber, P; Wise, RP; Iskander, J; Pratt, D; Mink, C; Chang, SJ; Braun, MM; Ball, R				Izurieta, HS; Haber, P; Wise, RP; Iskander, J; Pratt, D; Mink, C; Chang, SJ; Braun, MM; Ball, R			Adverse events reported following live, cold-adapted, intranasal influenza vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; CHILDREN; SAFETY	Context In June 2003, the US Food and Drug Administration licensed a trivalent live, attenuated influenza vaccine (LAIV-T) for intranasal administration to healthy persons 5 to 49 years of age. Although prelicensure testing involved 20228 vaccinees, clinical trials were not of sufficient size to detect rare adverse events reliably. Objective To identify adverse events reported following LAIV-T administration after licensure. Design, Setting, and Participants All adverse events reported to the US Vaccine Adverse Event Reporting System (VAERS) during the 2003-2004 and the 2004-2005 influenza seasons. Main Outcome Measures Numbers and proportions of reported adverse events and reporting rates of adverse events per 100 000 vaccinees. Results Approximately 2 500000 persons received LAIV-T during the first 2 post-licensure seasons. As of August 16, 2005, VAERS received 460 adverse event reports for vaccinations received from August 2003 through July 2005. No fatalities were reported. There were 7 reports of possible anaphylaxis, 2 reports of Guillain-Barre syndrome, 1 report of Bell palsy, and 8 reports of asthma exacerbation among individuals with a prior asthma history. Events in individuals for whom the vaccine was not indicated accounted for 73 reports (16%). Conclusions Reports to VAERS in the first 2 seasons of LAIV-T use did not identify any unexpected serious risks with this vaccine when used according to approved indications. Like many vaccines and other medical products, LAIV-T may rarely cause anaphylaxis. Secondary transmission of the vaccine virus merits further investigation. Reports of asthma exacerbations in vaccinees with prior asthma history highlight the risks of vaccine use inconsistent with approved labeling.	US FDA, Vaccine Safety Branch, Div Epidemiol, Off Biostat & Epidemiol,Ctr Biol Evaluat & Res, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Natl Immunizat Off, Off Chief Sci Officer, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Izurieta, HS (corresponding author), US FDA, Vaccine Safety Branch, Div Epidemiol, Off Biostat & Epidemiol,Ctr Biol Evaluat & Res, 1401 Rockville Pike,2nd Floor,Suite 200S,HFM-222, Rockville, MD 20852 USA.	hector.izurieta@fda.hhs.gov						Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Harper Scott A, 2003, MMWR Recomm Rep, V52, P1; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; *MED VACC INC, 2005, INFL VIR VACC LIV IN; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Redding G, 2002, PEDIATR INFECT DIS J, V21, P44, DOI 10.1097/00006454-200201000-00010; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Stratton K.R., 1994, ADVERSE EVENTS ASS C; TURNER W, 2003, COMMUNICATION   0617; Varricchio F, 1998, J TOXICOL-CLIN TOXIC, V36, P765, DOI 10.3109/15563659809162636; VESIKARI T, 2001, 41 INT C ANT AG CHEM; WAUBANT E, 2004, IMM SAF REV M, V5; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	18	98	107	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2720	2725		10.1001/jama.294.21.2720	http://dx.doi.org/10.1001/jama.294.21.2720			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333007	Bronze			2022-12-28	WOS:000233726900020
J	Wong, SM; Hui, ACF; Tong, PY; Poon, DWF; Yu, E; Wong, LKS				Wong, SM; Hui, ACF; Tong, PY; Poon, DWF; Yu, E; Wong, LKS			Treatment of lateral epicondylitis with botulinum toxin. A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							TENNIS ELBOW; A TOXIN; INJECTION	Background: Lateral epicondylitis is a common condition for which botulinum toxin has been reported to have a therapeutic role in uncontrolled studies. Objective: To determine if an injection of botulinum toxin is more effective than placebo for reducing pain in adults with lateral epicondylitis. Design: Randomized, double-blind, placebo-controlled trial conducted from September 2002 to December 2004. Setting: Outpatient clinics at a university hospital and a district hospital in Hong Kong. Participants: 60 patients with lateral epicondylitis. Measurements: The primary outcome was change in subjective pain as measured by a 100-mm visual analogue scale (VAS) ranging from 0 (no pain) to 10 (worst pain ever) at 4 weeks and 12 weeks. All patients completed post-treatment follow-up. Interventions: A single injection of 60 units of botulinum toxin type A or normal saline placebo. Results: Mean VAS scores for the botulinum group at baseline and at 4 weeks were 65.5 mm and 25.3 mm, respectively; respective scores for the placebo group were 66.2 mm and 50.5 mm (between-group difference of changes, 24.4 mm [95% CI, 13.0 to 35.8 mm]; P < 0.001). At week 12, mean VAS scores were 23.5 mm for the botulinum group and 43.5 mm 1:or the placebo group (between-group difference of changes, 19.3 mm [CI, 5.6 to 32.9 mm]; P = 0.006). Grip strength was not statistically significantly different between groups at any time. Mild paresis of the fingers occurred in 4 patients in the botulinum group at 4 weeks. One patient's symptoms persisted until week 12, whereas none of the patients receiving placebo had the same complaint. At 4 weeks, 10 patients in the botulinum group and 6 patents in the placebo group experienced weak finger extension on the same side as the injection site. Limitations: The trial was small, and most participants were women. The blinding protocol may have been ineffective because the 4 participants who experienced paresis of the fingers could have correctly assumed that they received an active treatment. Conclusions: Botulinum toxin injection may improve pain over a 3-month period in some patients with lateral epicondylitis, but injections may be associated with digit paresis and weakness of finger extension.	Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Wong, SM (corresponding author), PacifiCare, 12th Floor,Oterprise Square,26 Nathan Rd,Tsim Sha, Hong Kong, Hong Kong, Peoples R China.	jsmwong@hkstar.com	Wong, Ka Sing Lawrence/N-3434-2015	Wong, Ka Sing Lawrence/0000-0002-2031-9866				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Assendelft Willem, 2004, Clin Evid, P1633; CHESHIRE WP, 1994, PAIN, V59, P65, DOI 10.1016/0304-3959(94)90048-5; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FILIPPI GM, 1993, ACTA OTO-LARYNGOL, V113, P400, DOI 10.3109/00016489309135834; Guyer, 1999, Curr Rev Pain, V3, P427; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Hayton MJ, 2005, J BONE JOINT SURG AM, V87A, P503, DOI 10.2106/JBJS.D.01896; Keizer SB, 2002, CLIN ORTHOP RELAT R, P125; Molloy FM, 2002, NEUROLOGY, V58, P805, DOI 10.1212/WNL.58.5.805; Morre HHE, 1997, LANCET, V349, P1746, DOI 10.1016/S0140-6736(05)62958-3; Swartling C, 2001, EUR J NEUROL, V8, P451, DOI 10.1046/j.1468-1331.2001.00261.x; VERHAAR JAN, 1994, INT ORTHOP, V18, P263; Voller B, 2003, NEUROLOGY, V61, P940, DOI 10.1212/01.WNL.0000086374.92906.6A	14	105	115	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					793	797		10.7326/0003-4819-143-11-200512060-00007	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330790				2022-12-28	WOS:000233884900003
J	Brindusa, C				Brindusa, C			Marfan's syndrome: a daily struggle	LANCET			English	Editorial Material											Brindusa, C (corresponding author), Str Cetatii 28, Sibiu 550160, Romania.	brindusac@gmail.com							0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1977	1977		10.1016/S0140-6736(05)67790-2	http://dx.doi.org/10.1016/S0140-6736(05)67790-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325701				2022-12-28	WOS:000233777900027
J	Robinson, LF; Adkins, JF; Keigwin, LD; Southon, J; Fernandez, DP; Wang, SL; Scheirer, DS				Robinson, LF; Adkins, JF; Keigwin, LD; Southon, J; Fernandez, DP; Wang, SL; Scheirer, DS			Radiocarbon variability in the western North Atlantic during the last deglaciation	SCIENCE			English	Article							DEEP-SEA CORALS; MILLENNIAL-SCALE CHANGES; CAL KYR BP; GLACIAL MAXIMUM; SOUTHERN-OCEAN; THERMOHALINE CIRCULATION; SURFACE-TEMPERATURE; INTERMEDIATE WATER; AGE CALIBRATION; CLIMATE-CHANGE	We present a detailed history of glacial to Holocene radiocarbon in the deep western North Atlantic from deep-sea corals and paired benthic-planktonic foraminifera. The deglaciation is marked by switches between radiocarbon-enriched and -depleted waters, leading to large radiocarbon gradients in the water column. These changes played an important role in modulating atmospheric radiocarbon. The deep-ocean record supports the notion of a bipolar seesaw with increased Northem-source deep-water formation linked to Northern Hemisphere warming and the reverse. In contrast, the more frequent radiocarbon variations in the intermediate/deep ocean are associated with roughly synchronous changes at the poles.	CALTECH, Pasadena, CA 91125 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, McLean Lab, Woods Hole, MA 02543 USA; Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; US Geol Survey, Menlo Pk, CA 94025 USA	California Institute of Technology; Woods Hole Oceanographic Institution; University of California System; University of California Irvine; United States Department of the Interior; United States Geological Survey	Robinson, LF (corresponding author), CALTECH, MS 100-23,1200 E Calif Blvd, Pasadena, CA 91125 USA.	laurar@gps.caltech.edu	Adkins, Jess/GYI-8778-2022; Stott, Lowell/J-9460-2012	Robinson, Laura/0000-0001-6811-0140				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bostock HC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001047; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BROECKER W, 1988, RADIOCARBON, V30, P261, DOI 10.1017/S0033822200044234; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 1991, GLOBAL BIOGEOCHEM CY, V5, P87, DOI 10.1029/90GB02279; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1990, RADIOCARBON, V32, P119, DOI 10.1017/S003382220004011X; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; ELTGROTH S, UNPUB PALEOCEANOGRAP, P20601; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Frank N, 2004, EARTH PLANET SC LETT, V219, P297, DOI 10.1016/S0012-821X(03)00721-0; Gersonde R, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000809; Gersonde R, 2000, PALAEOGEOGR PALAEOCL, V162, P263, DOI 10.1016/S0031-0182(00)00131-0; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Goldstein SJ, 2001, EARTH PLANET SC LETT, V193, P167, DOI 10.1016/S0012-821X(01)00494-0; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; KEIGWIN LD, 1994, J GEOPHYS RES-OCEANS, V99, P12397, DOI 10.1029/94JC00525; Keigwin LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001074; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Keigwin LD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000283; Mangini A, 1998, NATURE, V392, P347, DOI 10.1038/32804; Marchitto TM, 1998, NATURE, V393, P557, DOI 10.1038/31197; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; Pahnke K, 2005, SCIENCE, V307, P1741, DOI 10.1126/science.1102163; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; RAISBECK GM, 1981, GEOPHYS RES LETT, V8, P1015, DOI 10.1029/GL008i009p01015; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Schroder-Ritzrau A, 2003, EARTH PLANET SC LETT, V216, P399, DOI 10.1016/S0012-821X(03)00511-9; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; STUIVER M, 1980, RADIOCARBON, V22, P1, DOI 10.1017/S0033822200004690; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wunsch C, 2003, QUATERNARY SCI REV, V22, P371, DOI 10.1016/S0277-3791(02)00177-4	47	202	203	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1469	1473		10.1126/science.1114832	http://dx.doi.org/10.1126/science.1114832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322451				2022-12-28	WOS:000233756500037
J	Xi, RW; Xie, T				Xi, RW; Xie, T			Stem cell self-renewal controlled by chromatin remodeling factors	SCIENCE			English	Article							DROSOPHILA-OVARY; HOMEOTIC GENES; GERMLINE; MAINTENANCE; PROLIFERATION; TRANSCRIPTION; DIVISIONS; HEDGEHOG; PROTEIN; BMI-1	The self-renewing ability of a stem cell is controlled by its specialized microenvironment or niche, whereas epigenetic regulation of gene expression by chromatin remodeling factors underlies cell fate determination. Here we report that the adenosine triphosphate-dependent chromatin remodeling factors ISWI and DOM control germline stem cell and somatic stem cell self-renewal in the Drosophila ovary, respectively. The iswi mutant germline stem cells are lost rapidly because of defects in responding to bone morphogenetic protein niche signals and in repressing differentiation, whereas the dom mutant somatic stem cells are lost because of defective self-renewal. This work demonstrates that different stem cell types can use different chromatin remodeling factors to control cell self-renewal.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org			NIGMS NIH HHS [R01 GM064428, 1R01 GM64428-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	26	120	124	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1487	1489		10.1126/science.1120140	http://dx.doi.org/10.1126/science.1120140			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322456				2022-12-28	WOS:000233756500042
J	Fischer, M; Bhatnagar, J; Guarner, J; Reagan, S; Hacker, JK; Van Meter, SH; Poukens, V; Whiteman, DB; Iton, A; Cheung, M; Dassey, DE; Shieh, WJ; Zaki, SR				Fischer, M; Bhatnagar, J; Guarner, J; Reagan, S; Hacker, JK; Van Meter, SH; Poukens, V; Whiteman, DB; Iton, A; Cheung, M; Dassey, DE; Shieh, WJ; Zaki, SR			Brief report - Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-THE-LITERATURE; UNITED-STATES; DIFFICILE CYTOTOXIN; POSTPARTUM; INFECTION; DEATHS; MIFEPRISTONE; PERFRINGENS; EPISIOTOMY; STRAINS	Endometritis and toxic shock syndrome associated with Clostridium sordiellii have previously been reported after childbirth and, in one case, after medical abortion. We describe four deaths due to endometritis and toxic shock syndrome associated with C. sordellii that occurred within one week after medically induced abortions. Clinical findings tachycardia, hypotension, edema, hemoconcentration, profound leukocytosis, absence of fever. These cases indicate the need for physician awareness of this and for further study of its association with medical abortion.	Ctr Dis Control & Prevent, Ft Collins, CO 80522 USA; Calif Emerging Infect Program, Richmond, CA USA; Alameda Cty Coroners Off, Oakland, CA USA; Dept Hlth, Oakland, CA USA; Dept Coroner, Los Angeles, CA USA; Dept Hlth Serv, Los Angeles, CA USA; Orange Cty Hlth Care Agcy, Santa Clara, CA USA	Centers for Disease Control & Prevention - USA; California Emerging Infections Program	Fischer, M (corresponding author), Ctr Dis Control & Prevent, POB 2087,Mailstop P-02, Ft Collins, CO 80522 USA.	mfischer@cdc.gov	Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541				Abdulla A, 2000, J CLIN PATHOL, V53, P709, DOI 10.1136/jcp.53.9.709; ADAMKIEWICZ TV, 1993, PEDIATR INFECT DIS J, V12, P253, DOI 10.1097/00006454-199303000-00020; Bartlett LA, 2004, OBSTET GYNECOL, V103, P729, DOI 10.1097/01.AOG.0000116260.81570.60; Bitti A, 1997, J CLIN PATHOL, V50, P259, DOI 10.1136/jcp.50.3.259; BROWDIE DA, 1975, J TRAUMA, V15, P515, DOI 10.1097/00005373-197506000-00011; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P724; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993; EATON CJ, 1971, AM J OBSTET GYNECOL, V109, P1162, DOI 10.1016/0002-9378(71)90658-2; EWING TL, 1979, AM J OBSTET GYNECOL, V134, P173, DOI 10.1016/0002-9378(79)90882-2; *FOOD DRUG ADM CTR, 2005, MIF MIF INF; GOLDE S, 1977, OBSTET GYNECOL, V50, P670; GREEN GA, 1995, GENE, V161, P57, DOI 10.1016/0378-1119(95)00263-6; GRIMWOOD K, 1990, PEDIATR INFECT DIS J, V9, P582, DOI 10.1097/00006454-199008000-00011; HAMMILL HA, 1989, OBSTET GYN CLIN N AM, V16, P329; Hausknecht R, 2003, CONTRACEPTION, V67, P463, DOI 10.1016/S0010-7824(03)00049-0; HOGAN SF, 1989, AM J CLIN PATHOL, V91, P104, DOI 10.1093/ajcp/91.1.104; Karasawa T, 2003, INFECT IMMUN, V71, P641, DOI 10.1128/IAI.71.2.641-646.2003; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353, DOI 10.1111/j.1348-0421.2002.tb02706.x; Kruse Beth, 2000, American Journal of Obstetrics and Gynecology, V183, pS65; MCGREGOR JA, 1989, AM J OBSTET GYNECOL, V161, P987, DOI 10.1016/0002-9378(89)90768-0; Miech RP, 2005, ANN PHARMACOTHER, V39, P1483, DOI 10.1345/aph.1G189; NAKAMURA S, 1986, ZBL BAKT-INT J MED M, V261, P345; NAKAMURA S, 1983, MICROBIOL IMMUNOL, V27, P495, DOI 10.1111/j.1348-0421.1983.tb00611.x; *NAT CTR HLTH STAT, 2001, VIT STAT US; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Rorbye C, 2000, ACTA OBSTET GYN SCAN, V79, P1134, DOI 10.1034/j.1600-0412.2000.0790121134.x; Saraiya M, 1999, OBSTET GYNECOL, V94, P172, DOI 10.1016/S0029-7844(99)00280-X; Shannon C, 2004, CONTRACEPTION, V70, P183, DOI 10.1016/j.contraception.2004.04.009; SHY KK, 1979, OBSTET GYNECOL, V54, P292; Sinave C, 2002, CLIN INFECT DIS, V35, P1441, DOI 10.1086/344464; Sobel J, 2005, J AM COLL SURGEONS, V201, P48, DOI 10.1016/j.jamcollsurg.2005.02.029; SOPER DE, 1986, OBSTET GYNECOL, V68, pS26; Sosolik R C, 1996, Infect Dis Obstet Gynecol, V4, P31, DOI 10.1155/S1064744996000087; STACKEBRANDT E, 1990, J GEN MICROBIOL, V136, P37, DOI 10.1099/00221287-136-1-37; SWEET RL, 1973, AM J OBSTET GYNECOL, V117, P1093, DOI 10.1016/0002-9378(73)90759-X; THADEPALLI H, 1973, AM J OBSTET GYNECOL, V117, P1034, DOI 10.1016/0002-9378(73)90750-3	38	162	168	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2352	2360		10.1056/NEJMoa051620	http://dx.doi.org/10.1056/NEJMoa051620			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319384				2022-12-28	WOS:000233574600007
J	Schelling, E; Wyss, K; Bechir, M; Moto, DD; Zinsstag, J				Schelling, E; Wyss, K; Bechir, M; Moto, DD; Zinsstag, J			Synergy between public health and veterinary services to deliver human and animal health interventions in rural low income settings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESOURCES		Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; Inst Trop Suisse, Ctr Support Sante Int, NDjamena, Chad; Swiss Trop Inst, Swiss Ctr Int Hlth, CH-4002 Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Schelling, E (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	esther.schelling@unibas.ch	Schelling, Esther/K-7990-2015; Zinsstag, Jakob/A-8317-2008	Schelling, Esther/0000-0001-6444-0898; Zinsstag, Jakob/0000-0002-8899-6097; Wyss, Kaspar/0000-0003-0156-5989				[Anonymous], [No title captured]; Bechir M, 2004, Med Trop (Mars), V64, P497; BONFIGLIOLI AM, 1992, UNICEF UNSO PROJECT; Cheneau Y, 2004, REV SCI TECH OIE, V23, P351, DOI 10.20506/rst.23.1.1489; DAOUD S, 2000, SEMPERVIRA, V8, P37; Forget G, 2001, INT J OCCUP ENV HEAL, V7, pS3, DOI DOI 10.1179/oeh.1999.5.1.38; Hampshire K, 2002, SOC SCI MED, V54, P1025, DOI 10.1016/S0277-9536(01)00078-8; HILL A, 1984, POPULATION, V39, P921, DOI 10.2307/1533041; Jamison D.T., 1993, DIS CONTROL PRIORITI; *LIV DEV, 1999, LIV POV FOC DEV; MESLIN FX, 1996, GLOBAL CHANGES PERSP, V1, P101; Niamir-Fuller M., 1999, MANAGING MOBILITY AF; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Schelling E, 2005, ACTA TROP, V95, P16, DOI 10.1016/j.actatropica.2005.03.006; Schwabe CW., 1984, VET MED HUMAN HLTH, V3rd; Shears P, 2000, ACTA TROP, V76, P3, DOI 10.1016/S0001-706X(00)00081-4; Thornton P.K., 2002, MAPPING POVERTY LIVE; Ward D. E., 1993, Nomadic Peoples, P55; WYSS K, 2003, J INT DEV, V15, P87, DOI DOI 10.1002/JID.967; ZINSSTAG J, IN PRESS LANCET	20	76	79	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1264	1267		10.1136/bmj.331.7527.1264	http://dx.doi.org/10.1136/bmj.331.7527.1264			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	16308393	Green Published, Bronze			2022-12-28	WOS:000233606800029
J	Cyranoski, D				Cyranoski, D			Property rights go East	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2005	438	7067					420	421		10.1038/438420a	http://dx.doi.org/10.1038/438420a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306959				2022-12-28	WOS:000233458200016
J	Schumacher, MA; Funnell, BE				Schumacher, MA; Funnell, BE			Structures of ParB bound to DNA reveal mechanism of partition complex formation	NATURE			English	Article							P1 PLASMID PARTITION; INTEGRATION HOST FACTOR; SPECIFICITY; SITE; BINDING; CENTROMERE; SEQUENCE; SYSTEM	The faithful inheritance of genetic information, which is essential for all organisms, requires accurate DNA partition (segregation) at cell division. In prokaryotes, partition is mediated by par systems, for which the P1 plasmid system of Escherichia coli is a prototype comprising a partition site and two proteins, ParA and ParB(1,2). To form the partition complex necessary for segregation, P1 ParB must recognize a complicated arrangement of A-box and B-box DNA motifs located on opposite ends of a sharply bent parS partition site of similar to 74 bp (refs 3-7). Here we describe structures of ParB bound to partition sites. ParB forms an asymmetric dimer with extended amino-terminal HTH (helix-turn-helix) domains that contact A-boxes. The two HTH domains emanate from a dimerized DNA-binding module composed of a six-stranded beta-sheet coiled-coil that binds B-boxes. Strikingly, these individual DNA-binding modules rotate freely about a flexible linker, enabling them to contact several arrangements of A- and B-boxes. Most notably, each DNA-binding element binds to and thus bridges adjacent DNA duplexes. These unique structural features of ParB explain how this protein can bind complex arrays of A- and B-box elements on adjacent DNA arms of the looped partition site.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	Oregon Health & Science University; University of Toronto	Schumacher, MA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	schumacm@ohsu.edu		Funnell, Barbara/0000-0002-1828-6567				Bouet JY, 2000, J BIOL CHEM, V275, P8213, DOI 10.1074/jbc.275.11.8213; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIS MA, 1990, EMBO J, V9, P991, DOI 10.1002/j.1460-2075.1990.tb08201.x; DeLano W.L, PYMOL MOL GRAPHICS S; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Funnell BE, 2004, PLASMID BIOLOGY, P81; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAYES F, 1993, P NATL ACAD SCI USA, V90, P9228, DOI 10.1073/pnas.90.19.9228; HAYES F, 1994, J MOL BIOL, V243, P190, DOI 10.1006/jmbi.1994.1646; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; MARTIN KA, 1991, J BACTERIOL, V173, P3630, DOI 10.1128/JB.173.12.3630-3634.1991; Radnedge L, 1998, EMBO J, V17, P6076, DOI 10.1093/emboj/17.20.6076; Radnedge L, 1996, EMBO J, V15, P1155, DOI 10.1002/j.1460-2075.1996.tb00454.x; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Surtees JA, 2003, CURR TOP DEV BIOL, V56, P145, DOI 10.1016/S0070-2153(03)01010-X; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839	30	90	90	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					516	519		10.1038/nature04149	http://dx.doi.org/10.1038/nature04149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306995				2022-12-28	WOS:000233458200054
J	Vogel, EK; McCollough, AW; Machizawa, MG				Vogel, EK; McCollough, AW; Machizawa, MG			Neural measures reveal individual differences in controlling access to working memory	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; MECHANISMS; ATTENTION; CAPACITY; SELECTION; REPRESENTATION; CONJUNCTIONS; INTELLIGENCE; FEATURES	The capacity of visual short-term memory is highly limited, maintaining only three to four objects simultaneously(1,2). This extreme limitation necessitates efficient mechanisms to select only the most relevant objects from the immediate environment to be represented in memory and to restrict irrelevant items from consuming capacity(3-5). Here we report a neurophysiological measure of this memory selection mechanism in humans that gauges an individual's efficiency at excluding irrelevant items from being stored in memory. By examining the moment-by-moment contents of visual memory(6), we observe that selection efficiency varies substantially across individuals and is strongly predicted by the particular memory capacity of each person. Specifically, high capacity individuals are much more efficient at representing only the relevant items than are low capacity individuals, who inefficiently encode and maintain information about the irrelevant items present in the display. These results provide evidence that under many circumstances low capacity individuals may actually store more information in memory than high capacity individuals. Indeed, this ancillary allocation of memory capacity to irrelevant objects may be a primary source of putative differences in overall storage capacity.	Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Vogel, EK (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	vogel@uoregon.edu	Machizawa, Maro G/B-5918-2008; Vogel, Edward K/AAW-9466-2021	Machizawa, Maro G/0000-0002-5727-1421; 				AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; BUNDESEN C, 1984, J EXP PSYCHOL HUMAN, V10, P329, DOI 10.1037/0096-1523.10.3.329; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Gale A., 1986, PSYCHOPHYSIOLOGY SYS, P431; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Jiang YH, 2004, PSYCHON B REV, V11, P495, DOI 10.3758/BF03196601; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Shih SI, 1996, J EXP PSYCHOL HUMAN, V22, P758, DOI 10.1037/0096-1523.22.3.758; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 2005, PSYCHOL SCI, V16, P106, DOI 10.1111/j.0956-7976.2005.00790.x	24	892	918	8	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					500	503		10.1038/nature04171	http://dx.doi.org/10.1038/nature04171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306992				2022-12-28	WOS:000233458200050
J	Swap, CJ; Nagurney, JT				Swap, CJ; Nagurney, JT			Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT PATIENTS; ACUTE CARDIAC ISCHEMIA; TROPONIN-T LEVELS; CLINICAL CHARACTERISTICS; CARE-UNIT; NONDIABETIC PATIENTS; SYMPTOM PRESENTATION; RISK STRATIFICATION; COST-EFFECTIVENESS	Context The chest pain history, physical examination, determination of coronary artery disease (CAD) risk factors, and the initial electrocardiogram compose the information immediately available to clinicians to help determine the probability of acute myocardial infarction (AMI) or acute coronary syndrome (ACS) in patients with chest pain. However, conflicting data exist about the usefulness of the chest pain history and which components are most useful. Objective To identify the elements of the chest pain history that may be most helpful to the clinician in identifying ACS in patients presenting with chest pain. Evidence Acquisition MEDLINE and Ovid were searched from 1970 to September 2005 by using specific key words and Medical Subject Heading terms. Reference lists of these articles and current cardiology textbooks were also consulted. Evidence Synthesis Certain chest pain characteristics decrease the likelihood of ACS or AMI, namely, pain that is stabbing, pleuritic, positional, or reproducible by palpation (likelihood ratios [LRs] 0.2-0.3). Conversely, chest pain that radiates to one shoulder or both shoulders or arms or is precipitated by exertion is associated with LRs (2.3-4.7) that increase the likelihood of ACS. The chest pain history itself has not proven to be a powerful enough predictive tool to obviate the need for at least some diagnostic testing. Combinations of elements of the chest pain history with other initially available information, such as a history of CAD, have identified certain groups that may be safe for discharge without further evaluation, but further study is needed before such a recommendation can be considered reasonable. Conclusion Although certain elements of the chest pain history are associated with increased or decreased likelihoods of a diagnosis of ACS or AMI, none of them alone or in combination identify a group of patients that can be safely discharged without further diagnostic testing.	Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Nagurney, JT (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Clin 115, Boston, MA 02114 USA.	jnagurney@partners.org						AASE O, 1993, EUR HEART J, V14, P433, DOI 10.1093/eurheartj/14.4.433; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Baxt WG, 2002, ANN EMERG MED, V40, P575, DOI 10.1067/mem.2002.129171; Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; BAYER AJ, 1986, J AM GERIATR SOC, V34, P263, DOI 10.1111/j.1532-5415.1986.tb04221.x; BERGER JP, 1990, J INTERN MED, V227, P165, DOI 10.1111/j.1365-2796.1990.tb00138.x; Blomkalns AL, 2003, ACAD EMERG MED, V10, P205, DOI 10.1111/j.1553-2712.2003.tb01991.x; BRAUNWALD E, 2001, BRAUNWALDS HEART DIS; BRUSH JE, 1985, NEW ENGL J MED, V312, P1137, DOI 10.1056/NEJM198505023121801; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; Caracciolo EA, 1996, CIRCULATION, V93, P2097, DOI 10.1161/01.CIR.93.12.2097; Chun AA, 2004, AM J MED, V117, P334, DOI 10.1016/j.amjmed.2004.03.021; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; CONSTANT J, 1990, Keio Journal of Medicine, V39, P187; Cooke RA, 1997, HEART, V78, P142, DOI 10.1136/hrt.78.2.142; Culic V, 2002, AM HEART J, V144, P1012, DOI 10.1067/mhj.2002.125625; CUNNINGHAM MA, 1989, J GEN INTERN MED, V4, P392, DOI 10.1007/BF02599688; DAVIES HA, 1985, J CLIN GASTROENTEROL, V7, P477, DOI 10.1097/00004836-198512000-00007; DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; Diercks DB, 2005, ANN EMERG MED, V45, P581, DOI 10.1016/j.annemergmed.2004.12.009; DROSTE C, 1989, ISRAEL J MED SCI, V25, P487; ERIKSSON B, 1994, J INTERN MED, V235, P473, DOI 10.1111/j.1365-2796.1994.tb01105.x; Everts B, 1996, HEART LUNG, V25, P430, DOI 10.1016/S0147-9563(96)80043-4; FERRY D, 2000, HURSTS HEART; FESMIRE FM, 1989, ANN EMERG MED, V18, P741, DOI 10.1016/S0196-0644(89)80007-1; Fesmire FM, 2000, ANN EMERG MED, V35, P521, DOI 10.1067/mem.2000.106387; FINEBERG HV, 1984, NEW ENGL J MED, V310, P1301, DOI 10.1056/NEJM198405173102006; Fruergaard P, 1996, EUR HEART J, V17, P1028; Geleijnse ML, 2000, EUR HEART J, V21, P397, DOI 10.1053/euhj.1999.1860; GELERNT MD, 1992, AM J CARDIOL, V69, P1512, DOI 10.1016/0002-9149(92)90918-O; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Gupta M, 2002, ANN EMERG MED, V40, P180, DOI 10.1067/mem.2002.126396; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Heberden W., 1772, MED T COLL PHYSICIAN, V2, P59; Hendrikson CA, 2003, ANN INTERN MED, V139, P979, DOI 10.7326/0003-4819-139-12-200312160-00007; HICKAM DH, 1985, J CHRON DIS, V38, P91, DOI 10.1016/0021-9681(85)90012-8; HOFGREN C, 1994, HEART LUNG, V23, P397; Hollander FE, 2004, ANN EMERG MED, V44, P199, DOI 10.1016/j.annemergmed.2004.02.037; HORNER SM, 1989, INT J CARDIOL, V24, P371, DOI 10.1016/0167-5273(89)90020-X; JAYES RL, 1992, J CLIN EPIDEMIOL, V45, P621, DOI 10.1016/0895-4356(92)90134-9; Jesse RL, 1997, CURR PROB CARDIOLOGY, V22, P154; Jones ID, 2001, EMERG MED CLIN N AM, V19, P269, DOI 10.1016/S0733-8627(05)70183-8; JONSBU J, 1991, J INTERN MED, V229, P143, DOI 10.1111/j.1365-2796.1991.tb00322.x; Jouriles NJ, 1998, EMERG MED CLIN N AM, V16, P717, DOI 10.1016/S0733-8627(05)70030-4; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; LEE TH, 1991, NEW ENGL J MED, V324, P1239, DOI 10.1056/NEJM199105023241803; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; Limkakeng A, 2001, ACAD EMERG MED, V8, P696, DOI 10.1111/j.1553-2712.2001.tb00187.x; Marx JA, 2002, ROSENS EMERGENCY MED, V5th; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; Milner KA, 2002, AM HEART J, V143, P283, DOI 10.1067/mhj.2002.119759; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; MURRAY DP, 1990, DIABETIC MED, V7, P580, DOI 10.1111/j.1464-5491.1990.tb01452.x; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; PASCERI V, 1995, AM J CARDIOL, V75, P224, DOI 10.1016/0002-9149(95)80024-M; Patel H, 2004, AM HEART J, V148, P27, DOI 10.1016/j.ahj.2004.03.005; PAUL O, 1987, BRIT HEART J, V58, P306; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Richman PB, 1999, ACAD EMERG MED, V6, P719, DOI 10.1111/j.1553-2712.1999.tb00441.x; ROLLAG A, 1992, J INTERN MED, V232, P299, DOI 10.1111/j.1365-2796.1992.tb00589.x; ROUAN GW, 1989, AM J CARDIOL, V64, P1087, DOI 10.1016/0002-9149(89)90857-6; Sanchis J, 2005, J AM COLL CARDIOL, V46, P443, DOI 10.1016/j.jacc.2005.04.037; Sanchis J, 2005, HEART, V91, P1013, DOI 10.1136/hrt.2004.041673; Schwartz G R, 1976, JACEP, V5, P981, DOI 10.1016/S0361-1124(76)80127-X; SERVI RJ, 1985, AM J EMERG MED, V3, P208, DOI 10.1016/0735-6757(85)90091-9; SOLOMON CG, 1989, AM J CARDIOL, V63, P772, DOI 10.1016/0002-9149(89)90040-4; Spalding L, 2003, J ROY SOC MED, V96, P122, DOI 10.1258/jrsm.96.3.122; Speake D, 2001, EMERG MED J, V18, P61, DOI 10.1136/emj.18.1.61-a; Summers RL, 1999, AM J MED SCI, V318, P142, DOI 10.1097/00000441-199909000-00008; TIERNEY WM, 1985, CRIT CARE MED, V13, P526, DOI 10.1097/00003246-198507000-00002; Tosteson ANA, 1996, CIRCULATION, V94, P143, DOI 10.1161/01.CIR.94.2.143; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; WRENN K, 1995, ANN EMERG MED, V26, P687, DOI 10.1016/S0196-0644(95)70038-2; Wu EB, 2001, INT J CARDIOL, V78, P257, DOI 10.1016/S0167-5273(01)00382-5	82	250	260	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2623	2629		10.1001/jama.294.20.2623	http://dx.doi.org/10.1001/jama.294.20.2623			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304077	Bronze			2022-12-28	WOS:000233436200028
J	Keogh, MC; Kim, JA; Downey, M; Fillingham, J; Chowdhury, D; Harrison, JC; Onishi, M; Datta, N; Galicia, S; Emili, A; Lieberman, J; Shen, XT; Buratowski, S; Haber, JE; Durocher, D; Greenblatt, JF; Krogan, NJ				Keogh, MC; Kim, JA; Downey, M; Fillingham, J; Chowdhury, D; Harrison, JC; Onishi, M; Datta, N; Galicia, S; Emili, A; Lieberman, J; Shen, XT; Buratowski, S; Haber, JE; Durocher, D; Greenblatt, JF; Krogan, NJ			A phosphatase complex that dephosphorylates gamma H2AX regulates DNA damage checkpoint recovery	NATURE			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HISTONE H2AX; G2/M ARREST; CELL-CYCLE; REPAIR; PROTEIN; PHOSPHORYLATION; RECOMBINATION	One of the earliest marks of a double-strand break (DSB) in eukaryotes is serine phosphorylation of the histone variant H2AX at the carboxy-terminal SQE motif to create gamma H2AX-containing nucleosomes(1). Budding-yeast histone H2A is phosphorylated in a similar manner by the checkpoint kinases Tel1 and Mec1 (ref. 2; orthologous to mammalian ATM and ATR, respectively) over a 50-kilobase region surrounding the DSB3. This modification is important for recruiting numerous DSB-recognition and repair factors to the break site, including DNA damage checkpoint proteins(4,5), chromatin remodellers(6) and cohesins(7,8). Multiple mechanisms for eliminating gamma H2AX as DNA repair completes are possible, including removal by histone exchange followed potentially by degradation, or, alternatively, dephosphorylation. Here we describe a three-protein complex (HTP-C, for histone H2A phosphatase complex) containing the phosphatase Pph3 that regulates the phosphorylation status of gamma H2AX in vivo and efficiently dephosphorylates gamma H2AX in vitro. gamma H2AX is lost from chromatin surrounding a DSB independently of the HTP-C, indicating that the phosphatase targets gamma H2AX after its displacement from DNA. The dephosphorylation of gamma H2AX by the HTP-C is necessary for efficient recovery from the DNA damage checkpoint.	Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Microbiol, Toronto, ON M5G 1L6, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; CBR Inst Biomed Res, Boston, MA 02115 USA; MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA	University of Toronto; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brandeis University; Brandeis University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Texas System; UTMD Anderson Cancer Center	Durocher, D (corresponding author), Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L6, Canada.	durocher@mshri.on.ca; jack.greenblatt@utoronto.ca	Lieberman, Judy/A-2717-2015; Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635; Haber, James/0000-0002-1878-0610; Shen, Xuetong/0000-0002-4267-5298				Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; CHOWDHURY D, IN PRESS MOL CELL; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113	30	360	378	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					497	501		10.1038/nature04384	http://dx.doi.org/10.1038/nature04384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16299494				2022-12-28	WOS:000234859200052
J	St John, JC; Alderson, J				St John, JC; Alderson, J			Stem-cell banking: the size of the task	LANCET			English	Editorial Material							EMBRYOS		Univ Birmingham, Sch Med, Mitochondrial & Reprod Genet Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	St John, JC (corresponding author), Univ Birmingham, Sch Med, Mitochondrial & Reprod Genet Grp, Birmingham B15 2TT, W Midlands, England.	j.stjohn1@bham.ac.uk	St. John, Justin C/A-2942-2010	St. John, Jus/0000-0002-3993-1449				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Bjuresten K, 2003, HUM REPROD, V18, P1353, DOI 10.1093/humrep/deg265; Choudhary M, 2004, HUM REPROD, V19, P2091, DOI 10.1093/humrep/deh401; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Holden C, 2005, SCIENCE, V310, P1402, DOI 10.1126/science.310.5753.1402; Hussain MA, 2004, LANCET, V364, P203, DOI 10.1016/S0140-6736(04)16635-X; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; *MRC STEER COMM UK, 2005, REG STEER COMM APPR; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Watkins P, 2003, DIABETES ITS MANAGEM	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					1991	1992		10.1016/S0140-6736(05)67797-5	http://dx.doi.org/10.1016/S0140-6736(05)67797-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338440				2022-12-28	WOS:000233826900007
J	Andrews, NC				Andrews, NC			Understanding heme transport	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IDENTIFICATION		Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Andrews, NC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.			Andrews, Nancy/0000-0003-0243-4462				Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAFFIN SB, 1974, J CLIN INVEST, V54, P1344, DOI 10.1172/JCI107881; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025	5	39	41	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2508	2509		10.1056/NEJMcibr053987	http://dx.doi.org/10.1056/NEJMcibr053987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339100				2022-12-28	WOS:000233754400015
J	Israel, G; Szopa, C; Raulin, F; Cabane, M; Niemann, HB; Atreya, SK; Bauer, SJ; Brun, JF; Chassefiere, E; Coll, P; Conde, E; Coscia, D; Hauchecorne, A; Millian, P; Nguyen, MJ; Owen, T; Riedler, W; Samuelson, RE; Siguier, JM; Steller, M; Sternberg, R; Vidal-Madjar, C				Israel, G; Szopa, C; Raulin, F; Cabane, M; Niemann, HB; Atreya, SK; Bauer, SJ; Brun, JF; Chassefiere, E; Coll, P; Conde, E; Coscia, D; Hauchecorne, A; Millian, P; Nguyen, MJ; Owen, T; Riedler, W; Samuelson, RE; Siguier, JM; Steller, M; Sternberg, R; Vidal-Madjar, C			Complex organic matter in Titan's atmospheric aerosols from in situ pyrolysis and analysis	NATURE			English	Article							OPTICAL-PROPERTIES; ACETYLENE; PLASMA; CLOUDS	Aerosols in Titan's atmosphere play an important role in determining its thermal structure(1-3). They also serve as sinks for organic vapours(4) and can act as condensation nuclei for the formation of clouds(5,6), where the condensation efficiency will depend on the chemical composition of the aerosols(5,7). So far, however, no direct information has been available on the chemical composition of these particles. Here we report an in situ chemical analysis of Titan's aerosols by pyrolysis at 600 degrees C. Ammonia (NH3) and hydrogen cyanide (HCN) have been identified as the main pyrolysis products. This clearly shows that the aerosol particles include a solid organic refractory core. NH3 and HCN are gaseous chemical fingerprints of the complex organics that constitute this core, and their presence demonstrates that carbon and nitrogen are in the aerosols.	Univ Paris 06, CNRS, UMR 7620, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Versailles St Quentin, F-91371 Verrieres Le Buisson, France; Univ Paris 12, CNRS, UMR 7583, Lab Interuniv Syst Atmospher, F-94010 Creteil, France; Univ Paris 07, F-94010 Creteil, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Graz Univ, Inst Meteorol & Geophys, A-8010 Graz, Austria; Ctr Natl Etud Spatiales, F-31401 Toulouse, France; Off Natl Etud & Rech Aerosp, F-31055 Toulouse, France; Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; Austrian Acad Sci, Space Res Inst, A-8010 Graz, Austria; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Austrian Acad Sci, Inst Weltraumforsch, A-8042 Graz, Austria; CNRS, UMR 7581, Lab Rech Polymeres, F-94320 Thiais, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; University of Graz; National Office for Aerospace Studies & Research (ONERA); University of Hawaii System; University of Hawaii Manoa; Austrian Academy of Sciences; University System of Maryland; University of Maryland College Park; Austrian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS)	Israel, G (corresponding author), Univ Paris 06, CNRS, UMR 7620, Serv Aeron, F-91371 Verrieres Le Buisson, France.	Guy.israel@aerov.jussieu.fr	Hauchecorne, Alain/A-8489-2013; szopa, cyril/C-6865-2015	szopa, cyril/0000-0002-0090-4056; Siguier, Jean-Michel/0000-0003-3568-9816; Hauchecorne, Alain/0000-0001-9888-6994; Bauer, Siegfried/0000-0003-4213-2047				BARNUN A, 1988, J GEOPHYS RES-ATMOS, V93, P8383, DOI 10.1029/JD093iD07p08383; Barth EL, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019825; Chang S., 1982, EARTHS EARLIEST BIOS, P53; Clarke DW, 1997, ICARUS, V127, P158, DOI 10.1006/icar.1996.5667; Coll P, 1998, ORIGINS LIFE EVOL B, V28, P195, DOI 10.1023/A:1006521601133; Coll P, 1999, PLANET SPACE SCI, V47, P1331, DOI 10.1016/S0032-0633(99)00054-9; DELGENIO AD, 1993, ICARUS, V101, P1, DOI 10.1006/icar.1993.1001; EHRENFREUND P, 1994, ADV SPACE RES, V15, P335; Imanaka H, 2004, ICARUS, V168, P344, DOI 10.1016/j.icarus.2003.12.014; ISRAEL G, 1991, ANN GEOPHYS, V9, P1; Israel G, 2002, SPACE SCI REV, V104, P433, DOI 10.1023/A:1023640723915; Khare B N, 1984, Adv Space Res, V4, P59, DOI 10.1016/0273-1177(84)90545-3; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Lebonnois S, 2002, ICARUS, V159, P505, DOI 10.1006/icar.2002.6943; Mayo LA, 2005, ICARUS, V176, P316, DOI 10.1016/j.icarus.2005.01.020; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; McKay CP, 1996, PLANET SPACE SCI, V44, P741, DOI 10.1016/0032-0633(96)00009-8; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Minard RD, 1998, ORIGINS LIFE EVOL B, V28, P461, DOI 10.1023/A:1006566125815; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; Rannou P, 2004, ICARUS, V170, P443, DOI 10.1016/j.icarus.2004.03.007; Somogyi A, 2005, J AM SOC MASS SPECTR, V16, P850, DOI 10.1016/j.jasms.2005.01.027; THOMPSON WR, 1991, ICARUS, V90, P57, DOI 10.1016/0019-1035(91)90068-5; Wilson EH, 2003, PLANET SPACE SCI, V51, P1017, DOI 10.1016/j.pss.2003.06.003	24	166	167	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					796	799		10.1038/nature04349	http://dx.doi.org/10.1038/nature04349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319825				2022-12-28	WOS:000233777800041
J	Wolf, PL; Kasyan, A				Wolf, PL; Kasyan, A			Pseudomembranous colitis associated with Clostridium difficile	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Vet Affairs Healthcare Med Ctr, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wolf, PL (corresponding author), Univ Calif San Diego, Vet Affairs Healthcare Med Ctr, San Diego, CA 92103 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2491	2491		10.1056/NEJMicm050923	http://dx.doi.org/10.1056/NEJMicm050923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339097				2022-12-28	WOS:000233754400010
J	Hirschmann, JV				Hirschmann, JV			Benjamin Franklin and medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Washington, VA Med Ctr, Med Serv 111, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle	Hirschmann, JV (corresponding author), Univ Washington, VA Med Ctr, Med Serv 111, 1660 S Columbian Way, Seattle, WA 98108 USA.	pepsi@u.washington.edu						BELL W, 1962, B CLEVELAND MED ASSN, V9, P51; BLOOM DA, 1994, J UROLOGY, V151, P317, DOI 10.1016/S0022-5347(17)34937-6; BOYD AS, 1990, INT J DERMATOL, V29, P401, DOI 10.1111/j.1365-4362.1990.tb03821.x; COHEN IB, 1990, B FRANKLINS SCI, P159; COHEN IB, 1990, B FRANKLINS SCI, P31; DARNTON R, 1968, MESMERISM END ENLIGH, P66; Darnton Robert, 1968, MESMERISM END ENLIGH, P3; EVANS C, 1757, MED OBSERVATIONS INQ, V1, P83; FENN EA, 2001, POX AM GREAT SMALLPO, P33; Fenner F, 1988, SMALLPOX ERADICATION, P209; FRANKLIN B, 1959, PAPERS B FRANKLIN, V27, P497; FRANKLIN B, 1959, PAPERS B FRANKLIN, V3, P364; FRANKLIN B, 1959, PAPERS B FRANKLIN, V3, P445; FRANKLIN B, 1959, PAPERS B FRANKLIN, V25, P777; FRANKLIN B, 1984, WRITINGS, P974; FRANKLIN B, 1959, PAPERS B FRANKLIN, V2, P154; FRANKLIN B, 1987, WRITINGS, P1424; FRANKLIN B, 1907, WRITINGS B FRANKLIN, V9, P656; FRANKLIN B, 1987, WRITINGS, P1164; FRANKLIN B, 1959, PAPERS B FRANKLIN, V4, P385; FRANKLIN B, 1907, WRITINGS B FRANKLIN, V9, P268; FRANKLIN B, 1987, WRITINGS, P1179; FRANKLIN B, 1959, PAPERS B FRANKLIN, V33, P97; FRANKLIN B, 1959, PAPERS B FRANKLIN, V3, P35; FRANKLIN B, 1987, WRITINGS 3, P1429; FRANKLIN B, 1987, WRITINGS, P779; FRANKLIN B, 1959, PAPERS B FRANKLIN, V4, P82; FRANKLIN B, 1959, PAPERS B FRANKLIN, V7, P298; FRANKLIN B, 1959, PAPERS B FRANKLIN, V1, P200; FRANKLIN B, 1987, WRITINGS, P751; FRANKLIN B, 1987, WRITINGS, P1109; FRANKLIN B, 1959, PAPERS B FRANKLIN, V8, P281; FRANKLIN B, 1907, WRITINGS B FRANKLIN, V9, P309; JOHNSON, 1785, B FRANKLIN OTHER COM, P1; JOHNSON J, 1985, REPORT B FRANKLIN OT, P1; Levene J R, 1972, Notes Rec R Soc Lond, V27, P141, DOI 10.1098/rsnr.1972.0015; LEWINTER MW, 2001, HURSTS HEART, P80; LOPEZ CA, 1975, PRIVATE FRANKLIN MAN, P50; MORGAN ES, 2002, B FRANKLIN, P26; PATTIE FA, 1994, MESMER ANIMAL MAGNET, P72; PEPPER W, 1910, MED SIDE B FRANKLIN, P88; SHELLEY WB, 1953, CLASSICS CLIN DERMAT, P5; THOMSON EH, 1958, J MED EDUC, V33, P614; VANDOREN C, 1991, B FRANKLIN, P700; 1992, AM HERITAGE DICT ENG, P1382	45	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					830	834		10.7326/0003-4819-143-11-200512060-00012	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330795				2022-12-28	WOS:000233884900015
J	Gurdon, JB				Gurdon, JB			Sinistral snails and gentlemen scientists	CELL			English	Editorial Material							LEFT-RIGHT ASYMMETRY; LIMNAEA-PEREGRA; INHERITANCE	A single gene mutation can cause a complete left-to-right and right-to-left inversion of the body axis. This mutation exemplifies a large class of so-called maternal effect genes that regulate key events during early development. This principle was first established nearly one hundred years ago, principally by the work of amateur naturalists.	Wellcome Canc Res UK Inst, Cambridge CB2 1QN, England		Gurdon, JB (corresponding author), Wellcome Canc Res UK Inst, Cambridge CB2 1QN, England.	jbg.1000@hermes.cam.ac.uk		GURDON, JOHN/0000-0002-5621-3799				Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; Boycott AE, 1927, NATURE, V119, P9, DOI 10.1038/119009a0; Boycott AE, 1931, PHILOS T R SOC LON B, V219, P51, DOI 10.1098/rstb.1931.0002; BROWN NA, 1990, DEVELOPMENT, V109, P1; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269	6	10	11	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					751	753		10.1016/j.cell.2005.11.015	http://dx.doi.org/10.1016/j.cell.2005.11.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325567	Bronze			2022-12-28	WOS:000233814100006
J	Laskey, R				Laskey, R			Solving mysteries of DNA replication and frog cloning	CELL			English	Editorial Material							CULTURED CELLS; NUCLEI; TRANSPLANTATION	Compared to sperm nuclei, nuclei from adult somatic cells replicate inefficiently in frog egg extract. In this issue of Cell, Lemaitre et al. (2005) show that pre-exposure of erythrocyte nuclei to a mitotic extract removes this difference, reorganizes the chromatin into shorter loops, and allows replication at much shorter intervals along the DNA. Remarkably, these observations also explain an old mystery of why serial nuclear transplantation was so successful for cloning frogs.	MRC, Canc Cell Unit, Res Ctr, Cambridge CB2 2XZ, England		Laskey, R (corresponding author), MRC, Canc Cell Unit, Res Ctr, Hills Rd, Cambridge CB2 2XZ, England.	ral19@cam.ac.uk						GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1970, J EMBRYOL EXP MORPH, V24, P227; LASKEY RA, 1970, NATURE, V228, P1332, DOI 10.1038/2281332a0; LEMAITRE JM, 2005, CELL; LENO GH, 1991, J CELL BIOL, V112, P557, DOI 10.1083/jcb.112.4.557; Lu ZH, 1999, MOL BIOL CELL, V10, P4091, DOI 10.1091/mbc.10.12.4091	6	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					760	762		10.1016/j.cell.2005.11.008	http://dx.doi.org/10.1016/j.cell.2005.11.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325570	Bronze			2022-12-28	WOS:000233814100009
J	Nijman, SMB; Luna-Vargas, MPA; Velds, A; Brummelkamp, TR; Dirac, AMG; Sixma, TK; Bernards, R				Nijman, SMB; Luna-Vargas, MPA; Velds, A; Brummelkamp, TR; Dirac, AMG; Sixma, TK; Bernards, R			A genomic and functional inventory of deubiquitinating enzymes	CELL			English	Review							NF-KAPPA-B; UBIQUITIN-SPECIFIC PROTEASE; HISTONE H2B UBIQUITYLATION; TUMOR-SUPPRESSOR CYLD; BINDING-PROTEIN; CYSTEINE PROTEASES; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; SIGNALING PATHWAY; JOSEPHIN DOMAIN	Posttranslational modification of proteins by the small molecule ubiquitin is a key regulatory event, and the enzymes catalyzing these modifications have been the focus of many studies. Deubiquitinating enzymes, which mediate the removal and processing of ubiquitin, may be functionally as important but are less well understood. Here, we present an inventory of the deubiquitinating enzymes encoded in the human genome. In addition, we review the literature concerning these enzymes, with particular emphasis on their function, specificity, and the regulation of their activity.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Nijman, SMB (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	s.nijman@nki.nl; rbernards@nki.nl		Bernards, Rene/0000-0001-8677-3423; Velds, Arno/0000-0003-4333-8872; Sixma, Titia K/0000-0001-6180-0632				AMBROGGIO XI, 2004, PLOS BIOL, V2; AMENIK AY, 2004, BIOCHIM BIOPHYS ACTA, V1695, P189; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; CUMMINS JM, 2004, NATURE, V428, P486, DOI [DOI 10.1038/NATURE02501, 10.1038/nature02501]; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; GUPTA K, 1994, ONCOGENE, V9, P1729; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Janssen JWG, 1998, ONCOGENE, V16, P1767, DOI 10.1038/sj.onc.1201695; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lygerou Z, 1999, MOL CELL BIOL, V19, P2008; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Paduch DA, 2005, REPROD BIOMED ONLINE, V10, P747; Park KC, 1997, ARCH BIOCHEM BIOPHYS, V347, P78, DOI 10.1006/abbi.1997.0311; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; Stouffs K, 2005, EUR J HUM GENET, V13, P336, DOI 10.1038/sj.ejhg.5201335; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vugmeyster Y, 2002, MOL IMMUNOL, V39, P431, DOI 10.1016/S0161-5890(02)00123-2; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; WICKS SJ, 2005, IN PRESS ONCOGENE; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	118	1363	1432	4	112	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					773	786		10.1016/j.cell.2005.11.007	http://dx.doi.org/10.1016/j.cell.2005.11.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325574	Bronze, Green Published			2022-12-28	WOS:000233814100013
J	Hamid, M; Bustamante-Manaog, T; Dung, TV; Akkhavong, K; Fu, HP; Ma, YX; Zhong, XQ; Salmela, R; Panisset, U; Pang, T				Hamid, M; Bustamante-Manaog, T; Dung, TV; Akkhavong, K; Fu, HP; Ma, YX; Zhong, XQ; Salmela, R; Panisset, U; Pang, T			EVIPNet: translating the spirit of Mexico	LANCET			English	Editorial Material							POLICY		WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland; Minist Hlth, Inst Hlth Syst Res, Kuala Lumpur, Malaysia; Dept Hlth, Hlth Policy Div, Manila, Philippines; Minist Hlth, Dept Sci & Training, Hanoi, Vietnam; Minist Hlth, Natl Publ Hlth Inst, Viangchan, Laos; Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; Shandong Prov Hlth Bur, Jinan, Peoples R China; Sichuan Prov Hlth Bur, Chengdu, Peoples R China; WHO, Western Pacific Reg Off, Manila, Philippines	World Health Organization; Kementerian Kesihatan Malaysia; Philippine Department Health; WHO Western Pacific Regional Office; World Health Organization	Pang, T (corresponding author), WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland.	pangt@who.int						[Anonymous], 2004, LANCET, V364, P1555; [Anonymous], 2004, LANCET, V364, P1911; DESAVIGNY D, 2004, FIXING HLTH SYSTEMS; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; *IBP EL COMM SYST, WPROEP COMM; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; PABLOSMENDEZ A, 2005, B WORLD HEALTH ORGAN, V84, P723; Sheldon T.A., 2005, J HLTH SERVICES RES, V10, P1; WHO, 2005, WHA5834 WHO; World Health Organization, 2004, WORLD REP KNOWL BETT	11	40	42	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1758	1760		10.1016/S0140-6736(05)67709-4	http://dx.doi.org/10.1016/S0140-6736(05)67709-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298204				2022-12-28	WOS:000233517200007
J	Hankey, GJ				Hankey, GJ			Vascular disease of the heart, brain and limbs: new insights into a looming epidemic	LANCET			English	Editorial Material							CASE-FATALITY; MYOCARDIAL-INFARCTION; EVENT RATES; MORTALITY		Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.	gjhankey@cyllene.uwa.edu.au	Hankey, Graeme/H-4968-2014	Hankey, Graeme/0000-0002-6044-7328				Asplund K, 2005, LANCET NEUROL, V4, P64, DOI 10.1016/S1474-4422(04)00967-6; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Feigin V, 2004, LANCET, V363, P1920, DOI 10.1016/S0140-6736(04)16436-2; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferguson JL, 2002, HEART, V88, P343, DOI 10.1136/heart.88.4.343; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Pendlebury ST, 2004, STROKE, V35, P2368, DOI 10.1161/01.STR.0000140632.83868.a2; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarti C, 2003, STROKE, V34, P1833, DOI 10.1161/01.STR.0000081224.15480.52; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	14	13	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1753	1754		10.1016/S0140-6736(05)67703-3	http://dx.doi.org/10.1016/S0140-6736(05)67703-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298201				2022-12-28	WOS:000233517200004
J	Lipka, V; Dittgen, J; Bednarek, P; Bhat, R; Wiermer, M; Stein, M; Landtag, J; Brandt, W; Rosahl, S; Scheel, D; Llorente, F; Molina, A; Parker, J; Somerville, S; Schulze-Lefert, P				Lipka, V; Dittgen, J; Bednarek, P; Bhat, R; Wiermer, M; Stein, M; Landtag, J; Brandt, W; Rosahl, S; Scheel, D; Llorente, F; Molina, A; Parker, J; Somerville, S; Schulze-Lefert, P			Pre- and postinvasion defenses both contribute to nonhost resistance in Arabidopsis	SCIENCE			English	Article							DISEASE RESISTANCE; POWDERY MILDEW; HOST; MICROBES; PROTEINS; ANIMALS; SIGNALS; PLANTS	Nonhost resistance describes the immunity of an entire plant species against nonadapted pathogen species. We report that Arabidopsis PEN2 restricts pathogen entry of two ascomycete powdery mildew fungi that in nature colonize grass and pea species. The PEN2 glycosyl hydrolase localizes to peroxisomes and acts as a component of an inducible preinvasion resistance mechanism. Postinvasion fungal growth is blocked by a separate resistance layer requiring the EDS1-PAD4-SAG101 signaling complex, which is known to function in basal and resistance (R) gene-triggered immunity. Concurrent impairment of pre- and postinvasion resistance renders Arabidopsis a host for both nonadapted fungi.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle Saale, Germany; Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle Saale, Germany; Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Lab Bioquim & Biol Mol, E-28040 Madrid, Spain	Max Planck Society; Carnegie Institution for Science; Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Universidad Politecnica de Madrid	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/B-6707-2011; Bednarek, Pawel/D-2561-2009; Wiermer, Marcel/F-4791-2018; de Gracia, Francisco Llorente/G-1760-2010; Bruening, Stefan/B-8505-2011; Lipka, Volker/C-5874-2009; Schulze-Lefert, Paul/A-7746-2008; Molina, Antonio/G-9789-2015	Bednarek, Pawel/0000-0002-3064-7775; Wiermer, Marcel/0000-0002-1232-2707; de Gracia, Francisco Llorente/0000-0003-1566-0266; Molina, Antonio/0000-0003-3137-7938; Stein, Monica/0000-0002-1926-4212				Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; JOHNSON LEB, 1982, CAN J BOT, V60, P1068, DOI 10.1139/b82-137; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Panstruga R, 2003, MICROBES INFECT, V5, P429, DOI 10.1016/S1286-4579(03)00053-4; Saenz GS, 1999, CAN J BOT, V77, P150, DOI 10.1139/cjb-77-1-150; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	18	579	596	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1180	1183		10.1126/science.1119409	http://dx.doi.org/10.1126/science.1119409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293760	Green Published			2022-12-28	WOS:000233437300044
J	Millar, JK; Pickard, BS; Mackie, S; James, R; Christie, S; Buchanan, SR; Malloy, MP; Chubb, JE; Huston, E; Baillie, GS; Thomson, PA; Hill, EV; Brandon, NJ; Rain, JC; Camargo, LM; Whiting, PJ; Houslay, MD; Blackwood, DHR; Muir, WJ; Porteous, DJ				Millar, JK; Pickard, BS; Mackie, S; James, R; Christie, S; Buchanan, SR; Malloy, MP; Chubb, JE; Huston, E; Baillie, GS; Thomson, PA; Hill, EV; Brandon, NJ; Rain, JC; Camargo, LM; Whiting, PJ; Houslay, MD; Blackwood, DHR; Muir, WJ; Porteous, DJ			DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling	SCIENCE			English	Article							PROTEIN-KINASE; PHOSPHODIESTERASE; PHOSPHORYLATION; TRANSLOCATION; ACTIVATION; FORM	The disrupted in schizophrenia 1 (DISC1) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B (PDE4B) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3',5'-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.	Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; Merck Sharp & Dohme Ltd MSD, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England; Hybrigen SA, F-75014 Paris, France; Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	University of Edinburgh; University of Glasgow; Merck & Company; Royal Infirmary of Edinburgh; University of Edinburgh	Millar, JK (corresponding author), Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland.	Kirsty.Millar@ed.ac.uk	Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021; Houslay, Miles/AAM-5281-2020; blackwood, douglas/AIB-8874-2022; Houslay, Miles D/A-6825-2011; Pickard, Benjamin S/K-3923-2014	Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106; Pickard, Benjamin S/0000-0002-2374-6329; James, Rachel/0000-0002-6529-5335; Brandon, Nicholas/0000-0002-3917-0096; RAIN, Jean-Christophe/0000-0001-8110-0641; Whiting, Paul/0000-0002-4121-1379; Houslay, Miles/0000-0002-3826-8091; Baillie, George/0000-0003-2469-6316	MRC [G8604010] Funding Source: UKRI; Medical Research Council [G8604010] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hayashi MAF, 2005, P NATL ACAD SCI USA, V102, P3828, DOI 10.1073/pnas.0500330102; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Lamprecht R, 1999, CELL MOL LIFE SCI, V55, P554, DOI 10.1007/s000180050314; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	20	513	540	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1187	1191		10.1126/science.1112915	http://dx.doi.org/10.1126/science.1112915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293762				2022-12-28	WOS:000233437300046
J	Ge, SY; Goh, ELK; Sailor, KA; Kitabatake, Y; Ming, GL; Song, HJ				Ge, SY; Goh, ELK; Sailor, KA; Kitabatake, Y; Ming, GL; Song, HJ			GABA regulates synaptic integration of newly generated neurons in the adult brain	NATURE			English	Article							POSTNATAL SUBVENTRICULAR ZONE; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; GRANULE CELLS; RECEPTOR ACTIVATION; NEUROGENESIS; COMMUNICATION; HIPPOCAMPUS; PROGENITORS; INHIBITION	Adult neurogenesis, the birth and integration of new neurons from adult neural stem cells, is a striking form of structural plasticity and highlights the regenerative capacity of the adult mammalian brain(1-8). Accumulating evidence suggests that neuronal activity regulates adult neurogenesis and that new neurons contribute to specific brain functions(1-8). The mechanism that regulates the integration of newly generated neurons into the pre-existing functional circuitry in the adult brain is unknown. Here we show that newborn granule cells in the dentate gyrus of the adult hippocampus are tonically activated by ambient GABA (gamma-aminobutyric acid) before being sequentially innervated by GABA- and glutamate-mediated synaptic inputs. GABA, the major inhibitory neurotransmitter in the adult brain, initially exerts an excitatory action on newborn neurons owing to their high cytoplasmic chloride ion content(9-12). Conversion of GABA- induced depolarization ( excitation) into hyperpolarization ( inhibition) in newborn neurons leads to marked defects in their synapse formation and dendritic development in vivo. Our study identifies an essential role for GABA in the synaptic integration of newly generated neurons in the adult brain, and suggests an unexpected mechanism for activity-dependent regulation of adult neurogenesis, in which newborn neurons may sense neuronal network activity through tonic and phasic GABA activation.	Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@bs.jhmi.edu; shongju1@bs.jhmi.edu	Sailor, Kurt/GSO-2237-2022; Sailor, Kurt Andrew/AFN-4046-2022; Goh, Eyleen/A-8006-2013; Ming, Guo-li/J-7880-2013	Sailor, Kurt/0000-0002-9574-6838; Sailor, Kurt Andrew/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Goh, Eyleen/0000-0002-8244-6959; Ming, Guo-li/0000-0002-2517-6075	NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NINDS NIH HHS [R01 NS047344] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chavas J, 2004, NEURON, V44, P701, DOI 10.1016/j.neuron.2004.11.002; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941	30	939	995	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					589	593		10.1038/nature04404	http://dx.doi.org/10.1038/nature04404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16341203	Green Accepted			2022-12-28	WOS:000235033900041
J	Khang, DY; Jiang, HQ; Huang, Y; Rogers, JA				Khang, DY; Jiang, HQ; Huang, Y; Rogers, JA			A stretchable form of single-crystal silicon for high-performance electronics on rubber substrates	SCIENCE			English	Article							THIN-FILM TRANSISTORS; LARGE-AREA; PRESSURE SENSOR; DISPLAYS; MATRIX; SOFT; FABRICATION; SURFACES; POLYMER; STRAIN	We have produced a stretchable form of silicon that consists of submicrometer single-crystal elements structured into shapes with microscale, periodic, wavelike geometries. When supported by an elastomeric substrate, this "wavy" silicon can be reversibly stretched and compressed to large levels of strain without damaging the silicon. The amplitudes and periods of the waves change to accommodate these deformations, thereby avoiding substantial strains in the silicon itself. Dielectrics, patterns of dopants, electrodes, and other elements directly integrated with the silicon yield fully formed, high-performance "wavy" metal oxide semiconductor field-effect transistors, p-n diodes, and other devices for electronic circuits that can be stretched or compressed to similarly large levels of strain.	Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Dept Mech & Ind Engn, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; Univ Illinois, Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, Y (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	huang9@uiuc.edu; jrogers@uiuc.edu	Huang, Yonggang/B-6998-2009; Jiang, Hanqing/B-1810-2008; Rogers, John/L-2798-2016	Jiang, Hanqing/0000-0002-1947-4420; 				Bietsch A, 2000, J APPL PHYS, V88, P4310, DOI 10.1063/1.1289816; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Chen X, 2004, J APPL MECH-T ASME, V71, P597, DOI 10.1115/1.1756141; Chen Y, 2003, NATURE, V423, P136, DOI 10.1038/423136a; Duan XF, 2003, NATURE, V425, P274, DOI 10.1038/nature01996; Faez R, 1999, POLYMER, V40, P5497, DOI 10.1016/S0032-3861(98)00775-7; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Gleskova H, 2004, J NON-CRYST SOLIDS, V338, P732, DOI 10.1016/j.jnoncrysol.2004.03.079; Gray DS, 2004, ADV MATER, V16, P393, DOI 10.1002/adma.200306107; Hsu PHI, 2004, IEEE T ELECTRON DEV, V51, P371, DOI 10.1109/TED.2003.822873; Huang ZY, 2005, J MECH PHYS SOLIDS, V53, P2101, DOI 10.1016/j.jmps.2005.03.007; Huck WTS, 2000, LANGMUIR, V16, P3497, DOI 10.1021/la991302l; Huitema HEA, 2001, NATURE, V414, P599, DOI 10.1038/414599a; Hur SH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1947380; *INSPEC I EL ENG, 1988, PROP SIL; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Jin HC, 2004, J VAC SCI TECHNOL B, V22, P2548, DOI 10.1116/1.1795249; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Lim HC, 2005, SENSOR ACTUAT A-PHYS, V119, P332, DOI 10.1016/j.sna.2004.10.012; Loo YL, 2002, P NATL ACAD SCI USA, V99, P10252, DOI 10.1073/pnas.162128299; Marquette CA, 2004, BIOSENS BIOELECTRON, V20, P197, DOI 10.1016/j.bios.2004.01.033; Menard E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866637; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Sekitani T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868868; Sheraw CD, 2002, APPL PHYS LETT, V80, P1088, DOI 10.1063/1.1448659; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Suo Z, 1999, APPL PHYS LETT, V74, P1177, DOI 10.1063/1.123478; VANDEPUTTE J, 2003, Patent No. 6580151; 2005, P IEEE, V93	32	1345	1465	29	1082	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					208	212		10.1126/science.1121401	http://dx.doi.org/10.1126/science.1121401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16357225				2022-12-28	WOS:000234722200036
J	Vanroose, W; Martin, F; Rescigno, TN; McCurdy, CW				Vanroose, W; Martin, F; Rescigno, TN; McCurdy, CW			Complete photo-induced breakup of the H-2 molecule as a probe of molecular electron correlation	SCIENCE			English	Article							PHOTO-DOUBLE-IONIZATION; DOUBLE PHOTOIONIZATION; FRAGMENTATION	Despite decades of progress in quantum mechanics, electron correlation effects are still only partially understood. Experiments in which both electrons are ejected from an oriented hydrogen molecule by absorption of a single photon have recently demonstrated a puzzling phenomenon: The ejection pattern of the electrons depends sensitively on the bond distance between the two nuclei as they vibrate in their ground state. Here, we report a complete numerical solution of the Schrodinger equation for the double photoionization of H-2. The results suggest that the distribution of photoelectrons emitted from aligned molecules reflects electron correlation effects that are purely molecular in origin.	Katholieke Univ Leuven, Dept Comp Sci, B-3001 Heverlee, Belgium; Univ Autonoma Madrid, Dept Quim C9, Madrid 28049, Spain; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	KU Leuven; Autonomous University of Madrid; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis	Vanroose, W (corresponding author), Katholieke Univ Leuven, Dept Comp Sci, Celestijnenlaan 200A, B-3001 Heverlee, Belgium.		MCCURDY, CLYDE/GRE-7874-2022; Martin, Fernando/C-3972-2014; Vanroose, Wim/J-4292-2013	Martin, Fernando/0000-0002-7529-925X; Vanroose, Wim/0000-0001-8349-1391				Colgan J, 2004, J PHYS B-AT MOL OPT, V37, pL377, DOI 10.1088/0953-4075/37/23/L01; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Eland JHD, 2000, FARADAY DISCUSS, V115, P119, DOI 10.1039/a909275g; Gisselbrecht M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1832411; HERZBERG G, 1950, MOL SPECTRA MOL STRU, V1, P391; HUETZ A, 1991, J PHYS B-AT MOL OPT, V24, P1917, DOI 10.1088/0953-4075/24/8/010; Lebech M, 2002, REV SCI INSTRUM, V73, P1866, DOI 10.1063/1.1458063; Malegat L, 1997, J PHYS B-AT MOL OPT, V30, P251, DOI 10.1088/0953-4075/30/2/018; McCurdy CW, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032707; McCurdy CW, 2004, J PHYS B-AT MOL OPT, V37, pR137, DOI 10.1088/0953-4075/37/17/R01; Reddish TJ, 1999, J PHYS B-AT MOL OPT, V32, P2473, DOI 10.1088/0953-4075/32/11/301; Rescigno TN, 1999, SCIENCE, V286, P2474, DOI 10.1126/science.286.5449.2474; Seccombe DP, 2002, J PHYS B-AT MOL OPT, V35, P3767, DOI 10.1088/0953-4075/35/17/312; Vanroose W, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.050703; Walter M, 2000, PHYS REV LETT, V85, P1630, DOI 10.1103/PhysRevLett.85.1630; Walter M, 1999, J PHYS B-AT MOL OPT, V32, P2487, DOI 10.1088/0953-4075/32/11/302; Weber T, 2004, NATURE, V431, P437, DOI 10.1038/nature02839; WEBER T, 2003, THESIS I KERNPHYSIK, P428; Weber T., COMMUNICATION	19	110	110	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1787	1789		10.1126/science.1120263	http://dx.doi.org/10.1126/science.1120263			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357254	Green Submitted			2022-12-28	WOS:000234093600038
J	Fuyuno, I				Fuyuno, I			Olympus finds market rival hard to swallow	NATURE			English	Article																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					913	913		10.1038/438913a	http://dx.doi.org/10.1038/438913a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355187	Bronze			2022-12-28	WOS:000233934600027
J	Talavera, K; Yasumatsu, K; Voets, T; Droogmans, G; Shigemura, N; Ninomiya, Y; Margolskee, RF; Nilius, B				Talavera, K; Yasumatsu, K; Voets, T; Droogmans, G; Shigemura, N; Ninomiya, Y; Margolskee, RF; Nilius, B			Heat activation of TRPM5 underlies thermal sensitivity of sweet taste	NATURE			English	Article							RECEPTOR-CELLS; CHANNELS; TEMPERATURE; MICE; TRANSDUCTION; VOLTAGE	TRPM5, a cation channel of the TRP superfamily, is highly expressed in taste buds of the tongue, where it has a key role in the perception of sweet, umami and bitter tastes(1,2). Activation of TRPM5 occurs downstream of the activation of G-protein-coupled taste receptors and is proposed to generate a depolarizing potential in the taste receptor cells(2). Factors that modulate TRPM5 activity are therefore expected to influence taste. Here we show that TRPM5 is a highly temperature-sensitive, heat-activated channel: inward TRPM5 currents increase steeply at temperatures between 15 and 35 degrees C. TRPM4, a close homologue of TRPM5, shows similar temperature sensitivity. Heat activation is due to a temperature-dependent shift of the activation curve, in analogy to other thermosensitive TRP channels(3). Moreover, we show that increasing temperature between 15 and 35 degrees C markedly enhances the gustatory nerve response to sweet compounds in wild-type but not in Trpm5 knockout mice. The strong temperature sensitivity of TRPM5 may underlie known effects of temperature on perceived taste in humans(4-6), including enhanced sweetness perception at high temperatures and 'thermal taste', the phenomenon whereby heating or cooling of the tongue evoke sensations of taste in the absence of tastants(7).	Catholic Univ Louvain, Fysiol Lab, B-3000 Louvain, Belgium; Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan; Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Universite Catholique Louvain; Kyushu University; Icahn School of Medicine at Mount Sinai	Talavera, K (corresponding author), Catholic Univ Louvain, Fysiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.	Karel.talavera@med.kuleuven.be	Talavera, Karel/K-7990-2014; Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012	Talavera, Karel/0000-0002-3124-138X; Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Margolskee, Robert/0000-0002-9572-2887; Shigemura, Noriatsu/0000-0002-3061-6362				BARTOSHUK LM, 1982, PHYSIOL BEHAV, V28, P905, DOI 10.1016/0031-9384(82)90212-8; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CORREA AM, 1992, BIOPHYS J, V61, P1332, DOI 10.1016/S0006-3495(92)81941-0; Cruz A, 2000, NATURE, V403, P889, DOI 10.1038/35002581; GREEN BG, 1988, PHYSIOL BEHAV, V43, P515, DOI 10.1016/0031-9384(88)90127-8; GREEN BG, 1987, CHEM SENSES, V12, P609, DOI 10.1093/chemse/12.4.609; Hille B., 2001, ION CHANNELS EXCITAB, P366; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Patapoutian A, 2005, CHEM SENSES, V30, pI193, DOI 10.1093/chemse/bjh180; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Rong MQ, 2005, CHEM SENSES, V30, pI33, DOI 10.1093/chemse/bjh099; Talavera K, 2003, J GEN PHYSIOL, V121, P511, DOI 10.1085/jgp.200308793; Tiwari JK, 1999, EUR BIOPHYS J BIOPHY, V28, P338, DOI 10.1007/s002490050216; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; VANLUNTEREN E, 1993, J PHYSIOL-LONDON, V466, P81; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	22	325	347	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					1022	1025		10.1038/nature04248	http://dx.doi.org/10.1038/nature04248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355226	Green Published			2022-12-28	WOS:000233934600068
J	Mozaffarian, D				Mozaffarian, D			Electron-beam computed tomography for coronary calcium - A useful test to screen for coronary heart disease?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ARTERY CALCIUM; PROGNOSTIC VALUE; RISK PREDICTION; FOLLOW-UP; CALCIFICATION; EVENTS; CANCER; CT		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2,Room 315, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008		NHLBI NIH HHS [K08-HL-075628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; American Heart Association, 2005, HEART DIS STROKE STA; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; BREEN JF, 1992, RADIOLOGY, V185, P435, DOI 10.1148/radiology.185.2.1410350; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; *LIF IM CTR, HEART COR ART SCREEN; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; O'Malley PG, 2004, AM HEART J, V148, P106, DOI 10.1016/j.ahj.2004.01.018; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Qu WC, 2003, DIABETES CARE, V26, P905, DOI 10.2337/diacare.26.3.905; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2005, J NUCL CARDIOL, V12, P96, DOI 10.1016/j.nuclcard.2004.11.005; Raggi P, 2004, J WOMENS HEALTH, V13, P273, DOI 10.1089/154099904323016437; Rumberger JA, 1999, J AM COLL CARDIOL, V33, P453, DOI 10.1016/S0735-1097(98)00583-X; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; TANENBAUM SR, 1989, AM J CARDIOL, V63, P870, DOI 10.1016/0002-9149(89)90060-X; UK National Screening Committee, CRIT APPR VIAB EFF A; United States Preventive Services Task Force, GUID CLIN PREV SERV; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; *WELLMAX CTR PREV, WELC WELLMAX	28	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2897	2901		10.1001/jama.294.22.2897	http://dx.doi.org/10.1001/jama.294.22.2897			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352798				2022-12-28	WOS:000233826700031
J	Smith, J; Dixon, J; Mays, N; McLeod, H; Goodwin, N; McClelland, S; Lewis, R; Wyke, S				Smith, J; Dixon, J; Mays, N; McLeod, H; Goodwin, N; McClelland, S; Lewis, R; Wyke, S			The NHS revolution: health care in the market place - Practice based commissioning: applying the research evidence	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England; Kings Fund, London W1G 0AN, England; Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Dept Publ Hlth & Policy, London WC1E 7HT, England; Univ Glamorgan, Sch Care Sci, Hlth Econ Res Unit, Pontypridd, M Glam, Wales; Univ Stirling, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland	University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; University of South Wales; University of Stirling	Smith, J (corresponding author), Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.	j.a.smith.20@bham.ac.uk	Smith, Judith/AAW-3070-2021	Smith, Judith/0000-0003-4036-4063; Goodwin, Nicholas/0000-0003-4900-3352				Butler T, 1998, BRIT MED J, V316, P214; Croxson B, 2001, J PUBLIC ECON, V79, P375, DOI 10.1016/S0047-2727(00)00074-8; *DEP HLTH, 2005, COMM PAT LED NHS; *DEP HLTH, 2003, BUILD BEST CHOIC RES; Department of Health, 2004, PRACT BAS COMM PROM; DOWLING B, 2003, NEW PRIMARY CARE MOD; DUSHEIKO M, 2003, U YORK TECHNICAL PAP, V26; GOODWIN N, 1998, LEARNING NHS INTERNA, P43; Health Service Journal, 2005, HLTH SERV J, V115, P8; HEWITT P, 2005, COMMUNICATION   0920; Kitchener M, 2000, ORGANIZATION, V7, P129, DOI 10.1177/135050840071007; Le Grand J, 1998, LEARNING NHS INTERNA; Locock L, 2004, Health Serv Manage Res, V17, P24, DOI 10.1258/095148404322772705; Mays N, 2001, PURCHASING HLTH CARE; OVRETVEIT J, 1995, PURCHASING HLTH MULT; Smith J, 2005, BRIT MED J, V331, P1156, DOI 10.1136/bmj.331.7526.1156; SMITH J, IN PRESS MANAGED PRI; Smith J, 2004, REV EFFECTIVENESS PR; WILKIN D, 2002, NATL TRACKER SURVEY	19	22	22	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1397	1399		10.1136/bmj.331.7529.1397	http://dx.doi.org/10.1136/bmj.331.7529.1397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16339254	Green Published, Green Accepted			2022-12-28	WOS:000233999300030
J	Taylor, CJ; Bolton, EM; Pocock, S; Sharples, LD; Pedersen, RA; Bradley, JA				Taylor, CJ; Bolton, EM; Pocock, S; Sharples, LD; Pedersen, RA; Bradley, JA			Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching	LANCET			English	Article							BLOOD-GROUP COMPATIBILITY; RENAL-TRANSPLANTATION; HUMAN BLASTOCYSTS; IN-VITRO; DIFFERENTIATION; THERAPY; DERIVATION; RECIPIENTS; SYSTEM	Background Human embryonic stem (hES) cells are a promising source for transplantation to replace diseased or damaged tissue, but their differentiated progeny express human leucocyte antigens (HLAs) that will probably cause graft rejection. The creation of a bank of HLA-typed hES cells, from which a best match could be selected, would help reduce the likelihood of graft rejection. We investigated how many hES cell lines would be needed to make matching possible in most cases. Methods The number of hES cell lines needed to achieve varying degrees of HLA match was estimated by use of, as a surrogate for hES-cell donor embryos, blood group and HLA types on a series of 10 000 consecutive UK cadaveric organ donors. The degree of blood group compatibility and HLA matching for a recipient population consisting of 6577 patients registered on the UK kidney transplant waiting list was determined, assuming all donor hES cell lines could provide a transplant for an unlimited number of recipients. Findings A bank of 150 consecutive donors provided a full match at HLA-A, HLA-B, and HLA-DR for a minority of recipients (<20%); a beneficial match (defined as one HLA-A or one HLA-B mismatch only) or better for 37.9% (range 27.9-47.5); and an HLA-DR match or better for 84.9% (77.5-90.0). Extending the number of donors beyond 150 conferred only a very gradual incremental benefit with respect to HLA matching. A panel of only ten donors homozygous for common HLA types selected from 10 000 donors provided a complete HLA-A, HLA-B and HLA-DR match for 37.7% of recipients, and a beneficial match for 67.4%. Interpretation Approximately 150 consecutive blood group compatible donors, 100 consecutive blood group 0 donors, or ten highly selected homozygous donors could provide the maximum practical benefit for HLA matching. The findings from these simulations have practical, political, and ethical implications for the establishment of hES-cell banks.	Univ Cambridge, Teaching Hosp, Tissue Typing Lab, Cambridge, England; Univ Cambridge, Sch Clin Med, Dept Surg, Cambridge CB2 1TN, England; MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; University of Cambridge; MRC Biostatistics Unit	Bradley, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Box 202, Cambridge CB2 2QQ, England.	Jab52@cam.ac.uk		Sharples, Linda/0000-0003-0894-966X; Bolton, Eleanor/0000-0002-7253-6045	Medical Research Council [G0100501, G0800784] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Borderie VM, 1997, CORNEA, V16, P1; Bradley JA, 2005, HUMAN EMBRYONIC STEM CELLS, P231; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Calhoun JD, 2004, BIOCHEM BIOPH RES CO, V323, P453, DOI 10.1016/j.bbrc.2004.08.117; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; CLAYTON HA, 1993, TRANSPLANTATION, V56, P1538; Conley BJ, 2004, INT J BIOCHEM CELL B, V36, P555, DOI 10.1016/j.biocel.2003.07.003; COOPER DKC, 1990, TRANSPLANT P, V22, P1457; Doss MX, 2004, J CELL MOL MED, V8, P465, DOI 10.1111/j.1582-4934.2004.tb00471.x; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Faden RR, 2003, HASTINGS CENT REP, V33, P13, DOI 10.2307/3527822; Fairchild PJ, 2004, TRENDS IMMUNOL, V25, P465, DOI 10.1016/j.it.2004.07.005; Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84; Gerecht-Nir S, 2004, AM J TRANSPLANT, V4, P51, DOI 10.1111/j.1600-6135.2004.0345.x; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Lang KJD, 2004, J NEUROSCI RES, V76, P184, DOI 10.1002/jnr.20036; Lin H, 2003, STEM CELLS, V21, P152, DOI 10.1634/stemcells.21-2-152; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; Opelz G, 1999, Rev Immunogenet, V1, P334; PAUL LC, 1987, TRANSPL P, V19, P4463; Petersdorf EW, 2001, NEW ENGL J MED, V345, P1794, DOI 10.1056/NEJMoa011826; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; SANFILIPPO F, 1987, TRANSPLANTATION, V43, P240, DOI 10.1097/00007890-198702000-00015; Stoffel M, 2004, SEMIN CELL DEV BIOL, V15, P327, DOI 10.1016/j.semcdb.2004.02.002; Taylor C J, 1993, Clin Transpl, P233; TAYLOR CJ, 1993, TRANSPLANT P, V25, P210; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *UK TRANSPL STAT, TRANSPL ACT REP; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4	32	323	345	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2019	2025		10.1016/S0140-6736(05)67813-0	http://dx.doi.org/10.1016/S0140-6736(05)67813-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338451				2022-12-28	WOS:000233826900021
J	Cohen, HT; McGovern, FJ				Cohen, HT; McGovern, FJ			Renal-cell carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LINDAU TUMOR-SUPPRESSOR; HYPOXIA-INDUCIBLE FACTOR; TRANSFORMING-GROWTH-FACTOR; HOGG-DUBE-SYNDROME; PARENCHYMAL SPARING SURGERY; COLLECTING DUCT CARCINOMA; INTEGRATED STAGING SYSTEM; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; DENDRITIC CELLS		Boston Univ, Sch Med, Evans Biomed Res Ctr, Dept Med,Renal Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Hematol Oncol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Hematol Oncol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Renal Sect, Boston, MA 02118 USA; Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Cohen, HT (corresponding author), Boston Univ, Sch Med, Evans Biomed Res Ctr, Dept Med,Renal Sect, 650 ALbany St,Rm X-535, Boston, MA 02118 USA.	htcohen@bu.edu		Cohen, Herbert/0000-0003-1900-8718	NCI NIH HHS [R01 CA079830, R01 CA79830] Funding Source: Medline; NIDDK NIH HHS [R01 DK67569, R01 DK067569] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067569] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1007/BF02524349; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bui MHT, 2003, CLIN CANCER RES, V9, P802; CHEN F, 1995, CANCER RES, V55, P4804; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Clark JI, 2003, J CLIN ONCOL, V21, P3133, DOI 10.1200/JCO.2003.02.014; CLAYMAN RV, 1991, J UROLOGY, V146, P278, DOI 10.1016/S0022-5347(17)37770-4; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; da Silva NF, 2003, J MED GENET, V40, P820; de Paulsen N, 2001, P NATL ACAD SCI USA, V98, P1387, DOI 10.1073/pnas.031587498; Delahunt B, 1997, MODERN PATHOL, V10, P537; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Everitt JI, 1997, MOL CARCINOGEN, V19, P213, DOI 10.1002/(SICI)1098-2744(199707)19:3<213::AID-MC9>3.3.CO;2-W; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Fischer J, 1998, ONCOGENE, V17, P733, DOI 10.1038/sj.onc.1201983; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; FLEMING ID, 1998, AJCC CANC STAGING HD, P215; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Gollob J A, 2001, Urology, V58, P1058, DOI 10.1016/S0090-4295(01)01411-X; Green FL, 2002, AJCC CANC STAGING MA, P323; Gunawan B, 2003, CANCER RES, V63, P6200; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Herring JC, 2001, J UROLOGY, V165, P777, DOI 10.1016/S0022-5347(05)66524-X; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Holtl L, 2002, CLIN CANCER RES, V8, P3369; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Javidan J, 1999, J UROLOGY, V162, P1277, DOI 10.1016/S0022-5347(05)68264-X; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Khoo SK, 2003, CANCER RES, V63, P4583; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kiuru M, 2001, AM J PATHOL, V159, P825, DOI 10.1016/S0002-9440(10)61757-9; Knebelmann B, 1998, CANCER RES, V58, P226; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Lubensky IA, 1999, AM J PATHOL, V155, P517, DOI 10.1016/S0002-9440(10)65147-4; Luiten RM, 1996, BRIT J CANCER, V74, P735, DOI 10.1038/bjc.1996.430; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Marten A, 2003, HUM GENE THER, V14, P483, DOI 10.1089/104303403321467243; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MELONI AM, 1993, CANCER GENET CYTOGEN, V65, P1, DOI 10.1016/0165-4608(93)90050-V; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Milowsky MI, 2002, CANCER, V94, P111, DOI 10.1002/cncr.10204; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Motzer RJ, 2003, J CLIN ONCOL, V21, P1193, DOI 10.1200/JCO.2003.12.072; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Novick AC, 2002, ANNU REV MED, V53, P393, DOI 10.1146/annurev.med.53.082901.103937; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Peyromaure M, 2004, CANCER, V100, P1406, DOI 10.1002/cncr.20128; Peyromaure M, 2003, J UROLOGY, V170, P1138, DOI 10.1097/01.ju.0000086616.40603.ad; Rowinsky EK, 2004, J CLIN ONCOL, V22, P3003, DOI 10.1200/JCO.2004.11.061; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Small E.J., 2003, RENAL ADRENAL TUMORS, P381; Srinivasan R, 2004, SEMIN ONCOL, V31, P47, DOI 10.1053/j.seminoncol.2003.11.002; Steffens MG, 1999, CLIN CANCER RES, V5, p3268S; Su Z, 2003, CANCER RES, V63, P2127; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; UCHIDA M, 1995, BRIT J UROL, V75, P132, DOI 10.1111/j.1464-410X.1995.tb07297.x; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Walther MM, 1999, J UROLOGY, V161, P1475, DOI 10.1016/S0022-5347(05)68930-6; Weirich G, 1998, J UROLOGY, V160, P335, DOI 10.1016/S0022-5347(01)62888-X; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; YAGODA A, 1995, SEMIN ONCOL, V22, P42; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Zbar B, 2003, ANNU REV MED, V54, P217, DOI 10.1146/annurev.med.54.101601.152514; ZBAR B, 1995, J UROLOGY, V153, P907, DOI 10.1016/S0022-5347(01)67601-8; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727; Zimmer M, 2004, MOL CANCER RES, V2, P89; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649; Zlotta AR, 1997, J ENDOUROL, V11, P251, DOI 10.1089/end.1997.11.251	103	1229	1307	1	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2477	2490		10.1056/NEJMra043172	http://dx.doi.org/10.1056/NEJMra043172			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339096				2022-12-28	WOS:000233754400009
J	Wyatt, JC; Sullivan, F				Wyatt, JC; Sullivan, F			ABC of health informatics - Communication and navigation around the healthcare system	BRITISH MEDICAL JOURNAL			English	Review									Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee	Wyatt, JC (corresponding author), Univ Dundee, Dundee DD1 4HN, Scotland.		Sullivan, Frank m/A-7767-2009; Sullivan, Frank/L-8286-2019; Wyatt, Jeremy/F-8160-2010	Sullivan, Frank/0000-0002-6623-4964; Wyatt, Jeremy/0000-0001-7008-1473				Coiera E, 1998, BRIT MED J, V316, P673, DOI 10.1136/bmj.316.7132.673; Coiera EW, 2002, MED J AUSTRALIA, V176, P415, DOI 10.5694/j.1326-5377.2002.tb04482.x; Coulter A, 2004, HEALTH EXPECT, V7, P95, DOI 10.1111/j.1369-7625.2004.00269.x; Ziguras SJ, 2002, BRIT J PSYCHIAT, V181, P17, DOI 10.1192/bjp.181.1.17	4	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2005	331	7528					1325	1327		10.1136/bmj.331.7528.1325	http://dx.doi.org/10.1136/bmj.331.7528.1325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322023	Green Published			2022-12-28	WOS:000233778500024
J	Turnell, AS; Stewart, GS; Grand, RJA; Rookes, SM; Martin, A; Yamano, H; Elledge, SJ; Gallimore, PH				Turnell, AS; Stewart, GS; Grand, RJA; Rookes, SM; Martin, A; Yamano, H; Elledge, SJ; Gallimore, PH			The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; ADENOVIRUS E1A; UBIQUITIN LIGASE; CBP COACTIVATOR; PROTEIN P300; P53; ACTIVATION; TRANSFORMATION; BINDING; PROTEOLYSIS	The anaphase- promoting complex/ cyclosome ( APC/ C) is a multicomponent E3 ubiquitin ligase that, by targeting protein substrates for 26S proteasome- mediated degradation through ubiquitination, coordinates the temporal progression of eukaryotic cells through mitosis and the subsequent G1 phase of the cell cycle(1-4). Other functions of the APC/ C are, however, less well defined. Here we show that two APC/ C components, APC5 and APC7, interact directly with the coactivators CBP and p300 through protein - protein interaction domains that are evolutionarily conserved in adenovirus E1A(5-8). This interaction stimulates intrinsic CBP/ p300 acetyltransferase activity and potentiates CBP/ p300- dependent transcription. We also show that APC5 and APC7 suppress E1A- mediated transformation in a CBP/ p300- dependent manner, indicating that these components of the APC/ C may be targeted during cellular transformation. Furthermore, we establish that CBP is required in APC/ C function; specifically, gene ablation of CBP by RNA- mediated interference markedly reduces the E3 ubiquitin ligase activity of the APC/ C and the progression of cells through mitosis. Taken together, our results define discrete roles for the APC/ C - CBP/ p300 complexes in growth regulation.	Univ Birmingham, Sch Med, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Marie Curie Res Inst, Surrey RH8 OTL, England; Harvard Univ, Sch Med, Ctr Genet & Genom, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Cancer Research UK; University of Birmingham; Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Turnell, AS (corresponding author), Univ Birmingham, Sch Med, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.	A.S.Turnell@bham.ac.uk		Stewart, Grant/0000-0002-0960-3241				Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; O'Connor MJ, 1999, J VIROL, V73, P3574; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhang X, 2004, J BIOL CHEM, V279, P25122, DOI 10.1074/jbc.M403287200	30	78	80	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					690	695		10.1038/nature04151	http://dx.doi.org/10.1038/nature04151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319895				2022-12-28	WOS:000233593100055
J	Yokoya, T; Nakamura, T; Matsushita, T; Muro, T; Takano, Y; Nagao, M; Takenouchi, T; Kawarada, H; Oguchi, T				Yokoya, T; Nakamura, T; Matsushita, T; Muro, T; Takano, Y; Nagao, M; Takenouchi, T; Kawarada, H; Oguchi, T			Origin of the metallic properties of heavily boron-doped superconducting diamond	NATURE			English	Article							VALENCE-BAND	The physical properties of lightly doped semiconductors are well described by electronic band- structure calculations and impurity energy levels(1). Such properties form the basis of present- day semiconductor technology. If the doping concentration n exceeds a critical value n(c), the system passes through an insulator- to- metal transition and exhibits metallic behaviour; this is widely accepted to occur as a consequence of the impurity levels merging to form energy bands(2). However, the electronic structure of semiconductors doped beyond nc have not been explored in detail. Therefore, the recent observation of superconductivity emerging near the insulator- to- metal transition(3) in heavily boron- doped diamond(4,5) has stimulated a discussion on the fundamental origin of the metallic states responsible for the superconductivity. Two approaches have been adopted for describing this metallic state: the introduction of charge carriers into either the impurity bands(6) or the intrinsic diamond bands(7-9). Here we show experimentally that the doping- dependent occupied electronic structures are consistent with the diamond bands, indicating that holes in the diamond bands play an essential part in determining the metallic nature of the heavily boron- doped diamond superconductor. This supports the diamond band approach and related predictions, including the possibility of achieving dopant- induced superconductivity in silicon and germanium(7). It should also provide a foundation for the possible development of diamond- based devices(10).	JASRI SPring8, Sayo, Hyogo 6795198, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; Waseda Univ, Sch Sci & Engn, Tokyo 1698555, Japan; Hiroshima Univ, Grad Sch Sci Matter ADSM, Dept Quantum Matter, Higashihiroshima 7398530, Japan	Japan Synchrotron Radiation Research Institute; Okayama University; National Institute for Materials Science; Waseda University; Hiroshima University	Yokoya, T (corresponding author), JASRI SPring8, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	yokoya@cc.okayama-u.ac.jp	YOKOYA, Takayoshi/B-1478-2011; Oguchi, Tamio/X-1205-2019; Kawarada, Hiroshi/L-6486-2017; TAKANO, Yoshihiko/H-2788-2011	Kawarada, Hiroshi/0000-0001-7496-4265; Matsushita, Tomohiro/0000-0002-2547-3811; Nagao, Masanori/0000-0002-1139-7838; Nakamura, Tetsuya/0000-0001-5647-9477				Ashcroft N. W., 1976, SOLID STATE PHYS, P561; BASKARAN G, 2004, CONDMAT0404286; Blase X, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237004; Boeri L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237002; Bustarret E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237005; CAMPUZANO JC, 2004, PHYS SUPERCONDUCTORS, V2, P184; COLLINS AT, 1971, J PHYS PART C SOLID, V4, P1789, DOI 10.1088/0022-3719/4/13/030; Ekimov EA, 2004, NATURE, V428, P542, DOI 10.1038/nature02449; GRAVELL RG, 1973, PHYS REV B, V7, P5313; INGLESFIELD JE, 1992, ANGLE RESOLVED PHOTO, P15; Jimenez I, 1997, PHYS REV B, V56, P7215, DOI 10.1103/PhysRevB.56.7215; Kamakura N, 2004, EUROPHYS LETT, V67, P240, DOI 10.1209/epl/i2004-10052-6; Lee KW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237003; Matsushita T, 2002, SURF REV LETT, V9, P1321, DOI 10.1142/S0218625X02003743; Mott N. E., 1990, METAL INSULATOR TRAN, P145; NAKAMURA J, 2004, CONDMAT0410144; NEBEL CE, 2004, THIN FILM DIAMOND, V2, P121; Takano Y, 2004, APPL PHYS LETT, V85, P2851, DOI 10.1063/1.1802389; UMEZAWA H, 2004, CONDMAT0503303; ZUNGER A, 1977, PHYS REV B, V15, P5049, DOI 10.1103/PhysRevB.15.5049	20	224	226	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					647	650		10.1038/nature04278	http://dx.doi.org/10.1038/nature04278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319887				2022-12-28	WOS:000233593100045
J	Mathew, D; Ataman, B; Chen, JY; Zhang, YL; Cumberledge, S; Budnik, V				Mathew, D; Ataman, B; Chen, JY; Zhang, YL; Cumberledge, S; Budnik, V			Wingless signaling at synapses is through cleavage and nuclear import of receptor DFrizzled2	SCIENCE			English	Article							DROSOPHILA; PROTEIN; FAMILY; DIFFERENTIATION; INHIBITION; EXPRESSION; WNT-7A	Wingless secretion provides pivotal signals during development by activating transcription of target genes. At Drosophila synapses, Wingless is secreted from presynaptic terminals and is required for synaptic growth and differentiation. Wingless binds the seven-pass transmembrane DFrizzled2 receptor, but the ensuing events at synapses are not known. We show that DFrizzled2 is endocytosed from the postsynaptic membrane and transported to the nucleus. The C terminus of DFrizzled2 is cleaved and translocated into the nucleus; the N-terminal region remains just outside the nucleus. Translocation of DFrizzled2-C into the nucleus, but not its cleavage and transport, depends on Wingless signaling. We conclude that, at synapses, Wingless signal transduction occurs through the nuclear localization of DFrizzled2-C for potential transcriptional regulation of synapse development.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu	Mathew, Dennis/A-7654-2012; Mathew, Dennis/AAF-7036-2020	Mathew, Dennis/0000-0002-2096-6334	NICHD NIH HHS [R01 HD036000] Funding Source: Medline; NIGMS NIH HHS [GM R01 HD36000] Funding Source: Medline; NIMH NIH HHS [R01 MH070000, R01 MH70000] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen MJ, 1999, J NEUROSCI, V19, P9374; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lucas FR, 1998, J CELL SCI, V111, P1351; Mathew D, 2003, J NEUROSCI, V23, P10710; Moline MM, 1999, DEVELOPMENT, V126, P4375; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; Zhang J, 1998, DEVELOPMENT, V125, P3075	20	134	142	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1344	1347		10.1126/science.1117051	http://dx.doi.org/10.1126/science.1117051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311339	Green Accepted			2022-12-28	WOS:000233600200046
J	Showalter, MR				Showalter, MR			Saturn's strangest ring becomes curiouser and curiouser	SCIENCE			English	Editorial Material							F-RING		SETI Inst, Mountain View, CA 94043 USA		Showalter, MR (corresponding author), SETI Inst, Mountain View, CA 94043 USA.	mshowalter@seti.org						Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; Charnoz S, 2005, SCIENCE, V310, P1300, DOI 10.1126/science.1119387; Showalter MR, 2004, ICARUS, V171, P356, DOI 10.1016/j.icarus.2004.05.006; Showalter MR, 1998, SCIENCE, V282, P1099, DOI 10.1126/science.282.5391.1099	4	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2005	310	5752					1287	1288		10.1126/science.1121223	http://dx.doi.org/10.1126/science.1121223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311324				2022-12-28	WOS:000233600200029
J	Belshe, RB				Belshe, RB			The origins of pandemic influenza - Lessons from the 1918 virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Louis Univ, Dept Internal Med, Div Infect Dis & Immunol, St Louis, MO 63103 USA	Saint Louis University	Belshe, RB (corresponding author), St Louis Univ, Dept Internal Med, Div Infect Dis & Immunol, St Louis, MO 63103 USA.		Lambkin-Williams, Robert/P-5963-2016	Lambkin-Williams, Robert/0000-0003-2107-0174				Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	3	151	174	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2209	2211		10.1056/NEJMp058281	http://dx.doi.org/10.1056/NEJMp058281			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986FC	16306515				2022-12-28	WOS:000233434500001
J	Endy, D				Endy, D			Foundations for engineering biology	NATURE			English	Review							ESCHERICHIA-COLI; TOGGLE SWITCH; NETWORK; RNA; CONSTRUCTION; GENE	Engineered biological systems have been used to manipulate information, construct materials, process chemicals, produce energy, provide food, and help maintain or enhance human health and our environment. Unfortunately, our ability to quickly and reliably engineer biological systems that behave as expected remains quite limited. Foundational technologies that make routine the engineering of biology are needed. Vibrant, open research communities and strategic leadership are necessary to ensure that the development and application of biological technologies remains overwhelmingly constructive.	MIT, Div Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Endy, D (corresponding author), MIT, Div Biol Engn, Room 68-580,Koch Biol Bldg,31 Ames St, Cambridge, MA 02139 USA.	endy@mit.edu		Endy, Drew/0000-0001-6952-8098				[Anonymous], 1999, Eur J Biochem, V264, P610; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CANTON B, 2005, MIT SYNTHETIC BIOL W; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Dyson F., 2005, TECHNOL REV; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; ENDY D, 2005, NATURE; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Graham-Rowe Duncan, 2003, NEW SCI; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; KNIGHT TF, 2002, MIT SYNTHETIC B 0522; Knight TF, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100028; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mead C., 1980, INTRO VLSI SYSTEMS; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Roberts RJ, 2005, NUCLEIC ACIDS RES, V33, pD230; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; SUROWIECKI J, 2002, WIRED 10 01; SZYBALSKI W, 1978, GENE, V4, P181; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; VARMUS H, 1987, SCI AM, V257, P56, DOI 10.1038/scientificamerican0987-56; VENTER JC, 2005, GENE SYNTHESIS TECHN; von Neumann J., 1961, COLLECTED WORKS; Weber M., 2004, VOCATION LECT; Whitesides GM, 2001, SCI AM, V285, P78, DOI 10.1038/scientificamerican0901-78; Wolfe SA, 2003, BIOCHEMISTRY-US, V42, P13401, DOI 10.1021/bi034830b; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	41	901	972	4	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					449	453		10.1038/nature04342	http://dx.doi.org/10.1038/nature04342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306983				2022-12-28	WOS:000233458200039
J	Bowman, SM; Zimmerman, FJ; Christakis, DA; Sharar, SR; Martin, DP				Bowman, SM; Zimmerman, FJ; Christakis, DA; Sharar, SR; Martin, DP			Hospital characteristics associated with the management of pediatric splenic injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONOPERATIVE MANAGEMENT; CONSERVATIVE MANAGEMENT; TRAUMA; RISK; SPLENECTOMY; INFECTION; SURGEONS	Context Despite evidence that more than 90% of children with traumatic injuries to the spleen can be successfully managed nonoperatively, there is significant variation in the use of splenectomy. As asplenic children are at increased risk of overwhelming postsplenectomy infection, nonoperative management may be considered a quality of care indicator. Objective To test the hypothesis that children are more likely to undergo splenectomy in general hospitals than in children's hospitals. Design Retrospective cohort study using data from the Kid's Inpatient Database (KID) for the year 2000. Multivariable regression was used to control for patient and hospital characteristics. Setting and Participants All children aged 0 to 16 years who were hospitalized with a traumatic (noniatrogenic) spleen injury in nonfederal short-stay hospitals in any of the 27 states participating in KID (N = 2851). Main Outcome Measure Splenectomy performed within 1 day of arrival. Results A total of 11 children (3%) with splenic injuries receiving care at children's hospitals underwent splenectomy compared with 383 children (15.4%) cared for at general hospitals (P < .001). After adjusting for patient characteristics, injury severity, and hospital characteristics, splenectomy was more likely among children treated at general hospitals (odds ratio, 5.01; 95% confidence interval, 2.21-11.36) than among children treated at children's hospitals. Conclusions There is considerable variation in the management of pediatric splenic injuries, with significantly lower rates of splenectomy at designated children's hospitals. Quality improvement interventions, including increased education and training for physicians in general hospitals, may be needed to increase the use of spleen-conserving management practices.	Washington State Dept Hlth, Off EMS & Trauma, Olympia, WA 98504 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Inst Child Hlth, Seattle, WA 98195 USA; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bowman, SM (corresponding author), Washington State Dept Hlth, Off EMS & Trauma, POB 47853, Olympia, WA 98504 USA.	smbowman@u.washington.edu	Zimmerman, Frederick/AAM-5432-2020; Zimmerman, Frederick/C-7259-2008; Bowman, Stephen/AAF-2154-2019	Zimmerman, Frederick/0000-0002-4163-9893; Zimmerman, Frederick/0000-0002-4163-9893; 	PHS HHS [1 D36 HP 10027] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AG HEALTHC RES QU, NAT EST 2000 KIDS IN; *AM COLL SURG COMM, 1998, RES OPT CAR INJ PAT; Bain IM, 1998, INJURY, V29, P177, DOI 10.1016/S0020-1383(97)00170-8; Beytout J, 2003, PRESSE MED, V32, pS5; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; COBURN MC, 1995, ARCH SURG-CHICAGO, V130, P332; CORNWELL EE, 1993, J NATL MED ASSOC, V85, P297; DEODHAR HA, 1993, BRIT MED J, V307, P1408, DOI 10.1136/bmj.307.6916.1408; DOUGLAS GJ, 1971, J PEDIATR SURG, V6, P565, DOI 10.1016/0022-3468(71)90380-0; *EAST, 2003, PRACT MAN GUID NON M; FELICIANO DV, 1996, TRAUMA, P55; Healthcare Cost and Utilization Project (HCUP), 2000, KIDS INP DAT KID; *J HOPK U TRIANALY, 1997, ICDMAP 90 INJ SEV CO; Lynch AM, 1996, INFECT DIS CLIN N AM, V10, P693, DOI 10.1016/S0891-5520(05)70322-6; Mooney DP, 2004, J TRAUMA, V56, P328, DOI 10.1097/01.TA.0000053737.16542.FB; MORSE MA, 1994, J PEDIATR SURG, V29, P23, DOI 10.1016/0022-3468(94)90516-9; Myers JG, 2000, J TRAUMA, V48, P801, DOI 10.1097/00005373-200005000-00002; Piontek FA, 2003, J TRAUMA, V54, P1041, DOI 10.1097/01.TA.0000061107.55798.31; Potoka DA, 2002, J PEDIATR SURG, V37, P294, DOI 10.1053/jpsu.2002.30824; Singer D B, 1973, Perspect Pediatr Pathol, V1, P285; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Weinberg JA, 2003, J TRAUMA, V54, P823, DOI 10.1097/01.TA.0000063001.61469.3E	22	71	74	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2611	2617		10.1001/jama.294.20.2611	http://dx.doi.org/10.1001/jama.294.20.2611			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304075	Bronze			2022-12-28	WOS:000233436200026
J	Chang, AB; Lasserson, TJ; Kiljander, TO; Connor, FL; Gaffney, JT; Garske, LA				Chang, AB; Lasserson, TJ; Kiljander, TO; Connor, FL; Gaffney, JT; Garske, LA			Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLACEBO; DIAGNOSIS	Objective To evaluate the efficacy of treatment for gastro-oesophageal reflux disease (GORD) on chronic cough in children mid adults without an underlying respiratory disease. Design Systematic review and meta-analysis. Data sources Cochrane, Medline, and Embase databases, references front review articles. Included studies Randomised controlled trials on GORD treatment for cough in children and adults Without primary lung disease. Two reviewers independently selected studies and extracted paediatric and adult data on primary (clinical failure) and secondary outcomes. Results 11 studies were included. Meta-analysis was limited to five Studies in adults that compared proton pump inhibitors with placebo. All outcomes favoured proton pump inhibitors: the odds ratio for clinical failure (primary outcome) was 0.24 (95% confidence interval 0.04 to 1.27); number needed to treat (NNT) was 5 (harm 50 to infinity to benefit 2.5). For secondary outcomes, the standardised mean difference between proton pump inhibitors and placebo was -0.51 (1.02 to 0.01) for mean cough score at the end of the trial an -0.29 (-0.62 to 0.04) for change in cough score at the end of the trial. Subgroup analysis with generic inverse variance analysis showed a significant mean change in cough (-0.41 SD units, -0.75 to -0.07). Conclusion Use of a proton pump inhibitor to treat cough associated with GORD has some effect in some adults. The effect, however, is less universal than suggested in consensus guidelines On Chronic Cough and its magnitude of effect is uncertain.	Royal Childrens Hosp, Dept Resp Med, Brisbane, Qld 4029, Australia; St George Hosp, Sch Med, Cochrane Airways Grp, London SW17 0RE, England; Med Ctr Mehilainen, FIN-20100 Turku, Finland; Royal Childrens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia; Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia	Royal Children's Hospital Brisbane; St Georges University London; Royal Children's Hospital Brisbane	Chang, AB (corresponding author), Royal Childrens Hosp, Dept Resp Med, Brisbane, Qld 4029, Australia.	annechang@ausdoctors.net	Chang, Anne/F-2066-2013; Garske, Luke/AAV-4965-2021; Connor, Frances/C-9641-2011	Chang, Anne/0000-0002-1331-3706; Connor, Frances/0000-0003-0888-7569; Garske, Luke/0000-0001-5577-5143				CHANG AB, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004823; Eccles R, 2002, PULM PHARMACOL THER, V15, P303, DOI 10.1006/pupt.2002.0364; Eherer AJ, 2003, SCAND J GASTROENTERO, V38, P462, DOI 10.1080/00365520310001860; Gregor JC, 2004, JAMA-J AM MED ASSOC, V292, P2012, DOI 10.1001/jama.292.16.2012; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Irwin RS, 2002, PULM PHARMACOL THER, V15, P261, DOI 10.1006/pupt.2002.0348; Kiljander TO, 2000, EUR RESPIR J, V16, P633, DOI 10.1034/j.1399-3003.2000.16d11.x; LAUKKA MA, 1994, J CLIN GASTROENTEROL, V19, P100, DOI 10.1097/00004836-199409000-00004; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2002, PULM PHARMACOL THER, V15, P253, DOI 10.1006/pupt.2002.0352	10	104	118	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2006	332	7532					11	14		10.1136/bmj.38677.559005.55	http://dx.doi.org/10.1136/bmj.38677.559005.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16330475	Bronze, Green Published			2022-12-28	WOS:000234684200013
J	Dezhina, I; Graham, LR				Dezhina, I; Graham, LR			Science foundations: A novelty in Russian science	SCIENCE			English	Article									Inst Econ Transit, Moscow 125993, Russia; MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dezhina, I (corresponding author), Inst Econ Transit, Gazetny 5, Moscow 125993, Russia.	degina@iet.ru; lrg@mit.edu	Dezhina, Irina G/F-7485-2014	Dezhina, Irina G/0000-0002-3402-3433				ALAKHVERDIAN A, 1996, MIROVAIA EKON MEZHDU, P35; BOK D, 1996, NY TIMES        1117, pA1; *CTR SCI RES STAT, 2004, SCI RUSS GLANC 2004, P68; *CTR SCI RES STAT, NAUK ROSS TSIFR STAT; DEZHINA I, 2004, RUSSIAN EC 2003 TEND, P256; DEZHINA I, 2000, INT SCI FDN PRESERVA, P151; DEZHINA I, 2003, POSITION WOMEN RES R; DEZHINA I, 2002, 24 CARN END INT PEAC; GRAHAM L, 2004, COMMUNICATION   0204; Graham Loren R., 1998, WHAT HAVE WE LEARNED, P74; KLIAUS V, 2004, NEZAVISIMAIA GA 1027, P12; KOCHETKOV G, 1994, MIT WORKSH, P9; MEYERS SL, 2005, NY TIMES        1124, pA1; 1998, NOVOSTI RFBR, P3	14	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1772	1773		10.1126/science.1117855	http://dx.doi.org/10.1126/science.1117855			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357247				2022-12-28	WOS:000234093600031
J	Wookey, J; Stackhouse, S; Kendall, JM; Brodholt, J; Price, GD				Wookey, J; Stackhouse, S; Kendall, JM; Brodholt, J; Price, GD			Efficacy of the post-perovskite phase as an explanation for lowermost-mantle seismic properties	NATURE			English	Article							MGSIO3 PEROVSKITE; ELASTIC-ANISOTROPY; VELOCITIES; TRANSITION; BOUNDARY; EARTH; WAVE	Constraining the chemical, rheological and electromagnetic properties of the lowermost mantle (D '') is important to understand the formation and dynamics of the Earth's mantle and core. To explain the origin of the variety of characteristics of this layer observed with seismology, a number of theories have been proposed(1), including core - mantle interaction, the presence of remnants of subducted material and that D '' is the site of a mineral phase transformation. This final possibility has been rejuvenated by recent evidence for a phase change in MgSiO3 perovskite ( thought to be the most prevalent phase in the lower mantle(2)) at near core - mantle boundary temperature and pressure conditions(3). Here we explore the efficacy of this 'post-perovskite' phase to explain the seismic properties of the lowermost mantle through coupled ab initio and seismic modelling of perovskite and post-perovskite polymorphs of MgSiO3, performed at lowermost-mantle temperatures and pressures. We show that a post-perovskite model can explain the topography and location of the D '' discontinuity, apparent differences in compressional- and shear-wave models(1) and the observation of a deeper, weaker discontinuity(4,5). Furthermore, our calculations show that the regional variations in lower-mantle shear-wave anisotropy are consistent with the proposed phase change in MgSiO3 perovskite.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; UCL, Dept Earth Sci, London WC1E 6BT, England; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Leeds; University of London; University College London; University of Bristol	Wookey, J (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	j.wookey@bristol.ac.uk	Price, Geoffrey D/C-1545-2008; Kendall, Michael/D-5973-2011; Brodholt, John P/B-7136-2011; Wookey, James/G-6113-2011	Price, Geoffrey D/0000-0001-8232-6853; Kendall, Michael/0000-0002-1486-3945; Brodholt, John P/0000-0001-7395-5834; Wookey, James/0000-0002-7403-4380; Stackhouse, Stephen/0000-0001-7605-3510	Natural Environment Research Council [NE/C518030/1, NER/O/S/2001/01227] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Brana L, 2004, GEOPHYS J INT, V158, P625, DOI 10.1111/j.1365-246X.2004.02306.x; Cordier P, 2004, NATURE, V428, P837, DOI 10.1038/nature02472; Garnero EJ, 1998, GEODYNAMICS-US, V28, P319; GUBBINS D, 1994, REV GEOPHYS, V32, P61, DOI 10.1029/93RG02602; Herlund J W, 2005, NATURE, V434, P882; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Iitaka T, 2004, NATURE, V430, P442, DOI 10.1038/nature02702; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; Karki BB, 1999, SCIENCE, V286, P1705, DOI 10.1126/science.286.5445.1705; Kendall J.M., 2000, EARTHS DEEP INTERIOR, V117, P133, DOI [10.1029/GM117p0133, DOI 10.1029/GM117P0133]; Kendall M, 2001, ASTRON GEOPHYS, V42, P26, DOI 10.1046/j.1468-4004.2001.42326.x; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Lay T, 1998, GEODYNAMICS, V28, P299; MASTERS G, 2000, EARTHS DEEP INTERIOR, V117, P201; Montagner JP, 1996, GEOPHYS J INT, V125, P229, DOI 10.1111/j.1365-246X.1996.tb06548.x; MULLER G, 1985, J GEOPHYS-Z GEOPHYS, V58, P153; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Stackhouse S, 2005, EARTH PLANET SC LETT, V230, P1, DOI 10.1016/j.epsl.2004.11.021; Tackley PJ, 1998, GEODYNAMICS, V28, P231; Thomas C, 2004, EARTH PLANET SC LETT, V225, P105, DOI 10.1016/j.epsl.2004.05.038; Thomas C, 1999, J GEOPHYS RES-SOL EA, V104, P15073, DOI 10.1029/1999JB900128; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Tsuchiya T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020278; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; Wentzcovitch RM, 1998, EARTH PLANET SC LETT, V164, P371, DOI 10.1016/S0012-821X(98)00230-1; Wysession ME, 1998, GEODYNAMICS, V28, P273	30	160	163	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1004	1007		10.1038/nature04345	http://dx.doi.org/10.1038/nature04345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355222				2022-12-28	WOS:000233934600064
J	Gopalamurugan, AB; Wheatcroft, S; Hunter, P; Thomas, MR				Gopalamurugan, AB; Wheatcroft, S; Hunter, P; Thomas, MR			Bilateral endophthalmitis and ARDS complicating group G streptococcal endocarditis	LANCET			English	Article									Kings Coll Hosp London, Dept Cardiol, London SE5 9RS, England; Kings Coll Hosp London, Dept Ophthalmol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Gopalamurugan, AB (corresponding author), Kings Coll Hosp London, Dept Cardiol, Denmark Hill, London SE5 9RS, England.	a.gopalamurugan@kcl.ac.uk						Barrau K, 2004, CLIN MICROBIOL INFEC, V10, P302, DOI 10.1111/j.1198-743X.2004.00776.x; BOUZA E, 1978, AM J CLIN PATHOL, V70, P108; BUCHER A, 1990, EUR J CLIN MICROBIOL, V9, P251, DOI 10.1007/BF01968055; Jackson TL, 2003, SURV OPHTHALMOL, V48, P403, DOI 10.1016/S0039-6257(03)00054-7; SMYTH EG, 1988, J INFECTION, V16, P169, DOI 10.1016/S0163-4453(88)94022-4	5	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2005	366	9502					2062	2062		10.1016/S0140-6736(05)67817-8	http://dx.doi.org/10.1016/S0140-6736(05)67817-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338455				2022-12-28	WOS:000233826900026
J	Zimmerberg, J; Chernomordik, LV				Zimmerberg, J; Chernomordik, LV			Synaptic membranes bend to the wilt of a neurotoxin	SCIENCE			English	Editorial Material							INFLUENZA HEMAGGLUTININ; BIOLOGICAL-MEMBRANES; FUSION; HEMIFUSION; EXOCYTOSIS		NICHHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zimmerberg, J (corresponding author), NICHHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA.	joshz@helix.nih.gov; chernoml@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409, ZIAHD001501, ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409, Z01HD001501, Z01HD001415] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARONA T, 2005, J BIOL CHEM     1010; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Chanturiya A, 1997, P NATL ACAD SCI USA, V94, P14423, DOI 10.1073/pnas.94.26.14423; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; ROLDAN ERS, 1993, J BIOL CHEM, V268, P13962; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Wei S, 2003, NEUROSCIENCE, V121, P891, DOI 10.1016/S0306-4522(03)00525-6; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zimmerberg J, 2000, TRAFFIC, V1, P366, DOI 10.1034/j.1600-0854.2000.010409.x; ZIMMERBERG J, 1994, J CELL BIOL, V127, P1885, DOI 10.1083/jcb.127.6.1885; ZIMMERBERG J, 2005, NAT REV MOL CEL 1115	19	28	30	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1626	1627		10.1126/science.1122439	http://dx.doi.org/10.1126/science.1122439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339436				2022-12-28	WOS:000233961700031
J	Loo, VG; Poirier, L; Miller, MA; Oughton, M; Libman, MD; Michaud, S; Bourgault, AM; Nguyen, T; Frenette, C; Kelly, M; Vibien, A; Brassard, P; Fenn, S; Dewar, K; Hudson, TJ; Horn, R; Rene, P; Monczak, Y; Dascal, A				Loo, VG; Poirier, L; Miller, MA; Oughton, M; Libman, MD; Michaud, S; Bourgault, AM; Nguyen, T; Frenette, C; Kelly, M; Vibien, A; Brassard, P; Fenn, S; Dewar, K; Hudson, TJ; Horn, R; Rene, P; Monczak, Y; Dascal, A			A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; PATHOGENICITY LOCUS; ADP-RIBOSYLTRANSFERASE; TOXIN PRODUCTION; SEVERE DISEASE; RISK-FACTORS; STRAIN; EPIDEMIOLOGY; PREVALENCE; INFECTION	BACKGROUND: In March 2003, several hospitals in Quebec, Canada, noted a marked increase in the incidence of Clostridium difficile-associated diarrhea. METHODS: In 2004 we conducted a prospective study at 12 Quebec hospitals to determine the incidence of nosocomial C. difficile-associated diarrhea and its complications and a case-control study to identify risk factors for the disease. Isolates of C. difficile were typed by pulsed-field gel electrophoresis and analyzed for binary toxin genes and partial deletions in the toxin A and B repressor gene tcdC. Antimicrobial susceptibility was evaluated in a subgroup of isolates. RESULTS: A total of 1703 patients with 1719 episodes of nosocomial C. difficile-associated diarrhea were identified. The incidence was 22.5 per 1000 admissions. The 30-day attributable mortality rate was 6.9 percent. Case patients were more likely than matched controls to have received fluoroquinolones (odds ratio, 3.9; 95 percent confidence interval, 2.3 to 6.6) or cephalosporins (odds ratio, 3.8; 95 percent confidence interval, 2.2 to 6.6). A predominant strain, resistant to fluoroquinolones, was found in 129 of 157 isolates (82.2 percent), and the binary toxin genes and partial deletions in the tcdC gene were present in 132 isolates (84.1 percent). CONCLUSIONS: A strain of C. difficile that was resistant to fluoroquinolones and had binary toxin and a partial deletion of the tcdC gene was responsible for this outbreak of C. difficile-associated diarrhea. Exposure to fluoroquinolones or cephalosporins was a risk factor.	McGill Univ, Ctr Hlth, Dept Microbiol, Montreal, PQ H3G 1A4, Canada; Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; Univ Montreal, Montreal, PQ, Canada; Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; St Marys Hosp, Montreal, PQ, Canada; Ctr Hosp Univ Montreal, Hop St Luc, Montreal, PQ, Canada; Hop Jean Talon, Montreal, PQ, Canada; Genome Quebec Innovat Ctr, Montreal, PQ, Canada; Cite SAnte Laval, Laval, PQ, Canada; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; Hop Charles LeMoyne, Longueuil, PQ, Canada; Reseau Sante Richelieu Yamaska, St Hyacinthe, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Loo, VG (corresponding author), McGill Univ, Ctr Hlth, Dept Microbiol, 1650 Cedar Ave,Rm D16-168, Montreal, PQ H3G 1A4, Canada.	vivian.loo@muhc.mcgill.ca	Brassard, Paul/F-4079-2018	Hudson, Thomas/0000-0002-1376-4849				Allen S.D., 2003, MANUAL CLIN MICROBIO, P835; Barbut F, 1996, ARCH INTERN MED, V156, P1449, DOI 10.1001/archinte.156.13.1449; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; *CLIN LAB STAND I, 2004, M11A6 CLIN LAB STAND; Cohen SH, 2000, J INFECT DIS, V181, P659, DOI 10.1086/315248; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Fawley WN, 2002, J CLIN MICROBIOL, V40, P3546, DOI 10.1128/JCM.40.9.3546-3547.2002; Gaynes R, 2004, CLIN INFECT DIS, V38, P640, DOI 10.1086/381551; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; Hyland M, 2001, Can J Infect Dis, V12, P81; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; Lai KK, 1997, INFECT CONT HOSP EP, V18, P628, DOI 10.2307/30141489; McCusker ME, 2003, EMERG INFECT DIS, V9, P730; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; Morris AM, 2002, ARCH SURG-CHICAGO, V137, P1096, DOI 10.1001/archsurg.137.10.1096; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; RUBIN MS, 1995, DIS COLON RECTUM, V38, P350, DOI 10.1007/BF02054220; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	32	1505	1591	0	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2442	2449		10.1056/NEJMoa051639	http://dx.doi.org/10.1056/NEJMoa051639			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16322602				2022-12-28	WOS:000233754400006
J	Crandall, C; Pregler, JP				Crandall, C; Pregler, JP			Update in women's health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material														Pregler, Janet/0000-0001-9420-161X					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					823	824		10.7326/0003-4819-143-11-200512060-00011	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330794				2022-12-28	WOS:000233884900007
J	Ham, C				Ham, C			Does the district general hospital have a future?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Ham, C (corresponding author), Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England.	c.j.ham@bham.ac.uk						Crisp N., 2005, CREATING PATIENT LED; Ministry of Health, 1962, HOSP PLAN ENGL WAL; *MORI, 2005, CHOIC BIRM BLACK COU; Robinson JC, 2001, HEALTH AFFAIR, V20, P81, DOI 10.1377/hlthaff.20.4.81; Smith J, 2004, REV EFFECTIVENESS PR; TIMMINS N, 2005, FINANCIAL TIMES 0614, P3	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2005	331	7528					1331	1333		10.1136/bmj.331.7528.1331	http://dx.doi.org/10.1136/bmj.331.7528.1331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	990YE	16322025	Green Published			2022-12-28	WOS:000233778500029
J	Nitz, UA; Mohrmann, S; Fischer, J; Lindemann, W; Berdel, WE; Jackisch, C; Werner, C; Ziske, C; Kirchner, H; Metzner, B; Souchon, R; Ruffert, U; Schutt, G; Pollmanns, A; Schmoll, HJ; Middecke, C; Baltzer, J; Schrader, I; Wiebringhaus, H; Ko, Y; Rosel, S; Schwenzer, T; Wernet, P; Hinke, A; Bender, HG; Frick, M				Nitz, UA; Mohrmann, S; Fischer, J; Lindemann, W; Berdel, WE; Jackisch, C; Werner, C; Ziske, C; Kirchner, H; Metzner, B; Souchon, R; Ruffert, U; Schutt, G; Pollmanns, A; Schmoll, HJ; Middecke, C; Baltzer, J; Schrader, I; Wiebringhaus, H; Ko, Y; Rosel, S; Schwenzer, T; Wernet, P; Hinke, A; Bender, HG; Frick, M		W German Study Grp	Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial	LANCET			English	Article							DOXORUBICIN; PACLITAXEL; CYCLOPHOSPHAMIDE; TRANSPLANTATION; THERAPY; SINGLE; NODES	Background Breast cancer with extensive axillary-lymph-node involvement has a poor prognosis after conventional treatment. In trials with historical controls, high-dose chemotherapy produced improved outcomes. We compared an intensive double-cycle high-dose chemotherapy regimen with an accelerated conventionally dosed regimen in high-risk breast cancer in a multicentre trial. Methods Patients with at least nine positive nodes were randomly assigned either two courses of accelerated (2-week intervals, with filgrastim support), conventionally dosed epirubicin and cyclophosphamide followed by two courses of high-dose chemotherapy (epirubicin, cyclophosphamide, and thiotepa supported by peripheral-blood progenitors) or four identical cycles of epirubicin and cyclophosphamide followed by three cycles of accelerated cyclophosphamide, methotrexate, and fluorouracil. The primary endpoint was event-free survival. Analyses were done both by intention to treat and per protocol. Findings 403 patients were enrolled; 201 were assigned high-dose chemotherapy and 202 conventional treatment. The mean number of positive nodes was 17.6, and median follow-up was 48.6 months. 4-year event-free survival (intention-to-treat analysis) was 60% (95% CI 53-67) in the high-dose chemotherapy group and 44% (37-52) in the control group (p=0.00069). The corresponding overall survival was 75% (69-82) versus 70% (64-77; p=0.02). There were no treatment-related deaths. Interpretation Our finding of significant improvements in both event-free and overall survival for high-dose chemotherapy compared with a dose-dense conventional regimen contrasts with the results of other studies. The discrepancy might be due partly to design differences (tandem, brief induction) between our regimen and those studied in other trials. This approach merits further study.	Univ Hosp Dusseldorf, Breast Ctr, D-40225 Dusseldorf, Germany; Univ Hosp Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany; Univ Hosp Dusseldorf, Dept Obstet & Gynaecol, D-40225 Dusseldorf, Germany; Catholic Hosp, Dept Haematol & Oncol, Hagen, Germany; Univ Hosp, Dept Obstet & Gynecol, Munster, Germany; Bethesda Clin, Dept Obstet & Gynaecol, Duisburg, Germany; Univ Hosp, Med Clin 1, Bonn, Germany; Siloah Clin, Dept Haematol & Oncol, Hannover, Germany; City Hosp, Dept Haematol & Oncol, Oldenburg, Germany; Allgemeines Krankenhaus, Dept Radiotherapy, Hagen, Germany; Inst Blutzellanal & Therapie, Jena, Germany; Protestant Clin, Dept Obstet & Gynaecol, Mulheim, Germany; Univ Hosp, Med Clin 4, Halle An Der Saale, Germany; Lippe Lemgo Gen Hosp, Med Clin 2, Lemgo, Germany; City Hosp, Dept Obstet & Gynaecol, Krefeld, Germany; Henrietten Fdn, Dept Gynaecol & Obstet Bethesda, Hannover, Germany; St Barbara Clin, Dept Obstet & Gynaecol, Hamm, Germany; Univ Bonn, Med Polyclin, D-5300 Bonn, Germany; City Hosp, Dept Haematol & Oncol, Gutersloh, Germany; City Hosp, Dept Obstet & Gynaecol, Dortmund, Germany; WiSP Res Inst, Langenfeld, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munster; University of Bonn; University of Bonn	Nitz, UA (corresponding author), Univ Hosp Dusseldorf, Breast Ctr, Moorenstr 5, D-40225 Dusseldorf, Germany.	nitzu@uni-duesseldorf.de	Metzner, Bernd/AAM-4054-2021; Schmoll, Hans-Joachim/AAG-5888-2019; schmoll, hans-joachim/AAO-5219-2021	Metzner, Bernd/0000-0002-1496-1377; schmoll, hans-joachim/0000-0001-8705-0593; Fischer, Johannes/0000-0002-2079-1845				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; BASSER R, 2003, 39 ANN M AM SOC CLIN; Bergh J, 2000, LANCET, V356, P1384, DOI 10.1016/S0140-6736(00)02841-5; BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542; Buzdar AU, 2002, CLIN CANCER RES, V8, P1073; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; CROWN J, 1992, J NATL CANCER I, V84, P1935, DOI 10.1093/jnci/84.24.1935; Crown J, 1995, ANN ONCOL, V6, P21, DOI 10.1093/annonc/6.suppl_4.S21; Crown JP, 2004, P 40 ANN M AM SOC CL; FARQUHAR C, 2003, COCHRANE DB SYST REV, V1; GIANNI A, 2001, P 37 ANN M AM SOC CL; GIANNI L, 2005, P 41 ANN M AM SOC CL; GOLDSTEIN L, 2005, P 41 ANN M AM SOC CL; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; HRYNIUK W, 1986, J CLIN ONCOL, V4, P1162, DOI 10.1200/JCO.1986.4.8.1162; JONES SE, 2003, P 39 ANN M AM SOC CL; KENNEDY MJ, 1991, J NATL CANCER I, V83, P920, DOI 10.1093/jnci/83.13.920; Leonard RCF, 2004, JNCI-J NATL CANCER I, V96, P1076, DOI 10.1093/jnci/djh188; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Peters WP, 2005, J CLIN ONCOL, V23, P2191, DOI 10.1200/JCO.2005.10.202; PETERS WP, 1993, J CLIN ONCOL, V11, P1132, DOI 10.1200/JCO.1993.11.6.1132; PETERS WP, 1999, P 35 ANN M AM SOC CL; POOLE CJ, 2003, P 39 ANN M AM SOC CL; ROCHE H, 2001, P 37 ANN M AM SOC CL; ROCHE H, 2004, P 27 ANN BREAST CANC; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; Tallman MS, 2003, NEW ENGL J MED, V349, P17, DOI 10.1056/NEJMoa030684; TEICHER BA, 1986, CANCER RES, V46, P4379; Zander AR, 2004, J CLIN ONCOL, V22, P2273, DOI 10.1200/JCO.2004.07.026	31	84	89	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1935	1944		10.1016/S0140-6736(05)67784-7	http://dx.doi.org/10.1016/S0140-6736(05)67784-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325695				2022-12-28	WOS:000233777900021
J	Timpson, NJ; Lawlor, DA; Harbord, RM; Gaunt, TR; Day, INM; Palmer, LJ; Hattersley, AT; Ebrahim, S; Lowe, GDO; Rumley, A; Smith, GD				Timpson, NJ; Lawlor, DA; Harbord, RM; Gaunt, TR; Day, INM; Palmer, LJ; Hattersley, AT; Ebrahim, S; Lowe, GDO; Rumley, A; Smith, GD			C-reactive protein and its role in metabolic syndrome: mendelian randomisation study	LANCET			English	Article							CORONARY-HEART-DISEASE; INSTRUMENTAL VARIABLES; GENETIC EPIDEMIOLOGY; INSULIN-RESISTANCE; WEAK INSTRUMENTS; STATIN THERAPY; PUBLIC-HEALTH; CRP GENE; INFLAMMATION; ASSOCIATION	Background Circulating C-reactive protein (CRP) is associated with the metabolic syndrome and might be causally linked to it. Our aim was to generate estimates of the association between plasma CRP and metabolic syndrome phenotypes that were free from confounding and reverse causation, to assess the causal role of this protein. Methods We examined associations between serum CRP concentration and metabolic syndrome phenotypes in the British Women's Heart and Health Study. We then compared these estimates with those derived from a mendelian randomised framework with common CRP gene haplotypes to generate unconfounded and unbiased estimates of any causal associations. Findings In a sample of British women, body-mass index (BMI), systolic blood pressure, waist-to-hip ratio, serum concentrations of HDL cholesterol and triglycerides, and insulin resistance were all associated with plasma CRP concentration. CRP haplotypes were associated with plasma CRP concentration (p<0.0001). With instrumental variable analyses, there was no association between plasma CRP concentration and any of the metabolic syndrome phenotypes analysed. There was strong evidence that linear regression and mendelian randomisation based estimation gave conflicting results for the CRP-BMI association (p=0.0002), and some evidence of conflicting results for the association of CRP with the score for insulin resistance (p=0.0139), triglycerides (p=0.0313), and HDL cholesterol (p=0.0688). Interpretation Disparity between estimates of the association between plasma CRP and phenotypes comprising the metabolic syndrome derived from conventional analyses and those from a mendelian randomisation approach suggests that there is no causal association between CRP and the metabolic syndrome phenotypes.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England; Western Australian Inst Med Res, Lab Genet Epidemiol, Perth, WA, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; Univ Exeter, Peninsular Med Sch, Exeter, Devon, England; Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Bristol; University of Southampton; University of Western Australia; University of Western Australia; University of Exeter; University of Glasgow	Timpson, NJ (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.	n.j.timpson@bristol.ac.uk	Timpson, Nicholas John/O-7548-2015; Palmer, Lyle John/N-1948-2019; Gaunt, Tom R/O-3918-2014; Davey Smith, George/A-7407-2013; Palmer, Lyle John/K-3196-2014; Fox, Laura J/C-6249-2016; Harbord, Roger M/A-8699-2008; Attrill, Lauren/V-1688-2018	Timpson, Nicholas John/0000-0002-7141-9189; Palmer, Lyle John/0000-0002-1628-3055; Gaunt, Tom R/0000-0003-0924-3247; Davey Smith, George/0000-0002-1407-8314; Palmer, Lyle John/0000-0002-1628-3055; Harbord, Roger M/0000-0002-2257-8271; Lawlor, Debbie A/0000-0002-6793-2262; Hattersley, Andrew/0000-0001-5620-473X				[Anonymous], 1954, REV INT STATISTIC I; Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; LOWE GD, 2005, J THROMB HAEMOST, V3, P1076; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/00004872-200310000-00002; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Sjoholm A, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	33	258	264	0	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1954	1959		10.1016/S0140-6736(05)67786-0	http://dx.doi.org/10.1016/S0140-6736(05)67786-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325697				2022-12-28	WOS:000233777900023
J	Maecker, H; Varfolomeev, E; Kischkel, F; Lawrence, D; LeBlanc, H; Lee, W; Hurst, S; Danilenko, D; Li, J; Filvaroff, E; Yang, B; Daniel, D; Ashkenazi, A				Maecker, H; Varfolomeev, E; Kischkel, F; Lawrence, D; LeBlanc, H; Lee, W; Hurst, S; Danilenko, D; Li, J; Filvaroff, E; Yang, B; Daniel, D; Ashkenazi, A			TWEAK attenuates the transition from innate to adaptive immunity	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; DENDRITIC CELLS; INTERFERON-GAMMA; T-CELLS; PERITONEAL-MACROPHAGES; FACTOR FAMILY; IN-VIVO	Innate immunity is the first line of defense against infection, protecting the host during the development of adaptive immunity and critically affecting the nature of the adaptive response. We show that, in contrast to tumor necrosis factor alpha (TNF-alpha), the related protein TWEAK attenuates the transition from innate to adaptive mechanisms. TWEAK(-/-) mice had overabundant natural killer (NK) cells and displayed hypersensitivity to bacterial endotoxin, with their innate immune cells producing excess interferon (IFN)-gamma and interleukin (IL)-12. TWEAK inhibited stimulation of the transcriptional activator STAT-1 and induced p65 nuclear factor (NF)-kappa B association with histone deacetylase 1, repressing cytokine production. TWEAK(-/-) mice developed oversized spleens with expanded memory and T helper 1 (T(H)1) subtype cells upon aging and mounted stronger innate and adaptive T(H)1-based responses against tumor challenge. Thus, TWEAK suppresses production of IFN-gamma and IL-12, curtailing the innate response and its transition to adaptive T(H)1 immunity.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Danilenko, Dimitry/0000-0002-8326-1921; Maecker, Heather/0000-0002-5378-1141				Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Araujo LM, 2000, INT IMMUNOL, V12, P1613, DOI 10.1093/intimm/12.11.1613; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Castriconi R, 2004, CR BIOL, V327, P533, DOI 10.1016/j.crvi.2003.12.001; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen NJ, 2001, J IMMUNOL, V166, P270, DOI 10.4049/jimmunol.166.1.270; Chen QY, 2002, IMMUNOLOGY, V107, P199, DOI 10.1046/j.1365-2567.2002.01485.x; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Coudert RD, 2002, J IMMUNOL, V169, P2979, DOI 10.4049/jimmunol.169.6.2979; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Diefenbach A, 2002, IMMUNOL REV, V188, P9, DOI 10.1034/j.1600-065X.2002.18802.x; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Emoto M, 2002, J IMMUNOL, V169, P1426, DOI 10.4049/jimmunol.169.3.1426; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Greene Warner C, 2004, Novartis Found Symp, V259, P208; HEREMANS H, 1994, EUR J IMMUNOL, V24, P1155, DOI 10.1002/eji.1830240522; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jakubowski A, 2002, J CELL SCI, V115, P267; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Leite-De-Moraes MC, 2001, J IMMUNOL, V166, P945, DOI 10.4049/jimmunol.166.2.945; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2002, MANUAL CLIN LAB IMMU, P338; Maecker HL, 2002, CANCER CELL, V2, P139, DOI 10.1016/S1535-6108(02)00095-8; Marodi L, 2001, CLIN EXP IMMUNOL, V126, P456, DOI 10.1046/j.1365-2249.2001.01693.x; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Nelson N, 1996, J IMMUNOL, V156, P3711; Oswald IP, 1999, EUR CYTOKINE NETW, V10, P533; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Palucka K, 1999, NAT MED, V5, P868, DOI 10.1038/11303; Pan JP, 2004, IMMUNOL LETT, V94, P141, DOI 10.1016/j.imlet.2004.05.003; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perez Omar D, 2004, Methods Mol Biol, V263, P67; Prevost-Blondel A, 2000, EUR J IMMUNOL, V30, P2507, DOI 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rothke, 1994, Assessment, V1, P1, DOI 10.1177/1073191194001001002; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Yang Q, 2003, INT J CANCER, V105, P512, DOI 10.1002/ijc.11119; Yang SX, 1997, CELL IMMUNOL, V179, P84, DOI 10.1006/cimm.1997.1151; Yei S, 2002, GENE THER, V9, P1302, DOI 10.1038/sj.gt.3301803; Zhan YF, 1998, J IMMUNOL, V161, P1447; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	63	192	202	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					931	944		10.1016/j.cell.2005.09.022	http://dx.doi.org/10.1016/j.cell.2005.09.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325585	Bronze			2022-12-28	WOS:000233814100024
J	Brebner, K; Wong, TP; Liu, LD; Liu, YT; Campsall, P; Gray, S; Phelps, L; Phillips, AG; Wang, YT				Brebner, K; Wong, TP; Liu, LD; Liu, YT; Campsall, P; Gray, S; Phelps, L; Phillips, AG; Wang, YT			Nucleus accumbens long-term depression and the expression of behavioral sensitization	SCIENCE			English	Article							AMPA RECEPTOR ENDOCYTOSIS; VENTRAL TEGMENTAL AREA; COCAINE SENSITIZATION; SYNAPTIC PLASTICITY; DOPAMINE; RATS; LTD; AMPHETAMINE; ADDICTION; GLUTAMATE	Drug-dependent neural plasticity related to drug addiction and schizophrenia can be modeled in animals as behavioral sensitization, which is induced by repeated noncontingent or self-administration of many drugs of abuse. Molecular mechanisms that are critical for behavioral sensitization have yet to be specified. Long-term depression (LTD) of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor (AMPAR)-mediated synaptic transmission in the brain has been proposed as a cellular substrate for learning and memory. The expression of LTD in the nucleus accumbens (NAc) required clathrin-dependent endocytosis of postsynaptic AMPARs. NAc LTD was blocked by a dynamin-derived peptide that inhibited clathrin-mediated endocytosis or by a GluR2-derived peptide that blocked regulated AMPAR endocytosis. Systemic or intra-NAc infusion of the membrane-permeable GluR2 peptide prevented the expression of amphetamine-induced behavioral sensitization in the rat.	Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Phillips, AG (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.	aphillips@psych.ubc.ca; ytwang@interchange.ubc.ca	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Liu, Lidong/0000-0002-7026-690X; Wong, Tak Pan/0000-0001-8611-4911				Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; FERRARIO CR, 2005, BIOL PSYCHIAT; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; PERUGINI M, 1994, J PHARMACOL EXP THER, V270, P690; Phillips AG, 1996, PSYCHOPHARMACOLOGY, V124, P279, DOI 10.1007/BF02246669; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; VEZINA P, 1990, BRAIN RES, V516, P99, DOI 10.1016/0006-8993(90)90902-N; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	30	226	236	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1340	1343		10.1126/science.1116894	http://dx.doi.org/10.1126/science.1116894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311338				2022-12-28	WOS:000233600200045
J	Brook, EJ				Brook, EJ			Tiny bubbles tell all	SCIENCE			English	Editorial Material							VOSTOK ICE CORE; ATMOSPHERIC METHANE; CLIMATE; RECORD; CO2; BP		Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA	Oregon State University	Brook, EJ (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA.	brooke@geo.oregonstate.edu	Brook, Edward/AAB-7807-2021					Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; BROOK E, 2001, CYCLES, V14, P559; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kaplan J., 2002, GEOPHYS RES LETT, V29, P1079; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Kennett JP, 2003, METHANE HYDRATES QUA; MACHIDA T, 1995, GEOPHYS RES LETT, V22, P2921, DOI 10.1029/95GL02822; Petit JR, 1997, NATURE, V387, P359, DOI 10.1038/387359a0; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Schmidt GA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021083; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sowers T, 2003, SCIENCE, V301, P945, DOI 10.1126/science.1085293; Sowers T, 2001, J GEOPHYS RES-ATMOS, V106, P31903, DOI 10.1029/2000JD900707; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; [No title captured], DOI DOI 10.1029/2005EO380003	23	17	17	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2005	310	5752					1285	1287		10.1126/science.1121535	http://dx.doi.org/10.1126/science.1121535			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311323				2022-12-28	WOS:000233600200028
J	Donati, JF; Paletou, F; Bouvier, J; Ferreira, J				Donati, JF; Paletou, F; Bouvier, J; Ferreira, J			Direct detection of a magnetic field in the innermost regions of an accretion disk	NATURE			English	Article							FU-ORIONIS; SHEAR INSTABILITY; STELLAR; OUTFLOW; STARS; JETS	Models(1-5) predict that magnetic fields play a crucial role in the physics of astrophysical accretion disks and their associated winds and jets(6,7). For example, the rotation of the disk twists around the rotation axis the initially vertical magnetic field, which responds by slowing down the plasma in the disk and by causing it to fall towards the central star. The magnetic energy flux produced in this process points away from the disk, pushing the surface plasma outwards, leading to a wind from the disk and sometimes a collimated jet. But these predictions have hitherto not been supported by observations. Here we report the direct detection of the magnetic field in the core of the protostellar accretion disk FU Orionis(8). The surface field reaches strengths of about 1 kG close to the centre of the disk, and it includes a significant azimuthal component, in good agreement with recent models(5). But we find that the field is very filamentary and slows down the disk plasma much more than models predict, which may explain why FU Ori fails to collimate its wind into a jet.	Observ Midi Pyrenees, Astrophys Lab, F-31400 Toulouse, France; Univ Grenoble 1, Lab Astrophys Grenoble, F-38041 Grenoble, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Donati, JF (corresponding author), Observ Midi Pyrenees, Astrophys Lab, F-31400 Toulouse, France.	donati@ast.obs-mip.fr	Paletou, Frédéric/S-1110-2018; Bouvier, Jerome/AAJ-2299-2020; Paletou, Frédéric/Q-7665-2019	Paletou, Frédéric/0000-0003-1970-2929; Paletou, Frédéric/0000-0003-1970-2929				BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BRANDENBURG A, 1995, ASTROPHYS J, V446, P741, DOI 10.1086/175831; BRIDLE AH, 1984, ANNU REV ASTRON ASTR, V22, P319, DOI 10.1146/annurev.aa.22.090184.001535; Donati JF, 2003, ASTR SOC P, V307, P41; Donati JF, 2003, MON NOT R ASTRON SOC, V345, P1145, DOI 10.1046/j.1365-2966.2003.07031.x; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P658, DOI 10.1093/mnras/291.4.658; Dubrulle B, 2005, ASTRON ASTROPHYS, V429, P1, DOI 10.1051/0004-6361:200400065; FERREIRA J, 1995, ASTRON ASTROPHYS, V295, P807; Ferreira J, 1997, ASTRON ASTROPHYS, V319, P340; Hartmann L, 1996, ANNU REV ASTRON ASTR, V34, P207, DOI 10.1146/annurev.astro.34.1.207; HARTMANN L, 1995, ASTRON J, V109, P1846, DOI 10.1086/117411; HERBIG GH, 1977, ASTROPHYS J, V217, P693, DOI 10.1086/155615; Herbig GH, 2003, ASTROPHYS J, V595, P384, DOI 10.1086/377194; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Hutawarakorn B, 2005, MON NOT R ASTRON SOC, V357, P338, DOI 10.1111/j.1365-2966.2005.08656.x; Hutawarakorn B, 1999, MON NOT R ASTRON SOC, V303, P845, DOI 10.1046/j.1365-8711.1999.02286.x; Johns-Krull CM, 2002, ASTROPHYS J, V573, P685, DOI 10.1086/340898; KENYON SJ, 1988, ASTROPHYS J, V325, P231, DOI 10.1086/165999; Keppens R, 2002, ASTROPHYS J, V569, pL121, DOI 10.1086/340666; Kurucz R., 1993, ATLAS 9 STELLAR ATMO; Malbet F, 2005, ASTRON ASTROPHYS, V437, P627, DOI 10.1051/0004-6361:20042556; PELLETIER G, 1992, ASTROPHYS J, V394, P117, DOI 10.1086/171565; PRESTON GW, 1967, ASTROPHYS J, V150, P547, DOI 10.1086/149358; PRINGLE JE, 1981, ANNU REV ASTRON ASTR, V19, P137, DOI 10.1146/annurev.aa.19.090181.001033; RAY TP, 1996, APJ, V468, P103; Reipurth B, 2004, ASTROPHYS J, V608, pL65, DOI 10.1086/422250; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; von Rekowski B, 2003, ASTRON ASTROPHYS, V398, P825, DOI 10.1051/0004-6361:20021699; Wang HC, 2004, ASTROPHYS J, V601, pL83, DOI 10.1086/381705	30	100	101	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					466	469		10.1038/nature04253	http://dx.doi.org/10.1038/nature04253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306985				2022-12-28	WOS:000233458200042
J	Uetz, P; Dong, YA; Zeretzke, C; Atzler, C; Baiker, A; Berger, B; Rajagopala, SV; Roupelieva, M; Rose, D; Fossum, E; Haas, J				Uetz, P; Dong, YA; Zeretzke, C; Atzler, C; Baiker, A; Berger, B; Rajagopala, SV; Roupelieva, M; Rose, D; Fossum, E; Haas, J			Herpesviral protein networks and their interaction with the human proteome	SCIENCE			English	Article							INTERACTION MAP; VIRUS	The comprehensive yeast two-hybrid analysis of intraviral protein interactions in two members of the herpesvirus family, Kaposi sarcoma-associated herpesvirus (KSHV) and varicella-zoster virus (VZV), revealed 123 and 173 interactions, respectively. Viral protein interaction networks resemble single, highly coupled modules, whereas cellular networks are organized in separate functional submodules. Predicted and experimentally verified interactions between KSHV and human proteins were used to connect the viral interactome into a prototypical human interactome and to simulate infection. The analysis of the combined system showed that the viral network adopts cellular network features and that protein networks of herpesviruses and possibly other intracellular pathogens have distinguishing topologies.	Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany; MIT, Dept Math, Cambridge, MA 02139 USA	University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; Massachusetts Institute of Technology (MIT)	Haas, J (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Pettenkoferstr 9A, D-80336 Munich, Germany.	haas@lmb.uni-muenchen.de	Fossum, Even/W-9136-2019; Uetz, Peter/A-7119-2012	Fossum, Even/0000-0001-7064-0327; Uetz, Peter/0000-0001-6194-4927	Medical Research Council [G0501453] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	13	313	326	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					239	242		10.1126/science.1116804	http://dx.doi.org/10.1126/science.1116804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16339411	Green Submitted			2022-12-28	WOS:000234722200045
J	Picardi, G; Plaut, JJ; Biccari, D; Bombaci, O; Calabrese, D; Cartacci, M; Cicchetti, A; Clifford, SM; Edenhofer, P; Farrell, WM; Federico, C; Frigeri, A; Gurnett, DA; Hagfors, T; Heggy, E; Herique, A; Huff, RL; Ivanov, AB; Johnson, WTK; Jordan, RL; Kirchner, DL; Kofman, W; Leuschen, CJ; Nielsen, E; Orosei, R; Pettinelli, E; Phillips, RJ; Plettemeier, D; Safaeinili, A; Seu, R; Stofan, ER; Vannaroni, G; Watters, TR; Zampolini, E				Picardi, G; Plaut, JJ; Biccari, D; Bombaci, O; Calabrese, D; Cartacci, M; Cicchetti, A; Clifford, SM; Edenhofer, P; Farrell, WM; Federico, C; Frigeri, A; Gurnett, DA; Hagfors, T; Heggy, E; Herique, A; Huff, RL; Ivanov, AB; Johnson, WTK; Jordan, RL; Kirchner, DL; Kofman, W; Leuschen, CJ; Nielsen, E; Orosei, R; Pettinelli, E; Phillips, RJ; Plettemeier, D; Safaeinili, A; Seu, R; Stofan, ER; Vannaroni, G; Watters, TR; Zampolini, E			Radar soundings of the subsurface of Mars	SCIENCE			English	Article							GEOLOGIC HISTORY; EVOLUTION	The martian subsurface has been probed to kilometer depths by the Mars Advanced Radar for Subsurface and Ionospheric Sounding instrument aboard the Mars Express orbiter. Signals penetrate the polar layered deposits, probably imaging the base of the deposits. Data from the northern lowlands of Chryse Planitia have revealed a shallowly buried quasi-circular structure about 250 kilometers in diameter that is interpreted to be an impact basin. In addition, a planar reflector associated with the basin structure may indicate the presence of a low-loss deposit that is more than 1 kilometer thick.	CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Alcatel Alenia Space Italia, I-00131 Rome, Italy; Lunar & Planetary Inst, Houston, TX 77058 USA; Ruhr Univ Bochum, Fak Elektrotech & Informat Tech, D-44780 Bochum, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Perugia, Dipartimento Sci Terra, I-06123 Perugia, Italy; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Lab Planetol Grenoble, F-38041 Grenoble, France; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Ist Nazl Astrofis, Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; Ist Nazl Astrofis, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Roma Tre, Dipartimento Fis, I-00146 Rome, Italy; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Tech Univ Dresden, Fak Elektrotech & Informat Tech, D-01062 Dresden, Germany; Proxemy Res, Laytonville, MD 20882 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; Alcatel-Lucent; Thales Group; Ruhr University Bochum; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Perugia; University of Iowa; Max Planck Society; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Roma Tre University; Washington University (WUSTL); Technische Universitat Dresden; Smithsonian Institution	Plaut, JJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	plaut@jpl.nasa.gov	Kofman, Wlodek/C-4556-2008; Frigeri, Alessandro/F-2151-2010; Heggy, Essam/E-8250-2013; Herique, Alain/E-7210-2017; Heggy, Essam/AAL-8124-2020; Farrell, William/I-4865-2013; Ivanov, Anton B/C-8944-2014	Kofman, Wlodek/0000-0002-6744-8796; Frigeri, Alessandro/0000-0002-9140-3977; Heggy, Essam/0000-0001-7476-2735; Herique, Alain/0000-0003-3699-883X; Heggy, Essam/0000-0001-7476-2735; Ivanov, Anton B/0000-0001-8376-8581; PETTINELLI, Elena/0000-0002-7066-6516; Cartacci, Marco/0000-0001-9825-1817; Calabrese, Diego/0000-0002-2598-1111; CICCHETTI, ANDREA/0000-0002-9588-6531				Byrne S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001615; CAIN JC, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2000JE001487; CHICARRO A, 2004, ESA PUBLICATIONS DIV, P313; Edgett KS, 2003, GEOMORPHOLOGY, V52, P289, DOI 10.1016/S0169-555X(02)00262-3; Farrell WM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022488; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; Frey HV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013832; FREY HV, IN PRESS J GEOPHYS R; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; Johnson CL, 2000, ICARUS, V144, P313, DOI 10.1006/icar.1999.6310; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; LUCCHITTA BK, 1986, J GEOPHYS RES-SOLID, V91, pE166, DOI 10.1029/JB091iB13p0E166; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MCGILL GE, 2005, US GEOL SURV MISC IN; Nouvel JF, 2004, RADIO SCI, V39, DOI 10.1029/2003RS002903; NUNES DC, UNPUB; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; ROTTO S, 1995, US GEOL SURV MISC IN; Safaeinili A, 2003, PLANET SPACE SCI, V51, P505, DOI 10.1016/S0032-0633(03)00048-5; SCOTT DH, 1987, US GEOL SURV MISC IN; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; Tanaka KL, 1997, J GEOPHYS RES-PLANET, V102, P4131, DOI 10.1029/96JE02862; TANAKA KL, 2005, US GEOL SURV MISC IN; Thomas P., 1992, MARS, P767; WITBECK NE, 1991, US GEOL SURV MISC IN; Xu Y., UNPUB	27	253	264	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1925	1928		10.1126/science.1122165	http://dx.doi.org/10.1126/science.1122165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16319122				2022-12-28	WOS:000234275400034
J	Chiswick, D				Chiswick, D			Mental health legislation should respect decision making capacity - Commentary: test of capacity has little practical benefit	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Edinburgh & Associated Hosp, Orchard Clin, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh	Chiswick, D (corresponding author), Royal Edinburgh & Associated Hosp, Orchard Clin, Edinburgh EH10 5HF, Midlothian, Scotland.	derek.chiswick@dial.pipex.com						Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Doyal L, 2005, BMJ-BRIT MED J, V331, P1467, DOI 10.1136/bmj.331.7530.1467	2	4	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1469	1470		10.1136/bmj.331.7530.1469	http://dx.doi.org/10.1136/bmj.331.7530.1469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356987	Green Published			2022-12-28	WOS:000234156400032
J	Coast, J; Noble, S; Noble, A; Horrocks, S; Asim, O; Peters, TJ; Salisbury, C				Coast, J; Noble, S; Noble, A; Horrocks, S; Asim, O; Peters, TJ; Salisbury, C			Economic evaluation of a general practitioner with special interest led dermatology service in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTREACH CLINICS	Objective To carry out an economic evaluation of a general practitioner with special interest service for non-urgent skin problems compared with hospital outpatient care. Design Cost effectiveness analysis and cost consequences analysis alongside a randomised controlled trial. Setting General practitioner with special interest dermatology service covering 29 general practices in Bristol. Participants Adults referred to a hospital dermatology clinic who were potentially suitable for management by a general practitioner with special interest. Interventions Participants were randomised 2:1 to receive either care by general practitioner with special interest service or usual hospital outpatient care. Main outcome measures Costs to NHS, patients, and companions, and costs of lost production. Cost effectiveness, using the two primary outcomes of dermatology life quality index scores and improved patient perceived access, was assessed by incremental cost effectiveness ratios and cost effectiveness acceptability curves. Cost consequences are presented in relation to all costs and both primary and secondary outcomes from the trial. Results Costs to the NHS for patients attending the general practitioner with special interest service were 208 ($361; E308) compared with 118 pound for hospital outpatient care. Based on analysis with imputation of missing data, costs to patients and companions were 48 pound and 51 pound, respectively; costs of lost production were 27 pound and 34 pound, respectively. The incremental cost effectiveness ratios for general practitioner with special interest care over outpatient care were 540 pound per one point gain in the dermatology life quality index and 66 pound per 10 point change in the access scale. Conclusions The general practitioner with special interest service for dermatology is more costly than hospital Outpatient care, but this additional cost needs to be weighed against improved access and broadly similar health outcomes.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ W England, Fac Hlth & Social Care, Bristol BS16 1DD, Avon, England; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol; University of Bristol; University of West England; University of Oxford; University of Bristol	Coast, J (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	j.coast@bham.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Noble, Sian/0000-0002-8011-0722; Coast, Joanna/0000-0002-3537-5166; Peters, Tim/0000-0003-2881-4180				Black M, 1997, BRIT J GEN PRACT, V47, P558; Bond M, 2000, J EPIDEMIOL COMMUN H, V54, P149, DOI 10.1136/jech.54.2.149; Bowling A, 2001, BRIT J GEN PRACT, V51, P264; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Coast J, 2000, J Health Serv Res Policy, V5, P42; Curtis L, 2004, UNIT COSTS HLTH SOCI; *DEP HLTH, 2002, IMPL SCHEM GEN PRACT; *DEP HLTH, 2004, NAT TAR 2005 6; Department of Health, 2002, REF NHS FIN FLOWS IN; Kernick DP, 2003, BRIT J GEN PRACT, V53, P553; Nocon A, 2004, DIABETIC MED, V21, P32, DOI 10.1046/j.1464-5491.2003.01063.x; Powell John, 2002, J Health Serv Res Policy, V7, P177, DOI 10.1258/135581902760082490; Rosen R, 2003, BRIT MED J, V327, P460, DOI 10.1136/bmj.327.7413.460; Salisbury C, 2005, BMJ-BRIT MED J, V331, P1441, DOI 10.1136/bmj.38670.494734.7C	14	47	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1444	1448		10.1136/bmj.38676.446910.7C	http://dx.doi.org/10.1136/bmj.38676.446910.7C			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16339217	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000234156400023
J	Phillips, RL				Phillips, RL			Primary care in the United States: problems and possibilities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FUTURE; GENERALISM; MEDICINE; SYSTEMS; HEALTH		Robert Graham Ctr, Washington, DC 20036 USA		Phillips, RL (corresponding author), Robert Graham Ctr, 1350 Connecticut Ave NW, Washington, DC 20036 USA.	bphillips@aafp.org						*AM AC FAM MED, 2004, NEW MOD PRIM CAR; *AMB CAR QUAL ALL, 2005, REC START SET CLIN P; *ASS AM MED COLL, 2005, MED STUD ED COST DEB; Bindman AB, 2003, BMJ-BRIT MED J, V326, P631, DOI 10.1136/bmj.326.7390.631; Bodenheimer T, 2003, BRIT MED J, V326, P796, DOI 10.1136/bmj.326.7393.796; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; DODOO MS, 2004, WHITE PAPER PRELIMIN; EMANUEL E, 2000, IS INEQUALITY BAD OU, P59; Ferrer RL, 2005, ANN INTERN MED, V142, P691, DOI 10.7326/0003-4819-142-8-200504190-00037; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Ginsburg PB, 2003, ANN INTERN MED, V138, P233, DOI 10.7326/0003-4819-138-3-200302040-00020; Gorey TM, 2004, ANN FAM MED, V2, pS3, DOI 10.1370/afm.130; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Green LA, 2004, PHYS WORKFORCE US FA; Larson EB, 2005, ANN INTERN MED, V142, P689, DOI 10.7326/0003-4819-142-8-200504190-00036; Larson EB, 2005, ANN INTERN MED, V142, P671, DOI 10.7326/0003-4819-142-8-200504190-00018; Leatherman S, 2000, BRIT MED J, V321, P1545, DOI 10.1136/bmj.321.7276.1545; *MED GROUP MAN ASS, 2004, PHYS COMP PROD SURV; Phillips Robert L Jr, 2005, BMJ, V330, pE357, DOI 10.1136/bmj.330.7504.E357; PORTER S, 2005, AAFP NEWS NOW   0101; RATTRAY MC, 2004, WHITE PAPER REVISITI; Sager A, 2005, HLTH COSTS ABSORB ON; Schor EL, 2003, PEDIATRICS, V111, P1541; Schwartz MD, 2005, ANN INTERN MED, V142, P715, DOI 10.7326/0003-4819-142-8-200504190-00040; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; STOVER J, 2005, AAFP NEWS NOW   1017; STRAUBE B, 2005, HLTH AFF MILWOO 1116; Whitcomb ME, 2004, NEW ENGL J MED, V351, P710, DOI 10.1056/NEJMsb045003; *WORK GROUP FIN IN, 2005, PAR PATHW QUAL HEALT	29	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1400	1402		10.1136/bmj.331.7529.1400	http://dx.doi.org/10.1136/bmj.331.7529.1400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16339255	Green Published			2022-12-28	WOS:000233999300031
J	Casey, CG; Iskander, JK; Roper, MH; Mast, EE; Wen, XJ; Torok, TJ; Chapman, LE; Swerdlow, DL; Morgan, J; Heffelfinger, JD; Vitek, C; Reef, SE; Hasbrouck, LM; Damon, I; Neff, L; Vellozzi, C; McCauley, M; Strikas, RA; Mootrey, G				Casey, CG; Iskander, JK; Roper, MH; Mast, EE; Wen, XJ; Torok, TJ; Chapman, LE; Swerdlow, DL; Morgan, J; Heffelfinger, JD; Vitek, C; Reef, SE; Hasbrouck, LM; Damon, I; Neff, L; Vellozzi, C; McCauley, M; Strikas, RA; Mootrey, G			Adverse events associated with smallpox vaccination in the United States, January-October 2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERALIZED VACCINIA; COMPLICATIONS; MYOCARDITIS; SAFETY; SURVEILLANCE; FORCE	Context On January 24, 2003, the US Department of Health and Human Services (DHHS) implemented a preparedness program in which smallpox (vaccinia) vaccine was administered to federal, state, and local volunteers who might be first responders during a bioterrorism event. Objective To describe results from the comprehensive DHHS smallpox vaccine safety monitoring and response system. Design, Setting, and Participants Descriptive study of adverse event reports from the DHHS smallpox vaccine safety monitoring and response system received between January 24 and October 31, 2003, through the Vaccine Adverse Event Reporting System (VAERS) and the Centers for Disease Control and Prevention. A total of 37 901 volunteers in 55 jurisdictions received at least 1 dose of smallpox vaccine. Main Outcome Measures Number of vaccinations administered and description of adverse events and reporting rates. Results A total of 38 885 smallpox vaccinations were administered, with a take rate of 92%. VAERS received 822 reports of adverse events following smallpox vaccination (overall reporting rate, 217 per 10 000 vaccinees). A total of 590 adverse events (72%) were reported within 14 days of vaccination. Nonserious adverse events (n=722) included multiple signs and symptoms of mild and self-limited local reactions. One hundred adverse events (12%) were designated as serious, resulting in 85 hospitalizations, 2 permanent disabilities, 10 life-threatening illnesses, and 3 deaths. Among the serious adverse events, 21 cases were classified as myocarditis and/or pericarditis and 10 as ischemic cardiac events that were not anticipated based on historical data. Two cases of generalized vaccinia and 1 case of postvaccinial encephalitis were detected. No preventable life-threatening adverse reactions, contact transmissions, or adverse reactions that required treatment with vaccinia immune globulin were identified. Serious adverse events were more common among older revaccinees than younger first-time vaccinees. Conclusions Rigorous smallpox vaccine safety screening, educational programs, and older vaccinees may have contributed to low rates of preventable life-threatening adverse reactions. Other rare, clinically significant, or unexpected cardiac adverse events were detected by timely review of VAERS data and intensive clinical case investigation.	Ctr Dis Control & Prevent, Smallpox Vaccine Adverse Event Monitoring & Respo, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis,Coordinating Ctr Infect Dis, Off Preparedness & Emergency Response, Atlanta, GA 30333 USA; Ctr Dis Control, Off Associate Director Sci, Natl Immunizat Program, Atlanta, GA 30333 USA; Logist Hlth Inc, La Crosse, WI USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Casey, CG (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Off Chief Sci Officer, Off Director, 1600 Clifton Rd,MS E-61, Atlanta, GA 30333 USA.	ccasey@cdc.gov		Santibanez, Scott/0000-0003-3505-8176				Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Baggs J, 2005, CLIN INFECT DIS, V40, P1133, DOI 10.1086/428731; Belongia EA, 2005, CLIN INFECT DIS, V40, P620, DOI 10.1086/427694; BENGTSSON ELLAS, 1957, CARDIOLOGIA, V30, P1, DOI 10.1159/000165631; Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244; CANGEMI VF, 1958, NEW ENGL J MED, V258, P1257, DOI 10.1056/NEJM195806192582507; *CDCP, SMALL POX VACC LAB T; *CDCP, CDC CLIN REG TERR EM; *CDCP, HLTH ADV SMALLP PEOP; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P475; *CDCP, CLIN INF LIN; *CDCP, IN PRESS MMWR MORB M; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P99; *CDCP, 1978, MMWR-MORBID MORTAL W, V27, P156; *CDCP, 2002, SMALL POX RESP PLAN; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P282; *CDCP, SMALL POX PREV INF P; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P492; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P386; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chen RT, 2003, LANCET, V362, P1345, DOI 10.1016/S0140-6736(03)14674-0; Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART), 1995, COD SYMB THES ADV RE; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; DOLGOPOL VB, 1955, ARCH NEURO PSYCHIATR, V73, P216, DOI 10.1001/archneurpsyc.1955.02330080094018; FEERY BJ, 1977, MED J AUSTRALIA, V2, P180, DOI 10.5694/j.1326-5377.1977.tb114544.x; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; FINLAYJONES LR, 1964, NEW ENGL J MED, V270, P41, DOI 10.1056/NEJM196401022700108; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; GERBERDING J, 2005, TRANSCRIPT CDC SMALL; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Greenberg RN, 2004, CLIN INFECT DIS, V38, P958, DOI 10.1086/382360; HELLE EPJ, 1978, ANN CLIN RES, V10, P280; *I MED NAT AC COMM, 1 I MED NAT AC COMM; ISKANDER J, 2004, PHARMACOEPIDEM DR S, V13, pS276; Jezek Z, 1988, HUMAN MONKEYPOX; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; KAYDOSDANIELS SC, 2004, 53 ANN EP INT SERV C; Klevens RM, 2005, AM J INFECT CONTROL, V33, P315, DOI 10.1016/j.ajic.2005.01.007; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Mason J W, 1999, Adv Intern Med, V44, P293; MCNALLEY MC, 1966, DIS CHEST, V49, P333, DOI 10.1378/chest.49.3.333; MEAD J, 1966, J AM GERIATR SOC, V14, P754, DOI 10.1111/j.1532-5415.1966.tb02902.x; Muralles AA, 2006, VACCINE, V24, P476, DOI 10.1016/j.vaccine.2005.07.089; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Naleway AL, 2003, ANN INTERN MED, V139, P1, DOI 10.7326/0003-4819-139-1-200307010-00006; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; NEFF JM, 1971, AM J EPIDEMIOL, V93, P245, DOI 10.1093/oxfordjournals.aje.a121254; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Sejvar J, 2005, HEADACHE, V45, P87, DOI 10.1111/j.1526-4610.2005.t01-5-05013.x; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; Sever JL, 2002, PHARMACOEPIDEM DR S, V11, P189, DOI 10.1002/pds.712; *STAT HLTH DEP, 2003, STAT HLTH DEP TRAIN; Talbot TR, 2003, JAMA-J AM MED ASSOC, V289, P3290, DOI 10.1001/jama.289.24.3290; Tasker SA, 2004, CLIN INFECT DIS, V38, P1320, DOI 10.1086/420938; Teutsch S.M., 2000, PRINCIPLES PRACTICE; *VAERS CONT ED, VACC SAF POST MARK S; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Vellozzi C, 2005, CLIN INFECT DIS, V41, P689, DOI 10.1086/432584; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; *WHO, 1980, HIST INT PUBLIC HLTH	72	127	128	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2734	2743		10.1001/jama.294.21.2734	http://dx.doi.org/10.1001/jama.294.21.2734			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333009	Bronze			2022-12-28	WOS:000233726900022
J	Gouaux, E; MacKinnon, R				Gouaux, E; MacKinnon, R			Principles of selective ion transport in channels and pumps	SCIENCE			English	Review							CLC CL-CHANNELS; SARCOPLASMIC-RETICULUM; PROKARYOTIC HOMOLOG; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CALCIUM-PUMP; NA+-ATPASE; POTASSIUM; COORDINATION; CONDUCTION	The transport of ions across the membranes of cells and organelles is a prerequisite for many of life's processes. Transport often involves very precise selectivity for specific ions. Recently, atomic-resolution structures have been determined for channels or pumps that are selective for sodium, potassium, calcium, and chloride: four of the most abundant ions in biology. From these structures we can begin to understand the principles of selective ion transport in terms of the architecture and detailed chemistry of the ion conduction pathways.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Howard Hughes Medical Institute; Rockefeller University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu; mackinn@rockefeller.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; DIETRICH B, 1985, J CHEM EDUC, V62, P954, DOI 10.1021/ed062p954; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; SNYDER EE, 1990, BIOCHEMISTRY-US, V29, P3937, DOI 10.1021/bi00468a021; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WHITE MM, 1979, J BIOL CHEM, V254, P161; WILLIAMS RJP, 1970, Q REV CHEM SOC, V24, P331, DOI 10.1039/qr9702400331; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	652	665	28	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1461	1465		10.1126/science.1113666	http://dx.doi.org/10.1126/science.1113666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322449				2022-12-28	WOS:000233756500035
J	Leroy, EM; Kumulungui, B; Pourrut, X; Rouquet, P; Hassanin, A; Yaba, P; Delicat, A; Paweska, JT; Gonzalez, JP; Swanepoel, R				Leroy, EM; Kumulungui, B; Pourrut, X; Rouquet, P; Hassanin, A; Yaba, P; Delicat, A; Paweska, JT; Gonzalez, JP; Swanepoel, R			Fruit bats as reservoirs of Ebola virus	NATURE			English	Editorial Material							DECLINE; AFRICA		Ctr Int Rech Med Franceville, Franceville, Gabon; Museum Natl Hist Nat, UMR 5202, F-75005 Paris, France; Natl Inst Communicable Dis, Special Pathogens Unit, ZA-2131 Johannesburg, South Africa; Mahidol Univ, UR178, Inst Rech Dev, Salaya 73170, Nakhonpathom, Thailand	Museum National d'Histoire Naturelle (MNHN); National Institute for Communicable Diseases (NICD); Mahidol University	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	HASSANIN, Alexandre/AAO-3327-2021; LEROY, Eric M/I-4347-2016; Hassanin, Alexandre/AAP-8634-2020; Hassanin, Alexandre/P-3329-2014; Gonzalez, J-P/C-3077-2013	LEROY, Eric M/0000-0003-0022-0890; Hassanin, Alexandre/0000-0002-4905-8540; Hassanin, Alexandre/0000-0002-4905-8540; Gonzalez, J-P/0000-0003-3063-1770				Arguin PM, 2002, EMERG INFECT DIS, V8, P258, DOI 10.3201/eid0803.010330; BERGMANS W, 1989, Beaufortia, V39, P89; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Langevin P., 1990, MAMMAL SPECIES, V357, P1; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; SANCHEZ A, 1992, J GEN VIROL, V73, P347, DOI 10.1099/0022-1317-73-2-347; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	10	964	1031	7	731	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					575	576		10.1038/438575a	http://dx.doi.org/10.1038/438575a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319873				2022-12-28	WOS:000233593100030
J	Aylward, RB; Birmingham, M				Aylward, RB; Birmingham, M			Eradicating pathogens - The human story	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland	World Health Organization	Aylward, RB (corresponding author), WHO, Dept Immunizat Vaccines & Biol, 20 Ave Appia, CH-1211 Geneva, Switzerland.	aylwardb@who.int						Aylward B, 2000, AM J PUBLIC HEALTH, V90, P1515, DOI 10.2105/AJPH.90.10.1515; Barrett S, 2004, B WORLD HEALTH ORGAN, V82, P683; Dowdle W.R., 1998, DAHL WORKSH ER INF D; Farid M. A., 1980, World Health Forum, V1, P8; HOPKINS DR, 1985, REV INFECT DIS, V7, pS338; Jezek Z, 1988, HUMAN MONKEYPOX; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; OTTESEN EA, 1998, DALHEM WORKSHOP REPO, P47; ROEDER P, 2005, BRIT MED J, V331, P1252; SOPER FL, 1965, PUBLIC HEALTH REP, V80, P855, DOI 10.2307/4592559; *WHO, 2004, EP PAND AL RESP SEV; *WHO UNAIDS, 2004, AIDS EP UPD DEC 2004; WHO (World Health Organization), 1998, B WORLD HEALTH ORGAN, V76, P1; World Health Organization, 2005, WORLD HLTH REP 2005; Yekutiel P., 1981, World Health Forum, V2, P465	15	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1261	1262		10.1136/bmj.331.7527.1261	http://dx.doi.org/10.1136/bmj.331.7527.1261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308391	Bronze, Green Published			2022-12-28	WOS:000233606800027
J	Huttelmaier, S; Zenklusen, D; Lederer, M; Dictenberg, J; Lorenz, M; Meng, XH; Bassell, GJ; Condeelis, J; Singer, RH				Huttelmaier, S; Zenklusen, D; Lederer, M; Dictenberg, J; Lorenz, M; Meng, XH; Bassell, GJ; Condeelis, J; Singer, RH			Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1	NATURE			English	Article							MESSENGER-RNA LOCALIZATION; DROSOPHILA HNRNPA/B HOMOLOG; ZIPCODE-BINDING PROTEIN; COMPLEX; TRANSPORT; VISUALIZATION; INTERPLAY; MOTILITY; DOMAINS; HRP48	Localization of beta-actin messenger RNA to sites of active actin polymerization modulates cell migration during embryogenesis, differentiation and possibly carcinogenesis(1-5). This localization requires the oncofetal protein ZBP1 (Zipcode binding protein 1), which binds to a conserved 54-nucleotide element in the 30 untranslated region of the beta-actin mRNA known as the 'zipcode'. ZBP1 promotes translocation of the beta-actin transcript to actin-rich protrusions in primary fibroblasts and neurons(6,7). It is not known how the ZBP1-RNA complex achieves asymmetric protein sorting by localizing beta-actin mRNA. Here we show that chicken ZBP1 modulates the translation of beta-actinmRNA. ZBP1 associates with the beta-actin transcript in the nucleus and prevents premature translation in the cytoplasm by blocking translation initiation. Translation only occurs when the ZBP1-RNA complex reaches its destination at the periphery of the cell. At the endpoint of mRNA transport, the protein kinase Src promotes translation by phosphorylating a key tyrosine residue in ZBP1 that is required for binding to RNA. These sequential events provide both temporal and spatial control over beta-actin mRNA translation, which is important for cell migration and neurite outgrowth.	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Univ Halle Wittenberg, Dept Med, ZAMED, D-06120 Halle An Der Saale, Germany; Yeshiva Univ Albert Einstein Coll Med, Rose Kennedy Ctr Mental Retardat, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Martin Luther University Halle Wittenberg; Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stefan.huettelmaier@medizin.uni-halle.de; rhsinger@aecom.yu.edu	Hüttelmaier, Stefan/AAQ-1203-2021; Zenklusen, Daniel/C-4503-2008	Zenklusen, Daniel/0000-0002-0067-0093				Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Eom T, 2003, J NEUROSCI, V23, P10433; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Mayer BJ, 2001, J CELL SCI, V114, P1253; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shestakova EA, 1999, CANCER RES, V59, P1202; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	25	464	473	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					512	515		10.1038/nature04115	http://dx.doi.org/10.1038/nature04115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306994				2022-12-28	WOS:000233458200053
J	Ray, JG; Vermeulen, MJ; Schull, MJ; Redelmeier, DA				Ray, JG; Vermeulen, MJ; Schull, MJ; Redelmeier, DA			Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study	LANCET			English	Article							GESTATIONAL DIABETES-MELLITUS; CORONARY-HEART-DISEASE; BODY-MASS INDEX; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; GLUCOSE-TOLERANCE; PREGNANCY COMPLICATIONS; HYPERTENSIVE DISORDERS; METABOLIC SYNDROME; NULLIPAROUS WOMEN	Background Maternal placental syndromes, including the hypertensive disorders of pregnancy and abruption or infarction of the placenta, probably originate from diseased placental vessels. The syndromes arise most often in women who have metabolic risk factors for cardiovascular disease, including obesity, pre-pregnancy hypertension, diabetes mellitus, and dyslipidaemia. Our aim was to assess the risk of premature vascular disease in women who had had a pregnancy affected by maternal placental syndromes. Methods We did a population-based retrospective cohort study in Ontario, Canada, of 1.03 million women who were free from cardiovascular disease before their first documented delivery. We defined the following as maternal placental syndromes: pre-eclampsia, gestational hypertension, placental abruption, and placental infarction. Our primary endpoint was a composite of cardiovascular disease, defined as hospital admission or revascularisation for coronary artery, cerebrovascular, or peripheral artery disease at least 90 days after the delivery discharge date. Findings The mean (SD) age of participants was 28.2 (5.5) years at the index delivery, and 75 380 (7%) women were diagnosed with a maternal placental syndrome. The incidence of cardiovascular disease was 500 per million person-years in women who had had a maternal placental syndrome compared with 200 per million in women who had not (adjusted hazard ratio [HR] 2.0, 95 CI 1.7-2.2). This risk was higher in the combined presence of a maternal placental syndrome and poor fetal growth (3.1, 2.2-4.5) or a maternal placental syndrome and intrauterine fetal death (4.4, 2.4-7.9), relative to neither. Interpretation The risk of premature cardiovascular disease is higher after a maternal placental syndrome, especially in the presence of fetal compromise. Affected women should have their blood pressure and weight assessed about 6 months postpartum, and a healthy lifestyle should be emphasised.	Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; Univ Toronto, Inst Clin Evaluat Sci, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Univ Toronto, Inst Clin Evaluat Sci, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	rayj@smh.toronto.on.ca	Schull, Michael J/A-7955-2013	Schull, Michael J/0000-0002-1318-6364				Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Cetin I, 2004, PLACENTA, V25, P753, DOI 10.1016/j.placenta.2004.02.004; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COUSTAN DR, 1993, AM J OBSTET GYNECOL, V168, P1139, DOI 10.1016/0002-9378(93)90358-P; DAMM P, 1992, AM J OBSTET GYNECOL, V167, P607, DOI 10.1016/S0002-9378(11)91559-2; Forest JC, 2005, OBSTET GYNECOL, V105, P1373, DOI 10.1097/01.AOG.0000163252.02227.f8; Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Graves JW, 2001, BLOOD PRESS MONIT, V6, P17, DOI 10.1097/00126097-200102000-00003; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Innes KE, 2001, OBSTET GYNECOL, V97, P905, DOI 10.1016/S0029-7844(01)01342-4; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jaffe R, 2001, Early Pregnancy, V5, P34; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Jomini V, 2002, J AM COLL CARDIOL, V40, P676, DOI 10.1016/S0735-1097(02)02017-X; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Katz David L, 2003, Public Health Rev, V31, P33; Kennedy CC, 2003, CAN J CARDIOL, V19, P655; Kestenbaum B, 2003, AM J KIDNEY DIS, V42, P982, DOI 10.1016/j.ajkd.2003.07.001; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; McCrindle B W, 2001, Adolesc Med, V12, P147; MCNICOLL S, 1995, CAN J CARDIOL, V11, P109; Norman RJ, 2001, HUM REPROD, V16, P1995, DOI 10.1093/humrep/16.9.1995; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Peters RK, 1996, LANCET, V347, P227, DOI 10.1016/S0140-6736(96)90405-5; Ray JG, 2004, FETAL MATERN MED REV, V15, P1; RAY JG, IN PRESS BR J OBSTET; Redman C W, 2001, Gynecol Obstet Fertil, V29, P518, DOI 10.1016/S1297-9589(01)00180-1; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Ros H, 2001, PREECLAMPSIA OTHER C; ROSSO S, 2001, EPIDEMIOL PREV S, V25, P1; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZEEK PM, 1950, AM J CLIN PATHOL, V20, P1099	41	650	668	2	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1797	1803		10.1016/S0140-6736(05)67726-4	http://dx.doi.org/10.1016/S0140-6736(05)67726-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298217				2022-12-28	WOS:000233517200024
J	Timmins, N				Timmins, N			The NHS revolution: health care in the market place - Challenges of private provision in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London SE1 9HL, England		Timmins, N (corresponding author), Financial Times, London SE1 9HL, England.	Nick.Timmins@FT.com						HEWITT P, 2005, ORAL EVIDENCE HOUSE; *NAT PAT SAF AG, 2005, BUILD MEM; TIMINS N, 2004, FINANCIAL TIMES 1221; TIMMINS N, 2004, FINANCIAL TIMES 1213; TIMMINS N, 2004, FINANCIAL TIMES 0626; TIMMINS N, 2004, FINANCIAL TIMES 0531; TIMMINS N, 2005, FINANCIAL TIMES 1021; TIMMINS N, 2005, FINANCIAL TIMES 0609; TIMMINS N, 2005, FINANCIAL TIMES 0616; TIMMINS N, 2005, FINANCIAL TIMES 0110; TIMMINS N, 2005, FINANCIAL TIMES 0926; TIMMINS N, 2005, FINANCIAL TIMES 0317; TIMMINS N, 2004, FINANCIAL TIMES 0422; TIMMINS N, 2004, FINANCIAL TIMES 0702	14	12	12	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1193	1195		10.1136/bmj.331.7526.1193	http://dx.doi.org/10.1136/bmj.331.7526.1193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988DG	16293843	Green Published			2022-12-28	WOS:000233571000025
J	Tassabehji, M; Hammond, P; Karmiloff-Smith, A; Thompson, P; Thorgeirsson, SS; Durkin, ME; Popescu, NC; Hutton, T; Metcalfe, K; Rucka, A; Stewart, H; Read, AP; Maconochie, M; Donnai, D				Tassabehji, M; Hammond, P; Karmiloff-Smith, A; Thompson, P; Thorgeirsson, SS; Durkin, ME; Popescu, NC; Hutton, T; Metcalfe, K; Rucka, A; Stewart, H; Read, AP; Maconochie, M; Donnai, D			GTF2IRD1 in craniofacial development of humans and mice	SCIENCE			English	Article							WILLIAMS-BEUREN-SYNDROME; TFII-I FAMILY; TRANSCRIPTION FACTORS; GENE-EXPRESSION; BINDING PROTEIN; DELETION; MEMBER; HEMIZYGOSITY; ENHANCER; BEN	Craniofacial abnormalities account for about one-third of all human congenital defects, but our understanding of the genetic mechanisms governing craniofacial development is incomplete. We show that GTF2/RD1 is a genetic determinant of mammalian craniofacial and cognitive development, and we implicate another member of the TFII-I transcription factor family, GTF2I, in both aspects. Gtf2ird1-null mice exhibit phenotypic abnormalities reminiscent of the human microdeletion disorder Williams-Beuren syndrome (WBS); craniofacial imaging reveals abnormalities in both skull and jaws that may arise through misregulation of goosecoid, a downstream target of Gtf2ird1. In humans, a rare WBS individual with an atypical deletion, including GTF2IRD1, shows facial dysmorphism and cognitive deficits that differ from those of classic WBS cases. We propose a mechanism of cumulative dosage effects of duplicated and diverged genes applicable to other human chromosomal disorders.	Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 9PL, Lancs, England; UCL, Eastman Dent Inst, London WC1E 6BT, England; UCL, Inst Child Hlth, London WC1E 6BT, England; NCI, Bethesda, MD 20892 USA; Churchill Hosp, Oxford OX3 7LJ, England; Univ Sussex, Sch Life Sci, Brighton BN1 9RH, E Sussex, England	University of Manchester; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Sussex	Tassabehji, M (corresponding author), Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 9PL, Lancs, England.	m.tassabehji@manchester.ac.uk	Karmiloff-Smith, Annette/N-4535-2014	Karmiloff-Smith, Annette/0000-0002-2470-5609; Thompson, Pamela/0000-0002-2660-6348	Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010038, ZIABC010038] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Botta A, 1999, J MED GENET, V36, P478; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Durkin ME, 2001, GENOMICS, V73, P20, DOI 10.1006/geno.2001.6507; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; HAMMOND P, IN PRESS AM J HUM GE; Heller R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e99; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174	26	151	158	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1184	1187		10.1126/science.1116142	http://dx.doi.org/10.1126/science.1116142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293761				2022-12-28	WOS:000233437300045
J	Edwards, N				Edwards, N			Using markets to reform health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY; COMPETITION; NHS		NHS Confederat, London SW1E 5ER, England		Edwards, N (corresponding author), NHS Confederat, London SW1E 5ER, England.	nigel.edwards@nhsconfed.org						Bodenheimer T, 2000, BRIT MED J, V320, P563, DOI 10.1136/bmj.320.7234.563; COOKSON R, IN PRESS ELGAR COMPA; DIXON A, 2003, 11 LOND SCH EC; DIXON J, 2003, CAN MARKET FORCES US; ENTHOVEN AC, 2005, HLTH AFF        0907; Freeman G., 2001, CONTINUITY CARE; FREY N, 1997, NOT JUST MONEY EC TH; GINGRICH NA, 2005, WASHINGTON POST 1112, pA25; Le Grand J, 1999, HEALTH AFFAIR, V18, P27, DOI 10.1377/hlthaff.18.3.27; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Marshall M, 2005, QUAL SAF HEALTH CARE, V14, P4, DOI 10.1136/qshc.2004.013193; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McKee M, 2004, CLIN MED, V4, P336, DOI 10.7861/clinmedicine.4-4-336; Propper C, 2004, J PUBLIC ECON, V88, P1247, DOI 10.1016/S0047-2727(02)00216-5; PROPPER C, 2005, EXTENDING CHOICE ENG; Schers H, 2005, FAM PRACT, V22, P15, DOI 10.1093/fampra/cmh721; Schers H, 2002, BRIT J GEN PRACT, V52, P459; Tarrant C, 2003, BRIT MED J, V326, P1310, DOI 10.1136/bmj.326.7402.1310; Timmins N, 2005, BRIT MED J, V331, P1193, DOI 10.1136/bmj.331.7526.1193; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239	20	8	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1464	1466		10.1136/bmj.331.7530.1464	http://dx.doi.org/10.1136/bmj.331.7530.1464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EE	16356985	Green Published			2022-12-28	WOS:000234156400030
J	Berger, E; Price, PA; Cenko, SB; Gal-Yam, A; Soderberg, M; Kasliwal, M; Leonard, DC; Cameron, PB; Frail, DA; Kulkarni, SR; Murphy, DC; Krzeminski, W; Piran, T; Lee, BL; Roth, KC; Moon, DS; Fox, DB; Harrison, FA; Persson, SE; Schmidt, BP; Penprase, BE; Rich, J; Peterson, BA; Cowie, LL				Berger, E; Price, PA; Cenko, SB; Gal-Yam, A; Soderberg, M; Kasliwal, M; Leonard, DC; Cameron, PB; Frail, DA; Kulkarni, SR; Murphy, DC; Krzeminski, W; Piran, T; Lee, BL; Roth, KC; Moon, DS; Fox, DB; Harrison, FA; Persson, SE; Schmidt, BP; Penprase, BE; Rich, J; Peterson, BA; Cowie, LL			The afterglow and elliptical host galaxy of the short gamma-ray burst GRB 050724	NATURE			English	Article							ENERGY RESERVOIR; FORMATION RATES; LUMINOSITY	Despite a rich phenomenology, gamma-ray bursts (GRBs) are divided(1) into two classes based on their duration and spectral hardness the long-soft and the short-hard bursts. The discovery of afterglow emission from long GRBs was a watershed event, pinpointing(2) their origin to star-forming galaxies, and hence the death of massive stars, and indicating(3) an energy release of about 10(51) erg. While theoretical arguments(4) suggest that short GRBs are produced in the coalescence of binary compact objects ( neutron stars or black holes), the progenitors, energetics and environments of these events remain elusive despite recent(5-8) localizations. Here we report the discovery of the first radio afterglow from the short burst GRB 050724, which unambiguously associates it with an elliptical galaxy at a redshift(9) z = 0.257. We show that the burst is powered by the same relativistic fireball mechanism as long GRBs, with the ejecta possibly collimated in jets, but that the total energy release is 10 - 1,000 times smaller. More importantly, the nature of the host galaxy demonstrates that short GRBs arise from an old (> 1 Gyr) stellar population, strengthening earlier suggestions(5,6) and providing support for coalescing compact object binaries as the progenitors.	Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Observ Carnegie Inst Washington, Observ Las Campanas, La Serena, Chile; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada; Gemini Observ, Hilo, HI 96720 USA; Australian Natl Univ, Mt Stromlo Observ, RSAA, Weston, ACT 2611, Australia; Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA	Carnegie Institution for Science; University of Hawaii System; California Institute of Technology; National Radio Astronomy Observatory (NRAO); Carnegie Institution for Science; Hebrew University of Jerusalem; University of Toronto; Australian National University; Claremont Colleges; Pomona College	Berger, E (corresponding author), Carnegie Inst Washington Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.	eberger@ociw.edu		Schmidt, Brian/0000-0001-6589-1287				BARRIS BJ, 2005, ARXIVORGASTROPH05075; Berger E, 2003, ASTROPHYS J, V590, P379, DOI 10.1086/374892; Bloom JS, 2002, ASTRON J, V123, P1111, DOI 10.1086/338893; BLOOM JS, 2005, 3679 GCN; BLOOM JS, 2005, ARXIVORGASTROPH05054; BURROWS DN, 2005, 3697 GCN; Christensen L, 2004, ASTRON ASTROPHYS, V425, P913, DOI 10.1051/0004-6361:20040361; Cole S, 2001, MON NOT R ASTRON SOC, V326, P255, DOI 10.1046/j.1365-8711.2001.04591.x; DAVANZO P, 2005, 3690 GCN; DRESSLER A, 1983, ASTROPHYS J, V270, P7, DOI 10.1086/161093; Fox DB, 2005, NATURE, V437, P845, DOI 10.1038/nature04189; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Freedman DL, 2001, ASTROPHYS J, V547, P922, DOI 10.1086/318386; Fryer CL, 1999, ASTROPHYS J, V526, P152, DOI 10.1086/307992; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Granot J, 2002, ASTROPHYS J, V568, P820, DOI 10.1086/338966; Guetta D, 2005, ASTRON ASTROPHYS, V435, P421, DOI 10.1051/0004-6361:20041702; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; Katz JI, 1996, ASTROPHYS J, V471, P915, DOI 10.1086/178018; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; KRIMM H, 2005, 3667 GCN; Lithwick Y, 2001, ASTROPHYS J, V555, P540, DOI 10.1086/321455; Pian E, 1998, ASTROPHYS J, V492, pL103, DOI 10.1086/311101; PRICE PA, 2005, 3605 GCN; Sari R, 1999, ASTROPHYS J, V519, pL17, DOI 10.1086/312109; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; VANDENBERGH S, 1990, PUBL ASTRON SOC PAC, V102, P1318, DOI 10.1086/132766; [No title captured]; [No title captured]	29	320	324	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					988	990		10.1038/nature04238	http://dx.doi.org/10.1038/nature04238			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355217	Green Submitted			2022-12-28	WOS:000233934600059
J	Morrow, DA; de Lemos, JA; Blazing, MA; Sabatine, MS; Murphy, SA; Jarolim, P; White, HD; Fox, KAA; Califf, RM; Braunwald, E				Morrow, DA; de Lemos, JA; Blazing, MA; Sabatine, MS; Murphy, SA; Jarolim, P; White, HD; Fox, KAA; Califf, RM; Braunwald, E		AZ Investigators	Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; N-TERMINAL PROATRIAL; TO-Z TRIAL; HEART-FAILURE; RISK STRATIFICATION; STRATEGY; DYSFUNCTION; PREDICTION; INHIBITOR	Context Elevated concentrations of B-type natriuretic peptide (BNP) at presentation in patients with acute coronary syndrome (ACS) are associated with long-term mortality. Few data exist regarding serial assessment of BNP levels during follow-up. Objective To determine whether concentrations of BNP at study entry (prior to hospital discharge for ACS) and at outpatient follow-up at 4 months and 12 months are associated with subsequent clinical outcomes. Design, Setting, and Patients Prospective observational substudy of 4497 patients with non-ST-elevation or ST-elevation ACS who were enrolled in phase Z of the A to Z trial, which was conducted in 41 countries at 322 acute care hospitals between 1999 and 2003. Main Outcome Measure Death from any cause or new onset of congestive heart failure (CHF) through 2 years. Results Levels of BNP were available in 4266 patients at study entry (prior to hospital discharge), 3618 patients at 4 months, and 2966 patients at 12 months. During follow-up there were 230 deaths and 163 incident cases of CHF. Adjusting for age, sex, index event, renal function, hypertension, prior heart failure, and diabetes, elevated levels of BNP (>80 pg/mL) were associated with subsequent death or new CHF when measured at study entry (111 [21%] vs 246 [7%]; adjusted hazard ratio [HR], 2.5; 95% confidence interval [CI], 2.0-3.3), at 4 months (34 [19%] vs 125 [4%]; adjusted HR, 3.9; 95% Cl, 2.6-6.0), and at 12 months (19 [11%] vs 37 [11%]; adjusted HR, 4.7; 95% Cl, 2.5-8.9). Patients with newly elevated levels of BNP at 4 months were at increased risk of death or new CHF (10 [15%] vs 105 [3%]); HR, 4.5; 95% Cl, 2.3-8.6). Patients with, elevated levels of BNP at study entry and with BNP levels lower than 80 pg/mL at 4 months tended to have only modestly increased risk (HR, 1.7; 95% Cl, 1.0-2.9) compared with patients with BNP levels lower than 80 pg/mL at both visits. Conclusions Serial determinations of BNP levels during outpatient follow-up after ACS predict the risk of death or new CHF. Changes in BNP levels over time are associated with long-term clinical outcomes and may provide a basis for enhanced clinical decision making in patients after onset of ACS. Clinical Trials Registration ClinicalTrials.gov Identifier: NCT00251576.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Auckland City Hosp, Green Lane Cardiovasc Res Unit, Auckland, New Zealand; Royal Infirm, Edinburgh, Midlothian, Scotland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Duke University; Auckland City Hospital; Royal Infirmary of Edinburgh	Morrow, DA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	dmorrow@partners.org	de Lemos, James/ABD-6669-2021; Sabatine, Marc/AAJ-6751-2020; Fox, keith A A/I-3742-2013	Sabatine, Marc/0000-0002-0691-3359; Fox, Keith/0000-0002-0140-2752				ARAKAWA N, 1994, CARDIOLOGY, V85, P334, DOI 10.1159/000176706; Arakawa N, 1996, J AM COLL CARDIOL, V27, P1656, DOI 10.1016/0735-1097(96)00067-8; Blazing MA, 2001, AM HEART J, V142, P211, DOI 10.1067/mhj.2001.116959; *COMM LAB MED PRAC, NAT AC CLIN BIOCH LA; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Heeschen C, 2004, CIRCULATION, V110, P3206, DOI 10.1161/01.CIR.0000147611.92021.2B; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Jernberg T, 2003, J AM COLL CARDIOL, V42, P1909, DOI 10.1016/j.jacc.2003.07.015; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lindahl B, 2005, J AM COLL CARDIOL, V45, P533, DOI 10.1016/j.jacc.2004.10.057; Mair J, 2001, CLIN CHEM LAB MED, V39, P571, DOI 10.1515/CCLM.2001.093; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; MOTWANI JG, 1993, LANCET, V341, P1109, DOI 10.1016/0140-6736(93)93126-L; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Richards AM, 1999, CIRCULATION, V99, P786, DOI 10.1161/01.CIR.99.6.786; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Silver Marc A, 2004, Congest Heart Fail, V10, P1, DOI 10.1111/j.1527-5299.2004.03271.x; Talwar S, 2000, EUR HEART J, V21, P1514, DOI 10.1053/euhj.1999.2045; Wu AHB, 2004, CLIN CHEM, V50, P867, DOI 10.1373/clinchem.2003.026138; Yusuf S, 2000, NEW ENGL J MED, V342, P145	30	172	189	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2866	2871		10.1001/jama.294.22.2866	http://dx.doi.org/10.1001/jama.294.22.2866			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352794	Bronze			2022-12-28	WOS:000233826700027
J	Bird, MK; Allison, M; Asmar, SW; Atkinson, DH; Avruch, IM; Dutta-Roy, R; Dzierma, Y; Edenhofer, P; Folkner, WM; Gurvits, LI; Johnston, DV; Plettemeier, D; Pogrebenko, SV; Preston, RA; Tyler, GL				Bird, MK; Allison, M; Asmar, SW; Atkinson, DH; Avruch, IM; Dutta-Roy, R; Dzierma, Y; Edenhofer, P; Folkner, WM; Gurvits, LI; Johnston, DV; Plettemeier, D; Pogrebenko, SV; Preston, RA; Tyler, GL			The vertical profile of winds on Titan	NATURE			English	Article							GENERAL-CIRCULATION; RADIO SCIENCE; SATURN SYSTEM; ATMOSPHERE; SUPERROTATION; TEMPERATURES; OCCULTATION; VOYAGER-1; DYNAMICS; VENUS	One of Titan's most intriguing attributes is its copious but featureless atmosphere. The Voyager 1 fly-by and occultation in 1980 provided the first radial survey of Titan's atmospheric pressure and temperature(1,2) and evidence for the presence of strong zonal winds(3). It was realized that the motion of an atmospheric probe could be used to study the winds, which led to the inclusion of the Doppler Wind Experiment(4) on the Huygens probe(5). Here we report a high resolution vertical profile of Titan's winds, with an estimated accuracy of better than 1 m s(-1). The zonal winds were prograde during most of the atmospheric descent, providing in situ confirmation of superrotation on Titan. A layer with surprisingly slow wind, where the velocity decreased to near zero, was detected at altitudes between 60 and 100 km. Generally weak winds (similar to 1 m s(-1)) were seen in the lowest 5 km of descent.	Univ Bonn, Inst Radioastron, D-53125 Bonn, Germany; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Idaho, Dept Elect & Comp Engn, Moscow, ID 83844 USA; Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands; Ruhr Univ Bochum, Inst HF Tech, D-44780 Bochum, Germany; Tech Univ Dresden, Elektrotech Inst, D-01062 Dresden, Germany; Stanford Univ, Ctr Radar Astron, Stanford, CA 94305 USA	University of Bonn; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Idaho; University of Idaho; Ruhr University Bochum; Technische Universitat Dresden; Stanford University	Bird, MK (corresponding author), Univ Bonn, Inst Radioastron, Auf Hugel 71, D-53125 Bonn, Germany.	mbird@astro.uni-bonn.de		Gurvits, Leonid/0000-0002-0694-2459				ALLISON M, 1994, J ATMOS SCI, V51, P694, DOI 10.1175/1520-0469(1994)051<0694:ZPVEFT>2.0.CO;2; ALLISON M, 1992, ESA, P113; ATKINSON DH, 1990, RADIO SCI, V25, P865, DOI 10.1029/RS025i005p00865; Bird MK, 2002, SPACE SCI REV, V104, P613, DOI 10.1023/A:1023683004351; BOUCHEZ AH, 2003, THESIS CALTECH; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Counselman CC, 1980, J GEOPHYS RES-SPACE, V85, P8026, DOI 10.1029/JA085iA13p08026; DelGenio AD, 1996, ICARUS, V120, P332, DOI 10.1006/icar.1996.0054; DELGENIO AD, 1993, ICARUS, V101, P1, DOI 10.1006/icar.1993.1001; DUTTAROY R, 2004, ESA, P109; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; FLASAR FM, 1997, ESA SP PUBL, V1177, P287; FLASAR FM, 1992, ESA SP, V338, P89; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; HUBBARD WB, 1993, ASTRON ASTROPHYS, V269, P541; Kliore AJ, 2004, SPACE SCI REV, V115, P1, DOI 10.1007/s11214-004-1436-y; Kostiuk T, 2001, GEOPHYS RES LETT, V28, P2361, DOI 10.1029/2000GL012617; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Luz D, 2003, ICARUS, V166, P343, DOI 10.1016/j.icarus.2003.08.014; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tokano T, 1999, PLANET SPACE SCI, V47, P493, DOI 10.1016/S0032-0633(99)00011-2; TYLER GL, 1981, SCIENCE, V212, P201, DOI 10.1126/science.212.4491.201	25	148	149	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					800	802		10.1038/nature04060	http://dx.doi.org/10.1038/nature04060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319831				2022-12-28	WOS:000233777800042
J	Jambou, R; Legrand, E; Niang, M; Khim, N; Lim, P; Volney, B; Ekala, MT; Bouchier, C; Esterre, P; Fandeur, T; Mercereau-Puijalon, O				Jambou, R; Legrand, E; Niang, M; Khim, N; Lim, P; Volney, B; Ekala, MT; Bouchier, C; Esterre, P; Fandeur, T; Mercereau-Puijalon, O			Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6	LANCET			English	Article							SUSCEPTIBILITY; CHLOROQUINE; ARTESUNATE; GENE	Artemisinin derivatives are an essential component of treatment against multidrug-resistant Plasmodium falciparum malaria. We aimed to investigate in-vitro resistance to arternisinin derivatives in field isolates. In-vitro susceptibility of 530 P faliciparum isolates from three countries (Cambodia, French Guiana, and Senegal) with different arternisinin use was assessed with an isotopic microtest. Artemether IC50 up to 117 and 45 nmol/L was seen in French Guiana and Senegal, respectively. DNA sequencing in a subsample of 60 isolates lends support to SERCA-PfATPase6 as the target for artemisinins. The S769N PfATPase6 mutation, noted exclusively in French Guiana, was associated with raised (>30 nmol/L) artemether IC(50)s (p<0.0001, Mann-Whitney). All resistant isolates came from areas with uncontrolled use of arternisinin derivatives. This rise in resistance indicates the need for increased vigilance and a coordinated and rapid deployment of drug combinations.	Inst Pasteur, Unite Immunol, Dakar, Senegal; Inst Pasteur, Ctr Natl Reference Chimioresistance Paludisme Ant, Cayenne, French Guiana; Inst Pasteur Cambodge, Lab Epidemiol Mol, Phnom Penh, Cambodia; Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France; Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jambou, R (corresponding author), Inst Pasteur, Unite Immunol, 36 Ave Pasteur,POB 220, Dakar, Senegal.	rjambou@pasteur.sn	JAMBOU, RONAN/CAG-3718-2022; Mercereau-Puijalon, Odile/AAA-2242-2020; Hua, QX/HGE-3640-2022; Lim, Pharath/AAF-6699-2020	Legrand, Eric/0000-0003-4725-0712; Lim, Pharath/0000-0002-1012-2461				Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Ferrer-Rodriguez I, 2004, J PARASITOL, V90, P152, DOI 10.1645/GE-3225; KIMURA M, 1993, J CELL SCI, V104, P1129; Lim P, 2005, ACTA TROP, V93, P31, DOI 10.1016/j.actatropica.2004.09.002; Ringwald P, 1999, AM J TROP MED HYG, V61, P187, DOI 10.4269/ajtmh.1999.61.187; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200	9	372	388	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1960	1963		10.1016/S0140-6736(05)67787-2	http://dx.doi.org/10.1016/S0140-6736(05)67787-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325698				2022-12-28	WOS:000233777900024
J	Judge, DP; Dietz, HC				Judge, DP; Dietz, HC			Marfan's syndrome	LANCET			English	Review							THORACIC AORTIC-ANEURYSMS; WEILL-MARCHESANI-SYNDROME; MOLECULAR-WEIGHT HEPARIN; PROSTHETIC HEART-VALVES; PECTUS-EXCAVATUM; DURAL ECTASIA; PULMONARY-FUNCTION; FETAL COMPLICATIONS; CONNECTIVE-TISSUE; ROOT REPLACEMENT	Marfan's syndrome is a systemic disorder of connective tissue caused by mutations in the extracellular matrix protein fibrillin 1. Cardinal manifestations include proximal aortic aneurysm, dislocation of the ocular lens, and long-bone overgrowth. important advances have been made in the diagnosis and medical and surgical care of affected individuals, yet substantial morbidity and premature mortality remain associated with this disorder. Progress has been made with genetically defined mouse models to elucidate the pathogenetic sequence that is initiated by fibrillin-1 deficiency. The new understanding is that many aspects of the disease are caused by altered regulation of transforming growth factor beta (TGF beta), a family of cytokines that affect cellular performance, highlighting the potential therapeutic application of TGF beta antagonists. Insights derived from studying this mendelian disorder are anticipated to have relevance for more common and non-syndromic presentations of selected aspects of the Marfan phenotype.	Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	hdietz@jhmi.edu		Judge, Daniel/0000-0002-3407-0248	NHLBI NIH HHS [K08 HL067056] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067056] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ageno Walter, 2004, Expert Opin Drug Saf, V3, P113, DOI 10.1517/14740338.3.2.113; ARN PH, 1989, J PEDIATR-US, V115, P954, DOI 10.1016/S0022-3476(89)80749-8; Bachet J, 1996, EUR J CARDIO-THORAC, V10, P207, DOI 10.1016/S1010-7940(96)80298-3; Bawazir OA, 2005, J PEDIATR SURG, V40, P863, DOI 10.1016/j.jpedsurg.2005.02.002; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BENTALL H, 1968, THORAX, V23, P338, DOI 10.1136/thx.23.4.338; Bethea BT, 2004, ANN THORAC SURG, V78, P767, DOI 10.1016/j.athoracsur.2004.03.040; Biery NJ, 1999, GENOMICS, V56, P70, DOI 10.1006/geno.1998.5697; Birks EJ, 1999, CIRCULATION, V100, P29; Borowitz D, 2003, J PEDIATR SURG, V38, P544, DOI 10.1053/jpsu.2003.50118; Braverman AC, 1998, MED SCI SPORT EXER, V30, pS387, DOI 10.1097/00005768-199810001-00007; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; CHEN SC, 1985, AM J DIS CHILD, V139, P273, DOI 10.1001/archpedi.1985.02140050067024; COHEN PR, 1989, INT J DERMATOL, V28, P291, DOI 10.1111/j.1365-4362.1989.tb01347.x; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; DAVID TE, 1992, J THORAC CARDIOV SUR, V103, P617; Davies RR, 2002, ANN THORAC SURG, V73, P17, DOI 10.1016/S0003-4975(01)03236-2; de Oliveira NC, 2003, J THORAC CARDIOV SUR, V125, P789, DOI 10.1067/mtc.2003.57; De Paulis R, 2002, J THORAC CARDIOV SUR, V123, P33, DOI 10.1067/mtc.2002.119066; DEBAKEY ME, 1965, J THORAC CARDIOV SUR, V49, P130, DOI 10.1016/S0022-5223(19)33323-9; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELDADAH ZA, 1995, NAT MED, V1, P798, DOI 10.1038/nm0895-798; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fattori R, 1999, LANCET, V354, P910, DOI 10.1016/S0140-6736(98)12448-0; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; FURLONG J, 1987, AM J MED GENET, V26, P599, DOI 10.1002/ajmg.1320260314; GALE AN, 1977, CHEST, V72, P668, DOI 10.1378/chest.72.5.668; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; Gott VL, 1999, NEW ENGL J MED, V340, P1307, DOI 10.1056/NEJM199904293401702; Gott VL, 2002, ANN THORAC SURG, V73, P438, DOI 10.1016/S0003-4975(01)03336-7; GRAY JR, 1994, J MED GENET, V31, P51, DOI 10.1136/jmg.31.1.51; Greally MT, 1998, AM J MED GENET, V76, P202, DOI 10.1002/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S; Guo DC, 2001, CIRCULATION, V103, P2461; Haller JA, 1996, ANN THORAC SURG, V61, P1618, DOI 10.1016/0003-4975(96)00179-8; Halliday D, 1999, HUM GENET, V105, P587, DOI 10.1007/s004390051150; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; HALPERN BL, 1971, JOHNS HOPKINS MED J, V129, P123; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Jones KB, 2002, SPINE, V27, P2003, DOI 10.1097/00007632-200209150-00008; Jones KB, 2005, SPINE, V30, P291, DOI 10.1097/01.brs.0000152166.88174.1c; JOSEPH KN, 1992, CLIN ORTHOP RELAT R, P251; Judge DP, 2001, AM J MED GENET, V99, P39, DOI 10.1002/1096-8628(20010215)99:1<39::AID-AJMG1114>3.0.CO;2-3; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; KAINULAINEN K, 1991, AM J HUM GENET, V49, P662; Kinoshita N, 2000, AM HEART J, V139, P723, DOI 10.1016/S0002-8703(00)90055-3; Lawson ML, 2005, J PEDIATR SURG, V40, P174, DOI 10.1016/j.jpedsurg.2004.09.040; Lev-Ran O, 2000, ANN THORAC SURG, V69, P264, DOI 10.1016/S0003-4975(99)00874-7; Loewenstein A, 2000, RETINA-J RET VIT DIS, V20, P358, DOI 10.1097/00006982-200007000-00006; Loeys B, 2004, HUM MUTAT, V24, P140, DOI 10.1002/humu.20070; Loeys B, 2001, ARCH INTERN MED, V161, P2447, DOI 10.1001/archinte.161.20.2447; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; Marfan AB, 1896, B MEM SOC MED HOP P, V13, P220; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; Marr JE, 2001, EYE, V15, P70, DOI 10.1038/eye.2001.17; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Meijboom LJ, 2005, EUR HEART J, V26, P914, DOI 10.1093/eurheartj/ehi103; Meijboom LJ, 2005, AM J CARDIOL, V95, P795, DOI 10.1016/j.amjcard.2004.11.042; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; NUSS D, J PEDIAT SURG, V33, P545; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; PEREIRA L, 1993, HUM MOL GENET, V2, P1762, DOI 10.1093/hmg/2.10.1762; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PYERITZ RE, 1988, AM J HUM GENET, V43, P726; PYERITZ RE, 1981, AM J MED, V71, P784, DOI 10.1016/0002-9343(81)90365-X; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; Quigley PM, 1996, J PEDIATR-US, V128, P638, DOI 10.1016/S0022-3476(96)80128-4; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Roberts N, 2001, BRIT J OBSTET GYNAEC, V108, P327; ROBERTS WC, 1982, AM HEART J, V104, P115, DOI 10.1016/0002-8703(82)90650-0; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Rossi-Foulkes R, 1999, AM J CARDIOL, V83, P1364, DOI 10.1016/S0002-9149(99)00101-0; ROSSITER JP, 1995, AM J OBSTET GYNECOL, V173, P1599, DOI 10.1016/0002-9378(95)90655-X; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SALIM MA, 1994, AM J CARDIOL, V74, P629, DOI 10.1016/0002-9149(94)90762-5; SARSAM MAI, 1993, J THORAC CARDIOV SUR, V105, P435; Savolainen A, 1997, J INTERN MED, V241, P221; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; SISK HE, 1983, AM J CARDIOL, V52, P353, DOI 10.1016/0002-9149(83)90138-8; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; STREETEN EA, 1987, CHEST, V91, P408, DOI 10.1378/chest.91.3.408; TAKEBAYASHI S, 1973, ACTA PATHOL JAPON, V23, P847; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; TSUJI T, 1986, J CUTAN PATHOL, V13, P144, DOI 10.1111/j.1600-0560.1986.tb01515.x; Vaughan CJ, 2001, CIRCULATION, V103, P2469; Villeirs GM, 1999, NEURORADIOLOGY, V41, P850, DOI 10.1007/s002340050856; Vitale N, 1999, J AM COLL CARDIOL, V33, P1637, DOI 10.1016/S0735-1097(99)00044-3; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032	109	693	720	5	172	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1965	1976		10.1016/S0140-6736(05)67789-6	http://dx.doi.org/10.1016/S0140-6736(05)67789-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325700	Green Accepted			2022-12-28	WOS:000233777900026
J	Smith, A				Smith, A			The battlefield of pluripotency	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION	How embryonic stem cells maintain the potential to differentiate into multiple cell lineages is still unclear. In this issue of Cell, Niwa et al. (2005) show that a duel between the transcription factors Oct3/4 and Cdx2 can restrict embryonic stem cells to either embryonic or placental fate. The vulnerability of lineage potential to transcriptional perturbation may reflect an essential feature of pluripotency.	Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Cambridge, Inst Stem Cell Biol, Cambridge CB2 1TN, England	University of Edinburgh; University of Cambridge	Smith, A (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	austin.smith@ed.ac.uk		Smith, Austin/0000-0002-3029-4682				Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 2005, CELL; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399	10	26	27	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					757	760		10.1016/j.cell.2005.11.012	http://dx.doi.org/10.1016/j.cell.2005.11.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325569	Bronze			2022-12-28	WOS:000233814100008
J	Vong, QP; Cao, K; Li, HY; Iglesias, PA; Zheng, YX				Vong, QP; Cao, K; Li, HY; Iglesias, PA; Zheng, YX			Chromosome alignment and segregation regulated by ubiquitination of survivin	SCIENCE			English	Article							DROSOPHILA-FAT-FACETS; AURORA-B; DEUBIQUITINATING ENZYME; GENE; SUBSTRATE; SEQUENCES; CDC48/P97; DYNAMICS; MCAK; EYE	Proper chromosome segregation requires the attachment of sister kinetochores to microtubules from opposite spindle poles to form bi-oriented chromosomes on the metaphase spindle. The chromosome passenger complex containing Survivin and the kinase Aurora B regulates this process from the centromeres. We report that a de-ubiquitinating enzyme, hFAM, regulates chromosome alignment and segregation by controlling both the dynamic association of Survivin with centromeres and the proper targeting of Survivin and Aurora B to centromeres. Survivin is ubiquitinated in mitosis through both Lys(48) and LyS(63) ubiquitin linkages. LyS(63) de-ubiquitination mediated by hFAM is required for the dissociation of Survivin from centromeres, whereas LyS(63) ubiquitination mediated by the ubiquitin binding protein Ufd1 is required for the association of Survivin with centromeres. Thus, ubiquitinaton regulates dynamic protein-protein interactions and chromosome segregation independently of protein degradation.	Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Iglesias, PA (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	pi@jhu.edu; zheng@ciwemb.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X; Li, Hoi Yeung/0000-0002-8603-1953	NIGMS NIH HHS [GM56312] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Delacour-Larose M, 2004, CELL CYCLE, V3, P1418, DOI 10.4161/cc.3.11.1203; EARNSHAW W, 1986, J CLIN INVEST, V77, P426, DOI 10.1172/JCI112320; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang YZ, 1996, DEVELOPMENT, V122, P3207; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Noma T, 2002, MECH DEVELOP, V119, pS91, DOI 10.1016/S0925-4773(03)00098-4; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhao J, 2000, J CELL SCI, V113, P4363	30	196	214	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1499	1504		10.1126/science.1120160	http://dx.doi.org/10.1126/science.1120160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322459				2022-12-28	WOS:000233756500046
J	Roeder, PL				Roeder, PL			The animal story	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RINDERPEST; VIRUS		UN, Food & Agr Org, Emergency Prevent Syst Transboundary Anim Dis, Anim Hlth Serv, I-00100 Rome, Italy	Food & Agriculture Organization of the United Nations (FAO)	Roeder, PL (corresponding author), UN, Food & Agr Org, Emergency Prevent Syst Transboundary Anim Dis, Anim Hlth Serv, Vialle Terme Caracalla, I-00100 Rome, Italy.	peter.roeder@fao.org						ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; BIRMINGHAM M, 1996, P FAO TECHN CONS GLO, P133; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Mariner JC, 2003, REV SCI TECH OIE, V22, P837, DOI 10.20506/rst.22.3.1439; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; Mariner JC, 1991, J TISS CULT METHODS, V13, P253; PLOWRIGHT W., 1962, RES VET SCI, V3, P172; ROEDER PL, IN PRESS BIOL ANIMAL, V2; SCOTT GR, 1992, FAO EXP CONS STRAT G, P109; Taylor WP, 2002, TROP ANIM HEALTH PRO, V34, P471, DOI 10.1023/A:1021289103737; TAYLOR WP, IN PRESS ELSEVIER BI, V2	12	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1262	1264		10.1136/bmj.331.7527.1262	http://dx.doi.org/10.1136/bmj.331.7527.1262			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308392	Green Published, Bronze			2022-12-28	WOS:000233606800028
J	Attiyeh, EF; London, WB; Mosse, YP; Wang, Q; Winter, C; Khazi, D; McGrady, PW; Seeger, RC; Look, AT; Shimada, H; Brodeur, GM; Cohn, SL; Matthay, KK; Maris, JM				Attiyeh, EF; London, WB; Mosse, YP; Wang, Q; Winter, C; Khazi, D; McGrady, PW; Seeger, RC; Look, AT; Shimada, H; Brodeur, GM; Cohn, SL; Matthay, KK; Maris, JM		Children's Oncology Grp	Chromosome 1p and 11q deletions and outcome in neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 13-17, 2005	Orlando, FL	Amer Soc Clin Oncol			TUMOR-CELL PLOIDY; GENE AMPLIFICATION; ALLELIC DELETION; STAGE; PROGRESSION; DEFINITION; ONCOGENE; THERAPY; BIOLOGY; COMMON	BACKGROUND Neuroblastoma is a childhood cancer with considerable morbidity and mortality. Tumor-derived biomarkers may improve risk stratification. METHODS We screened 915 samples of neuroblastoma for loss of heterozygosity (LOH) at chromosome bands 1p36 and 11q23. Additional analyses identified a subgroup of cases of 11q23 LOH with unbalanced 11q LOH (unb11q LOH; defined as loss of 11q with retention of 11p). The associations of LOH with relapse and survival were determined. RESULTS LOH at 1p36 was identified in 209 of 898 tumors (23 percent) and LOH at 11q23 in 307 of 913 (34 percent). Unb11q LOH was found in 151 of 307 tumors with 11q23 LOH (17 percent of the total cohort). There was a strong association of 1p36 LOH, 11q23 LOH, and unb11q LOH with most high-risk disease features (P<0.001). LOH at 1p36 was associated with amplification of the MYCN oncogene (P<0.001), but 11q23 LOH and unb11q LOH were not (P<0.001 and P=0.002, respectively). Cases with unb11q LOH were associated with three-year event-free and overall survival rates (+/-SE) of 50+/-5 percent and 66+/-5 percent, respectively, as compared with 74+/-2 percent and 83+/-2 percent among cases without unb11q LOH (P<0.001 for both comparisons). In a multivariate model, unb11q LOH was independently associated with decreased event-free survival (P=0.009) in the entire cohort, and both 1p36 LOH and unb11q LOH were independently associated with decreased progression-free survival in the subgroup of patients with features of low-risk and intermediate-risk disease (P=0.002 and P=0.02, respectively). CONCLUSIONS Unb11q LOH and 1p36 LOH are independently associated with a worse outcome in patients with neuroblastoma.	Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst, Philadelphia, PA USA; Childrens Oncol Grp, Arcadia, CA USA; Univ Florida, Dept Stat, Gainesville, FL 32611 USA; Childrens Oncol Grp, Gainesville, FL USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Children's Oncology Group (COG); State University System of Florida; University of Florida; Children's Oncology Group (COG); Children's Hospital Los Angeles; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Abramson Pediat Res Ctr 902A, Div Oncol, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	maris@email.chop.edu	London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021; Cohn, Susan/AAB-6010-2021	London, Wendy Beth/0000-0003-3571-6538; Cohn, Susan/0000-0001-5749-7650	NATIONAL CANCER INSTITUTE [U10CA098543, R01CA039771, U10CA078966, R01CA087847] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA39771, U10-CA78966, R01-CA87847, U10-CA98543] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alvarado CS, 2000, J PEDIAT HEMATOL ONC, V22, P197, DOI 10.1097/00043426-200005000-00003; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brodeur GM, 2002, PRINCIPLES PRACTICE, P895; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; COX DR, 1972, J R STAT SOC B, V34, P187; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzenstein HM, 1998, J CLIN ONCOL, V16, P2007, DOI 10.1200/JCO.1998.16.6.2007; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Luttikhuis MEMO, 2001, BRIT J CANCER, V85, P531, DOI 10.1054/bjoc.2001.1960; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2001, MED PEDIATR ONCOL, V36, P24, DOI 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Matthay KK, 1998, J CLIN ONCOL, V16, P1256, DOI 10.1200/JCO.1998.16.4.1256; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nickerson HJ, 2000, J CLIN ONCOL, V18, P477, DOI 10.1200/JCO.2000.18.3.477; Perez CA, 2000, J CLIN ONCOL, V18, P18, DOI 10.1200/JCO.2000.18.1.18; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Plantaz D, 1997, AM J PATHOL, V150, P81; Pritchard J, 2005, PEDIATR BLOOD CANCER, V44, P348, DOI 10.1002/pbc.20219; Seeger R C, 1988, Prog Clin Biol Res, V271, P41; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; Simon T, 2004, J CLIN ONCOL, V22, P3549, DOI 10.1200/JCO.2004.08.143; Spitz R, 2003, CLIN CANCER RES, V9, P52; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306	30	382	395	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2243	2253		10.1056/NEJMoa052399	http://dx.doi.org/10.1056/NEJMoa052399			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	986FC	16306521				2022-12-28	WOS:000233434500007
J	De Tomaso, AW; Nyholm, SV; Palmeri, KJ; Ishizuka, KJ; Ludington, WB; Mitchel, K; Weissman, IL				De Tomaso, AW; Nyholm, SV; Palmeri, KJ; Ishizuka, KJ; Ludington, WB; Mitchel, K; Weissman, IL			Isolation and characterization of a protochordate histocompatibility locus	NATURE			English	Article							KILLER-CELL RECEPTORS; BOTRYLLUS-SCHLOSSERI; IMMUNOGLOBULIN SUPERFAMILY; GERM CELLS; RECOGNITION; EVOLUTION; ALLORECOGNITION; UROCHORDATE; PROTEINS; LIGANDS	Histocompatibility - the ability of an organism to distinguish its own cells and tissue from those of another - is a universal phenomenon in the Metazoa. In vertebrates, histocompatibility is a function of the immune system controlled by a highly polymorphic major histocompatibility complex (MHC), which encodes proteins that target foreign molecules for immune cell recognition. The association of the MHC and immune function suggests an evolutionary relationship between metazoan histocompatibility and the origins of vertebrate immunity. However, the MHC of vertebrates is the only functionally characterized histocompatibility system; the mechanisms underlying this process in non-vertebrates are unknown. A primitive chordate, the ascidian Botryllus schlosseri, also undergoes a histocompatibility reaction controlled by a highly polymorphic locus. Here we describe the isolation of a candidate gene encoding an immunoglobulin superfamily member that, by itself, predicts the outcome of histocompatibility reactions. This is the first non-vertebrate histocompatibility gene described, and may provide insights into the evolution of vertebrate adaptive immunity.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA; Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA	Stanford University; Stanford University; Stanford University	De Tomaso, AW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	tdet@stanford.edu			NIAID NIH HHS [R01 AI041588] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BOYD HC, 1986, BIOL BULL, V170, P91, DOI 10.2307/1541383; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Davidson B, 2002, DEVELOPMENT, V129, P4739; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Flajnik M., 2003, FUNDAMENTAL IMMUNOLO, P519; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Grosberg RK, 2000, SCIENCE, V289, P2111, DOI 10.1126/science.289.5487.2111; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; IZZARD CS, 1968, BIOL BULL, V135, P424; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	33	155	160	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					454	459		10.1038/nature04150	http://dx.doi.org/10.1038/nature04150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306984	Green Accepted			2022-12-28	WOS:000233458200040
J	Vukusic, P; Hooper, I				Vukusic, P; Hooper, I			Directionally controlled fluorescence emission in butterflies	SCIENCE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	p.vukusic@ex.ac.uk		Hooper, Ian/0000-0002-5736-8610	Biotechnology and Biological Sciences Research Council [JF16983] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Erchak AA, 2001, APPL PHYS LETT, V78, P563, DOI 10.1063/1.1342048; Kelber A, 2001, J EXP BIOL, V204, P2469; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Vos WL, 2001, MRS BULL, V26, P642, DOI 10.1557/mrs2001.160	5	122	128	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2005	310	5751					1151	1151		10.1126/science.1116612	http://dx.doi.org/10.1126/science.1116612			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293753				2022-12-28	WOS:000233437300036
J	Carol, RJ; Takeda, S; Linstead, P; Durrant, MC; Kakesova, H; Derbyshire, P; Drea, S; Zarsky, V; Dolan, L				Carol, RJ; Takeda, S; Linstead, P; Durrant, MC; Kakesova, H; Derbyshire, P; Drea, S; Zarsky, V; Dolan, L			A RhoGDP dissociation inhibitor spatially regulates growth in root hair cells	NATURE			English	Article							NADPH OXIDASE; GTPASE; MORPHOGENESIS; EXPANSION	Root hairs are cellular protuberances extending from the root surface into the soil; there they provide access to immobile inorganic ions such as phosphate, which are essential for growth(1). Their cylindrical shape results from a polarized mechanism of cell expansion called tip growth in which elongation is restricted to a small area at the surface of the hair-forming cell (trichoblast) tip(2-4). Here we identify proteins that spatially control the sites at which cell growth occurs by isolating Arabidopsis mutants (scn1) that develop ectopic sites of growth on trichoblasts. We cloned SCN1 and showed that SCN1 is a RhoGTPase GDP dissociation inhibitor ( RhoGDI) that spatially restricts the sites of growth to a single point on the trichoblast. We showed previously that localized production of reactive oxygen species by RHD2/AtrbohC NADPH oxidase is required for hair growth(5); here we show that SCN1/AtrhoGDI1 is a component of the mechanism that focuses RHD2/AtrbohC-catalysed production of reactive oxygen species to hair tips during wild-type development. We propose that the spatial organization of growth in plant cells requires the local RhoGDI-regulated activation of the RHD2/AtrbohC NADPH oxidase.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Computat Biol Grp, Norwich NR4 7UH, Norfolk, England; Charles Univ Prague, Dept Plant Physiol, Prague 12800 2, Czech Republic; Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague, Czech Republic	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Drea, Sinead/F-6166-2011; Zarsky, Viktor/G-7352-2014; Žárský, Viktor/P-3673-2018	Zarsky, Viktor/0000-0002-5301-0339; Žárský, Viktor/0000-0002-5301-0339; Takeda, Seiji/0000-0003-0183-7390; Carol, Rachel/0000-0002-6193-5163; Dolan, Liam/0000-0003-1206-7096	Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Barcelo AR, 1999, FREE RADICAL RES, V31, pS147; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bischoff F, 2000, PLANT MOL BIOL, V42, P515, DOI 10.1023/A:1006341210147; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Favery B, 2001, GENE DEV, V15, P79, DOI 10.1101/gad.188801; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gahoonia TS, 1997, PLANT SOIL, V191, P181, DOI 10.1023/A:1004270201418; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Rivero F, 2002, EMBO J, V21, P4539, DOI 10.1093/emboj/cdf449; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Shaw SL, 2000, PLANT PHYSIOL, V124, P959, DOI 10.1104/pp.124.3.959; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	22	252	264	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1013	1016		10.1038/nature04198	http://dx.doi.org/10.1038/nature04198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355224				2022-12-28	WOS:000233934600066
J	Dolin, R				Dolin, R			Influenza - Interpandemic as well as pandemic disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION		Harvard Univ, Sch Med, Acad Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Clin Program, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Dolin, R (corresponding author), Harvard Univ, Sch Med, Acad Program, Boston, MA 02115 USA.							Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333	6	18	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2535	2537		10.1056/NEJMp058276	http://dx.doi.org/10.1056/NEJMp058276			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354889				2022-12-28	WOS:000233926500002
J	Gore, AV; Maegawa, S; Cheong, A; Gilligan, PC; Weinberg, ES; Sampath, K				Gore, AV; Maegawa, S; Cheong, A; Gilligan, PC; Weinberg, ES; Sampath, K			The zebrafish dorsal axis is apparent at the four-cell stage	NATURE			English	Article							NODAL-RELATED GENES; DROSOPHILA OOGENESIS; XENOPUS EMBRYOS; SPECIFICATION; ORGANIZER; EXPRESSION; SIGNALS; SQUINT; LAYER; FISH	A central question in the development of multicellular organisms pertains to the timing and mechanisms of specification of the embryonic axes. In many organisms, specification of the dorsoventral axis requires signalling by proteins of the Transforming growth factor-beta and Wnt families(1-3). Here we show that maternal transcripts of the zebrafish Nodal-related morphogen, Squint (Sqt), can localize to two blastomeres at the four-cell stage and predict the dorsal axis. Removal of cells containing sqt transcripts from four-to-eight-cell embryos or injection of antisense morpholino oligonucleotides targeting sqt into oocytes can cause a loss of dorsal structures. Localization of sqt transcripts is independent of maternal Wnt pathway function and requires a highly conserved sequence in the 3' untranslated region. Thus, the dorsoventral axis is apparent by early cleavage stages and may require the maternally encoded morphogen Sqt and its associated factors. Because the 3' untranslated region of the human nodal gene can also localize exogenous sequences to dorsal cells, this mechanism may be evolutionarily conserved.	Temasek Life Sci Lab, Vertebrate Dev Grp, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	National University of Singapore; University of Pennsylvania	Sampath, K (corresponding author), Temasek Life Sci Lab, Vertebrate Dev Grp, 1 Res Link, Singapore 117604, Singapore.	karuna@tll.org.sg	Maegawa, Shingo/AAB-3924-2021	Sampath, Karuna/0000-0002-0729-1977; Gore, Aniket/0000-0003-4088-5264				ABDELILAH S, 1994, NATURE, V370, P468, DOI 10.1038/370468a0; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Feldman B, 2001, GENESIS, V30, P175, DOI 10.1002/gene.1058; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Gore AV, 2002, MECH DEVELOP, V112, P153, DOI 10.1016/S0925-4773(01)00622-0; Heasman J, 1997, DEVELOPMENT, V124, P4179; HELDE KA, 1994, SCIENCE, V265, P517, DOI 10.1126/science.8036493; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KLEIN SL, 1987, DEV BIOL, V120, P299, DOI 10.1016/0012-1606(87)90127-8; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Mizuno T, 1997, DEV GENES EVOL, V206, P389, DOI 10.1007/s004270050068; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Oppenheimer JM, 1936, J EXP ZOOL, V72, P247, DOI 10.1002/jez.1400720204; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; SCHIER AF, 2005, ANN REV GENET   0809; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815	30	106	110	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1030	1035		10.1038/nature04184	http://dx.doi.org/10.1038/nature04184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355228				2022-12-28	WOS:000233934600070
J	Parfitt, SA; Barendregt, RW; Breda, M; Candy, I; Collins, MJ; Coope, GR; Durbidge, P; Field, MH; Lee, JR; Lister, AM; Mutch, R; Penkman, KEH; Preece, RC; Rose, J; Stringer, CB; Symmons, R; Whittaker, JE; Wymer, JJ; Stuart, AJ				Parfitt, SA; Barendregt, RW; Breda, M; Candy, I; Collins, MJ; Coope, GR; Durbidge, P; Field, MH; Lee, JR; Lister, AM; Mutch, R; Penkman, KEH; Preece, RC; Rose, J; Stringer, CB; Symmons, R; Whittaker, JE; Wymer, JJ; Stuart, AJ			The earliest record of human activity in northern Europe	NATURE			English	Article							EASTERN ENGLAND; COLONIZATION; HOMINIDS; REMAINS; BRITAIN; AGE	The colonization of Eurasia by early humans is a key event after their spread out of Africa, but the nature, timing and ecological context of the earliest human occupation of northwest Europe is uncertain and has been the subject of intense debate(1). The southern Caucasus was occupied about 1.8 million years (Myr) ago(2), whereas human remains from Atapuerca-TD6, Spain ( more than 780 kyr ago)(3) and Ceprano, Italy ( about 800 kyr ago)(4) show that early Homo had dispersed to the Mediterranean hinterland before the Brunhes - Matuyama magnetic polarity reversal ( 780 kyr ago). Until now, the earliest uncontested artefacts from northern Europe were much younger, suggesting that humans were unable to colonize northern latitudes until about 500 kyr ago(5,6). Here we report flint artefacts from the Cromer Forest-bed Formation at Pakefield (52 degrees N), Suffolk, UK, from an interglacial sequence yielding a diverse range of plant and animal fossils. Event and lithostratigraphy, palaeomagnetism, amino acid geochronology and biostratigraphy indicate that the artefacts date to the early part of the Brunhes Chron ( about 700 kyr ago) and thus represent the earliest unequivocal evidence for human presence north of the Alps.	UCL, Dept Biol, London WC1E 6BT, England; UCL, Inst Archaeol, London WC1H 0PY, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Lethbridge, Lethbridge, AB TK1 3M4, Canada; Univ Padua, Dipartimento Geol Paleontol & Geofis, I-35100 Padua, Italy; Univ Loughborough, Dept Geog, Loughborough LE11 3TU, Leics, England; Univ London Royal Holloway & Bedford New Coll, Dept Geog, Egham TW20 0EX, Surrey, England; Univ York, BioArch, York YO10 5YW, N Yorkshire, England; Univ Birmingham, Dept Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; Lowestoft Museum, Lowestoft NR33 9JR, Suffolk, England; Church Cottage, Fenny Compton CV47 2YE, Warwick, England; British Geol Survey, Keyworth NG12 5GG, Notts, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	University of London; University College London; University of London; University College London; Natural History Museum London; University of Lethbridge; University of Padua; Loughborough University; University of London; Royal Holloway University London; University of York - UK; University of Birmingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Cambridge; Durham University	Stuart, AJ (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.	tony@megafauna.freeserve.co.uk	Collins, Matthew J/A-7534-2008; Collins, Matthew James/O-1095-2019; Barendregt, Rene/J-7633-2012; Penkman, Kirsty E/D-1952-2012	Collins, Matthew J/0000-0003-4226-5501; Collins, Matthew James/0000-0003-4226-5501; Penkman, Kirsty E/0000-0002-6226-9799; Lister, Adrian/0000-0002-7985-138X; Lee, Jonathan/0000-0001-8610-2400	Natural Environment Research Council [bgs03002] Funding Source: researchfish; NERC [bgs03002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ATKINSON TC, 1987, NATURE, V325, P587, DOI 10.1038/325587a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; BISHOP MJ, 1975, NATURE, V253, P95, DOI 10.1038/253095a0; BLAKE JH, 1890, MEMOIRS GEOLOGY SURV; Bowen D.Q., 1999, GEOL MAG; CANDY I, IN PRESS BOREAS; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Dennell R, 1996, ANTIQUITY, V70, P535, DOI 10.1017/S0003598X00083691; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gamble C., 1999, PALAEOLITHIC SOC EUR; GIBBARD PL, 1988, PHILOS T ROY SOC B, V318, P559, DOI 10.1098/rstb.1988.0024; Kaufman DS, 1998, QUATERNARY SCI REV, V17, P987, DOI 10.1016/S0277-3791(97)00086-3; Lee JR, 2004, QUATERNARY SCI REV, V23, P1551, DOI 10.1016/j.quascirev.2004.02.002; LEE JR, IN PRESS J QUAT SCI; Manzi G, 2004, EVOL ANTHROPOL, V13, P11, DOI 10.1002/evan.10127; Newton ET., 1882, VERTEBRATA FOREST BE; PENKMAN KEH, 2005, THESIS U NEWCASTLE; Pevzner Mikhail, 2001, Bollettino della Societa Paleontologica Italiana, V40, P269; Preece RC, 2001, QUATERNARY SCI REV, V20, P1643, DOI 10.1016/S0277-3791(01)00032-4; Reid C, 1882, GEOLOGY COUNTRY CROM; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Rose J, 2001, QUATERN INT, V79, P5, DOI 10.1016/S1040-6182(00)00119-1; Stuart A.J., 1996, P9; Stuart AJ, 2001, QUATERNARY SCI REV, V20, P1677, DOI 10.1016/S0277-3791(01)00034-8; Sykes G.A., 1995, ORGANIC GEOCHEMISTRY, V23, P1039; Turner C., 1996, EARLY MIDDLE PLEISTO, P295; WEST R. G., 1980, PREGLACIAL PLEISTOCE; Wymer J.J., 1999, LOWER PALAEOLITHIC O	30	299	305	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1008	1012		10.1038/nature04227	http://dx.doi.org/10.1038/nature04227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355223				2022-12-28	WOS:000233934600065
J	Bhalla, N; Dernburg, AF				Bhalla, N; Dernburg, AF			Conserved checkpoint monitors meiotic chromosome synapsis in Caenorhabditis elegans	SCIENCE			English	Article							DAMAGE-INDUCED APOPTOSIS; C-ELEGANS; CELL-DEATH; GENETIC-CONTROL; RECOMBINATION; GERMLINE; HOMOLOG; PROGRESSION; PROTEINS; MEIOSIS	We report the discovery of a checkpoint that monitors synapsis between homologous chromosomes to ensure accurate meiotic segregation. Oocytes containing unsynapsed chromosomes selectively undergo apoptosis even if a germline DNA damage checkpoint is inactivated. This cutting mechanism is specifically activated by unsynapsed pairing centers, cis-acting chromosome sites that are also required to promote synapsis in Caenorhabditis elegans. Apoptosis due to synaptic failure also requires the C. elegans homolog of PCH2, a budding yeast pachytene checkpoint gene, which suggests that this surveillance mechanism is widely conserved.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dernburg, AF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	afdernburg@lbl.gov		Dernburg, Abby/0000-0001-8037-1079	NIGMS NIH HHS [F32 GM067408-02, 1 F32 GM67408-01A1, F32 GM067408-01A1, F32 GM067408, 1 R01 GM/CA655591-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Cha RS, 2000, GENE DEV, V14, P493; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Egozcue S, 2000, J ASSIST REPROD GEN, V17, P307, DOI 10.1023/A:1009444709504; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GIROUX CN, 1989, GENOME, V31, P88, DOI 10.1139/g89-017; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Kelly WG, 2002, DEVELOPMENT, V129, P479; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MACQUEEN AJ, IN PRESS; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; PHILLIPS CM, IN PRESS CELL; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; VILLENEUVE AM, 1994, GENETICS, V136, P887; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	29	155	171	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1683	1686		10.1126/science.1117468	http://dx.doi.org/10.1126/science.1117468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339446				2022-12-28	WOS:000233961700046
J	Goodman, RP; Schaap, IAT; Tardin, CF; Erben, CM; Berry, RM; Schmidt, CF; Turberfield, AJ				Goodman, RP; Schaap, IAT; Tardin, CF; Erben, CM; Berry, RM; Schmidt, CF; Turberfield, AJ			Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication	SCIENCE			English	Article							SINGLE-STRANDED-DNA; OCTAHEDRON; ELASTICITY; HELIX	Practical components for three-dimensional molecular nanofabrication must be simple to produce, stereopure, rigid, and adaptable. We report a family of DNA tetrahedra, less than 10 nanometers on a side, that can self-assemble in seconds with near-quantitative yield of one diastereomer. They can be connected by programmable DNA linkers. Their triangulated architecture confers structural stability; by compressing a DNA tetrahedron with an atomic force microscope, we have measured the axial compressibility of DNA and observed the buckling of the double helix under high loads.	Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 H Amsterdam, Netherlands	University of Oxford; Vrije Universiteit Amsterdam	Turberfield, AJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	a.turberfield@physics.ox.ac.uk	Schmidt, Christoph F/G-3787-2011; Schaap, Iwan A. T./L-3177-2013; Turberfield, Andrew J/O-2135-2017	Schmidt, Christoph F/0000-0003-2864-6973; Schaap, Iwan A. T./0000-0001-6665-5104; Turberfield, Andrew J/0000-0002-3876-0190	Engineering and Physical Sciences Research Council [GR/A10274/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; CONWAY JH, 1970, COMPUTATION PROBLEMS; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; DORENBECK A, 2000, THESIS RUHR U BOCHUM; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Malo J, 2005, ANGEW CHEM INT EDIT, V44, P3057, DOI 10.1002/anie.200463027; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	22	814	859	18	445	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1661	1665		10.1126/science.1120367	http://dx.doi.org/10.1126/science.1120367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339440				2022-12-28	WOS:000233961700039
J	Neetu, S; Suresh, I; Shankar, R; Shankar, D; Shenoi, SSC; Shetye, SR; Sundar, D; Nagarajan, B				Neetu, S; Suresh, I; Shankar, R; Shankar, D; Shenoi, SSC; Shetye, SR; Sundar, D; Nagarajan, B			Comment on "The great Sumatra-Andaman earthquake of 26 December 2004"	SCIENCE			English	Editorial Material								Lay et at. (Research Articles, 20 May 2005, p. 1127) estimated a 600-km length for the tsunami source region. Adding tide-gauge data from Paradip, the northernmost of the Indian east-coast stations and therefore the most critical constraint on the northern extent of the source, we estimate that its length was greater by similar to 30%.	Natl Inst Oceanog, Panaji 403004, Goa, India; Inst Math Sci, Madras 600113, Tamil Nadu, India; Survey India, Geodet & Res Branch, Dehra Dun 248001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Institute of Mathematical Sciences (IMSc) India	Neetu, S (corresponding author), Natl Inst Oceanog, Panaji 403004, Goa, India.	neetu@nio.org	I, Suresh/C-2126-2012	I, Suresh/0000-0001-9049-5091				Bilham R, 2005, SCIENCE, V308, P1126, DOI 10.1126/science.1113363; Lay T, 2005, SCIENCE, V308, P1127, DOI 10.1126/science.1112250; NAGARAJAN B, IN PRESS EARTH PLANE; RAMADASS GA, 2005, COMMUNICATION	4	28	28	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753								10.1126/science.1118950	http://dx.doi.org/10.1126/science.1118950			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322440				2022-12-28	WOS:000233756500022
J	Ryugo, DK; Kretzmer, EA; Niparko, JK				Ryugo, DK; Kretzmer, EA; Niparko, JK			Restoration of auditory nerve synapses in cats by cochlear implants	SCIENCE			English	Article							DEAF WHITE CATS; PRIMARY AXOSOMATIC ENDINGS; ELECTRICAL-STIMULATION; ULTRASTRUCTURAL ANALYSIS; CONGENITAL DEAFNESS; SPEECH-PERCEPTION; NUCLEUS; MICE; MORPHOLOGY; ENDBULBS	Congenital deafness results in abnormal synaptic structure in endings of the auditory nerve. If these abnormalities persist after restoration of auditory nerve activity by a cochlear implant, the processing of time-varying signals such as speech would likely be impaired. We stimulated congenitally deaf cats for 3 months with a six-channel cochlear implant. The device used human speech-processing programs, and cats responded to environmental sounds. Auditory nerve fibers exhibited a recovery of normal synaptic structure in these cats. This rescue of synapses is attributed to a return of spike activity in the auditory nerve and may help explain cochlear implant benefits in childhood deafness.	Johns Hopkins Univ, Ctr Hearing & Balance, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Ctr Hearing & Balance, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Ryugo, DK (corresponding author), Johns Hopkins Univ, Ctr Hearing & Balance, Dept Otolaryngol Head & Neck Surg, 720 Rutland Ave, Baltimore, MD 21205 USA.	dryugo@bme.jhu.edu	Ryugo, David K./G-1940-2012	Ryugo, David K./0000-0002-5250-7503	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005864, R01DC000232] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC00232, F31 DC05864] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Babalian AL, 2003, EXP BRAIN RES, V153, P452, DOI 10.1007/s00221-003-1619-x; Busby PA, 1999, J ACOUST SOC AM, V105, P1841, DOI 10.1121/1.426721; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Cheng AK, 1999, ARCH OTOLARYNGOL, V125, P1214, DOI 10.1001/archotol.125.11.1214; Francis HW, 2003, PEDIATR CLIN N AM, V50, P341, DOI 10.1016/S0031-3955(03)00034-8; Frijns JHM, 2002, EAR HEARING, V23, P184, DOI 10.1097/00003446-200206000-00003; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawano A, 1996, Nihon Jibiinkoka Gakkai Kaiho, V99, P884; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kral A, 2005, CEREB CORTEX, V15, P552, DOI 10.1093/cercor/bhh156; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Lee DJ, 2003, J NEUROCYTOL, V32, P229, DOI 10.1023/B:NEUR.0000010082.99874.14; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Limb CJ, 2000, JARO-J ASSOC RES OTO, V1, P103, DOI 10.1007/s101620010032; LUSTIG LR, 1994, HEARING RES, V74, P29, DOI 10.1016/0378-5955(94)90173-2; MATSUSHIMA JI, 1991, HEARING RES, V56, P133, DOI 10.1016/0378-5955(91)90162-3; Meisami E, 1978, Prog Brain Res, V48, P211; Naito Y, 1997, ACTA OTO-LARYNGOL, V117, P490, DOI 10.3109/00016489709113426; Oleskevich S, 2004, J PHYSIOL-LONDON, V560, P709, DOI 10.1113/jphysiol.2004.066662; Oleskevich S, 2002, J PHYSIOL-LONDON, V540, P447, DOI 10.1113/jphysiol.2001.013821; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 1998, J COMP NEUROL, V397, P532, DOI 10.1002/(SICI)1096-9861(19980810)397:4<532::AID-CNE6>3.0.CO;2-2; Ryugo DK, 1997, J COMP NEUROL, V385, P230, DOI 10.1002/(SICI)1096-9861(19970825)385:2<230::AID-CNE4>3.0.CO;2-2; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; Saada AA, 1996, BRAIN RES, V736, P315, DOI 10.1016/0006-8993(96)00719-6; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shepherd RK, 1999, J NEUROPHYSIOL, V82, P1363, DOI 10.1152/jn.1999.82.3.1363; Svirsky MA, 2004, AUDIOL NEURO-OTOL, V9, P224, DOI 10.1159/000078392; TAITELBAUMSWEAD R, IN PRESS INT J PEDIA; Trussell LO, 2002, CURR OPIN NEUROBIOL, V12, P400, DOI 10.1016/S0959-4388(02)00335-5; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vollmer M, 2005, J NEUROPHYSIOL, V93, P3339, DOI 10.1152/jn.00900.2004; WEST CD, 1973, J COMP NEUROL, V151, P377, DOI 10.1002/cne.901510406; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P973	37	99	101	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1490	1492		10.1126/science.1119419	http://dx.doi.org/10.1126/science.1119419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322457				2022-12-28	WOS:000233756500043
J	Antonioli, C; Reveley, MA				Antonioli, C; Reveley, MA			Randomised controlled trial of animal facilitated therapy with dolphins in the treatment of depression	BMJ-BRITISH MEDICAL JOURNAL			English	Article							URBANIZATION	Objective To evaluate the effectiveness of animal facilitated therapy with dolphins, controlling for the influence of the natural setting, in the treatment of mild to moderate depression and in the context of the biophilia hypothesis. Setting The study was carried out in Honduras, and recruitment took place in the United States and Honduras. Design Single blind, randomised, controlled trial. Participants Outpatients, recruited through announcements on the internet, radio, newspapers, and hospitals. Results Of the 30 patients randomly assigned to the two groups of treatment, two dropped out of the treatment group after the first week and three withdrew their consent in the control group after they had been randomly allocated. For the participants who completed the study, the mean severity of the depressive symptoms was more reduced in the treatment group than in the control group (Hamilton rating scale for depression, P = 0.002; Beck depression inventory, P = 0.006). For the sample analysed by modified intention to treat and last observation carried forward, the mean differences for die. Hamilton and Beck scores between the two groups was highly significant (P = 0.007 and P = 0.012, respectively). Conclusions The therapy was effective in alleviating symptoms of depression after two weeks of treatment. Animal facilitated therapy with dolphins is an effective treatment for mild to moderate depression, which is based on a holistic approach, through interaction with animals in nature.	Univ Leicester, Sch Med, Leicester Gen Hosp, Dept Hlth Sci,Div Clin Psychiat, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Reveley, MA (corresponding author), Univ Leicester, Sch Med, Leicester Gen Hosp, Dept Hlth Sci,Div Clin Psychiat, Leicester LE5 4PW, Leics, England.	rev@le.ac.uk						*AM PSYCH ASS, 2000, AM J PSYCHIAT, P515; [Anonymous], 1991, PRACTICAL STAT MED R, P87; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BLEHAR MC, 1989, ARCH GEN PSYCHIAT, V46, P469; COOPER JE, 1976, BRIT MED J, V1, P698, DOI 10.1136/bmj.1.6011.698; DAWSON A, 2001, DEPRESSION SOCIAL EC, P3; FROMM E, ANATOMY HUMAN DESTRU, P366; GELDER M, 1996, OXFORD TXB PSYCHIAT, P211; Hamilton M, 1976, BRIT J SOC CLIN PSYC, V6, P278; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; KATCHER A, 1983, NEW PERSPECTIVE OUR, P407; KELLERT SR, 1993, BIOPHILIA HYPOTHESIS, P180; KELLERT SR, 1997, KINSHIP MASTERY BIOP, P3; LEVINE BA, 1984, PSYCHOL REP, V55, P526, DOI 10.2466/pr0.1984.55.2.526; LORENZ M, 1973, ACHT TODSUNDEN ZIVIL, P15; NESSE RM, 1996, HUM NATURE, V1, P261; Peen J, 2003, SOC PSYCH PSYCH EPID, V38, P535, DOI 10.1007/s00127-003-0671-y; Piper R, 1973, ACHT TODSUNDEN ZIVIL, P15; PRICE J, 1994, BRIT J PSYCHIAT, V164, P309, DOI 10.1192/bjp.164.3.309; PRICE J, 1967, LANCET, V2, P243; RICE RW, 1973, FRACTURE MECH CERAMI, V1, P323; Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; WHO, 1993, ICD 10 CLASS MENT BE; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	25	62	62	8	363	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1231	1234		10.1136/bmj.331.7527.1231	http://dx.doi.org/10.1136/bmj.331.7527.1231			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308382	Bronze, Green Published			2022-12-28	WOS:000233606800016
J	Muller, C; Schlindwein, V; Eckstaller, A; Miller, H				Muller, C; Schlindwein, V; Eckstaller, A; Miller, H			Singing icebergs	SCIENCE			English	Article							VOLCANIC TREMOR		Datenverarbeitung mbH, FIELAX Gesell Wissensch, D-27568 Bremerhaven, Germany; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Muller, C (corresponding author), Datenverarbeitung mbH, FIELAX Gesell Wissensch, Schifferstr 10-14, D-27568 Bremerhaven, Germany.	muetter@fielax.de		Miller, Heinrich/0000-0003-1015-2828				AKI K, 1981, J GEOPHYS RES, V86, P7095, DOI 10.1029/JB086iB08p07095; Busselberg T., 2001, TERRA ANTARTICA, V8, P41; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; Konstantinou KI, 2003, J VOLCANOL GEOTH RES, V119, P161, DOI 10.1016/S0377-0273(02)00311-6; Long DG, 2002, EOS T AGU, V83, P469, DOI DOI 10.1029/2002EO000330; SCAMBOS T, 2004, ADV VERY HIGH RESOLU	6	29	30	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1299	1299		10.1126/science.1117145	http://dx.doi.org/10.1126/science.1117145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311327	Green Submitted			2022-12-28	WOS:000233600200032
J	Dickerson, BC; Holtzman, D; Grant, PE; Tian, D; Walsh, R; Harris, NL				Dickerson, BC; Holtzman, D; Grant, PE; Tian, D; Walsh, R; Harris, NL			A woman with seizure, disturbed gait, and altered mental status - Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (the MELAS syndrome).	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COMPLEX-I; MUTATION; DNA; ENCEPHALOPATHY; EPIDEMIOLOGY; DEMENTIA; DISEASE; GENE; MYOPATHIES; DISORDERS		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Div Pediat Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Brigham & Womens Hosp, Dept Neurol, Div Cognit & Behav Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dickerson, BC (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013				Andreu AL, 2003, J NEUROL, V250, P1403, DOI 10.1007/s00415-003-0281-3; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T; Dashe JF, 1998, NEW ENGL J MED, V339, P1914, DOI 10.1056/NEJM199812243392608; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022; Erkinjuntti T, 2004, STROKE, V35, P1010, DOI 10.1161/01.STR.0000120731.88236.33; Geldmacher DS, 1996, NEW ENGL J MED, V335, P330, DOI 10.1056/NEJM199608013350507; HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102; HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816; JACKSON JH, 1931, SELECTED WRITINGS JH, P30; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Masuhr E, 2004, J NEUROL, V251, P11, DOI 10.1007/s00415-004-0321-7; Mendez MF, 2003, DEMENTIA CLIN APPROA; MESULAM MM, 2005, HARRISONS PRINCIPLES, P145; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Panagos PD, 2002, EMERG MED CLIN N AM, V20, P631, DOI 10.1016/S0733-8627(02)00015-9; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317; Pulkes T, 2000, ANN NEUROL, V47, P841; Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167; Scheffler IE, 1999, MITOCHONDRIA; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schwartz RB, 2002, NEUROLOGIST, V8, P22, DOI 10.1097/00127893-200201000-00003; Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	35	13	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2271	2280		10.1056/NEJMcpc059032	http://dx.doi.org/10.1056/NEJMcpc059032			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306525				2022-12-28	WOS:000233434500012
J	Schmeing, TM; Huang, KS; Strobel, SA; Steitz, TA				Schmeing, TM; Huang, KS; Strobel, SA; Steitz, TA			An induced-fit mechanism to promote peptide bond formation and exclude hydrolysis of peptidyl-tRNA	NATURE			English	Article							LARGE RIBOSOMAL-SUBUNIT; FACTOR RF2; GGQ MOTIF; RELEASE; SITE; CRYSTALLOGRAPHY; INTERMEDIATE; TERMINATION; CATALYSIS; MIMICS	The large ribosomal subunit catalyses the reaction between the alpha-amino group of the aminoacyl-tRNA bound to the A site and the ester carbon of the peptidyl-tRNA bound to the P site(1), while preventing the nucleophilic attack of water on the ester, which would lead to unprogrammed deacylation of the peptidyl-tRNA. Here we describe three new structures of the large ribosomal subunit of Haloarcula marismortui (Hma) complexed with peptidyl transferase substrate analogues that reveal an induced-fit mechanism in which substrates and active-site residues reposition to allow the peptidyl transferase reaction. Proper binding of an aminoacyl-tRNA analogue to the A site induces specific movements of 23S rRNA nucleotides 2618-2620 (Escherichia coli numbering 2583-2585) and 2541(2506), thereby reorienting the ester group of the peptidyl-tRNA and making it accessible for attack. In the absence of the appropriate A-site substrate, the peptidyl transferase centre positions the ester link of the peptidyl-tRNA in a conformation that precludes the catalysed nucleophilic attack by water. Protein release factors(2) may also function, in part, by inducing an active-site rearrangement similar to that produced by the A-site aminoacyl-tRNA, allowing the carbonyl group and water to be positioned for hydrolysis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Huang, Kevin/AAT-7389-2020; Steitz, Thomas A./C-6559-2009	Huang, Kevin/0000-0002-9930-0972; 				Agmon I, 2004, FEBS LETT, V567, P20, DOI 10.1016/j.febslet.2004.03.065; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Green R, 2002, CELL, V110, P665, DOI 10.1016/S0092-8674(02)00965-0; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koshland D., 1959, ENZYMES, V1, P305; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weinger JS, 2004, NUCLEIC ACIDS RES, V32, P1502, DOI 10.1093/nar/gkh311; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	29	267	276	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					520	524		10.1038/nature04152	http://dx.doi.org/10.1038/nature04152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306996				2022-12-28	WOS:000233458200055
J	Baxter, NN; Habermann, EB; Tepper, JE; Durham, SB; Virnig, BA				Baxter, NN; Habermann, EB; Tepper, JE; Durham, SB; Virnig, BA			Risk of pelvic fractures in older women following pelvic irradiation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSUFFICIENCY FRACTURES; RECTAL-CARCINOMA; PREOPERATIVE RADIOTHERAPY; OSTEOPOROTIC FRACTURES; UNITED-STATES; HIP FRACTURE; RADIATION; CANCER; ENDOMETRIAL; COMPONENTS	Context Pelvic fractures, including hip fractures, area major source of morbidity and mortality in older women. Although therapeutic pelvic irradiation could increase the risk of such fractures, this effect has not been studied. Objective To determine if women who undergo pelvic irradiation for pelvic malignancies (anal, cervical, or rectal cancers) have a higher rate of pelvic fracture than women with pelvic malignancies who do not undergo irradiation. Design, Setting, and Participants We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) cancer registry data linked to Medicare claims data. A total of 6428 women aged 65 years and older diagnosed with pelvic malignancies from 1986 through 1999 were included. We compared results for women who did (n = 2855) Vs did not (n = 3573) undergo radiation therapy. To assess the influence of selection bias, we also evaluated the effect of irradiation on osteoporotic fractures in nonirradiated sites (arm and spine). Main Outcome Measure We evaluated the effect of irradiation on the incidence of pelvic fractures over time, and adjusted for potential confounders using a proportional hazards model. Results Women who underwent radiation therapy were more likely to have a pelvic fracture than women who did not undergo radiation therapy (cumulative 5-year fracture rate, 14.0% vs 7.5% in women with anal cancer, 8.2% vs 5.9% in women with cervical cancer, and 11.2% vs 8.7% in women with rectal cancer); the difference was statistically significant and most fractures (90%) were hip fractures. We controlled for potential confounders including age, race, cancer stage, and geographic location. The impact of irradiation varied by cancer site: treatment for anal cancer was associated with a higher risk of pelvic fractures (hazard ratio, 3.16; 95% confidence interval, 1.48-6.73); than for cervical cancer (hazard ratio, 1.66; 95% confidence interval, 1.06-2.59); or rectal cancer (hazard ratio, 1.65; 95% confidence interval, 1.33-2.05). No statistically significant difference was found in the rate of arm or spine fractures between the irradiated and nonirradiated groups (hazard ratio, 1.15; 95% confidence interval, 0.89-1.48). Conclusions Pelvic irradiation substantially increases the risk of pelvic fractures in older women. Given the high baseline risk of pelvic fracture, this finding is of particular concern.	Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Comprehens Canc, Minneapolis, MN 55455 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baxter, NN (corresponding author), Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, MMC 450,420 Delaware St SE, Minneapolis, MN 55455 USA.	baxtern@smh.toronto.on.ca	Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620; Habermann, Elizabeth/0000-0002-1140-003X				Allal AS, 1997, INT J RADIAT ONCOL, V39, P1099, DOI 10.1016/S0360-3016(97)00390-8; Baxter NN, 2005, DIS COLON RECTUM, V48, P9, DOI 10.1007/s10350-004-0792-8; Bliss P, 1996, BRIT J RADIOL, V69, P548, DOI 10.1259/0007-1285-69-822-548; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; EWING J, 1926, ACTA RADIOL, V6, P399; FU AL, 1994, AM J CLIN ONCOL-CANC, V17, P248, DOI 10.1097/00000421-199406000-00015; Holm T, 1996, CANCER, V78, P968, DOI 10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8; Hopewell JW, 2003, MED PEDIATR ONCOL, V41, P208, DOI 10.1002/mpo.10338; Huh SJ, 2002, GYNECOL ONCOL, V86, P264, DOI 10.1006/gyno.2002.6756; Jacobs JJ, 1995, J BONE JOINT SURG AM, V77A, P1829, DOI 10.2106/00004623-199512000-00006; Jenkins P J, 1995, Clin Oncol (R Coll Radiol), V7, P123, DOI 10.1016/S0936-6555(05)80815-5; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Konski A, 1996, INT J RADIAT ONCOL, V35, P361, DOI 10.1016/0360-3016(95)02139-6; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847, DOI 10.1302/0301-620X.77B6.7593093; Melton LJ, 2000, J BONE MINER RES, V15, P2309, DOI 10.1359/jbmr.2000.15.12.2309; MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010; Mumber MP, 1997, SKELETAL RADIOL, V26, P94, DOI 10.1007/s002560050200; OVERGAARD M, 1988, ACTA ONCOL, V27, P117, DOI 10.3109/02841868809090331; Parikh VA, 1998, DIS COLON RECTUM, V41, P254, DOI 10.1007/BF02238256; POTOSKY AL, 1993, MED CARE, V31, P732; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Surveillance Epidemiology and End Results Program, SURV EP END RES PROG; Tai P, 2000, RADIOTHER ONCOL, V56, P23, DOI 10.1016/S0167-8140(00)00178-X; *US PHS, 1992, DHHS PUBL PHS	28	243	260	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2587	2593		10.1001/jama.294.20.2587	http://dx.doi.org/10.1001/jama.294.20.2587			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304072	Bronze			2022-12-28	WOS:000233436200023
J	Xu, Y; Reid, MJ; Zheng, XW; Menten, KM				Xu, Y; Reid, MJ; Zheng, XW; Menten, KM			The distance to the Perseus spiral arm in the Milky Way	SCIENCE			English	Article							GHZ METHANOL MASERS; KINEMATICS; GALAXIES; REGIONS; W3(OH)	We have measured the distance to the massive star-forming region W3OH in the Perseus Spiral arm of the Milky Way to be 1.95 +/- 0.04 kitoparsecs (5.86 X 10(16) km). This distance was determined by triangulation, with Earth's orbit as one segment of a triangle, using the Very Long Baseline Array. This resolves the long-standing problem that there is a discrepancy of a factor of 2 between different techniques used to determine distances. The reason for the discrepancy is that this portion of the Perseus arm has anomalous motions. The orientation of the anomalous motion agrees with spiral density-wave theory, but the magnitude of the motion is somewhat larger than most models predict.	Nanjing Univ, Dept Astron, Nanjing 210093, Peoples R China; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Chinese Acad Sci, Shanghai Astron Observ, Shanghai, Peoples R China; Max Planck Inst Radioastron, D-53121 Bonn, Germany	Nanjing University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; Max Planck Society	Xu, Y (corresponding author), Nanjing Univ, Dept Astron, Nanjing 210093, Peoples R China.							BLOEMHOF EE, 1992, ASTROPHYS J, V397, P500, DOI 10.1086/171807; Dehnen W, 1998, MON NOT R ASTRON SOC, V298, P387, DOI 10.1046/j.1365-8711.1998.01600.x; Dennison B, 1997, ASTROPHYS J, V474, pL31, DOI 10.1086/310427; Fish VL, 2003, ASTROPHYS J, V587, P701, DOI 10.1086/368284; GEORGELIN YM, 1976, ASTRON ASTROPHYS, V49, P57; HACHISUKA K, IN PRESS ASTROPHYS J; Honma M, 2000, P SOC PHOTO-OPT INS, V4015, P624, DOI 10.1117/12.390461; HUMPHREYS RM, 1978, ASTROPHYS J SUPPL S, V38, P309, DOI 10.1086/190578; JOHNSON DRH, 1987, ASTRON J, V93, P864, DOI 10.1086/114370; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; LIN CC, 1969, ASTROPHYS J, V155, P721, DOI 10.1086/149907; MENTEN KM, 1988, ASTROPHYS J, V333, pL83, DOI 10.1086/185292; Moscadelli L, 1999, ASTROPHYS J, V519, P244, DOI 10.1086/307365; Oey MS, 2005, ASTRON J, V129, P393, DOI 10.1086/426333; Reynolds RJ, 2001, ASTROPHYS J, V558, pL101, DOI 10.1086/323638; ROBERTS WW, 1972, ASTROPHYS J, V259, P283; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; [No title captured]	18	272	282	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2006	311	5757					54	57		10.1126/science.1120914	http://dx.doi.org/10.1126/science.1120914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16339410	Green Submitted			2022-12-28	WOS:000234546300029
J	Bennett, K; Teeling, M; Feely, J				Bennett, K; Teeling, M; Feely, J			Overprescribing antidepressants to children: pharmacoepidemiological study in primary care	BRITISH MEDICAL JOURNAL			English	Article									St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland	Trinity College Dublin	Bennett, K (corresponding author), St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland.	bennettk@tcd.ie		Bennett, Kathleen/0000-0002-2861-7665				Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; *GEN MED SERV, 2003, FIN STAT AN CLAIMS P; *IR MED BOARD, 2003, STAT BEH IR MED BOAR; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; *SSRI VENL US CHIL, 2003, CURR PROBL PHARMACOV, V29, P4	5	13	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1451	1452		10.1136/bmj.331.7530.1451	http://dx.doi.org/10.1136/bmj.331.7530.1451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356982	Green Published, Bronze			2022-12-28	WOS:000234156400026
J	Albarede, F				Albarede, F			Helium feels the heat in Earth's mantle	SCIENCE			English	Editorial Material							CONSTRAINTS; EVOLUTION; ISOTOPES		Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON)	Albarede, F (corresponding author), Ecole Normale Super Lyon, Lab Sci Terre, 46 Allee Italie, F-69364 Lyon, France.	francis.albarede@ens-lyon.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428				Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; Boyet M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021873; Castro MC, 2005, EARTH PLANET SC LETT, V237, P893, DOI 10.1016/j.epsl.2005.06.037; Coltice N, 1999, EARTH PLANET SC LETT, V174, P125, DOI 10.1016/S0012-821X(99)00258-7; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; GRAND SP, 1994, J GEOPHYS RES-SOL EA, V99, P11591, DOI 10.1029/94JB00042; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; OXBURGH ER, 1987, SCIENCE, V237, P1583, DOI 10.1126/science.237.4822.1583; Parman SW, 2005, NATURE, V437, P1140, DOI 10.1038/nature04215; van Keken PE, 2001, EARTH PLANET SC LETT, V188, P421, DOI 10.1016/S0012-821X(01)00343-0; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; Xie SX, 2004, PHYS EARTH PLANET IN, V146, P417, DOI 10.1016/j.pepi.2004.04.003	14	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1777	1778		10.1126/science.1120194	http://dx.doi.org/10.1126/science.1120194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357250				2022-12-28	WOS:000234093600034
J	Lamason, RL; Mohideen, MAPK; Mest, JR; Wong, AC; Norton, HL; Aros, MC; Jurynec, MJ; Mao, XY; Humphreville, VR; Humbert, JE; Sinha, S; Moore, JL; Jagadeeswaran, P; Zhao, W; Ning, G; Makalowska, I; McKeigue, PM; O'Donnell, D; Kittles, R; Parra, EJ; Mangini, NJ; Grunwald, DJ; Shriver, MD; Canfield, VA; Cheng, KC				Lamason, RL; Mohideen, MAPK; Mest, JR; Wong, AC; Norton, HL; Aros, MC; Jurynec, MJ; Mao, XY; Humphreville, VR; Humbert, JE; Sinha, S; Moore, JL; Jagadeeswaran, P; Zhao, W; Ning, G; Makalowska, I; McKeigue, PM; O'Donnell, D; Kittles, R; Parra, EJ; Mangini, NJ; Grunwald, DJ; Shriver, MD; Canfield, VA; Cheng, KC			SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans	SCIENCE			English	Article							HERMANSKY-PUDLAK-SYNDROME; GENE; MELANOSOMES; MUTATIONS; INDUCTION; PROTEIN; COLOR; MAP	Lighter variations of pigmentation in humans are associated with diminished number, size, and density of melanosomes, the pigmented organelles of melanocytes. Here we show that zebrafish golden mutants share these melanosomal changes and that golden encodes a putative cation exchanger slc24a5 (nckx5) that localizes to an intracellular membrane, likely the melanosome or its precursor. The human ortholog is highly similar in sequence and functional in zebrafish. The evolutionarily conserved ancestral allele of a human coding polymorphism predominates in African and East Asian populations. In contrast, the variant allele is nearly fixed in European populations, is associated with a substantial reduction in regional heterozygosity, and correlates with lighter skin pigmentation in admixed populations, suggesting a key role for the SLC24AS gene in human pigmentation.	Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Intercoll Grad Degree Program Genet, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Weis Ctr Res, Dept Genet, Danville, PA 17822 USA; Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; Indiana Univ, Sch Med NW, Dept Anat & Cell Biol, Gary, IN 46408 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Utah System of Higher Education; University of Utah; University of North Texas System; University of North Texas Denton; University College Dublin; University System of Ohio; Ohio State University; University of Toronto; University Toronto Mississauga; Indiana University System; Indiana University Northwest	Cheng, KC (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA.	kcheng@psu.edu	Cheng, Keith/B-6506-2011; Parra, Esteban J/A-4957-2008; Jurynec, Michael/AAH-8765-2020; Makalowska, Izabela/AAF-4967-2021; mao, xianyun/B-4664-2014; Makalowska, Izabela/AAU-2682-2021	Makalowska, Izabela/0000-0002-8144-5671; mao, xianyun/0000-0002-1236-4800; parra, esteban J/0000-0002-2057-8577; Lamason, Rebecca/0000-0002-2762-7917; Cheng, Keith/0000-0002-5350-5825; Shriver, Mark/0000-0003-0006-0479	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037572, R01HD040179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA073935] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017441] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131956, CA73935] Funding Source: Medline; NCRR NIH HHS [RR017441] Funding Source: Medline; NEI NIH HHS [EY11308] Funding Source: Medline; NHGRI NIH HHS [HG002154] Funding Source: Medline; NHLBI NIH HHS [HL077910] Funding Source: Medline; NICHD NIH HHS [HD40179, HD37572, R01 HD040179] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amemiya CT, 1999, GENOMICS, V58, P211, DOI 10.1006/geno.1999.5827; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BOLOGNIA JL, 2003, DERMATOLOGY, P935; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frudakis T, 2003, GENETICS, V165, P2071; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Gregory M, 2002, BLOOD CELL MOL DIS, V28, P418, DOI 10.1006/bcmd.2002.0527; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; HEWITT AT, 1989, RETINA, P57; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; KING RA, 2001, METABOLIC MOL BASES, P5587; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen T, 2004, J INVEST DERMATOL, V122, P452, DOI 10.1046/j.0022-202X.2004.22117.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salceda R, 2000, CELL CALCIUM, V27, P223, DOI 10.1054/ceca.2000.0111; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smit NPM, 2001, PHOTOCHEM PHOTOBIOL, V74, P424, DOI 10.1562/0031-8655(2001)074<0424:MOPAIO>2.0.CO;2; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WALKER C, 1983, GENETICS, V103, P125; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200	38	719	765	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1782	1786		10.1126/science.1116238	http://dx.doi.org/10.1126/science.1116238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357253				2022-12-28	WOS:000234093600037
J	Stark, A; Brennecke, J; Bushati, N; Russell, RB; Cohen, SM				Stark, A; Brennecke, J; Bushati, N; Russell, RB; Cohen, SM			Animal microRNAs confer robustness to gene expression and have a significant impact on 3 ' UTR evolution	CELL			English	Article							ENCODES; PROTEIN; LET-7; IDENTIFICATION; PREDICTION; PROMOTERS; REVEALS; LETHAL; SHOWS; RNAS	MicroRNAs are small noncoding RNAs that serve as posttranscriptional regulators of gene expression in higher eukaryotes. Their widespread and important role in animals is highlighted by recent estimates that 20%-30% of all genes are microRNA targets. Here, we report that a large set of genes involved in basic cellular processes avoid microRNA regulation due to short 3'UTRs that are specifically depleted of microRNA binding sites. For individual microRNAs, we find that coexpressed genes avoid microRNA sites, whereas target genes and microRNAs are preferentially expressed in neighboring tissues. This mutually exclusive expression argues that microRNAs confer accuracy to developmental gene-expression programs, thus ensuring tissue identity and supporting cell-lineage decisions.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Stark, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl.de	Brennecke, Julius/C-1626-2015; Cohen, Stephen M/G-9930-2011; Russell, Rob/AAH-9145-2019; Stark, Alexander/D-1473-2012; Russell, Robert/GWU-6389-2022; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Cohen, Stephen M/0000-0003-2858-9163; Russell, Rob/0000-0002-1905-4717; Stark, Alexander/0000-0003-2611-0841; Russell, Robert/0000-0002-7213-1398; Brennecke, Julius/0000-0002-5141-0814				Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; HANKE PD, 1988, MOL CELL BIOL, V8, P3591, DOI 10.1128/MCB.8.9.3591; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stivers C, 2000, MECH DEVELOP, V97, P205, DOI 10.1016/S0925-4773(00)00409-3; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	46	850	920	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1133	1146		10.1016/j.cell.2005.11.023	http://dx.doi.org/10.1016/j.cell.2005.11.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16337999	Bronze			2022-12-28	WOS:000234177200020
J	Carmeliet, P				Carmeliet, P			Angiogenesis in life, disease and medicine	NATURE			English	Review							TUMOR VASCULATURE; GROWTH; CANCER; CELLS; LYMPHANGIOGENESIS; RECEPTORS; THERAPY; VEGF; STEM	The growth of blood vessels ( a process known as angiogenesis) is essential for organ growth and repair. An imbalance in this process contributes to numerous malignant, inflammatory, ischaemic, infectious and immune disorders. Recently, the first anti-angiogenic agents have been approved for the treatment of cancer and blindness. Angiogenesis research will probably change the face of medicine in the next decades, with more than 500 million people worldwide predicted to benefit from pro- or anti-angiogenesis treatments.	Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Carmeliet, P (corresponding author), Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; Yin, ming/F-3737-2012	Carmeliet, Peter/0000-0001-7961-1821; 				Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Buttery RC, 2004, INT J BIOCHEM CELL B, V36, P1154, DOI 10.1016/S1357-2725(03)00261-9; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Fletcher JA, 2004, SEMIN ONCOL, V31, P4, DOI 10.1053/j.seminoncol.2004.03.034; Gilbert S.F., 2000, DEV BIOL; GRUNEWALD M, IN PRESS CELL; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; HOYER M, 2005, B ACAD CRACOV 2, P451; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, IN PRESS NATURE CLIN; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Lambrechts D, 2004, TRENDS MOL MED, V10, P275, DOI 10.1016/j.molmed.2004.04.004; Luttun A, 2004, BBA-REV CANCER, V1654, P79, DOI 10.1016/j.bbcan.2003.09.002; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	2594	2759	8	408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					932	936		10.1038/nature04478	http://dx.doi.org/10.1038/nature04478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355210				2022-12-28	WOS:000233934600051
J	Rosenfield, RL				Rosenfield, RL			Hirsutism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; HORMONE-BINDING GLOBULIN; ANDROGEN EXCESS; TESTOSTERONE BINDING; ADRENAL-HYPERPLASIA; WOMEN; HYPERANDROGENISM; PHARMACOLOGY; FINASTERIDE; PREVALENCE		Univ Chicago, Pritzker Sch Med, Sect Pediat Endocrinol, Dept Pediat & Med, Chicago, IL 60637 USA	University of Chicago	Rosenfield, RL (corresponding author), Univ Chicago, Pritzker Sch Med, Sect Pediat Endocrinol, Dept Pediat & Med, 5841 S Maryland Ave,MC-5053, Chicago, IL 60637 USA.	robros@peds.bsd.uchicago.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039267] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00055] Funding Source: Medline; NICHD NIH HHS [HD-39267] Funding Source: Medline; PHS HHS [U54-041859] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Collegeof Obstetricians and Gynecologists, 2002, Obstet Gynecol, V100, P1389; Azziz R, 2005, FERTIL STERIL, V83, P1343, DOI 10.1016/j.fertnstert.2005.01.085; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; AZZIZ R, 1994, J CLIN ENDOCR METAB, V78, P810, DOI 10.1210/jc.78.4.810; Azziz R, 2003, OBSTET GYNECOL, V101, P995, DOI 10.1016/S0029-7844(02)02725-4; Azziz R, 2000, ENDOCR REV, V21, P347, DOI 10.1210/er.21.4.347; Balfour J A, 2001, Am J Clin Dermatol, V2, P197; Battle Eliot F Jr, 2004, Dermatol Ther, V17, P177, DOI 10.1111/j.1396-0296.2004.04018.x; Buggs C, 2005, ENDOCRIN METAB CLIN, V34, P677, DOI 10.1016/j.ecl.2005.04.005; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Deplewski D, 2000, ENDOCR REV, V21, P363, DOI 10.1210/er.21.4.363; Dierickx CC, 2002, DERMATOL CLIN, V20, P135, DOI 10.1016/S0733-8635(03)00052-4; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; EHRMANN DA, 1992, NEW ENGL J MED, V327, P157, DOI 10.1056/NEJM199207163270304; FARQUHAR C, 2003, COCHRANE DB SYST REV, V4; Glintborg D, 2005, J CLIN ENDOCR METAB, V90, P1347, DOI 10.1210/jc.2004-1214; Goodman N F, 2001, Endocr Pract, V7, P120; HANCOCK KW, 1974, J OBSTET GYN BR COMM, V81, P804; Harborne L, 2003, LANCET, V361, P1894, DOI 10.1016/S0140-6736(03)13493-9; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; HEINER JS, 1995, J CLIN ENDOCR METAB, V80, P3412, DOI 10.1210/jc.80.12.3412; Hogeveen KN, 2002, J CLIN INVEST, V109, P973, DOI 10.1172/JCI200214060; Kaltsas GA, 2003, J CLIN ENDOCR METAB, V88, P2634, DOI 10.1210/jc.2002-020922; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Krattenmacher R, 2000, CONTRACEPTION, V62, P29, DOI 10.1016/S0010-7824(00)00133-5; Kuhl H, 1996, DRUGS, V51, P188, DOI 10.2165/00003495-199651020-00002; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Lord J.M., 2003, COCHRANE DATABASE SY, DOI [10.1002/14651858.Cd003053, DOI 10.1002/14651858.CD003053]; MARYNICK SP, 1983, NEW ENGL J MED, V308, P981, DOI 10.1056/NEJM198304283081701; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Moghetti P, 2000, J CLIN ENDOCR METAB, V85, P89, DOI 10.1210/jc.85.1.89; MOLL GW, 1979, J CLIN ENDOCR METAB, V49, P730, DOI 10.1210/jcem-49-5-730; Nelson-DeGrave VL, 2004, ENDOCRINOLOGY, V145, P799, DOI 10.1210/en.2003-0940; NESTLER JE, 1991, J CLIN ENDOCR METAB, V72, P83, DOI 10.1210/jcem-72-1-83; Petitti DB, 2003, NEW ENGL J MED, V349, P1443, DOI 10.1056/NEJMcp030751; PETITTI DB, 2004, NEW ENGL J MED, V350, P92; POLSON DW, 1988, LANCET, V1, P870; Quinkler M, 2004, J ENDOCRINOL, V183, P331, DOI 10.1677/joe.1.05762; REINGOLD SB, 1987, ARCH DERMATOL, V123, P209, DOI 10.1001/archderm.123.2.209; RITTMASTER RS, 1988, J CLIN ENDOCR METAB, V67, P400, DOI 10.1210/jcem-67-2-400; Rosenfield R, 1983, ANDROGENIZATION WOME, P25; ROSENFIELD RL, 1979, AM J MED, V66, P417, DOI 10.1016/0002-9343(79)91061-1; ROSENFIELD RL, 1987, J REPROD MED, V32, P363; ROSENFIELD RL, 1971, J CLIN ENDOCR METAB, V32, P717, DOI 10.1210/jcem-32-6-717; ROSENFIELD RL, IN PRESS J INVEST DE; ROSNER W, 1990, ENDOCR REV, V11, P80, DOI 10.1210/edrv-11-1-80; Souter I, 2004, AM J OBSTET GYNECOL, V191, P1914, DOI 10.1016/j.ajog.2004.06.064; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381; Van der Spuy ZM, 2003, COCHRANE DB SYST REV, V4; van Vloten WA, 2004, AM J CLIN DERMATOL, V5, P435, DOI 10.2165/00128071-200405060-00008; Venturoli S, 1999, J CLIN ENDOCR METAB, V84, P1304, DOI 10.1210/jc.84.4.1304; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; WILD RA, 1983, AM J OBSTET GYNECOL, V146, P602, DOI 10.1016/0002-9378(83)90998-5; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377; 1995, INT J GYNAECOL OBSTE, V49, P341	56	163	171	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2578	2588		10.1056/NEJMcp033496	http://dx.doi.org/10.1056/NEJMcp033496			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354894				2022-12-28	WOS:000233926500007
J	Kaaja, RJ; Greer, IA				Kaaja, RJ; Greer, IA			Manifestations of chronic disease during pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; INSULIN-RESISTANCE; INTRAHEPATIC CHOLESTASIS; AUTOIMMUNE-THYROIDITIS; VENOUS THROMBOEMBOLISM; ORAL-CONTRACEPTIVES; CARDIOVASCULAR RISK; MULTIPLE-SCLEROSIS; HIGH PREVALENCE	Context Physiologic changes of pregnancy include insulin resistance, thrombophilia, immunosuppression, and hypervolemia. These changes may herald the development of disease in later life. Objective To summarize current evidence on how pregnancy reveals risk of chronic disease. Evidence Acquisition MEDLINE was searched for articles published between 1990 and 2005 relating pregnancy conditions to the development of chronic disease. Bibliographies and the Web sites of the International Society of Obstetric Medicine and International Society for the Study of Hypertension in Pregnancy were also reviewed. Evidence Synthesis Pregnancy exaggerates atherogeniclike responses, including insulin resistance and dyslipidemia, manifesting as preeclampsia or gestational diabetes. These complications herald an increased risk of postpartum cardiovascular disease, with a 2-fold increased risk of coronary artery disease and stroke. Women with gestational diabetes mellitus can progress to type 2 diabetes mellitus. The rate of progression varies from 6% to 92% depending on diagnostic criteria, race/ethnicity, and duration of surveillance (from 6 months to 28 years). Pregnancy increases risk of venous thrombosis by 7- to 10-fold. Heritable thrombophilia is present in at least 15% of Western populations and underlies at least 50% of gestational venous thromboses. Thus, the proccragulant changes during pregnancy can unmask hereditary thrombophilia. An important adaptation leading to immunotolerance of the fetoplacental unit is a switch from helper T-cell (T-H) 1 dominance to T(H)2 dominance. Patients with a T(H)1-dominant immune disease, such as rheumatoid arthritis or multiple sclerosis, improve during pregnancy. However, rheumatoid arthritis is 5 times more likely to develop after delivery than at any other time. During pregnancy, there is a 50% increase in plasma volume, which can unmask glomerulopathies, peripartum cardiomyopathy, arterial aneurysms, or arteriovenous malformations. Development of intrahepatic cholestasis of pregnancy predicts increased risk of later cholelithiasis. Conclusions The physiologic changes of pregnancy can reveal risk of chronic diseases. Exaggerated responses reflective of the metabolic syndrome are seen in preeclampsia and gestational diabetes and can herald future cardiovascular and metabolic disease. Pregnancy is therefore an important screening opportunity for cardiovascular and metabolic disease risk factors, with the possibility of early intervention.	Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki 00290, Finland; Univ Glasgow, Glasgow Royal Infirm, Dept Obstet & Gynecol, Glasgow G31 2ER, Lanark, Scotland	University of Helsinki; Helsinki University Central Hospital; University of Glasgow	Kaaja, RJ (corresponding author), Helsinki Univ Hosp, Dept Obstet & Gynecol, Haartmaninkatu 2, Helsinki 00290, Finland.	risto.kaaja@hus.fi			NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Shammri S, 2004, J NEUROL SCI, V222, P21, DOI 10.1016/j.jns.2004.03.027; AMINO N, 1982, NEW ENGL J MED, V306, P849, DOI 10.1056/NEJM198204083061405; Barrett J M, 1982, Obstet Gynecol Surv, V37, P557, DOI 10.1097/00006254-198209000-00001; Bates SA, 2004, CHEST, V126, p627S, DOI 10.1378/chest.126.3_suppl.627S; Benjamin SM, 2003, DIABETES CARE, V26, P645, DOI 10.2337/diacare.26.3.645; Bernheim J, 2005, NEPHROL DIAL TRANSPL, V20, P451, DOI 10.1093/ndt/gfh512; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; Bultmann BD, 2005, AM J OBSTET GYNECOL, V193, P363, DOI 10.1016/j.ajog.2005.01.022; BUYON JP, 1999, SYSTEMIC LUPUS ERYTH, P337; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clark CM, 1997, DIABETES CARE, V20, P867, DOI 10.2337/diacare.20.5.867; Clark DA, 1999, AM J REPROD IMMUNOL, V41, P5; Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Conway DL, 1999, AM J OBSTET GYNECOL, V181, P610, DOI 10.1016/S0002-9378(99)70500-4; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DALEN E, 1974, ACTA MED SCAND, V195, P459; Davison John, 1995, P226; Dorup I, 1999, AM J PHYSIOL-HEART C, V276, pH821; Eloranta ML, 2001, CLIN GENET, V60, P42, DOI 10.1034/j.1399-0004.2001.600106.x; FELBO M, 1961, ACTA OBSTET GYN SCAN, V40, P116; Felker GM, 1999, MEDICINE, V78, P270, DOI 10.1097/00005792-199907000-00005; Gavin JR, 1999, DIABETES CARE, V22, pS5; GINSBERG J, 1977, LANCET, V1, P1125; GREER IA, 1989, BRIT J OBSTET GYNAEC, V96, P978, DOI 10.1111/j.1471-0528.1989.tb03358.x; Greer IA, 2003, THROMB RES, V109, P73, DOI 10.1016/S0049-3848(03)00095-1; Haukkamaa L, 2004, AM J CARDIOL, V93, P805, DOI 10.1016/j.amjcard.2003.11.065; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Heider A L, 1999, Obstet Gynecol Surv, V54, P526, DOI 10.1097/00006254-199908000-00023; HORTON JC, 1990, NEUROSURGERY, V27, P867, DOI 10.1227/00006123-199012000-00002; IHLE BU, 1987, BRIT MED J, V294, P79, DOI 10.1136/bmj.294.6564.79; Jacquemin E, 1999, LANCET, V353, P210, DOI 10.1016/S0140-6736(05)77221-4; JANSSON R, 1984, J CLIN ENDOCR METAB, V58, P681, DOI 10.1210/jcem-58-4-681; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Julkunen H, 2001, ARTHRITIS RHEUM, V44, P647, DOI 10.1002/1529-0131(200103)44:3<647::AID-ANR113>3.3.CO;2-9; Jungers P, 1997, KIDNEY INT, V52, P871, DOI 10.1038/ki.1997.408; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; KAAJA R, 1995, OBSTET GYNECOL, V85, P353, DOI 10.1016/0029-7844(94)00380-V; Kaaja RJ, 1999, HYPERTENS PREGNANCY, V18, P173, DOI 10.3109/10641959909023077; Khalil RA, 2002, AM J PHYSIOL-REG I, V283, pR29, DOI 10.1152/ajpregu.00762.2001; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; KJOS SL, 1995, DIABETES, V44, P586, DOI 10.2337/diabetes.44.5.586; Kohno K, 2000, INTERNAL MED, V39, P1013, DOI 10.2169/internalmedicine.39.1013; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; Kuller JA, 2001, AM J OBSTET GYNECOL, V184, P1093, DOI 10.1067/mob.2001.114917; Kupferminc Michael J, 2003, Reprod Biol Endocrinol, V1, P111, DOI 10.1186/1477-7827-1-111; LAATIKAINEN T, 1975, ANN CHIR GYNAECOL FE, V64, P155; Laivuori H, 1998, J CLIN ENDOCR METAB, V83, P344, DOI 10.1210/jc.83.2.344; Laivuori H, 1996, J CLIN ENDOCR METAB, V81, P2908, DOI 10.1210/jc.81.8.2908; Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0; LaRosa JC, 2002, AM HEART J, V144, pS21, DOI 10.1067/mhj.2002.130299; Lauenborg J, 2004, DIABETES CARE, V27, P1194, DOI 10.2337/diacare.27.5.1194; Lensen R, 2000, BRIT J HAEMATOL, V110, P939, DOI 10.1046/j.1365-2141.2000.02236.x; Letsky Elizabeth A., 1995, P33; Martinelli I, 2002, THROMB HAEMOSTASIS, V87, P791; Messerli FH, 2004, J HYPERTENS, V22, P1845, DOI 10.1097/00004872-200410000-00001; Metzger BE, 1998, DIABETES CARE, V21, pB161; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Mostello D, 2002, AM J OBSTET GYNECOL, V187, P425, DOI 10.1067/mob.2002.123608; Muller AF, 2001, ENDOCR REV, V22, P605, DOI 10.1210/er.22.5.605; OKA M, 1953, ANN RHEUM DIS, V12, P227, DOI 10.1136/ard.12.3.227; Ostensen M, 1999, ANN NY ACAD SCI, V876, P131, DOI 10.1111/j.1749-6632.1999.tb07630.x; OTHMAN S, 1990, CLIN ENDOCRINOL, V32, P559, DOI 10.1111/j.1365-2265.1990.tb00898.x; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; Peters RK, 1996, LANCET, V347, P227, DOI 10.1016/S0140-6736(96)90405-5; Popham P, 2003, INT J OBSTET ANESTH, V12, P117, DOI 10.1016/S0959-289X(02)00187-5; POSER S, 1983, NEUROLOGY, V33, P1422, DOI 10.1212/WNL.33.11.1422; Ramsay Ian, 1995, P459; Redberg RF, 2003, PROG CARDIOVASC DIS, V46, P239, DOI 10.1016/j.pcad.2003.09.002; Redman Christopher W. G., 1995, P182; Ridker PM, 2003, AM J CARDIOL, V92, p17K, DOI 10.1016/S0002-9149(03)00774-4; Robertson L, 2005, CURR OPIN OBSTET GYN, V17, P113, DOI 10.1097/01.gco.0000162177.30607.59; ROBERTSON L, IN PRESS BR J HAEMAT; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Rosmorduc O, 2001, GASTROENTEROLOGY, V120, P1459, DOI 10.1053/gast.2001.23947; ROVINSKY JJ, 1965, AM J OBSTET GYNECOL, V93, P1; Ryan EA, 2003, LANCET, V362, P1777, DOI 10.1016/S0140-6736(03)14942-2; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Savander M, 2003, GUT, V52, P1025, DOI 10.1136/gut.52.7.1025; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; Seely EW, 2003, J CLIN ENDOCR METAB, V88, P2393, DOI 10.1210/jc.2003-030241; Shepard Dale R., 2003, Comprehensive Therapy, V29, P7; SILMAN A, 1992, ARTHRITIS RHEUM, V35, P152, DOI 10.1002/art.1780350205; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Sorensen TK, 2003, HYPERTENSION, V41, P1273, DOI 10.1161/01.HYP.0000072270.82815.91; STIRLING Y, 1984, THROMB HAEMOSTASIS, V52, P176; Stoodley MA, 1998, NEUROSURG CLIN N AM, V9, P549; Sundstrom J. Bruce, 2002, Autoimmunity Reviews, V1, P73, DOI 10.1016/S1568-9972(01)00009-X; Suzuki Y, 2002, J PHYSIOL-LONDON, V545, P269, DOI 10.1113/jphysiol.2002.022384; Vig S, 2004, EUR J VASC ENDOVASC, V28, P124, DOI 10.1016/j.ejvs.2004.03.027; Watanabe M, 1997, AM J REPROD IMMUNOL, V37, P368; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104; Wu O, 2005, THROMB HAEMOSTASIS, V94, P17, DOI 10.1160/TH04-11-0759	99	248	269	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2751	2757		10.1001/jama.294.21.2751	http://dx.doi.org/10.1001/jama.294.21.2751			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333011				2022-12-28	WOS:000233726900024
J	Chen, JY; Kutana, A; Collier, CP; Giapis, KP				Chen, JY; Kutana, A; Collier, CP; Giapis, KP			Electrowetting in carbon nanotubes	SCIENCE			English	Article							TIPS; CAPILLARITY; MORPHOLOGY	We demonstrate reversible wetting and fitting of open single-watt carbon nanotubes with mercury by means of electrocapillary pressure originating from the application of a potential across an individual nanotube in contact with a mercury drop. Wetting improves the conductance in both metallic and semiconducting nanotube probes by decreasing contact resistance and forming a mercury nanowire inside the nanotube. Molecular dynamics simulations corroborate the electrocapillary-driven filling process and provide estimates for the imbibition speed and electrocapillary pressure.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Collier, CP (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	collier@caltech.edu; giapis@cheme.caltech.edu	Collier, Charles/C-9206-2016; Kutana, Alex/AAC-1671-2019	Collier, Charles/0000-0002-8198-793X; Kutana, Alex/0000-0001-6405-6466				ADAM NK, 1968, PHYS CHEM SURFACES, P20601; AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Ajayan PM, 1997, REP PROG PHYS, V60, P1025, DOI 10.1088/0034-4885/60/10/001; Awasthi A, 1996, MEAS SCI TECHNOL, V7, P753, DOI 10.1088/0957-0233/7/5/005; Dujardin E, 1998, ADV MATER, V10, P1472, DOI 10.1002/(SICI)1521-4095(199812)10:17<1472::AID-ADMA1472>3.0.CO;2-R; DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850; Ebbesen TW, 1996, J PHYS CHEM SOLIDS, V57, P951, DOI 10.1016/0022-3697(95)00381-9; Fialkowski M, 2004, J PHYS CHEM B, V108, P5026, DOI 10.1021/jp0365413; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Gogotsi Y, 2001, APPL PHYS LETT, V79, P1021, DOI 10.1063/1.1391228; GUERRET-PIECOURT C, 1994, NATURE, V372, P761, DOI 10.1038/372761a0; Hafner JH, 2001, J PHYS CHEM B, V105, P743, DOI 10.1021/jp003498o; HUMMEL RE, 1994, INT MATER REV, V39, P97, DOI 10.1179/095066094790326194; Kiang CH, 1999, J PHYS CHEM B, V103, P7449, DOI 10.1021/jp991424m; Lippmann G., 1875, ANN CHIM PHYS, V5, P494; Martic G, 2002, LANGMUIR, V18, P7971, DOI 10.1021/la020068n; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Monthioux M, 2002, CARBON, V40, P1809, DOI 10.1016/S0008-6223(02)00102-1; Poncharal P, 2002, J PHYS CHEM B, V106, P12104, DOI 10.1021/jp021271u; Prins MWJ, 2001, SCIENCE, V291, P277, DOI 10.1126/science.291.5502.277; Regan BC, 2004, NATURE, V428, P924, DOI 10.1038/nature02496; Shan B, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.233405; Supple S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214501; TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0; Ugarte D, 1996, SCIENCE, V274, P1897, DOI 10.1126/science.274.5294.1897; Wade LA, 2004, NANO LETT, V4, P725, DOI 10.1021/nl049976q; Wilson NR, 2002, J PHYS CHEM B, V106, P13102, DOI 10.1021/jp026583b	27	106	112	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1480	1483		10.1126/science.1120385	http://dx.doi.org/10.1126/science.1120385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322454				2022-12-28	WOS:000233756500040
J	Behnia, R; Munro, S				Behnia, R; Munro, S			Organelle identity and the signposts for membrane traffic	NATURE			English	Review							GUANINE-NUCLEOTIDE-EXCHANGE; PLASMA-MEMBRANE; GOLGI MEMBRANES; RAB GTPASES; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PHOSPHOINOSITIDE METABOLISM; ENDOPLASMIC-RETICULUM; BINDING PROTEINS; ARF; RECRUITMENT	Eukaryotic cells have systems of internal organelles to synthesize lipids and membrane proteins, to release secreted proteins, to take up nutrients and to degrade membrane- bound and internalized molecules. Proteins and lipids move from organelle to organelle using transport vesicles. The accuracy of this traffic depends upon organelles being correctly recognized. In general, organelles are identified by the activated GTPases and specific lipid species that they display. These short- lived determinants provide organelles with an identity that is both unique and flexible. Recent studies have helped to establish how cells maintain and restrict these determinants and explain how this system is exploited by invading pathogens.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sean@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773				Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Banfield DK, 2001, TRENDS BIOCHEM SCI, V26, P67, DOI 10.1016/S0968-0004(00)01744-8; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Calero M, 2002, BIOCHEM BIOPH RES CO, V290, P676, DOI 10.1006/bbrc.2001.6242; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Ellson CD, 2002, J CELL SCI, V115, P1099; Faulhammer F, 2005, J CELL BIOL, V168, P185, DOI 10.1083/jcb.200407118; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Munro S, 2005, CURR OPIN CELL BIOL, V17, P395, DOI 10.1016/j.ceb.2005.06.013; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Robert CH, 2004, J MOL BIOL, V337, P969, DOI 10.1016/j.jmb.2004.01.052; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Roy CR, 2005, P NATL ACAD SCI USA, V102, P1271, DOI 10.1073/pnas.0409531101; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shakoori A, 2003, BIOCHEM BIOPH RES CO, V312, P850, DOI 10.1016/j.bbrc.2003.10.197; Shin HW, 2004, TRENDS BIOCHEM SCI, V29, P513, DOI 10.1016/j.tibs.2004.08.007; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	102	353	368	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					597	604		10.1038/nature04397	http://dx.doi.org/10.1038/nature04397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319879				2022-12-28	WOS:000233593100037
J	Gonen, T; Cheng, YF; Sliz, P; Hiroaki, Y; Fujiyoshi, Y; Harrison, SC; Walz, T				Gonen, T; Cheng, YF; Sliz, P; Hiroaki, Y; Fujiyoshi, Y; Harrison, SC; Walz, T			Lipid-protein interactions in double-layered two-dimensional AQPO crystals	NATURE			English	Article							MAJOR INTRINSIC PROTEIN; HUMAN LENS; WATER PERMEATION; ELECTRON CRYSTALLOGRAPHY; MOLECULAR-BASIS; MEMBRANE; AQUAPORIN-0; CHANNEL; JUNCTIONS; DYNAMICS	Lens- specific aquaporin-O ( AQPO) functions as a specific water pore and forms the thin junctions between fibre cells. Here we describe a 1.9 angstrom resolution structure of junctional AQPO, determined by electron crystallography of double-layered two- dimensional crystals. Comparison of junctional and non- junctional AQPO structures shows that junction formation depends on a conformational switch in an extracellular loop, which may result from cleavage of the cytoplasmic amino and carboxy termini. In the centre of the water pathway, the closed pore in junctional AQPO retains only three water molecules, which are too widely spaced to form hydrogen bonds with each other. Packing interactions between AQPO tetramers in the crystalline array are mediated by lipid molecules, which assume preferred conformations. We were therefore able to build an atomic model for the lipid bilayer surrounding the AQPO tetramers, and we describe lipid - protein interactions.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Kyoto Univ, Dept Biophys, Kitashirakawa Sakyo Ku, Kyoto 6068502, Japan	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Kyoto University	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu	Hiroaki, Yoko/F-8463-2010; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Cheng, Yifan/0000-0001-9535-0369; Sliz, Piotr/0000-0002-6522-0835; Walz, Thomas/0000-0003-2606-2835	NEI NIH HHS [R01 EY015107] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Ball LE, 2003, INVEST OPHTH VIS SCI, V44, P4820, DOI 10.1167/iovs.02-1317; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISTLER J, 1980, FEBS LETT, V111, P73, DOI 10.1016/0014-5793(80)80764-2; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Okamura T, 2003, GENOMICS, V81, P361, DOI 10.1016/S0888-7543(03)00029-6; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; ROY D, 1979, EXP EYE RES, V28, P353, DOI 10.1016/0014-4835(79)90097-6; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schey KL, 2000, INVEST OPHTH VIS SCI, V41, P175; Shiels A, 2000, FASEB J, V14, P2207, DOI 10.1096/fj.99-1071com; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; TAKEMOTO L, 1986, INVEST OPHTH VIS SCI, V27, P443; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Wiener MC, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P97; ZAMPIGHI G, 1982, J CELL BIOL, V93, P175, DOI 10.1083/jcb.93.1.175; Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1	42	500	517	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					633	638		10.1038/nature04321	http://dx.doi.org/10.1038/nature04321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319884	Green Submitted, Green Accepted			2022-12-28	WOS:000233593100042
J	Greene, MF				Greene, MF			Fatal infections associated with mifepristone-induced abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Greene, MF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P724; Christin-Maitre S, 2000, NEW ENGL J MED, V342, P946, DOI 10.1056/NEJM200003303421307	2	15	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2317	2318		10.1056/NEJMp058260	http://dx.doi.org/10.1056/NEJMp058260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319378				2022-12-28	WOS:000233574600001
J	Mayon-White, R				Mayon-White, R			Commentary: Pets - pleasures and problems	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Mayon-White, R (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England.	richard.mayon-white@dphpc.ox.ac.uk						Chen M, 2000, BRIT MED J, V321, P1565, DOI 10.1136/bmj.321.7276.1565; Dalziel DJ, 2003, SEIZURE-EUR J EPILEP, V12, P115, DOI 10.1016/S105913110200225X; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; Guay DRP, 2001, AM J INFECT CONTROL, V29, P178, DOI 10.1067/mic.2001.115873; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252	5	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2005	331	7527					1254	1255		10.1136/bmj.331.7527.1254	http://dx.doi.org/10.1136/bmj.331.7527.1254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308388	Green Published, Bronze			2022-12-28	WOS:000233606800024
J	Church, G				Church, G			Let us go forth and safely multiply	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Church, G (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969				Aldhous P, 2005, NEW SCI, V188, P8; Alibek Ken., 1999, BIOHAZARD; CHURCH GM, 2004, SYNTHETIC CELL PROJE; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Kurzweil R., 2005, SINGULARITY IS NEAR; 2005, STUDY EXPLORE RISKS	6	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2005	438	7067					423	423		10.1038/438423a	http://dx.doi.org/10.1038/438423a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306966	Bronze			2022-12-28	WOS:000233458200022
J	Robinson, EJH; Jackson, DE; Holcombe, M; Ratnieks, FLW				Robinson, EJH; Jackson, DE; Holcombe, M; Ratnieks, FLW			Insect communication - 'No entry' signal in ant foraging	NATURE			English	Editorial Material									Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield; University of Sheffield	Robinson, EJH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	e.robinson@dcs.sheffield.ac.uk	Robinson, Elva J H/AAC-9785-2019	Robinson, Elva/0000-0003-4914-9327				BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Britton N., 1998, Journal of Biological Systems, V6, P315, DOI 10.1142/S0218339098000212; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; Stickland TR, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P83; SUDD J. H., 1957, BRIT JOUR ANIMAL BEHAVIOUR, V5, P104, DOI 10.1016/S0950-5601(57)80005-7; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224	8	113	114	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2005	438	7067					442	442		10.1038/438442a	http://dx.doi.org/10.1038/438442a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306981	Bronze			2022-12-28	WOS:000233458200035
J	Rubin, AI; Chen, EH; Ratner, D				Rubin, AI; Chen, EH; Ratner, D			Current concepts - Basal-cell carcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NONMELANOMA SKIN-CANCER; MOHS MICROGRAPHIC SURGERY; RANDOMIZED CONTROLLED-TRIAL; IMIQUIMOD 5-PERCENT CREAM; PHOTODYNAMIC THERAPY; TREATMENT MODALITIES; SURGICAL EXCISION; RECURRENCE RATES; RISK; MUTATIONS		Columbia Univ, Dept Dermatol, New York, NY 10032 USA	Columbia University	Ratner, D (corresponding author), Columbia Univ, Dept Dermatol, 161 Ft Washington Ave,12th Fl, New York, NY 10032 USA.	dr221@columbia.edu						*AM CANC SOC, 2003, CANC FACTS FIG; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Avril MF, 1997, BRIT J CANCER, V76, P100, DOI 10.1038/bjc.1997.343; Batra RS, 2002, ARCH DERMATOL, V138, P1043, DOI 10.1001/archderm.138.8.1043; Benedetto AV, 2002, J AM ACAD DERMATOL, V47, P727, DOI 10.1067/mjd.2002.124075; Boulinguez S, 2004, BRIT J DERMATOL, V151, P623, DOI 10.1111/j.1365-2133.2004.06135.x; de Vries E, 2004, J INVEST DERMATOL, V123, P634, DOI 10.1111/j.0022-202X.2004.23306.x; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P157, DOI 10.1001/archderm.131.2.157; Geisse J, 2004, J AM ACAD DERMATOL, V50, P722, DOI 10.1016/j.jaad.2003.11.066; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green A, 1999, LANCET, V354, P723; Guo HR, 2001, CANCER CAUSE CONTROL, V12, P909, DOI 10.1023/A:1013712203455; Halpern AC, 2005, INT J DERMATOL, V44, P107, DOI 10.1111/j.1365-4632.2005.02090.x; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Jemec GBE, 2003, TRANSPLANTATION, V75, P253, DOI 10.1097/01.TP.0000044135.92850.75; Kim MY, 2002, J DERMATOL SCI, V29, P1, DOI 10.1016/S0923-1811(01)00170-0; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; Lear JT, 1997, J ROY SOC MED, V90, P371, DOI 10.1177/014107689709000704; Lear JT, 1997, J INVEST DERMATOL, V108, P519, DOI 10.1111/1523-1747.ep12289738; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; Lovatt TJ, 2005, J AM ACAD DERMATOL, V52, P468, DOI 10.1016/j.jaad.2004.08.060; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Montague M, 2001, HEALTH EDUC BEHAV, V28, P290, DOI 10.1177/109019810102800304; *NAT COMPR CANC NE, 2005, COMPL LIB NCCN CLIN; Nijsten TEC, 2003, J INVEST DERMATOL, V121, P252, DOI 10.1046/j.1523-1747.2003.12350.x; Nole Gregory, 2004, Dermatol Ther, V17 Suppl 1, P57, DOI 10.1111/j.1396-0296.2004.04S1007.x; Otley CC, 2005, LANCET, V365, P1226, DOI 10.1016/S0140-6736(05)74804-2; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Rhodes LE, 2004, ARCH DERMATOL, V140, P17, DOI 10.1001/archderm.140.1.17; Robinson JK, 2000, ARCH DERMATOL, V136, P1318, DOI 10.1001/archderm.136.11.1318; Rowe DE, 1995, CLIN DERMATOL, V13, P617, DOI 10.1016/0738-081X(95)00067-P; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Saldanha G, 2003, BRIT J DERMATOL, V148, P195, DOI 10.1046/j.1365-2133.2003.05151.x; SEXTON M, 1990, J AM ACAD DERMATOL, V23, P1118, DOI 10.1016/0190-9622(90)70344-H; Shriner DL, 1998, J AM ACAD DERMATOL, V39, P79, DOI 10.1016/S0190-9622(98)70405-0; Shumack S, 2002, ARCH DERMATOL, V138, P1165, DOI 10.1001/archderm.138.9.1165; SILVERMAN MK, 1992, J DERMATOL SURG ONC, V18, P471, DOI 10.1111/j.1524-4725.1992.tb03307.x; SILVERMAN MK, 1991, J DERMATOL SURG ONC, V17, P713, DOI 10.1111/j.1524-4725.1991.tb03424.x; Smeets NWJ, 2004, LANCET, V364, P1766, DOI 10.1016/S0140-6736(04)17399-6; Smith BJ, 2002, HEALTH PROMOT INT, V17, P51, DOI 10.1093/heapro/17.1.51; SNOW SN, 1994, CANCER-AM CANCER SOC, V73, P328, DOI 10.1002/1097-0142(19940115)73:2<328::AID-CNCR2820730216>3.0.CO;2-U; Stanley MA, 2002, CLIN EXP DERMATOL, V27, P571, DOI 10.1046/j.1365-2230.2002.01151.x; Sterry W, 2002, BRIT J DERMATOL, V147, P1227, DOI 10.1046/j.1365-2133.2002.05069.x; Stryker JE, 2005, ARCH DERMATOL, V141, P491, DOI 10.1001/archderm.141.4.491; Swetter SM, 2003, PREV MED, V36, P164, DOI 10.1016/S0091-7435(02)00027-0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tas S, 2004, EUR J DERMATOL, V14, P96; Thissen MRTM, 1999, ARCH DERMATOL, V135, P1177, DOI 10.1001/archderm.135.10.1177; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; Tilli CMLJ, 2005, BRIT J DERMATOL, V152, P1108, DOI 10.1111/j.1365-2133.2005.06587.x; Veness Michael, 2003, Australas J Dermatol, V44, P159, DOI 10.1046/j.1440-0960.2003.06711.x; Walling HW, 2004, CANCER METAST REV, V23, P389, DOI 10.1023/B:CANC.0000031775.04618.30; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	60	536	560	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2262	2269		10.1056/NEJMra044151	http://dx.doi.org/10.1056/NEJMra044151			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306523				2022-12-28	WOS:000233434500009
J	Kalliala, I; Anttila, A; Pukkala, E; Nieminen, P				Kalliala, I; Anttila, A; Pukkala, E; Nieminen, P			Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HISTORIES; WOMEN	Objective To study the long term risk of cervical and other cancers after treatment for cervical intraepithelial neoplasia. Design Retrospective Cohort study. Setting University Hospital, Helsinki, Finland. Participants 7564 women treated for cervical intraepithelial neoplasia during 1974 and 2001 and followed tip through the Finnish cancer registry until 2003. Main outcome measures Standardised incidence ratio for cervical cancer and other cancers. Results During follow-up 22 cases of invasive cervical cancer occurred in women treated for cervical intraepithelial neoplasia (standardised incidence ratio 2.8, 95% confidence interval 1.7 to 4.2). The highest risk was during the second decade (10 cases observed: 3.1, 1.5 to 5.7). The standardised incidence ratio for cervical intraepithelial cancer type 1 was 3.1 (1.4 to 6.2) and for type 2 was 3.7 (0.9 to 10.7). Conclusions The risk of cervical cancer in the first 20 years after treatment for cervical intraepithelial neoplasia is higher than in the average population. The risk of smoking related cancers is also increased.	Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, FIN-00029 Helsinki, Finland; Finnish Canc Registry, Mass Screening Registry, FIN-00170 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Finnish Cancer Registry	Kalliala, I (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Box 140, FIN-00029 Helsinki, Finland.	ilkka.kalliala@helsinki.fi	Kalliala, Ilkka/ABC-9253-2021; Nieminen, Pekka/W-8570-2019; Kalliala, Ilkka/O-6346-2014	Kalliala, Ilkka/0000-0002-7664-0587; Kalliala, Ilkka/0000-0002-7664-0587				Andersson-Ellstrom A, 2000, ACTA OBSTET GYN SCAN, V79, P221, DOI 10.1034/j.1600-0412.2000.079003221.x; ANTTILA A, 2000, EVALUATING MONITORIN; Baldauf JJ, 1997, ACTA CYTOL, V41, P1431, DOI 10.1159/000332855; Gornall RJ, 2000, INT J GYNECOL CANCER, V10, P198, DOI 10.1046/j.1525-1438.2000.010003198.x; HAKAMA M, 1976, AM J EPIDEMIOL, V103, P512, DOI 10.1093/oxfordjournals.aje.a112253; International Agency for Research on Cancer 'Cervix Cancer Screening, 2005, IARC HDB CANC PREV, V10, P302; Martin-Hirsch P, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001318, DOI 10.1002/14651858.CD001318]; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430	10	103	106	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1183	1185		10.1136/bmj.38663.459039.7C	http://dx.doi.org/10.1136/bmj.38663.459039.7C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293840	Green Published, Bronze			2022-12-28	WOS:000233571000022
J	Prasad, V; Stromberg, CAE; Alimohammadian, H; Sahni, A				Prasad, V; Stromberg, CAE; Alimohammadian, H; Sahni, A			Dinosaur coprolites and the early evolution of grasses and grazers	SCIENCE			English	Article							LAMETA FORMATION; INDIA; AGE; COEVOLUTION; ORIGIN	Silicified plant tissues (phytoliths) preserved in Late Cretaceous coprolites from India show that at least five taxa from extant grass (Poaceae) subclades were present on the Indian subcontinent during the latest Cretaceous. This taxonomic diversity suggests that crown-group Poaceae had diversified and spread in Gondwana before India became geographically isolated. Other phytoliths extracted from the coprolites (from dicotyledons, conifers, and palms) suggest that the suspected dung producers (titanosaur sauropods) fed indiscriminately on a wide range of plants. These data also make plausible the hypothesis that gondwanatherian mammals with hypsodont cheek teeth were grazers.	Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden; Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India; Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India	Swedish Museum of Natural History; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Panjab University	Stromberg, CAE (corresponding author), Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden.	caroline.stromberg@nrm.se		Stromberg, Caroline A. E./0000-0003-0612-0305				[Anonymous], 1939, RECORDS GEOLOGICAL S; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; CHITALEY S D, 1971, Journal of the Indian Botanical Society, V50, P137; Clyde WC, 2003, GEOLOGY, V31, P1097, DOI 10.1130/G19956.1; COURTILLOT V, 1988, NATURE, V333, P843, DOI 10.1038/333843a0; Ghosh P, 2003, CRETACEOUS RES, V24, P743, DOI 10.1016/j.cretres.2003.08.002; Hay WW, 1999, GEOL S AM S, P1; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; KHAJURIA CK, 1994, NEWSL STRATIGR, V31, P21; Krause DW, 2003, ACTA PALAEONTOL POL, V48, P321; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; PATIL GV, 1984, GHOSH COMMEMORATION, P89; Patnaik Rajeev, 2001, Journal of the Palaeontological Society of India, V46, P15; Rana RS, 2003, ACTA PALAEONTOL POL, V48, P331; Rodriguez-de la Rosa RA, 1998, PALAEOGEOGR PALAEOCL, V142, P231, DOI 10.1016/S0031-0182(98)00052-2; SAMANT B, 2003, 19 IND C MICR STRAT; Sharma N, 2005, MICROPALEONTOLOGY, V51, P73, DOI 10.2113/51.1.73; STEBBINS GL, 1981, ANN MO BOT GARD, V68, P75, DOI 10.2307/2398811; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; TRIVEDI BS, 1982, J INDIAN BOT SOC, V61, P320; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1; Widdowson M, 2000, J PETROL, V41, P1177, DOI 10.1093/petrology/41.7.1177; WILSON JA, 1998, MEMOIR SOC VERTEBRAT, V5, P1, DOI DOI 10.2307/3889325	30	320	351	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1177	1180		10.1126/science.1118806	http://dx.doi.org/10.1126/science.1118806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293759				2022-12-28	WOS:000233437300043
J	Bell, S; Wustenberg, B; Kaiser, S; Menges, F; Netscher, T; Pfaltz, A				Bell, S; Wustenberg, B; Kaiser, S; Menges, F; Netscher, T; Pfaltz, A			Asymmetric hydrogenation of unfunctionalized, purely alkyl-substituted olefins	SCIENCE			English	Article							ENANTIOSELECTIVE HYDROGENATION; LIGANDS; STEREOISOMERS	Asymmetric hydrogenation of olefins is one of the most useful reactions for the synthesis of optically active compounds, especially in industry. However, the application range of the catalysts developed so far is limited to alkenes with a coordinating functional group or an aryl substituent next to the double bond. We have found a class of chiral iridium catalysts that give high enantioselectivity in the hydrogenation of unfunctionalized, trialkyl-substituted olefins. Because these catalysts do not require the presence of any particular functional group or aryl substituent in the substrate, they considerably broaden the scope of asymmetric hydrogenation.	Univ Basel, Dept Chem, CH-4056 Basel, Switzerland; DSM Nutr Prod Ltd, Res & Dev, CH-4002 Basel, Switzerland	University of Basel; DSM NV	Bell, S (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.	andreas.pfaltz@unibas.ch						BROENE RD, 1993, J AM CHEM SOC, V115, P12569, DOI 10.1021/ja00079a040; Brown J.M, 1999, COMPREHENSIVE ASYMME, V1, P121; Bunlaksananusorn T, 2003, ANGEW CHEM INT EDIT, V42, P3941, DOI 10.1002/anie.200351936; COHEN N, 1981, HELV CHIM ACTA, V64, P1158, DOI 10.1002/hlca.19810640422; CONTICELLO VP, 1992, J AM CHEM SOC, V114, P2761, DOI 10.1021/ja00033a085; Cui XH, 2005, CHEM REV, V105, P3272, DOI 10.1021/cr0500131; DANHEISER RL, 1991, J ORG CHEM, V56, P1176, DOI 10.1021/jo00003a047; Drury WJ, 2004, ANGEW CHEM INT EDIT, V43, P70, DOI 10.1002/anie.200352755; Fan YB, 2004, J AM CHEM SOC, V126, P16688, DOI 10.1021/ja044240g; KAISER S, 2005, THESIS U BASEL; Kallstrom K, 2004, J AM CHEM SOC, V126, P14308, DOI 10.1021/ja0464241; Knowles W.S., 2004, ASYMMETRIC CATALYSIS, P21; Knowles WS, 2002, ANGEW CHEM INT EDIT, V41, P1999; Lightfoot A, 1998, ANGEW CHEM INT EDIT, V37, P2897, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2897::AID-ANIE2897>3.0.CO;2-8; Liu D, 2004, ORG LETT, V6, P513, DOI 10.1021/ol0362717; Menges F, 2002, ORG LETT, V4, P4713, DOI 10.1021/ol027253c; MENGES F, 2004, THESIS U BASEL; Netscher T, 1996, CHIMIA, V50, P563; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Pfaltz A, 2003, ADV SYNTH CATAL, V345, P33, DOI 10.1002/adsc.200390027; Smidt SP, 2004, CHEM-EUR J, V10, P4685, DOI 10.1002/chem.200400284; Smidt SP, 2004, ORG LETT, V6, P2023, DOI 10.1021/ol049235w; Walther W, 1996, CHIRALITY, V8, P397, DOI 10.1002/(SICI)1520-636X(1996)8:5<397::AID-CHIR7>3.3.CO;2-V; WEDLER C, 1995, J ORG CHEM, V60, P758, DOI 10.1021/jo00108a052; WUSTENBERG B, 2003, THESIS U BASEL	25	251	253	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					642	644		10.1126/science.1121977	http://dx.doi.org/10.1126/science.1121977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	011GY	16339409				2022-12-28	WOS:000235257400042
J	Bhat, N; Wright, JG; Broder, KR; Murray, EL; Greenberg, ME; Glover, MJ; Likos, AM; Posey, DL; Klimov, A; Lindstrom, SE; Balish, A; Medina, MJ; Wallis, TR; Guarner, J; Paddock, CD; Shieh, WJ; Zaki, SR; Sejvar, JJ; Shay, DK; Harper, SA; Cox, NJ; Fukuda, K; Uyeki, TM				Bhat, N; Wright, JG; Broder, KR; Murray, EL; Greenberg, ME; Glover, MJ; Likos, AM; Posey, DL; Klimov, A; Lindstrom, SE; Balish, A; Medina, MJ; Wallis, TR; Guarner, J; Paddock, CD; Shieh, WJ; Zaki, SR; Sejvar, JJ; Shay, DK; Harper, SA; Cox, NJ; Fukuda, K; Uyeki, TM		Influenza Special Investigations T	Influenza-associated deaths among children in the United States, 2003-2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; OUTPATIENT VISITS; HOSPITALIZATIONS; MORTALITY; INFANTS; INFECTION; ILLNESS; BURDEN	BACKGROUND: Although influenza is common among children, pediatric mortality related to laboratory-confirmed influenza has not been assessed nationally. METHODS: During the 2003-2004 influenza season, we requested that state health departments report any death associated with laboratory-confirmed influenza in a U.S. resident younger than 18 years of age. Case reports, medical records, and autopsy reports were reviewed, and available influenza-virus isolates were analyzed at the Centers for Disease Control and Prevention. RESULTS: One hundred fifty-three influenza-associated deaths among children were reported by 40 state health departments. The median age of the children was three years, and 96 of them (63 percent) were younger than five years old. Forty-seven of the children (31 percent) died outside a hospital setting, and 45 (29 percent) died within three days after the onset of illness. Bacterial coinfections were identified in 24 of the 102 children tested (24 percent). Thirty-three percent of the children had an underlying condition recognized to increase the risk of influenza-related complications, and 20 percent had other chronic conditions; 47 percent had previously been healthy. Chronic neurologic or neuromuscular conditions were present in one third. The mortality rate was highest among children younger than six months of age (0.88 per 100,000 children; 95 percent confidence interval, 0.52 to 1.39 per 100,000). CONCLUSIONS: A substantial number of influenza-associated deaths occurred among U.S. children during the 2003-2004 influenza season. High priority should be given to improvements in influenza-vaccine coverage and improvements in the diagnosis and treatment of influenza to reduce childhood mortality from influenza.	CDC, Epidem Intelligence Serv,Career Dev Div, Off Workforce & Career Dev, Div Viral & Rickettsial Div,Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDC, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDC, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bhat, N (corresponding author), CDC, Epidem Intelligence Serv,Career Dev Div, Off Workforce & Career Dev, Div Viral & Rickettsial Div,Natl Ctr Infect Dis, Mailstop A-32,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	nbhat@cdc.gov	Greenberg, Michael E/AGZ-9651-2022; Fischer, Thea K/AAH-9892-2019; Guarner, Jeannette/B-8273-2013	Fischer, Thea K/0000-0003-4812-980X; Guarner, Jeannette/0000-0001-5610-3541; Fukuda, Keiji/0000-0002-9598-9565; Shay, David/0000-0001-9619-4820				BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; BRIDGES CB, 2003, MMWR-MORBID MORTAL W, V52, P526; BROCKLEBANK JT, 1972, LANCET, V2, P497; *CDCP, 2005, 2004 05 US INFL SEAS; *CENS BUR, 2003, ANN EST POP SEX RAC; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P837; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Council of State and Territorial Epidemiologists, 2004, INFL ASS PED MORT; *EM INF PROGR NETW, 2004, STREPT PNEUM 2003 AC; Erhart LM, 2004, J PEDIATR-US, V144, P191, DOI 10.1016/j.jpeds.2003.11.007; Gindler J, 2004, J INFECT DIS, V189, pS69, DOI 10.1086/378565; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; HAMILTON BE, 2004, DHHS PUBLICATION; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kappagoda C, 2000, J PAEDIATR CHILD H, V36, P318, DOI 10.1046/j.1440-1754.2000.00507.x; Kendal AP, 1982, CONCEPTS PROCEDURES; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shui I., 2004, Morbidity and Mortality Weekly Report, V52, P1286; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; VARGOSKO AJ, 1959, NEW ENGL J MED, V261, P1, DOI 10.1056/NEJM195907022610101; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; 2004, MMWR MORB MORTAL WKL, V52, P1254	36	475	508	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2559	2567		10.1056/NEJMoa051721	http://dx.doi.org/10.1056/NEJMoa051721			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354892				2022-12-28	WOS:000233926500005
J	Alonso, PL; Sacarlal, J; Aponte, JJ; Leach, A; Macete, E; Aide, P; Sigauque, B; Milman, J; Mandomando, I; Bassat, Q; Guinovart, C; Espasa, M; Corachan, S; Lievens, M; Navia, MM; Dubois, MC; Menendez, C; Dubovsky, F; Cohen, J; Thompson, R; Ballou, WR				Alonso, PL; Sacarlal, J; Aponte, JJ; Leach, A; Macete, E; Aide, P; Sigauque, B; Milman, J; Mandomando, I; Bassat, Q; Guinovart, C; Espasa, M; Corachan, S; Lievens, M; Navia, MM; Dubois, MC; Menendez, C; Dubovsky, F; Cohen, J; Thompson, R; Ballou, WR			Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial	LANCET			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; EFFICACY; INFECTION; RESPONSES; RTS,S	Background RTS,S/AS02A is a pre-erythrocytic stage malaria vaccine that provides partial protection against infection in malaria-naive adult volunteers and hyperimmune adults. A previous report showed that this vaccine reduced risk of clinical malaria, delayed time to new infection, and reduced episodes of severe malaria over 6 months in African children. An important remaining issue is the durability of protection against clinical disease in these children. Methods We did a randomised, controlled, phase IIb trial of RTS,S/AS02A given at 0, 1, and 2 months in 2022 Mozambican children aged 1-4 years. We previously determined vaccine efficacy (VE) against clinical malaria in a double-blind phase that included study months 2.5-8.5 (VE2 5-8 5). We now report VE in a single-blind phase up to month 21 (VE8 5-21). The primary endpoint was time to first or only clinical episode of Plasmodium falciparum malaria (axillary temperature >= 37.5 degrees C and P falciparum asexual parasitaemia >2500 per mu L) detected through a passive case detection system. We also determined VE for other case definitions and for episodes of severe malaria. This study is registered with the ClinicalTrials.gov identifier NCT00197041. Findings During the single-blind phase, VE(8 5-21) was 28.9% (95% CI 8.4-44.8; p=0.008). At month 21, prevalence of P falciparum infection was 29% lower in the RTS,S/AS02A group than in the control (p=0.017). Considering the entire study period, VE(2 5-21) was 35.3% (95% CI 21.6-46.6; p<0.0001) and VE(2 5-21) for severe malaria was 48.6% (95% CI 12.3-71.0; p=0.02). Interpretation These results show that RTS,S/AS02A confers partial protection in African children aged 1-4 years living in rural endemic areas against a range of clinical disease caused by P falciparum for at least 18 months, and confirm the potential of malaria vaccines to become credible control tools for public-health use.	Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Ctr Salut Int, E-08036 Barcelona, Spain; Minist Saude, Ctr Invest Saude Manhica, Maputo, Mozambique; Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; Minist Saude, Direccao Nacl Saude, Inst Nacl Saude, Maputo, Mozambique; GlaxoSmithKline Biol, Rixensart, Belgium; PATH Malaria Vaccine Initiat, Bethesda, MD USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University; GlaxoSmithKline	Alonso, PL (corresponding author), Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Ctr Salut Int, Villarroel 170, E-08036 Barcelona, Spain.	palonso@clinic.ub.es	ESPASA, MATEU/L-4587-2014; Mandomando, Inacio/ABD-8007-2020; Sacarlal, Jahit/R-3172-2016; Alonso, Pedro L/AAZ-3645-2020; Aide, Pedro/D-8771-2018; Menéndez, Clara/Q-3446-2016; Guinovart, Caterina/ABH-2981-2020; Leach, Amanda/AAS-1120-2020; Bassat, Quique/P-2341-2016	ESPASA, MATEU/0000-0003-4822-1024; Mandomando, Inacio/0000-0002-1078-2187; Sacarlal, Jahit/0000-0003-1059-217X; Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Leach, Amanda/0000-0002-7114-9967; Bassat, Quique/0000-0003-0875-7596				ALONSO PL, 1991, LANCET, V338, P897, DOI 10.1016/0140-6736(91)91564-B; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alonso PL, 2002, POPULATION HLTH DEV, P189; Ballou W Ripley, 2005, Expert Opin Emerg Drugs, V10, P489, DOI 10.1517/14728214.10.3.489; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; GRAVES P, 2003, COCHRANE DB SYST REV, V1; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; MOORTHY VS, 2004, PLOS MED, DOI DOI 10.1371/JOURNAL.PMED0010033; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; Smith PG, 2005, LANCET, V365, P472; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; *WHO, 2000, WHO MAN SEV MAL PRAC	16	298	312	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2012	2018		10.1016/S0140-6736(05)67669-6	http://dx.doi.org/10.1016/S0140-6736(05)67669-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338450				2022-12-28	WOS:000233826900020
J	Laumon, B; Gadegbeku, B; Martin, JL; Biecheler, MB				Laumon, B; Gadegbeku, B; Martin, JL; Biecheler, MB		SAM Grp	Cannabis intoxication and fatal road crashes in France: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							MOTOR-VEHICLE CRASHES; RESPONSIBILITY ANALYSIS; DRIVER CULPABILITY; ATTRIBUTABLE RISK; TRAFFIC CRASHES; INJURED DRIVERS; ALCOHOL; DRUGS; BENZODIAZEPINES; STIMULANTS	Objectives To evaluate the relative risk of being responsible for a fatal crash while driving under die influence of cannabis, the prevalence of such drivers within the driving population, and the corresponding share of fatal crashes. Design Population based case-control study. Participants 10 748 drivers, with known drug and alcohol concentrations, who were involved in fatal crashes in France from October 2001 to September 2003. Main outcome measures The cases were the 6766 drivers considered at fault in their crash; the controls were 3006 drivers selected from the 3982 other drivers. Positive detection of cannabis was defined as a blood concentration of Delta(9) tetrahydrocannabinol of over 1 ng/ml. The prevalence of positive drivers in the driving population was estimated by standardising controls off drivers not at fault who were involved in crashes resulting in slight injuries. Results 681 drivers were positive for cannabis (cases 8.8%, controls 2.8% including 285 with an illegal blood alcohol concentration (>= 0.5 g/l). Positive cannabis detection was associated with increased risk of responsibility (odds ratio 3.32, 95% confidence interval 2.63 to 4.18). A significant dose effect was identified; the odds ratio increased from 2.18 (1.22 to 3.89) if 0 < Delta(9) tetrahydrocarmabinol < 1 ng/ml to 4.72 (3.04 to 7.33) if Delta(9) tetrahydrocarniabinol >= 5 ng/ml. The effect of cannabis remains significant after adjustment for different cofactors, including alcohol, with which no statistical interaction was observed. The prevalence of cannabis (2.9%) estimated for the driving population is similar to that for alcohol (2.7%). At least 2.5% (1.5% to 3.5%) of fatal crashes were estimated as being attributable to cannabis, compared with 28.6% for alcohol (26.8% to 30.5%). Conclusions Driving under the influence of cannabis increases the risk of involvement in a crash. However, in France its share in fatal crashes is significantly lower than that associated with positive blood alcohol concentration.	French Natl Inst Transport & Safety Res INRETS, Epidemiol Res & Surveillance Unit Transport Occup, F-69675 Bron, France; Univ Lyon 1, INRETS, Inst Veille Sanitaire InVS UMRESTTE, F-69622 Villeurbanne, France	Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS); Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS)	Laumon, B (corresponding author), French Natl Inst Transport & Safety Res INRETS, Epidemiol Res & Surveillance Unit Transport Occup, 25 Ave Francois Mitterrand, F-69675 Bron, France.	bernard.laumon@inrets.fr	Martin, Jean-Louis/X-6588-2019; Gadegbeku, Blandine/AAE-3618-2019	Martin, Jean-Louis/0000-0002-3426-9601; Gadegbeku, Blandine/0000-0001-6720-206X				ASSAILLY JP, 2002, CONDUITE AUTOMOBILE, P87; Bates MN, 1999, EPIDEMIOL REV, V21, P222, DOI 10.1093/oxfordjournals.epirev.a017998; Berghaus G., 1995, P 13 INT C ALC DRUGS, P403; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; Davis G. A., 1993, TRANSPORT RES REC, V1401, P43; DiCiccio TJ, 1996, STAT SCI, V11, P189; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Drummer OH, 2003, FORENSIC SCI INT, V134, P154, DOI 10.1016/S0379-0738(03)00134-8; DUSSAULT C, 2002, ALCOHOL DRUGS TRAFFI, P423; Evans L., 1991, TRAFFIC SAFETY DRIVE; Everett SA, 1999, ACCIDENT ANAL PREV, V31, P667, DOI 10.1016/S0001-4575(99)00027-5; HUESTIS MA, 1992, J ANAL TOXICOL, V16, P276, DOI 10.1093/jat/16.5.276; *INSERM, 2001, CANN QUELS EFF COMP, P165; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; LATNERS C, 2000, 809020 US DOT HS NAT; LAUMON B, 2005, STUPEFIANTS ACCIDE 3; Liguori A, 1998, BEHAV PHARMACOL, V9, P599, DOI 10.1097/00008877-199811000-00015; Llorca J, 2000, STAT MED, V19, P1089, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1089::AID-SIM411>3.0.CO;2-0; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P623, DOI 10.1016/S0001-4575(99)00110-4; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P613, DOI 10.1016/S0001-4575(99)00111-6; Mann RE, 2003, IMPACTS CANNABIS DRI; MOSKOWITZ H, 1985, ACCIDENT ANAL PREV, V17, P323, DOI 10.1016/0001-4575(85)90034-X; *ONISR, 2003, SEC ROUL FRANC BIL A, P137; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; ROBBE H, 1999, 808939 US DOT HS NAT; Roberts RG, 1994, AUSTR ABORIGINAL STU, V2, P2; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; Rothman K., 1998, MODERN EPIDEMIOLOGY; SEXTON B, 2000, 477 TRL, P106; SMILEY A, 1998, MARIJUANA ON ROAD DR, P526; TERHUNE KW, 1983, ACCIDENT ANAL PREV, V15, P237, DOI 10.1016/0001-4575(83)90024-6; VERSTRAETE A, 2004, ROAD TRAFFIC PSYCHOA, P155	32	200	208	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1371	1374		10.1136/bmj.38648.617986.1F	http://dx.doi.org/10.1136/bmj.38648.617986.1F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16321993	Green Published, Bronze			2022-12-28	WOS:000233999300018
J	Sall, M; Sylla, J				Sall, M; Sylla, J			African Prime Ministers take lead in child survival	LANCET			English	Editorial Material												bndiaye@clm.sn						Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; *MIN SANT PREV MED, 2005, SEN ENQ DEM SANT 200; 2005, LANCET, V365, P2152	3	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					1988	1989		10.1016/S0140-6736(05)67796-3	http://dx.doi.org/10.1016/S0140-6736(05)67796-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991PW	16338438				2022-12-28	WOS:000233826900005
J	Rustichini, A				Rustichini, A			Emotion and reason in making decisions	SCIENCE			English	Editorial Material							MODEL UNCERTAINTY; AMBIGUITY; CHOICE		Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Rustichini, A (corresponding author), Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA.	arust@econ.umn.edu						Chamberlain G, 2001, AM ECON REV, V91, P55, DOI 10.1257/aer.91.2.55; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Epstein LG, 2001, AM ECON REV, V91, P45, DOI 10.1257/aer.91.2.45; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Hansen LP, 2001, AM ECON REV, V91, P60, DOI 10.1257/aer.91.2.60; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Sims CA, 2001, AM ECON REV, V91, P51, DOI 10.1257/aer.91.2.51; SNELL J, 2005, SOC NEUR M WASH DC 1	10	31	32	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1624	1625		10.1126/science.1122179	http://dx.doi.org/10.1126/science.1122179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993NV	16339434				2022-12-28	WOS:000233961700029
J	Bradbury, AW; Ruckley, CV; Fowkes, FGR; Forbes, JF; Gillespie, I; Adam, DJ; Beard, JD; Cleveland, T; Bell, J; Raab, G; Storkey, H				Bradbury, AW; Ruckley, CV; Fowkes, FGR; Forbes, JF; Gillespie, I; Adam, DJ; Beard, JD; Cleveland, T; Bell, J; Raab, G; Storkey, H		BASIL Trial Participants	Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial	LANCET			English	Article							PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SEVERE LIMB ISCHEMIA; SUBINTIMAL ANGIOPLASTY; MANAGEMENT; SURGERY; DISEASE	Background The treatment of rest pain, ulceration, and gangrene of the leg (severe limb ischaemia) remains controversial. We instigated the BASIL trial to compare the Outcome of bypass surgery and balloon angioplasty in such patients. Methods We randomly assigned 452 patients, who presented to 27 UK hospitals with severe limb ischaemia due to infra-inguinal disease, to receive a surgery-first (n=228) or an angioplasty-first (n=224) strategy. The primary endpoint was amputation (of trial leg) free survival. Analysis was by intention to treat. The BASIL trial is registered with the National Research Register (NRR) and as an International Standard Randomised Controlled Trial, number ISRCTN45398889. Findings The trial ran for 5.5 years, and follow-up finished when patients reached an endpoint (amputation of trial leg above the ankle or death). Seven individuals were lost to follow-up after randomisation (three assigned angioplasty, two surgery); of these, three were lost (one angioplasty, two surgery) during the first year of follow-up. 195 (86%) of 228 patients assigned to bypass surgery and 216 (96%) of 224 to balloon angioplasty underwent an attempt at their allocated intervention at a median (IQR) of 6 (3-16) and 6 (2-20) days after randomisation, respectively. At the end of follow-up, 248 (55%) patients were alive without amputation (of trial leg), 38 (8%) alive with amputation, 36 (8%) dead after amputation, and 130 (29%) dead without amputation. After 6 months, the two strategies did not differ significantly in amputation-free survival (48 vs 60 patients; unadjusted hazard ratio 1.07, 95% CI 0.72-1.6; adjusted hazard ratio 0.73, 0.49-1.07). We saw no difference in health-related quality of life between the two strategies, but for the first year the hospital costs associated with a surgery-first strategy were about one third higher than those with an angioplasty-first strategy. Interpretation In patients presenting with severe limb ischaemia due to infra-inguinal disease and who are suitable for surgery and angioplasty, a bypass-surgery-first and a balloon-angioplasty-first strategy are associated with broadly similar outcomes in terms of amputation-free survival, and in the short-term, surgery is more expensive than angioplasty.	Univ Birmingham, Heart England NHS Fdn Trust, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England; Aberdeen Royal Infirm, Aberdeen, Scotland; Ayr Hosp, Ayr, Scotland; City Hosp, Birmingham, W Midlands, England; Royal Edinburgh Infirm, Edinburgh, Midlothian, Scotland; Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; Gartnavel Royal Hosp, Glasgow G12 0YN, Lanark, Scotland; Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; Good Hope Hosp, Birmingham, W Midlands, England; Leicester Royal Infirm, Leicester, Leics, England; Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; New Cross Hosp, Wolverhampton, England; Ninewells Hosp, Dundee DD1 9SY, Scotland; Norfolk & Norwich Hosp, Norwich NR1 3SR, Norfolk, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; Queen Elizabeth Hosp, Gateshead, England; Queen Margaret Hosp, Dunfermline, Fife, Scotland; Royal Bolton Infirm, Bolton, England; Royal Free Hosp, London NW3 2QG, England; Russells Hall Hosp, Dudley, England; Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England; So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; Staffordshire Gen Hosp, Stafford, England; St George Hosp, London, England; St James Hosp, Leeds LS9 7TF, W Yorkshire, England; Walsall Manor Hosp, Walsall, W Midlands, England; Wythenshawe Hosp, Manchester M23 9LT, Lancs, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Aberdeen; University of Birmingham; Royal Infirmary of Edinburgh; Newcastle Freeman Hospital; Newcastle University - UK; Gartnavel Royal Hospital; University of Glasgow; Birmingham City University; Heart of England NHS Foundation Trust; Good Hope Hospital; University of Leicester; University of Manchester; New Cross Hospital; University of Dundee; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Northern General Hospital; Royal Bolton Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Russells Hall Hospital; University of Glasgow; St Georges University London; Saint James's University Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Bradbury, AW (corresponding author), Univ Birmingham, Heart England NHS Fdn Trust, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England.		Forbes, John F/L-2558-2013	Forbes, John F/0000-0002-8255-3762	Department of Health [96/05/01] Funding Source: Medline; National Institute for Health Research [96/05/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Al-Omran M, 2003, J VASC SURG, V38, P279, DOI 10.1016/S0741-5214(03)00274-X; Albers M, 2005, J VASC SURG, V42, P449, DOI 10.1016/j.jvs.2005.05.031; [Anonymous], 2000, Eur J Vasc Endovasc Surg, V19 Suppl A, pS144; Atar E, 2005, EUR J RADIOL, V53, P287, DOI 10.1016/j.ejrad.2004.02.016; Baird RN, 2003, ACTA CHIR BELG, V103, P383; Baker D., 2000, COCHRANE DB SYST REV, V3; Bates MC, 2004, J ENDOVASC THER, V11, P107, DOI 10.1583/04-1324.1; Bell J, 2000, VASCULAR ENDOVASCULA, P485; Bradbury A, 2004, J VASC SURG, V39, P1026, DOI 10.1016/j.jvs.2004.01.031; Bradbury AW, 2002, EUR J VASC ENDOVASC, V24, P411, DOI 10.1053/ejvs.2002.1709; Bradbury AW, 1996, LANCET, V347, P277, DOI 10.1016/S0140-6736(96)90460-2; BRADBURY AW, 2003, VASCULAR ENDOVASCULA, P295; Burns P, 2003, BMJ-BRIT MED J, V326, P584, DOI 10.1136/bmj.326.7389.584; Caruana MF, 2005, EUR J VASC ENDOVASC, V29, P443, DOI 10.1016/j.ejvs.2005.01.015; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Clair DG, 2005, ANN VASC SURG, V19, P63, DOI 10.1007/s10016-004-0136-0; Conte MS, 2005, J VASC SURG, V42, P456, DOI 10.1016/j.jvs.2005.05.001; Desgranges P, 2004, EUR J VASC ENDOVASC, V28, P138, DOI 10.1016/j.ejvs.2004.02.020; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Giswold ME, 2003, J VASC SURG, V37, P47, DOI 10.1067/mva.2003.4; Hernandez-Osma E, 2002, EUR J VASC ENDOVASC, V23, P491, DOI 10.1053/ejvs.2002.1644; Hobbs SD, 2005, EUR J VASC ENDOVASC, V29, P301, DOI 10.1016/j.ejvs.2004.11.002; Holm J, 1991, Eur J Vasc Surg, V5, P517, DOI 10.1016/S0950-821X(05)80338-X; Ishii Yoshiyori, 2004, Vascular, V12, P225, DOI 10.2310/6670.2004.00021; Jackson MJ, 2001, ACTA CHIR BELG, V101, P6; Lipsitz EC, 2004, J ENDOVASC THER, V11, P269, DOI 10.1583/03-1149.1; Lipsitz EC, 2004, J CARDIOVASC SURG, V45, P231; Loftus IM, 2004, J CARDIOVASC SURG, V45, P217; MICHAELS J, 2000, HLTH TECHNOL ASSESS, V4; Nasr MK, 2002, EUR J VASC ENDOVASC, V23, P398, DOI 10.1053/ejvs.2002.1615; Nguyen LL, 2004, J VASC SURG, V40, P916, DOI 10.1016/j.jvs.2004.08.038; *NHS NAT SERV SCOT, 2004, SCOTT HLTH SERV COST; Papavassiliou VG, 2003, EUR J VASC ENDOVASC, V25, P125, DOI 10.1053/ejvs.2002.1822; Roddy SP, 2003, J VASC SURG, V37, P399, DOI 10.1067/mva.2003.99; Saketkhoo Ramin R, 2004, Tech Vasc Interv Radiol, V7, P23, DOI 10.1053/j.tvir.2004.01.006; Salas CA, 2004, EUR J VASC ENDOVASC, V28, P142, DOI 10.1016/j.ejvs.2004.03.023; Schermerhorn ML, 2003, ANNU REV MED, V54, P269, DOI 10.1146/annurev.med.54.101601.152509; Surowiec SM, 2005, J VASC SURG, V41, P269, DOI 10.1016/j.jvs.2004.11.031; Tartari Stefano, 2004, Radiol Med, V108, P265; Tefera G, 2005, J VASC SURG, V41, P988, DOI 10.1016/j.jvs.2005.03.018; Treiman GS, 2004, SURG CLIN N AM, V84, P1365, DOI 10.1016/j.suc.2004.04.010; Trocciola SM, 2005, AM SURGEON, V71, P474; Tsetis D, 2004, BRIT J RADIOL, V77, P1007, DOI 10.1259/bjr/97382129; van der Zaag ES, 2004, EUR J VASC ENDOVASC, V28, P132, DOI 10.1016/j.ejvs.2004.04.003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WARE JE, 2000, SCORE VERSION 2 SF3; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILSON SE, 1989, J VASC SURG, V9, P1, DOI 10.1067/mva.1989.vs0090001; Wolfe JHN, 1997, EUR J VASC ENDOVASC, V13, P578, DOI 10.1016/S1078-5884(97)80067-6; Wolfle KD, 2003, EUR J VASC ENDOVASC, V25, P229, DOI 10.1053/ejvs.2002.1849	51	1370	1461	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1925	1934		10.1016/S0140-6736(05)67707-5	http://dx.doi.org/10.1016/S0140-6736(05)67707-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325694				2022-12-28	WOS:000233777900020
J	Ojha, A; Anand, M; Bhatt, A; Kremer, L; Jacobs, WR; Hatfull, GF				Ojha, A; Anand, M; Bhatt, A; Kremer, L; Jacobs, WR; Hatfull, GF			GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria	CELL			English	Article							KETOACYL-ACP SYNTHASE; HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; ISONIAZID RESISTANCE; CRYSTAL-STRUCTURE; TUBERCULOSIS; KASA; GENE; VIRULENCE; SMEGMATIS	Mycobacteria are unusual in encoding two GroEL paralogs, GroEL1 and GroEL2. GroEL2 is essential-presumably providing the housekeeping chaperone functions-while groEL1 is nonessential, contains the attB site for phage Bxb1 integration, and encodes a putative chaperone with unusual structural features. Inactivation of the Mycobacterium smegmatis groEL1 gene by phage Bxb1 integration allows normal planktonic growth but prevents the formation of mature biofilms. GroEL1 modulates synthesis of mycolates-long-chain fatty acid components of the mycobacterial cell wall-specifically during biofilm formation and physically associates with KasA, a key component of the type II Fatty Acid Synthase involved in mycolic acid synthesis. Biofilm formation is associated with elevated synthesis of short-chain (C-56-C-68) fatty acids, and strains with altered mycolate profiles-including an InhA mutant resistant to the antituberculosis drug isoniazid and a strain overexpressing KasA-are defective in biofilm formation.	UIiv Pittsburgh, Dept Biol Sci, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; Univ Montpellier 2, CNRS, UMR 5539, Lab Dynam Mol Interact Membranires, F-34095 Montpellier, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hatfull, GF (corresponding author), UIiv Pittsburgh, Dept Biol Sci, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Jacobs, William/0000-0003-3321-3080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R01AI028927, R22AI026170, R01AI026170, R29AI028927] Funding Source: NIH RePORTER; NIAID NIH HHS [AI26170, AI28927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barreiro C, 2005, J BACTERIOL, V187, P884, DOI 10.1128/JB.187.3.884-889.2005; Beloin C, 2005, TRENDS MICROBIOL, V13, P16, DOI 10.1016/j.tim.2004.11.008; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Coates Anthony R. M., 1996, P267, DOI 10.1016/B978-012237455-5/50011-7; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fisher MT, 1998, BIOCHEMISTRY-MOSCOW+, V63, P382; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grimaud R, 1998, J BACTERIOL, V180, P1148, DOI 10.1128/JB.180.5.1148-1153.1998; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; HARTL DL, 1992, GENETICA, V86, P47, DOI 10.1007/BF00133710; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P136, DOI 10.1073/pnas.75.1.136; HERMAN C, 2000, ENCY MICROBIOLOGY, P598; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; HUSSON RN, 1987, P NATL ACAD SCI USA, V84, P1679, DOI 10.1073/pnas.84.6.1679; Karlin S, 2000, P NATL ACAD SCI USA, V97, P11348, DOI 10.1073/pnas.97.21.11348; Kim AI, 2003, MOL MICROBIOL, V50, P463, DOI 10.1046/j.1365-2958.2003.03723.x; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; KONG TH, 1993, P NATL ACAD SCI USA, V90, P2608, DOI 10.1073/pnas.90.7.2608; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kressel AB, 2001, INFECT CONT HOSP EP, V22, P414, DOI 10.1086/501926; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lewis William M. Jr., 2000, Lakes Reservoirs Research and Management, V5, P35, DOI 10.1046/j.1440-1770.2000.00091.x; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; OGAWA J, 1995, GENE DEV, V9, P714, DOI 10.1101/gad.9.6.714; ORME IM, 1993, J IMMUNOL, V151, P518; PRIMM TP, 2004, J BACTERIOL, V183, P5718; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Rose L, 2004, MICROBES INFECT, V6, P965, DOI 10.1016/j.micinf.2004.05.011; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; SCHULZEROBBECKE R, 1992, TUBERCLE LUNG DIS, V73, P141, DOI 10.1016/0962-8479(92)90147-C; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Taneja B, 2001, PROTEIN ENG, V14, P391, DOI 10.1093/protein/14.6.391; Teng R, 2003, FEMS MICROBIOL LETT, V227, P171, DOI 10.1016/S0378-1097(03)00584-6; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x	70	270	276	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					861	873		10.1016/j.cell.2005.09.012	http://dx.doi.org/10.1016/j.cell.2005.09.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325580	Bronze			2022-12-28	WOS:000233814100019
J	Solter, D				Solter, D			Politically correct human embryonic stemm cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLASTOMERES		Max Planck Inst Immunbiol, Dept Dev Biol, D-7800 Freiburg, Germany	Max Planck Society	Solter, D (corresponding author), Max Planck Inst Immunbiol, Dept Dev Biol, Stubeweg 51, D-7800 Freiburg, Germany.		Solter, Davor/Q-5476-2019					CHUNG Y, IN PRESS NATURE; MEISSNER A, IN PRESS NATURE; MOORE NW, 1968, J REPROD FERTIL, V17, P527, DOI 10.1530/jrf.0.0170527; Wade Nicholas, 2005, NY TIMES        1017; WILLADSEN SM, 1981, J EMBRYOL EXP MORPH, V65, P165	5	21	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2321	2323		10.1056/NEJMp058283	http://dx.doi.org/10.1056/NEJMp058283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988EO	16319380				2022-12-28	WOS:000233574600003
J	Palmer, S; Brown, D; Morgan, D				Palmer, S; Brown, D; Morgan, D			Early qualitative risk assessment of the emerging zoonotic potential of animal diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEPATITIS-E VIRUS; BOVINE ENTERIC CALICIVIRUSES; MOLECULAR CHARACTERIZATION; PUBLIC-HEALTH; INFECTION; IDENTIFICATION; ANTIBODIES; XENOTRANSPLANTATION; PREVALENCE; HUMANS		Cardiff Univ, Dept Epidemiol Stat & Publ Hlth, Cardiff CF4 4XN, S Glam, Wales; Hlth Protect Agcy, Ctr Infect, London NW9 5HT, England	Cardiff University; Health Protection Agency	Palmer, S (corresponding author), Cardiff Univ, Dept Epidemiol Stat & Publ Hlth, Cardiff CF4 4XN, S Glam, Wales.	palmersr@cardiff.ac.uk						Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Audelo-del-Valle J, 2003, EMERG INFECT DIS, V9, P265; Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; Boneva RS, 2004, ANN MED, V36, P504, DOI 10.1080/07853890410018826; Brown KE, 2004, J INFECT DIS, V190, P1900, DOI 10.1086/425420; *CAB OFF STRAT UN, 2002, RISK IMPR GOV CAP HA; Cash RA, 2000, B WORLD HEALTH ORGAN, V78, P1358; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Chalmers RM, 2005, QJM-INT J MED, V98, P255, DOI 10.1093/qjmed/hci039; *CHIEF VET OFF, 2004, AN HLTH 2003; Choi IS, 2003, J CLIN MICROBIOL, V41, P3602, DOI 10.1128/JCM.41.8.3602-3608.2003; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cook N, 2004, J INFECTION, V48, P289, DOI 10.1016/j.jinf.2004.01.018; Cotto E, 2003, J CLIN MICROBIOL, V41, P5577, DOI 10.1128/JCM.41.12.5577-5581.2003; Davidson F, 2004, VOX SANG, V86, P148, DOI 10.1111/j.0042-9007.2004.00395.x; *DEP HLTH, 1997, COMM RISK PUBL HLTH; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Ellis JA, 2000, J AM VET MED ASSOC, V217, P1645, DOI 10.2460/javma.2000.217.1645; Emerson SU, 2004, NEW ENGL J MED, V351, P2367, DOI 10.1056/NEJMp048285; Ericsson TA, 2003, P NATL ACAD SCI USA, V100, P6759, DOI 10.1073/pnas.1138025100; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; *FOOD STAND AG, 1998, FOOD SAF INF B, V103; Green J, 2000, VIRUS GENES, V20, P227, DOI 10.1023/A:1008140611929; GREEN K, 2001, HUMAN CALICIVIRUSES, P841; Gummow B, 2003, J S AFR VET ASSOC, V74, P72; Hattermann K, 2004, XENOTRANSPLANTATION, V11, P547, DOI 10.1111/j.1399-3089.2004.00181.x; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Juncker-Voss M, 2004, BERL MUNCH TIERARZTL, V117, P404; KORING M, 2004, DTSCH TIEVARZTL WOCH, V111, P335; Lane SE, 2000, NEPHROL DIAL TRANSPL, V15, P23, DOI 10.1093/ndt/15.1.23; Lanska DJ, 1998, J PUBLIC HEALTH POL, V19, P160, DOI 10.2307/3343296; Liu BL, 1999, J VIROL, V73, P819, DOI 10.1128/JVI.73.1.819-825.1999; Lopman BA, 2002, J CLIN VIROL, V24, P137, DOI 10.1016/S1386-6532(01)00243-8; MENG XJ, 2000, INFECT DIS REV, V2, P35; MORGAN D, 2005, P 2 INT C PREV CONTR; Morgan-Capner P, 1998, ZOONOSES, P319; Murray AG, 2002, EMERG INFECT DIS, V8, P1, DOI 10.3201/eid0801.010144; NAKAGOMI T, 1989, J VIROL, V63, P1431, DOI 10.1128/JVI.63.3.1431-1434.1989; Oliver SL, 2003, J VIROL, V77, P2789, DOI 10.1128/JVI.77.4.2789-2798.2003; PALMER S, 2002, OXFORD TXB PUBLIC HL, V3, P1397; Pantoja CR, 2004, EMERG INFECT DIS, V10, P2106, DOI 10.3201/eid1012.040419; PHILLIPS, 2000, BSE INQUIRY, V1; Post KW, 2001, AMERICAN ASSOCIATION OF SWINE VETERINARIANS 2001, PROCEEDINGS, P373; Poxton IR, 2005, J MED MICROBIOL, V54, P97, DOI 10.1099/jmm.0.45951-0; Scientific Committee on Animal Health and Animal Welfare, 2000, ASS ZOON RISK INF SA; Smiley JR, 2003, J CLIN MICROBIOL, V41, P3089, DOI 10.1128/JCM.41.7.3089-3099.2003; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thomas D. R., 1999, Journal of Agricultural Safety and Health, V5, P373; *UK XEN INT REG AU, 1998, WORKSH PORC END RETR; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; *WHO, 1998, WHOEMC200981; *WHO DEP COMM DIS, WHOCDSCSREPH20011 DE; Wibawa IDN, 2004, J MED VIROL, V73, P38, DOI 10.1002/jmv.20059; Withers MR, 2002, AM J TROP MED HYG, V66, P384, DOI 10.4269/ajtmh.2002.66.384; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; ZWANENBERG, 2005, BSE RISK SCI GOVERNA	57	40	40	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1256	1260		10.1136/bmj.331.7527.1256	http://dx.doi.org/10.1136/bmj.331.7527.1256			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308389	Green Published, Bronze			2022-12-28	WOS:000233606800025
J	Lin, JP; Balabin, IA; Beratan, DN				Lin, JP; Balabin, IA; Beratan, DN			The nature of aqueous tunneling pathways between electron-transfer proteins	SCIENCE			English	Article							TRANSFER SELF-EXCHANGE; CYTOCHROME-C; DYNAMICS; ELEMENT; WATER; B(5)	Structured water molecules near redox cofactors were found recently to accelerate electron-transfer (ET) kinetics in several systems. Theoretical study of interprotein electron transfer across an aqueous interface reveals three distinctive electronic coupling mechanisms that we describe here: (i) a protein-mediated regime when the two proteins are in van der Waals contact; (ii) a structured water-mediated regime featuring anomalously weak distance decay at relatively close protein-protein contact distances; and (iii) a bulk water-mediated regime at large distances. Our analysis explains a range of otherwise puzzling biological ET kinetic data and provides a framework for including explicit water-mediated tunneling effects on ET kinetics.	Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Dept Biochem, Durham, NC 27708 USA	Duke University; Duke University	Beratan, DN (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	david.beratan@duke.edu	Beratan, David N/C-5098-2011; Balabin, Ilya/P-2421-2019; Balabin, Ilya/B-3967-2013	Beratan, David N/0000-0003-4758-8676; Balabin, Ilya/0000-0001-6245-3855; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-048043, R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW SM, 1993, J AM CHEM SOC, V115, P5516, DOI 10.1021/ja00066a020; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; Barnett RN, 2001, SCIENCE, V294, P567, DOI 10.1126/science.1062864; Benjamin I, 1997, J CHEM PHYS, V106, P6647, DOI 10.1063/1.474079; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Blankenship RE, 2001, NAT STRUCT BIOL, V8, P94, DOI 10.1038/84191; DIXON DW, 1990, J AM CHEM SOC, V112, P1082, DOI 10.1021/ja00159a030; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HEGESH E, 1986, NEW ENGL J MED, V314, P757, DOI 10.1056/NEJM198603203141206; Jones ML, 2002, J PHYS CHEM A, V106, P2002, DOI 10.1021/jp0133743; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kawatsu T, 2002, J PHYS CHEM B, V106, P5068, DOI 10.1021/jp013975u; LARSSON S, 1984, J PHYS CHEM-US, V88, P1321, DOI 10.1021/j150651a016; Liang ZX, 2004, J AM CHEM SOC, V126, P2785, DOI 10.1021/ja038163l; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCLENDON G, 1992, CHEM REV, V92, P481, DOI 10.1021/cr00011a007; Miller NE, 1999, J PHYS CHEM A, V103, P1084, DOI 10.1021/jp983171n; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Newton MD, 1997, J ELECTROANAL CHEM, V438, P3, DOI 10.1016/S0022-0728(96)05025-5; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Onda K, 2005, SCIENCE, V308, P1154, DOI 10.1126/science.1109366; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Ponce A, 2000, J AM CHEM SOC, V122, P8187, DOI 10.1021/ja000017h; SIDDARTH P, 1993, J PHYS CHEM-US, V97, P13078, DOI 10.1021/j100152a008; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898; UTECHT RE, 1988, BIOCHIM BIOPHYS ACTA, V953, P164, DOI 10.1016/0167-4838(88)90021-0; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Verlet JRR, 2005, SCIENCE, V307, P93, DOI 10.1126/science.1106719; Wenger OS, 2005, SCIENCE, V307, P99, DOI 10.1126/science.1103818	38	201	207	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1311	1313		10.1126/science.1118316	http://dx.doi.org/10.1126/science.1118316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311331	Green Accepted			2022-12-28	WOS:000233600200036
J	Lim, MK				Lim, MK			Hostile use of the life sciences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Univ Singapore, Dept Community Occupat & Family Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore	National University of Singapore	Lim, MK (corresponding author), Natl Univ Singapore, Dept Community Occupat & Family Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore.							BROAD WJ, 2002, NY TIMES A      0615, P1; Coupland R, 2005, SCIENCE, V308, P1841, DOI 10.1126/science.1115436; Nathanson Vivienne, 2004, BIOTECHNOLOGY WEAPON; PEARSON GS, 2004, 13 U BRADF DEP PEAC; RYOHEI S, 1952, SUNDAY MAINICHI 0127	5	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2214	2215		10.1056/NEJMp058288	http://dx.doi.org/10.1056/NEJMp058288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306517				2022-12-28	WOS:000233434500003
J	Borghi, J; Thapa, B; Osrin, D; Jan, S; Morrison, J; Tamang, S; Shrestha, BP; Wade, A; Manandhar, DS; Costello, AMD				Borghi, J; Thapa, B; Osrin, D; Jan, S; Morrison, J; Tamang, S; Shrestha, BP; Wade, A; Manandhar, DS; Costello, AMD			Economic assessment of a women's group intervention to improve birth outcomes in rural Nepal	LANCET			English	Article								We did a cost-effectiveness analysis alongside a cluster-randomised controlled trial of a participatory intervention with women's groups to improve birth outcomes in rural Nepal. The average provider cost of the women's group intervention was US $0.75 per person per year ($0.90 with health-service strengthening) in a population of 86 704. The incremental cost per life-year saved (LYS) was $211 ($251), and expansion could rationalise on start-up costs and technical assistance, reducing the cost per LYS to $138 ($179). Sensitivity analysis showed a variation from $83 to $263 per LYS for most variables. This intervention could provide a cost-effective way of reducing neonatal deaths.	Univ London London Sch Hyg & Trop Med, Infect Dis & Epidemiol Unit, London WC1E 7HT, England; UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England; Mother & Infant Res Act, Kathmandu, Nepal; Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Borghi, J (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis & Epidemiol Unit, Keppel St, London WC1E 7HT, England.	jo.borghi@lshtm.ac.uk	Jan, Stephen/AAG-3333-2021	Jan, Stephen/0000-0003-2839-1405; Tamang, Suresh/0000-0002-9659-1700; Osrin, David/0000-0001-9691-9684; Borghi, Josephine/0000-0002-0482-5451; Morrison, Joanna/0000-0002-9241-8863				Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS108, DOI 10.1038/sj.jp.7211278; BORGHI J, IN PRESS TROP MED IN; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; *MIN HLTH NEP ORC, 2002, DEM HLTH SURV 2001	7	68	70	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1882	1884		10.1016/S0140-6736(05)67758-6	http://dx.doi.org/10.1016/S0140-6736(05)67758-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310555				2022-12-28	WOS:000233643200027
J	Keech, A; Simes, RJ; Barter, P; Best, J; Scott, R; Taskinen, MR; Forder, P; Pillai, A; Davis, T; Glasziou, P; Drury, P; Kesaniemi, YA; Sullivan, D; Hunt, D; Colman, P; d'Emden, M; Whiting, M; Ehnholm, C; Laakso, M				Keech, A; Simes, RJ; Barter, P; Best, J; Scott, R; Taskinen, MR; Forder, P; Pillai, A; Davis, T; Glasziou, P; Drury, P; Kesaniemi, YA; Sullivan, D; Hunt, D; Colman, P; d'Emden, M; Whiting, M; Ehnholm, C; Laakso, M		FIELD Study Investigators	Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial	LANCET			English	Article							CORONARY-HEART-DISEASE; REQUIRING PROLONGED OBSERVATION; PRIMARY-PREVENTION; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; RISK-FACTORS; MORTALITY; INTERVENTION; INSULIN; DYSLIPIDEMIA	Background Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease, partly owing to dyslipidaemia, which can be amenable to fibrate therapy. We designed the Fenofibrate intervention and Event Lowering in Diabetes (FIELD) study to assess the effect of fenofibrate on cardiovascular disease events in these patients. Methods We did a multinational, randomised controlled trial with 9795 participants aged 50-75 years, with type 2 diabetes mellitus, and not taking statin therapy at study entry. After a placebo and a fenofibrate run-in phase, we randomly assigned patients (2131 with previous cardiovascular disease and 7664 without) with a total-cholesterol concentration of 3.0-6.5 mmol/L and a total-cholesterol/HDL-cholesteroI ratio of 4.0 or more or plasma triglyceride of 1.0-5.0 mmol/L to micronised fenofibrate 200 mg daily (n=4895) or matching placebo (n=4900). Our primary outcome was coronary events (coronary heart disease death or non-fatal myocardial infarction); the outcome for prespecified subgroup analyses was total cardiovascular events (the composite of cardiovascular death, myocardial infarction, stroke, and coronary and carotid revascularisation). Analysis was by intention to treat. The study was prospectively registered (number ISRCTN 64783481). Findings Vital status was confirmed on all but 22 patients. Averaged over the 5 years' study duration, similar proportions in each group discontinued study medication (10% placebo vs 11% fenofibrate) and more patients allocated placebo (17%) than fenofibrate (8%; p<0.0001) commenced other lipid treatments, predominantly statins. 5.9% (n=288) of patients on placebo and 5.2% (n=256) of those on fenofibrate had a coronary event (relative reduction of 11%; hazard ratio [HR] 0.89, 95% Cl 0.75-1.05; p=0.16). This finding corresponds to a significant 24% reduction in non-fatal myocardial infarction (0.76, 0.62-0.94; p=0.010) and a non-significant increase in coronary heart disease mortality (1.19, 0.90-1.57; p=0.22). Total cardiovascular disease events were significantly reduced from 13.9% to 12.5% (0.89, 0.80-0.99; p=0.035). This finding included a 21% reduction in coronary revascularisation (0.79, 0.68-0.93; p=0.003). Total mortality was 6.6% in the placebo group and 7.3% in the fenofibrate group (p=0.18). Fenofibrate was associated with less albuminuria progression (p=0.002), and less retinopathy needing laser treatment (5.2% vs 3.6%, p=0.0003). There was a slight increase in pancreatitis (0.5% vs 0.8%, p=0.031) and pulmonary embolism (0.7% vs 1.1%, p=0.022), but no other significant adverse effects. Interpretation Fenofibrate did not significantly reduce the risk of the primary outcome of coronary events. It did reduce total cardiovascular events, mainly due to fewer non-fatal myocardial infarctions and revascularisations. The higher rate of starting statin therapy in patients allocated placebo might have masked a moderately larger treatment benefit.	Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia	University of Sydney	Keech, A (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, Mallett St Campus, Sydney, NSW 2006, Australia.	FIELDTrial@ctc.usyd.edu.au	Simes, Robert John/P-1497-2014; Nolan, Christopher J/B-2026-2008; Taskinen, Marja-Riitta/AAN-5432-2020; Adiels, Martin/C-9278-2011; Glasziou, Paul/A-7832-2008; Davis, Timothy ME/M-5144-2014	Nolan, Christopher J/0000-0002-6964-3819; Taskinen, Marja-Riitta/0000-0002-6229-3588; Glasziou, Paul/0000-0001-7564-073X; Best, James/0000-0002-5239-9274				Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; ASSMANN G, 1991, ATHER REV, V22, P51; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BARRETTCONNOR E, 1985, NATL DIABETES DATA G; Barter P, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-9; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collett D., 1994, MODELING SURVIVAL DA; Collins R, 2003, LANCET, V361, P2005; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, 2001, JAMA-J AM MED ASSOC, V285, P2487; FEINGOLD KR, 1992, ARTERIOSCLER THROMB, V12, P1496, DOI 10.1161/01.ATV.12.12.1496; FONTBONNE A, 1989, DIABETOLOGIA, V32, P300, DOI 10.1007/BF00265546; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gami AS, 2003, BMJ-BRIT MED J, V326, P528, DOI 10.1136/bmj.326.7388.528; HEADY JA, 1992, LANCET, V340, P1405, DOI 10.1016/0140-6736(92)92588-7; Hottelart C, 2002, NEPHRON, V92, P536, DOI 10.1159/000064083; Keating GM, 2002, DRUGS, V62, P1909, DOI 10.2165/00003495-200262130-00013; Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; LAAKSO M, 1985, ATHEROSCLEROSIS, V56, P271, DOI 10.1016/0021-9150(85)90003-6; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Scott R, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-13; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Steiner G, 2001, LANCET, V357, P905; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; Syvanne M, 2004, ATHEROSCLEROSIS, V172, P267, DOI 10.1016/j.atherosclerosis.2003.10.003; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154; Wilson P W, 1985, Monogr Atheroscler, V13, P1; ZUANETTI G, 1993, J AM COLL CARDIOL, V22, P1788, DOI 10.1016/0735-1097(93)90758-S	34	2242	2381	0	155	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1849	1861		10.1016/S0140-6736(05)67667-2	http://dx.doi.org/10.1016/S0140-6736(05)67667-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310551				2022-12-28	WOS:000233643200023
J	Fogg, DK; Sibon, C; Miled, C; Jung, S; Aucouturier, P; Littman, DR; Cumano, A; Geissmann, F				Fogg, DK; Sibon, C; Miled, C; Jung, S; Aucouturier, P; Littman, DR; Cumano, A; Geissmann, F			A clonogenic bone marrow progenitor specific for macrophages and dendritic cells	SCIENCE			English	Article							COMMON MYELOID PROGENITOR; COLONY-STIMULATING FACTOR; BLOOD MONOCYTES; HEMATOPOIETIC PRECURSORS; IN-VIVO; MOUSE; DIFFERENTIATION; IDENTIFICATION; INTERLEUKIN-4; RECOGNITION	Macrophages and dendritic cells (DCs) are crucial for immune and inflammatory responses and belong to a network of cells that has been termed the mononuclear phagocyte system (MPS). However, the origin and lineage of these cells remain poorly understood. Here, we describe the isolation and clonal analysis of a mouse bone marrow progenitor that is specific for monocytes, several macrophage subsets, and resident spleen DCs in vivo. It was also possible to recapitulate this differentiation in vitro by using treatment with the cytokines macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Thus, macrophages and DCs appear to renew from a common progenitor, providing a cellular and molecular basis for the concept of the MPS.	Necker Enfants Malad Inst, Avenir Team, Lab Mononucl Phagocyte Biol, INSERM, F-75015 Paris, France; INSERM, U712, F-75012 Paris, France; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA; INSERM, U668, F-75015 Paris, France; Inst Pasteur, Lymphocyte Dev Unit, F-75015 Paris, France; Univ Paris, Descartes Fac Med, Hop Necker Enfants Malad, Dept Pathol, F-75015 Paris, France; Assistance Publ Hop Paris, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Geissmann, F (corresponding author), Necker Enfants Malad Inst, Avenir Team, Lab Mononucl Phagocyte Biol, INSERM, F-75015 Paris, France.	geissman@necker.fr	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline; PHS HHS [A133856] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; COLLINS LS, 1987, J IMMUNOL, V138, P1082; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; McKenna HJ, 2001, CURR OPIN HEMATOL, V8, P149, DOI 10.1097/00062752-200105000-00004; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	28	741	759	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					83	87		10.1126/science.1117729	http://dx.doi.org/10.1126/science.1117729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16322423				2022-12-28	WOS:000234546300038
J	Ford, T; Sayal, K; Meltzer, H; Goodman, R				Ford, T; Sayal, K; Meltzer, H; Goodman, R			Parental concerns about their child's emotions and behaviour and referral to specialist services: general population survey	BRITISH MEDICAL JOURNAL			English	Article							PSYCHIATRIC-DISORDERS		Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Off Natl Stat, London SW1V 2QQ, England	University of London; King's College London	Ford, T (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England.	tamsin.ford@slam.nhs.uk	Ford, Tamsin/V-5908-2019	Ford, Tamsin/0000-0001-5295-4904; Sayal, Kapil/0000-0002-2050-4316; Goodman, Robert/0000-0001-5596-1667	MRC [G108/625] Funding Source: UKRI; Medical Research Council [G108/625] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ford Tamsin, 2005, Child Adolesc Ment Health, V10, P2, DOI 10.1111/j.1475-3588.2005.00108.x; Glazebrook C, 2003, CHILD CARE HLTH DEV, V29, P141, DOI 10.1046/j.1365-2214.2003.00324.x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Kramer T, 1998, BRIT J PSYCHIAT, V173, P508, DOI 10.1192/bjp.173.6.508; MELZER H, 2000, MENTAL HLTH CHILDREN	6	27	29	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1435	1436		10.1136/bmj.331.7530.1435	http://dx.doi.org/10.1136/bmj.331.7530.1435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EE	16356977	Bronze, Green Published			2022-12-28	WOS:000234156400018
J	Farh, KKH; Grimson, A; Jan, C; Lewis, BP; Johnston, WK; Lim, LP; Burge, CB; Bartel, DP				Farh, KKH; Grimson, A; Jan, C; Lewis, BP; Johnston, WK; Lim, LP; Burge, CB; Bartel, DP			The widespread impact of mammalian microRNAs on mRNA repression and evolution	SCIENCE			English	Article							TARGET; EXPRESSION; GENES; IDENTIFICATION; PREDICTION	Thousands of mammalian messenger RNAs are under selective pressure to maintain 7-nucleotide sites matching microRNAs (miRNAs). We found that these conserved targets are often highly expressed at developmental stages before miRNA expression and that their levels tend to fall as the miRNA that targets them begins to accumulate. Nonconserved sites, which outnumber the conserved sites 10 to 1, also mediate repression. As a consequence, genes preferentially expressed at the same time and place as a miRNA have evolved to selectively avoid sites matching the miRNA. This phenomenon of selective avoidance extends to thousands of genes and enables spatial and temporal specificities of miRNAs to be revealed by finding tissues and developmental stages in which messages with, corresponding sites are expressed at lower levels.	MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Rosetta Inpharmat, Seattle, WA 98109 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Merck & Company	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	23	1224	1317	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1817	1821		10.1126/science.1121158	http://dx.doi.org/10.1126/science.1121158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16308420				2022-12-28	WOS:000234093600047
J	Seibel, BA; Robison, BH; Haddock, SHD				Seibel, BA; Robison, BH; Haddock, SHD			Post-spawning egg care by a squid	NATURE			English	Article							GONATUS-ONYX CEPHALOPODA; LIFE-HISTORY; TEUTHOIDEA		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Seibel, BA (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	seibel@uri.edu						Arkhipkin AI, 1999, POLAR BIOL, V22, P357, DOI 10.1007/s003000050429; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139, DOI 10.1017/S0954102094000210; Childress JJ, 1998, J EXP BIOL, V201, P1223; CHILDRESS JJ, 1983, MAR BIOL, V76, P165, DOI 10.1007/BF00392733; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P979, DOI 10.1098/rstb.1996.0088; HOCHACHKA PW, 1992, EXPERIENTIA, V48, P570, DOI 10.1007/BF01920241; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Hunt JC, 2000, MAR BIOL, V136, P543, DOI 10.1007/s002270050714; Nesis KN., 1999, RUSS J MAR BIOL+, V25, P499; Okutani T., 1988, Bulletin of the Ocean Research Institute University of Tokyo, V26, P159; ROBISON BH, 1992, MAR TECHNOL SOC J, V26, P32; Seibel BA, 2000, MAR BIOL, V137, P519, DOI 10.1007/s002270000359; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270	13	57	57	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					929	929		10.1038/438929a	http://dx.doi.org/10.1038/438929a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355206	Bronze			2022-12-28	WOS:000233934600045
J	Chou, CW; de Riedmatten, H; Felinto, D; Polyakov, SV; van Enk, SJ; Kimble, HJ				Chou, CW; de Riedmatten, H; Felinto, D; Polyakov, SV; van Enk, SJ; Kimble, HJ			Measurement-induced entanglement for excitation stored in remote atomic ensembles	NATURE			English	Article							QUANTUM STATE TRANSFER; COMMUNICATION; MATTER	A critical requirement for diverse applications in quantum information science is the capability to disseminate quantum resources over complex quantum networks(1,2). For example, the coherent distribution of entangled quantum states together with quantum memory ( for storing the states) can enable scalable architectures for quantum computation(3), communication(4) and metrology(5). Here we report observations of entanglement between two atomic ensembles located in distinct, spatially separated set-ups. Quantum interference in the detection of a photon emitted by one of the samples projects the otherwise independent ensembles into an entangled state with one joint excitation stored remotely in 10(5) atoms at each site(6). After a programmable delay, we confirm entanglement by mapping the state of the atoms to optical fields and measuring mutual coherences and photon statistics for these fields. We thereby determine a quantitative lower bound for the entanglement of the joint state of the ensembles. Our observations represent significant progress in the ability to distribute and store entangled quantum states.	CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	California Institute of Technology; Alcatel-Lucent; Lucent Technologies; AT&T	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Felinto, Daniel/M-8756-2014; de Riedmatten, Hugues/P-7563-2017	Felinto, Daniel/0000-0001-9078-7756; de Riedmatten, Hugues/0000-0002-4418-0723				ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; Copsey D, 2003, IEEE J SEL TOP QUANT, V9, P1552, DOI 10.1109/JSTQE.2003.820922; Duan LM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023818; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233602; Felinto D, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053809; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Haffner H, 2005, APPL PHYS B-LASERS O, V81, P151, DOI 10.1007/s00340-005-1917-z; Jiang W, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043819; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Mandel L., 1995, OPTICAL COHERENCE QU; Marcikic I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180502; Matsukevich DN, 2005, SCIENCE, V309, DOI 10.1126/science.1111237; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Nielsen Michael A., 2002, QUANTUM COMPUTATION; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Polyakov SV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.263601; Turchette QA, 1998, PHYS REV LETT, V81, P3631, DOI 10.1103/PhysRevLett.81.3631; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; VANENK SJ, 2005, SCIENCE, V309, pB1187; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; 2004, QUANTUM INFORMATION	30	446	454	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					828	832		10.1038/nature04353	http://dx.doi.org/10.1038/nature04353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341008	Green Submitted, Green Accepted			2022-12-28	WOS:000233777800045
J	Usherwood, JR; Wilson, AM				Usherwood, JR; Wilson, AM			No force limit on greyhound sprint speed	NATURE			English	Editorial Material							HORSE EQUUS-CABALLUS; DOGS		Univ London Royal Vet Coll, Struct & Mot Lab, N Mymms AL9 7TA, Herts, England; UCL, Ctr Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Usherwood, JR (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, N Mymms AL9 7TA, Herts, England.	jusherwood@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455				ALEXANDER RM, 1974, J ZOOL, V173, P549, DOI 10.1111/j.1469-7998.1974.tb04134.x; ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Gray J., 1968, ANIMAL LOCOMOTION; GREENE PR, 1987, J BIOMECH, V20, P667, DOI 10.1016/0021-9290(87)90033-9; Gregersen CS, 1998, J EXP BIOL, V201, P3197; Lee DV, 1999, J EXP BIOL, V202, P3565; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Witte TH, 2004, J EXP BIOL, V207, P3639, DOI 10.1242/jeb.01182	9	78	80	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					753	754		10.1038/438753a	http://dx.doi.org/10.1038/438753a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341003				2022-12-28	WOS:000233777800030
J	Chen, I; Christie, PJ; Dubnau, D				Chen, I; Christie, PJ; Dubnau, D			The ins and outs of DNA transfer in bacteria	SCIENCE			English	Review							IV SECRETION SYSTEMS; AGROBACTERIUM-TUMEFACIENS; PROTEIN-SECRETION; GENETIC-TRANSFORMATION; HELICOBACTER-PYLORI; CELL POLES; CONJUGATION; TRANSPORT; BINDING; TRWB	Transformation and conjugation permit the passage of DNA through the bacterial membranes and represent dominant modes for the transfer of genetic information between bacterial cells or between bacterial and eukaryotic cells. As such, they are responsible for the spread of fitness-enhancing traits, including antibiotic resistance. Both processes usually involve the recognition of double-stranded DNA, followed by the transfer of single strands. Elaborate molecular machines are responsible for negotiating the passage of macromolecular DNA through the layers of the cell surface. All or nearly all the machine components involved in transformation and conjugation have been identified, and here we present models for their roles in DNA transport.	Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Publ Hlth Res Inst, Newark, NJ 07103 USA	University of Texas System	Christie, PJ (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Peter.J.Christie@uth.tmc.edu; dubnau@phri.org		Chen, Ines/0000-0002-1405-9703	NIGMS NIH HHS [GM057720, R01 GM048746-14, R01 GM043756, R01 GM048746, GM48746, R01 GM057720, GM43756] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057720, R01GM043756, R01GM048746, R29GM048746] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Baron C, 2005, FEMS MICROBIOL LETT, V253, P163, DOI 10.1016/j.femsle.2005.09.030; Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CHEN IG, UNPUB; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Chung YS, 1998, MOL MICROBIOL, V29, P905, DOI 10.1046/j.1365-2958.1998.00989.x; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DANNER DB, 1980, GENE, V11, P311, DOI 10.1016/0378-1119(80)90071-2; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Facius D, 1996, FEMS MICROBIOL LETT, V137, P159; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; GABOR M, 1966, P NATL ACAD SCI USA, V56, P1441, DOI 10.1073/pnas.56.5.1441; Gilmour MW, 2004, J BACTERIOL, V186, P1606, DOI 10.1128/JB.186.6.1606-1613.2004; Gomis-Ruth FX, 2004, CURR PHARM DESIGN, V10, P1551, DOI 10.2174/1381612043384817; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Harris RL, 2004, J BACTERIOL, V186, P5480, DOI 10.1128/JB.186.16.5480-5485.2004; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Hormaeche I, 2002, J BIOL CHEM, V277, P46456, DOI 10.1074/jbc.M207250200; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Kidane D, 2005, CELL, V122, P73, DOI 10.1016/j.cell.2005.04.036; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; KOOMEY M, COMMUNICATION; Krause S, 2000, J BACTERIOL, V182, P2761, DOI 10.1128/JB.182.10.2761-2770.2000; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LONDONOVALLEJO JA, 1994, MOL MICROBIOL, V13, P197, DOI 10.1111/j.1365-2958.1994.tb00415.x; Lybarger SR, 2004, SCIENCE, V304, P1122, DOI 10.1126/science.1098806; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Marrero J, 2005, DEV CELL, V8, P963, DOI 10.1016/j.devcel.2005.05.004; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; PALMEN R, 1994, BBA-BIOENERGETICS, V1183, P417, DOI 10.1016/0005-2728(94)90072-8; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; REDFIELD RJ, 1993, J HERED, V84, P400, DOI 10.1093/oxfordjournals.jhered.a111361; Samuels AL, 2000, J BACTERIOL, V182, P2709, DOI 10.1128/JB.182.10.2709-2715.2000; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schroder G, 2003, J BACTERIOL, V185, P4371, DOI 10.1128/JB.185.15.4371-4381.2003; Simone M, 2001, MOL MICROBIOL, V41, P1283, DOI 10.1046/j.1365-2958.2001.02582.x; SMITH HO, 1995, SCIENCE, V269, P538, DOI 10.1126/science.7542802; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; TOMB JF, 1991, GENE, V104, P1, DOI 10.1016/0378-1119(91)90457-M; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200	79	284	296	9	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1456	1460		10.1126/science.1114021	http://dx.doi.org/10.1126/science.1114021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322448	Green Accepted			2022-12-28	WOS:000233756500034
J	Muthukumar, T; Dadhania, D; Ding, RC; Snopkowski, C; Naqvi, R; Lee, JB; Hartono, C; Li, BG; Sharma, VK; Seshan, SV; Kapur, S; Hancock, WW; Schwartz, JE; Suthanthiran, M				Muthukumar, T; Dadhania, D; Ding, RC; Snopkowski, C; Naqvi, R; Lee, JB; Hartono, C; Li, BG; Sharma, VK; Seshan, SV; Kapur, S; Hancock, WW; Schwartz, JE; Suthanthiran, M			Messenger RNA for FOXP3 in the urine of renal-allograft recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; REJECTION EPISODES; KIDNEY-TRANSPLANTS; TOLERANCE; EXPRESSION; BIOPSY; COMPLICATIONS; ENTEROPATHY; PATHOLOGY; SCURFIN	Background: The outcome of renal transplantation after an episode of acute rejection is difficult to predict, even with an allograft biopsy. Methods: We studied urine specimens from 36 subjects with acute rejection, 18 subjects with chronic allograft nephropathy, and 29 subjects with normal biopsy results. Levels of messenger RNA (mRNA) for FOXP3, a specification and functional factor for regulatory T lymphocytes, and mRNA for CD25, CD3(epsilon), perforin, and 18S ribosomal RNA (rRNA) were measured with a kinetic, quantitative polymerase-chain-reaction assay. We examined associations of mRNA levels with acute rejection, rejection reversal, and graft failure. Results: The log-transformed mean (+/-SE) ratio of FOXP3 mRNA copies to 18S ribosomal RNA copies was higher in urine from the group with acute rejection (3.8+/-0.5) than in the group with chronic allograft nephropathy (1.3+/-0.7) or the group with normal biopsy results (1.6+/-0.4) (P<0.001 by the Kruskal-Wallis test). FOXP3 mRNA levels were inversely correlated with serum creatinine levels measured at the time of biopsy in the acute-rejection group (Spearman's correlation coefficient =-0.38, P=0.02) but not in the group with chronic allograft nephropathy or the group with normal biopsy results. Analyses of receiver-operating-characteristic curves demonstrated that reversal of acute rejection can be predicted with 90 percent sensitivity and 73 percent specificity with use of the optimal identified cutoff for FOXP3 mRNA of 3.46 (P=0.001). FOXP3 mRNA levels identified subjects at risk for graft failure within six months after the incident episode of acute rejection (relative risk for the lowest third of FOXP3 mRNA levels, 6; P=0.02). None of the other mRNA levels were predictive of reversal of acute rejection or graft failure. Conclusions: Measurement of FOXP3 mRNA in urine may offer a noninvasive means of improving the prediction of outcome of acute rejection of renal transplants.	Cornell Univ, Weill Med Coll, Dept Med, Div Nephrol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Surg, New York, NY 10021 USA; New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA; Rogosin Inst, New York, NY USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Suthanthiran, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Nephrol, 525 E 68th St,Box 3, New York, NY 10021 USA.	msuthan@med.cornell.edu	Suthanthiran, Manikkam/AAL-9104-2020; Dadhania, Darshana/L-4651-2019	Schwartz, Joseph/0000-0002-8944-3566	NIAID NIH HHS [AI51652, AI60706, R01 AI054720, AI54720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060706, R01AI054720, R01AI051652, R37AI051652] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agodoa L, 1997, KIDNEY INT, pS144; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; BECKINGHAM IJ, 1994, BRIT J UROL, V73, P13, DOI 10.1111/j.1464-410X.1994.tb07449.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BURDICK JF, 1984, TRANSPLANTATION, V38, P679, DOI 10.1097/00007890-198412000-00026; CHEIGH JS, 1983, NEPHRON, V35, P6, DOI 10.1159/000183036; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ding RC, 2003, TRANSPLANTATION, V75, P1307, DOI 10.1097/01.TP.0000064210.92444.B5; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gonzalez A, 2001, NAT IMMUNOL, V2, P1117, DOI 10.1038/ni738; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; GULANIKAR AC, 1992, TRANSPLANTATION, V53, P323, DOI 10.1097/00007890-199202010-00013; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hayry P, 2000, TRANSPLANTATION, V69, P1038; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; HURAIB S, 1989, AM J KIDNEY DIS, V14, P13, DOI 10.1016/S0272-6386(89)80087-3; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Langone AJ, 2003, NEW ENGL J MED, V349, P704, DOI 10.1056/NEJMe038117; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Luo ZR, 2005, TRANSPLANTATION, V79, P1091, DOI 10.1097/01.TP.0000161223.54452.A2; Maluccio M, 2003, TRANSPLANTATION, V76, P597, DOI 10.1097/01.TP.0000081399.75231.3B; MATAS AJ, 1983, ANN SURG, V197, P226, DOI 10.1097/00000658-198302000-00017; Opelz G, 1997, TRANSPL P, V29, P73, DOI 10.1016/S0041-1345(96)00013-9; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Siddiqi N, 2004, KIDNEY INT, V65, P1906, DOI 10.1111/j.1523-1755.2004.00589.x; Sijpkens YWJ, 2003, TRANSPLANTATION, V75, P204, DOI 10.1097/01.TP.0000041722.34000.21; STROM TB, 1975, NEW ENGL J MED, V292, P1257, DOI 10.1056/NEJM197506122922402; Tatapudi RR, 2004, KIDNEY INT, V65, P2390, DOI 10.1111/j.1523-1755.2004.00663.x; Tejani A H, 1998, Pediatr Transplant, V2, P318; Vasconcellos LM, 1998, TRANSPLANTATION, V66, P562, DOI 10.1097/00007890-199809150-00002; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0	40	435	470	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2342	2351		10.1056/NEJMoa051907	http://dx.doi.org/10.1056/NEJMoa051907			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319383				2022-12-28	WOS:000233574600006
J	Wang, PS; Schneeweiss, S; Avorn, J; Fischer, MA; Mogun, H; Solomon, DH; Brookhart, MA				Wang, PS; Schneeweiss, S; Avorn, J; Fischer, MA; Mogun, H; Solomon, DH; Brookhart, MA			Risk of death in elderly users of conventional vs. atypical antipsychotic medications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISPERIDONE; MORTALITY; EFFICACY	Background: Recently, the Food and Drug Administration (FDA) issued an advisory stating that atypical antipsychotic medications increase mortality among elderly patients. However, the advisory did not apply to conventional antipsychotic medications; the risk of death with these older agents is not known. Methods: We conducted a retrospective cohort study involving 22,890 patients 65 years of age or older who had drug insurance benefits in Pennsylvania and who began receiving a conventional or atypical antipsychotic medication between 1994 and 2003. Analyses of mortality rates and Cox proportional-hazards models were used to compare the risk of death within 180 days, less than 40 days, 40 to 79 days, and 80 to 180 days after the initiation of therapy with an antipsychotic medication. We controlled for potential confounding variables with the use of traditional multivariate Cox models, propensity-score adjustments, and an instrumental-variable analysis. Results: Conventional antipsychotic medications were associated with a significantly higher adjusted risk of death than were atypical antipsychotic medications at all intervals studied (lessthan/equal 180 days: relative risk, 1.37; 95 percent confidence interval, 1.27 to 1.49; <40 days: relative risk, 1.56; 95 percent confidence interval, 1.37 to 1.78; 40 to 79 days: relative risk, 1.37; 95 percent confidence interval, 1.19 to 1.59; and 80 to 180 days: relative risk, 1.27; 95 percent confidence interval, 1.14 to 1.41) and in all subgroups defined according to the presence or absence of dementia or nursing home residency. The greatest increases in risk occurred soon after therapy was initiated and with higher dosages of conventional antipsychotic medications. Increased risks associated with conventional as compared with atypical antipsychotic medications persisted in confirmatory analyses performed with the use of propensity-score adjustment and instrumental-variable estimation. Conclusions: If confirmed, these results suggest that conventional antipsychotic medications are at least as likely as atypical agents to increase the risk of death among elderly persons and that conventional drugs should not be used to replace atypical agents discontinued in response to the FDA warning.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wang, PS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	pwang@rics.bwh.harvard.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069772] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH069772] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], 1989, PHYS CURR PROC TERM; Barak Y, 2002, J CLIN PSYCHOPHARM, V22, P115, DOI 10.1097/00004714-200204000-00003; Briesacher BA, 2005, ARCH INTERN MED, V165, P1280, DOI 10.1001/archinte.165.11.1280; BROOKHART MA, IN PRESS EPIDEMIOLOG; Chan YC, 1999, PHARMACOTHERAPY, V19, P811, DOI 10.1592/phco.19.10.811.31560; Colenda CC, 2002, AM J GERIAT PSYCHIAT, V10, P609; Department of Health and Human Services PHS, 1988, INT CLASS DIS; Dewa CS, 2002, CLIN THER, V24, P1466, DOI 10.1016/S0149-2918(02)80050-9; Dolder CR, 2002, AM J PSYCHIAT, V159, P514; Food and Drug Administration, FDA PUBL HLTH ADV DE; Giron MST, 2001, INT J GERIATR PSYCH, V16, P900, DOI 10.1002/gps.438; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V293, P2462, DOI 10.1001/jama.293.20.2462; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; Maixner SM, 1999, J CLIN PSYCHIAT, V60, P29; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Nasrallah HA, 2004, AM J GERIAT PSYCHIAT, V12, P437, DOI 10.1176/appi.ajgp.12.4.437; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RJ Bowden, 1984, INSTRUMENTAL VARIABL; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salzman C, 2005, CLIN GERIATRIC PSYCH; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; *SOC SEC ADM, 2004, SOC SEC ADM DEATH MA; STRONG C, 2005, NEUROPSYCHIATRY REV, V6, P1; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P29; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; 1993, ST ANTHONYS DRG WORK	28	659	674	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2335	2341		10.1056/NEJMoa052827	http://dx.doi.org/10.1056/NEJMoa052827			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319382				2022-12-28	WOS:000233574600005
J	Hudson, NPH; Dunlop, MG				Hudson, NPH; Dunlop, MG			Horses for courses. Comparative gastroenterology: common ground and collaborative potential	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFLAMMATORY-BOWEL-DISEASE; ENTERIC NERVOUS-SYSTEM; EQUINE GRASS SICKNESS; INTERSTITIAL-CELLS; MANIPULATION; CAJAL; DIAGNOSIS; PATHOLOGY; INSIGHTS; GUT		Univ Edinburgh, Royal Dick Sch Vet Studies, Gastrointestinal Motil & Dis Lab, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Acad Coloproctol, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Hudson, NPH (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Gastrointestinal Motil & Dis Lab, Edinburgh EH9 1QH, Midlothian, Scotland.	neil.hudson@ed.ac.uk			Medical Research Council [MC_U127527198] Funding Source: Medline; MRC [MC_U127527198] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ardizzone S, 2002, J INTERN MED, V252, P475, DOI 10.1046/j.1365-2796.2002.01067.x; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Bourdu S, 2005, GASTROENTEROLOGY, V128, P1996, DOI 10.1053/j.gastro.2005.03.082; Brown SJ, 2001, NYU SA CTR SER F M I, V6, P1; BURNS GA, 1990, CORNELL VET, V80, P53; Cottrell DF, 1999, NEUROGASTROENT MOTIL, V11, P79; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; De Giorgio R, 2004, GUT, V53, P1549, DOI 10.1136/gut.2004.043968; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P143, DOI 10.1111/j.1743-3150.2004.00491.x; Fintl C, 2004, EQUINE VET J, V36, P474, DOI 10.2746/0425164044877314; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Guilford W. G., 1996, Strombeck's small animal gastroenterology., P532; HEATON ND, 1988, AUTONOMIC FAILURE TX, P238; Hudson N, 2002, AUTON NEUROSCI-BASIC, V99, P119, DOI 10.1016/S1566-0702(02)00065-6; Hudson N, 2001, AUTON NEUROSCI-BASIC, V92, P37, DOI 10.1016/S1566-0702(01)00316-2; Hudson NPH, 2005, EQUINE VET EDUC, V17, P19, DOI 10.1111/j.2042-3292.2005.tb00329.x; Hudson NPH, 2000, VET RES COMMUN, V24, P299, DOI 10.1023/A:1006439904937; HUNT JM, 1986, EQUINE VET J, V18, P264, DOI 10.1111/j.2042-3306.1986.tb03623.x; Jergens AE, 2002, J FELINE MED SURG, V4, P175, DOI 10.1053/jfms.2002.0179; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kamm MA, 2000, GUT, V47, P8; KOHN CW, 1992, VET GASTROENTEROLOGY, P173; KUBOTA M, 1983, AM J PHYSIOL, V244, pG406, DOI 10.1152/ajpgi.1983.244.4.G406; Little D, 2005, EQUINE VET J, V37, P329, DOI 10.2746/0425164054529472; LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; LOVE S, 1992, VET REC, V130, P217, DOI 10.1136/vr.130.11.217; Mann SD, 1997, GUT, V41, P675, DOI 10.1136/gut.41.5.675; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Milne E., 1994, Equine Veterinary Education, V6, P217, DOI 10.1111/j.2042-3292.1994.tb01139.x; MILNE EM, 1997, CURRENT THERAPY EQUI, V4, P203; MURRAY MJ, 1988, J AM VET MED ASSOC, V192, P917; POLLIN MM, 1992, J COMP PATHOL, V106, P99, DOI 10.1016/0021-9975(92)90041-R; Satsangi J, 2003, BEST PRACT RES CL GA, V17, P3, DOI 10.1053/bega.2002.0349; Schumacher J, 2000, J VET INTERN MED, V14, P258, DOI 10.1892/0891-6640(2000)014&lt;0258:CIIBDO&gt;2.3.CO;2; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Simpson JW, 1998, J NUTR, V128, p2717S, DOI 10.1093/jn/128.12.2717S; Sonnenberg A, 1994, CONSTIPATION, P19; Spiller Robin C, 2004, Br Med Bull, V72, P15; TAMS TR, 1992, CURRENT VET THERAPY, V11, P604; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; TURNAGE RH, 1998, GASTROINTESTINAL LIV, P1799; Vanderwinden JM, 1999, MICROSC RES TECHNIQ, V47, P344, DOI 10.1002/(SICI)1097-0029(19991201)47:5<344::AID-JEMT6>3.0.CO;2-1; Washabau RJ, 1996, AM J VET RES, V57, P580; White N. A., 1990, The equine acute abdomen., P49; Whitwell K, 1996, VET REC, V139, P323	48	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1248	1251		10.1136/bmj.331.7527.1248	http://dx.doi.org/10.1136/bmj.331.7527.1248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308386	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000233606800022
J	de la Salle, H; Mariotti, S; Angenieux, C; Gilleron, M; Garcia-Alles, LF; Malm, D; Berg, T; Paoletti, S; Maitre, B; Mourey, L; Salamero, J; Cazenave, JP; Hanau, D; Mori, L; Puzo, G; De Libero, G				de la Salle, H; Mariotti, S; Angenieux, C; Gilleron, M; Garcia-Alles, LF; Malm, D; Berg, T; Paoletti, S; Maitre, B; Mourey, L; Salamero, J; Cazenave, JP; Hanau, D; Mori, L; Puzo, G; De Libero, G			Assistance of microbial glycolipid antigen processing by CD1e	SCIENCE			English	Article							T-CELL RECOGNITION; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-TUBERCULOSIS; PHOSPHATIDYLINOSITOL MANNOSIDES; SELF-GLYCOLIPIDS; ACYLATION STATE; MOLECULES; INFECTION	Complexes between CD1 molecules and self or microbial glycolipids represent important immunogenic ligands for specific subsets of T cells. However, the function of one of the CD1 family members, CD1e, has yet to be determined. Here, we show that the mycobacterial antigens hexamannosylated phosphatidyl-myo-inositols (PIM6) stimulate CD1b-restricted T cells only after partial digestion of the oligomannose moiety by lysosomal a-mannosidase and that soluble CD1e is required for this processing. Furthermore, recombinant CD1e was able to bind glycolipids and assist in the digestion of PIM6. We propose that, through this form of glycolipid editing, CD1e helps expand the repertoire of glycolipidic T cell antigens to optimize antimicrobial immune responses.	CNRS, UMR 5089, F-31077 Toulouse, France; Etab Francais Sang Alsace, INSERM, U725, F-67065 Strasbourg, France; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; Univ Hosp No Norway, Dept Med, N-9038 Tromso, Norway; Univ Hosp No Norway, Dept Pathol, N-9038 Tromso, Norway; Inst Curie, CNRS, UMR 144, F-75005 Paris, France; Etab Francais Sang Alsace, INSERM, U311, F-67065 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Puzo, G (corresponding author), CNRS, UMR 5089, F-31077 Toulouse, France.	germain.puzo@ipbs.fr; gennaro.delibero@unibas.ch	MARIOTTI, SABRINA/M-4361-2015; De La Salle, Henri/H-9353-2016; Cazenave, Jean-Pierre/AAE-2935-2019; Mourey, Lionel/B-5662-2009; De Libero, Gennaro/P-2694-2017	MARIOTTI, SABRINA/0000-0002-7009-7616; De La Salle, Henri/0000-0001-5136-0776; Mourey, Lionel/0000-0002-8259-1259; salamero, jean/0000-0002-2610-5826; GILLERON, Martine/0000-0002-2581-3302; De Libero, Gennaro/0000-0003-0853-7868; Garcia-Alles, Luis/0000-0002-1141-0393; maitre, blandine/0000-0002-3264-7330				Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Malm Dag, 1995, Tidsskrift for den Norske Laegeforening, V115, P594; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Sakai T, 1999, J MED CHEM, V42, P1836, DOI 10.1021/jm990054n; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; TULSIANI DRP, 1983, ARCH BIOCHEM BIOPHYS, V224, P594, DOI 10.1016/0003-9861(83)90247-3	24	203	207	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1321	1324		10.1126/science.1115301	http://dx.doi.org/10.1126/science.1115301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311334				2022-12-28	WOS:000233600200039
J	Bartholomew, C; Bartholomew, M; Jones, A				Bartholomew, C; Bartholomew, M; Jones, A			HIV transmission from surrogate breastfeeding	LANCET			English	Editorial Material							MILK		Med Res Fdn, Med Res Ctr, Port Of Spain, Trinidad Tobago; Univ W Indies, Gen Hosp, Port Of Spain, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Bartholomew, C (corresponding author), Med Res Fdn, Med Res Ctr, 7 Queens Pk E, Port Of Spain, Trinidad Tobago.	cbartholomew@mrftt.org						CHOTO RG, 1990, CENT AFR J MED, V36, P296; DUATI R, 2000, JAMA-J AM MED ASSOC, V283, P1167; Pombo-de-Oliveira MS, 2001, LEUKEMIA LYMPHOMA, V42, P135, DOI 10.3109/10428190109097685; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1902	1902		10.1016/S0140-6736(05)67759-8	http://dx.doi.org/10.1016/S0140-6736(05)67759-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310559				2022-12-28	WOS:000233643200031
J	Smits, LJM; de Bie, RA; Essed, GG; van den Brandt, PA				Smits, LJM; de Bie, RA; Essed, GG; van den Brandt, PA			Time to pregnancy and sex of offspring: cohort study	BRITISH MEDICAL JOURNAL			English	Article							RATIO		Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Smits, LJM (corresponding author), Maastricht Univ, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands.	luc.smits@epid.unimaas.nl	Smits, Luc/C-5331-2008	van den Brandt, Piet/0000-0001-8781-8099; Smits, Luc/0000-0003-0785-1345				ERICSSON RJ, 1973, NATURE, V246, P421, DOI 10.1038/246421a0; KEYE WR, 1995, INFERTILITY EVALUATI; Martin JF, 1997, SOC BIOL, V44, P283; Martin JF, 1997, HUM REPROD, V12, P611; Weijin Z, 1996, OCCUP ENVIRON MED, V53, P503, DOI 10.1136/oem.53.7.503-b	5	25	25	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1437	1438		10.1136/bmj.331.7530.1437	http://dx.doi.org/10.1136/bmj.331.7530.1437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356978	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000234156400019
J	Verlet, JRR; Bragg, AE; Kammrath, A; Cheshnovsky, O; Neumark, DM				Verlet, JRR; Bragg, AE; Kammrath, A; Cheshnovsky, O; Neumark, DM			Comment on "Characterization of excess electrons in water-cluster anions by quantum simulations"	SCIENCE			English	Editorial Material							DYNAMICS	The conclusion by Turi et al. (Reports, 5 August 2005, p. 914) that all experimental spectral and energetic data on water-cluster anions point toward surface-bound electrons is overstated. Comparison of experimental vertical detachment energies with their calculated values for (H(2)O)(n)(-) clusters with surface-bound and internalized electrons supports previous arguments that both types of clusters exist.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Tel Aviv Univ, Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Tel Aviv University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Neumark, DM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dneumark@berkeley.edu	Neumark, Daniel M/B-9551-2009; Verlet, Jan RR/G-5940-2012	Neumark, Daniel M/0000-0002-3762-9473; Verlet, Jan RR/0000-0002-9480-432X				Ayotte P, 1997, J CHEM PHYS, V106, P811, DOI 10.1063/1.473167; Bragg AE, 2005, J AM CHEM SOC, V127, P15283, DOI 10.1021/ja052811e; Bragg AE, 2004, SCIENCE, V306, P669, DOI 10.1126/science.1103527; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Hammer NI, 2004, SCIENCE, V306, P675, DOI 10.1126/science.1102792; Turi L, 2005, SCIENCE, V309, P914, DOI 10.1126/science.1115808; Verlet JRR, 2005, SCIENCE, V307, P93, DOI 10.1126/science.1106719	7	44	46	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1769	1769		10.1126/science.1119113	http://dx.doi.org/10.1126/science.1119113			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357246	Green Submitted			2022-12-28	WOS:000234093600023
J	Johnston, S; Kennedy, C				Johnston, S; Kennedy, C			Pemphigus foliaceus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Johnston, S (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2589	2589		10.1056/NEJMicm050028	http://dx.doi.org/10.1056/NEJMicm050028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354895				2022-12-28	WOS:000233926500008
J	Subramaniam, AB; Abkarian, M; Mahadevan, L; Stone, HA				Subramaniam, AB; Abkarian, M; Mahadevan, L; Stone, HA			Non-spherical bubbles	NATURE			English	Article							SHELLS		Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Subramaniam, AB (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	has@deas.harvard.edu	Stone, Howard A/B-6435-2008	Subramaniam, Anand/0000-0002-1998-9299; ABKARIAN, Manouk/0000-0003-0411-3187				ALEXANDROV PS, 1961, ELEMENTARY CONCEPTS; BOYS CV, 1959, SOAP BUBBLES THEIR C; JOACHIM S, 2000, NATURE, V407, P1022; JOHNSON BD, 1981, SCIENCE, V213, P209, DOI 10.1126/science.213.4504.209; Kim DH, 2003, LANGMUIR, V19, P8455, DOI 10.1021/la034779c; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Ratanabanangkoon P, 2003, LANGMUIR, V19, P1054, DOI 10.1021/la026251y; Subramaniam AB, 2005, NAT MATER, V4, P553, DOI 10.1038/nmat1412; Vella D, 2004, EUROPHYS LETT, V68, P212, DOI 10.1209/epl/i2004-10202-x	9	234	242	7	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					930	930		10.1038/438930a	http://dx.doi.org/10.1038/438930a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355208	Bronze			2022-12-28	WOS:000233934600046
J	Gillespie, AR; Montgomery, DR; Mushkin, A				Gillespie, AR; Montgomery, DR; Mushkin, A			Are there active glaciers on Mars?	NATURE			English	Editorial Material									Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gillespie, AR (corresponding author), Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA.	alan@rad.ess.washington.edu						GARLICK GD, 1988, GEOL SOC AM CORDILLE, P162; Head JW, 2005, NATURE, V434, P346, DOI 10.1038/nature03359; Kargel J.S., 2004, MARS WARMER WETTER P; Komatsu G., 2000, LUNAR PLANET SCI, VXXXI; LUCHITTA BK, 1981, ICARUS, V45, P264; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Montgomery DR, 2005, GEOLOGY, V33, P625, DOI 10.1130/G21270.1; SHARP RP, 1973, J GEOPHYS RES, V78, P4073, DOI 10.1029/JB078i020p04073	8	5	5	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					E9	E10		10.1038/nature04357	http://dx.doi.org/10.1038/nature04357			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16340962				2022-12-28	WOS:000233777800033
J	Wright, CF; Teichmann, SA; Clarke, J; Dobson, CM				Wright, CF; Teichmann, SA; Clarke, J; Dobson, CM			The importance of sequence diversity in the aggregation and evolution of proteins	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; AMYLOID FIBRILS; IN-VITRO; BETA; SUPERFAMILY; SPECIFICITY; DOMAINS; TITIN	Incorrect folding of proteins, leading to aggregation and amyloid formation, is associated with a group of highly debilitating medical conditions(1,2) including Alzheimer's disease and late-onset diabetes. The issue of how unwanted protein association is normally avoided in a living system is particularly significant in the context of the evolution of multidomain proteins, which account for over 70% of all eukaryotic proteins(3), where the effective local protein concentration in the vicinity of each domain is very high. Here we describe the aggregation kinetics of multidomain protein constructs of immunoglobulin domains and the ability of different homologous domains to aggregate together. We show that aggregation of these proteins is a specific process and that the efficiency of coaggregation between different domains decreases markedly with decreasing sequence identity. Thus, whereas immunoglobulin domains with more than about 70% identity are highly prone to coaggregation, those with less than 30 - 40% sequence identity do not detectably interact. A bioinformatics analysis of consecutive homologous domains in large multidomain proteins shows that such domains almost exclusively have sequence identities of less than 40%, in other words below the level at which coaggregation is likely to be efficient. We propose that such low sequence identities could have a crucial and general role in safeguarding proteins against misfolding and aggregation.	Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.	jc162@cam.ac.uk; cmd44@cam.ac.uk	Wright, Caroline/N-5355-2015	Wright, Caroline/0000-0003-2958-5076; Teichmann, Sarah/0000-0002-6294-6366	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; Linke WA, 1998, J CELL SCI, V111, P1567; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Oosawa F., 1975, THERMODYNAMICS POLYM; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Raffen R, 1999, PROTEIN SCI, V8, P509; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348	30	251	255	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					878	881		10.1038/nature04195	http://dx.doi.org/10.1038/nature04195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341018				2022-12-28	WOS:000233777800056
J	Clark, WF; Stewart, AK; Rock, GA; Sternbach, M; Sutton, DM; Barrett, BL; Heidenheim, AP; Garg, AX; Churchill, DN				Clark, WF; Stewart, AK; Rock, GA; Sternbach, M; Sutton, DM; Barrett, BL; Heidenheim, AP; Garg, AX; Churchill, DN		Canadian Apheresis Grp	Plasma exchange when myeloma presents as acute renal failure - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIPLE-MYELOMA; PROGNOSTIC-FACTORS; IMMUNOPATHOLOGY GROUP; HISTOLOGICAL LESIONS; DISEASE; KIDNEY; SURVIVAL; FEATURES; THERAPY; PLASMAPHERESIS	Background: Two small, randomized trials provide conflicting evidence about the benefits of plasma exchange for patients with acute renal failure at the onset of multiple myeloma. Objective: To assess the effect of 5 to 7 plasma exchanges on a composite outcome in patients with acute renal failure at the onset of multiple myeloma. Design: Randomized, open, controlled trial, stratified by chemotherapy and dialysis dependence, conducted from 1998 to 2004. Setting: Hospital plasma exchange units in 14 Canadian medical centers. Participants: 104 patients between 18 and 81 years of age with acute renal failure at the onset of myeloma. Intervention: Study participants were randomly assigned to conventional therapy plus 5 to 7 plasma exchanges of 50 mL per kg of body weight of 5% human serum albumin for 10 days or conventional therapy alone. Ninety-seven participants completed the 6-month follow-up. Measurements: The primary outcome was a composite measure of death, dialysis dependence, or glomerular filtration rate less than 0.29 mL . s(-2). m(-2) (<30 mL/min per 1.73 m(2)). Results: At enrollment, the plasma exchange and control groups were similar for dialysis dependence, chemotherapy, sex, age, hypercalcemia, serum albumin level, 24-hour urine protein level, serum creatinine level, and Durie-Salmon staging. The primary composite end point occurred in 33 of 57 (57.9%) patients in the plasma exchange group and in 27 of 39 (69.2%) patients in the control group (difference between groups, 11.3% [95% CI, -8.3% to 29.1%]; P = 0.36). One third of patients in each group died. Limitations: The study was small, used a composite outcome, and did not use renal biopsy as an inclusion criterion. Recruiting physicians were blinded to treatment allocation but not to treatment thereafter. Conclusions: In patients with acute renal failure at the onset of multiple myeloma, there is no conclusive evidence that 5 to 7 plasma exchanges substantially reduce a composite outcome of death, dialysis dependence, or glomerular filtration rate less than 0.29 mL. s(-2). m(-2) (<30 mL/min per 1.73 m(2)) at 6 months.	Univ Western Ontario, London, ON N6A 3K7, Canada; Univ Toronto, Toronto, ON, Canada; Univ Ottawa, Ottawa, ON K1N 6N5, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada; Mem Univ Newfoundland, St John, NF A1C 5S7, Canada	Western University (University of Western Ontario); University of Toronto; University of Ottawa; McMaster University; Memorial University Newfoundland	Clark, WF (corresponding author), London Hlth Sci Ctr, 800 Commissioners Rd E, London, ON N6A 4G5, Canada.		Garg, Amit X/G-3295-2011; Clark, Bill/G-3287-2011					Abdulkadyrov KM, 1996, RENAL FAILURE, V18, P139, DOI 10.3109/08860229609052784; Blade J, 1998, ARCH INTERN MED, V158, P1889, DOI 10.1001/archinte.158.17.1889; *CAN APH GROUP, 1998, P CAN APH GROUP ANN; Clark AD, 1999, BLOOD REV, V13, P79, DOI 10.1016/S0268-960X(99)90014-0; Clark WF, 2003, JAMA-J AM MED ASSOC, V290, P1351, DOI 10.1001/jama.290.10.1351; Corso A, 2003, ANN HEMATOL, V82, P487, DOI 10.1007/s00277-003-0699-9; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Durie Brian G M, 2003, Hematol J, V4, P379; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HUANG ZQ, 1993, J CLIN INVEST, V92, P2975, DOI 10.1172/JCI116920; JOHNSON WJ, 1990, ARCH INTERN MED, V150, P863, DOI 10.1001/archinte.150.4.863; Kaplan AA, 2001, THER APHER, V5, P134, DOI 10.1046/j.1526-0968.2001.005002134.x; KNUDSEN LM, 1994, EUR J HAEMATOL, V53, P207; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; MACLENNAN ICM, 1989, EUR J HAEMATOL, V43, P60; Madore F, 1996, J AM SOC NEPHROL, V7, P367; MISIANI R, 1987, AM J KIDNEY DIS, V10, P28, DOI 10.1016/S0272-6386(87)80007-0; MISIANI R, 1979, AM J MED, V66, P684, DOI 10.1016/0002-9343(79)91185-9; Moist L, 1999, AM J NEPHROL, V19, P45, DOI 10.1159/000013424; Montseny JJ, 1998, NEPHROL DIAL TRANSPL, V13, P1438, DOI 10.1093/ndt/13.6.1438; PASQUALI S, 1990, CLIN NEPHROL, V34, P247; PASQUALI S, 1987, CLIN NEPHROL, V27, P222; PICHETTE V, 1993, AM J KIDNEY DIS, V22, P398, DOI 10.1016/S0272-6386(12)70142-7; PICKEN MM, 1994, ULTRASTRUCT PATHOL, V18, P105, DOI 10.3109/01913129409016279; POZZI C, 1987, CLIN NEPHROL, V28, P1; Pozzi C, 2003, AM J KIDNEY DIS, V42, P1154, DOI 10.1053/j.ajkd.2003.08.040; RAYNER HC, 1991, Q J MED, V79, P517; RIEDEL DA, 1992, HEMATOL ONCOL CLIN N, V6, P225, DOI 10.1016/S0889-8588(18)30341-1; Rosner B, 1982, FUNDAMENTALS BIOSTAT; SANDERS PW, 1993, SEMIN NEPHROL, V13, P324; Smith JW, 2003, TRANSFUSION, V43, P820, DOI 10.1046/j.1537-2995.2003.00397.x; TORRA R, 1995, BRIT J HAEMATOL, V91, P854, DOI 10.1111/j.1365-2141.1995.tb05400.x; WINEARLS CG, 1995, KIDNEY INT, V48, P1347, DOI 10.1038/ki.1995.421; ZUCCHELLI P, 1988, KIDNEY INT, V33, P1175, DOI 10.1038/ki.1988.127; [No title captured]	36	233	252	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					777	784		10.7326/0003-4819-143-11-200512060-00005	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330788				2022-12-28	WOS:000233884900001
J	Starner, TD; McCray, PB				Starner, TD; McCray, PB			Pathogenesis of early lung disease in cystic fibrosis: A window of opportunity to eradicate bacteria	ANNALS OF INTERNAL MEDICINE			English	Review							PSEUDOMONAS-AERUGINOSA INFECTION; AIRWAY EPITHELIAL-CELLS; CONDUCTANCE REGULATOR PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; YOUNG-CHILDREN; MUCOCILIARY CLEARANCE; NEUTROPHIL ELASTASE; INITIAL COLONIZATION; INHALED TOBRAMYCIN; PULMONARY-FUNCTION	T he patient, a previously asymptomatic 18-year-old man with cysticfibrosts, presented with a chronic, nonproductive cough. His medical history was significant for pancreatic insufficiency and homozygosity for the Delta F508 CFTR mutation. Pancreatic insufficiency was well controlled by enzyme supplementation, and the patient achieved a normal height and weight. He had Pseudomonas aeruginosa detected by bronchoscopy at the age of 5 years and by throat culture at the age of 16years, both of which were successfully eradicated by prolonged courses of antibiotics. Chest radiographs were normal, and he did not have chronic respiratory symptoms until cough 2 months earlier. Bronchoscopy was done to evaluate the patient for respiratory infections and inflammation. The culture of the bronchoalveolar lavage fluid tested positive for I strain Of nonmucoid Pseudomonas aeruginosa in high numbers (1.2 million colony-forming units/mL of bronchoalveolar lavage fluid) and showed increased neutrophils (8016 of leukocytes [normal values <5%6]). Because the patient was not known to have chronic P. aeruginosa infection, he was treated with inhaled and oral antibloticsfor 3 months in an attempt to eradicate this pathogen.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa	McCray, PB (corresponding author), Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Starner, Timothy/0000-0002-1933-7477; McCray, Paul/0000-0002-4067-577X				ABMAN SH, 1991, J PEDIATR-US, V119, P211, DOI 10.1016/S0022-3476(05)80729-2; Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; AMITANI R, 1991, AM J RESP CELL MOL, V4, P26, DOI 10.1165/ajrcmb/4.1.26; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; BRITIGAN BE, 1991, J CLIN INVEST, V88, P1092, DOI 10.1172/JCI115408; Bryan R, 1998, AM J RESP CELL MOL, V19, P269, DOI 10.1165/ajrcmb.19.2.2889; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; CARNOY C, 1994, INFECT IMMUN, V62, P1896, DOI 10.1128/IAI.62.5.1896-1900.1994; Chmiel JF, 1999, AM J RESP CRIT CARE, V160, P2040, DOI 10.1164/ajrccm.160.6.9901043; CHOW CW, 1982, EUR J PEDIATR, V139, P240, DOI 10.1007/BF00442171; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; *CYST FIBR FDN, 2002, CYST FIBR FDN NAT CY; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Del Donno M, 2000, CHEST, V118, P1142, DOI 10.1378/chest.118.4.1142; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; FICK RB, 1984, J CLIN INVEST, V74, P236, DOI 10.1172/JCI111407; Frederiksen B, 1999, PEDIATR PULM, V28, P159, DOI 10.1002/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; Gibson RL, 2003, AM J RESP CRIT CARE, V167, P841, DOI 10.1164/rccm.200208-855OC; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Griese M, 2002, EUR J MED RES, V7, P79; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Gutierrez JP, 2001, EUR RESPIR J, V17, P281, DOI 10.1183/09031936.01.17202810; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hiatt PW, 1999, PEDIATRICS, V103, P619, DOI 10.1542/peds.103.3.619; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; Hoiby N, 2000, Paediatr Drugs, V2, P451; Hoiby Niels, 2002, J Cyst Fibros, V1, P249, DOI 10.1016/S1569-1993(02)00104-2; Hull J, 1997, THORAX, V52, P557, DOI 10.1136/thx.52.6.557; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; JOHANSEN HK, 1992, THORAX, V47, P109, DOI 10.1136/thx.47.2.109; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; JOSPEH T, 2005, AM J PHYSIOL-LUNG C, V288, pL471; Kanthakumar K, 1996, PULM PHARMACOL THER, V9, P223, DOI 10.1006/pulp.1996.0028; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; Lee TWR, 2004, PEDIATR PULM, V37, P104, DOI 10.1002/ppul.10401; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McShane D, 2004, EUR RESPIR J, V24, P95, DOI 10.1183/09031936.04.00097503; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Munck A, 2001, PEDIATR PULM, V32, P288, DOI 10.1002/ppul.1121; MUNRO NC, 1989, J APPL PHYSIOL, V67, P316, DOI 10.1152/jappl.1989.67.1.316; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parad RB, 1999, INFECT IMMUN, V67, P4744, DOI 10.1128/IAI.67.9.4744-4750.1999; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Ratjen F, 2001, LANCET, V358, P983, DOI 10.1016/S0140-6736(01)06124-4; Robinson M, 2002, PEDIATR PULM, V33, P293, DOI 10.1002/ppul.10079; Rosenfeld M, 2003, CURR OPIN PULM MED, V9, P492, DOI 10.1097/00063198-200311000-00008; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; SCHUSTER A, 1995, EUR RESPIR J, V8, P10, DOI 10.1183/09031936.95.08010010; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; STURGESS J, 1982, AM J PATHOL, V106, P303; SVARTENGREN M, 1986, EUR J RESPIR DIS, V68, P267; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; TOSI MF, 1990, J CLIN INVEST, V86, P300, DOI 10.1172/JCI114699; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Venaille TJ, 1998, RESP MED, V92, P233, DOI 10.1016/S0954-6111(98)90101-9; Wiesemann HG, 1998, PEDIATR PULM, V25, P88, DOI 10.1002/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.3.CO;2-9	88	37	40	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					816	822		10.7326/0003-4819-143-11-200512060-00010	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330793				2022-12-28	WOS:000233884900006
J	Niwa, H; Toyooka, T; Shimosato, D; Strumpf, D; Takahashi, K; Yagi, R; Rossant, J				Niwa, H; Toyooka, T; Shimosato, D; Strumpf, D; Takahashi, K; Yagi, R; Rossant, J			Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation	CELL			English	Article							EMBRYONIC STEM-CELLS; PREIMPLANTATION MOUSE EMBRYO; SELF-RENEWAL; ES CELLS; EXPRESSION; OCT-3/4; GENE; TRANSACTIVATION; PROLIFERATION; PLURIPOTENCY	Trophectoderm (TE), the first differentiated cell lineage of mammalian embryogenesis, forms the placenta, a structure unique to mammalian development. The differentiation of TE is a hallmark event in early mammalian development, but molecular mechanisms underlying this first differentiation event remain obscure. Embryonic stem (ES) cells can be induced to differentiate into the TE lineage by forced repression of the POU-family transcription factor, Oct3/4. We show here that this event can be mimicked by overexpression of Caudal-related homeobox 2 (Cdx2), which is sufficient to generate proper trophoblast stem (T) cells. Cdx2 is dispensable for trophectoderm differentiation induced by Oct3/4 repression but essential for TS cell self-renewal. In preimplantation embryos, Cdx2 is initially coexpressed with Oct3/4 and they form a complex for the reciprocal repression of their target genes in ES cells. This suggests that reciprocal inhibition between lineagespecific transcription factors might be involved in the first differentiation event of mammalian development.	RIKEN, Lab Pluripotent Cell Studies, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; CREST, Core Res Evolut Sci & Technol, Japn Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	RIKEN; Kobe University; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Niwa, H (corresponding author), RIKEN, Lab Pluripotent Cell Studies, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp						BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Ezashi T, 2001, MOL CELL BIOL, V21, P7883, DOI 10.1128/MCB.21.23.7883-7891.2001; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kurosaka S, 2004, BIOL REPROD, V71, P1578, DOI 10.1095/biolreprod.104.029322; Louvet S, 1996, DEV BIOL, V177, P568, DOI 10.1006/dbio.1996.0186; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUTHERLAND AE, 1990, DEV BIOL, V137, P13, DOI 10.1016/0012-1606(90)90003-2; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310	32	853	887	1	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					917	929		10.1016/j.cell.2005.08.040	http://dx.doi.org/10.1016/j.cell.2005.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325584	Bronze			2022-12-28	WOS:000233814100023
J	Frey, U; Brodbeck, T; Majumdar, A; Taylor, DR; Town, GI; Silverman, M; Suki, B				Frey, U; Brodbeck, T; Majumdar, A; Taylor, DR; Town, GI; Silverman, M; Suki, B			Risk of severe asthma episodes predicted from fluctuation analysis of airway function	NATURE			English	Article							VARIABILITY	Asthma is an increasing health problem worldwide(1), but the long-term temporal pattern of clinical symptoms is not understood and predicting asthma episodes is not generally possible(2,3). We analyse the time series of peak expiratory flows, a standard measurement of airway function that has been assessed twice daily in a large asthmatic population during a long- term crossover clinical trial(4). Here we introduce an approach to predict the risk of worsening airflow obstruction by calculating the conditional probability that, given the current airway condition, a severe obstruction will occur within 30 days. We find that, compared with a placebo, a regular long- acting bronchodilator ( salmeterol) that is widely used to improve asthma control decreases the risk of airway obstruction. Unexpectedly, however, a regular short- acting beta(2)-agonist bronchodilator ( albuterol) increases this risk. Furthermore, we find that the time series of peak expiratory flows show long- range correlations that change significantly with disease severity, approaching a random process with increased variability in the most severe cases. Using a nonlinear stochastic model, we show that both the increased variability and the loss of correlations augment the risk of unstable airway function. The characterization of fluctuations in airway function provides a quantitative basis for objective risk prediction of asthma episodes and for evaluating the effectiveness of therapy.	Univ Hosp Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ Otago, Dunedin Sch Med, Fac Med, Dunedin, New Zealand; Univ Otago, Christchurch Sch Med, Fac Med, Dunedin, New Zealand; Univ Leicester, Inst Lung Hlth, Leicester LE2 7LX, Leics, England	University of Bern; University Hospital of Bern; Boston University; University of Otago; University of Otago; University of Leicester	Frey, U (corresponding author), Univ Hosp Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland.	urs.frey@insel.ch	Majumdar, Arnab/A-8096-2008					ANDERSON HR, 2004, BRIT MED J, V330, P117; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Holgate ST, 1999, J ALLERGY CLIN IMMUN, V104, P1139, DOI 10.1016/S0091-6749(99)70005-9; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; *NHLBI, 2004, PUBL NHLBI; OBRYNE PM, 2005, AM J RESP CRIT CARE, V15, P129; Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Plaza V, 2002, EUR RESPIR J, V19, P846, DOI 10.1183/09031936.02.00241502; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Suki B, 2003, J APPL PHYSIOL, V95, P2122, DOI 10.1152/japplphysiol.00636.2003; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; TAYLOR DR, 1993, THORAX, V48, P134, DOI 10.1136/thx.48.2.134; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Zhang J, 2002, EUR RESPIR J, V20, P1102, DOI 10.1183/09031936.02.02402001	17	172	178	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					667	670		10.1038/nature04176	http://dx.doi.org/10.1038/nature04176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319891				2022-12-28	WOS:000233593100050
J	Larner, AJ				Larner, AJ			Delayed motor and visual complications after attempted suicide	LANCET			English	Editorial Material									Walton Ctr Neurol & Neurosurg, Liverpool L9 7LJ, Merseyside, England	Walton Centre	Larner, AJ (corresponding author), Walton Ctr Neurol & Neurosurg, Liverpool L9 7LJ, Merseyside, England.	a.larner@thewaltoncentre.nhs.uk						Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; FERRIER D, 1994, CAN ASSOC RADIOL J, V45, P466; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Hara S, 2002, ARCH TOXICOL, V76, P596, DOI 10.1007/s00204-002-0385-z; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1826	1826		10.1016/S0140-6736(05)67730-6	http://dx.doi.org/10.1016/S0140-6736(05)67730-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	987KQ	16298223				2022-12-28	WOS:000233517200030
J	Cowen, RK; Paris, CB; Srinivasan, A				Cowen, RK; Paris, CB; Srinivasan, A			Scaling of connectivity in marine populations	SCIENCE			English	Article							LARVAL DISPERSAL; CARIBBEAN CORAL; LOCAL RETENTION; RECRUITMENT	Defining the scale of connectivity, or exchange, among marine populations and determining the factors driving this-exchange are pivotal to our understanding of the population dynamics, genetic structure, and biogeography of many coastal species. Using a high-resolution biophysical model for the Caribbean region, we report that typical larval dispersal distances of ecologically relevant magnitudes are on the scale of only 10 to 100 kilometers for a variety of reef fish species. We also show the importance of the early onset of active larval movement mediating the dispersal potential. In addition to self -recruitment, larval import from outside the local area is required to sustain most populations, although these population subsidies are very limited in particular systems. The results reveal distinct regions of population isolation based on larval dispersal that also correspond to genetic and morphological clines observed across a range of marine organisms.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami	Cowen, RK (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	rcowen@rsmas.miami.edu		Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Botsford LW, 2001, ECOL LETT, V4, P144; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; COE WR, 1953, ECOLOGY, V34, P225, DOI 10.2307/1930330; Colin P., 1975, COLIN; COWEN RK, 1985, J MAR RES, V43, P719, DOI 10.1357/002224085788440376; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; EFFORD I E, 1970, Crustaceana (Leiden), V18, P293, DOI 10.1163/156854070X00248; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; HILL AE, 1990, MAR ECOL PROG SER, V64, P217, DOI 10.3354/meps064217; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Largier JL, 2003, ECOL APPL, V13, pS71; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; SAMMARCO PW, 1989, LIMNOL OCEANOGR, V34, P896, DOI 10.4319/lo.1989.34.5.0896; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Shanks AL, 2003, ECOL APPL, V13, pS159; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; THORSON G, 1950, MEDD DOMM DAN FISK P, V4, P1; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Warner RR, 2002, B MAR SCI, V70, P245; Werner FE, 2001, SARSIA, V86, P411, DOI 10.1080/00364827.2001.10420483; Wolanski E, 1997, NATURWISSENSCHAFTEN, V84, P262, DOI 10.1007/s001140050394	34	1016	1042	6	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					522	527		10.1126/science.1122039	http://dx.doi.org/10.1126/science.1122039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16357224				2022-12-28	WOS:000235071400046
J	Vignuzzi, M; Stone, JK; Arnold, JJ; Cameron, CE; Andino, R				Vignuzzi, M; Stone, JK; Arnold, JJ; Cameron, CE; Andino, R			Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population	NATURE			English	Article							DEPENDENT RNA-POLYMERASE; ERROR CATASTROPHE; VIRUS; POLIOVIRUS; MUTATIONS; EXTINCTION; RIBAVIRIN; EVOLUTION; FIDELITY; MUTANTS	An RNA virus population does not consist of a single genotype; rather, it is an ensemble of related sequences, termed quasispecies(1-4). Quasispecies arise from rapid genomic evolution powered by the high mutation rate of RNA viral replication(5-8). Although a high mutation rate is dangerous for a virus because it results in nonviable individuals, it has been hypothesized that high mutation rates create a 'cloud' of potentially beneficial mutations at the population level, which afford the viral quasispecies a greater probability to evolve and adapt to new environments and challenges during infection(4,9-11). Mathematical models predict that viral quasispecies are not simply a collection of diverse mutants but a group of interactive variants, which together contribute to the characteristics of the population(4,12). According to this view, viral populations, rather than individual variants, are the target of evolutionary selection(4,12). Here we test this hypothesis by examining the consequences of limiting genomic diversity on viral populations. We find that poliovirus carrying a high-fidelity polymerase replicates at wild-type levels but generates less genomic diversity and is unable to adapt to adverse growth conditions. In infected animals, the reduced viral diversity leads to loss of neurotropism and an attenuated pathogenic phenotype. Notably, using chemical mutagenesis to expand quasispecies diversity of the high-fidelity virus before infection restores neurotropism and pathogenesis. Analysis of viruses isolated from brain provides direct evidence for complementation between members in the quasispecies, indicating that selection indeed occurs at the population level rather than on individual variants. Our study provides direct evidence for a fundamental prediction of the quasispecies theory and establishes a link between mutation rate, population dynamics and pathogenesis.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	andino@itsa.ucsf.edu		Vignuzzi, Marco/0000-0002-4400-771X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045818, R01AI036178, R01AI040085, R21AI040085, U01AI054776] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045818-07, R01 AI036178, N01AI40085, R01 AI045818, R01 AI045818-08, R01 AI040085, U01 AI054776] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; BALTERA RF, 1989, J VIROL, V63, P4441, DOI 10.1128/JVI.63.10.4441-4444.1989; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; DOMINGO E, 1994, MUTATION RATES RAPID, P161; Domingo E., 1988, RNA GENETICS; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Eigen M., 1988, RNA GENETICS, V3, P211; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; PINCUS SE, 1986, J VIROL, V57, P638, DOI 10.1128/JVI.57.2.638-646.1986; REN RB, 1992, J INFECT DIS, V166, P747, DOI 10.1093/infdis/166.4.747; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357	24	772	799	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					344	348		10.1038/nature04388	http://dx.doi.org/10.1038/nature04388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16327776	Green Accepted			2022-12-28	WOS:000234682100047
J	Palliser, D; Chowdhury, D; Wang, QY; Lee, SJ; Bronson, RT; Knipe, DM; Lieberman, J				Palliser, D; Chowdhury, D; Wang, QY; Lee, SJ; Bronson, RT; Knipe, DM; Lieberman, J			An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT INTERFERING RNA; REPLICATION-DEFECTIVE MUTANT; DNA-BINDING PROTEIN; HERPES; INHIBITION; ESCAPE; CHALLENGE; CELLS	Herpes simplex virus 2 (HSV-2) infection causes significant morbidity(1) and is an important cofactor for the transmission of HIV infection(2). A microbicide to prevent sexual transmission of HSV-2 would contribute substantially to controlling the spread of HIV and other infections(3,4). Because RNA interference (RNAi) provides effective antiviral defence in plants and other organisms, several studies have focused on harnessing RNAi to inhibit viral infection(5). Here we show that vaginal instillation of small interfering RNAs (siRNAs) targeting HSV-2 protects mice from lethal infection. siRNAs mixed with lipid are efficiently taken up by epithelial and lamina propria cells and silence gene expression in the mouse vagina and ectocervix for at least nine days. Intravaginal application of siRNAs targeting the HSV-2 UL27 and UL29 genes ( which encode an envelope glycoprotein and a DNA binding protein(6), respectively) was well tolerated, did not induce interferon-responsive genes or cause inflammation, and protected mice when administered before and/or after lethal HSV-2 challenge. These results suggest that siRNAs are attractive candidates for the active component of a microbicide designed to prevent viral infection or transmission.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015					Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; GAO M, 1989, J VIROL, V63, P5258, DOI 10.1128/JVI.63.12.5258-5267.1989; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Pilcher H, 2004, NATURE, V430, P138, DOI 10.1038/430138a; Roizman B., 2001, FIELDS VIROLOGY, V4th ed., P2399; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SPANG AE, 1983, J VIROL, V45, P332, DOI 10.1128/JVI.45.1.332-342.1983; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	29	333	375	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					89	94		10.1038/nature04263	http://dx.doi.org/10.1038/nature04263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16306938				2022-12-28	WOS:000234378700040
J	Alitalo, K; Tammela, T; Petrova, TV				Alitalo, K; Tammela, T; Petrova, TV			Lymphangiogenesis in development and human disease	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; LYMPHEDEMA-DISTICHIASIS SYNDROME; SARCOMA-ASSOCIATED HERPESVIRUS; PROMOTES LYMPHATIC METASTASIS; VEGF-C; FACTOR RECEPTOR-3; TUMOR LYMPHANGIOGENESIS; TYROSINE PHOSPHORYLATION; CANCER METASTASIS; VESSEL FORMATION	The lymphatic vasculature forms a vessel network that drains interstitial fluid from tissues and returns it to the blood. Lymphatic vessels are also an essential part of the body's immune defence. They have an important role in the pathogenesis of several diseases, such as cancer, lymphoedema and various inflammatory conditions. Recent biological and technological developments in lymphatic vascular biology will lead to a better understanding and treatment of these diseases.	Univ Helsinki, Ludwig Inst Canc Res, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Mol Cell Biol Program, Haartman Inst, FIN-00014 Helsinki, Finland; Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland	Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Alitalo, K (corresponding author), Univ Helsinki, Ludwig Inst Canc Res, Mol Canc Biol Lab, POB 63 Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	Kari.Alitalo@Helsinki.FI	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; /0000-0003-3675-6961				Aalami OO, 2000, SURGERY, V128, P761, DOI 10.1067/msy.2000.109502; Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ferrell RE, 2002, ANN NY ACAD SCI, V979, P39, DOI 10.1111/j.1749-6632.2002.tb04866.x; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gannon G, 2002, CANCER RES, V62, P603; Groot ACGD, 2004, DEV DYNAM, V230, P378, DOI 10.1002/dvdy.20054; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2004, J DERMATOL SCI, V35, P1, DOI 10.1016/j.jdermsci.2003.10.006; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Jeltsch M, 2003, CELL TISSUE RES, V314, P69, DOI 10.1007/s00441-003-0777-2; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2001, CANCER RES, V61, P1786; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Krishnan J, 2003, CANCER RES, V63, P713; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Maula SM, 2003, CANCER RES, V63, P1920; Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Pullinger BD, 1937, J PATHOL BACTERIOL, V45, P157, DOI 10.1002/path.1700450115; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Saban MR, 2004, BLOOD, V104, P3228, DOI 10.1182/blood-2004-04-1428; Sabin FR, 1909, AM J ANAT, V9, P43, DOI 10.1002/aja.1000090104; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schneider M, 1999, DEV DYNAM, V216, P311, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<311::AID-DVDY1>3.3.CO;2-D; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang JF, 2001, J BIOL CHEM, V276, P41950, DOI 10.1074/jbc.M101370200; WEIS S, 2005, NATURE, V65, P9789; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; WONG SY, CANC RES, V65, P9789; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang XF, 2005, J BIOL CHEM, V280, P26216, DOI 10.1074/jbc.M411392200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	99	922	997	5	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					946	953		10.1038/nature04480	http://dx.doi.org/10.1038/nature04480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355212				2022-12-28	WOS:000233934600053
J	Gariano, RF; Gardner, TW				Gariano, RF; Gardner, TW			Retinal angiogenesis in development and disease	NATURE			English	Review							ENDOTHELIAL-GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; HEMATOPOIETIC STEM-CELLS; VASCULAR DEVELOPMENT; VEGF EXPRESSION; BLOOD-VESSELS; MOUSE MODEL; VASO-OBLITERATION; NORRIE-DISEASE; MICE LACKING	The retina has long been regarded as 'an approachable part of the brain' for investigating neurosensory processes. Cell biologists are now capitalizing on the accessibility of the retina to investigate important aspects of developmental angiogenesis, including how it relates to neuronal and glial development, morphogenesis, oxygen sensing and progenitor cells. Pathological angiogenesis also occurs in the retina and is a major feature of leading blinding diseases, particularly diabetic retinopathy. The retina and its clinical disorders have a pivotal role in angiogenesis research and provide model systems in which to investigate neurovascular relationships and angiogenic diseases.	Stanford Univ, Sch Med, Dept Ophthalmol, Palo Alto, CA 94305 USA; Penn State Coll Med, Dept Ophthalmol, Hershey, PA 17033 USA; Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gariano, RF (corresponding author), Stanford Univ, Sch Med, Dept Ophthalmol, A-157,300 Pasteur Dr, Palo Alto, CA 94305 USA.	raygariano@hotmail.com		Gardner, Thomas/0000-0002-5112-5810				ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Arfken CL, 1998, DIABETES CARE, V21, P792, DOI 10.2337/diacare.21.5.792; ASHTON N, 1966, AM J OPHTHALMOL, V62, P412, DOI 10.1016/0002-9394(66)91322-5; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chan-Ling T, 2004, INVEST OPHTH VIS SCI, V45, P2020, DOI 10.1167/iovs.03-1169; CHANLING T, 1990, CURR EYE RES, V9, P459, DOI 10.3109/02713689008999612; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; CONNOLLY SE, 1988, MICROVASC RES, V36, P275, DOI 10.1016/0026-2862(88)90028-3; Curatola AM, 2005, EXP EYE RES, V81, P147, DOI 10.1016/j.exer.2005.06.001; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DIAZARAYA CM, 1995, J COMP NEUROL, V363, P53, DOI 10.1002/cne.903630106; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dorrell MI, 2004, BLOOD, V103, P3420, DOI 10.1182/blood-2003-09-3012; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; DORRELL MI, 2003, MOL BIOL CELL S, V14, P260; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Feeney SA, 2003, INVEST OPHTH VIS SCI, V44, P839, DOI 10.1167/iovs.02-0040; FLOWER RW, 1985, INVEST OPHTH VIS SCI, V26, P957; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Galimi F, 2005, BLOOD, V105, P2400, DOI 10.1182/blood-2004-02-0612; GARDNER TW, 1908, SURV OPHTHALMOL S2, V47, pS253; Gariano RF, 2003, PROG RETIN EYE RES, V22, P295, DOI 10.1016/S1350-9462(02)00062-9; Gariano RF, 1996, INVEST OPHTH VIS SCI, V37, P2367; GARIANO RF, IN PRESS MECH DEV GE; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Harris A, 1996, BRIT J OPHTHALMOL, V80, P209, DOI 10.1136/bjo.80.3.209; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Koyama R, 2003, J CHROMATOGR B, V792, P5, DOI 10.1016/S1570-0232(03)00133-8; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; Ma WB, 2003, CANCER RES, V63, P5320; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; Miyawaki T, 2004, J NEUROSCI, V24, P8124, DOI 10.1523/JNEUROSCI.2235-04.2004; Nguyen QD, 2004, INVEST OPHTH VIS SCI, V45, P617, DOI 10.1167/iovs.03-0557; Niehrs C, 2004, DEV CELL, V6, P453, DOI 10.1016/S1534-5807(04)00102-9; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; PHELPS DL, 1990, INVEST OPHTH VIS SCI, V31, P2194; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sarlos S, 2003, AM J PATHOL, V163, P879, DOI 10.1016/S0002-9440(10)63448-7; Sengupta N, 2003, INVEST OPHTH VIS SCI, V44, P4908, DOI 10.1167/iovs.03-0342; Shih SC, 2003, P NATL ACAD SCI USA, V100, P15859, DOI 10.1073/pnas.2136855100; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STEFANSSON E, 1986, AM J OPHTHALMOL, V101, P657, DOI 10.1016/0002-9394(86)90765-8; STEFANSSON E, 1992, AM J OPHTHALMOL, V113, P36, DOI 10.1016/S0002-9394(14)75750-2; STEFANSSON E, 1989, AM J PHYSIOL, V256, pH1127, DOI 10.1152/ajpheart.1989.256.4.H1127; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VERNON RB, 1992, LAB INVEST, V66, P536; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; WISE GN, 1961, AM J OPHTHALMOL, V52, P637, DOI 10.1016/0002-9394(61)90149-0; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	79	509	540	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					960	966		10.1038/nature04482	http://dx.doi.org/10.1038/nature04482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355161				2022-12-28	WOS:000233934600055
J	Hope, T; Frith, P; Craze, J; Mussai, F; Chadha-Gupta, A; Noble, D				Hope, T; Frith, P; Craze, J; Mussai, F; Chadha-Gupta, A; Noble, D			Developing guidelines for medical students about the examination of patients under 18 years old	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTIMATE EXAMINATIONS; GENITAL EXAMINATION; CHAPERONES		Univ Oxford, Oxford OX3 7LF, England; John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Hope, T (corresponding author), Univ Oxford, Oxford OX3 7LF, England.	tony.hope@ethox.ox.ac.uk		Mussai, Francis/0000-0003-3342-0047				Bignell CJ, 1999, BMJ-BRIT MED J, V319, P137, DOI 10.1136/bmj.319.7203.137; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Croft M, 1999, BMJ-BRIT MED J, V319, P1266, DOI 10.1136/bmj.319.7219.1266; MacDougall J, 2003, BRIT MED J, V326, P100; Nesheim BI, 2003, BRIT MED J, V326, P100; Randall S, 1998, BRIT J FAM PLAN, V24, P83; *ROYAL COLL OBST G, 1997, INT EX REP WORK PART; Torrance CJ, 1999, BRIT MED J, V319, P159, DOI 10.1136/bmj.319.7203.159	8	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1384	1386		10.1136/bmj.331.7529.1384	http://dx.doi.org/10.1136/bmj.331.7529.1384			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339250	Bronze, Green Published			2022-12-28	WOS:000233999300023
J	Wyatt, JC; Sullivan, F				Wyatt, JC; Sullivan, F			ABC of health informatics - eHealth and the future: promise or peril?	BRITISH MEDICAL JOURNAL			English	Review									Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee	Wyatt, JC (corresponding author), Univ Dundee, Dundee DD1 4HN, Scotland.		Sullivan, Frank/L-8286-2019; Wyatt, Jeremy/F-8160-2010; Sullivan, Frank m/A-7767-2009	Sullivan, Frank/0000-0002-6623-4964; Wyatt, Jeremy/0000-0001-7008-1473; 				Bessell Tracey L, 2002, Health Expect, V5, P28, DOI 10.1046/j.1369-6513.2002.00156.x; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; Eminovic N, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e17; Gustafson DH, 2004, BMJ-BRIT MED J, V328, P1150, DOI 10.1136/bmj.328.7449.1150; Rigby M, 2001, BMJ-BRIT MED J, V323, P552, DOI 10.1136/bmj.323.7312.552; TURNER R, 1993, BRIT MED J, V307, P1623, DOI 10.1136/bmj.307.6919.1623; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; WYATT JC, 2002, NEW PRACTITIONERS FU	8	48	49	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1391	1393		10.1136/bmj.331.7529.1391	http://dx.doi.org/10.1136/bmj.331.7529.1391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339252	Green Published			2022-12-28	WOS:000233999300028
J	Shuster, DL; Ehlers, TA; Rusmore, ME; Farley, KA				Shuster, DL; Ehlers, TA; Rusmore, ME; Farley, KA			Rapid glacial erosion at 1.8 Ma revealed by He-4/He-3 thermochronometry	SCIENCE			English	Article							SOUTHWESTERN BRITISH-COLUMBIA; ACTIVE MOUNTAIN BELTS; RELIEF PRODUCTION; HELIUM DIFFUSION; COAST MOUNTAINS; (U-TH)/HE AGES; CLIMATE-CHANGE; SIERRA-NEVADA; APATITE; RANGES	Alpine glaciation and river incision control the topography of mountain ranges, but their relative contributions have been debated for years. Apatite He-4/He-3 thermochronometry tightly constrains the timing and rate of glacial erosion within one of the largest valleys in the southern Coast Mountains of British Columbia, Canada. Five proximate samples require accelerated denudation of the Klinaklini Valley initiating 1.8 +/- 0.2 million years ago (Ma). At least 2 kilometers of overlying rock were removed from the valley at >= 5 millimeters per year, indicating that glacial valley deepening proceeded >= 6,times as fast as erosion rates before similar to 1.8 Ma. This intense erosion may be related to a global transition to enhanced climate instability similar to 1.9 Ma.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Occidental Coll, Dept Geol, Los Angeles, CA 90041 USA	California Institute of Technology; University of Michigan System; University of Michigan; Occidental College	Shuster, DL (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.	dshuster@bgc.org	Farley, Kenneth/AAE-7735-2020; Shuster, David/A-4838-2011; Ehlers, Todd A/A-9582-2012	Ehlers, Todd A/0000-0001-9436-0303; Farley, Kenneth/0000-0002-7846-7546				Alley RB, 2003, NATURE, V424, P758, DOI 10.1038/nature01839; Anderson RS, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2004JF000120; Brocklehurst SH, 2002, GEOMORPHOLOGY, V42, P1, DOI 10.1016/S0169-555X(01)00069-1; Brozovic N, 1997, SCIENCE, V276, P571, DOI 10.1126/science.276.5312.571; CLAGUE JJ, 1989, QUATERNARY GEOLOGY C, P17; Ehlers TA, 2003, EARTH PLANET SC LETT, V206, P1, DOI 10.1016/S0012-821X(02)01069-5; Farley KA, 1996, GEOCHIM COSMOCHIM AC, V60, P4223, DOI 10.1016/S0016-7037(96)00193-7; Farley KA, 2000, J GEOPHYS RES-SOL EA, V105, P2903, DOI 10.1029/1999JB900348; Farley KA, 2002, REV MINERAL GEOCHEM, V47, P819, DOI 10.2138/rmg.2002.47.18; Farley KA, 1999, ANAL CHEM, V71, P2059, DOI 10.1021/ac9813078; Farley KA, 2001, GEOLOGY, V29, P99, DOI 10.1130/0091-7613(2001)029<0099:PMUAEO>2.0.CO;2; Fechtig H., 1966, POTASSIUM ARGON DATI, P68, DOI DOI 10.1007/978-3-642-87895-4_4; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; House MA, 1998, NATURE, V396, P66, DOI 10.1038/23926; HUMPHREY NF, 1994, J GLACIOL, V40, P539, DOI 10.1017/S0022143000012429; HYNDMAN RD, 1976, J GEOPHYS RES, V81, P337, DOI 10.1029/JB081i002p00337; LEWIS TJ, 1985, CAN J EARTH SCI, V22, P1262, DOI 10.1139/e85-131; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Montgomery DR, 2002, GEOLOGY, V30, P1047, DOI 10.1130/0091-7613(2002)030<1047:VFBFAG>2.0.CO;2; OSULLIVAN PB, 1995, EARTH PLANET SC LETT, V132, P213, DOI 10.1016/0012-821X(95)00058-K; PARRISH RR, 1983, TECTONICS, V2, P601, DOI 10.1029/TC002i006p00601; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reynolds BC, 2004, GEOLOGY, V32, P861, DOI 10.1130/G20734.1; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P19, DOI 10.1016/S0012-821X(03)00594-6; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P1, DOI 10.1016/S0012-821X(03)00595-8; Small EE, 1998, GEOLOGY, V26, P123, DOI 10.1130/0091-7613(1998)026<0123:PRPILM>2.3.CO;2; Spotila JA, 2004, GEOLOGY, V32, P501, DOI 10.1130/G20343.1; STJOHN KEK, 2004, SEDIMENTARY RECORD, V4, P4; Tomkin JH, 2002, AM J SCI, V302, P169, DOI 10.2475/ajs.302.3.169; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Winter BL, 1997, GEOCHIM COSMOCHIM AC, V61, P4181, DOI 10.1016/S0016-7037(97)00215-9; Zhang PZ, 2001, NATURE, V410, P891, DOI 10.1038/35073504	34	118	125	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1668	1670		10.1126/science.1118519	http://dx.doi.org/10.1126/science.1118519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339442				2022-12-28	WOS:000233961700041
J	Hnasko, TS; Sotak, BN; Palmiter, RD				Hnasko, TS; Sotak, BN; Palmiter, RD			Morphine reward in dopamine-deficient mice	NATURE			English	Article							VENTRAL TEGMENTAL AREA; KNOCK-OUT MICE; NUCLEUS-ACCUMBENS; LOCOMOTOR-ACTIVITY; PLACE PREFERENCE; RECEPTOR; RATS; ANALGESIA; SYSTEM; AMPHETAMINE	Dopamine has been widely implicated as a mediator of many of the behavioural responses to drugs of abuse(1). To test the hypothesis that dopamine is an essential mediator of various opiate-induced responses, we administered morphine to mice unable to synthesize dopamine. We found that dopamine-deficient mice are unable to mount a normal locomotor response to morphine, but a small dopamine-independent increase in locomotion remains. Dopamine-deficient mice have a rightward shift in the dose - response curve to morphine on the tail-flick test ( a pain sensitivity assay), suggesting either a decreased sensitivity to the analgesic effects of morphine and/or basal hyperalgesia. In contrast, dopamine-deficient mice display a robust conditioned place preference for morphine when given either caffeine or L-dihydroxyphenylalanine ( a dopamine precursor that restores dopamine throughout the brain) during the testing phases. Together, these data demonstrate that dopamine is a crucial component of morphine-induced locomotion, dopamine may contribute to morphine analgesia, but that dopamine is not required for morphine-induced reward as measured by conditioned place preference.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@u.washington.edu		Hnasko, Thomas/0000-0001-6176-8513				Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; BECHARA A, 1989, J NEUROSCI, V9, P3400; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; BOZARTH MA, 1987, BRAIN RES, V414, P77, DOI 10.1016/0006-8993(87)91327-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; Elmer GI, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0004.2002; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Franklin KBJ, 1998, PHARMACOL BIOCHEM BE, V59, P993, DOI 10.1016/S0091-3057(97)00535-2; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kim DS, 2003, P NATL ACAD SCI USA, V100, P1346, DOI 10.1073/pnas.252753799; King MA, 2001, J NEUROSCI, V21, P7788, DOI 10.1523/JNEUROSCI.21-19-07788.2001; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Manzanedo C, 2001, BEHAV BRAIN RES, V121, P189, DOI 10.1016/S0166-4328(01)00164-4; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; OLDS ME, 1982, BRAIN RES, V237, P429, DOI 10.1016/0006-8993(82)90454-1; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; SHIPPENBERG TS, 1993, J PHARMACOL EXP THER, V265, P53; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	29	183	197	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					854	857		10.1038/nature04172	http://dx.doi.org/10.1038/nature04172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341013				2022-12-28	WOS:000233777800051
J	Kaplan, RN; Riba, RD; Zacharoulis, S; Bramley, AH; Vincent, L; Costa, C; MacDonald, DD; Jin, DK; Shido, K; Kerns, SA; Zhu, ZP; Hicklin, D; Wu, Y; Port, JL; Altorki, N; Port, ER; Ruggero, D; Shmelkov, SV; Jensen, KK; Rafii, S; Lyden, D				Kaplan, RN; Riba, RD; Zacharoulis, S; Bramley, AH; Vincent, L; Costa, C; MacDonald, DD; Jin, DK; Shido, K; Kerns, SA; Zhu, ZP; Hicklin, D; Wu, Y; Port, JL; Altorki, N; Port, ER; Ruggero, D; Shmelkov, SV; Jensen, KK; Rafii, S; Lyden, D			VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-1; ENDOTHELIAL-CELLS; CHEMOKINE RECEPTORS; TUMOR ANGIOGENESIS; STEM; ADHESION; INTEGRINS; MMP-9; RECRUITMENT; PROGRESSION	The cellular and molecular mechanisms by which a tumour cell undergoes metastasis to a predetermined location are largely unknown. Here we demonstrate that bone marrow-derived haematopoietic progenitor cells that express vascular endothelial growth factor receptor 1 (VEGFR1; also known as Flt1) home to tumour-specific pre-metastatic sites and form cellular clusters before the arrival of tumour cells. Preventing VEGFR1 function using antibodies or by the removal of VEGFR1(+) cells from the bone marrow of wild-type mice abrogates the formation of these pre-metastatic clusters and prevents tumour metastasis, whereas reconstitution with selected Id3 ( inhibitor of differentiation 3)-competent VEGFR1(+) cells establishes cluster formation and tumour metastasis in Id3 knockout mice. We also show that VEGFR1(+) cells express VLA-4 ( also known as integrin alpha(4)beta(1)), and that tumour-specific growth factors upregulate fibronectin - a VLA-4 ligand - in resident fibroblasts, providing a permissive niche for incoming tumour cells. Conditioned media obtained from distinct tumour types with unique patterns of metastatic spread redirected fibronectin expression and cluster formation, thereby transforming the metastatic profile. These findings demonstrate a requirement for VEGFR1(+) haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1(+)VLA-4(+) clusters dictate organ-specific tumour spread.	Cornell Univ, Weill Cornell Med Coll, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Cornell Med Coll, Childrens Blood Fdn Labs, New York, NY 10021 USA; Cornell Univ, Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Imclone Syst Inc, New York, NY 10014 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Eli Lilly; Fox Chase Cancer Center	Lyden, D (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pediat, 1300 York Ave, New York, NY 10021 USA.	srafii@med.cornell.edu; dcl2001@med.cornell.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Costa, Carla/0000-0001-5977-6207	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067839, R01HL061849, R01HL058707] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL061849, R01 HL061849-04, P01 HL067839-020004, R01 HL061849-03, P01 HL067839, P01 HL067839-030004, R01 HL058707-03, R01 HL061849-03S1, R01 HL061849-05, P01 HL067839-010004, P01 HL067839-050004, R01 HL061849-02, P01 HL067839-040004, R01 HL058707-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Burger JA, 2003, BRIT J HAEMATOL, V122, P579, DOI 10.1046/j.1365-2141.2003.04466.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; JONJIC N, 1992, J IMMUNOL, V148, P2080; Kessinger A, 2001, EXP HEMATOL, V29, P775, DOI 10.1016/S0301-472X(01)00642-7; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neeson PJ, 2003, PATHOLOGY, V35, P50, DOI 10.1080/003130202201478; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian F, 2001, P NATL ACAD SCI USA, V98, P3976, DOI 10.1073/pnas.061633698; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; TAM PP, 1999, DEVELOPMENT, V124, P1631; Yakubenko VP, 2000, EXP CELL RES, V260, P73, DOI 10.1006/excr.2000.5002	36	2258	2379	4	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					820	827		10.1038/nature04186	http://dx.doi.org/10.1038/nature04186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341007	Green Accepted			2022-12-28	WOS:000233777800044
J	Kaufmann, SHE				Kaufmann, SHE			Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.		Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268				Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Koch R., 1912, GESAMMELTE WERKE R K	2	35	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2423	2426		10.1056/NEJMp058131	http://dx.doi.org/10.1056/NEJMp058131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339091				2022-12-28	WOS:000233754400002
J	Pacheco, G; Cavallasca, JA				Pacheco, G; Cavallasca, JA			Deforming gout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital de Clinicas Jose de San Martin	Pacheco, G (corresponding author), Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina.			Cavallasca, Javier/0000-0003-4621-519X					0	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					E20	E20		10.1056/NEJMicm040861	http://dx.doi.org/10.1056/NEJMicm040861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339089				2022-12-28	WOS:000233754400011
J	Donaldson, C; Ruta, D				Donaldson, C; Ruta, D			The NHS revolution: health care in the market place - Should the NHS follow the American way?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOLLAR		Newcastle Univ, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England	Newcastle University - UK	Donaldson, C (corresponding author), Newcastle Univ, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	cam.donaldson@ncl.ac.uk	Ruta, Danny A/E-4472-2013	Ruta, Danny/0000-0002-2024-3267; Donaldson, Cam/0000-0003-4670-5340				ALTMAN DE, 2002, HLTH AFF MILLWOOD S, pW83; David DS, 2002, BMJ-BRIT MED J, V324, P1332; *DEP HLTH, 2005, DEP REP 2005; Department of Health, 2005, CREAT PAT LED NHS; DONALDSON C, 2005, PUBLIC PRIVATE MIX H; Donaldson C, 2005, EC HLTH CARE FINANCI, V2nd; DUSHEIKO M, 2003, EFFECT PRACTICE BUDG; Edwards Nigel, 2002, BMJ, V324, P1332; EVANS RG, 1990, J HEALTH POLIT POLIC, V15, P101, DOI 10.1215/03616878-15-1-101; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Himmelstein DU, 2002, BRIT MED J, V324, P1332, DOI 10.1136/bmj.324.7349.1332; Le Grand J, 1999, HEALTH AFFAIR, V18, P27, DOI 10.1377/hlthaff.18.3.27; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; Miller RH, 2002, HEALTH AFFAIR, V21, P63, DOI 10.1377/hlthaff.21.4.63; *PREM ADV COUNC HL, 2001, FRAM REF; Romanow RJ, 2002, SHAPE FUTURE HLTH CA; Ruta D, 2005, BRIT MED J, V330, P1501, DOI 10.1136/bmj.330.7506.1501	17	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1328	1330		10.1136/bmj.331.7528.1328	http://dx.doi.org/10.1136/bmj.331.7528.1328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	990YE	16322024	Green Published			2022-12-28	WOS:000233778500025
J	Papageorgiou, KI; Mathew, RG; Kaniorou-Larai, MG; Yiakoumetis, A				Papageorgiou, KI; Mathew, RG; Kaniorou-Larai, MG; Yiakoumetis, A			Pyoderma gangrenosum in ulcerative colitis: considerations for an early diagnosis	BRITISH MEDICAL JOURNAL			English	Review							DISEASE		Broomfield Hosp, Dept Ophthalmol, Chelmsford CM1 7ET, Essex, England; G Gennimatas 6th IKA Oncol Hosp, Dept Plast & Reconstruct Surg, Athens 11473, Greece	Mid Essex Hospital Services NHS Trust; Broomfield Hospital	Papageorgiou, KI (corresponding author), Broomfield Hosp, Dept Ophthalmol, Chelmsford CM1 7ET, Essex, England.	papageorgiouk@doctors.org.uk						Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; Brunsting LA, 1930, ARCH DERMATOL SYPH, V22, P655, DOI 10.1001/archderm.1930.01440160053009; Chow RKP, 1996, J AM ACAD DERMATOL, V34, P1047, DOI 10.1016/S0190-9622(96)90285-6; Langholz E, 1999, DAN MED BULL, V46, P400; LONG CC, 1992, BRIT J DERMATOL, V127, P45, DOI 10.1111/j.1365-2133.1992.tb14826.x; Powell FC, 1996, J AM ACAD DERMATOL, V34, P395, DOI 10.1016/S0190-9622(96)90428-4; POWELL FC, 1985, Q J MED, V55, P173; SCHWAEGERLE SM, 1988, J AM ACAD DERMATOL, V18, P559, DOI 10.1016/S0190-9622(88)70080-8; Wolff K., 2011, FITZPATRICKS DERMATO, V8	9	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2005	331	7528					1323	1324		10.1136/bmj.331.7528.1323	http://dx.doi.org/10.1136/bmj.331.7528.1323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322022	Green Published			2022-12-28	WOS:000233778500023
J	Johnston, DT; Wing, BA; Farquhar, J; Kaufman, AJ; Strauss, H; Lyons, TW; Kah, LC; Canfield, DE				Johnston, DT; Wing, BA; Farquhar, J; Kaufman, AJ; Strauss, H; Lyons, TW; Kah, LC; Canfield, DE			Active microbial sulfur disproportionation in the Mesoproterozoic	SCIENCE			English	Article							ELEMENTAL SULFUR; ATMOSPHERIC OXYGEN; ISOTOPE; SULFATE; EVOLUTION; OCEAN; REDUCTION; CYCLES; CARBON	The environmental expression of sulfur compound disproportionation has been placed between 640 and 1050 million years ago (Ma) and linked to increases in atmospheric oxygen. These arguments have their basis in temporal changes in the magnitude of S-34/S-32 fractionations between sulfate and sulfide. Here, we present a Proterozoic seawater sulfate isotope record that includes the less abundant sulfur isotope S-33. These measurements imply that sulfur compound disproportionation was an active part of the sulfur cycle by 1300 Ma and that progressive Earth surface oxygenation may have characterized the Mesoproterozoic.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Univ Munster, Inst Geol Palaontol, D-48149 Munster, Germany; Univ Munster, Geol Palaontol Museum, D-48149 Munster, Germany; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; So Denmark Univ, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; So Denmark Univ, Inst Biol, DK-5230 Odense, Denmark	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Munster; University of Munster; University of California System; University of California Riverside; University of Tennessee System; University of Tennessee Knoxville; University of Southern Denmark; University of Southern Denmark	Johnston, DT (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	dtj@geol.umd.edu; wing@essic.umd.edu	Canfield, Don/C-1735-2012; Kah, Linda C/J-3754-2019; Johnston, David/A-9796-2010	Canfield, Don/0000-0001-7602-8366; Kah, Linda C/0000-0001-7172-2033; Johnston, David/0000-0002-2487-1084				BAK F, 1987, ARCH MICROBIOL, V147, P184, DOI 10.1007/BF00415282; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 1998, LIMNOL OCEANOGR, V43, P253, DOI 10.4319/lo.1998.43.2.0253; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Frank TD, 2003, GEOL MAG, V140, P397, DOI 10.1017/S0016756803007830; GARRELS RM, 1981, P NATL ACAD SCI USA, V78, P4652, DOI 10.1073/pnas.78.8.4652; Gellatly AM, 2005, GEOCHIM COSMOCHIM AC, V69, P3813, DOI 10.1016/j.gca.2005.01.019; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HATTORI K, 1983, NATURE, V302, P323, DOI 10.1038/302323a0; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Johnston DT, 2005, AM J SCI, V305, P645, DOI 10.2475/ajs.305.6-8.645; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; PERRY EC, 1971, SCIENCE, V171, P1015, DOI 10.1126/science.171.3975.1015; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2	27	173	177	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1477	1479		10.1126/science.1117824	http://dx.doi.org/10.1126/science.1117824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322453	Green Submitted			2022-12-28	WOS:000233756500039
J	Oh, M; Mirkin, CA				Oh, M; Mirkin, CA			Chemically tailorable colloidal particles from infinite coordination polymers	NATURE			English	Article							ORGANIC NANOPARTICLES; OPTICAL-PROPERTIES; COMPLEXES; CATALYSIS; NANOCRYSTALS; REDUCTION; CRYSTAL; SILVER; DNA	Micrometre- and nanometre- sized particles play important roles in many applications, including catalysis(1), optics(2,3), biosensing(4-8) and data storage(9). Organic particles(10) are usually prepared through polymerization of suitable monomers(11) or precipitation methods(12). In the case of inorganic materials, particle fabrication tends to involve the reduction of a metal salt(13), or the controlled mixing of salt solutions supplying a metal cation and an elemental anion ( for example, S2-, Se2- , O2-) (14), respectively; in some instances, these methods even afford direct control over the shape of the particles produced(14 - 17). Another class of materials are metal- organic coordination polymers(18 - 23), which are based on metal ions coordinated by polydentate organic ligands and explored for potential use in catalysis(18), gas storage(19,20), nonlinear optics(21) and molecular recognition and separations(22,23). In a subset of these materials, the use of organometallic complexes as ligands ( so- called metalloligands) provides an additional level of tailorability, but these materials have so far not yet been fashioned into nano- or microparticles. Here we show that simple addition of an initiation solvent to a precursor solution of metal ions and metalloligands results in the spontaneous and fully reversible formation of a new class of metal - metalloligand particles. We observe initial formation of particles with diameters of a few hundred nanometres, which then coalesce and anneal into uniform and smooth microparticles. The ease with which these particles can be fabricated, and the ability to tailor their chemical and physical properties through the choice of metal and organic ligand used, should facilitate investigations of their scope for practical applications.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627				Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Chen JY, 2005, ANGEW CHEM INT EDIT, V44, P2589, DOI 10.1002/anie.200462668; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Evans OR, 2002, ACCOUNTS CHEM RES, V35, P511, DOI 10.1021/ar0001012; Fu HB, 2001, J AM CHEM SOC, V123, P1434, DOI 10.1021/ja0026298; Henglein A, 2001, LANGMUIR, V17, P2329, DOI 10.1021/la001081f; Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Kilsa K, 2004, J PHYS CHEM B, V108, P15640, DOI 10.1021/jp0369995; Kosal ME, 2002, NAT MATER, V1, P118, DOI 10.1038/nmat730; MIRKIN CA, 1996, NATURE, V382, P609; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Roscoe SB, 1998, SCIENCE, V280, P270, DOI 10.1126/science.280.5361.270; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Ruck RT, 2002, J AM CHEM SOC, V124, P2882, DOI 10.1021/ja025588j; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Splan KE, 2003, EUR J INORG CHEM, P2348, DOI 10.1002/ejic.200200665; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Tabellion FM, 2001, ANGEW CHEM INT EDIT, V40, P1529, DOI 10.1002/1521-3773(20010417)40:8<1529::AID-ANIE1529>3.0.CO;2-B; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	26	537	552	11	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					651	654		10.1038/nature04191	http://dx.doi.org/10.1038/nature04191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319888				2022-12-28	WOS:000233593100046
J	Cao, AY; Dickrell, PL; Sawyer, WG; Ghasemi-Nejhad, MN; Ajayan, PM				Cao, AY; Dickrell, PL; Sawyer, WG; Ghasemi-Nejhad, MN; Ajayan, PM			Super-compressible foamlike carbon nanotube films	SCIENCE			English	Article							OPEN-CELL FOAMS; ELASTIC PROPERTIES; STRAIN	We report that freestanding films of vertically aligned carbon nanotubes exhibit super-compressible foamlike behavior. Under compression, the nanotubes collectively form zigzag buckles that can fully unfold to their original length upon load release. Compared with conventional low-density flexible foams, the nanotube films show much higher compressive strength, recovery rate, and sag factor, and the open-cell nature of the nanotube arrays gives excellent breathability. The nanotube films present a class of open-cell foam structures, consisting of well-arranged one-dimensional units (nanotube struts). The lightweight, highly resilient nanotube films may be useful as compliant and energy-absorbing coatings.	Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA; Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA	University of Hawaii System; University of Hawaii Manoa; State University System of Florida; University of Florida; Rensselaer Polytechnic Institute	Cao, AY (corresponding author), Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA.	anyuan@hawaii.edu; ajayan@rpi.edu	Cao, Anyuan/C-3685-2012; Sawyer, Wallace G/A-7983-2008	Sawyer, Wallace G/0000-0002-4461-7227				Andrews R, 1999, CHEM PHYS LETT, V303, P467, DOI 10.1016/S0009-2614(99)00282-1; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Cao AY, 2005, NAT MATER, V4, P540, DOI 10.1038/nmat1415; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Falvo MR, 1997, NATURE, V389, P582, DOI 10.1038/39282; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; Gibson LJ, 2000, ANNU REV MATER SCI, V30, P191, DOI 10.1146/annurev.matsci.30.1.191; Hilyard N. C., 1982, MECH CELLULAR PLASTI, P103; Hilyard NC, 1994, LOW DENSITY CELLULAR; Iijima S, 1996, J CHEM PHYS, V104, P2089, DOI 10.1063/1.470966; Kinney JH, 2001, J APPL POLYM SCI, V80, P1746, DOI 10.1002/app.1269; Klempner D., 1991, HDB POLYM FOAMS FOAM; Lourie O, 1998, PHYS REV LETT, V81, P1638, DOI 10.1103/PhysRevLett.81.1638; Lu JP, 1997, PHYS REV LETT, V79, P1297, DOI 10.1103/PhysRevLett.79.1297; Qian D., 2002, APPL MECH REV, V55, P495, DOI [DOI 10.1115/1.1490129, 10.1115/1.1490129]; Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Suhr J, 2005, NAT MATER, V4, P134, DOI 10.1038/nmat1293; Timoshenko S., 1936, THEORY ELASTIC STABI; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Zhu HX, 1997, J MECH PHYS SOLIDS, V45, P319, DOI 10.1016/S0022-5096(96)00090-7; Zhu HX, 1997, J MECH PHYS SOLIDS, V45, P1875, DOI 10.1016/S0022-5096(97)00027-6	24	659	685	10	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1307	1310		10.1126/science.1118957	http://dx.doi.org/10.1126/science.1118957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311330				2022-12-28	WOS:000233600200035
J	Miller, KG; Kominz, MA; Browning, JV; Wright, JD; Mountain, GS; Katz, ME; Sugarman, PJ; Cramer, BS; Christie-Blick, N; Pekar, SF				Miller, KG; Kominz, MA; Browning, JV; Wright, JD; Mountain, GS; Katz, ME; Sugarman, PJ; Cramer, BS; Christie-Blick, N; Pekar, SF			The phanerozoic record of global sea-level change	SCIENCE			English	Review							NEW-JERSEY; RUSSIAN PLATFORM; NORTH-ATLANTIC; COASTAL-PLAIN; TIME-SCALE; SEQUENCES; STRATIGRAPHY; OLIGOCENE; EVENTS; EARTH	We review Phanerozoic sea-level changes [543 million years ago (Ma) to the present] on various time scales and present a new sea-level. record for the past 100 million years (My). Long-term sea level peaked at 100 50 meters during the Cretaceous, implying that ocean-crust production rates were much lower than previously inferred. Sea level mirrors oxygen isotope variations, reflecting ice-volume change on the 10(4)- to 10(6)-year scale, but a link between oxygen isotope and sea level on the 10(7)-year scale must be due to temperature changes that we attribute to tectonicaliy controlled carbon dioxide variations. Sea-level change has influenced phytoplankton evolution, ocean chemistry, and the loci of carbonate, organic carbon, and siliciclastic sediment burial. Over the past 100 My, sea-level changes reflect global climate evolution from a time of ephemeral Antarctic ice sheets (100 to 33 Ma), through a time of large ice sheets primarily in Antarctica (33 to 2.5 Ma), to a world with large Antarctic and large, variable Northern Hemisphere ice sheets (2.5 Ma to the present).	Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Western Michigan Univ, Dept Geosci, Kalamazoo, MI 49008 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; New Jersey Geol Survey, Trenton, NJ 08625 USA; Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA	Rutgers State University New Brunswick; Western Michigan University; Columbia University; University of Oregon; City University of New York (CUNY) System; Queens College NY (CUNY)	Miller, KG (corresponding author), Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA.	kgm@rci.rutgers.edu	Cramer, Benjamin/A-5303-2008; Miller, Kenneth/J-6845-2012; Wright, James/AAF-7180-2019	kominz, michelle/0000-0002-8640-2742; Wright, James/0000-0001-5212-9146				Allen MR, 1996, J CLIMATE, V9, P3373, DOI 10.1175/1520-0442(1996)009<3373:MCSDIO>2.0.CO;2; ANDERSON DL, 1982, NATURE, V297, P391, DOI 10.1038/297391a0; [Anonymous], 1989, SOC ECON PA, DOI DOI 10.2110/PEC.89.44.0039; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BOND GC, 1979, TECTONOPHYSICS, V61, P285, DOI 10.1016/0040-1951(79)90302-0; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Christie-Blick N., 1990, SEA LEVEL CHANGE, P116; Dingle RV, 1997, J GEOL SOC LONDON, V154, P257, DOI 10.1144/gsjgs.154.2.0257; Donnelly JP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018933; Donovan D.T., 1979, J GEOL SOC LONDON, V136, P187; FAIRBANKS RG, 1989, NATURE, V339, P532; Frakes L. A, 1992, CLIMATE MODES PHANER; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Hallam A., 1992, PHANEROZOIC SEA LEVE; Haq BU, 2005, GEOARABIA, V10, P127; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harrison C. G. A., 1990, SEA LEVEL CHANGE, P141; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HAYS JD, 1973, NATURE, V246, P18, DOI 10.1038/246018a0; Hodell DA, 2001, PALEOCEANOGRAPHY, V16, P164, DOI 10.1029/1999PA000487; John CM, 2004, GEOLOGY, V32, P829, DOI 10.1130/G20580.1; Katz ME, 2004, ANNU REV ECOL EVOL S, V35, P523, DOI 10.1146/annurev.ecolsys.35.112202.130137; KOMINZ M, 1995, BASIN RES, V7, P221, DOI 10.1111/j.1365-2117.1995.tb00107.x; Kominz MA, 2001, GEOL SOC AM BULL, V113, P291, DOI 10.1130/0016-7606(2001)113<0291:OEFTDS>2.0.CO;2; KOMINZ MA, 1984, AM ASS PET GEOL MEM, V36, P108; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LEVY M, 1991, GEOL SOC AM BULL, V103, P1590, DOI 10.1130/0016-7606(1991)103<1590:TSOTEP>2.3.CO;2; Lightner DA, 1982, BILIRUBIN, P1; LYLE M, 1987, GEOPHYS RES LETT, V14, P595, DOI 10.1029/GL014i006p00595; Marchant D.R., 1993, GEOGR ANN A, V75A, P269, DOI [DOI 10.2307/521204, DOI 10.1080/04353676.1993.11880397]; MIALL AD, 1991, J SEDIMENT PETROL, V61, P497; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Miller KG, 1998, REV GEOPHYS, V36, P569, DOI 10.1029/98RG01624; Miller KG, 2005, MAR GEOL, V217, P215, DOI 10.1016/j.margeo.2005.02.007; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Miller KG, 2004, GEOL SOC AM BULL, V116, P368, DOI 10.1130/B25279.1; MILLER KG, 1997, P ODP X, V150, P1; MILLER KG, 1998, P ODP AX, V174, P43; MILLER KG, 1999, P OCEAN DRILLING PRO, V174, P1; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; PITMAN WC, 1983, SEPM SPECIAL PUBLICA, V33, P41; Ramsey K.W., 1996, DELAWARE GEOLOGICAL, V54, P1; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Revelle R., 1990, SEA LEVEL CHANGE; ROBERTS DG, 1984, INITIAL REP DEEP SEA, V81, P913; RONOV AB, 1994, AM J SCI, V294, P777, DOI 10.2475/ajs.294.7.777; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Sahagian D, 1996, AAPG BULL, V80, P1433; SAHAGIAN D, 1993, GEOL SOC AM BULL, V105, P1109, DOI 10.1130/0016-7606(1993)105<1109:QMJTPE>2.3.CO;2; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; SLOSS LL, 1963, GEOL SOC AM BULL, V74, P93, DOI 10.1130/0016-7606(1963)74[93:SITCIO]2.0.CO;2; Vail P.R., 1977, GEOPHYS RES LETT, V26, P49; Van Sickel WA, 2004, BASIN RES, V16, P451, DOI 10.1111/j.1365-2117.2004.00242.x; WATTS AB, 1979, M EWING SERIES, V3, P218, DOI DOI 10.1029/ME003P0218; WILLIAMS RS, 1999, 1386A US GEOL SURV; WRIGHT JD, 1998, TECTONIC BOUNDARY CO, P192; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528	64	2205	2315	20	648	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1293	1298		10.1126/science.1116412	http://dx.doi.org/10.1126/science.1116412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311326	Green Submitted			2022-12-28	WOS:000233600200031
J	Reddien, PW; Oviedo, NJ; Jennings, JR; Jenkin, JC; Alvarado, AS				Reddien, PW; Oviedo, NJ; Jennings, JR; Jenkin, JC; Alvarado, AS			SMEDWI-2 is a PIWI-like protein that regulates planarian stem cells	SCIENCE			English	Article							REGENERATION; GENE; SPERMATOGENESIS; IDENTIFICATION; ARGONAUTE2; HOMOLOG; FAMILY; RNAI	We have identified two genes, smedwi-1 and smedwi-2, expressed in the dividing adult stem cells (neoblasts) of the planarian Schmidtea mediterranea. Both genes encode proteins that belong to the Argonaute/PIWI protein family and that share highest homology with those proteins defined by Drosophila PIWI. RNA interference (RNAi) of smedwi-2 blocks regeneration, even though neoblasts are present, irradiation-sensitive, and capable of proliferating in response to wounding; smedwi-2(RNAi) neoblast progeny migrate to sites of cell turnover but, unlike normal cells, fail at replacing aged tissue. We suggest that SMEDWI-2 functions within dividing neoblasts to support the generation of cells that promote regeneration and homeostasis.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.	sanchez@neuro.utah.edu		/0000-0002-5569-333X	NIGMS NIH HHS [R0-1 GM57260] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057260] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Asami M, 2002, ZOOL SCI, V19, P1257, DOI 10.2108/zsj.19.1257; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004	19	437	458	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1327	1330		10.1126/science.1116110	http://dx.doi.org/10.1126/science.1116110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311336				2022-12-28	WOS:000233600200041
J	Kushner, BH; Cheung, NKV				Kushner, BH; Cheung, NKV			Neuroblastoma - from genetic profiles to clinical challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kushner, BH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.							Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cheung N-K, 2005, NEUROBLASTOMA	2	17	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2215	2217		10.1056/NEJMp058251	http://dx.doi.org/10.1056/NEJMp058251			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306518				2022-12-28	WOS:000233434500004
J	Mannella, N; Yang, WL; Zhou, XJ; Zheng, H; Mitchell, JF; Zaanen, J; Devereaux, TP; Nagaosa, N; Hussain, Z; Shen, ZX				Mannella, N; Yang, WL; Zhou, XJ; Zheng, H; Mitchell, JF; Zaanen, J; Devereaux, TP; Nagaosa, N; Hussain, Z; Shen, ZX			Nodal quasiparticle in pseudogapped colossal magnetoresistive manganites	NATURE			English	Article							FERMI-SURFACE; DISPERSION; OXIDES	A characteristic feature of the copper oxide high-temperature superconductors is the dichotomy between the electronic excitations along the nodal (diagonal) and antinodal (parallel to the Cu-O bonds) directions in momentum space, generally assumed to be linked to the 'd-wave' symmetry of the superconducting state. Angle-resolved photoemission measurements in the superconducting state have revealed a quasiparticle spectrum with a d-wave gap structure that exhibits a maximum along the antinodal direction and vanishes along the nodal direction(1). Subsequent measurements have shown that, at low doping levels, this gap structure persists even in the high-temperature metallic state, although the nodal points of the superconducting state spread out in finite 'Fermi arcs'(2). This is the so-called pseudogap phase, and it has been assumed that it is closely linked to the superconducting state, either by assigning it to fluctuating superconductivity(3) or by invoking orders which are natural competitors of d-wave superconductors(4,5). Here we report experimental evidence that a very similar pseudogap state with a nodal-antinodal dichotomous character exists in a system that is markedly different from a superconductor: the ferromagnetic metallic groundstate of the colossal magnetoresistive bilayer manganite La1.2Sr1.8Mn2O7. Our findings therefore cast doubt on the assumption that the pseudogap state in the copper oxides and the nodal-antinodal dichotomy are hallmarks of the superconductivity state.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands; Univ Waterloo, Dept Phys, Waterloo, ON N2L 3G1, Canada; Univ Tokyo, Dept Appl Phys, CREST, Bunkyo Ku, Tokyo 1138656, Japan; AIST, Correlated Electron Res Ctr, Tsukuba, Ibaraki 3058562, Japan	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; Leiden University; Leiden University - Excl LUMC; University of Waterloo; Japan Science & Technology Agency (JST); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	NMannella@lbl.gov; zxshen@stanford.edu	Yang, Wanli/D-7183-2011; Mitchell, John F/A-1907-2012; Nagaosa, Naoto/G-7057-2012; Mannella, Norman/Z-1949-2019	Yang, Wanli/0000-0003-0666-8063; Mannella, Norman/0000-0002-3490-6041				Campistol JM, 2001, AMYLOID, V8, P65, DOI 10.3109/13506120108993816; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Chuang YD, 2001, SCIENCE, V292, P1509, DOI 10.1126/science.1059255; DAGOTTO E, 2002, NANOSCALE PHASE SEPA, pCH2; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Dessau DS, 1998, PHYS REV LETT, V81, P192, DOI 10.1103/PhysRevLett.81.192; EMERY VJ, 1995, PHYS REV LETT, V74, P3253, DOI 10.1103/PhysRevLett.74.3253; ENGELSBERG S, 1963, PHYS REV, V131, P993, DOI 10.1103/PhysRev.131.993; Freeland JW, 2005, NAT MATER, V4, P62, DOI 10.1038/nmat1280; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Honerkamp C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.177002; Huang XY, 2000, PHYS REV B, V62, P13318, DOI 10.1103/PhysRevB.62.13318; Kaminski A, 2001, PHYS REV LETT, V86, P1070, DOI 10.1103/PhysRevLett.86.1070; MILLIS AJ, 1995, PHYS REV LETT, V74, P5144, DOI 10.1103/PhysRevLett.74.5144; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Mitchell JF, 1997, PHYS REV B, V55, P63, DOI 10.1103/PhysRevB.55.63; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; Palstra TTM, 1997, PHYS REV B, V56, P5104, DOI 10.1103/PhysRevB.56.5104; Perebeinos V, 2000, PHYS REV LETT, V85, P5178, DOI 10.1103/PhysRevLett.85.5178; Ronning F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094518; Rosch O, 2005, EUR PHYS J B, V43, P11, DOI 10.1140/epjb/e2005-00022-x; Saitoh T, 2000, PHYS REV B, V62, P1039, DOI 10.1103/PhysRevB.62.1039; Shen KM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267002; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; SHEN ZX, 1993, PHYS REV LETT, V70, P1553, DOI 10.1103/PhysRevLett.70.1553; TOKURA Y, 2000, COLOSSAL MAGNETORESI, pCH1; Vasiliu-Doloc L, 1999, PHYS REV LETT, V83, P4393, DOI 10.1103/PhysRevLett.83.4393; WELLS BO, 1995, PHYS REV LETT, V74, P964, DOI 10.1103/PhysRevLett.74.964; Yoshida T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.027001	29	206	207	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					474	478		10.1038/nature04273	http://dx.doi.org/10.1038/nature04273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306987	Green Submitted, Green Published			2022-12-28	WOS:000233458200044
J	Pearson, SD; Rawlins, MD				Pearson, SD; Rawlins, MD			Quality, innovation, and value for money - NICE and the British National Health Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL EXCELLENCE; TECHNOLOGY-ASSESSMENT; INSTITUTE; MEDICARE; GUIDANCE; COVERAGE; CRITERIA; TIME	The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into account both clinical effectiveness and cost-effectiveness. This article describes how NICE has responded to the challenge and considers whether its experience of balancing quality, innovation, and value for money holds policy lessons for the United States.	Natl Inst Clin Excellence, London, England; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Univ Newcastle, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne, Tyne & Wear, England	National Institute for Health & Care Excellence; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Newcastle University - UK	Pearson, SD (corresponding author), 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	spearson99@yahoo.com						*AUD COMM, 2005, MAN FIN IMPL NICE GU; BARTON J, 2005, COMMUNICATION   0304; Bergthold L. A., 2002, USING EVIDENCE COST; Brickwood D., 2004, IMPLEMENTATION NICE; Cookson R, 2001, BRIT MED J, V323, P743, DOI 10.1136/bmj.323.7315.743; *DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Eisenberg JM, 2002, INT J TECHNOL ASSESS, V18, P192, DOI 10.1017/S026646230200020X; Gafni A, 2003, PHARMACOECONOMICS, V21, P149, DOI 10.2165/00019053-200321030-00001; GARBER AM, 2004, HLTH AFF MILLWOO JAN; Gillick MR, 2004, NEW ENGL J MED, V350, P2199, DOI 10.1056/NEJMsb032612; Hill S, 2003, TECHNOLOGY APPRAISAL; Hlatky MA, 2005, HEALTH AFFAIR, V24, P42, DOI 10.1377/hlthaff.24.1.42; HOWARD S, 2004, MEASURING IMPACT NIC; Klein R, 1998, BMJ-BRIT MED J, V317, P959, DOI 10.1136/bmj.317.7164.959; Maynard A, 2004, BMJ-BRIT MED J, V329, P227, DOI 10.1136/bmj.329.7459.227; Milburn Alan, 2002, Health Aff (Millwood), V21, P129; *NAT I CLIN EXC, GUID US ET INFL TREA; *NAT I HLTH CLIN E, GUID NICE; Neumann PJ, 2004, AM J MANAG CARE, V10, P308; PEARSON SD, 2003, NO MARGIN NO MISSION, P67; Rawlins M, 1999, LANCET, V353, P1079, DOI 10.1016/S0140-6736(99)02381-8; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; *ROYAL COLL PHYS, 1995, SETT PRIOR NHS FRAM; Schubert F, 2002, INT J TECHNOL ASSESS, V18, P184, DOI 10.1017/S0266462302000193; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091; 2002, FED REG, V67, P79109	28	126	126	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2618	2622		10.1001/jama.294.20.2618	http://dx.doi.org/10.1001/jama.294.20.2618			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304076				2022-12-28	WOS:000233436200027
J	Lee, LP; Szema, R				Lee, LP; Szema, R			Inspirations from biological, optics for advanced phtonic systems	SCIENCE			English	Review							ARRAY; LENS; EYES; MICROLENSES	Observing systems in nature has inspired humans to create. technological tools that allow us to better understand and imitate biology. Biomimetics, in particular, owes much of its current development to advances in materials science and creative optical system designs. New investigational tools, such as those for microscopic imaging and chemical analyses, have added to our understanding of biological optics. Biologically inspired optical science has become the emerging topic among researchers and scientists. This is in part due to the availability of polymers with customizable optical properties and the ability to rapidly fabricate complex designs using soft lithography and three-dimensional microscale processing techniques.	Univ Calif Berkeley, Dept Bioengn, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lee, LP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.	lplee@berkeley.edu	Lee, Luke/AAN-6695-2021					Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ANGEL JRP, 1979, ASTROPHYS J, V233, P364, DOI 10.1086/157397; Chronis N, 2003, OPT EXPRESS, V11, P2370, DOI 10.1364/OE.11.002370; DENTON M, 1998, NATURES DESTINY, P354; Duparre J, 2004, PROC SPIE, V5346, P89, DOI 10.1117/12.530208; HARTLINE BK, 1980, SCIENCE, V207, P47, DOI 10.1126/science.207.4426.47; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; JEONG K, BIOL INSPIRED OPTICA; Jeong KH, 2004, OPT EXPRESS, V12, P2494, DOI 10.1364/OPEX.12.002494; Kim JY, 2005, OPT LETT, V30, P5, DOI 10.1364/OL.30.000005; KOIKE Y, 1986, APPL OPTICS, V25, P3356, DOI 10.1364/AO.25.003356; LAND MF, 1988, CONTEMP PHYS, V29, P435, DOI 10.1080/00107518808222601; Land MF, 2002, ANIMAL EYES; Luneburg R., 1944, MATH THEORY OPTICS, P208; MILLERD C, 1980, INTERPRETATION EMPED; OGATA S, 1994, OPT ENG, V33, P3649, DOI 10.1117/12.179889; ROACH J, 2004, NATL GEOGRAPHIC 0308; SABRA A, 1989, OPTICS IBNHAYTHAM DI; Smythe R. H., 1975, VISION ANIMAL WORLD; Sowards LA, 2001, ANN ENTOMOL SOC AM, V94, P686, DOI 10.1603/0013-8746(2001)094[0686:COBMAC]2.0.CO;2; Szema R., 2004, Journal of Medical Engineering & Technology, V28, P117, DOI 10.1080/0309190042000193883; Tanida J, 2003, OPT EXPRESS, V11, P2109, DOI 10.1364/OE.11.002109; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Zhang DY, 2003, APPL PHYS LETT, V82, P3171, DOI 10.1063/1.1573337	25	244	257	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1148	1150		10.1126/science.1115248	http://dx.doi.org/10.1126/science.1115248			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293752				2022-12-28	WOS:000233437300035
J	Roland, M				Roland, M			Deprivation and volunteering by general practices: cross sectional analysis of a national primary care system	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Roland, M (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	m.roland@man.ac.uk						COAST J, 2005, BRIT MED J, V331, P14444; Duckett S, 2003, ANN ROY COLL SURG, V85, P195, DOI 10.1308/003588403321661389; Maddison P, 2004, BRIT MED J, V329, P1325, DOI 10.1136/bmj.329.7478.1325; ROLAND M, 1998, SPECIALIST OUTREACH; Salisbury C, 2005, BMJ-BRIT MED J, V331, P1441, DOI 10.1136/bmj.38670.494734.7C; SANDERSON D, 2002, EVALUATION GPS SPECI; SCHOFIELD JK, 2005, BRIT J DERMATOL S1, V153, pO1	7	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1448	1449		10.1136/bmj.38676.769711.7C	http://dx.doi.org/10.1136/bmj.38676.769711.7C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16339218	Green Published			2022-12-28	WOS:000234156400024
J	Pine, DJ; Gollub, JP; Brady, JF; Leshansky, AM				Pine, DJ; Gollub, JP; Brady, JF; Leshansky, AM			Chaos and threshold for irreversibility in sheared suspensions	NATURE			English	Article							INDUCED SELF-DIFFUSION; CONCENTRATED SUSPENSIONS; INDUCED PARTICLE; SPHERES; PREDICTABILITY; DIFFUSIVITIES; SEDIMENTATION; DYNAMICS	Systems governed by time reversible equations of motion often give rise to irreversible behaviour(1-3). The transition from reversible to irreversible behaviour is fundamental to statistical physics, but has not been observed experimentally in many-body systems. The flow of a newtonian fluid at low Reynolds number can be reversible: for example, if the fluid between concentric cylinders is sheared by boundary motion that is subsequently reversed, then all fluid elements return to their starting positions(4). Similarly, slowly sheared suspensions of solid particles, which occur widely in nature and science(5), are governed by time reversible equations of motion. Here we report an experiment showing precisely how time reversibility(6) fails for slowly sheared suspensions. We find that there is a concentration dependent threshold for the deformation or strain beyond which particles do not return to their starting configurations after one or more cycles. Instead, their displacements follow the statistics of an anisotropic random walk(7). By comparing the experimental results with numerical simulations, we demonstrate that the threshold strain is associated with a pronounced growth in the Lyapunov exponent ( a measure of the strength of chaotic particle interactions). The comparison illuminates the connections between chaos, reversibility and predictability.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, KITP, Santa Barbara, CA 93106 USA; NYU, Dept Phys, New York, NY 10003 USA; NYU, Ctr Soft Matter Res, New York, NY 10003 USA; Haverford Coll, Dept Phys, Haverford, PA 19041 USA; Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel	California Institute of Technology; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; New York University; New York University; Haverford College; Technion Israel Institute of Technology	Pine, DJ (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	pine@nyu.edu; jfb@cheme.caltech.edu	Pine, David J/B-7740-2016	Pine, David J/0000-0002-3304-6684; Leshansky, Alexander/0000-0001-9272-8987				AREF H, 1990, PHILOS T ROY SOC A, V333, P273, DOI 10.1098/rsta.1990.0161; Berg, 2018, RANDOM WALKS BIOL; Boffetta G, 2002, PHYS REP, V356, P367, DOI 10.1016/S0370-1573(01)00025-4; Breedveld V, 1998, J FLUID MECH, V375, P297, DOI 10.1017/S0022112098002808; Breedveld V, 2001, J CHEM PHYS, V114, P5923, DOI 10.1063/1.1355315; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Drazer G, 2002, J FLUID MECH, V460, P307, DOI 10.1017/S0022112002008261; ECKSTEIN EC, 1977, J FLUID MECH, V79, P191, DOI 10.1017/S0022112077000111; Janosi IM, 1997, PHYS REV E, V56, P2858, DOI 10.1103/PhysRevE.56.2858; Krishnan GP, 1996, J FLUID MECH, V321, P371, DOI 10.1017/S0022112096007768; Lamb JSW, 1998, PHYSICA D, V112, P1, DOI 10.1016/S0167-2789(97)00199-1; Leal L. G., 1992, LAMINAR FLOW CONVECT; LEIGHTON D, 1987, J FLUID MECH, V177, P109, DOI 10.1017/S0022112087000880; LIGHTHILL J, 1986, P ROY SOC LOND A MAT, V407, P35, DOI 10.1098/rspa.1986.0082; Marchioro M, 2001, J FLUID MECH, V443, P101, DOI 10.1017/S0022112001005122; MORRISON ID, 2003, COLLOIDAL DISPERSION; Segre PN, 1997, PHYS REV LETT, V79, P2574, DOI 10.1103/PhysRevLett.79.2574; Segre PN, 2001, NATURE, V409, P594, DOI 10.1038/35054518; Sierou A, 2004, J FLUID MECH, V506, P285, DOI 10.1017/S0022112004008651; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; Taylor G., 1966, LOW REYNOLDS NUMBER; TAYLOR GI, 2000, KINEMATIC REVERSIBIL; Tolman RC, 1938, PRINCIPLES STAT MECH; Voth GA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.234301; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601; Zarraga IE, 2002, PHYS FLUIDS, V14, P2194, DOI 10.1063/1.1483304	27	268	268	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					997	1000		10.1038/nature04380	http://dx.doi.org/10.1038/nature04380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355220				2022-12-28	WOS:000233934600062
J	Mills, EJ; Singh, S; Singh, JA; Orbinski, JJ; Warren, M; Upshur, RE				Mills, EJ; Singh, S; Singh, JA; Orbinski, JJ; Warren, M; Upshur, RE			Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPING-COUNTRIES; VACCINE; AIDS; WORLD; CARE		McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; Univ KwaZulu Natal, Howard Coll, Sch Law, Durban, South Africa; Univ Toronto, St Michaels Hosp, Bioeth & Hlth Law Programme, Toronto, ON M5B 1W8, Canada; AIDS Vaccine Advocacy Coalit, New York, NY USA; Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	McMaster University; University of North Carolina; University of North Carolina Chapel Hill; University of Kwazulu Natal; University of Kwazulu Natal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Mills, EJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, HSC-2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	millsej@mcmaster.ca	Singh, Jerome Amir/ABG-1573-2021; Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X; Upshur, Ross/0000-0003-1128-0557				*ACT UP PAR, TEN UN TRIAL; ATATAH C, 2005, POST NEWS LINE; Beyrer C, 2002, LANCET, V360, P246, DOI 10.1016/S0140-6736(02)09465-5; *CDC, CDC FACT SHEET CDC T; COHEN J, 2005, SCI SCI NOW      FEB, P4; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; DAGOSTINO N, 2004, SUNDAY NATION; Duan NH, 2005, LANCET, V365, P1119, DOI 10.1016/S0140-6736(05)71857-2; *FAM HLTH INT, 2004, ENR CONS FORM 9780 V; Farmer P, 2002, LANCET, V360, P1266, DOI 10.1016/S0140-6736(02)11357-2; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; HASSANI B, 2005, U TORONTO MED J, V82, P212; Hoffman J, 2005, NAT MED, V11, P5, DOI 10.1038/nm0105-5b; *HUM RIGHTS WATCH, THAIL ANT CAMP REACH; *INT REG INF NETW, NIG TRIAL TEN PROPH; Lange JMA, 2005, PLOS MED, V2, P833, DOI 10.1371/journal.pmed.0020248; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; MILLS EJ, IN PRESS BMC INT HLT; Rutherford G, 2002, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003939, 10.1002/14651858.CD003939]]; Schuklenk U, 2004, J MED ETHICS, V30, P194, DOI 10.1136/jme.2003.006981; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Singh JA, 2004, LANCET, V364, P920, DOI 10.1016/S0140-6736(04)17040-2; SINGH JA, 2005, UNAIDS SO E AFRICAN; Streefland PH, 2003, VACCINE, V21, P1304, DOI 10.1016/S0264-410X(02)00685-0; *THAI DRUG US NETW, OP LETT US CTR DIS C; *UNAIDS, 2004, AIDS EP UPD; *WOM NETW UN, 2004, BACKGR WNU PRESS C T; WOODS DR, 1991, PUBLIC HEALTH REP, V106, P616	29	33	33	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1403	1406		10.1136/bmj.331.7529.1403	http://dx.doi.org/10.1136/bmj.331.7529.1403			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16339256	Green Submitted, Green Published			2022-12-28	WOS:000233999300032
J	Rutgeerts, P; Sandborn, WJ; Feagan, BG; Reinisch, W; Olson, A; Johanns, J; Travers, S; Rachmilewitz, D; Hanauer, SB; Lichtenstein, GR; de Villiers, WJS; Present, D; Sands, BE; Colombel, JF				Rutgeerts, P; Sandborn, WJ; Feagan, BG; Reinisch, W; Olson, A; Johanns, J; Travers, S; Rachmilewitz, D; Hanauer, SB; Lichtenstein, GR; de Villiers, WJS; Present, D; Sands, BE; Colombel, JF			Infliximab for induction and maintenance therapy for ulcerative colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; POUCH-ANAL ANASTOMOSIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; MEDICAL THERAPY; T-LYMPHOCYTES; CANCER-RISK; ANTIBODY; EXPRESSION	BACKGROUND: Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor (alpha), is an established treatment for Crohn's disease but not ulcerative colitis. METHODS: Two randomized, double-blind, placebo-controlled studies -- the Active Ulcerative Colitis Trials 1 and 2 (ACT 1 and ACT 2, respectively) -- evaluated the efficacy of infliximab for induction and maintenance therapy in adults with ulcerative colitis. In each study, 364 patients with moderate-to-severe active ulcerative colitis despite treatment with concurrent medications received placebo or infliximab (5 mg or 10 mg per kilogram of body weight) intravenously at weeks 0, 2, and 6 and then every eight weeks through week 46 (in ACT 1) or week 22 (in ACT 2). Patients were followed for 54 weeks in ACT 1 and 30 weeks in ACT 2. RESULTS: In ACT 1, 69 percent of patients who received 5 mg of infliximab and 61 percent of those who received 10 mg had a clinical response at week 8, as compared with 37 percent of those who received placebo (P<0.001 for both comparisons with placebo). A response was defined as a decrease in the Mayo score of at least 3 points and at least 30 percent, with an accompanying decrease in the subscore for rectal bleeding of at least 1 point or an absolute rectal-bleeding subscore of 0 or 1. In ACT 2, 64 percent of patients who received 5 mg of infliximab and 69 percent of those who received 10 mg had a clinical response at week 8, as compared with 29 percent of those who received placebo (P<0.001 for both comparisons with placebo). In both studies, patients who received infliximab were more likely to have a clinical response at week 30 (P lessthan/equal 0.002 for all comparisons). In ACT 1, more patients who received 5 mg or 10 mg of infliximab had a clinical response at week 54 (45 percent and 44 percent, respectively) than did those who received placebo (20 percent, P<0.001 for both comparisons). CONCLUSIONS: Patients with moderate-to-severe active ulcerative colitis treated with infliximab at weeks 0, 2, and 6 and every eight weeks thereafter were more likely to have a clinical response at weeks 8, 30, and 54 than were those receiving placebo. (ClinicalTrials.gov numbers, NCT00036439 and NCT00096655.).	Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Univ Western Ontario, Robarts Res Inst, London, ON, Canada; Allgemeines Krankenhaus Wien, Univ Klin Innere Med 4, Vienna, Austria; Centocor Inc, Malvern, PA 19355 USA; Shaare Zedek Med Ctr, Jerusalem, Israel; Univ Chicago, Chicago, IL 60637 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Kentucky, Lexington, KY USA; Mt Sinai Med Ctr, New York, NY 10029 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; CHU Lille, Hop Huriez, Ctr Invest Clin, INSERM, F-59037 Lille, France; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	KU Leuven; University Hospital Leuven; Western University (University of Western Ontario); Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Chicago; University of Pennsylvania; University of Kentucky; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Mayo Clinic	Sandborn, WJ (corresponding author), Univ Ziekenhuizen Leuven, UZ Gasthuisberg, Herestr 49, B-3000 Louvain, Belgium.	sandborn.william@mayo.edu	Feagan, Brian G/M-4283-2015; Sands, Bruce/R-7887-2019; Feagan, Brian/G-3292-2011; Pavli, Paul/GZL-0607-2022; Sandborn, William/ABE-8342-2020	Sands, Bruce/0000-0001-5762-5042; 				Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; *CENT, 2004, REM INFL 4 INJ PACK; Chey WY, 2001, INFLAMM BOWEL DIS, V7, pS30, DOI 10.1002/ibd.3780070507; Colombel JF, 2004, GASTROENTEROLOGY, V126, P19, DOI 10.1053/j.gastro.2003.10.047; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Hahnloser D, 2004, ANN SURG, V240, P615, DOI 10.1097/01.sla.0000141157.32234.9d; Hanauer SB, 2004, GASTROENTEROLOGY, V126, P1582, DOI 10.1053/j.gastro.2004.02.071; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; KORNBLUTH A, 1995, J CLIN GASTROENTEROL, V20, P280, DOI 10.1097/00004836-199506000-00004; LANGHOLZ E, 1992, GASTROENTEROLOGY, V103, P1444, DOI 10.1016/0016-5085(92)91163-X; Leeb SN, 2003, GASTROENTEROLOGY, V125, P1341, DOI 10.1016/j.gastro.2003.07.004; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Ljung T, 2004, GUT, V53, P849, DOI 10.1136/gut.2003.018515; MCINTYRE PB, 1994, DIS COLON RECTUM, V37, P303; Melgar S, 2003, CLIN EXP IMMUNOL, V134, P127, DOI 10.1046/j.1365-2249.2003.02268.x; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Ochsenkuhn T, 2004, EUR J GASTROEN HEPAT, V16, P1167, DOI 10.1097/00042737-200411000-00014; Ording OK, 2002, GASTROENTEROLOGY, V122, P15; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Probert CSJ, 2003, GUT, V52, P998, DOI 10.1136/gut.52.7.998; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Rutter MD, 2004, GUT, V53, P1813, DOI 10.1136/gut.2003.038505; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Sands BE, 2004, CLIN GASTROENTEROL H, V2, P912, DOI 10.1016/S1542-3565(04)00414-8; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Stein RB, 2000, DRUG SAFETY, V23, P429, DOI 10.2165/00002018-200023050-00006; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; ten Hove T, 2004, J LEUKOCYTE BIOL, V75, P1010, DOI 10.1189/jlb.0803400; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206	39	2712	2835	6	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2462	2476		10.1056/NEJMoa050516	http://dx.doi.org/10.1056/NEJMoa050516			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339095				2022-12-28	WOS:000233754400008
J	Sankaran, M; Hanan, NP; Scholes, RJ; Ratnam, J; Augustine, DJ; Cade, BS; Gignoux, J; Higgins, SI; Le Roux, X; Ludwig, F; Ardo, J; Banyikwa, F; Bronn, A; Bucini, G; Caylor, KK; Coughenour, MB; Diouf, A; Ekaya, W; Feral, CJ; February, EC; Frost, PGH; Hiernaux, P; Hrabar, H; Metzger, KL; Prins, HHT; Ringrose, S; Sea, W; Tews, J; Worden, J; Zambatis, N				Sankaran, M; Hanan, NP; Scholes, RJ; Ratnam, J; Augustine, DJ; Cade, BS; Gignoux, J; Higgins, SI; Le Roux, X; Ludwig, F; Ardo, J; Banyikwa, F; Bronn, A; Bucini, G; Caylor, KK; Coughenour, MB; Diouf, A; Ekaya, W; Feral, CJ; February, EC; Frost, PGH; Hiernaux, P; Hrabar, H; Metzger, KL; Prins, HHT; Ringrose, S; Sea, W; Tews, J; Worden, J; Zambatis, N			Determinants of woody cover in African savannas	NATURE			English	Article							TREE-GRASS COEXISTENCE; QUANTILE REGRESSION; FIRE; VEGETATION; MECHANISMS; STABILITY; SYSTEMS	Savannas are globally important ecosystems of great significance to human economies. In these biomes, which are characterized by the co-dominance of trees and grasses, woody cover is a chief determinant of ecosystem properties(1-3). The availability of resources ( water, nutrients) and disturbance regimes ( fire, herbivory) are thought to be important in regulating woody cover(1,2,4,5), but perceptions differ on which of these are the primary drivers of savanna structure. Here we show, using data from 854 sites across Africa, that maximum woody cover in savannas receiving a mean annual precipitation (MAP) of less than similar to 650 mm is constrained by, and increases linearly with, MAP. These arid and semi-arid savannas may be considered 'stable' systems in which water constrains woody cover and permits grasses to coexist, while fire, herbivory and soil properties interact to reduce woody cover below the MAP-controlled upper bound. Above a MAP of similar to 650 mm, savannas are 'unstable' systems in which MAP is sufficient for woody canopy closure, and disturbances ( fire, herbivory) are required for the coexistence of trees and grass. These results provide insights into the nature of African savannas and suggest that future changes in precipitation(6) may considerably affect their distribution and dynamics.	Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; CSIR, Div Forest Sci & Technol, ZA-001 Pretoria, South Africa; Forest Serv, USDA, Commanche Natl Grassland, Springfield, CO 81073 USA; US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; Univ Paris 06, CNRS, UMR 7625, Lab Ecol,Ecole Normale Super, F-75230 Paris, France; UFZ Helmholtz Ctr Environm Res, Sekt Okosyst Anal, D-04318 Leipzig, Germany; Univ Lyon 1, CNRS, UMR 5557,Microbial Ecol Lab, USC INRA 1193, F-69622 Villeurbanne, France; CSIRO Plant Ind, CSIRO Ctr Environm & Life Sci, Wembley, WA 6913, Australia; Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden; Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; Port Elizabeth Technikon, Dept Agr & Game Management, ZA-6000 Port Elizabeth, South Africa; Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; Ctr Suivi Ecol, Dakar, Senegal; Univ Nairobi, Dept Range Management, Nairobi, Kenya; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; Univ Zimbabwe, Inst Environm Studies, Harare, Zimbabwe; CESBIO, F-31401 Toulouse, France; Univ Pretoria, Mammal Res Inst, ZA-002 Pretoria, South Africa; Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wageningen & Res Ctr, Resource Ecol Grp, NL-6708 PD Wageningen, Netherlands; Univ Botswana, Harry Oppenheimer Okavango Res Ctr, Maun, Botswana; Univ Potsdam, Inst Biochem & Biol Plant Ecol & Nat Conservat, D-14469 Potsdam, Germany; Kruger Natl Pk, Sci Serv, ZA-1350 Skukuza, South Africa	Colorado State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Lund University; University of Dar es Salaam; Nelson Mandela University; Princeton University; University of Nairobi; University of Virginia; University of Cape Town; University of Zimbabwe; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Pretoria; University of Wisconsin System; University of Wisconsin Madison; Wageningen University & Research; University of Botswana; University of Potsdam	Sankaran, M (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	mahesh@nrel.colostate.edu	Noojipady, Praveen/B-2511-2010; Augustine, David/H-6167-2011; Caylor, Kelly/B-7734-2008; Caylor, Kelly/ABF-2818-2020; Higgins, Steven I/A-5138-2012; Ludwig, Fulco/N-7732-2013; Mitchard, Edward T A/C-6346-2009	Caylor, Kelly/0000-0002-6466-6448; Caylor, Kelly/0000-0002-6466-6448; Higgins, Steven I/0000-0001-5695-9665; Mitchard, Edward T A/0000-0002-5690-4055; Ringrose, Susan/0000-0003-4788-4133; Augustine, David/0000-0003-3144-0466; Ardo, Jonas/0000-0002-9318-0973; LUDWIG, FULCO/0000-0001-6479-9657; Prins, Herbert/0000-0003-1131-5107; LE ROUX, Xavier/0000-0001-9695-0825; Scholes, Robert/0000-0001-5537-6935; Hanan, Niall/0000-0002-9130-5306; Sea, William/0000-0001-6631-6735				[Anonymous], 2001, CLIMATE CHANGE 2001; Barbosa PM, 1999, GLOBAL BIOGEOCHEM CY, V13, P933, DOI 10.1029/1999GB900042; Bond WJ, 2003, S AFR J BOT, V69, P79, DOI 10.1016/S0254-6299(15)30362-8; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Breiman L., 1984, CLASSIFICATION REGRE; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chiu GS, 2002, THESIS S FRASER U; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Frost P.G.H., 1986, RESPONSE SAVANNAS ST; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jeltsch F, 2000, PLANT ECOL, V150, P161, DOI 10.1023/A:1026590806682; Koenker R, 1996, J ECONOMETRICS, V71, P265, DOI 10.1016/0304-4076(96)84507-6; Koenker R., 1994, ASYMPTOTIC STAT, P349, DOI [10.1007/978-3-642-57984-4_29, DOI 10.1007/978-3-642-57984-4_29]; Koenker R, 1987, APPL STAT-J ROY ST C, V36, P383, DOI DOI 10.2307/2347802; MCNAUGHTON SJ, 1992, J VEG SCI, V3, P301, DOI 10.2307/3235755; Rejwan C, 1999, ECOLOGY, V80, P341, DOI 10.1890/0012-9658(1999)080[0341:TRAOTN]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Simioni G, 2003, ECOLOGY, V84, P1879, DOI 10.1890/0012-9658(2003)084[1879:TLSSCA]2.0.CO;2; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Walker B. H., 1982, Ecology of tropical savannas, P556; Walker BH, 1997, J BIOGEOGR, V24, P813, DOI 10.1046/j.1365-2699.1997.00123.x; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Walter H., 1971, ECOLOGY TROPICAL SUB; Weltzin J.F., 2003, CHANGING PRECIPITATI; White F., 1983, VEGETATION AFRICA DE; [No title captured]	30	1247	1282	10	535	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					846	849		10.1038/nature04070	http://dx.doi.org/10.1038/nature04070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341012				2022-12-28	WOS:000233777800049
J	Jessup, JM; Stewart, A; Greene, FL; Minsky, BD				Jessup, JM; Stewart, A; Greene, FL; Minsky, BD			Adjuvant chemotherapy for stage III colon cancer - Implications of race/ethnicity, age, and differentiation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DATA-BASE REPORT; COLORECTAL-CANCER; BOWEL PROJECT; AFRICAN-AMERICANS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; POOLED ANALYSIS; BREAST-CANCER; THERAPY; FLUOROURACIL	Context A 1990 National Institutes of Health Consensus Conference recommended that patients with stage III colon cancer receive adjuvant chemotherapy because survival was improved in clinical trials in patients who received a 5-fluorouracil-based regimen. Objective To determine whether adjuvant chemotherapy is used in the community as a standard of practice that improves outcome and whether it failed to benefit any specific sets of patients. Design, Setting, and Participants Prospective data from 85 934 patients with stage III colon cancer from 560 hospital cancer registries were entered into the National Cancer Data Base between 1990 and 2002 and included standard clinical, pathological, and first course of treatment variables. Main Outcome Measures Prevalence of adjuvant chemotherapy usage and 5-year survival in patients treated in US hospitals. Results Adjuvant chemotherapy use increased from 39% in 1991 to 64% in 2002 but was lower in black, female, and elderly patients. It improved 5-year survival from almost 8% in 1991 to more than 16% in 1997 compared with surgery alone. Adjuvant chemotherapy increases survival in elderly patients as much as it does in younger patients. However, the benefit of adjuvant chemotherapy in blacks and, those with high-grade cancers is not as great. Conclusions Adjuvant chemotherapy use has increased from 1990 to 2002 for patients with stage III colon cancer with an associated increase in 5-year survival of 16%. The benefit of adjuvant chemotherapy seems to be lower in black patients and high-grade cancers. Women have the same benefit but are less often treated. Elderly patients have the same benefit as younger patients but are less frequently treated. New options for adjuvant therapy in 2004-2005 may further improve the outcome of patients with stage III colon cancer.	NCI, Canc Diag Program, Div Canc Treatment & Diag, Rockville, MD 20892 USA; Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; Amer Coll Surg, Canc Dept, Chicago, IL USA; Carolinas Med Ctr, Dept Surg, Charlotte, NC 28203 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; American College of Surgeons; Carolinas Medical Center; Memorial Sloan Kettering Cancer Center	Jessup, JM (corresponding author), NCI, Canc Diag Program, Div Canc Treatment & Diag, Execut Plaza N 6040,6130 Execut Blvd, Rockville, MD 20892 USA.	jessupj@mail.nih.gov						*AM COLL SURG COMM, 1990, DATA ACQ MAN; Andre T, 2003, J CLIN ONCOL, V21, P2896, DOI 10.1200/JCO.2003.10.065; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Beart R W, 1995, J Am Coll Surg, V181, P225; Bouchardy C, 2001, BRIT J CANCER, V85, P1251, DOI 10.1054/bjoc.2001.2035; COX DR, 1972, J R STAT SOC B, V34, P187; DAYAL H, 1987, J CHRON DIS, V40, P857, DOI 10.1016/0021-9681(87)90185-8; Dignam JJ, 1999, JNCI-J NATL CANCER I, V91, P1933, DOI 10.1093/jnci/91.22.1933; Fremgen AM, 1999, CA-CANCER J CLIN, V49, P145, DOI 10.3322/canjclin.49.3.145; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; GORDON B, 1994, DATA EXCHANGE STANDA, V1; Greene FL, 2002, ANN SURG, V236, P416, DOI 10.1097/00000658-200210000-00003; Greene FL, 2002, AJCC CANC STAGING MA, P113; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hershman D, 2003, J NATL CANCER I, V95, P1545, DOI 10.1093/jnci/djg073; Jessup JM, 1996, CANCER-AM CANCER SOC, V78, P918; Jessup JM, 1998, CANCER, V83, P2408, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2408::AID-CNCR22>3.0.CO;2-G; Keku T, 2002, CANCER EPIDEM BIOMAR, V11, P1611; LAURIE JA, 1989, J CLIN ONCOL, V7, P1447, DOI 10.1200/JCO.1989.7.10.1447; Mahoney T, 2000, ARCH SURG-CHICAGO, V135, P182, DOI 10.1001/archsurg.135.2.182; Malin JL, 2002, J NATL CANCER I, V94, P835, DOI 10.1093/jnci/94.11.835; McCollum AD, 2002, JNCI-J NATL CANCER I, V94, P1160; Menck HR, 1997, CANCER, V80, P2296, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2296::AID-CNCR11>3.0.CO;2-P; Menck HR, 1998, CANCER, V83, P2649, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2649::AID-CNCR32>3.3.CO;2-M; Mettlin CJ, 1997, CANCER, V79, P2052, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2052::AID-CNCR29>3.0.CO;2-S; Milano G, 1999, BRIT J CANCER, V79, P627, DOI 10.1038/sj.bjc.6690098; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schneider EC, 2004, J CLIN ONCOL, V22, P2985, DOI 10.1200/JCO.2004.09.087; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; SHAMBAUGH E, 1995, STAT EPIDEMIOLOGY CA; Shepherd T, 2000, GASTROENTEROLOGY, V118, P1039, DOI 10.1016/S0016-5085(00)70356-8; STEELE GD, 1994, CANCER, V74, P1979, DOI 10.1002/1097-0142(19941001)74:7<1979::AID-CNCR2820740725>3.0.CO;2-J; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Sundararajan V, 2001, CANCER J, V7, P213; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; VanEenwyk J, 2002, CANCER, V95, P39, DOI 10.1002/cncr.10645; *WHO, 1992, INT CLASS DIS ONC; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Wolmark N, 1999, J CLIN ONCOL, V17, P3553, DOI 10.1200/JCO.1999.17.11.3553; WOLMARK N, 1996, P AN M AM SOC CLIN, V15, P460	43	244	250	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2703	2711		10.1001/jama.294.21.2703	http://dx.doi.org/10.1001/jama.294.21.2703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333005	Bronze			2022-12-28	WOS:000233726900018
J	Ronalds, GA; De Stavola, BL; Leon, DA				Ronalds, GA; De Stavola, BL; Leon, DA			The cognitive cost of being a twin: evidence from comparisons within families in the Aberdeen children of 1950s cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; EARLY-LIFE; CHILDHOOD INTELLIGENCE; HEALTH; AGE; IQ; MORTALITY	Objectives To determine whether twins have lower IQ scores in childhood than singletons in the same family and, if so, whether differences in fetal growth explain this deficit. Design Cohort study. Setting Scotland. Participants 9832 singletons and 236 twins born in Aberdeen between 1950 and 1956. Results At age 7, the mean IQ score of twins was 5.3 points lower (95% confidence interval 1.5 to 9.1) and at age 9, 6.0 points lower (1.7 to 10.2) than that of singletons in the same family. Adjustment for sex, mother's age, and number of older siblings had little effect on these differences. Further adjustment for birth weight and gestational age attenuated the IQ difference between twins and singletons: the difference in mean IQ was 2.6 points (- 1.5 to 6.7) at age 7 and 4.1 points (-0.5 to 8.8) at.age 9. Conclusions Twins have substantially lower IQ in childhood than singletons in the same family. This effect cannot be explained by confounding due to socioeconomic, maternal, or other family characteristics, or by recruitment bias. The reduced prenatal growth and shorter gestations of twins may explain an important part of their lower IQ in childhood.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, Keppel St, London WC1E 7HT, England.	david.leon@lsthm.ac.uk	Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; De Stavola, Bianca Lucia/0000-0001-7853-0528				ALIN AB, 1991, ACTA GENET MED GEMEL, V40, P29; Altman D.G., 1991, PRACTICAL STAT MED R; BALTAGI BH, 1994, J ECONOMETRICS, V62, P67, DOI 10.1016/0304-4076(94)90017-5; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Batty GD, 2004, PAEDIATR PERINAT EP, V18, P221, DOI 10.1111/j.1365-3016.2004.00552.x; Birch HG, 1970, MENTAL SUBNORMALITY; Boomsma DI, 2002, TWIN RES, V5, P401, DOI 10.1375/twin.5.5.401; Boomsma DI, 2001, BRIT MED J, V323, P1426, DOI 10.1136/bmj.323.7326.1426a; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; Bulmer M. G., 1970, BIOL TWINNING MAN; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; HAY DA, 1984, ACTA GENET MED GEMEL, V33, P223, DOI 10.1017/S0001566000007261; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P656, DOI 10.1136/jech.2004.030205; Mall FP, 1900, Z MORPHOL ANTHROPOL, V2, P1; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; MEHOTRA SN, 1949, POPULATION STUDIES, V3, P295; MYRIANTHOPOULOS NC, 1976, ACTA GENET MED GEMEL, V25, P376, DOI 10.1017/S0001566000014458; Najman JM, 2004, SOC SCI MED, V58, P1147, DOI 10.1016/S0277-9536(03)00286-7; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Posthuma D, 2000, Twin Res, V3, P83, DOI 10.1375/136905200320565535; RECORD RG, 1969, ANN HUM GENET, V33, P61, DOI 10.1111/j.1469-1809.1969.tb01630.x; RECORD RG, 1970, ANN HUM GENET, V34, P11, DOI 10.1111/j.1469-1809.1970.tb00215.x; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; SAMPHIER M, 1981, PROSPECTIVE LONGITUD, P61; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989	28	64	65	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1306	+		10.1136/bmj.38633.594387.3A	http://dx.doi.org/10.1136/bmj.38633.594387.3A			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	990YE	16299014	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000233778500017
J	Moore, P				Moore, P			Cell biology: Ion channels and stem cells	NATURE			English	Article																			0	5	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					699	704		10.1038/438699a	http://dx.doi.org/10.1038/438699a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319900	Bronze			2022-12-28	WOS:000233593100059
J	Smith, DL; Dushoff, J; Snow, RW; Hay, SI				Smith, DL; Dushoff, J; Snow, RW; Hay, SI			The entomological inoculation rate and Plasmodium falciparum infection in African children	NATURE			English	Article							GLOBAL DISTRIBUTION; MALARIA; TRANSMISSION; POPULATION; DISEASE; MODEL; RISK	Malaria is an important cause of global morbidity and mortality. The fact that some people are bitten more often than others has a large effect on the relationship between risk factors and prevalence of vector-borne diseases(1-3). Here we develop a mathematical framework that allows us to estimate the heterogeneity of infection rates from the relationship between rates of infectious bites and community prevalence. We apply this framework to a large, published data set that combines malaria measurements from more than 90 communities(4). We find strong evidence that heterogeneous biting or heterogeneous susceptibility to infection are important and pervasive factors determining the prevalence of infection: 20% of people receive 80% of all infections. We also find that individual infections last about six months on average, per infectious bite, and children who clear infections are not immune to new infections. The results have important implications for public health interventions: the success of malaria control will depend heavily on whether efforts are targeted at those who are most at risk of infection.	NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; KEMRI, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Kenyatta Hosp, Nairobi 00100, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Princeton University; Kenyatta National Hospital; University of Oxford; University of Oxford	Smith, DL (corresponding author), NIH, Fogarty Int Ctr, Bldg 16,16 Ctr Dr, Bethesda, MD 20892 USA.	smitdave@helix.nih.gov	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022; Hay, Simon Iain/F-8967-2015	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [069045, 058992] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aron J.L., 1982, P139; Bailey N. T. J., 1982, BIOMATHEMATICS MALAR; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dietz K., 1980, Lecture Notes in Biomathematics, V39, P264; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Gu WD, 2003, ACTA TROP, V86, P71, DOI 10.1016/S0001-706X(03)00020-2; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HETHCOTE HW, 1984, LECT NOTES BIOMATHS, V56, P1; JAMISON DT, 1999, WORLD HLTH REPORT 19; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Molineaux L, 1980, THE GARKI PROJECT; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NAJERA JA, 1974, B WORLD HEALTH ORGAN, V50, P449; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Ross R., 1911, PREVENTION MALARIA; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Snow RW, 2002, ESSENTIAL MALARIOLOG, P85; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; WALTON GA, 1947, ANN TROP MED PARASIT, V41, P380, DOI 10.1080/00034983.1947.11685341; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	29	209	210	0	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					492	495		10.1038/nature04024	http://dx.doi.org/10.1038/nature04024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306991	Green Accepted			2022-12-28	WOS:000233458200048
J	Coulter, A				Coulter, A			The NHS revolution: health care in the market place - What do patients and the public want from primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSULTATION; DOCTORS; VIEWS		Picker Inst Europe, Oxford OX1 1RX, England		Coulter, A (corresponding author), Picker Inst Europe, Oxford OX1 1RX, England.	angela.coulter@pickereurope.ac.uk	Coulter, Angela/N-6998-2019	Coulter, Angela/0000-0002-6308-8375				Cabinet Office, 2000, OP ALL HOURS RES PEO; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Coulter A, 2005, EUR J PUBLIC HEALTH, V15, P355, DOI 10.1093/eurpub/cki004; Coulter A, 2001, HEALTH AFFAIR, V20, P244, DOI 10.1377/hlthaff.20.3.244; Coulter A, 2003, EUROPEAN PATIENT FUT; Coulter A, 2002, AUTONOMOUS PATIENT; COULTER A, 2004, HOSP CHOICES PATIENT; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; *DEP HLTH, 2005, HEW ASKS PUBL HELP S; Ellins J, 2005, ENGAGED ARE PEOPLE T; Health and Social Care Information Centre, 2005, NAT QUAL OUTC FRAM S; *HEALTHC COMM, 2005, PRIM CAR TRUST SURV; Jung Hans Peter, 2003, Health Expect, V6, P160; Kinnersley P, 2000, BRIT MED J, V320, P1043, DOI 10.1136/bmj.320.7241.1043; Little P, 2001, BMJ-BRIT MED J, V322, P468, DOI 10.1136/bmj.322.7284.468; Magee H, 2003, J ROY SOC MED, V96, P338, DOI 10.1258/jrsm.96.7.338; Mainous AG, 2001, FAM MED, V33, P22; McKinley RK, 1999, BRIT J GEN PRACT, V49, P796; Picker Institute, 2005, IS NHS GETT BETT WOR; SCHOEN C, 2004, HLTH AFFAIRS W, V4, P487, DOI DOI 10.1377/HLTHAFF.W4.487; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Wensing M, 1998, SOC SCI MED, V47, P1573, DOI 10.1016/S0277-9536(98)00222-6; *YOUGOV, DAIL TEL SURV GPS	23	107	109	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2005	331	7526					1199	1201		10.1136/bmj.331.7526.1199	http://dx.doi.org/10.1136/bmj.331.7526.1199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988DG	16293845	Green Submitted, Green Published			2022-12-28	WOS:000233571000027
J	Summerskill, W				Summerskill, W			Cochrane Collaboration and the evolution of evidence	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), Lancet, London NW1 7BY, England.							*COCHR COLL, 2005, 13 COCHR C; *COCHR COLL, 2005, EV AID SUMM REL NAT	2	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1760	1760		10.1016/S0140-6736(05)67710-0	http://dx.doi.org/10.1016/S0140-6736(05)67710-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298205				2022-12-28	WOS:000233517200008
J	Christofides, NJ; Muirhead, D; Jewkes, RK; Penn-Kekana, L; Conco, DN				Christofides, NJ; Muirhead, D; Jewkes, RK; Penn-Kekana, L; Conco, DN			Women's experiences of, and preferences for, services after rape in South Africa: interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONJOINT-ANALYSIS; SURVIVORS; QUALITY	Objectives To describe aspects of delivery of health services after rape, including trade-offs, that would most influence choice of service, and to compare views of patients who had used such services with views of members of the community who may be Future users or may have experienced barriers to service use. Design Discrete choice analysis of stated preferences with interviews. Attributes included travel time to the service, availability of HIV prophylaxis, number of returns to the hospital, medical examination, and counselling skills and attitude of the provider. Setting One rural and one urban site in South Africa. Participants 319 women: 155 who had been raped and four carers recruited through health facilities and 160 comparable women recruited from the community. Of these, 156 were from an urban site and 163 from a rural site. Main outcome measures Strength of preferences over a range of attributes through die estimation of a benefit function through random effects probit modelling. Results Factors such as die availability of prophylactic treatment for HIV infection and having a sensitive healthcare provider who could provide counselling care are more important in women's decisions to seek care after rape dian die travel time necessary to access those services. Conclusion Our findings support the need for holistic rape services.	MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; Univ Witwatersrand, Sch Publ Hlth, Ctr Hlth Policy, ZA-0001 Johannesburg, South Africa; Aurum Hlth Res, ZA-2107 Marshalltown, South Africa; Univ Witwatersrand, Sch Publ Hlth, Womens Hlth Project, ZA-2050 Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Christofides, NJ (corresponding author), MRC, Gender & Hlth Res Unit, Private Bag X385, ZA-0001 Pretoria, South Africa.	nicola.chris@mrc.ac.za	Conco, Daphney Nozizwe/A-9833-2019	Conco, Daphney Nozizwe/0000-0003-4999-7502; Christofides, Nicola/0000-0002-3559-6401; Jewkes, Rachel/0000-0002-4330-6267				Campbell R, 2001, J INTERPERS VIOLENCE, V16, P1239, DOI 10.1177/088626001016012002; Christofides NJ, 2005, B WORLD HEALTH ORGAN, V83, P495; CHRISTOFIDES NJ, 2004, INCLUDING PEP POST S; DEACON H, 2004, 2 AFR C SOC ASP HIV, P9; *DEP HLTH, 2003, SEX ASS CLIN MAN GUI; *DOH, PRIM HLTH CAR PACK S; Ericksen Janet, 2002, J Emerg Nurs, V28, P86, DOI 10.1067/men.2002.121740; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; Human Rights Watch,, 1997, S AFR VIOL WOM MED L; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; JEWKES R, IN PRESS TROP MED IN; Kim JC, 2003, REPROD HEALTH MATTER, V11, P101, DOI 10.1016/S0968-8080(03)02285-7; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; McCauley J, 1998, J GEN INTERN MED, V13, P549, DOI 10.1046/j.1525-1497.1998.00166.x; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Resnick H, 2000, J CLIN PSYCHOL, V56, P1317, DOI 10.1002/1097-4679(200010)56:10<1317::AID-JCLP5>3.0.CO;2-H; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; SUFFA S, 2001, EVALUATION MEDICOLEG; TESLER H, 2002, HEALTH ECON, V11, P129; VETTEN L, 2004, FACTORS AFFECTING AD; World Health Organization, 2003, GUID MED LEG CAR VIC	22	35	35	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2006	332	7535					209	212A		10.1136/bmj.38664.482060.55	http://dx.doi.org/10.1136/bmj.38664.482060.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	009BU	16330476	Green Published, Bronze			2022-12-28	WOS:000235086900018
J	Badano, JL; Leitch, CC; Ansley, SJ; May-Simera, H; Lawson, S; Lewis, RA; Beales, PL; Dietz, HC; Fisher, S; Katsanis, N				Badano, JL; Leitch, CC; Ansley, SJ; May-Simera, H; Lawson, S; Lewis, RA; Beales, PL; Dietz, HC; Fisher, S; Katsanis, N			Dissection of epistasis in oligogenic Bardet-Biedl syndrome	NATURE			English	Article							HUMAN OBESITY SYNDROME; HUMAN GENETIC-DISEASE; TRIALLELIC INHERITANCE; PROTEIN; MUTATIONS; BBS1; IDENTIFICATION; DISORDER	Epistatic interactions have an important role in phenotypic variability, yet the genetic dissection of such phenomena remains challenging(1). Here we report the identification of a novel locus, MGC1203, that contributes epistatic alleles to Bardet-Biedl syndrome (BBS), a pleiotropic, oligogenic disorder(2-9). MGC1203 encodes a pericentriolar protein that interacts and colocalizes with the BBS proteins. Sequencing of two independent BBS cohorts revealed a significant enrichment of a heterozygous C430T mutation in patients, and a transmission disequilibrium test (TDT) showed strong over-transmission of this variant. Further analyses showed that the 430T allele enhances the use of a cryptic splice acceptor site, causing the introduction of a premature termination codon (PTC) and the reduction of steady-state MGC1203 messenger RNA levels. Finally, recapitulation of the human genotypes in zebrafish shows that modest suppression of mgc1203 exerts an epistatic effect on the developmental phenotype of BBS morphants. Our data demonstrate how the combined use of biochemical, genetic and in vivo tools can facilitate the dissection of epistatic phenomena, and enhance our appreciation of the genetic basis of phenotypic variability.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21205 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Fisher, Shannon/K-7351-2012; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; May-Simera, Helen/0000-0002-9477-4036; Badano, Jose/0000-0002-0706-8652	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fauser S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e104; FU X, 1992, SCIENCE, V256, P533; Gabut M, 2005, MOL CELL BIOL, V25, P3286, DOI 10.1128/MCB.25.8.3286-3294.2005; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; KACSER H, 1981, GENETICS, V97, P639; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Lele Z, 2002, DEVELOPMENT, V129, P3281; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	30	202	212	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2006	439	7074					326	330		10.1038/nature04370	http://dx.doi.org/10.1038/nature04370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16327777				2022-12-28	WOS:000234682100043
J	Godfray, C; Hassell, M				Godfray, C; Hassell, M			Richard Southwood (1931-2005) - Obituary	NATURE			English	Biographical-Item									Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England	Imperial College London	Godfray, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	c.godfray@imperial.ac.uk; m.hassell@imperial.ac.uk						SOUTHWOOD R, PUBLICATION LIST	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					928	928		10.1038/438928a	http://dx.doi.org/10.1038/438928a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355205	Bronze			2022-12-28	WOS:000233934600044
J	Becker, MA; Schumacher, HR; Wortmann, RL; MacDonald, PA; Eustace, D; Palo, WA; Streit, J; Joseph-Ridge, N				Becker, MA; Schumacher, HR; Wortmann, RL; MacDonald, PA; Eustace, D; Palo, WA; Streit, J; Joseph-Ridge, N			Febuxostat compared with allopurinol in patients with hyperuricemia and gout	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							XANTHINE OXIDASE/XANTHINE DEHYDROGENASE; MONOSODIUM URATE; SERUM URATE; NON-PURINE; SELECTIVE INHIBITOR; ARTHRITIS; THERAPY; OXIDASE; CRYSTALLIZATION; SOLUBILITY	BACKGROUND: Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, is a potential alternative to allopurinol for patients with hyperuricemia and gout. METHODS: We randomly assigned 762 patients with gout and with serum urate concentrations of at least 8.0 mg per deciliter (480 micromol per liter) to receive either febuxostat (80 mg or 120 mg) or allopurinol (300 mg) once daily for 52 weeks; 760 received the study drug. Prophylaxis against gout flares with naproxen or colchicine was provided during weeks 1 through 8. The primary end point was a serum urate concentration of less than 6.0 mg per deciliter (360 micromol per liter) at the last three monthly measurements. The secondary end points included reduction in the incidence of gout flares and in tophus area. RESULTS: The primary end point was reached in 53 percent of patients receiving 80 mg of febuxostat, 62 percent of those receiving 120 mg of febuxostat, and 21 percent of those receiving allopurinol (P<0.001 for the comparison of each febuxostat group with the allopurinol group). Although the incidence of gout flares diminished with continued treatment, the overall incidence during weeks 9 through 52 was similar in all groups: 64 percent of patients receiving 80 mg of febuxostat, 70 percent of those receiving 120 mg of febuxostat, and 64 percent of those receiving allopurinol (P=0.99 for 80 mg of febuxostat vs. allopurinol; P=0.23 for 120 mg of febuxostat vs. allopurinol). The median reduction in tophus area was 83 percent in patients receiving 80 mg of febuxostat and 66 percent in those receiving 120 mg of febuxostat, as compared with 50 percent in those receiving allopurinol (P=0.08 for 80 mg of febuxostat vs. allopurinol; P=0.16 for 120 mg of febuxostat vs. allopurinol). More patients in the high-dose febuxostat group than in the allopurinol group (P=0.003) or the low-dose febuxostat group discontinued the study. Four of the 507 patients in the two febuxostat groups (0.8 percent) and none of the 253 patients in the allopurinol group died; all deaths were from causes that the investigators (while still blinded to treatment) judged to be unrelated to the study drugs (P=0.31 for the comparison between the combined febuxostat groups and the allopurinol group). CONCLUSIONS: Febuxostat, at a daily dose of 80 mg or 120 mg, was more effective than allopurinol at the commonly used fixed daily dose of 300 mg in lowering serum urate. Similar reductions in gout flares and tophus area occurred in all treatment groups.	Univ Chicago, Pritzker Sch Med, Med Ctr, Chicago, IL 60637 USA; Univ Penn, Sch Med, Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; Univ Oklahoma, Dept Med, Tulsa, OK USA; TAP Pharmaceut Prod, Res & Dev, Lake Forest, IL USA	University of Chicago; University of Chicago Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Oklahoma System; University of Oklahoma - Tulsa; Abbott Laboratories; Takeda Pharmaceutical Company Ltd; TAP Pharmaceuticals	Becker, MA (corresponding author), Univ Chicago, Pritzker Sch Med, Med Ctr, MC0930,5841 S Maryland Ave, Chicago, IL 60637 USA.	mbecker@medicine.bsd.uchicago.edu						ALLEN DJ, 1965, ARTHRITIS RHEUM-US, V8, P1123, DOI 10.1002/art.1780080611; Becker MA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1111, DOI 10.1081/NCN-200027372; BLUESTONE R, 1974, J RHEUMATOL, V1, P230; BREWIS I, 1975, ANN RHEUM DIS, V34, P256, DOI 10.1136/ard.34.3.256; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Fam AG, 1998, DRUG AGING, V13, P229, DOI 10.2165/00002512-199813030-00006; FIDDIS RW, 1983, ANN RHEUM DIS, V42, P12, DOI 10.1136/ard.42.Suppl_1.12; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; Harris MD, 1999, AM FAM PHYSICIAN, V59, P925; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Horiuchi H, 1999, RES COMMUN MOL PATH, V104, P307; Hoshide S, 2000, DRUG METAB REV S2, V32, P269; Khosravan R, 2004, ARTHRITIS RHEUM, V50, pS337; KOT TV, 1993, MED J AUSTRALIA, V159, P182, DOI 10.5694/j.1326-5377.1993.tb137784.x; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Mayer Michael D, 2005, Am J Ther, V12, P22, DOI 10.1097/00045391-200501000-00005; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P356, DOI 10.1002/art.10511; Perez-Ruiz F, 1998, ANN RHEUM DIS, V57, P545, DOI 10.1136/ard.57.9.545; PERLTREVES D, 1988, PROC R SOC SER B-BIO, V235, P145, DOI 10.1098/rspb.1988.0069; RODNAN GP, 1975, JAMA-J AM MED ASSOC, V231, P1143, DOI 10.1001/jama.231.11.1143; Schlesinger N, 2004, DRUGS, V64, P2399, DOI 10.2165/00003495-200464210-00003; Schlesinger N, 2001, CURR OPIN RHEUMATOL, V13, P240, DOI 10.1097/00002281-200105000-00016; SCHUMACHER HR, IN PRESS J RHEUMATOL; Shoji A, 2004, ARTHRIT RHEUM-ARTHR, V51, P321, DOI 10.1002/art.20405; TAK HK, 1980, ARTHRITIS RHEUM, V23, P574, DOI 10.1002/art.1780230509; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WILCOX WR, 1972, MED BIOL ENG, V10, P522, DOI 10.1007/BF02474201; Wortmann RL, 2002, CURR OPIN RHEUMATOL, V14, P281, DOI 10.1097/00002281-200205000-00015; Wortmann RL, 2001, KELLEYS TXB RHEUMATO, P1339; Yamada H, 1998, INT OFFSHORE POLAR E, P13; YUE TF, 1961, ANN INTERN MED, V55, P179, DOI 10.7326/0003-4819-55-2-179	37	873	981	14	153	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2450	2461		10.1056/NEJMoa050373	http://dx.doi.org/10.1056/NEJMoa050373			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339094				2022-12-28	WOS:000233754400007
J	Fry, AM; Shay, DK; Holman, RC; Curns, AT; Anderson, LJ				Fry, AM; Shay, DK; Holman, RC; Curns, AT; Anderson, LJ			Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZA VACCINATION; RISK-FACTORS; ANTIBODY-RESPONSE; INFECTION; DISEASE; POPULATION; STROKE; MORTALITY	Context Pneumonia causes significant mortality and morbidity among persons aged 65 years or older. However, few studies have explored trends according to age groups, which may affect intervention strategies. Objectives To examine trends in hospitalizations for pneumonia among persons aged 65 years or older and to compare characteristics, outcomes, and comorbid diagnoses. Design, Setting, and Patients Data from 1988 through 2002 on pneumonia and comorbid diagnoses among patients aged 65 to 74 years, 75 to 84 years, and 85 years or older from the National Hospital Discharge Survey. Main Outcome Measures Hospitalization rates by first-listed and any-listed discharge codes for pneumonia; proportions of hospitalizations reporting comorbid diagnoses for the 3 age groups (65-74 years, 75-84 years, >= 85 years). Results Hospitalization rates by both first-listed and any-listed discharge codes for pneumonia increased by 20% from 1988-1990 to 2000-2002 for patients aged 65 to 74 years (P=.01) and for patients aged 75 to 84 years (P<.001). Rates of hospitalization for pneumonia were 2-fold higher for patients aged 85 years or older (51 per 1000 population for first-listed discharge code of pneumonia; 95% confidence interval [CI], 46-55 per 1000 population) than among patients aged 75 to 84 years (26 per 1000 population; 95% Cl, 24-28 per 1000 population), but did not significantly increase from 1988-1990 to 2000-2002. The proportion of patients aged 65 years or older diagnosed with pneumonia and a chronic cardiac disease, chronic pulmonary disease, or diabetes mellitus increased from 66% (SE, 1.0%) in 1988-1990 to 77% (SE, 0.8%) in 2000-2002. The risk of death during a hospitalization for pneumonia compared with the risk of death during a hospital stay for the 10 other most frequent causes of hospitalization was 1.5 (95% Cl, 1.4-1.7) and remained constant from 19881990 to 2000-2002. Conclusions Hospitalization rates for pneumonia have increased among US adults aged 64 to 74 years and aged 75 to 84 years during the past 15 years. Among those aged 85 years or older, at least 1 in 20 patients were hospitalized each year due to pneumonia. Concomitantly, the proportion of comorbid chronic diseases has increased. Efforts to prevent pneumonia should include reducing preventable comorbid conditions and improving vaccine effectiveness and vaccination programs in elderly persons.	Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-34, Atlanta, GA 30333 USA.	afry@cdc.gov		Shay, David/0000-0001-9619-4820				[Anonymous], 1979, HLTH PEOPL SURG GEN; [Anonymous], 1996, US BUREAU CENSUS CUR; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; Barker WH, 1997, STROKE, V28, P284, DOI 10.1161/01.STR.28.2.284; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Dennison C, 2000, Vital Health Stat 1, P1; Dorrell L, 1997, INT J STD AIDS, V8, P776, DOI 10.1258/0956462971919264; Falsey AR, 1998, VACCINE, V16, P1775, DOI 10.1016/S0264-410X(98)00142-X; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Farr BM, 2000, RESP MED, V94, P954, DOI 10.1053/rmed.2000.0865; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GILLIUM BS, 1996, TRENDS HOSP UTILIZAT; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; KOIVULA I, 1994, AM J MED, V96, P313, DOI 10.1016/0002-9343(94)90060-4; KOZAK LJ, 2005, VITAL HLTH STAT, V13, P1729; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; MCBEAN AM, 1993, ARCH INTERN MED, V153, P2105, DOI 10.1001/archinte.153.18.2105; MCELHANEY JE, 1990, J AM GERIATR SOC, V38, P652, DOI 10.1111/j.1532-5415.1990.tb01424.x; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Muder RR, 1998, AM J MED, V105, P319, DOI 10.1016/S0002-9343(98)00262-9; *NAT CTR HLTH STAT, 2004, NAT HOSP DISCH SURV; *NAT HLTH INT SURV, INFL VACC DAT; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Remarque EJ, 1999, EXP GERONTOL, V34, P109, DOI 10.1016/S0531-5565(98)00060-6; Shah BV, 1996, SUDAAN USERS MANUAL; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Simonsen L, 1998, ARCH INTERN MED, V158, P1923, DOI 10.1001/archinte.158.17.1923; Thompson WW, 2005, ARCH INTERN MED, V165, P2038, DOI 10.1001/archinte.165.17.2038-b; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US BUR CENS, 2003, INT EST POP AG SEX R; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; *US EPA, 1991, NAT AIR QUAL EM TREN; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907	52	313	328	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2712	2719		10.1001/jama.294.21.2712	http://dx.doi.org/10.1001/jama.294.21.2712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333006	Bronze			2022-12-28	WOS:000233726900019
J	Khashu, M; Rudman, D; Osiovich, H				Khashu, M; Rudman, D; Osiovich, H			Gastric pneumatosis in a preterm infant	LANCET			English	Editorial Material									Univ British Columbia, Childrens & Womens Hlth Ctr British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC V6H 3V4, Canada	BC Women's Hospital & Health Centre; University of British Columbia	Osiovich, H (corresponding author), Univ British Columbia, Childrens & Womens Hlth Ctr British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC V6H 3V4, Canada.	hosiovich@cw.bc.ca	Khashu, Minesh/GRF-0302-2022; Khashu, Minesh/GLT-6749-2022	Khashu, Minesh/0000-0003-2673-5948					0	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1808	1808		10.1016/S0140-6736(05)67727-6	http://dx.doi.org/10.1016/S0140-6736(05)67727-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298219				2022-12-28	WOS:000233517200026
J	Oransky, I				Oransky, I			Michael Ward - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						WARD MD, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 5	2005	366	9497					1602	1602		10.1016/S0140-6736(05)67651-9	http://dx.doi.org/10.1016/S0140-6736(05)67651-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980VU	16320383				2022-12-28	WOS:000233047100013
J	Hurd, SS; Lenfant, C				Hurd, SS; Lenfant, C			COPD: good lung health is the key	LANCET			English	Editorial Material									Global Initiat Chron Obstruct Lung Dis, Gaithersburg, MD 20883 USA; NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hurd, SS (corresponding author), Global Initiat Chron Obstruct Lung Dis, Gaithersburg, MD 20883 USA.	shurd@prodigy.net						Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; *GLOB IN CHRON OBS, 2005, GLOB STRAT DIAGN MAN; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; *NAT HEART LUNG BL, 2004, MORB MORT CHARTB CAR; Pauwels R, 2004, RESP MED, V98, P99, DOI 10.1016/j.rmed.2003.09.001; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011	8	9	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1832	1834		10.1016/S0140-6736(05)67634-9	http://dx.doi.org/10.1016/S0140-6736(05)67634-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310538				2022-12-28	WOS:000233643200006
J	Scheffel, A; Gruska, M; Faivre, D; Linaroudis, A; Plitzko, JM; Schuler, D				Scheffel, A; Gruska, M; Faivre, D; Linaroudis, A; Plitzko, JM; Schuler, D			An acidic protein aligns magnetosomes along a filamentous structure in magnetotactic bacteria	NATURE			English	Article							MAGNETOSPIRILLUM; MAGNETITE; MEMBRANE; VESICLES; REVEALS; ICE	Magnetotactic bacteria are widespread aquatic microorganisms that use unique intracellular organelles to navigate along the Earth's magnetic field. These organelles, called magnetosomes, consist of membrane-enclosed magnetite crystals that are thought to help to direct bacterial swimming towards growth-favouring microoxic zones at the bottom of natural waters(1). Questions in the study of magnetosome formation include understanding the factors governing the size and redox-controlled synthesis of the nano-sized magnetosomes and their assembly into a regular chain in order to achieve the maximum possible magnetic moment, against the physical tendency of magnetosome agglomeration. A deeper understanding of these mechanisms is expected from studying the genes present in the identified chromosomal 'magnetosome island', for which the connection with magnetosome synthesis has become evident(2). Here we use gene deletion in Magnetospirillum gryphiswaldense to show that magnetosome alignment is coupled to the presence of the mamJ gene product. MamJ is an acidic protein associated with a novel filamentous structure, as revealed by fluorescence microscopy and cryoelectron tomography. We suggest a mechanism in which MamJ interacts with the magnetosome surface as well as with a cytoskeleton-like structure. According to our hypothesis, magnetosome architecture represents one of the highest structural levels achieved in prokaryotic cells.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Schuler, D (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	dschuele@mpi-bremen.de	faivre, damien/D-3713-2009; Plitzko, Juergen M/H-9576-2014	faivre, damien/0000-0001-6191-3389; Plitzko, Juergen M/0000-0002-6402-8315; Schuler, Dirk/0000-0002-2327-0762				Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1994, MICROSC RES TECHNIQ, V27, P389, DOI 10.1002/jemt.1070270505; BAZYLINSKI DA, 1995, ASM NEWS, V61, P337; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; Evans JS, 2003, CURR OPIN COLLOID IN, V8, P48, DOI 10.1016/S1359-0294(03)00009-8; Grimm R, 1996, ULTRAMICROSCOPY, V63, P169, DOI 10.1016/0304-3991(96)00035-6; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; KIRSCHVINK JL, 1982, EARTH PLANET SC LETT, V59, P388, DOI 10.1016/0012-821X(82)90140-6; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Philipse AP, 2002, LANGMUIR, V18, P9977, DOI 10.1021/la0205811; Sambrook J., 2001, MOL CLONING LAB MANU; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; Schultheiss D, 2004, APPL ENVIRON MICROB, V70, P3624, DOI 10.1128/aem.70.6.3624-3631.2004; Schultheiss D, 2003, ARCH MICROBIOL, V179, P89, DOI 10.1007/s00203-002-0498-z; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; VALI H, 1991, IRON BIOMINERALS, P97	23	392	418	6	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					110	114		10.1038/nature04382	http://dx.doi.org/10.1038/nature04382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16299495				2022-12-28	WOS:000235685700050
J	Salisbury, C; Noble, A; Horrocks, S; Crosby, Z; Harrison, V; Coast, J; de Berker, D; Peters, T				Salisbury, C; Noble, A; Horrocks, S; Crosby, Z; Harrison, V; Coast, J; de Berker, D; Peters, T			Evaluation of a general practitioner with special interest service for dermatology: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effectiveness, accessibility, and acceptability of a general practitioner with special interest service for skin problems compared with a hospital dermatology clinic. Design Randomised controlled trial. Setting General practitioner with special interest dermatology service and hospital dermatology clinic. Participants Adults referred to a hospital dermatology clinic and assessed by a consultant: or the general practitioner with special interest service. Suitable patients had non-urgent. skin problems and had been identified from the referral letter as suitable for management by a general practitioner with special interest. Interventions Participants were randomised in 2:1 ratio to receive management by a general practitioner with special interest or usual hospital outpatient care. Main outcome measures Primary outcomes were disease related quality of life (dermatology life quality index) and improvement in patients' perception of access to services, assessed nine months after randomisation. Secondary outcomes were patient satisfaction, preference for site of care, proportion of failed appointments, and waiting tunes to first appointment. Results 49% of the participants were judged suitable for care by the general practitioner with special interest service. Of 768 patients eligible, 556 (72.4%) were randomised (354 to general practitioner with special interest, 202 to hospital outpatient care). After nine months, 422 (76%) were followed tip. No noticeable differences were found between the groups in clinical outcome (median dermatology life quality index score = 1 both arms, ratio of geometric means 0.99, 95% confidence interval 0.85 to 1.15). The general practitioner with special interest service was more accessible (difference between means on access scale 14, 11 to 19) and waited a mean of 40 (35 to 46) days less. Patients expressed slightly greater satisfaction with consultations with a general practitioner with special interest (difference in mean satisfaction score 4, 1 to 7) and at baseline and after nine months 61% said they preferred care at the service. Conclusions The general practitioner with special interest service for dermatology was more accessible than hospital outpatient care and was preferred by patients, achieving similar clinical outcomes.	Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ W England, Fac Hlth & Social Care, Bristol BS16 1DD, Avon, England; Univ Southampton, Dept Primary Hlth Care, Lymington SO41 9GH, Hants, England; Bristol S Primary Care Trust, Bristol BS2 8EE, Avon, England; Bristol W Primary Care Trust, Bristol BS2 8EE, Avon, England; Bristol N Primary Care Trust, Bristol BS2 8EE, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; United Bristol Hlth Care Trust, Dermatol Clin, Bristol BS2 8HW, Avon, England; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol; University of West England; University of Southampton; University of Bristol; University of Bristol	Salisbury, C (corresponding author), Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England.	c.salisbury@bristol.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Peters, Tim/0000-0003-2881-4180; Coast, Joanna/0000-0002-3537-5166				Audit Commission, 2004, QUICK TREATM CLOS HO; BAKER R, 1990, BRIT J GEN PRACT, V40, P487; Bowling A, 2001, BRIT J GEN PRACT, V51, P264; Coast J, 2005, BMJ-BRIT MED J, V331, P1444, DOI 10.1136/bmj.38676.446910.7C; *DEP HLTH, 2003, ACT DERM GOOD PRACT; *DEP HLTH, 2002, IMPL SCHEM GEN PRACT; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2003, PRACT SPEC INT BRING; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Jones R, 2002, BRIT J GEN PRACT, V52, P833; Nocon A, 2004, BRIT J GEN PRACT, V54, P50; Powell John, 2002, J Health Serv Res Policy, V7, P177, DOI 10.1258/135581902760082490; *ROYAL COLL GEN PR, 2003, GUID APP GEN PRACT S; SANDERSON D, 2002, EVALUATION GPS SPECI	14	46	46	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1441	1444		10.1136/bmj.38670.494734.7C	http://dx.doi.org/10.1136/bmj.38670.494734.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16332728	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000234156400022
J	Tanvir, NR; Chapman, R; Levan, AJ; Priddey, RS				Tanvir, NR; Chapman, R; Levan, AJ; Priddey, RS			An origin in the local Universe for some short gamma-ray bursts	NATURE			English	Article							OPTICAL AFTERGLOW; NEUTRON-STARS; FLARE; SGR-1806-20; CONSTRAINTS; ANISOTROPY; CATALOG	Gamma-ray bursts (GRBs) divide into two classes(1): 'long', which typically have initial durations of T-90 > 2 s, and 'short', with durations of T-90 < 2 s (where T-90 is the time to detect 90% of the observed fluence). Long bursts, which on average have softer gamma-ray spectra(2), are known to be associated with stellar core-collapse events - in some cases simultaneously producing powerful type Ic supernovae(3-5). In contrast, the origin of short bursts has remained mysterious until recently. A subsecond intense 'spike' of gamma-rays during a giant flare from the Galactic soft gamma-ray repeater, SGR 1806 - 20, reopened an old debate over whether some short GRBs could be similar events seen in galaxies out to similar to 70 Mpc (refs 6 - 10; redshift z approximate to 0.016). Shortly after that, localizations of a few short GRBs ( with optical afterglows detected in two cases(11,12)) have shown an apparent association with a variety of host galaxies at moderate redshifts(11-14). Here we report a correlation between the locations of previously observed short bursts and the positions of galaxies in the local Universe, indicating that between 10 and 25 per cent of short GRBs originate at low redshifts ( z < 0.025).	Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Tanvir, NR (corresponding author), Univ Hertfordshire, Ctr Astrophys Res, Coll Lane, Hatfield AL10 9AB, Herts, England.	nrt@star.herts.ac.uk						Balazs LG, 1998, ASTRON ASTROPHYS, V339, P1; BERGER E, 2005, ARXIVORGASTROPH05081; BERGER E, IN PRESS NATURE; BLOOM J, ARXIVORGASTROPH05054; BLOOM J, IN PRESS ASTROPHYS J; Briggs MS, 1999, ASTROPHYS J SUPPL S, V122, P503, DOI 10.1086/313221; BUTLER N, 2005, 3570 GRB; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Gorosabel J, 2002, ASTRON ASTROPHYS, V383, P112, DOI 10.1051/0004-6361:20011716; Hakkila J, 2003, AIP CONF PROC, V662, P176; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kalogera V, 2004, ASTROPHYS J, V601, pL179, DOI 10.1086/382155; Klotz A, 2003, ASTRON ASTROPHYS, V404, P815, DOI 10.1051/0004-6361:20030121; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; KRIMM H, 2005, 3667 GRB; Lazzati D, 2005, NATURE, V434, P1075, DOI 10.1038/4341075a; Magliocchetti M, 2003, MON NOT R ASTRON SOC, V343, P255, DOI 10.1046/j.1365-8711.2003.06657.x; MOCHKOVITCH R, 1993, NATURE, V361, P236, DOI 10.1038/361236a0; NAKAR E, 2005, IN PRESS ASTROPHYS J; NORRIS JP, 1984, NATURE, V308, P434, DOI 10.1038/308434a0; Paciesas WS, 1999, ASTROPHYS J SUPPL S, V122, P465, DOI 10.1086/313224; Palmer DM, 2005, NATURE, V434, P1107, DOI 10.1038/nature03525; Pendleton GN, 1999, ASTROPHYS J, V512, P362, DOI 10.1086/306735; POPOV SB, UNPUB MON NOT R ASTR; Rosswog S, 2003, MON NOT R ASTRON SOC, V345, P1077, DOI 10.1046/j.1365-2966.2003.07032.x; Rosswog S, 2003, MON NOT R ASTRON SOC, V343, pL36, DOI 10.1046/j.1365-8711.2003.06889.x; Saunders W, 2000, MON NOT R ASTRON SOC, V317, P55, DOI 10.1046/j.1365-8711.2000.03528.x; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359	32	102	104	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					991	993		10.1038/nature04310	http://dx.doi.org/10.1038/nature04310			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355218	Green Submitted			2022-12-28	WOS:000233934600060
J	Masuda, K; Ozawa, H; Fujii, M; Kimura, S; Nagasaki, K; Matsunaga, T; Tsunoda, K				Masuda, K; Ozawa, H; Fujii, M; Kimura, S; Nagasaki, K; Matsunaga, T; Tsunoda, K			Critical spontaneous rupture of a common carotid artery pseudo-aneurysm	LANCET			English	Editorial Material									Natl Tokyo Med Ctr, Dept Otolaryngol, Meguro Ku, Tokyo 15218902, Japan; Natl Tokyo Med Ctr, Dept Cardiovasc Surg, Meguro Ku, Tokyo 15218902, Japan; Natl Inst Sensory Organs, Meguro Ku, Tokyo 15218902, Japan		Masuda, K (corresponding author), Natl Tokyo Med Ctr, Dept Otolaryngol, Meguro Ku, Higashigaoka 2-5-1, Tokyo 15218902, Japan.	kana-y@xc4.so-net.ne.jp	Tsunoda, Koichi/L-4188-2019; OZAWA, HIROYUKI/AAG-4386-2021	OZAWA, HIROYUKI/0000-0002-0990-831X; matsunaga, tatsuo/0000-0001-9647-1496					0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2034	2034		10.1016/S0140-6736(05)67815-4	http://dx.doi.org/10.1016/S0140-6736(05)67815-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338453	Bronze			2022-12-28	WOS:000233826900023
J	Netuveli, G; Wiggins, RD; Hildon, Z; Montgomery, SM; Blane, D				Netuveli, G; Wiggins, RD; Hildon, Z; Montgomery, SM; Blane, D			Functional limitation in long standing illness and quality of life: evidence from a national survey	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England; Karolinska Inst, Karolinska Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; City Univ London, Dept Sociol, London EC1V OHB, England	Imperial College London; Karolinska Institutet; Karolinska University Hospital; City University London	Netuveli, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England.	g.netuveli@ic.ac.uk	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494	Economic and Social Research Council [RES-544-28-5001, RES-337-25-0001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Department of Health, 2002, NAT SERV FRAM OLD PE; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; Marmot M, 2003, HLTH WEALTH LIFESTYL; Steffick DE, 2000, DOCUMENTATION AFFECT; Wiggins RD, 2004, AGEING SOC, V24, P693, DOI 10.1017/S0144686X04002284	5	34	34	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1382	+		10.1136/bmj.331.7529.1382	http://dx.doi.org/10.1136/bmj.331.7529.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339249	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000233999300022
J	Tegmark, M; Bostrom, N				Tegmark, M; Bostrom, N			Is a doomsday catastrophe likely?	NATURE			English	Editorial Material									MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Oxford, Fac Philosophy, Future Human Inst, Oxford OX1 4JJ, England	Massachusetts Institute of Technology (MIT); University of Oxford	Tegmark, M (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	tegmark@mit.edu						Bostrom N., 2002, ANTHROPIC BIAS OBSER; Carter B., 1974, IAU Symposium no.63 on Confrontation of Cosmological Theories with Observational Data, P291; Dar A, 1999, PHYS LETT B, V470, P142, DOI 10.1016/S0370-2693(99)01307-6; HUT P, 1983, NATURE, V302, P508, DOI 10.1038/302508a0; Jaffe RL, 2000, REV MOD PHYS, V72, P1125, DOI 10.1103/RevModPhys.72.1125; Lineweaver CH, 2004, SCIENCE, V303, P59, DOI 10.1126/science.1092322	6	18	18	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					754	754		10.1038/438754a	http://dx.doi.org/10.1038/438754a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341005				2022-12-28	WOS:000233777800031
J	Campbell, PJ; Scott, LM; Buck, G; Wheatley, K; East, CL; Marsden, JT; Duffy, A; Boyd, EM; Bench, AJ; Scott, MA; Vassiliou, GS; Milligan, DW; Smith, SR; Erber, WN; Bareford, D; Wilkins, BS; Reilly, JT; Harrison, CN; Green, AR				Campbell, PJ; Scott, LM; Buck, G; Wheatley, K; East, CL; Marsden, JT; Duffy, A; Boyd, EM; Bench, AJ; Scott, MA; Vassiliou, GS; Milligan, DW; Smith, SR; Erber, WN; Bareford, D; Wilkins, BS; Reilly, JT; Harrison, CN; Green, AR		United Kingdom Myeloproliferative	Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study	LANCET			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; MESSENGER-RNA EXPRESSION; TYROSINE KINASE JAK2; DIAGNOSTIC-CRITERIA; RISK; MYELOFIBROSIS; PLATELETS; SURVIVAL; TRIALS; COHORT	Background An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia Vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why the same mutation is associated with different disease phenotypes. Methods Two sensitive PCR-based methods were used to assess the JAK2 mutation status of 806 patients with essential thrombocythaemia, including 776 from the Medical Research Council's Primary Thrombocythaemia trial (MRC PT-1) and two other prospective studies. Laboratory and clinical features, response to treatment, and clinical events were compared for V617F-positive and V617F-negative patients with essential thrombocythaemia. Findings Mutation-positive patients had Multiple features resembling polycythaemia Vera, with significantly increased haemoglobin (mean increase 9.6 g/L, 95% CI 7.6-11.6 g/L; p<0.0001), neutrophil counts (1.1 X 10(9)/L, 0.7-1.5 X 10(9)/L; p<0.0001), bone marrow erythropoiesis and granulopoiesis, more venous thromboses, and a higher rate of polycythaemic transformation than those without the mutation. Mutation-positive patients had lower serum erythropoietin (mean decrease 13.8 U/L; 95% CI, 10.8-16.9 U/L; p<0.0001) and ferritin (n=182; median 58 vs 91 mu g/L; p=0.01.) concentrations than did mutation-negative patients. Mutation-negative patients did, nonetheless, show many clinical and laboratory features that were characteristic of a myeloproliferative disorder. V617F-positive individuals were more sensitive to therapy with hydroxyurea, but not anagrelide, than those without the JAK2 mutation. Interpretation Our results suggest that JAK2 V617F-positive essential thrombocythaemia and polycythaemia Vera form a biological continuum, with the degree of erythrocytosis determined by physiological or genetic modifiers.	Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Birmingham, Clin Trials Unit, Birmingham, W Midlands, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge, England; Kings Coll Hosp London, Dept Clin Biochem, London, England; Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England; Torbay Hosp, Dept Haematol, Torquay, England; Russells Hall Hosp, Dept Haematol, Dudley, England; Royal Victoria Infirm, Dept Histopathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Sheffield, Dept Haematol, Sheffield, S Yorkshire, England; St Thomas Hosp, Dept Haematol, London SE1 7EH, England	University of Cambridge; Radcliffe Infirmary; University of Oxford; University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Heart of England NHS Foundation Trust; University of Birmingham; Russells Hall Hospital; Newcastle University - UK; University of Sheffield; Guy's & St Thomas' NHS Foundation Trust	Green, AR (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	Erber, Wendy/A-1955-2012; Scott, Linda/D-9777-2012	Scott, Linda/0000-0003-0334-1479; Green, Anthony/0000-0002-9795-0218; Vassiliou, George/0000-0003-4337-8022; Buck, Georgina/0000-0001-5909-4265; Erber, Wendy/0000-0002-1028-9376				Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; ElKassar N, 1997, BLOOD, V89, P128, DOI 10.1182/blood.V89.1.128.128_128_134; Griesshammer M, 2004, ANN HEMATOL, V83, P364, DOI 10.1007/s00277-004-0864-9; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; Harrison CN, 2003, HEMATOL ONCOL CLIN N, V17, P1175, DOI 10.1016/S0889-8588(03)00082-0; Harrison CN, 1999, BLOOD, V93, P417, DOI 10.1182/blood.V93.2.417.402a33_417_424; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2003, BLOOD, V102, P1869, DOI 10.1182/blood-2003-03-0744; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; SIMON R, 1986, ANN INTERN MED, V105, P429, DOI 10.7326/0003-4819-105-3-429; Spivak Jerry L, 2003, Hematology Am Soc Hematol Educ Program, P200; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Tefferi A, 2001, BLOOD REV, V15, P121, DOI 10.1054/blre.2001.0158; Teofili L, 2002, BLOOD, V100, P714, DOI 10.1182/blood.V100.2.714; Thiele J, 2003, ANN HEMATOL, V82, P148, DOI 10.1007/s00277-002-06040-y; Thiele J, 2000, HAEMATOLOGICA, V85, P1126; Wilkins, 2001, BONE MARROW PATHOLOG	29	532	584	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1945	1953		10.1016/S0140-6736(05)67785-9	http://dx.doi.org/10.1016/S0140-6736(05)67785-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325696				2022-12-28	WOS:000233777900022
J	Fazi, F; Rosa, A; Fatica, A; Gelmetti, V; De Marchis, ML; Nervi, C; Bozzoni, I				Fazi, F; Rosa, A; Fatica, A; Gelmetti, V; De Marchis, ML; Nervi, C; Bozzoni, I			A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBP alpha regulates human granulopoiesis	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-ALPHA; RETINOIC ACID; GRANULOCYTIC DIFFERENTIATION; IN-VITRO; RAR-ALPHA; GENE; EXPRESSION; PROMOTER; EPSILON	MicroRNAs play important roles in cell differentiation by acting as translational inhibitors of specific target genes. Here we show that human granulocytic differentiation is controlled by a regulatory circuitry involving miR-223 and two transcriptional factors, NFI-A and C/EBP alpha. The two factors compete for binding to the miR-223 promoter: NFI-A maintains miR-223 at low levels, whereas its replacement by C/EBP alpha, following retinoic acid (RA)-induced differentiation, upregulates miR-223 expression. The competition by C/EBP alpha and the granulocytic differentiation are favored by a negative-feedback loop in which miR-223 represses NFI-A translation. In line with this, both RNAi against NFI-A and ectopic expression of miR-223 in acute promyelocytic leukemia (APL) cells enhance differentiation, whereas miR-223 knockdown inhibits the differentiation response to RA. Altogether, our data indicate that miR-223 plays a crucial role during granulopoiesis and point to the NFI-A repression as an important molecular pathway mediating gene reprogramming in this cell lineage.	Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00128 Rome, Italy; Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy; Univ Roma La Sapienza, IBPM, I-00185 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Nervi, C (corresponding author), Univ Roma La Sapienza, Dept Histol & Med Embryol, Via Castel Romano 100, I-00128 Rome, Italy.	clara.nervi@uniroma1.it; irene.bozzoni@uniroma1.it	Alessandro, Rosa/A-3860-2012; Fatica, Alessandro/L-2866-2019; Fazi, Francesco/K-5304-2018; De Marchis, Maria Laura/J-8803-2016; De Marchis, Maria Laura/O-6315-2019	Alessandro, Rosa/0000-0001-9999-7223; Fazi, Francesco/0000-0003-2910-7912; De Marchis, Maria Laura/0000-0002-3720-6550; De Marchis, Maria Laura/0000-0002-3720-6550; Fatica, Alessandro/0000-0002-0743-7905; bozzoni, irene/0000-0002-3485-8537; NERVI, Clara/0000-0001-9341-0188				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bachurski CJ, 1997, J BIOL CHEM, V272, P32759, DOI 10.1074/jbc.272.52.32759; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamin D, 1996, J IMMUNOL, V156, P1626; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; GARLATTI M, 1993, J BIOL CHEM, V268, P6567; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Khanna-Gupta A, 2001, P NATL ACAD SCI USA, V98, P8000, DOI 10.1073/pnas.141229598; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LANOTTE M, 1991, BLOOD, V77, P1080; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lo Coco F, 2002, CANCER RES, V62, P5618; LOCOCO F, 1992, LANCET, V340, P1437, DOI 10.1016/0140-6736(92)92625-P; Lodie TA, 1999, BLOOD, V94, p692A; Mandelli F, 1997, BLOOD, V90, P1014; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tenen DG, 2001, LEUKEMIA, V15, P688, DOI 10.1038/sj.leu.2402088; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571	43	789	863	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					819	831		10.1016/j.cell.2005.09.023	http://dx.doi.org/10.1016/j.cell.2005.09.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325577	Bronze			2022-12-28	WOS:000233814100016
J	Gates, J; Peifer, M				Gates, J; Peifer, M			Can 1000 reviews be wrong? Actin, alpha-catenin, and adherens junctions	CELL			English	Review							CELL-ADHESION; DE-CADHERIN; POLYMERIZATION; COMPLEX; LOCALIZATION; ARMADILLO; PROTEINS; POLARITY	Coupling between cell adhesion and the actin cytoskeleton is thought to require a stable link between the cadherin-catenin complex and actin that is mediated by alpha-catenin. In this issue of Cell, the Weis and Nelson groups call this static model into question, showing that alpha-catenin can directly regulate actin dynamics (Drees et al., 2005; Yamada et al., 2005).	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gates, J (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	peifer@unc.edu		Peifer, Mark/0000-0003-1412-3987				Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; DREES F, 2005, CELL; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Quinlan MP, 1999, CELL GROWTH DIFFER, V10, P839; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; YAMADA S, 2005, CELL	18	147	149	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					769	772		10.1016/j.cell.2005.11.009	http://dx.doi.org/10.1016/j.cell.2005.11.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325573	Bronze			2022-12-28	WOS:000233814100012
J	Simons, K; Featherstone, C				Simons, K; Featherstone, C			The European Research Council on the brink	CELL			English	Editorial Material							SCIENCE	Basic research in Europe is about to receive a shot in the arm with the creation of a European Research Council (ERC). This new agency will sustain fundamental investigation into all aspects of scientific knowledge and should drive up standards of scientific research across the continent.	ELSO, D-01307 Dresden, Germany; Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; ELSO Career Dev Comm, F-31450 Fourquevaux, France	Max Planck Society	Simons, K (corresponding author), ELSO, D-01307 Dresden, Germany.	simons@mpi-cbg.de		Featherstone, Carol/0000-0002-7881-7235; Simons, Kai/0000-0002-9231-9996				Banda E, 2002, SCIENCE, V295, P443; *EUR COUNC, 2003, NEW STRUCT SUPP HIGH; European Council, 2000, PRES CONCL; LOCATELLI PE, 2005, REPORT SCI TECHNOLOG; Sapir, 2003, AGENDA GROWING EUROP; Wigzell H, 2002, SCIENCE, V295, P443; Winnacker EL, 2002, SCIENCE, V295, P446, DOI 10.1126/science.1068921; 2004, SCIENCE, V305, P776	8	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					747	750		10.1016/j.cell.2005.11.016	http://dx.doi.org/10.1016/j.cell.2005.11.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325566	Bronze			2022-12-28	WOS:000233814100005
J	Patrono, C; Rodriguez, LAG; Landolfi, R; Baigent, C				Patrono, C; Rodriguez, LAG; Landolfi, R; Baigent, C			Drug therapy - Low-dose aspirin for the prevention of atherothrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ACETYLSALICYLIC-ACID; RANDOMIZED-TRIAL; THROMBOXANE BIOSYNTHESIS; ANTIPLATELET AGENTS; RISK REDUCTION; DOUBLE-BLIND; INHIBITION		Univ Roma La Sapienza, Dept Pharmacol, Rome, Italy; Spanish Ctr Pharmacoepidemiol Res, Madrid, Spain; Catholic Univ, Sch Med, Dept Med, Rome, Italy; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England	Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; University of Oxford	Patrono, C (corresponding author), Univ Roma La Sapienza, Osped Sant Andrea, Via Grottarossa 1035, I-00189 Rome, Italy.	cpatrono@unich.it	Landolfi, Raffaele/AAL-4496-2020; rodriguez, luis a garcia/B-1980-2010	Landolfi, Raffaele/0000-0002-7913-8576; Patrono, Carlo/0000-0002-6447-2424				Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P419, DOI 10.1016/S0735-1097(97)00502-0; [Anonymous], 1988, LANCET, V2, P349; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent Colin, 2005, BMJ, V330, P1442, DOI 10.1136/bmj.330.7505.1442; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Belton O, 2000, CIRCULATION, V102, P840; BURCH JW, 1978, J CLIN INVEST, V61, P314, DOI 10.1172/JCI108941; Caccese D, 2000, THROMB HAEMOSTASIS, V83, P485, DOI 10.1055/s-0037-1613841; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cattaneo M, 2004, ARTERIOSCL THROM VAS, V24, P1980, DOI 10.1161/01.ATV.0000145980.39477.a9; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Cipollone F, 1997, CIRCULATION, V96, P1109, DOI 10.1161/01.CIR.96.4.1109; Cipollone F, 2000, CIRCULATION, V102, P1007, DOI 10.1161/01.CIR.102.9.1007; CLARKE RJ, 1991, NEW ENGL J MED, V325, P1137, DOI 10.1056/NEJM199110173251605; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; *COLL GROUP PRIM P, 2001, LANCET, V357, P1134; Corman SL, 2005, ANN PHARMACOTHER, V39, P1073, DOI 10.1345/aph.1E514; Cullen L, 1998, J PHARMACOL EXP THER, V287, P578; Di Luca M, 2000, EUR J PHARMACOL, V405, P277, DOI 10.1016/S0014-2999(00)00559-8; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harrison P, 2005, STROKE, V36, P1001, DOI 10.1161/01.STR.0000162719.11058.bd; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HENNEKENS CH, IN PRESS NAT CLIN PR; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Laheij RJF, 2003, ALIMENT PHARM THER, V18, P109, DOI 10.1046/j.1365-2036.2003.01656.x; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas Angel, 2002, Expert Opin Drug Saf, V1, P245; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Latini R, 2000, J AM COLL CARDIOL, V35, P1801, DOI 10.1016/S0735-1097(00)00638-0; Levin RI, 2005, NEW ENGL J MED, V352, P1366, DOI 10.1056/NEJMe058051; LINDBLAD B, 1993, STROKE, V24, P1125, DOI 10.1161/01.STR.24.8.1125; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P5890; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Meade TW, 1998, LANCET, V351, P233; MENE P, 1995, SEMIN NEPHROL, V15, P244; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Patrono C, 2004, EUR HEART J, V25, P166, DOI 10.1016/j.ehj.2003.10.013; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; PATRONO C, 1986, J CLIN INVEST, V77, P590, DOI 10.1172/JCI112341; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; PIERUCCI A, 1989, NEW ENGL J MED, V320, P421, DOI 10.1056/NEJM198902163200703; QUICK AJ, 1966, AM J MED SCI, V252, P265, DOI 10.1097/00000441-196609000-00003; Ramanuja S, 2004, CIRCULATION, V110, pE1, DOI 10.1161/01.CIR.0000134306.28561.2A; REILLY IAG, 1987, BLOOD, V69, P180; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rocca B, 2005, J THROMB HAEMOST, V3, P1597, DOI 10.1111/j.1538-7836.2005.01380.x; Rocca B, 2002, P NATL ACAD SCI USA, V99, P7634, DOI 10.1073/pnas.112202999; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Teo KK, 2002, LANCET, V360, P1037, DOI 10.1016/S0140-6736(02)11138-X; Teo Koon K, 2003, Lancet (North American Edition), V361, P90; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; van Kooten F, 1999, STROKE, V30, P1542, DOI 10.1161/01.STR.30.8.1542; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; WALLENTIN L, 1990, LANCET, V336, P827; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zanchetti A, 2002, J HYPERTENS, V20, P1015, DOI 10.1097/00004872-200205000-00038	96	850	905	3	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2373	2383		10.1056/NEJMra052717	http://dx.doi.org/10.1056/NEJMra052717			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319386				2022-12-28	WOS:000233574600009
J	Ptacek, J; Devgan, G; Michaud, G; Zhu, H; Zhu, XW; Fasolo, J; Guo, H; Jona, G; Breitkreutz, A; Sopko, R; McCartney, RR; Schmidt, MC; Rachidi, N; Lee, SJ; Mah, AS; Meng, L; Stark, MJR; Stern, DF; De Virgilio, C; Tyers, M; Andrews, B; Gerstein, M; Schweitzer, B; Predki, PF; Snyder, M				Ptacek, J; Devgan, G; Michaud, G; Zhu, H; Zhu, XW; Fasolo, J; Guo, H; Jona, G; Breitkreutz, A; Sopko, R; McCartney, RR; Schmidt, MC; Rachidi, N; Lee, SJ; Mah, AS; Meng, L; Stark, MJR; Stern, DF; De Virgilio, C; Tyers, M; Andrews, B; Gerstein, M; Schweitzer, B; Predki, PF; Snyder, M			Global analysis of protein phosphorylation in yeast	NATURE			English	Article							DATABASE; GENOME	Protein phosphorylation is estimated to affect 30% of the proteome and is a major regulatory mechanism that controls many basic cellular processes(1-3). Until recently, our biochemical understanding of protein phosphorylation on a global scale has been extremely limited; only one half of the yeast kinases have known in vivo substrates and the phosphorylating kinase is known for less than 160 phosphoproteins. Here we describe, with the use of proteome chip technology(4), the in vitro substrates recognized by most yeast protein kinases(5): we identified over 4,000 phosphorylation events involving 1,325 different proteins. These substrates represent a broad spectrum of different biochemical functions and cellular roles. Distinct sets of substrates were recognized by each protein kinase, including closely related kinases of the protein kinase A family and four cyclin- dependent kinases that vary only in their cyclin subunits. Although many substrates reside in the same cellular compartment or belong to the same functional category as their phosphorylating kinase, many others do not, indicating possible new roles for several kinases. Furthermore, integration of the phosphorylation results with protein - protein interaction(6-10) and transcription factor binding data(11,12) revealed novel regulatory modules. Our phosphorylation results have been assembled into a first- generation phosphorylation map for yeast. Because many yeast proteins and pathways are conserved, these results will provide insights into the mechanisms and roles of protein phosphorylation in many eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Invitrogen Corp, Carlsbad, CA 92008 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Univ Dundee, Sch Life Sci, Divb Gene Regulat & Express, Dundee DD1 5EH, Scotland; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Geneva, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M55 1A8, Canada	Yale University; Yale University; Thermo Fisher Scientific; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Dundee; Yale University; California Institute of Technology; University of Geneva; University of Toronto	Snyder, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	michael.snyder@yale.edu	Stark, Michael J. R./B-2815-2014; De Virgilio, Claudio/B-4707-2012; Tyers, Michael/ABE-3194-2021; Yang, Chen/G-1379-2010	Stark, Michael J. R./0000-0001-9086-191X; De Virgilio, Claudio/0000-0001-8826-4323; Snyder, Michael/0000-0003-0784-7987; Zhu, Xiaowei/0000-0002-5731-3177; Jona, Ghil/0000-0002-4526-6182; Rachidi, Najma/0000-0002-1247-7768	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; BREITKREUTZ BJ, 2003, GENOME BIOL, V4; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Pan XW, 1999, MOL CELL BIOL, V19, P4874; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	27	764	797	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					679	684		10.1038/nature04187	http://dx.doi.org/10.1038/nature04187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319894				2022-12-28	WOS:000233593100053
J	Severe, P; Leger, P; Charles, M; Noel, F; Bonhomme, G; Bois, G; George, E; Kenel-Pierre, S; Wright, PF; Gulick, R; Johnson, WD; Pape, JW; Fitzgerald, DW				Severe, P; Leger, P; Charles, M; Noel, F; Bonhomme, G; Bois, G; George, E; Kenel-Pierre, S; Wright, PF; Gulick, R; Johnson, WD; Pape, JW; Fitzgerald, DW			Antiretroviral therapy in a thousand patients with AIDS in Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; COMBINATION THERAPY; RANDOMIZED-TRIAL; NATURAL-HISTORY; HIV TREATMENT; EXPERIENCE; EFAVIRENZ; MORTALITY; INDINAVIR	Background: The one-year survival rate of adults and children with the acquired immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 percent in Haiti. Antiretroviral therapy has recently become available in Haiti and in other developing countries. Data on the efficacy of antiretroviral therapy in developing countries are limited. High rates of coinfection with tropical diseases and tuberculosis, along with malnutrition and limited laboratory monitoring of therapy, may decrease the efficacy of antiretroviral therapy in these countries. Methods: We studied the efficacy of antiretroviral therapy in the first 1004 consecutive patients with AIDS and without previous antiretroviral therapy who were treated beginning in March 2003 in Port-au-Prince, Haiti. Results: During a 14-month period, three-drug antiretroviral therapy was initiated in 1004 patients, including 94 children under 13 years of age. At enrollment, the median CD4 T-cell count in adults and adolescents was 131 per cubic millimeter (interquartile range, 55 to 211 per cubic millimeter); in children, a median of 13 percent of T cells were CD4-positive (interquartile range, 8 to 20 percent). According to a Kaplan-Meier survival analysis, 87 percent of adults and adolescents and 98 percent of children were alive one year after beginning treatment. In a subgroup of 100 adult and adolescent patients who were followed for 48 to 56 weeks, 76 patients had fewer than 400 copies of human immunodeficiency virus RNA per milliliter. In adults and adolescents, the median increase in the CD4 T-cell count from baseline to 12 months was 163 per cubic millimeter (interquartile range, 77 to 251 per cubic millimeter). In children, the median percentage of CD4 T cells rose from 13 percent at baseline to 26 percent (interquartile range, 22 to 36 percent) at 12 months. Treatment-limiting toxic effects occurred in 102 of the 910 adults and adolescents (11 percent) and 5 of the 94 children (5 percent). Conclusions: This report documents the feasibility of effective antiretroviral therapy in a large number of patients in an impoverished country. Overall, the outcomes are similar to those in the United States. These results provide evidence in support of international efforts to make antiretroviral therapy available to patients with AIDS in developing countries.	Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA; Grp Haitien Etud Sarcome Kaposi & Infect Opportun, Port Au Prince, Haiti; Vanderbilt Univ, Div Pediat Infect Dis, Nashville, TN USA	Cornell University; Vanderbilt University	Fitzgerald, DW (corresponding author), Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Room A-421,1300 York Ave, New York, NY 10021 USA.	dfitzgerald@gheskio.org		Kenel-Pierre, Stefan/0000-0003-0011-8511	FOGARTY INTERNATIONAL CENTER [U2RTW006901, U2RTW006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI051966, U01AI038858, U01AI058257, R21AI064021] Funding Source: NIH RePORTER; FIC NIH HHS [TW00002, TW006901, TW006896, TW00018] Funding Source: Medline; NIAID NIH HHS [AI 07613, AI64021, AI51966, AI38858, AI58257] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adje-Toure C, 2003, AIDS, V17, pS23, DOI 10.1097/00002030-200317003-00004; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; BARTLETT JA, 2005, 12 C RETR OPP INF BO; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fawzi W, 2005, J NUTR, V135, P938, DOI 10.1093/jn/135.4.938; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Haas DW, 2004, AIDS, V18, P2391; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hofer CB, 2004, JAIDS-J ACQ IMM DEF, V36, P967, DOI 10.1097/00126334-200408010-00011; *I HAIT ENF CTR GH, 2001, ET SER METH SENT PRE; *I MED, 2005, SCAL TREATM GLOB AID, P75; Jean SS, 1999, PEDIATR INFECT DIS J, V18, P58, DOI 10.1097/00006454-199901000-00014; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Lucas GM, 2003, JAIDS-J ACQ IMM DEF, V33, P321, DOI 10.1097/00126334-200307010-00005; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Mouton Y, 1997, AIDS, V11, pF101, DOI 10.1097/00002030-199712000-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN CLIN PRACT TR, 2005, GUID US ANT AG HIV I; PAPE J, 1993, CLIN INFECT DIS, V17, pS341, DOI 10.1093/clinids/17.Supplement_2.S341; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; SCHNEIDER M, NATURAL HIST MORTALI; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WORLD BANK, HAIT AT GLANC; World Bank, EC GROWTH GLOSS; World Health Organization, 2004, SCAL ANT THER RES LT; 2005, MMWR MORB MORTAL WKL, V53, P1203; 1994, WKLY EPIDEMIOL REC, V37, P273	35	205	209	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2325	2334		10.1056/NEJMoa051908	http://dx.doi.org/10.1056/NEJMoa051908			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319381	Bronze			2022-12-28	WOS:000233574600004
J	McNicholas, J; Gilbey, A; Rennie, A; Ahmedzai, S; Dono, JA; Ormerod, E				McNicholas, J; Gilbey, A; Rennie, A; Ahmedzai, S; Dono, JA; Ormerod, E			Pet ownership and human health: a brief review of evidence and issues	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLERGIC SENSITIZATION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DOGS; EXPOSURE; LIFE		Croit Cullach, Dundonnell, Rossshire, Scotland; Massey Univ, Palmerston North, New Zealand; Soc Compan Anim Studies, Blue Cross, Burford, Oxon, England; Univ Sheffield, Royal Hallamshire Hosp, Sheffield S10 2TN, S Yorkshire, England	Massey University; University of Sheffield	McNicholas, J (corresponding author), Croit Cullach, Dundonnell, Rossshire, Scotland.	june@cullach.fsnet.co.uk	Gilbey, Andrew/AFK-4901-2022	Ahmedzai, Sam/0000-0002-2028-8510; Gilbey, Andrew/0000-0001-6292-1807				ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; Behrens T, 2005, INT ARCH ALLERGY IMM, V137, P53, DOI 10.1159/000084613; Frew AJ, 2005, J ALLERGY CLIN IMMUN, V115, P1197, DOI 10.1016/j.jaci.2005.03.006; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Guay DRP, 2001, AM J INFECT CONTROL, V29, P178, DOI 10.1067/mic.2001.115873; HEADEY B, 1998, SOC INDIC RES, P1; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Lane DR, 1998, APPL ANIM BEHAV SCI, V59, P49, DOI 10.1016/S0168-1591(98)00120-8; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; MCNICHOLAS J, 2001, 10 INT C HUM AN INT; MCNICHOLAS J, 1993, SOCIAL CARE RES FIND, V44; MCNICHOLAS J, CATS ASTHMA REV RECE; MCNICHOLAS J, 1998, 9 INT C HUM AN INT P; MCNICHOLAS J, 2005, WALTHAM BOOK HUMAN C; MCNICHOLAS J, 2004, 10 INT C HUM AN INT; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Parslow RA, 2005, GERONTOLOGY, V51, P40, DOI 10.1159/000081433; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Parslow RA, 2003, ANTHROZOOS, V16, P43, DOI 10.2752/089279303786992305; PODBERCECK AL, 2000, COMPANION ANIMALS US; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; UK PET OWNERSHIP GRO	24	244	249	1	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1252	1254		10.1136/bmj.331.7527.1252	http://dx.doi.org/10.1136/bmj.331.7527.1252			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308387	Green Published, Bronze			2022-12-28	WOS:000233606800023
J	Charnoz, S; Porco, CC; Deau, E; Brahic, A; Spitale, JN; Bacques, G; Baillie, K				Charnoz, S; Porco, CC; Deau, E; Brahic, A; Spitale, JN; Bacques, G; Baillie, K			Cassini discovers a kinematic spiral ring around Saturn	SCIENCE			English	Article							F-RING; IMAGING SCIENCE; PLANE CROSSINGS; PROMETHEUS; AUGUST	Since the time of the Voyager flybys of Saturn in 1980-1981, Saturn's eccentric F ring has been known to be accompanied on either side by faint strands of material. New Cassini observations show that these strands, initially interpreted as concentric ring segments, are in fact connected and form a single one-arm trailing spiral winding at least three times around Saturn. The spiral rotates around Saturn with the orbital motion of its constituent particles. This structure is likely the result of differential orbital motion stretching an initial cloud of particles scattered from the dense core of the F ring. Different scenarios of formation, implying ringlet-satellite interactions, are explored. A recently discovered moon candidate, S/2004 S6, is on an orbit that crosses the F-ring core at the intersection of the spiral with the ring, which suggests a dynamical connection between S/2004 S6 and the spiral.	Univ Paris 07, CEA Saclay, SAp, DAPNIA,DSM,CNRS, F-91191 Gif Sur Yvette, France; Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Charnoz, S (corresponding author), Univ Paris 07, CEA Saclay, SAp, DAPNIA,DSM,CNRS, F-91191 Gif Sur Yvette, France.	charnoz@cea.fr		Deau, Estelle/0000-0002-1041-0156				Bosh AS, 2002, ICARUS, V157, P57, DOI 10.1006/icar.2002.6791; Burns JA, 2001, ASTR AST LI, P641; DERMOTT SF, 1981, NATURE, V290, P454, DOI 10.1038/290454a0; HAMILTON DP, 1993, NATURE, V365, P498, DOI 10.1038/365498c0; HANNINEN J, 1993, ICARUS, V103, P104, DOI 10.1006/icar.1993.1061; KOLVOORD RA, 1990, NATURE, V345, P695, DOI 10.1038/345695a0; Lewis MC, 2000, ASTRON J, V120, P3295, DOI 10.1086/316853; Murray CD, 1996, NATURE, V380, P139, DOI 10.1038/380139a0; Murray CD, 2005, NATURE, V437, P1326, DOI 10.1038/nature04212; Murray CD, 1997, ICARUS, V129, P304, DOI 10.1006/icar.1997.5774; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; PORCO CC, 2004, 8432 IAU, P1; Poulet F, 2000, ICARUS, V144, P135, DOI 10.1006/icar.1999.6267; SHOWALTER MR, 1992, ICARUS, V100, P394, DOI 10.1016/0019-1035(92)90107-I; Showalter MR, 2004, ICARUS, V171, P356, DOI 10.1016/j.icarus.2004.05.006; Showalter MR, 1998, SCIENCE, V282, P1099, DOI 10.1126/science.282.5391.1099; SHOWALTER MR, 1982, ICARUS, V52, P526, DOI 10.1016/0019-1035(82)90013-6; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; SPITALE JN, UNPUB	20	44	44	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1300	1304		10.1126/science.1119387	http://dx.doi.org/10.1126/science.1119387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311328				2022-12-28	WOS:000233600200033
J	Pihlstrom, BL; Michalowicz, BS; Johnson, NW				Pihlstrom, BL; Michalowicz, BS; Johnson, NW			Periodontal diseases	LANCET			English	Review							CORONARY-HEART-DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; C-REACTIVE PROTEIN; LOW-BIRTH-WEIGHT; PAPILLON-LEFEVRE-SYNDROME; BONE-MINERAL DENSITY; PORPHYROMONAS-GINGIVALIS; ORAL MANIFESTATIONS; PRETERM BIRTH; CIGARETTE-SMOKING	The periodontal diseases are highly prevalent and can affect up to 90% of the worldwide population. Gingivitis, the mildest form of periodontal disease, is caused by the bacterial biofilm (dental plaque) that accumulates on teeth adjacent to the gingiva (gums). However, gingivitis does not affect the underlying supporting structures of the teeth and is reversible. Periodontitis results in loss of connective tissue and bone support and is a major cause of tooth loss in adults. In addition to pathogenic microorganisms in the biofilm, genetic and environmental factors, especially tobacco use, contribute to the cause of these diseases. Genetic, dermatological, haematological, granulomatous, immunosuppressive, and neoplastic disorders can also have periodontal manifestations. Common forms of periodontal disease have been associated with adverse pregnancy outcomes, cardiovascular disease, stroke, pulmonary disease, and diabetes, but the causal relations have not been established. Prevention and treatment are aimed at controlling the bacterial biofilm and other risk factors, arresting progressive disease, and restoring lost tooth support.	Natl Inst Dent & Craniofacial Res, Clin Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Minnesota, Sch Dent, Div Periodontol, Minneapolis, MN 55455 USA; Griffith Univ, Sch Dent & Oral Hlth, Southport, Qld, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Minnesota System; University of Minnesota Twin Cities; Griffith University	Pihlstrom, BL (corresponding author), Natl Inst Dent & Craniofacial Res, Clin Res Ctr, NIH, Bethesda, MD 20892 USA.	bruce.pihlstrom@nih.gov	Johnson, Newell W/D-8152-2019	Johnson, Newell W/0000-0001-5866-262X				AINAMO J, 1982, INT DENT J, V32, P281; Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; ALDRIDGE JP, 1995, J CLIN PERIODONTOL, V22, P271, DOI 10.1111/j.1600-051X.1995.tb00147.x; [Anonymous], 2004, J PERIODONTOL, V75, P1553; [Anonymous], 2000, J Periodontol, V71 Suppl 5S, P859, DOI 10.1902/jop.2000.71.5-S.859; Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Arendorf TM, 1998, J ORAL PATHOL MED, V27, P176; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Armitage GC, 2004, PERIODONTOL 2000, V34, P22, DOI 10.1046/j.0906-6713.2002.003422.x; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P239, DOI 10.1111/j.1600-051X.1981.tb02035.x; Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Beck JD, 2005, CIRCULATION, V112, P19, DOI 10.1161/CIRCULATIONAHA.104.511998; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; BECK JD, 2005, ATHEROSCLEROSIS 0510, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.03.017; Bergstrom Jan, 2004, Odontology, V92, P1; Butt F M, 2001, East Afr Med J, V78, P398; Cairo F, 2004, J PERIODONTAL RES, V39, P442, DOI 10.1111/j.1600-0765.2004.00761.x; Chai-U-Dom O, 2002, J PERIODONTAL RES, V37, P147, DOI 10.1034/j.1600-0765.2002.00032.x; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; CHRISTEN AG, 1979, J AM DENT ASSOC, V98, P584, DOI 10.14219/jada.archive.1979.0100; Christodoulides N, 2005, LAB CHIP, V5, P261, DOI 10.1039/b414194f; Cobb C M, 1996, Ann Periodontol, V1, P443, DOI 10.1902/annals.1996.1.1.443; Cobb CM, 2002, J CLIN PERIODONTOL, V29, P6; COREY LA, 1993, J PERIODONTOL, V64, P1205, DOI 10.1902/jop.1993.64.12.1205; Cueto A, 2005, J PERIODONTAL RES, V40, P36, DOI 10.1111/j.1600-0765.2004.00766.x; CURTIS MA, 1993, FEMS MICROBIOL LETT, V110, P167, DOI 10.1016/0378-1097(93)90461-A; D'Aiuto F, 2005, ATHEROSCLEROSIS, V179, P413, DOI 10.1016/j.atherosclerosis.2004.10.036; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, CYTOKINE, V28, P29, DOI 10.1016/j.cyto.2004.06.005; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Dasanayake A P, 1998, Ann Periodontol, V3, P206, DOI 10.1902/annals.1998.3.1.206; DASILVA AMM, 1995, J CLIN PERIODONTOL, V22, P516; Davenport ES, 2002, J DENT RES, V81, P313, DOI 10.1177/154405910208100505; DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dongari-Bagtzoglou A, 2004, J PERIODONTOL, V75, P1424; Drisko CH, 2001, PERIODONTOL 2000, V25, P77, DOI 10.1034/j.1600-0757.2001.22250106.x; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Eley BM, 1998, BRIT DENT J, V184, P373, DOI 10.1038/sj.bdj.4809636; Ellis JS, 1999, J PERIODONTOL, V70, P63, DOI 10.1902/jop.1999.70.1.63; Engebretson SP, 2005, STROKE, V36, P561, DOI 10.1161/01.STR.0000155734.34652.6c; Enwonwu CO, 2000, CRIT REV ORAL BIOL M, V11, P159, DOI 10.1177/10454411000110020201; Fine DH, 2002, J PERIODONTOL, V73, P624, DOI 10.1902/jop.2002.73.6.624; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71; Genco RJ, 1999, J PERIODONTOL, V70, P711, DOI 10.1902/jop.1999.70.7.711; Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153; GLICK M, 1994, ORAL SURG ORAL MED O, V77, P344, DOI 10.1016/0030-4220(94)90195-3; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696; Greenstein G, 2002, J PERIODONTOL, V73, P231, DOI 10.1902/jop.2002.73.2.231; Grossi SG, 1997, J PERIODONTOL, V68, P713, DOI 10.1902/jop.1997.68.8.713; Grossi SG, 1997, J AM DENT ASSOC, V128, P599, DOI 10.14219/jada.archive.1997.0259; Gustke CJ, 1998, J DENT RES, V77, P1497, DOI 10.1177/00220345980770070401; HAFFAJEE AD, 1991, J CLIN PERIODONTOL, V18, P117, DOI 10.1111/j.1600-051X.1991.tb01700.x; Haffajee AD, 2004, J CLIN PERIODONTOL, V31, P996, DOI 10.1111/j.1600-051X.2004.00597.x; HAFFAJEE AD, 1983, J CLIN PERIODONTOL, V10, P298, DOI 10.1111/j.1600-051X.1983.tb01278.x; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Hanes Philip J, 2003, Ann Periodontol, V8, P79, DOI 10.1902/annals.2003.8.1.79; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hart TC, 1999, J MED GENET, V36, P881; Hart TC, 2000, J MED GENET, V37, P88, DOI 10.1136/jmg.37.2.88; Hewitt C, 2004, HUM MUTAT, V23, P222, DOI 10.1002/humu.10314; Howell TH, 2001, J AM COLL CARDIOL, V37, P445, DOI 10.1016/S0735-1097(00)01130-X; Hugoson A, 2002, J CLIN PERIODONTOL, V29, P247, DOI 10.1034/j.1600-051x.2002.290311.x; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Hujoel PP, 2003, COMMUNITY DENT ORAL, V31, P1, DOI 10.1034/j.1600-0528.2003.00061.x; Hujoel PP, 2001, J AM DENT ASSOC, V132, P883, DOI 10.14219/jada.archive.2001.0300; Hung HC, 2002, J CLIN PERIODONTOL, V29, P975, DOI 10.1034/j.1600-051X.2002.291102.x; Ilgenli T, 1999, J PERIODONTOL, V70, P967, DOI 10.1902/jop.1999.70.9.967; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; JEFFCOAT MK, 1995, PERIODONTOL 2000, V7, P54, DOI 10.1111/j.1600-0757.1995.tb00036.x; Jeffcoat MK, 2003, J PERIODONTOL, V74, P1214, DOI 10.1902/jop.2003.74.8.1214; Jeffcoat MK, 2001, J AM DENT ASSOC, V132, P875, DOI 10.14219/jada.archive.2001.0299; Johnson G K, 2001, J Dent Educ, V65, P313; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Jordan RCK, 2004, PERIODONTOL 2000, V34, P217, DOI 10.1046/j.0906-6713.2002.003433.x; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; JOSS A, 1994, J CLIN PERIODONTOL, V21, P402, DOI 10.1111/j.1600-051X.1994.tb00737.x; Kaldahl WB, 1996, J PERIODONTOL, V67, P675, DOI 10.1902/jop.1996.67.7.675; KARJALAINEN KM, 1994, J PERIODONTOL, V65, P1067, DOI 10.1902/jop.1994.65.11.1067; Kinane DF, 2003, CRIT REV ORAL BIOL M, V14, P430, DOI 10.1177/154411130301400605; Kiran M, 2005, J CLIN PERIODONTOL, V32, P266, DOI 10.1111/j.1600-051X.2005.00658.x; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x; Kuramitsu H K, 2001, Ann Periodontol, V6, P41, DOI 10.1902/annals.2001.6.1.41; Labriola A, 2005, PERIODONTOL 2000, V37, P124, DOI 10.1111/j.1600-0757.2004.03793.x; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; LANG NP, 1973, J PERIODONTOL, V44, P396, DOI 10.1902/jop.1973.44.7.396; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; LeResche L, 2002, PERIODONTOL 2000, V30, P91, DOI 10.1034/j.1600-0757.2002.03009.x; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Lim AAT, 2001, ANN ACAD MED SINGAP, V30, P600; LINDHE J, 1983, J CLIN PERIODONTOL, V10, P590, DOI 10.1111/j.1600-051X.1983.tb01297.x; LINDHE J, 1983, J CLIN PERIODONTOL, V10, P100, DOI 10.1111/j.1600-051X.1983.tb01271.x; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Listgarten Max A, 2003, Ann Periodontol, V8, P182, DOI 10.1902/annals.2003.8.1.182; LOE H, 1978, J PERIODONTOL, V49, P607, DOI 10.1902/jop.1978.49.12.607; LOE H, 1986, J CLIN PERIODONTOL, V13, P431, DOI 10.1111/j.1600-051X.1986.tb01487.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911; Lopez NJ, 2002, J DENT RES, V81, P58, DOI 10.1177/154405910208100113; Lopez NJ, 2000, J PERIODONTOL, V71, P79, DOI 10.1902/jop.2000.71.1.79; Majola MP, 2000, J CLIN PERIODONTOL, V27, P506, DOI 10.1034/j.1600-051x.2000.027007506.x; MANDEL ID, 1994, J AM DENT ASSOC, V125, pS2, DOI 10.1016/S0002-8177(94)14001-X; MANDELL RL, 1981, J PERIODONTOL, V52, P593, DOI 10.1902/jop.1981.52.10.593; Marshall RI, 1999, AUST DENT J, V44, P219, DOI 10.1111/j.1834-7819.1999.tb00224.x; MCDONALD H, 1988, PATHOLOGY, V20, P74, DOI 10.3109/00313028809085203; MICHALOWICZ BS, 1991, J PERIODONTOL, V62, P293, DOI 10.1902/jop.1991.62.5.293; Michalowicz BS, 2000, J PERIODONTOL, V71, P981, DOI 10.1902/jop.2000.71.6.981; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; MICHALOWICZ BS, 1991, J DENT RES, V70, P1431, DOI 10.1177/00220345910700110701; Mitchell-Lewis D, 2001, EUR J ORAL SCI, V109, P34, DOI 10.1034/j.1600-0722.2001.00966.x; MODEER T, 1980, ACTA ODONTOL SCAND, V38, P223, DOI 10.3109/00016358009003493; Mol A, 2004, PERIODONTOL 2000, V34, P34, DOI 10.1046/j.0906-6713.2003.003423.x; Moore S, 2004, BRIT DENT J, V197, P251, DOI 10.1038/sj.bdj.4811620; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Mulligan R, 2004, COMMUNITY DENT ORAL, V32, P86, DOI 10.1111/j.0301-5661.2004.00128.x; NEWMAN MG, 1976, J PERIODONTOL, V47, P373, DOI 10.1902/jop.1976.47.7.373; Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8; Pihlstrom BL, 2001, PERIODONTOL 2000, V25, P37, DOI 10.1034/j.1600-0757.2001.22250104.x; PIHLSTROM BL, 1980, J PERIODONTOL, V51, P311, DOI 10.1902/jop.1980.51.6.311; PIHLSTROM BL, 1992, J PERIODONTOL, V63, P1072, DOI 10.1902/jop.1992.63.12s.1072; PREBER H, 1990, J CLIN PERIODONTOL, V17, P324, DOI 10.1111/j.1600-051X.1990.tb01098.x; PREBER H, 1986, J CLIN PERIODONTOL, V13, P319, DOI 10.1111/j.1600-051X.1986.tb02229.x; Preshaw Philip M, 2004, Dent Update, V31, P570; Preshaw PM, 2004, J PERIODONTOL, V75, P1068, DOI 10.1902/jop.2004.75.8.1068; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Ramberg P, 2003, J CLIN PERIODONTOL, V30, P990, DOI 10.1034/j.1600-051X.2003.00419.x; Ramirez-Amador V, 2003, MEDICINE, V82, P39, DOI 10.1097/00005792-200301000-00004; Reddy LV, 1997, MOL DIAGN, V2, P113, DOI 10.1016/S1084-8592(97)80017-3; Reddy MS, 1999, PERIODONTOL 2000, V19, P87, DOI 10.1111/j.1600-0757.1999.tb00149.x; Reich E, 2002, INT DENT J, V52, P346, DOI 10.1002/j.1875-595X.2002.tb00882.x; Renvert S, 2004, PERIODONTOL 2000, V36, P179, DOI 10.1111/j.1600-0757.2004.03680.x; ROBERTSON PB, 1990, J PERIODONTOL, V61, P438, DOI 10.1902/jop.1990.61.7.438; Robinson PC, 2002, ORAL DIS, V8, P144, DOI 10.1034/j.1601-0825.8.s2.5.x; Robinson PG, 2002, ORAL DIS, V8, P91, DOI 10.1034/j.1601-0825.2002.00019.x; Rodrigues DC, 2003, J PERIODONTOL, V74, P1361, DOI 10.1902/jop.2003.74.9.1361; Ronderos M, 2001, J CLIN PERIODONTOL, V28, P995, DOI 10.1034/j.1600-051X.2001.281102.x; Ronderos M, 2000, J CLIN PERIODONTOL, V27, P778, DOI 10.1034/j.1600-051x.2000.027010778.x; Rosling B, 1997, J CLIN PERIODONTOL, V24, P873, DOI 10.1111/j.1600-051X.1997.tb01205.x; Salvi GE, 1997, J CLIN PERIODONTOL, V24, P8, DOI 10.1111/j.1600-051X.1997.tb01178.x; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; Saremi A, 2005, DIABETES CARE, V28, P27, DOI 10.2337/diacare.28.1.27; Scabbia A, 2001, J PERIODONTOL, V72, P43, DOI 10.1902/jop.2001.72.1.43; SCANNAPIECO FA, 1992, CRIT CARE MED, V20, P740, DOI 10.1097/00003246-199206000-00007; Scannapieco Frank A, 2003, Dent Today, V22, P79; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Scheutz F, 1997, J CLIN PERIODONTOL, V24, P580, DOI 10.1111/j.1600-051X.1997.tb00232.x; Skaleric Uros, 2004, J Int Acad Periodontol, V6, P160; Slots Jorgen, 2004, J Int Acad Periodontol, V6, P113; Socransky S S, 1994, Periodontol 2000, V5, P7, DOI 10.1111/j.1600-0757.1994.tb00016.x; Socransky SS, 2002, J CLIN PERIODONTOL, V29, P260, DOI 10.1034/j.1600-051x.2002.290313.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 2003, CLIN PERIODONTOLOGY; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Sreenivasan P, 2002, J CLIN PERIODONTOL, V29, P965, DOI 10.1034/j.1600-051X.2002.291101.x; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; STOLTENBERG JL, 1993, J PERIODONTOL, V64, P853, DOI 10.1902/jop.1993.64.9.853; Suvan JE, 2005, PERIODONTOL 2000, V37, P48, DOI 10.1111/j.1600-0757.2004.03794.x; Tabak L A, 2001, J Dent Educ, V65, P1335; Tanner A, 1996, J PERIODONTAL RES, V31, P195, DOI 10.1111/j.1600-0765.1996.tb00484.x; Tanner A, 1998, J CLIN PERIODONTOL, V25, P85, DOI 10.1111/j.1600-051X.1998.tb02414.x; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; TERVONEN T, 1993, J CLIN PERIODONTOL, V20, P431, DOI 10.1111/j.1600-051X.1993.tb00384.x; Tezal M, 2004, J CLIN PERIODONTOL, V31, P484, DOI 10.1111/j.1600-051X.2004.00503.x; THORSTENSSON H, 1995, J CLIN PERIODONTOL, V22, P449, DOI 10.1111/j.1600-051X.1995.tb00176.x; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Trombelli L, 2003, J CLIN PERIODONTOL, V30, P81, DOI 10.1034/j.1600-051X.2003.10182.x; Van Dyke Thomas E, 2005, J Int Acad Periodontol, V7, P3; van Palenstein Helderman W H, 1996, Int Dent J, V46, P76; VANDERVELDEN U, 1986, J CLIN PERIODONTOL, V13, P894; VANDERVELDEN U, 1985, J CLIN PERIODONTOL, V12, P61; vonTroilLinden B, 1997, J CLIN PERIODONTOL, V24, P893; Walker CB, 2004, PERIODONTOL 2000, V36, P146, DOI 10.1111/j.1600-0757.2004.03677.x; Watt RG, 2005, PERIODONTOL 2000, V37, P35, DOI 10.1111/j.1600-0757.2004.03796.x; World Health Organization, 2003, WORLD OR HLTH REP 20; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yamazaki K, 2003, HISTOL HISTOPATHOL, V18, P889, DOI 10.14670/HH-18.889; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Yoshihara A, 2004, J CLIN PERIODONTOL, V31, P680, DOI 10.1111/j.1600-051X.2004.00548.x	197	2418	2532	30	702	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1809	1820		10.1016/S0140-6736(05)67728-8	http://dx.doi.org/10.1016/S0140-6736(05)67728-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298220	Green Submitted			2022-12-28	WOS:000233517200027
J	Anderson, PW; Brinkman, WF; Huse, DA				Anderson, PW; Brinkman, WF; Huse, DA			Thermodynamics of an incommensurate quantum crystal	SCIENCE			English	Article							THERMAL VACANCIES; HE-4; HELIUM; PHASE; BCC	We present a theory of the thermodynamics of an incommensurate quantum solid. The ground state of the solid is assumed to. be an incommensurate crystal, with quantum zero-point vacancies and interstitials and thus a non-integer number of atoms per unit cell. We show that at low temperature T, the variation of the net vacancy concentration should be as T-4 and that the first correction to the specific heat due to this varies as T-7; these are quite consistent with experiments on solid helium-4. We also make some observations about the recent experimental reports of "supersolidity" in solid helium-4 that motivate a renewed interest in quantum crystals.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University	Huse, DA (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	huse@princeton.edu						ANDERSON PW, 2005, CONDMAT0504731; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; BISHOP DJ, 1978, PHYS REV LETT, V40, P1727, DOI 10.1103/PhysRevLett.40.1727; BURNS CA, 1994, J LOW TEMP PHYS, V95, P695, DOI 10.1007/BF00754711; Ceperley DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155303; Chaudhuri B, 1999, PHYS REV B, V60, P3271, DOI 10.1103/PhysRevB.60.3271; FRAASS BA, 1989, PHYS REV B, V39, P124, DOI 10.1103/PhysRevB.39.124; GALLI DE, PHYS REV B, V71; GARDNER WR, 1973, PHYS REV A, V7, P1029, DOI 10.1103/PhysRevA.7.1029; GREYWALL DS, 1977, PHYS REV B, V15, P2604, DOI 10.1103/PhysRevB.15.2604; HEALD SM, 1984, PHYS REV B, V30, P2531, DOI 10.1103/PhysRevB.30.2531; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; SIMMONS RO, 2005, COMMUNICATION	14	60	61	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1164	1166		10.1126/science.1118625	http://dx.doi.org/10.1126/science.1118625			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293755	Green Submitted			2022-12-28	WOS:000233437300039
J	Coker, R; McKee, M; Atun, R; Dimitrova, B; Dodonova, E; Kuznetsov, S; Drobniewski, F				Coker, R; McKee, M; Atun, R; Dimitrova, B; Dodonova, E; Kuznetsov, S; Drobniewski, F			Risk factors for pulmonary tuberculosis in Russia: case-control study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine risk factors for pulmonary tuberculosis in Russia. Design Case-control study of exposure to a variety of risk factors before and during the development of pulmonary tuberculosis. Setting Large city in Russia. Participants Cases were 334 consecutive adults diagnosed as having culture confirmed pulmonary tuberculosis between I January 2003 and 31 December 2003. Controls were 334 individuals sampled from a validated population registry, matched for age and sex to the patients with tuberculosis. A questionnaire collected information on potential risk factors. Main outcome measures Risk factors associated with the development of tuberculosis. Results The main risk factors for tuberculosis were low accumulated wealth (univariate odds ratio 16.70), financial insecurity (5.67), consumption of unpasteuriscd milk (3.58), diabetes (2.66), living with a relative with tuberculosis (2.94), being unemployed (6.10), living in overcrowded conditions (2.99), illicit drug use (8.74), and a history of incarceration in both pretrial detention centres (5.70) and prison (12.50). Conclusions When prevalence of exposure is taken into account the most important factors in the development of pulmonary tuberculosis in Russia are exposure to raw milk and unemployment.	Univ London London Sch Hyg Trop Med, Dept Publ Hlth Policy, European Ctr Hlth Societies Transit, London WC1E 7HT, England; Univ London Imperial Coll Sci & Technol, Tanaka Business Sch, London, England; Samara Social Res Inst, Samara, Russia; Samara Oblast Hlth Dept, Dept Adult Healthcare, Samara, Russia; Queen Marys Sch Med, Inst Cell & Mol Sci, Mycobacterium Reference Unit, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; Queen Mary University London	Coker, R (corresponding author), Univ London London Sch Hyg Trop Med, Dept Publ Hlth Policy, European Ctr Hlth Societies Transit, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Atun, Rifat/AAH-5537-2021; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683; Atun, Rifat/0000-0002-1531-5983				Drobniewski FA, 2004, INT J STD AIDS, V15, P641, DOI 10.1258/0956462041944303; *FAO UN, 1999, MILK PROD PROC, V7; FARMER P, 1999, GLOBAL IMPACT DRUG R; STERN V, 1999, SENTENCED DUE PROBLE; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; TULUPOV VP, 1989, GIG SANIT, V12, P68	6	120	124	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					85	87		10.1136/bmj.38684.687940.80	http://dx.doi.org/10.1136/bmj.38684.687940.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16339219	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000234777000019
J	Jespersen, CM				Jespersen, CM		CLARICOR Trial Grp	Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial	BRITISH MEDICAL JOURNAL			English	Article							CHLAMYDIA-PNEUMONIAE; SECONDARY PREVENTION; ARTERY-DISEASE; EVENTS; AZITHROMYCIN; ANTIBIOTICS; ATHEROSCLEROSIS; ROXITHROMYCIN; ERADICATION; HYPOTHESIS	Objective To determine if the macrolide clarithromycin affects mortality and cardiovascular morbidity in patients with stable coronary heart disease. Design Centrally randomised multicentre trial. All parties at all stages were blinded. Analyses were by intention to treat. Setting Five Copenhagen University cardiology departments and a coordinating centre. Participants 13 702 patients aged 18 to 85 years who had a discharge diagnosis of myocardial infarction or angina pectoris in 1993-9 and alive in August 1999 were invited by letter; 4373 were randomised. Interventions Two weeks' treatment with clarithromycin 500 mg/day or matching placebo. Main outcome measures Primary outcome: composite of all cause mortality, myocardial infarction, or unstable angina pectoris during three years' follow-up. Secondary outcome: composite of cardiovascular mortality, myocardial infarction, or unstable angina pectoris. The outcomes were obtained from Danish registers and were blindly assessed by the event committee. Results 2172 participants were randomised to clarithromycin and 2201 to placebo. We found no significant effects of clarithromycin on the primary outcome (hazard ratio 1.15, 95% confidence interval 0.99 to 1.34) or secondary outcome (1.17, 0.98 to 1.40). Mortality was significantly higher in the clarithromycin arm (1.27, 1.03 to 1.54; P = 0.03) as a result of significantly higher cardiovascular mortality (1.45, 1.09 to 1.92; P = 0.01). Conclusions Short term clarithromycin in patients with stable coronary heart disease may cause significantly higher cardiovascular mortality. The long term safety of clarithromycin in patients with stable ischaemic heart disease should be examined. Trial registration ClinicalTrials.gov NCTOO 121550.	Copenhagen Univ Hosp, Dept Cardiol Y, Bispebjerg Hosp, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Jespersen, CM (corresponding author), Copenhagen Univ Hosp, Dept Cardiol Y, Bispebjerg Hosp, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	cmj01@bbh.hosp.dk	Gluud, Christian/AAY-1027-2021	Gluud, Christian/0000-0002-8861-0799				Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Berg HF, 2005, CLIN INFECT DIS, V40, P358, DOI 10.1086/427111; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Danesh J, 2005, LANCET, V365, P365; Gelfand EV, 2004, AM HEART J, V147, P202, DOI 10.1016/j.ahj.2003.09.011; Gieffers J, 2001, CARDIOVASC DRUG THER, V15, P259, DOI 10.1023/A:1011972424529; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hansen Stig, 2001, HeartDrug, V1, P14, DOI 10.1159/000022705; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Martin D, 1998, LANCET, V351, P1858, DOI 10.1016/S0140-6736(05)78804-8; Melissano G, 1999, EUR J VASC ENDOVASC, V18, P355, DOI 10.1053/ejvs.1999.0915; Muhlestein JB, 2003, CIRCULATION, V107, P220, DOI 10.1161/01.CIR.0000043909.78380.A0; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Sinisalo J, 2002, CIRCULATION, V105, P1555, DOI 10.1161/01.CIR.0000012544.07696.1F; Taylor-Robinson D, 2005, BMJ-BRIT MED J, V331, P361, DOI 10.1136/bmj.331.7513.361	20	119	121	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					22	24		10.1136/bmj.38666.653600.55	http://dx.doi.org/10.1136/bmj.38666.653600.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16339220	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000234684200016
J	Lovel, HJ; Newby, RM; Hillier, VF				Lovel, HJ; Newby, RM; Hillier, VF			Severe placental malaria and maternal shortness, thinness, and small skeletal size in rural Congo: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Manchester, WHO Collaborating Ctr Primary Care, Sch Primary Care, Eusholme Hlth Ctr, Manchester M14 5NP, Lancs, England; DR Congo Kasaji Hosp, Kasaji, DEM REP CONGO; Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Lovel, HJ (corresponding author), Univ Manchester, WHO Collaborating Ctr Primary Care, Sch Primary Care, Eusholme Hlth Ctr, Manchester M14 5NP, Lancs, England.	hlovel04@yahoo.co.uk						MATTEELLI A, 1994, ANN TROP MED PARASIT, V88, P475, DOI 10.1080/00034983.1994.11812894; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Moore SE, 1998, P NUTR SOC, V57, P241, DOI 10.1079/PNS19980038; NEWBY RM, 2000, THESIS U MANCHESTER; REINHARDT MC, 1978, HELV PAEDIATR ACTA, P65	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1439	1440		10.1136/bmj.331.7530.1439	http://dx.doi.org/10.1136/bmj.331.7530.1439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356980	Green Published, Bronze			2022-12-28	WOS:000234156400021
J	Casas, JP; Chua, WL; Loukogeorgakis, S; Vallance, P; Smeeth, L; Hingorani, AD; MacAllister, RJ				Casas, JP; Chua, WL; Loukogeorgakis, S; Vallance, P; Smeeth, L; Hingorani, AD; MacAllister, RJ			Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis	LANCET			English	Article							CONVERTING ENZYME-INHIBITORS; BLOOD-PRESSURE; DISEASE; NEPHROPATHY; PROGRESSION; MAGNESIUM; EVENTS; RISK	Background A consensus has emerged that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) have specific renoprotective effects. Guidelines specify that these are the drugs of choice for the treatment of hypertension in patients with renal disease. We sought to determine to what extent this consensus is supported by the available evidence. Methods Electronic databases were searched up to January, 2005, for randomised trials assessing antihypertensive drugs and progression of renal disease. Effects on primary discrete endpoints (doubling of creatinine and end-stage renal disease) and secondary continuous markers of renal outcomes (creatinine, albuminuria, and glomerular filtration rate) were calculated with random-effect models. The effects of ACE inhibitors or ARBs in placebo-controlled trials were compared with the effects seen in trials that used an active comparator drug. Findings Comparisons of ACE inhibitors or ARBs with other antihypertensive drugs yielded a relative risk of 0.71 (95% CI 0.49-1.04) for doubling of creatinine and a small benefit on end-stage renal disease (relative risk 0.87, 0.75-0.99). Analyses of the results by study size showed a smaller benefit in large studies. In patients with diabetic nephropathy, no benefit was seen in comparative trials of ACE inhibitors or ARBs on the doubling of creatinine (1.09, 0.55-2.15), end-stage renal disease (0.89, 0.74-1.07), glomerular filtration rate, or creatinine amounts. Placebo-controlled trials of ACE inhibitors or ARBs showed greater benefits than comparative trials on all renal outcomes, but were accompanied by substantial reductions in blood pressure in favour of ACE inhibitors or ARBs. Interpretation The benefits of ACE inhibitors or ARBs on renal outcomes in placebo-controlled trials probably result from a blood-pressure-lowering effect. In patients with diabetes, additional renoprotective actions of these substances beyond lowering blood pressure remain unproven, and there is uncertainty about the greater renoprotection seen in non-diabetic renal disease.	UCL, BHF Labs, Dept Med, Ctr Clin Pharmacol, London WC1E 6JF, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Casas, JP (corresponding author), UCL, BHF Labs, Dept Med, Ctr Clin Pharmacol, London WC1E 6JF, England.	juan.pablo-casas@lsthm.ac.uk	; Smeeth, Liam/X-5862-2018	Hingorani, Aroon/0000-0001-8365-0081; Smeeth, Liam/0000-0002-9168-6022	MRC [G108/492] Funding Source: UKRI; Medical Research Council [G108/492] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Altman DG, 1991, PRACTICAL STAT MED R; [Anonymous], 2005, DIABETES CARE, V28, pS4; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1995, LANCET, V345, P669; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DEEKS JJ, 2004, COCHRANE REV HDB, V422; EGGER M, 1995, BMJ-BRIT MED J, V310, P752, DOI 10.1136/bmj.310.6982.752; Fox KM, 2003, LANCET, V362, P782; Gerstein HC, 2000, LANCET, V355, P253; Giatras I, 1997, ANN INTERN MED, V127, P337, DOI 10.7326/0003-4819-127-5-199709010-00001; He J, 1999, AM HEART J, V138, pS211, DOI 10.1016/S0002-8703(99)70312-1; *HOPE STUD INV, 2000, NEW ENGL J MED, V342, P165; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Law M, 2003, Health Technol Assess, V7, P1; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; *LOND ROYAL COLL P, 2002, REN ASS TREATM AD CH; McIntosh AHA, 2002, CLIN GUIDELINES EVID; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Strippoli GFM, 2004, BMJ-BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; TEO KK, 1991, BMJ-BRIT MED J, V303, P1499, DOI 10.1136/bmj.303.6816.1499; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turnbull F, 2003, LANCET, V362, P1527; Voyaki SM, 2001, J HYPERTENS, V19, P511, DOI 10.1097/00004872-200103000-00020; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; YUSUF S, 1995, BRIT MED J, V310, P751, DOI 10.1136/bmj.310.6982.751	33	507	531	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2026	2033		10.1016/S0140-6736(05)67814-2	http://dx.doi.org/10.1016/S0140-6736(05)67814-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338452				2022-12-28	WOS:000233826900022
J	Chrzan, DC				Chrzan, DC			Metallurgy in the age of silicon	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Chrzan, DC (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	dcchrzan@berkeley.edu						Frenkel J, 1926, Z PHYS, V37, P572, DOI 10.1007/BF01397292; Hirth IP, 1992, THEORY DISLOCATIONS; Lund JR, 2001, CIV ENG ENVIRON SYST, V18, P243, DOI 10.1080/02630250108970302; PATEL JR, 1966, PHYS REV, V143, P601, DOI 10.1103/PhysRev.143.601; PINK E, 1979, PROG MATER SCI, V24, P1, DOI 10.1016/0079-6425(79)90010-0; Trinkle DR, 2005, SCIENCE, V310, P1665, DOI 10.1126/science.1118616	6	6	6	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1623	1624		10.1126/science.1121019	http://dx.doi.org/10.1126/science.1121019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339433				2022-12-28	WOS:000233961700028
J	Davidson, G; Wu, W; Shen, JL; Bilic, J; Fenger, U; Stannek, P; Glinka, A; Niehrs, C				Davidson, G; Wu, W; Shen, JL; Bilic, J; Fenger, U; Stannek, P; Glinka, A; Niehrs, C			Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction	NATURE			English	Article							PROTEIN-5; MECHANISM; PATHWAY	Signalling by Wnt proteins ( Wingless in Drosophila) has diverse roles during embryonic development and in adults, and is implicated in human diseases, including cancer(1,2). LDL-receptor-related proteins 5 and 6 (LRP5 and LRP6; Arrow in Drosophila) are key receptors required for transmission of Wnt/beta-catenin signalling in metazoa(3). Although the role of these receptors in Wnt signalling is well established, their coupling with the cytoplasmic signalling apparatus remains poorly defined. Using a protein modification screen for regulators of LRP6, we describe the identification of Xenopus Casein kinase 1 gamma (CK1 gamma), a membrane-bound member of the CK1 family. Gain-of-function and loss-of-function experiments show that CK1 gamma is both necessary and sufficient to transduce LRP6 signalling in vertebrates and Drosophila cells. In Xenopus embryos, CK1 gamma is required during anterio-posterior patterning to promote posteriorizing Wnt/beta-catenin signalling. CK1 gamma is associated with LRP6, which has multiple, modular CK1 phosphorylation sites. Wnt treatment induces the rapid CK1 gamma-mediated phosphorylation of these sites within LRP6, which, in turn, promotes the recruitment of the scaffold protein Axin. Our results reveal an evolutionarily conserved mechanism that couples Wnt receptor activation to the cytoplasmic signal transduction apparatus.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.davidson@dkfz-heidelberg.de; Niehrs@dkfz-heidelberg.de	Davidson, Gary/AAA-7321-2021; Shen, Jinlong/D-5389-2009; Davidson, Gary/J-6059-2013	Davidson, Gary/0000-0002-2264-5518; Bilic Zimmermann, Josipa/0000-0001-9642-6265				Belanger C, 2001, FEBS LETT, V499, P59, DOI 10.1016/S0014-5793(01)02513-3; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dosch R, 1997, DEVELOPMENT, V124, P2325; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Shibamoto S, 1998, GENES CELLS, V3, P659; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717	23	437	485	2	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					867	872		10.1038/nature04170	http://dx.doi.org/10.1038/nature04170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341016				2022-12-28	WOS:000233777800054
J	Zarnecki, JC; Leese, MR; Hathi, B; Ball, AJ; Hagermann, A; Towner, MC; Lorenz, RD; McDonnell, JAM; Green, SF; Patel, MR; Ringrose, TJ; Rosenberg, PD; Atkinson, KR; Paton, MD; Banaszkiewicz, M; Clark, BC; Ferri, F; Fulchignoni, M; Ghafoor, NAL; Kargl, G; Svedhem, H; Delderfield, J; Grande, M; Parker, DJ; Challenor, PG; Geake, JE				Zarnecki, JC; Leese, MR; Hathi, B; Ball, AJ; Hagermann, A; Towner, MC; Lorenz, RD; McDonnell, JAM; Green, SF; Patel, MR; Ringrose, TJ; Rosenberg, PD; Atkinson, KR; Paton, MD; Banaszkiewicz, M; Clark, BC; Ferri, F; Fulchignoni, M; Ghafoor, NAL; Kargl, G; Svedhem, H; Delderfield, J; Grande, M; Parker, DJ; Challenor, PG; Geake, JE			A soft solid surface on Titan as revealed by the Huygens Surface Science Package	NATURE			English	Article							CASSINI; IMPACT; SPACECRAFT; PROBE	The surface of Saturn's largest satellite - Titan - is largely obscured by an optically thick atmospheric haze, and so its nature has been the subject of considerable speculation and discussion(1). The Huygens probe entered Titan's atmosphere on 14 January 2005 and descended to the surface using a parachute system(2). Here we report measurements made just above and on the surface of Titan by the Huygens Surface Science Package(3,4). Acoustic sounding over the last 90 m above the surface reveals a relatively smooth, but not completely flat, surface surrounding the landing site. Penetrometry and accelerometry measurements during the probe impact event reveal that the surface was neither hard ( like solid ice) nor very compressible ( like a blanket of fluffy aerosol); rather, the Huygens probe landed on a relatively soft solid surface whose properties are analogous to wet clay, lightly packed snow and wet or dry sand. The probe settled gradually by a few millimetres after landing.	Open Univ, Milton Keynes MK7 6AA, Bucks, England; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Polish Acad Sci, PL-00716 Warsaw, Poland; Lockheed Martin Astronaut, Denver, CO 80201 USA; Univ Padua, CISAS G Colombo, I-35131 Padua, Italy; Observ Paris, LESIA, F-92195 Meudon, France; MD Robot, Brampton, ON L6S 4J3, Canada; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; European Space Agcy, Estec, Res & Sci Support Dept, NL-2200 AG Noordwijk, Netherlands; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; UMIST, Dept Phys, Manchester M60 1QD, Lancs, England	Open University - UK; University of Arizona; Polish Academy of Sciences; Lockheed Martin; University of Padua; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Austrian Academy of Sciences; European Space Agency; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; NERC National Oceanography Centre; University of Southampton; University of Manchester	Zarnecki, JC (corresponding author), Open Univ, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	J.C.Zarnecki@open.ac.uk	Grande, Manuel/C-2242-2013; Lorenz, Ralph D/B-8759-2016; Banaszkiewicz, Marek/HII-4723-2022; Ball, Andrew/B-6747-2009; Rosenberg, Phil/C-7724-2013; Green, Simon F/C-7408-2009; Challenor, Peter G/M-2579-2016	Grande, Manuel/0000-0002-2233-2618; Lorenz, Ralph D/0000-0001-8528-4644; Ball, Andrew/0000-0003-1593-3279; Green, Simon F/0000-0002-9153-9786; Challenor, Peter G/0000-0001-8661-2718; Rosenberg, Phil/0000-0002-6920-0559; Hagermann, Axel/0000-0002-1818-9396; Ferri, Francesca/0000-0003-2395-5275; Kargl, Gunter/0000-0001-9125-0256				Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Komle N.I., 2001, PENETROMETRY SOLAR S; Lorenz RD, 2005, PLANET SPACE SCI, V53, P557, DOI 10.1016/j.pss.2004.06.004; LORENZ RD, 1994, ESA J-EUR SPACE AGEN, V18, P93; LORENZ RD, 1994, MEAS SCI TECHNOL, V5, P1033, DOI 10.1088/0957-0233/5/9/001; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Seiff A, 2005, PLANET SPACE SCI, V53, P594, DOI 10.1016/j.pss.2004.05.002; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Zarnecki JC, 2002, SPACE SCI REV, V104, P593, DOI 10.1023/A:1023628321189; ZARNECKI JC, 1997, HUYGENS SCI PAYLOAD, P177	11	101	103	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					792	795		10.1038/nature04211	http://dx.doi.org/10.1038/nature04211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319828				2022-12-28	WOS:000233777800040
J	Zeng, X; Tamai, K; Doble, B; Li, ST; Huang, H; Habas, R; Okamura, H; Woodgett, J; He, X				Zeng, X; Tamai, K; Doble, B; Li, ST; Huang, H; Habas, R; Okamura, H; Woodgett, J; He, X			A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation	NATURE			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; SUBSTRATE-SPECIFICITY; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; PATHWAY; AXIN; DROSOPHILA; MUTANTS; FAMILY	Signalling by the Wnt family of secreted lipoproteins has essential functions in development and disease(1). The canonical Wnt/beta-catenin pathway requires a single-span transmembrane receptor, low-density lipoprotein (LDL)-receptor-related protein 6 (LRP6)(2-4), whose phosphorylation at multiple PPPSP motifs is induced upon stimulation by Wnt and is critical for signal transduction(5). The kinase responsible for LRP6 phosphorylation has not been identified. Here we provide biochemical and genetic evidence for a 'dual-kinase' mechanism for LRP6 phosphorylation and activation. Glycogen synthase kinase 3 (GSK3), which is known for its inhibitory role in Wnt signalling through the promotion of beta-catenin phosphorylation and degradation, mediates the phosphorylation and activation of LRP6. We show that Wnt induces sequential phosphorylation of LRP6 by GSK3 and casein kinase 1, and this dual phosphorylation promotes the engagement of LRP6 with the scaffolding protein Axin. We show further that a membrane-associated form of GSK3, in contrast with cytosolic GSK3, stimulates Wnt signalling and Xenopus axis duplication. Our results identify two key kinases mediating Wnt co-receptor activation, reveal an unexpected and intricate logic of Wnt/beta-catenin signalling, and illustrate GSK3 as a genuine switch that dictates both on and off states of a pivotal regulatory pathway.	Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol,Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol,Neurobiol Program, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Doble, Bradley/V-7848-2019; Woodgett, Jim/F-1087-2010; Doble, Brad/L-7551-2016	Doble, Bradley/0000-0002-0260-2983; Woodgett, Jim/0000-0003-3731-5797; Doble, Brad/0000-0002-0260-2983; Li, Shitao/0000-0002-1398-8519	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074241, R01 GM074241-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101	30	618	669	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					873	877		10.1038/nature04185	http://dx.doi.org/10.1038/nature04185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341017	Green Accepted			2022-12-28	WOS:000233777800055
J	Ho, NCY; Tran, JR; Bektas, A				Ho, NCY; Tran, JR; Bektas, A			Marfan's syndrome	LANCET			English	Editorial Material							MUTATIONS		Johns Hopkins Med Inst, Dept Pediat, Bethesda, MD 20814 USA; NIH, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ho, NCY (corresponding author), Johns Hopkins Med Inst, Dept Pediat, 8315 N Brook Lane, Bethesda, MD 20814 USA.	nho1@jhmi.edu						DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Gott VL, 1999, NEW ENGL J MED, V340, P1307, DOI 10.1056/NEJM199904293401702; HALL JR, 1984, ANN THORAC SURG, V37, P500, DOI 10.1016/S0003-4975(10)61142-3; HO NC, 2001, RADIOLOGY, V223, P767; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Marfan AB-J, 1938, ANN MED, V44, P5; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; ROBINS PR, 1975, J BONE JOINT SURG AM, VA 57, P358, DOI 10.2106/00004623-197557030-00014; SCHERER LR, 1988, J PEDIATR SURG, V23, P1169, DOI 10.1016/S0022-3468(88)80335-X; TOLLISS D, 1995, NURS TIMES, V91, P47	14	46	52	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1978	1981		10.1016/S0140-6736(05)66995-4	http://dx.doi.org/10.1016/S0140-6736(05)66995-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325702				2022-12-28	WOS:000233777900028
J	Gourmelen, N; Amelung, F				Gourmelen, N; Amelung, F			Postseismic mantle relaxation in the Central Nevada Seismic Belt	SCIENCE			English	Article							PEAK-DIXIE VALLEY; EARTHQUAKE SEQUENCE; DEFORMATION; VISCOSITY; RHEOLOGY; BASIN; AREA	Holocene acceleration of deformation and postseismic relaxation are two hypotheses to explain the present-day deformation in the Central Nevada Seismic Belt (CNSB). Discriminating between these two mechanisms is critical for understanding the dynamics and seismic potential of the Basin and Range province. Interferometric synthetic aperture radar detected a broad area of uplift (2 to 3 millimeters per year) that can be explained by postseismic mantle relaxation after a sequence of large crustal earthquakes from 1915 to 1954. The results lead to a broad agreement between geologic and geodetic strain indicators and support a model of a rigid Basin and Range between the CNSB and the Wasatch fault.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Miami, FL 33149 USA	University of Miami	Gourmelen, N (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	ngourmelen@rsmas.miami.edu	Amelung, Falk/J-9042-2012					Abbott RE, 2001, J GEOPHYS RES-SOL EA, V106, P4169, DOI 10.1029/2000JB900385; Amelung F, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001953; Bell JW, 2004, B SEISMOL SOC AM, V94, P1229, DOI 10.1785/012003226; Bell JW, 1999, GEOL SOC AM BULL, V111, P791, DOI 10.1130/0016-7606(1999)111<0791:SFAPHO>2.3.CO;2; Bennett RA, 2003, TECTONICS, V22, DOI 10.1029/2001TC001355; BILLS BG, 1994, J GEOPHYS RES-SOL EA, V99, P22059, DOI 10.1029/94JB01192; Caskey SJ, 2004, B SEISMOL SOC AM, V94, P1255, DOI 10.1785/012003012; Caskey SJ, 1996, B SEISMOL SOC AM, V86, P761; CATCHINGS RD, 1992, GEOL SOC AM BULL, V104, P1178, DOI 10.1130/0016-7606(1992)104<1178:ARAGTA>2.3.CO;2; Dixon JE, 2004, EARTH PLANET SC LETT, V222, P451, DOI 10.1016/j.epsl.2004.03.022; DIXON TH, 1995, TECTONICS, V14, P755, DOI 10.1029/95TC00931; DOSER DI, 1988, J GEOPHYS RES-SOLID, V93, P15001, DOI 10.1029/JB093iB12p15001; DOSER DI, 1986, J GEOPHYS RES-SOLID, V91, P2572, DOI 10.1029/JB091iB12p12572; Frankel AD., 2002, US GEOL SURV OPEN FI; Hammond WC, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002746; Hammond WC, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003678; Hetland EA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002257; Hodgkinson KM, 1996, J GEOPHYS RES-SOL EA, V101, P25437, DOI 10.1029/96JB01643; Kaufmann G, 2000, J GEOPHYS RES-SOL EA, V105, P16341, DOI 10.1029/2000JB900079; LIENKAEMPER JJ, 1984, B SEISMOL SOC AM, V74, P2357; Malservisi R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017408; Nishimura T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002191; Pollitz FF, 2000, J GEOPHYS RES-SOL EA, V105, P8035, DOI 10.1029/1999JB900380; POLLITZ FF, 1992, J GEOPHYS RES, V102, P17921; SELLA G, COMMUNICATION; SLEMMONS DB, 1965, B SEISMOL SOC AM, V55, P537; SVARC JL, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/20014B000579; Thatcher W, 1999, SCIENCE, V283, P1714, DOI 10.1126/science.283.5408.1714; WALLACE RE, 1984, US GEOL SURV PROF A, V1274; WERNICKE B, 2000, GSA TODAY, V10, P1	30	79	83	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1473	1476		10.1126/science.1119798	http://dx.doi.org/10.1126/science.1119798			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322452				2022-12-28	WOS:000233756500038
J	Engelman, DM				Engelman, DM			Membranes are more mosaic than fluid	NATURE			English	Editorial Material							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISM; PROTEIN; COMPLEXES; TRACKING; RECEPTOR; CHANNEL; OXIDASE	The wealth of new data on membrane protein structures and functions is changing our general view of membrane architecture. Some of the key themes that are emerging are that membranes are patchy, with segregated regions of structure and function, that lipid regions vary in thickness and composition, and that crowding and ectodomains limit exposure of lipid to the adjacent aqueous regions.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Engelman, DM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Box 208114, New Haven, CT 06520 USA.	don@mail.csb.yale.edu						Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Liu Y, 2002, GENOME BIOL, V3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Petrache HI, 2002, LANGMUIR, V18, P1340, DOI 10.1021/la011338p; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	34	655	660	3	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					578	580		10.1038/nature04394	http://dx.doi.org/10.1038/nature04394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319876	Bronze			2022-12-28	WOS:000233593100034
J	Haffner, H; Hansel, W; Roos, CF; Benhelm, J; Chek-al-kar, D; Chwalla, M; Korber, T; Rapol, UD; Riebe, M; Schmidt, PO; Becher, C; Guhne, O; Dur, W; Blatt, R				Haffner, H; Hansel, W; Roos, CF; Benhelm, J; Chek-al-kar, D; Chwalla, M; Korber, T; Rapol, UD; Riebe, M; Schmidt, PO; Becher, C; Guhne, O; Dur, W; Blatt, R			Scalable multiparticle entanglement of trapped ions	NATURE			English	Article							CURRENT SITUATION; QUANTUM; COMMUNICATION; SEPARABILITY; STATES	The generation, manipulation and fundamental understanding of entanglement lies at the very heart of quantum mechanics. Entangled particles are non- interacting but are described by a common wavefunction; consequently, individual particles are not independent of each other and their quantum properties are inextricably interwoven(1-3). The intriguing features of entanglement become particularly evident if the particles can be individually controlled and physically separated. However, both the experimental realization and characterization of entanglement become exceedingly difficult for systems with many particles. The main difficulty is to manipulate and detect the quantum state of individual particles as well as to control the interaction between them. So far, entanglement of four ions(4) or five photons(5) has been demonstrated experimentally. The creation of scalable multiparticle entanglement demands a non- exponential scaling of resources with particle number. Among the various kinds of entangled states, the 'W state'(6-8) plays an important role as its entanglement is maximally persistent and robust even under particle loss. Such states are central as a resource in quantum information processing(9) and multiparty quantum communication. Here we report the scalable and deterministic generation of four-, five-, six-, seven- and eight- particle entangled states of the W type with trapped ions. We obtain the maximum possible information on these states by performing full characterization via state tomography(10), using individual control and detection of the ions. A detailed analysis proves that the entanglement is genuine. The availability of such multiparticle entangled states, together with full information in the form of their density matrices, creates a test- bed for theoretical studies of multiparticle entanglement. Independently, ' Greenberger - Horne - Zeilinger' entangled states(11) with up to six ions have been created and analysed in Boulder(12).	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences	Haffner, H (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	Hartmut.Haeffner@uibk.ac.at	Becher, Christoph/AAE-8756-2020; Schmidt, Piet/F-6384-2011; Blatt, Rainer/H-9527-2014; Roos, Christian F/D-8475-2011; Haeffner, Hartmut/D-8046-2012; Becker, Jonas/GZG-4234-2022; Gühne, Otfried/C-7940-2009	Becher, Christoph/0000-0003-4645-6882; Schmidt, Piet/0000-0003-0773-5889; Roos, Christian F/0000-0001-7121-8259; Haeffner, Hartmut/0000-0002-5113-9622; Dur, Wolfgang/0000-0002-0234-7425; Rapol, Umakant/0000-0003-0340-6017				Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bourennane M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.087902; Buhrman H, 1999, PHYS REV A, V60, P2737, DOI 10.1103/PhysRevA.60.2737; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Dur W, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042314; Dur W, 2001, J PHYS A-MATH GEN, V34, P6837, DOI 10.1088/0305-4470/34/35/310; FANO U, 1957, REV MOD PHYS, V29, P74, DOI 10.1103/RevModPhys.29.74; Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Hradil Z, 2004, LECT NOTES PHYS, V649, P59; Joo J, 2005, J KOREAN PHYS SOC, V46, P763; JOO J, 2002, QUANTPH0204003; Koashi M, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.050302; MIYAKE A, 2005, QUANTPH0506092; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt-Kaler F, 2003, APPL PHYS B-LASERS O, V77, P789, DOI 10.1007/s00340-003-1346-9; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Sen A, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062306; Terhal BM, 2000, PHYS LETT A, V271, P319, DOI 10.1016/S0375-9601(00)00401-1; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Zeilinger A., 1992, NASA C PUBLICATION, V3135, P73; Zhao Z, 2004, NATURE, V430, P54, DOI 10.1038/nature02643	27	878	889	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					643	646		10.1038/nature04279	http://dx.doi.org/10.1038/nature04279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319886	Green Submitted			2022-12-28	WOS:000233593100044
J	Siegenthaler, U; Stocker, TF; Monnin, E; Luthi, D; Schwander, J; Stauffer, B; Raynaud, D; Barnola, JM; Fischer, H; Masson-Delmotte, V; Jouzel, J				Siegenthaler, U; Stocker, TF; Monnin, E; Luthi, D; Schwander, J; Stauffer, B; Raynaud, D; Barnola, JM; Fischer, H; Masson-Delmotte, V; Jouzel, J			Stable carbon cycle-climate relationship during the late Pleistocene	SCIENCE			English	Article							VOSTOK ICE CORE; ATMOSPHERIC CO2 CONCENTRATION; TAYLOR-DOME; ANTARCTIC ICE; RECORD; HOLOCENE; VARIABILITY; AIR; AGE	A record of atmospheric carbon dioxide (CO2) concentrations measured on the EPICA (European Project for Ice Coring in Antarctica) Dome Concordia ice core extends the Vostok CO2 record back to 650,000 years before the present (yr B.P.). Before 430,000 yr B.P., partial pressure of atmospheric CO2 lies within the range of 260 and 180 parts per million by volume. This range is almost 30% smaller than that of the last four glacial cycles; however, the apparent sensitivity between deuterium and CO2 remains stable throughout the six glacial cycles, suggesting that the relationship between CO2 and Antarctic climate remained rather constant over this interval.	Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Ctr Etud Saclay, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, CEA CNRS 1572, F-91191 Gif Sur Yvette, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Stocker, TF (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Stocker, Thomas/B-1273-2013; Raynaud, Dominique/H-9626-2016; Fischer, Hubertus/A-1211-2014; raynaud, dominique/ABG-4718-2020; Masson-Delmotte, Valerie L/G-1995-2011	Fischer, Hubertus/0000-0002-2787-4221; Masson-Delmotte, Valerie L/0000-0001-8296-381X				Ahn J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004415; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; Flower BP, 2000, PALEOCEANOGRAPHY, V15, P388, DOI 10.1029/1999PA000430; Fluckiger J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001417; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; Joos F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002156; JOUZEL J, 1987, NATURE, V329, P403, DOI 10.1038/329403a0; JOUZEL J, UNPUB; Kawamura K, 2003, TELLUS B, V55, P126, DOI 10.1034/j.1600-0889.2003.00050.x; Landais A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004193; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Masson V, 2000, QUATERNARY RES, V54, P348, DOI 10.1006/qres.2000.2172; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; SCHWANDER J, 1984, NATURE, V311, P45, DOI 10.1038/311045a0; Schwander J, 2001, GEOPHYS RES LETT, V28, P4243, DOI 10.1029/2000GL011981; Siegenthaler U, 2005, TELLUS B, V57, P51, DOI 10.1111/j.1600-0889.2005.00131.x; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Stauffer B, 1998, NATURE, V392, P59, DOI 10.1038/32133; WOLFF EW, UNPUB	32	594	632	4	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1313	1317		10.1126/science.1120130	http://dx.doi.org/10.1126/science.1120130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311332	Green Submitted			2022-12-28	WOS:000233600200037
J	Ruiz, MC; Soler-Gonzalez, J				Ruiz, MC; Soler-Gonzalez, J			Unfortunate ingestion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Salud Rambla Ferran, Lleida 25007, Spain		Ruiz, MC (corresponding author), Ctr Salud Rambla Ferran, Lleida 25007, Spain.		soler-gonzalez, jorge/D-1686-2011	soler-gonzalez, jorge/0000-0001-8359-3355					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2270	2270		10.1056/NEJMicm040916	http://dx.doi.org/10.1056/NEJMicm040916			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306524				2022-12-28	WOS:000233434500010
J	Sullivan, F; Wyatt, JC				Sullivan, F; Wyatt, JC			ABC of health informatics - Improving services with informatics tools	BRITISH MEDICAL JOURNAL			English	Review									Univ Dundee, Dundee DD1 4HN, Scotland	University of Dundee			Sullivan, Frank m/A-7767-2009; Sullivan, Frank/L-8286-2019; Wyatt, Jeremy/F-8160-2010	Sullivan, Frank/0000-0002-6623-4964; Wyatt, Jeremy/0000-0001-7008-1473				Berwick DM, 2003, NEW ENGL J MED, V348, P2570, DOI 10.1056/NEJMe030044; FAHEY T, 1995, BRIT MED J, V311, P1056, DOI 10.1136/bmj.311.7012.1056; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; LOWRENCE WW, 2002, LEARNING EXPERIENCE; *NHS HLTH TECHN AS, EFF EFF GUID DISS IM	5	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1190	1192		10.1136/bmj.331.7526.1190	http://dx.doi.org/10.1136/bmj.331.7526.1190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293842	Green Published			2022-12-28	WOS:000233571000024
J	Li, DK; Willinger, M; Petitti, DB; Odouli, R; Liu, LY; Hoffman, HJ				Li, DK; Willinger, M; Petitti, DB; Odouli, R; Liu, LY; Hoffman, HJ			Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							POSITION; COT	Objectives To examine the association between use of a dummy (pacifier) during sleep and the risk of sudden infant death syndrome (STDS) in relation to other risk factors. Design Population based case-control study. Setting Eleven counties in California. Participants Mothers or carers of 185 infants whose deaths were attributed to SIDS and 312 randomly selected controls matched for race or ethnicity and age. Main outcome measure Use of a dummy during sleep determined through interviews. Results The adjusted odds ratio for SIDS associated with using a dummy during the last sleep was 0.08 (95% confidence interval 0.03 to 0.21). Use was associated with a reduction in risk in every category of sociodemographic characteristics and risk factors examined. The reduced risk associated with use seemed to be greater with adverse sleep conditions (such as sleeping prone or on side and sleeping with a mother who smoked), although the observed interactions were not significant. For example, infants who did not use a dummy and slept prone or on their sides (v on their back) had an increased risk of SIDS (2.61, 1.56 to 4.38). In infants who used dummies, there was no increased risk associated with sleeping position (0.66, 0.12 to 3.59). While cosleeping with a mother who smoked was also associated with increased risk of SIDS among infants who did not use a dummy (4.5, 1.3 to 15.1), there was no such association among those who did (1.1, 0.1 to 13.4). Conclusions Use of a dummy seems to reduce the risk of SIDS and possibly reduces the influence of known risk factors in the sleep environment.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Kaiser Permanente So Calif, Res & Evaluat, Pasadena, CA 91188 USA; NICHHD, Prenancy & Perinatol Branch, Ctr Res Mothers & Children, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Epidemiol & Biostat Program, Div Sci Programs, NIH, Bethesda, MD 20892 USA	Kaiser Permanente; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Li, DK (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	dkl@dor.kaiser.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD053227] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-5-3227] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arnestad M, 1997, EUR J PEDIATR, V156, P968, DOI 10.1007/s004310050753; Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; Franco P, 2000, J PEDIATR-US, V136, P775, DOI 10.1067/mpd.2000.105365; Franco P, 2004, EARLY HUM DEV, V77, P99, DOI 10.1016/j.earlhumdev.2004.02.002; Hauck FR, 2003, PEDIATRICS, V111, P1207; L'Hoir MP, 1999, EUR J PEDIATR, V158, P896, DOI 10.1007/s004310051237; Li DK, 2003, AM J EPIDEMIOL, V157, P446, DOI 10.1093/aje/kwf226; MITCHELL EA, 1993, ARCH DIS CHILD, V68, P501, DOI 10.1136/adc.68.4.501; Willinger M, 2000, JAMA-J AM MED ASSOC, V283, P2135, DOI 10.1001/jama.283.16.2135	9	68	71	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 7	2006	332	7532					18	21		10.1136/bmj.38671.640475.55	http://dx.doi.org/10.1136/bmj.38671.640475.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LR	16339767	Green Published, Bronze			2022-12-28	WOS:000234684200015
J	Doyal, L; Sheather, J				Doyal, L; Sheather, J			Mental health legislation should respect decision making capacity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Queen Mary Coll, Barts & London Sch Med & Dent, London E1 2AD, England; BMA, Med Eth Dept, London WC1H 9JP, England	University of London; Queen Mary University London	Doyal, L (corresponding author), Univ London, Queen Mary Coll, Barts & London Sch Med & Dent, London E1 2AD, England.	jsheather@bma.org.uk						Hull A, 1999, BRIT MED J, V319, P916, DOI 10.1136/bmj.319.7214.916; MASON JK, 2002, LAW MED ETHICS, P312; Monahan J., 2001, RETHINKING RISK ASSE; Pearson G., 1999, LAW ENFORCEMENT, P159; RICHARDSON G, 2002, MOD LAW REV, V65, P5; Wolff N, 2002, J HEALTH POLIT POLIC, V27, P801, DOI 10.1215/03616878-27-5-801	6	18	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1467	1469		10.1136/bmj.331.7530.1467	http://dx.doi.org/10.1136/bmj.331.7530.1467			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EE	16356986	Green Published, Bronze			2022-12-28	WOS:000234156400031
J	Braveman, PA; Cubbin, C; Egerter, S; Chideya, S; Marchi, KS; Metzler, M; Posner, S				Braveman, PA; Cubbin, C; Egerter, S; Chideya, S; Marchi, KS; Metzler, M; Posner, S			Socioeconomic status in health research - One size does not fit all	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; CAUSE-SPECIFIC MORTALITY; MIDDLE-AGED MEN; SOCIAL-CLASS; UNITED-STATES; BIRTH-WEIGHT; RISK-FACTORS; EUROPEAN COUNTRIES; STROKE MORTALITY; ADULT MORTALITY	Problems with measuring socioeconomic status (SES-frequently included in clinical and public health studies as a control variable and less frequently as the variable(s) of main interest-could affect research findings and conclusions, with implications for practice and policy. We critically examine standard SES measurement approaches, illustrating problems with examples from new analyses and the literature. For example, marked racial/ethnic differences in income at a given educational level and in wealth at a given income level raise questions about the socioeconomic comparability of individuals who are similar on education or income alone. Evidence also shows that conclusions about nonsocioeconomic causes of racial/ethnic differences in health may depend on the measure eg, income, wealth, education, occupation, neighborhood socioeconomic characteristics, or past socioeconomic experiences-used to "control for SES," suggesting that findings from studies that have measured limited aspects of SES should be reassessed. We recommend an outcome- and social group-specific approach to SES measurement that involves (1) considering plausible explanatory pathways and mechanisms, (2) measuring as much relevant socioeconomic information as possible, (3) specifying the particular socioeconomic factors measured (rather than SES overall), and (4) systematically considering how potentially important unmeasured socioeconomic factors may affect conclusions. Better SES measures are needed in data sources, but improvements could be made by using existing information more thoughtfully and acknowledging its limitations.	Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adult & Community Hlth, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Braveman, PA (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, 500 Parnassus Ave,MU-3E,Box 0900, San Francisco, CA 94143 USA.	braveman@fcm.ucsf.edu		Posner, Samuel/0000-0003-1574-585X	ATSDR CDC HHS [TS-0842] Funding Source: Medline	ATSDR CDC HHS		ABRAMSON JH, 1982, SOC SCI MED, V16, P1739, DOI 10.1016/0277-9536(82)90267-2; ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; [Anonymous], NAT HLTH INT SURV NH; ARBER S, 1993, SOC SCI MED, V36, P33, DOI 10.1016/0277-9536(93)90303-L; Avendano M, 2005, AM J EPIDEMIOL, V161, P52, DOI 10.1093/aje/kwi011; Backlund E, 1996, ANN EPIDEMIOL, V6, P12, DOI 10.1016/1047-2797(95)00090-9; Bamshad M, 2005, JAMA-J AM MED ASSOC, V294, P937, DOI 10.1001/jama.294.8.937; BAMSHAD M, 2005, JAMA-J AM MED ASSOC, V294, P1620; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Basso O, 1997, BRIT MED J, V315, P1498, DOI 10.1136/bmj.315.7121.1498; Benzeval M, 2001, SOC POLICY ADMIN, V35, P376, DOI 10.1111/1467-9515.00240; Berkman L F, 1997, IARC Sci Publ, P51; BLACK D, 1999, INEQUALITIES HLTH BL, P29; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Bosma H, 1999, BRIT MED J, V318, P18; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; BRENNER MH, 1991, WORK HLTH PRODUCTIVI, P241; BREWSTER KL, 1994, AM SOCIOL REV, V59, P408, DOI 10.2307/2095941; Centers for Disease Control and Prevention, 3 NAT HLTH NUTR EX S; Chandola T, 1998, SOC SCI MED, V47, P525, DOI 10.1016/S0277-9536(98)00141-5; Chung EK, 2003, AMBUL PEDIATR, V3, P234, DOI 10.1367/1539-4409(2003)003<0234:ISPAMA>2.0.CO;2; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; Cubbin Catherine, 2001, Ethnicity and Disease, V11, P687; Cubbin Catherine, 2002, Matern Child Health J, V6, P237, DOI 10.1023/A:1021158016268; Diderichsen F, 1997, INT J EPIDEMIOL, V26, P782, DOI 10.1093/ije/26.4.782; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Duncan GJ, 1996, INT J HEALTH SERV, V26, P419, DOI 10.2190/1KU0-4Y3K-ACFL-BYU7; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Galbraith AA, 2003, PEDIATRICS, V111, P364, DOI 10.1542/peds.111.2.364; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gazmararian JA, 1996, AM J PREV MED, V12, P108, DOI 10.1016/S0749-3797(18)30353-2; Gilthorpe MS, 2003, SOC SCI MED, V57, P2055, DOI 10.1016/S0277-9536(03)00071-6; Griffin JM, 2002, SOC SCI MED, V54, P783, DOI 10.1016/S0277-9536(01)00109-5; Hadden WC, 1996, AM J PUBLIC HEALTH, V86, P1525, DOI 10.2105/AJPH.86.11.1525; Heck KE, 2003, BIRTH-ISS PERINAT C, V30, P153, DOI 10.1046/j.1523-536X.2003.00239.x; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Kaplan GA, 1996, INT J HEALTH SERV, V26, P507, DOI 10.2190/4CUU-7B3G-G4XR-0K0B; KARASEK R, 1990, J ORGAN BEHAV, V11, P171, DOI 10.1002/job.4030110302; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; KORENMAN S, 1995, CHILD YOUTH SERV REV, V17, P127, DOI 10.1016/0190-7409(95)00006-X; KRIEGER N, 1994, INT J HEALTH SERV, V24, P25, DOI 10.2190/2JG7-YMD5-WCP2-XXNT; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Kuh D, 1997, LIFE COURSE APPROACH; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; Lannin DR, 1998, JAMA-J AM MED ASSOC, V279, P1801, DOI 10.1001/jama.279.22.1801; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Lowry R, 1996, JAMA-J AM MED ASSOC, V276, P792, DOI 10.1001/jama.276.10.792; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P389, DOI 10.2105/AJPH.88.3.389; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Macintyre S, 1998, J EPIDEMIOL COMMUN H, V52, P657, DOI 10.1136/jech.52.10.657; Macintyre S, 2003, J PUBLIC HEALTH MED, V25, P288, DOI 10.1093/pubmed/fdg089; Macintyre S, 2000, BRIT J SPORT MED, V34, P6, DOI 10.1136/bjsm.34.1.6; MACINTYRE S, 1986, SOC SCI MED, V23, P393, DOI 10.1016/0277-9536(86)90082-1; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; Mackenbach JP, 2005, INT J EPIDEMIOL, V34, P286, DOI 10.1093/ije/dyh338; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marmot M, 1997, SOC SCI MED, V44, P901, DOI 10.1016/S0277-9536(96)00194-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Massey D., 2004, DU BOIS REV, V1, P7, DOI DOI 10.1017/S1742058X04040032; MAYER SE, 1989, J HUM RESOUR, V24, P88, DOI 10.2307/145934; McCarthy PL, 2000, PEDIATRICS, V105, P1349; McCullagh P., 1989, GEN LINEAR MODELS; McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MILLER JE, 1994, AM J EPIDEMIOL, V140, P233, DOI 10.1093/oxfordjournals.aje.a117242; Mirowsky J, 1998, RES AGING, V20, P415, DOI 10.1177/0164027598204003; Morland K, 2002, AM J PUBLIC HEALTH, V92, P1761, DOI 10.2105/AJPH.92.11.1761; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Muntaner C, 1997, AM J EPIDEMIOL, V146, P607; Nicolaidis Christina, 2004, BMC Pregnancy Childbirth, V4, P10, DOI 10.1186/1471-2393-4-10; *NIH, NAT LONG STUD AD HLT; PAMUK ER, 1988, EUR J POPUL, V4, P1, DOI 10.1007/BF01797104; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Power C, 1998, LANCET, V351, P1009, DOI 10.1016/S0140-6736(97)11082-0; Prevention CfDCa, 2000, BEH RISK FACT SURV S; Rahkonen O, 1997, SOC SCI MED, V44, P327, DOI 10.1016/S0277-9536(96)00102-5; *RES TRIANGL I, 2005, SUDAAN VERS 9 0 1; Reynolds JR, 1998, SOC PROBL, V45, P221, DOI 10.1525/sp.1998.45.2.03x0167k; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; RODGERS JR, 1995, SOC SCI QUART, V76, P178; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Ross CE, 1997, J HEALTH SOC BEHAV, V38, P275, DOI 10.2307/2955371; Ross CE, 1999, DEMOGRAPHY, V36, P445, DOI 10.2307/2648083; Roux AVD, 2002, AM J EPIDEMIOL, V155, P516, DOI 10.1093/aje/155.6.516; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; *SAS I INC, 2002, SAS VERS 9 1; SINGER B, 1997, STAT SOC SCI PUBL P, P89; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Smith GD, 1997, J EPIDEMIOL COMMUN H, V51, P134, DOI 10.1136/jech.51.2.134; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; SMITH GD, 1990, J EPIDEMIOL COMMUN H, V44, P265, DOI 10.1136/jech.44.4.265; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Stansfeld SA, 1998, SOC PSYCH PSYCH EPID, V33, P1; Steptoe A, 2002, EUR HEART J, V23, P13, DOI 10.1053/euhj.2001.2611; Sundquist J, 1997, SOC SCI MED, V45, P1757, DOI 10.1016/S0277-9536(97)00107-X; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Theorell T, 1998, AM J PUBLIC HEALTH, V88, P382, DOI 10.2105/AJPH.88.3.382; TIENDA M, 1991, MACROMICRO LINKAGES, P244; U.S. Census Bureau, 2003, CURR POP REP; *US CENS BUR, 2000 STAND OCC CLASS; *US DEP LAB, NLSY79 NAT LONG SURV; Vagero D, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(97)26033-2; van de Mheen H, 1998, J EPIDEMIOL COMMUN H, V52, P15, DOI 10.1136/jech.52.1.15; von dem Knesebeck O, 2003, SOC SCI MED, V57, P1643, DOI 10.1016/S0277-9536(03)00020-0; Warren JR, 1997, AM SOCIOL REV, V62, P561, DOI 10.2307/2657426; Weber Max, 1978, MAX WEBER SELECTIONS, P43; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; Williams DR, 1996, INT J HEALTH SERV, V26, P483, DOI 10.2190/U9QT-7B7Y-HQ15-JT14; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Winch C, 2002, J PHILOS EDUC, V36, P101, DOI 10.1111/1467-9752.00262; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; WRIGHT EO, 1980, AM J SOCIOL, V85, P1433, DOI 10.1086/227175; Yen IH, 1999, ANNU REV PUBL HEALTH, V20, P287, DOI 10.1146/annurev.publhealth.20.1.287	128	1421	1442	7	233	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2879	2888		10.1001/jama.294.22.2879	http://dx.doi.org/10.1001/jama.294.22.2879			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991PU	16352796				2022-12-28	WOS:000233826700029
J	Longo, DR; Hewett, JE; Ge, B; Schubert, S				Longo, DR; Hewett, JE; Ge, B; Schubert, S			The long road to patient safety - A status report on patient safety systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORDER ENTRY SYSTEMS; HEALTH-CARE; ORGANIZATIONAL SIZE; MEDICAL ERRORS; QUALITY	Context Since the Institute of Medicine (IOM) reports on medical errors and quality, national attention has focused on improving patient safety through changes in "systems" of care. These reports resulted in a new paradigm that, rather than centering on individual errors, focuses on the "systems" necessary to facilitate and enhance quality and protect patients. Objectives To assess the, status of hospital patient safety systems since the release of the IOM reports and to identify changes over time in 2 states that collaborated on a patient safety project funded by the Agency for Healthcare Research and Quality. Design, Setting, and Participants Survey of all acute care hospitals in Missouri and Utah at 2 points in time, in 2002 and 2004, using a 91-item comprehensive questionnaire (n = 126 for survey 1 and n = 128 for survey 2). To assess changes over time, we also studied the cohort of 107 hospitals that responded to both surveys. Main Outcome Measures Responses to the 91-question survey as well as changes in responses to the survey questions over an 18-month period. Seven latent variables were constructed to represent the most important patient safety constructs studied: computerized physician order entry systems, computerized test results, and assessments of adverse events; specific patient safety policies, use of data in patient safety programs; drug storage, administration, and safety procedures; manner of handling adverse event/error reporting; prevention policies; and root cause analysis. For each hospital, the 7 latent variables were summed to give an overall measure of the patient safety status of the hospital. Results Development and implementation of patient safety systems is at best modest. Self-reported regression in patient safety systems was also found. While 74% of hospitals reported full implementation of a written patient safety plan, nearly 9% reported no plan. The area of surgery appears to have the greatest level of patient safety systems. Other areas, such as medications, with a long history of efforts in patient safety and error prevention, showed improvements, but the percentage of hospitals with various safety systems was already high at baseline for many systems. Some findings are surprising, given the overall trends; for example, while a Substantial percentage of hospitals have medication safety systems, only 3% reported full implementation at survey 2 of computerized physician order entry systems for medications, despite the growth of computer technology in general and in hospital billing systems in particular. Conclusions The current status of hospital patient safety systems is not close to meeting IOM recommendations. Data are consistent with recent reports that patient safety system progress is slow and is a cause for great concern. Efforts for improvement must be accelerated.	Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Biostat Grp, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Longo, DR (corresponding author), Univ Missouri, Sch Med, Dept Family & Community Med, MA306 Med Sci Bldg, Columbia, MO 65212 USA.	longod@health.missouri.edu	Hug, Balthasar L./G-1568-2010		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011885] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HEALTHC RES QU, 2004, 2004 NAT HEALTHC QUA; Altman DE, 2004, NEW ENGL J MED, V351, P2041, DOI 10.1056/NEJMp048243; *AM HOSP ASS, 2004, HOSP STAT; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Ashmos DP, 2000, J ORGAN CHANGE MANAG, V13, P577, DOI 10.1108/09534810010378597; Bates David W, 2002, Jt Comm J Qual Improv, V28, P651; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; BATES DW, 2002, JOINT COMM J QUAL IM, V28, P633; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; BLUEDORN AC, 1993, J MANAGE, V19, P163, DOI 10.1016/0149-2063(93)90051-N; BLUMENTHAL D, 1994, JAMA-J AM MED ASSOC, V272, P1867, DOI 10.1001/jama.272.23.1867; Casarett D, 1999, ACAD MED, V74, P19, DOI 10.1097/00001888-199901001-00011; Chassin MR, 1996, NEW ENGL J MED, V335, P1060, DOI 10.1056/NEJM199610033351413; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COOK RI, 1999, ENHANCING PATIENT SA; Detmer D E, 2001, Front Health Serv Manage, V18, P3; Evans R S, 1991, Proc Annu Symp Comput Appl Med Care, P23; GALLETLY DC, 1991, ANAESTH INTENS CARE, V19, P66, DOI 10.1177/0310057X9101900112; Galvin RS, 2005, HEALTH AFFAIR, V24, P228, DOI 10.1377/hlthaff.24.1.228; Gooding R. Z., 1985, ADM SCI Q, V30, P462, DOI [DOI 10.2307/2392692, 10.2307/2392692]; Hsieh TC, 2004, J AM MED INFORM ASSN, V11, P482, DOI 10.1197/jamia.M1556; Katz D., 1978, SOCIAL PSYCHOL ORG; KIMBERLY JR, 1976, ADMIN SCI QUART, V21, P571, DOI 10.2307/2391717; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; KUPERMAN GJ, 2004, MEDINFO 2004, P1701; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Longo D R, 2001, J Health Care Finance, V28, P92; Longo DR, 1997, JAMA-J AM MED ASSOC, V278, P1579, DOI 10.1001/jama.278.19.1579; Mawji Zubina, 2002, Jt Comm J Qual Improv, V28, P373; McNally KM, 1997, AM J HEALTH-SYST PH, V54, P171, DOI 10.1093/ajhp/54.2.171; MYERS CE, 1993, AM J HOSP PHARM, V50, P914; *NAT SUMM MED ERR, 2000, RES AG MED ERR PAT S; NIGHTINGALE F, 1863, NOTES HOSP ENLARGED; Pennell NA, 2005, NEW ENGL J MED, V352, P726; Poon EG, 2004, HEALTH AFFAIR, V23, P184, DOI 10.1377/hlthaff.23.4.184; Poon Eric G, 2003, AMIA Annu Symp Proc, P975; Pronovost Peter J, 2004, Jt Comm J Qual Saf, V30, P59; REESE CE, 1994, INTRO FACTOR ANAL; Rex J H, 2000, Jt Comm J Qual Improv, V26, P563; Sagan SD., 1993, LIMITS SAFETY ORG AC; Schiff GD, 2003, ARCH INTERN MED, V163, P893, DOI 10.1001/archinte.163.8.893; Scott W R, 1984, Med Care Rev, V41, P213, DOI 10.1177/107755878404100401; Scott WR, 2014, MANAGEMENT, V17, P136, DOI 10.3917/mana.172.0136; SCOTT WR, 1979, MILBANK FUND Q, V57, P234, DOI 10.2307/3349764; SCOTT WR, 1983, HLTH CARE MANAGEMENT, P418; SMITH KG, 1989, ORGAN STUD, V10, P63, DOI 10.1177/017084068901000104; Stewart D.W., 2014, FOCUS GROUPS THEORY; Turnbull J E, 1998, Jt Comm Perspect, V18, P34; WACHTER RM, 2004, HLTH AFF MILLW S JUL	55	138	139	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2858	2865		10.1001/jama.294.22.2858	http://dx.doi.org/10.1001/jama.294.22.2858			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352793	Bronze			2022-12-28	WOS:000233826700026
J	Park, Y; Hunter, DJ; Spiegelman, D; Bergkvist, L; Berrino, F; van den Brandt, PA; Buring, JE; Colditz, GA; Freudenheim, JL; Fuchs, CS; Giovannucci, E; Goldbohm, RA; Graham, S; Harnack, L; Hartman, AM; Jacobs, DR; Kato, I; Krogh, V; Leitzmann, MF; McCullough, ML; Miller, AB; Pietinen, P; Rohan, TE; Schatzkin, A; Willett, WC; Wolk, A; Zeleniuch-Jacquotte, A; Zhang, SMM; Smith-Warner, SA				Park, Y; Hunter, DJ; Spiegelman, D; Bergkvist, L; Berrino, F; van den Brandt, PA; Buring, JE; Colditz, GA; Freudenheim, JL; Fuchs, CS; Giovannucci, E; Goldbohm, RA; Graham, S; Harnack, L; Hartman, AM; Jacobs, DR; Kato, I; Krogh, V; Leitzmann, MF; McCullough, ML; Miller, AB; Pietinen, P; Rohan, TE; Schatzkin, A; Willett, WC; Wolk, A; Zeleniuch-Jacquotte, A; Zhang, SMM; Smith-Warner, SA			Dietary fiber intake and risk of colorectal cancer - A pooled analysis of prospective cohort studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD FREQUENCY QUESTIONNAIRE; SCALE PROSPECTIVE COHORT; COLON-CANCER; REGRESSION-MODELS; RANDOMIZED TRIAL; LOW-FAT; REPRODUCIBILITY; RECURRENCE; ADENOMA; PREVENTION	Context Inconsistent findings from observational studies have continued the controversy over the effects of dietary fiber on colorectal cancer. Objective To evaluate the association between dietary fiber intake and risk of colorectal cancer. Design, Setting, and Participants From 13 prospective cohort studies included in the Pooling Project of Prospective Studies of Diet and Cancer, 725 628 men and women were followed up for 6 to 20 years across studies. Study- and sex-specific relative risks (RRs) were estimated with the Cox proportional hazards model and were subsequently pooled using a random-effects model. Main Outcome Measure Incident colorectal cancer. Results During 6 to 20 years of follow-up across studies, 8081 colorectal cancer cases were identified. For comparison of the highest vs lowest study- and sex-specific quintile of dietary fiber intake, a significant inverse association was found in the age-adjusted model (pooled RR=0.84; 95% confidence interval [CI], 0.77-0.92). However, the association was attenuated and no longer statistically significant after adjusting for other risk factors (pooled multivariate RR=0.94; 95% Cl, 0.86-1.03). In categorical analyses compared with dietary fiber intake of 10 to <15 g/d, the pooled multivariate RR was 1.18 (95% Cl, 1.05-1.31) for less than 10 g/d (11% of the overall study population); and RR, 1.00 (95% Cl, 0.85-1.17) for 30 or more g/d. Fiber intake from cereals, fruits, and vegetables was not associated with risk of colorectal cancer. The pooled multivariate RRs comparing the highest vs lowest study- and sex-specific quintile of dietary fiber intake were 1.00 (95% Cl, 0.90-1.11) for colon cancer and 0.85 (95% Cl, 0.72-1.01) for rectal cancer (P for common effects by tumor site=.07). Conclusions In this large pooled analysis, dietary fiber intake was inversely associated with risk of colorectal cancer in age-adjusted analyses. However, after accounting for other dietary risk factors, high dietary fiber intake was not associated with a reduced risk of colorectal cancer.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Ctr Canc Prevent, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Cent Hosp Vasteras, Dept Surg, Vasteras, Sweden; Cent Hosp Vasteras, Clin Res Ctr, Vasteras, Sweden; Natl Canc Inst, Epidemiol Unit, I-20133 Milan, Italy; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; TNO, Nutr & Food Res Inst, Dept Epidemiol, NL-3700 AJ Zeist, Netherlands; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; NCI, Risk Factor Monitoring & Methods Branch, Appl Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA; NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Amer Canc Soc, Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; NYU, Dept Environm Med, New York, NY 10016 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Vasteras Central Hospital; Vasteras Central Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; Maastricht University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Netherlands Organization Applied Science Research; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Barbara Ann Karmanos Cancer Institute; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; University of Toronto; Finland National Institute for Health & Welfare; Yeshiva University; Albert Einstein College of Medicine; Karolinska Institutet; New York University	Smith-Warner, SA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	pooling@hsphsun2.harvard.edu	Colditz, Graham/A-3963-2009; franceschi, silvia/M-2452-2014; Krogh, Vittorio/K-2628-2016; Negri, Eva/B-7244-2013; Krogh, Vittorio/AAA-9171-2019; Berrino, Franco/AAC-2364-2020; Parpinel, Maria/B-1605-2012	Colditz, Graham/0000-0002-7307-0291; franceschi, silvia/0000-0003-4181-8071; Krogh, Vittorio/0000-0003-0122-8624; Negri, Eva/0000-0001-9712-8526; Krogh, Vittorio/0000-0003-0122-8624; Berrino, Franco/0000-0002-4858-1866; Parpinel, Maria/0000-0003-1309-4467; Freudenheim, Jo/0000-0002-9301-0499; McCullough, Marjorie/0000-0003-3025-6341; Jacobs, David/0000-0002-7232-0543; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Harnack, Lisa/0000-0003-1963-5316; Park, Yikyung/0000-0002-6281-489X; van den Brandt, Piet/0000-0001-8781-8099	NCI NIH HHS [CA55075, CA78548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA078548] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; Bingham SA, 2005, CANCER EPIDEM BIOMAR, V14, P1552, DOI 10.1158/1055-9965.EPI-04-0891; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; COX DR, 1972, J R STAT SOC B, V34, P187; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Feskanich Diane, 1994, Annals of Epidemiology, V4, P181, DOI 10.1016/1047-2797(94)90095-7; Flagg EW, 2000, EPIDEMIOLOGY, V11, P462, DOI 10.1097/00001648-200007000-00017; Fuchs CS, 1999, NEW ENGL J MED, V340, P169, DOI 10.1056/NEJM199901213400301; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Higginbotham S, 2004, JNCI-J NATL CANCER I, V96, P229, DOI 10.1093/jnci/djh020; *HIR INT CORP, 1993, EPICURE US GUID PEAN; JAIN MG, 1982, AM J CLIN NUTR, V36, P931, DOI 10.1093/ajcn/36.5.931; KAAKS R, 1995, EUR J CLIN NUTR, V49, pS10; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Lipkin M, 1999, ANNU REV NUTR, V19, P545, DOI 10.1146/annurev.nutr.19.1.545; MACLENNAN R, 1995, J NATL CANCER I, V87, P1760, DOI 10.1093/jnci/87.23.1760; Mai V, 2003, INT J EPIDEMIOL, V32, P234, DOI 10.1093/ije/dyg052; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P959, DOI 10.1023/B:CACO.0000007983.16045.a1; MCKEOWNEYSSEN GE, 1994, J CLIN EPIDEMIOL, V47, P525, DOI 10.1016/0895-4356(94)90299-2; Michels KB, 2005, CANCER EPIDEM BIOMAR, V14, P842, DOI 10.1158/1055-9965.EPI-04-0544; MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Peters U, 2003, LANCET, V361, P1491, DOI 10.1016/S0140-6736(03)13173-X; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P667, DOI 10.1093/oxfordjournals.aje.a115014; Platz EA, 1997, CANCER EPIDEM BIOMAR, V6, P661; POTTER JD, 1997, FOOD NUTR PREVENTION; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sanjoaquin MA, 2004, BRIT J CANCER, V90, P118, DOI 10.1038/sj.bjc.6601441; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Sieri S, 2002, NUTR CANCER, V42, P10, DOI 10.1207/S15327914NC421_2; STEINMETZ KA, 1994, AM J EPIDEMIOL, V139, P1; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Terry P, 2002, INT J CANCER, V97, P864, DOI 10.1002/ijc.10138; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zucker DM, 2004, BIOMETRICS, V60, P324, DOI 10.1111/j.0006-341X.2004.00176.x	51	304	322	3	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2849	2857		10.1001/jama.294.22.2849	http://dx.doi.org/10.1001/jama.294.22.2849			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352792	Green Published, Bronze			2022-12-28	WOS:000233826700025
J	Stolzenberg-Solomon, RZ; Graubard, BI; Chari, S; Limburg, P; Taylor, PR; Virtamo, J; Albanes, D				Stolzenberg-Solomon, RZ; Graubard, BI; Chari, S; Limburg, P; Taylor, PR; Virtamo, J; Albanes, D			Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-I; C-PEPTIDE; COLORECTAL-CANCER; EXOGENOUS INSULIN; PHYSICAL-ACTIVITY; PLASMA-GLUCOSE; HAMSTER MODEL; RISK; MORTALITY; COHORT	Context Obesity, diabetes mellitus, and glucose intolerance have been associated with increased pancreatic cancer risk; however, prediagnostic serum insulin concentration has not been evaluated as a predictor of this malignancy. Objective To investigate whether prediagnostic fasting glucose and insulin concentrations and insulin resistance are associated with subsequent incidence of exocrine pancreatic cancer in a cohort of male smokers. Design, Setting, and Participants A case-cohort prospective study within,the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (1985-1988) cohort of 29 133 male Finnish smokers ages 50 to 69 years. The study included 400 randomly sampled subcohort control participants and 169 incident pancreatic cancer cases that occurred after the fifth year of follow-up. All participants were followed up through December 2001 (up to 16.7 years of follow-up). Main Outcome Measures Incident exocrine pancreatic cancer identified from the Finnish Cancer Registry. Results After adjusting forage, smoking, and body mass index, higher baseline fasting serum concentrations of glucose, insulin, and insulin resistance were positively associated with pancreatic cancer. The presence of biochemically defined diabetes mellitus (glucose, >= 126 mg/dL [>= 6.99 mmo/L]) and insulin concentration in the highest vs lowest quartile both showed a significant 2-fold increased risk (hazard ratio [HRI], 2.13; 95% confidence interval [CI], 1.04-4.35; and HR, 2.01; 95% Cl, 1.03-3.93; respectively). There were significant interactions for all the biomarker exposures by follow-up time, such that the positive associations were stronger among the cases that occurred more than 10 years after baseline (highest vs lowest quartile: glucose, HR, 2.16; 95% Cl, 1.05-4.42; P for trend=.02; insulin, HR, 2.90; 95% Cl, 1.22-6.92; P for trend=.005; and insulin resistance, HR, 2.71; 95% Cl, 1.19-6.18; P for trend =.006). Conclusions These results support the hypothesis that exposure to higher insulin concentrations and insulin resistance predicts the risk of exocrine pancreatic cancer.	NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; NCI, Biostat Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Finland National Institute for Health & Welfare	Stolzenberg-Solomon, RZ (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, 6120 Execut Blvd,Suite 320, Rockville, MD 20852 USA.	rs221z@nih.gov	Chari, Suresh/K-9297-2015	Chari, Suresh/0000-0002-3924-0971	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035, N01-RC-37004] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS		*ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BALKAU B, 1993, DIABETES METAB, V19, P458; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; BELL RH, 1988, AM J SURG, V155, P159, DOI 10.1016/S0002-9610(88)80274-5; Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fears TR, 2000, CANCER EPIDEM BIOMAR, V9, P403; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Hennig R, 2004, HISTOL HISTOPATHOL, V19, P999, DOI 10.14670/HH-19.999; Hjalgrim H, 1997, J INTERN MED, V241, P471; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kazakoff K, 1996, NUTR CANCER, V26, P265, DOI 10.1080/01635589609514483; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Leach SD, 2004, CANCER CELL, V5, P7, DOI 10.1016/S1535-6108(03)00337-4; Lukanova A, 2004, INT J CANCER, V108, P262, DOI 10.1002/ijc.11544; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; POUR PM, 1990, CANCER RES, V50, P1634; POUR PM, 1984, J NATL CANCER I, V72, P1205; Reaven G, 2003, J AM COLL CARDIOL, V41, P1044, DOI 10.1016/S0735-1097(02)02982-0; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Stolzenberg-Solomon RZ, 2002, CANCER CAUSE CONTROL, V13, P417, DOI 10.1023/A:1015729615148; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105	33	283	290	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2872	2878		10.1001/jama.294.22.2872	http://dx.doi.org/10.1001/jama.294.22.2872			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352795				2022-12-28	WOS:000233826700028
J	Hingorani, A; Humphries, S				Hingorani, A; Humphries, S			Nature's randomised trials	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; DISEASE; GENES		British Heart Fdn Labs, UCL, Div Med, Ctr Cardiovasc Genet, London WC1E 6JJ, England; British Heart Fdn Labs, UCL, Div Med, Ctr Clin Pharmacol, London WC1E 6JJ, England	University of London; University College London; University of London; University College London	Hingorani, A (corresponding author), British Heart Fdn Labs, UCL, Div Med, Ctr Cardiovasc Genet, London WC1E 6JJ, England.	steve.humphries@ucl.ac.uk		Hingorani, Aroon/0000-0001-8365-0081				Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Keavney B, 2004, INT J EPIDEMIOL, V33, P11, DOI 10.1093/ije/dyh056; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pradhan AD, 2003, ARTERIOSCL THROM VAS, V23, P650, DOI 10.1161/01.ATV.0000065636.15310.9C; Sattar N, 2004, ARTERIOSCL THROM VAS, V24, P583, DOI 10.1161/01.ATV.0000118277.41584.63; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E	13	133	137	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1906	1908		10.1016/S0140-6736(05)67767-7	http://dx.doi.org/10.1016/S0140-6736(05)67767-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325682				2022-12-28	WOS:000233777900005
J	Holt, G; Vass, C; Kumar, CS				Holt, G; Vass, C; Kumar, CS			Lessons of the week - Acute crystal arthritis mimicking infection after total knee arthroplasty	BRITISH MEDICAL JOURNAL			English	Review							GOUT; ARTHROPATHY; REPLACEMENT; PSEUDOGOUT; ASPIRATION; REVISION; JOINT; HIP		Glasgow Royal Infirm, Dept Orthopaed & Trauma Surg, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Holt, G (corresponding author), Glasgow Royal Infirm, Dept Orthopaed & Trauma Surg, Glasgow G4 0SF, Lanark, Scotland.	graemeholt@btinternet.com						Archibeck MJ, 2001, CLIN ORTHOP RELAT R, P377; Barrack RL, 1997, CLIN ORTHOP RELAT R, P8; Blyth P, 1999, J ARTHROPLASTY, V14, P380, DOI 10.1016/S0883-5403(99)90067-0; BRAUSE BD, 1982, ORTHOP CLIN N AM, V13, P245; DIEPPE PA, 1982, ANN RHEUM DIS, V41, P371, DOI 10.1136/ard.41.4.371; Duff GP, 1996, CLIN ORTHOP RELAT R, P132; HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206; HEALEY JH, 1984, J BONE JOINT SURG AM, V66A, P610, DOI 10.2106/00004623-198466040-00018; JOSEPH J, 1995, GERIATRICS, V50, P33; Kobayashi H, 2002, ARCH ORTHOP TRAUM SU, V122, P469, DOI 10.1007/s00402-002-0414-7; LEVIN BR, 1991, TRENDS ECOL EVOL, V6, P237, DOI 10.1016/0169-5347(91)90067-8; Minnema B, 2004, INFECT CONT HOSP EP, V25, P477, DOI 10.1086/502425; Schumacher HR, 1989, TXB RHEUMATOLOGY, P637; Tsukayama DT, 2003, J BONE JOINT SURG AM, V85A, P75, DOI 10.2106/00004623-200300001-00014; WILLIAMSON SC, 1994, J BONE JOINT SURG AM, V76A, P126, DOI 10.2106/00004623-199401000-00018	15	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 3	2005	331	7528					1322	1323		10.1136/bmj.331.7528.1322	http://dx.doi.org/10.1136/bmj.331.7528.1322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16322021	Green Published			2022-12-28	WOS:000233778500022
J	Macilwain, C				Macilwain, C			Swiss star finds it tough at the top	NATURE			English	News Item								On the banks of Lake Geneva, at a cost of US$ 260 million, Serono is building a new headquarters. From next autumn the complex will house 1,200 research and administrative staff, and it provides concrete proof that the Swiss company is in the top tier of global biotechnology. Serono holds more than half of the global market in fertility treatments with drugs such as GONAL-f (follitropin-alpha), which induces ovulation in infertile women. But two-thirds of its revenues are generated by Rebif (recombinant beta-interferon), which is used to treat multiple sclerosis.											0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					557	557		10.1038/438557a	http://dx.doi.org/10.1038/438557a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319858	Bronze			2022-12-28	WOS:000233593100016
J	Ray, WA				Ray, WA			Observational studies of drugs and mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; TRIALS		Vanderbilt Univ, Sch Med, Dept Prevent Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA.							Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Yusuf S, 2002, AM HEART J, V143, P22, DOI 10.1067/mhj.2002.119770	5	39	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2319	2321		10.1056/NEJMp058267	http://dx.doi.org/10.1056/NEJMp058267			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319379				2022-12-28	WOS:000233574600002
J	Annas, GJ				Annas, GJ			Jumping frogs, endangered toads, and California's medical-marijuana law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1990, JAMA-J AM MED ASSOC, V263, P858, DOI 10.1001/jama.263.6.858; Annas GJ, 1997, NEW ENGL J MED, V337, P435, DOI 10.1056/NEJM199708073370621; Annas GJ, 1997, NEW ENGL J MED, V337, P1098, DOI 10.1056/NEJM199710093371523; CUMMINGS J, 2005, WALL STREET J   0815, pA3; NEIDER C, 1957, COMPLETE SHORT STORI, P1	5	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2291	2296		10.1056/NEJMlim053151	http://dx.doi.org/10.1056/NEJMlim053151			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986FC	16306529	Green Published			2022-12-28	WOS:000233434500016
J	Sprinzak, D; Elowitz, MB				Sprinzak, D; Elowitz, MB			Reconstruction of genetic circuits	NATURE			English	Review							ESCHERICHIA-COLI; TRANSCRIPTION NETWORKS; SYNTHETIC BIOLOGY; NOISE-PROPAGATION; MAMMALIAN-CELLS; TOGGLE SWITCH; SINGLE-CELL; EXPRESSION; RIBOREGULATORS; AUTOREGULATION	The complex genetic circuits found in cells are ordinarily studied by analysis of genetic and biochemical perturbations. The inherent modularity of biological components like genes and proteins enables a complementary approach: one can construct and analyse synthetic genetic circuits based on their natural counterparts. Such synthetic circuits can be used as simple in vivo models to explore the relation between the structure and function of a genetic circuit. Here we describe recent progress in this area of synthetic biology, highlighting newly developed genetic components and biological lessons learned from this approach.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Sprinzak, David/0000-0001-6776-6957				Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Arkin AP, 2001, CURR OPIN BIOTECH, V12, P638, DOI 10.1016/S0958-1669(01)00273-7; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bolon DN, 2002, CURR OPIN CHEM BIOL, V6, P125, DOI 10.1016/S1367-5931(02)00303-4; Brent R, 2004, NAT BIOTECHNOL, V22, P1211, DOI 10.1038/nbt1004-1211; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; GUET CC, 2004, THESIS PRINCETON U; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Judson HF., 1979, 8 DAY CREATION; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McDaniel R, 2005, CURR OPIN BIOTECH, V16, P476, DOI 10.1016/j.copbio.2005.07.002; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	48	261	280	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					443	448		10.1038/nature04335	http://dx.doi.org/10.1038/nature04335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306982				2022-12-28	WOS:000233458200038
J	Henry, DA; Hill, SR; Harris, A				Henry, DA; Hill, SR; Harris, A			Drug prices and value for money - The Australian Pharmaceutical Benefits Scheme	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-EXCELLENCE; NATIONAL-INSTITUTE; NICE; GUIDANCE; SERVICE; WILL		Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia; Monash Univ, Ctr Hlth Econ, Clayton, Vic 3168, Australia	University of Newcastle; Monash University	Henry, DA (corresponding author), Newcastle Mater Misericordiae Hosp, Level 5 Clin Sci Bldg, Waratah, NSW 2298, Australia.	david.henry@newcastle.edu.au	Henry, David/AAJ-4332-2020; Henry, David/AAU-4650-2020	Henry, David/0000-0003-2934-2242; Henry, David/0000-0001-7169-7704; Harris, Anthony/0000-0003-1641-3320				Birch Stephen, 2004, Health Care Manag Sci, V7, P35, DOI 10.1023/B:HCMS.0000005396.69890.48; Birkett DJ, 2001, HEALTH AFFAIR, V20, P104, DOI 10.1377/hlthaff.20.3.104; Cookson R, 2001, BRIT MED J, V323, P743, DOI 10.1136/bmj.323.7315.743; HARRIS AH, 2005, INT HLTH EC ASS 5 WO; Harvey KJ, 2004, MED J AUSTRALIA, V181, P256, DOI 10.5694/j.1326-5377.2004.tb06264.x; Henry DA, 2001, MED J AUSTRALIA, V174, P209, DOI 10.5694/j.1326-5377.2001.tb143234.x; HILL S, 2001, INFORMING JUDGEMENT; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; Laupacis A, 2005, MED CARE, V43, P15; Lu CY, 2004, BMJ-BRIT MED J, V329, P415, DOI 10.1136/bmj.329.7463.415; Maynard A, 2004, BMJ-BRIT MED J, V329, P227, DOI 10.1136/bmj.329.7459.227; Pearson SD, 2005, JAMA-J AM MED ASSOC, V294, P2618, DOI 10.1001/jama.294.20.2618; Poole-Wilson PA, 2002, HEART, V87, P510, DOI 10.1136/heart.87.6.510; RICHARDSON J, 2004, RULE RESCUE; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; U.S. Department of Commerce International Trade Administration, 2004, PHARM PRIC CONTR OEC; Weekes LM, 2005, BRIT J CLIN PHARMACO, V59, P112, DOI 10.1111/j.1365-2125.2005.02231.x; Whitty P, 2005, BRIT J PSYCHIAT, V186, P177, DOI 10.1192/bjp.186.3.177	18	78	81	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2630	2632		10.1001/jama.294.20.2630	http://dx.doi.org/10.1001/jama.294.20.2630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304078				2022-12-28	WOS:000233436200029
J	Sanloup, C; Schmidt, BC; Perez, EMC; Jambon, A; Gregoryanz, E; Mezouar, M				Sanloup, C; Schmidt, BC; Perez, EMC; Jambon, A; Gregoryanz, E; Mezouar, M			Retention of xenon in quartz and Earth's missing xenon	SCIENCE			English	Article							SILICATE MELTS; NOBLE-GASES; ORIGIN; ATMOSPHERES; ICE	The reactivity of xenon with terrestrial oxides was investigated by in situ synchrotron x-ray diffraction. At high temperature (T > 500 kelvin), some silicon was reduced, and the pressure stability of quartz was expanded, attesting to the substitution of some xenon for silicon. When the quartz was quenched, xenon diffused out and only a few weight percent remained trapped in samples. These results show that xenon can be covalently bonded to oxygen in quartz in the lower continental crust, providing an answer to the missing xenon problem; synthesis paths of rare gas compounds are also opened.	Univ Paris 06, F-75252 Paris, France; Inst Phys Globe, F-75252 Paris, France; Bayer Geoinst, D-95440 Bayreuth, Germany; Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon, France; Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; European Synchrotron Radiat Facil, F-38043 Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; University of Bayreuth; Ecole Normale Superieure de Lyon (ENS de LYON); University of Edinburgh; University of Edinburgh; European Synchrotron Radiation Facility (ESRF)	Sanloup, C (corresponding author), Univ Paris 06, F-75252 Paris, France.	sanloup@ccr.jussieu.fr	Sanloup, Chrystèle/D-9923-2015; Sanloup, Chrystele/AAI-3610-2020	Sanloup, Chrystèle/0000-0003-2412-6073; Gregoryanz, Eugene/0000-0001-9080-8756				ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; BELLISSENTFUNEL MC, 1992, PHYS REV B, V45, P4605, DOI 10.1103/PhysRevB.45.4605; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Brooker RA, 2003, NATURE, V423, P738, DOI 10.1038/nature01708; Caldwell WA, 1997, SCIENCE, V277, P930, DOI 10.1126/science.277.5328.930; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; ChamorroPerez E, 1996, EARTH PLANET SC LETT, V145, P97, DOI 10.1016/S0012-821X(96)00188-4; Friesen M, 1999, J CHEM PHYS, V111, P7881, DOI 10.1063/1.480123; Gerken M, 2002, INORG CHEM, V41, P198, DOI 10.1021/ic010627y; GUNDERSEN G, 1970, J CHEM PHYS, V52, P812, DOI 10.1063/1.1673060; Hansen M., 1958, CONSTITUTION BINARY, V2nd ed., P1175; Jephcoat AP, 1998, NATURE, V393, P355, DOI 10.1038/30712; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; KRUMMENACHER D, 1962, GEOCHIM COSMOCHIM AC, V26, P231, DOI 10.1016/0016-7037(62)90014-5; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; KURODA PK, 1978, ABUNDANCES ISOTOPIC, P63; MATSUDA J, 1989, GEOPHYS RES LETT, V16, P81, DOI 10.1029/GL016i001p00081; Ozima M, 1999, J GEOPHYS RES-SOL EA, V104, P25493, DOI 10.1029/1999JB900257; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; Perrillat JP, 2003, J PETROL, V44, P773, DOI 10.1093/petrology/44.4.773; Pettersson M, 1999, EUR J INORG CHEM, P729; Pyykko P, 2000, J PHYS CHEM A, V104, P3826, DOI 10.1021/jp994038d; Sanloup C, 2002, P NATL ACAD SCI USA, V99, P25, DOI 10.1073/pnas.221602698; SANLOUP C, 2005, GEOPHYS RES LETT, V29, P30; Schmidt BC, 2002, EARTH PLANET SC LETT, V195, P277, DOI 10.1016/S0012-821X(01)00584-2; SIFNER O, 1994, J PHYS CHEM REF DATA, V23, P63, DOI 10.1063/1.555956; SILL GT, 1978, ICARUS, V33, P13, DOI 10.1016/0019-1035(78)90020-9; WACKER JF, 1984, GEOCHIM COSMOCHIM AC, V48, P2373, DOI 10.1016/0016-7037(84)90232-1; WETHERILL GW, 1975, ANNU REV NUCL PART S, V25, P283, DOI 10.1146/annurev.ns.25.120175.001435	29	80	83	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1174	1177		10.1126/science.1119070	http://dx.doi.org/10.1126/science.1119070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293758				2022-12-28	WOS:000233437300042
J	Colhoun, H				Colhoun, H			After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?	LANCET			English	Editorial Material							ATORVASTATIN; EFFICACY		Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland	University College Dublin	Colhoun, H (corresponding author), Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	helen.colhoun@ucd.ie		Colhoun, Helen/0000-0002-8345-3288				*ACCORD, 2002, ACCORD PURP PROT ABS; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; American Diabetes Association, 2005, DIABETES CARE S1, V28, P54; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; FRICK MH, 1993, ANN MED, V25, P41, DOI 10.3109/07853899309147855; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y	13	24	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1829	1831		10.1016/S0140-6736(05)67668-4	http://dx.doi.org/10.1016/S0140-6736(05)67668-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310536				2022-12-28	WOS:000233643200004
J	Benn, CS; Martins, C; Rodrigues, A; Jensen, H; Lisse, IM; Aaby, P				Benn, CS; Martins, C; Rodrigues, A; Jensen, H; Lisse, IM; Aaby, P			Randomised study of effect of different doses of vitamin A on childhood morbidity and mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOUTHERN INDIA; SUPPLEMENTATION; TRIAL; IMPACT; IMMUNIZATION; INFANTS; METAANALYSIS; CHILDREN	Objectives To determine whether the dose of vitamin A currently recommended by the World Health Organization or half this dose gives better protection against childhood morbidity and mortality. Design Randomised study. Setting A combined oral polio vaccine and vitamin A supplementation campaign in Guinea-Bissau, Africa. Participants 4983 children aged 6 months to 5 years. Interventions One of two doses of vitamin A (recommended and half); oral polio vaccine. Main outcome measures Mortality and morbidity at six and nine months. Results Mortality was lower in the children who took half the recommended dose of vitamin A compared with the full dose at both six months (mortality rate ratio 0.69, 95% confidence interval 0.36 to 1.35) and nine months (0.62, 0.36 to 1.06) of follow-up. There was a significant interaction between sex and dose, the lower dose being associated with significantly reduced mortality in girls (0.19, 0.06 to 0.66) but not in boys (1.98, 0.74 to 5.29). The lower dose of vitamin A was consistently associated with lower hospital case fatality in girls (0.19, 0.02 to 1.45). Paradoxically, in children aged 6-18 months, the low dose was associated with slightly higher morbidity. Conclusions Half the dose of vitamin A currently recommended by WHO may provide equally good or better protection against mortality but not against morbidity.	State Serum Inst, Danish Epidemiol Sci Ctr, Copenhagen, Denmark; Projecto Saude Bandim, Bissau, Guinea Bissau	Aarhus University; Statens Serum Institut	Benn, CS (corresponding author), State Serum Inst, Danish Epidemiol Sci Ctr, Copenhagen, Denmark.	cb@ssi.dk		Aaby, Peter/0000-0001-8331-1389				ABDELJABER MH, 1991, AM J PUBLIC HEALTH, V81, P1654, DOI 10.2105/AJPH.81.12.1654; Bahl R, 2002, J NUTR, V132, P3243; BEATON GH, 1993, STATE ART SERIES; Benn CS, 2003, INT J EPIDEMIOL, V32, P822, DOI 10.1093/ije/dyg208; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; RAHMATHULLAH L, 1991, AM J CLIN NUTR, V54, P568, DOI 10.1093/ajcn/54.3.568; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Semba RD, 2001, ACTA PAEDIATR, V90, P1107, DOI 10.1080/080352501317061477; SOMMER A, 1986, LANCET, V1, P1169; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; *WHO UNICEF IVACG, 1997, VIT A SUPPL GUID THE	18	51	52	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1428	1430B		10.1136/bmj.38670.639340.55	http://dx.doi.org/10.1136/bmj.38670.639340.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16306060	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000234156400014
J	Penrose, O				Penrose, O			An asymmetric world	NATURE			English	Article									Heriot Watt Univ, Dept Math, Edinburgh, Midlothian, Scotland	Heriot Watt University	Penrose, O (corresponding author), Heriot Watt Univ, Dept Math, Edinburgh, Midlothian, Scotland.								0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					919	919		10.1038/438919a	http://dx.doi.org/10.1038/438919a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355197	Bronze			2022-12-28	WOS:000233934600037
J	Chen, D; Steele, AD; Lindquist, S; Guarente, L				Chen, D; Steele, AD; Lindquist, S; Guarente, L			Increase in activity during calorie restriction requires Sirt1	SCIENCE			English	Article							LONGEVITY; RATS		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			NATIONAL INSTITUTE ON AGING [R01AG011119, R37AG011119] Funding Source: NIH RePORTER; NIA NIH HHS [AG11119] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; McCarter RJM, 1997, AGING-CLIN EXP RES, V9, P73, DOI 10.1007/BF03340130; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Weindruch R., 1988, RETARDATION AGING DI	6	347	373	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1641	1641		10.1126/science.1118357	http://dx.doi.org/10.1126/science.1118357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339438				2022-12-28	WOS:000233961700034
J	Rigoni, M; Caccin, P; Gschmeissner, S; Koster, G; Postle, AD; Rossetto, O; Schiavo, G; Montecucco, C				Rigoni, M; Caccin, P; Gschmeissner, S; Koster, G; Postle, AD; Rossetto, O; Schiavo, G; Montecucco, C			Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures	SCIENCE			English	Article							MEMBRANE-FUSION; HEMIFUSION; A(2); MECHANISMS; EXOCYTOSIS; INTERPLAY; TAIPOXIN; NOTEXIN	Snake presynaptic phospholipase A2 neurotoxins (SPANS) paralyze the neuromuscular junction (NMJ). Upon intoxication, the NMJ enlarges and has a reduced content of synaptic vesicles, and primary neuronal cultures show synaptic swelling with surface exposure of the lumenal domain of the synaptic vesicle protein synaptotagmin I. Concomitantly, these neurotoxins induce exocytosis of neurotransmitters. We found that an equimolar mixture of lysophospholipids and fatty acids closely mimics all of the biological effects of SPANS. These results draw attention to the possible role of local lipid changes in synaptic vesicle release and provide new tools for the study of exocytosis.	Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; Univ Padua, CNR, Inst Neurosci, I-35100 Padua, Italy; Canc Res UK, London Res Inst, London, England; Univ Southampton, Sch Med, Southampton SO9 5NH, Hants, England	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Cancer Research UK; University of Southampton	Montecucco, C (corresponding author), Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.	cesare.montecucco@unipd.it	koster, grielof/F-3129-2012; rossetto, ornella/AAC-3866-2022	rossetto, ornella/0000-0002-6113-3857; Postle, Anthony/0000-0001-7361-0756; Schiavo, Giampietro/0000-0002-4319-8745	Telethon [GP0272Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bonanomi D, 2005, MOL PHARMACOL, V67, P1901, DOI 10.1124/mol.104.005678; CHEN I, 1970, VIRCHOWS ARCH B, V6, P318; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; CULLCANDY SG, 1976, NEUROSCIENCE, V1, P175, DOI 10.1016/0306-4522(76)90074-9; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Harris JB, 2000, EXP NEUROL, V161, P517, DOI 10.1006/exnr.1999.7275; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kini R.M., 1997, VENOM PHOSPHOLIPASE; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; Montecucco C, 2000, TRENDS BIOCHEM SCI, V25, P266, DOI 10.1016/S0968-0004(00)01556-5; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Rigoni M, 2004, J CELL SCI, V117, P3561, DOI 10.1242/jcs.01218; ROLDAN ERS, 1998, FRONT BIOSCI, V3, P1119; Rosenberg P., 1997, VENOM PHOSPHOLIPASE, P155; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Wang JX, 2004, BRIT J PHARMACOL, V141, P586, DOI 10.1038/sj.bjp.0705646; Wei S, 2003, NEUROSCIENCE, V121, P891, DOI 10.1016/S0306-4522(03)00525-6; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yang CC, 1997, VENOM PHOSPHOLIPASE, P185	25	153	159	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1678	1680		10.1126/science.1120640	http://dx.doi.org/10.1126/science.1120640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339444				2022-12-28	WOS:000233961700044
J	Jakosky, BM; Haberle, RM; Arvidson, RE				Jakosky, BM; Haberle, RM; Arvidson, RE			The changing picture of volatiles and climate on Mars	SCIENCE			English	Editorial Material							ICE; CAP		Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Washington University (WUSTL)	Jakosky, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu						Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Colaprete A, 2005, NATURE, V435, P184, DOI 10.1038/nature03561; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Jakosky BM, 2003, ASTROBIOLOGY, V3, P343, DOI 10.1089/153110703769016433; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Sackmann IJ, 2003, ASTROPHYS J, V583, P1024, DOI 10.1086/345408; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; SHEAN DE, 2005, J GEOPHYS RES, V110, P20601, DOI DOI 10.1029/2004JE002630; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Thomas PC, 2005, ICARUS, V174, P535, DOI 10.1016/j.icarus.2004.07.028; Wood BE, 2005, ASTROPHYS J, V628, pL143, DOI 10.1086/432716	17	13	13	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1439	1440		10.1126/science.1118031	http://dx.doi.org/10.1126/science.1118031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322442				2022-12-28	WOS:000233756500028
J	Kang, JH; Shi, YF; Xiang, B; Qu, B; Su, WJ; Zhu, M; Zhang, M; Bao, GB; Wang, FF; Zhang, XQ; Yang, RX; Fan, FJ; Chen, XQ; Pei, G; Ma, L				Kang, JH; Shi, YF; Xiang, B; Qu, B; Su, WJ; Zhu, M; Zhang, M; Bao, GB; Wang, FF; Zhang, XQ; Yang, RX; Fan, FJ; Chen, XQ; Pei, G; Ma, L			A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; BETA-ARRESTINS; EXPORT SIGNAL; MCM PROTEINS; MICE LACKING; CELL-CYCLE; P38 MAPK; C-FOS; CHROMATIN	Chromatin modification is considered to be a fundamental mechanism of regulating gene expression to generate coordinated responses to environmental changes, however, whether it could be directly regulated by signals mediated by G protein-coupled receptors (GPCRs), the largest surface receptor family, is not known. Here, we show that stimulation of delta-opioid receptor, a member of the GPCR family, induces nuclear translocation of beta-arrestin 1 (beta arr1), which was previously known as a cytosolic regulator and scaffold of GPCR signaling. In response to receptor activation, beta arr1 translocates to the nucleus and is selectively enriched at specific promoters such as that of p27 and c-fos, where it facilitates the recruitment of histone acetyltransferase p300, resulting in enhanced local histone H4 acetylation and transcription of these genes. Our results reveal a novel function of beta arr1 as a cytoplasm-nucleus messenger in GPCR signaling and elucidate an epigenetic mechanism for direct GPCR signaling from cell membrane to the nucleus through signal-dependent histone modification.	Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Fudan Univ, Grad Sch, Pharmacol Res Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Ma, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	lanma@fudan.edu.cn	Zhang, Xiaoqing/O-3424-2017; Qu, Bin/AAK-2260-2021; Qu, Bin/M-9049-2017; Ma, Lan/B-9295-2009	Zhang, Xiaoqing/0000-0002-7405-1893; Qu, Bin/0000-0002-9382-3203; Fan, Fengjuan/0000-0001-8727-5258; Ma, Lan/0000-0001-9034-5472				Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; CURRAN T, 1985, CANCER SURV, V4, P655; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Eisinger DA, 2004, J PHARMACOL EXP THER, V309, P776, DOI 10.1124/jpet.103.061788; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Garcia C, 2004, J NEUROSCI RES, V78, P338, DOI 10.1002/jnr.20254; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shahabi NA, 2003, CELL IMMUNOL, V221, P122, DOI 10.1016/S0008-8749(03)00068-6; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Usenko T, 2003, ONCOGENE, V22, P7661, DOI 10.1038/sj.onc.1206975; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; YU VC, 1986, J BIOL CHEM, V261, P1065; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x; Zhao J, 1997, BIOCHEM BIOPH RES CO, V238, P71, DOI 10.1006/bbrc.1997.7242	45	248	262	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					833	847		10.1016/j.cell.2005.09.011	http://dx.doi.org/10.1016/j.cell.2005.09.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325578	Bronze			2022-12-28	WOS:000233814100017
J	Nimmerjahn, F; Ravetch, JV				Nimmerjahn, F; Ravetch, JV			Divergent immunoglobulin G subclass activity through selective Fc receptor binding	SCIENCE			English	Article							IGG-FC; FUCOSE	Subclasses of immunoglobulin G (IgG) display substantial differences in their ability to mediate effector responses, contributing to variable activity of antibodies against microbes and tumors. We demonstrate that the mechanism underlying this long-standing observation of subclass dominance in function is provided by the differential affinities of IgG subclasses for specific activating IgG Fc receptors compared with their affinities for the inhibitory IgG Fc receptor. The significant differences in the ratios of activating-to-inhibitory receptor binding predicted the in vivo activity. We suggest that these highly predictable functions assigned by Fc binding will be an important consideration in the design of therapeutic antibodies and vaccines.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Nimmerjahn, Falk/J-4986-2013; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; JANEWAY CA, 2001, IMMUNOBIOLOGY, V5, P20601; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; STAVNEZER J, 1995, J IMMUNOL, V155, P1647; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375	24	755	857	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1510	1512		10.1126/science.1118948	http://dx.doi.org/10.1126/science.1118948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322460				2022-12-28	WOS:000233756500048
J	Holbourn, A; Kuhnt, W; Schulz, M; Erlenkeuser, H				Holbourn, A; Kuhnt, W; Schulz, M; Erlenkeuser, H			Impacts of orbital forcing and atmospheric carbon dioxide on Miocene ice-sheet expansion	NATURE			English	Article							MIDDLE MIOCENE; CLIMATE TRANSITION; SOUTHWEST PACIFIC; ORGANIC-CARBON; OCEAN; EVOLUTION; CYCLE; PALEOCEANOGRAPHY; GLACIATION; INSOLATION	The processes causing the middle Miocene global cooling, which marked the Earth's final transition into an 'icehouse' climate about 13.9 million years ago (Myr ago)(1-4), remain enigmatic. Tectonically driven circulation changes(5,6) and variations in atmospheric carbon dioxide levels(7,8) have been suggested as driving mechanisms, but the lack of adequately preserved sedimentary successions has made rigorous testing of these hypotheses difficult. Here we present high-resolution climate proxy records, covering the period from 14.7 to 12.7 million years ago, from two complete sediment cores from the northwest and southeast subtropical Pacific Ocean. Using new chronologies through the correlation to the latest orbital model(9), we find relatively constant, low summer insolation over Antarctica coincident with declining atmospheric carbon dioxide levels at the time of Antarctic ice-sheet expansion and global cooling, suggesting a causal link. We surmise that the thermal isolation of Antarctica played a role in providing sustained long-term climatic boundary conditions propitious for ice-sheet formation. Our data document that Antarctic glaciation was rapid, taking place within two obliquity cycles, and coincided with a striking transition from obliquity to eccentricity as the drivers of climatic change.	Univ Kiel, Inst Geosci, D-24118 Kiel, Germany; Univ Bremen, Dept Geosci, D-28334 Bremen, Germany; Univ Bremen, Res Ctr Ocean Margins, D-28334 Bremen, Germany; Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, D-24118 Kiel, Germany	University of Kiel; University of Bremen; University of Bremen; University of Kiel	Holbourn, A (corresponding author), Univ Kiel, Inst Geosci, Olshaussenstr 40, D-24118 Kiel, Germany.	ah@gpi.uni-kiel.de	Schulz, Michael/P-7276-2016	Schulz, Michael/0000-0001-6500-2697; Holbourn, Ann/0000-0002-3167-0862				BERGER WH, 1994, GEOPHYS MONOGR SER, V85, P295, DOI DOI 10.1029/GM085P0295; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; FERRAZMELLO S, 1981, ASTRON J, V86, P619, DOI 10.1086/112924; FLOWER BP, 1993, PALEOCEANOGRAPHY, V8, P811, DOI 10.1029/93PA02196; FLOWER BP, 1995, PALEOCEANOGRAPHY, V10, P1095, DOI 10.1029/95PA02022; Hall IR, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000817; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; KENNETT JP, 1975, J GEOPHYS RES, V82, P3843; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Loutre MF, 2004, EARTH PLANET SC LETT, V221, P1, DOI 10.1016/S0012-821X(04)00108-6; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Mudelsee M, 1997, EARTH PLANET SC LETT, V151, P117, DOI 10.1016/S0012-821X(97)00114-3; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Sugden D, 2004, GEOL SOC AM BULL, V116, P840, DOI 10.1130/B25356.1; Vimeux F, 2001, J GEOPHYS RES-ATMOS, V106, P31863, DOI 10.1029/2001JD900076; Vincent E., 1985, CARBON CYCLE ATMOSPH, V32, P455, DOI [10.1029/GM032p0455, DOI 10.1029/GM032P0455]; Wang PX, 2003, GEOLOGY, V31, P239, DOI 10.1130/0091-7613(2003)031<0239:CRCPMI>2.0.CO;2; Woodruff F, 1991, PALEOCEANOGRAPHY, V6, P755, DOI 10.1029/91PA02561; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	30	246	260	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					483	487		10.1038/nature04123	http://dx.doi.org/10.1038/nature04123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306989				2022-12-28	WOS:000233458200046
J	Matsukage, KN; Jing, ZC; Karato, S				Matsukage, KN; Jing, ZC; Karato, S			Density of hydrous silicate melt at the conditions of Earth's deep upper mantle	NATURE			English	Article							HIGH-PRESSURE; THERMAL EXPANSIVITY; PERIDOTITE KLB-1; TRANSITION-ZONE; PHASE-RELATIONS; GPA; LIQUIDS; SYSTEM; WATER; MODEL	The chemical evolution of the Earth and the terrestrial planets is largely controlled by the density of silicate melts. If melt density is higher than that of the surrounding solid, incompatible elements dissolved in the melt will be sequestered in the deep mantle(1,2). Previous studies on dry (water-free) melts showed that the density of silicate melts can be higher than that of surrounding solids under deep mantle conditions(3-8). However, melts formed under deep mantle conditions are also likely to contain some water(2), which will reduce the melt density. Here we present data constraining the density of hydrous silicate melt at the conditions of similar to 410 km depth. We show that the water in the silicate melt is more compressible than the other components, and therefore the effect of water in reducing melt density is markedly diminished under high-pressure conditions. Our study indicates that there is a range of conditions under which a ( hydrous) melt could be trapped at the 410-km boundary and hence incompatible elements could be sequestered in the deep mantle, although these conditions are sensitive to melt composition as well as the composition of the surrounding mantle.	Ibaraki Univ, Dept Environm Sci, Ibaraki 3100056, Japan; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Ibaraki University; Yale University	Matsukage, KN (corresponding author), Ibaraki Univ, Dept Environm Sci, Ibaraki 3100056, Japan.	kmatsu@mx.ibaraki.ac.jp	Jing, Zhicheng/A-4549-2009	Jing, Zhicheng/0000-0002-1508-3238				Agee CB, 1998, PHYS EARTH PLANET IN, V107, P63, DOI 10.1016/S0031-9201(97)00124-6; AGEE CB, 1988, PHYS EARTH PLANET IN, V114, P315; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; BOTTINGA Y, 1970, AM J SCI, V269, P169, DOI 10.2475/ajs.269.2.169; BURNHAM CW, 1971, AM J SCI, V270, P54, DOI 10.2475/ajs.270.1.54; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fei Y, 1995, MINERAL PHYS CRYSTAL, P29, DOI DOI 10.1029/RF002P0029; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; Inoue T, 1992, HIGH PRESSURE RES AP, P323; ITO E, 1989, GEOPHYS RES LETT, V16, P425, DOI 10.1029/GL016i005p00425; Lange RA, 1997, CONTRIB MINERAL PETR, V130, P1, DOI 10.1007/s004100050345; LANGE RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2931, DOI 10.1016/0016-7037(87)90368-1; Li J, 2003, HIGH PRESSURE RES, V23, P389, DOI 10.1080/0895795031000088269; Litasov K, 2002, PHYS EARTH PLANET IN, V134, P105, DOI 10.1016/S0031-9201(02)00152-8; Matsukage KN, 2003, AM MINERAL, V88, P1271; MATSUKAGE KN, IN PRESS J GEOPHYS R; MORISHIMA H, 1994, SCIENCE, V265, P1202, DOI 10.1126/science.265.5176.1202; Nishihara Y, 2001, EARTH PLANET SC LETT, V190, P65, DOI 10.1016/S0012-821X(01)00378-8; NISHIHARA Y, IN PRESS PHYS EARTH; Ochs FA, 1997, CONTRIB MINERAL PETR, V129, P155, DOI 10.1007/s004100050329; Ochs FA, 1999, SCIENCE, V283, P1314, DOI 10.1126/science.283.5406.1314; OHTANI E, 1993, P JPN ACAD B-PHYS, V69, P23, DOI 10.2183/pjab.69.23; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; Richet P, 2000, CONTRIB MINERAL PETR, V138, P337, DOI 10.1007/s004100050567; STOLPER E, 1981, J GEOPHYS RES, V86, P6261, DOI 10.1029/JB086iB07p06261; Suzuki A, 2003, PHYS CHEM MINER, V30, P449, DOI 10.1007/s00269-003-0322-6; SUZUKI A, 1995, SCIENCE, V269, P216, DOI 10.1126/science.269.5221.216; Suzuki A, 1998, PHYS EARTH PLANET IN, V107, P53, DOI 10.1016/S0031-9201(97)00123-4; TAKAHASHI E, 1993, PHILOS T ROY SOC A, V342, P105, DOI 10.1098/rsta.1993.0008; Zhang J, 1996, PHYS CHEM MINER, V23, P1, DOI 10.1007/BF00202987	30	111	122	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					488	491		10.1038/nature04241	http://dx.doi.org/10.1038/nature04241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306990				2022-12-28	WOS:000233458200047
J	Chen, J; Perebeinos, V; Freitag, M; Tsang, J; Fu, Q; Liu, J; Avouris, P				Chen, J; Perebeinos, V; Freitag, M; Tsang, J; Fu, Q; Liu, J; Avouris, P			Bright infrared emission from electrically induced excitons in carbon nanotubes	SCIENCE			English	Article							IMPACT IONIZATION; SPECTRA	We used the high local electric fields at the junction between the suspended and supported parts of a single carbon nanotube molecule to produce unusually bright infrared emission under unipolar operation. Carriers were accelerated by band-bending at the suspension interface; and they created excitons that radiatively recombined. This excitation mechanism is similar to 1000 times more efficient than recombination of independently injected electrons and holes, and it results from weak electron-phonon scattering and strong electron-hole binding caused by one-dimensional confinement. The ensuing high excitation density allows us to observe emission from higher excited states not seen by photoexcitation. The excitation mechanism of these states was analyzed.	IBM Corp, Thomas J Watson Res Ctr, Div Res, Yorktown Hts, NY 10598 USA; Duke Univ, Dept Chem, Durham, NC 27708 USA	International Business Machines (IBM); Duke University	Chen, J (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Div Res, POB 218, Yorktown Hts, NY 10598 USA.	chenjia@us.ibm.com; avouris@us.ibm.com	Liu, Jie/B-4440-2010	Liu, Jie/0000-0003-0451-6111; Avouris, Phaedon/0000-0001-9902-8000				Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; Avouris P, 2004, MRS BULL, V29, P403, DOI 10.1557/mrs2004.123; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; BENEDICT LX, 1995, PHYS REV B, V52, P8541, DOI 10.1103/PhysRevB.52.8541; Chou SG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.127402; Freitag M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076803; Freitag M, 2004, NANO LETT, V4, P1063, DOI 10.1021/nl049607u; Hagen A, 2004, APPL PHYS A-MATER, V78, P1137, DOI 10.1007/s00339-003-2465-1; HEINZE S, 2005, IN PRESS INTROD MOL; Htoon H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.127403; Islam MF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037404; Javey A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.106804; Kono J, 2004, APPL PHYS A-MATER, V78, P1093, DOI 10.1007/s00339-003-2458-0; Lefebvre J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217401; Ma YZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157402; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; OKUTO Y, 1972, PHYS REV B, V6, P3076, DOI 10.1103/PhysRevB.6.3076; Ostojic GN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.097401; Park JY, 2004, NANO LETT, V4, P517, DOI 10.1021/nl035258c; Perebeinos V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.086802; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; PEREBEINOS V, IN PRESS NANO LETT; Qiu XH, 2005, NANO LETT, V5, P749, DOI 10.1021/nl050227y; Rahman A, 2003, IEEE T ELECTRON DEV, V50, P1853, DOI 10.1109/TED.2003.815366; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; TEDESCO C, 1993, IEEE T ELECTRON DEV, V40, P1211, DOI 10.1109/16.216423; van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Wang F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.177401; Weisman RB, 2003, NANO LETT, V3, P1235, DOI 10.1021/nl034428i; YAN RH, 1992, IEEE T ELECTRON DEV, V39, P1704, DOI 10.1109/16.141237; Yu P., 1996, FUNDAMENTALS SEMICON	32	305	312	0	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1171	1174		10.1126/science.1119177	http://dx.doi.org/10.1126/science.1119177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293757				2022-12-28	WOS:000233437300041
J	Discher, DE; Janmey, P; Wang, YL				Discher, DE; Janmey, P; Wang, YL			Tissue cells feel and respond to the stiffness of their substrate	SCIENCE			English	Review							EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; MYOSIN-II; IN-VIVO; MECHANICAL-PROPERTIES; TRACTION FORCE; TENSION; GROWTH; MODEL; RHO	Normal tissue cells are generally not viable when suspended in a fluid and are therefore said to be anchorage dependent. Such cells must adhere to a solid, but a solid can be as rigid as glass or softer than a baby's skin. The behavior of some cells on, soft materials is. characteristic of important phenotypes; for example, cell growth on soft agar gels is used to identify cancer cells. However, an understanding of how tissue cells-including fibroblasts, myocytes, neurons, and other cell types-sense matrix stiffness is just emerging with quantitative studies of cells adhering to gels (or to other cells) with which elasticity can be tuned to approximate that of tissues. Key roles in molecular pathways are played by adhesion complexes and the actin-myosin cytoskeleton, whose contractile forces are transmitted through transcellular structures. The feedback of local matrix stiffness on cell state likely has important implications for development, differentiation, disease, and regeneration.	Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; Univ Massachusetts, Dept Physiol, Worcester, MA 01655 USA; Univ Massachusetts, Dept Cell Biol, Worcester, MA 01655 USA	University of Pennsylvania; University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Discher, DE (corresponding author), Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu		discher, dennis/0000-0001-6163-2229; Wang, Yu-Li/0000-0001-7917-0165				Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Asthagiri AR, 2000, J CELL SCI, V113, P4499; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Beningo KA, 2002, J CELL SCI, V115, P849; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; Diridollou S, 2000, SKIN RES TECHNOL, V6, P214, DOI 10.1034/j.1600-0846.2000.006004214.x; Doyle A, 2004, J CELL SCI, V117, P2203, DOI 10.1242/jcs.01087; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler A. C., UNPUB; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; EVANS E, 1993, J CELL BIOL, V122, P1295, DOI 10.1083/jcb.122.6.1295; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fung Y.C., 1994, 1 COURSE CONTINUUM M; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; GEORGES PC, UNPUB; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; Gratzer PF, 2004, BIOMATERIALS, V25, P2081, DOI 10.1016/j.biomaterials.2003.08.059; Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496; Griffin MA, 2005, J CELL SCI, V118, P1405, DOI 10.1242/jcs.01717; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101; JAY PY, 1995, J CELL SCI, V108, P387; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; LEADER WM, 1983, J CELL SCI, V64, P1; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Marganski WA, 2003, METHOD ENZYMOL, V361, P197; McKnight AL, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781411; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; Pelham RJ, 1998, P NATL ACAD SCI USA, V95, P12070; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAEZ A, IN PRESS BIOPHYS J; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Shikinami Y, 2003, BIOMATERIALS, V24, P3161, DOI 10.1016/S0142-9612(03)00155-8; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; TRINKAUS JP, 1964, DEV BIOL, V9, P115, DOI 10.1016/0012-1606(64)90017-X; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WANG Y, UNPUB; Welch DR, 2000, CANCER RES, V60, P1552; Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yoshikawa Y, 1999, BIOCHEM BIOPH RES CO, V256, P13, DOI 10.1006/bbrc.1999.0279; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723	86	4557	4674	47	1594	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1139	1143		10.1126/science.1116995	http://dx.doi.org/10.1126/science.1116995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293750	Green Submitted			2022-12-28	WOS:000233437300033
J	Mayer, G				Mayer, G			Rigid biological systems as models for synthetic composites	SCIENCE			English	Review							MECHANICAL-PROPERTIES; TOUGHNESS; SKELETON; BEHAVIOR	Advances that have been made in understanding the mechanisms underlying the mechanical behavior of a number of biological materials (namely mollusk shells and sponge spicules) are discussed here. Attempts at biomimicry of the structure of a nacreous layer of a mollusk shell have shown reasonable success. However, they have revealed additional issues that must be addressed if new synthetic composite materials that are based on natural systems are to be constructed. Some of the important advantages and limitations of copying from nature are also described here.	Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mayer, G (corresponding author), Univ Washington, Dept Mat Sci & Engn, Roberts Hall 335,Box 352120, Seattle, WA 98195 USA.	gmayer@u.washington.edu						Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; BREBBIA CA, 2002, DESIGN NATURE; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Currey J.D., 1980, Symposia of the Society for Experimental Biology, P75; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954; Currey JD, 2002, BONES STRUCTURE MECH; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; GRUNER BM, 2003, THESIS U WASHINGTON; Han YJ, 2004, MATER RES SOC SYMP P, V823, P115; JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516; Mann S, 2001, BIOMINERALIZATION; Mayer G, 2005, MATER RES SOC SYMP P, V844, P79; MAYER G, IN PRESS MAT SCI E C; *NAT MAT ADV BOARD, 1990, NMAB464; Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P113, DOI 10.1016/j.msec.2005.01.004; POCIUS AV, 2002, COMMUNICATION    MAR; RODRIGUEZ M, 2004, THESIS U WASHINGTON; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; SARIKAYA M, 1990, P AM SOC COMP 5 TECH, P176; Scurr DJ, 2005, MATER RES SOC SYMP P, V844, P87; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Vecchio KS, 2005, JOM-US, V57, P25, DOI 10.1007/s11837-005-0229-4; WALTER SG, IN PRESS MAT SCI E C; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800	32	494	516	8	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1144	1147		10.1126/science.1116994	http://dx.doi.org/10.1126/science.1116994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293751				2022-12-28	WOS:000233437300034
J	Coultas, L; Chawengsaksophak, K; Rossant, J				Coultas, L; Chawengsaksophak, K; Rossant, J			Endothelial cells and VEGF in vascular development	NATURE			English	Review							ARTERIAL-VENOUS DIFFERENTIATION; ENDOCHONDRAL BONE-FORMATION; BLOOD-VESSEL FORMATION; GROWTH-FACTOR VEGF; HEMATOPOIETIC STEM; CARDIOVASCULAR DEVELOPMENT; DEFINITIVE HEMATOPOIESIS; EMBRYONIC LETHALITY; SIGNALING PATHWAY; DIGESTIVE-SYSTEM	The intricate patterning processes that establish the complex vascular system during development depend on a combination of intrinsic pre-patterning and extrinsic responses to environmental parameters. Mutational studies in mice and fish have shown that the vascular system is highly sensitive to genetic disruption and have identified potential targets for therapeutic interventions. New insights into non-vascular roles of vascular endothelial growth factor and the requirement for endothelial cells in adult organs and stem-cell niches highlight possible side effects of anti-angiogenic therapy and the need for new targets.	Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rossant, J (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	janet.rossant@sickkids.ca	Chawengsaksophak, Kallayanee/G-4427-2014	Chawengsaksophak, Kallayanee/0000-0001-9401-2122				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Betsholtz C, 2005, EXP SUPPL, V94, P115; Bikfalvi A, 2002, TRENDS PHARMACOL SCI, V23, P576, DOI 10.1016/S0165-6147(02)02109-0; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Choi K, 1998, DEVELOPMENT, V125, P725; Chung YS, 2002, DEVELOPMENT, V129, P5511, DOI 10.1242/dev.00149; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; COFFIN JD, 1988, DEVELOPMENT, V102, P735; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Herzog Y, 2005, DEV DYNAM, V232, P1047, DOI 10.1002/dvdy.20257; Hirashima M, 2003, P NATL ACAD SCI USA, V100, P15637, DOI 10.1073/pnas.2635424100; Hogan KA, 2004, CURR TOP DEV BIOL, V62, P55; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones EAV, 2002, GENESIS, V34, P228, DOI 10.1002/gene.10162; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kinder SJ, 2001, TRENDS CARDIOVAS MED, V11, P177, DOI 10.1016/S1050-1738(01)00091-3; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lawson ND, 2001, DEVELOPMENT, V128, P3675; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Mattot V, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013925.19218.7B; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Moyon D, 2001, DEVELOPMENT, V128, P3359; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Nimmagadda S, 2005, DEV BIOL, V280, P100, DOI 10.1016/j.ydbio.2005.01.005; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reese DE, 2004, DEV CELL, V6, P699, DOI 10.1016/S1534-5807(04)00127-3; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Sumoy L, 1997, MECH DEVELOP, V63, P15, DOI 10.1016/S0925-4773(97)00671-0; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	100	733	790	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					937	945		10.1038/nature04479	http://dx.doi.org/10.1038/nature04479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355211				2022-12-28	WOS:000233934600052
J	Granger, BB; Swedberg, K; Ekman, I; Granger, CB; Olofsson, B; McMurray, JJV; Yusuf, S; Michelson, EL; Pfeffer, MA				Granger, BB; Swedberg, K; Ekman, I; Granger, CB; Olofsson, B; McMurray, JJV; Yusuf, S; Michelson, EL; Pfeffer, MA		CHARM investigators	Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial	LANCET			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; MEDICATION ADHERENCE; SELF-CARE; MORTALITY; GUIDELINES; RISK; NONCOMPLIANCE; INTERVENTION; PREDICTORS	Background Chronic heart failure (CHF) is an important cause of hospital admission and death. Poor adherence to medication is common in some chronic illnesses and might reduce the population effectiveness of proven treatments. Because little is known about adherence in patients with CHF and about the consequences of nonadherence, we assessed the association between adherence and clinical outcome in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) programme. Methods CHARM was a double-blind, randomised, controlled clinical trial, comparing the effects of the angiotensin receptor blocker candesartan with placebo in 7599 patients with CHF. Median follow-up was 38 months. The proportion of time patients took more than 80% of their study medication was defined as good adherence and 80% or less as poor adherence. We used a Cox proportional hazards regression model, with adherence as a time-dependent covariate in the model, to examine the association between adherence and mortality in the candesartan and placebo groups. Findings We excluded 187 patients because of missing information on adherence. In the time-dependent Cox regression model, after adjustment for predictive factors (demographics, physiological and severity-of-illness variables, smoking history, and number of concomitant medications), good adherence was associated with lower all-cause mortality in all patients (hazard ratio [HR] 0.65, 95% CI 0.57-0.75, p<0.0001). The adjusted HR for good adherence was similar in the candesartan (0.66, 0.55-0.81, p<0.0001) and placebo (0.64, 0.53-0.78, p<0.0001) groups. Interpretation Good adherence to medication is associated with a lower risk of death than poor adherence in patients with CHF, irrespective of assigned treatment. This finding suggests that adherence is a marker for adherence to effective treatments other than study medications, or to other adherence behaviours that affect outcome. Understanding these factors could provide an opportunity for new interventions, including those aimed at improving adherence.	Duke Univ, Med Ctr, Durham, NC USA; Duke Univ, Sch Nursing, Durham, NC USA; Sahlgrens Univ Hosp, Gothenburg, Sweden; Univ Gothenburg, Fac Hlth & Caring Sci, Inst Nursing, Gothenburg, Sweden; AstraZeneca R&D, Molndal, Sweden; Univ Glasgow, Glasgow, Lanark, Scotland; Hamilton Hlth Sci & Univ, Hamilton, ON, Canada; Brigham & Womens Hosp, Boston, MA 02115 USA; AstraZeneca LP, Wilmington, DE USA	Duke University; Duke University; Sahlgrenska University Hospital; University of Gothenburg; AstraZeneca; University of Glasgow; Harvard University; Brigham & Women's Hospital; AstraZeneca	Granger, BB (corresponding author), 8020 Willardville Stn Rd, Bahama, NC 27503 USA.	grang004@mc.duke.edu	mcmurray, John/B-2467-2013; Swedberg, Karl/B-2475-2008; Granger, Christopher B/D-3458-2014	mcmurray, John/0000-0002-6317-3975; Granger, Christopher B/0000-0002-0045-3291; Yusuf, Salim/0000-0003-4776-5601				*AM HEART ASS, 2004, HEART DIS STROK STAT; Ansari M, 2003, CIRCULATION, V107, P2799, DOI 10.1161/01.CIR.0000070952.08969.5B; Apter AJ, 1998, AM J RESP CRIT CARE, V157, P1810, DOI 10.1164/ajrccm.157.6.9712007; Balkrishnan R, 1998, CLIN THER, V20, P764, DOI 10.1016/S0149-2918(98)80139-2; Bennett S J, 1998, Am J Crit Care, V7, P168; Bohachick Patricia, 2002, Prog Cardiovasc Nurs, V17, P160, DOI 10.1111/j.0889-7204.2002.01643.x; Bouvy ML, 2003, J CARD FAIL, V9, P404, DOI 10.1054/S1071-9164(03)00130-1; Brown C, 2001, FAM PRACT, V18, P314, DOI 10.1093/fampra/18.3.314; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Carlson B, 2001, HEART LUNG, V30, P351, DOI 10.1067/mhl.2001.118611; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Dunbar-Jacob Jacqueline, 2003, J Cardiovasc Nurs, V18, P209; Ekman I, 2002, EUR HEART J, V23, P1323, DOI 10.1053/euhj.2002.3178; EKMAN I, 2005, PATIENT ED COUNS; Evangelista LS, 2001, HEART LUNG, V30, P294, DOI 10.1067/mhl.2001.116011; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Goetghebeur E, 2002, EPIDEMIOL REV, V24, P85, DOI 10.1093/epirev/24.1.85; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P749, DOI 10.1345/aph.17423; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Horowitz CR, 2004, SOC SCI MED, V58, P631, DOI 10.1016/S0277-9536(03)00232-6; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; HORWITZ RI, 1993, ARCH INTERN MED, V153, P1863, DOI 10.1001/archinte.153.16.1863; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; Jaarsma Tiny, 2002, Prog Cardiovasc Nurs, V17, P96, DOI 10.1111/j.0889-7204.2002.01520.x; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Loeys T, 2001, STAT MED, V20, P3753, DOI 10.1002/sim.1169; Mattocks KM, 2000, BIOL PSYCHIAT, V47, P693, DOI 10.1016/S0006-3223(00)00839-8; McDonald K, 2001, EUR J HEART FAIL, V3, P209, DOI 10.1016/S1388-9842(00)00134-3; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Moser D K, 2000, Annu Rev Nurs Res, V18, P91; Ni H, 1999, ARCH INTERN MED, V159, P1613, DOI 10.1001/archinte.159.14.1613; Nieminen MS, 2005, EUR HEART J, V26, P384; Park DC, 1999, J AM GERIATR SOC, V47, P172, DOI 10.1111/j.1532-5415.1999.tb04575.x; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RUBERMAN W, 1984, NEW ENGL J MED, V311, P552, DOI 10.1056/NEJM198408303110902; Russell LB, 2001, AM J PREV MED, V20, P26, DOI 10.1016/S0749-3797(00)00262-2; Schiff GD, 2003, AM J MED, V114, P625, DOI 10.1016/S0002-9343(03)00132-3; Sereika SM, 2001, AM HEART MONOGR S, P263; Stewart S, 2002, CIRCULATION, V105, P2861, DOI 10.1161/01.CIR.0000019067.99013.67; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Struthers A D, 2001, Congest Heart Fail, V7, P43, DOI 10.1111/j.1527-5299.2001.990867.x; Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Torp-Pedersen C, 2005, AM HEART J, V149, P370, DOI 10.1016/j.ahj.2004.10.002; van der Wal MHL, 2005, EUR J HEART FAIL, V7, P5, DOI 10.1016/j.ejheart.2004.04.007; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wagner JA, 1998, DIABETES CARE, V21, P1046, DOI 10.2337/diacare.21.7.1046; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	53	333	350	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2005	2011		10.1016/S0140-6736(05)67760-4	http://dx.doi.org/10.1016/S0140-6736(05)67760-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338449				2022-12-28	WOS:000233826900019
J	Janes, KA; Albeck, JG; Gaudet, S; Sorger, PK; Lauffenburger, DA; Yaffe, MB				Janes, KA; Albeck, JG; Gaudet, S; Sorger, PK; Lauffenburger, DA; Yaffe, MB			Systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis	SCIENCE			English	Article							LEAST-SQUARES REGRESSION; TNF-ALPHA; TRANSDUCTION PATHWAY; PROTEIN-KINASE; CELL-DEATH; ACTIVATION; NECROSIS; PHOSPHORYLATION; REDUNDANCY; MAP	Signal transduction pathways control cellular responses to stimuli, but it is unclear how molecular information is processed as a network. We constructed a systems model of 7980 intracellular signaling events that directly links measurements to 1440 response outputs associated with apoptosis. The model accurately predicted multiple time-dependent apoptotic responses induced by a combination of the death-inducing cytokine tumor necrosis factor with the prosurvival factors epidermal growth factor and insulin. By capturing the rote of unsuspected autocrine circuits activated by transforming growth factor-alpha and interteukin-1 alpha, the model revealed new molecular mechanisms connecting signaling to apoptosis. The model derived two groupings of intracellular signals that constitute fundamental dimensions (molecular "basis axes") within the apoptotic signaling network. Projection along these axes captures the entire measured apoptotic network, suggesting that cell survival is determined by signaling through this canonical basis set.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu		Sorger, Peter/0000-0002-3364-1838; Gaudet, Suzanne/0000-0002-5701-2825	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM059281] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM059281, P50-GM68762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu-Martin MT, 1999, AM J PHYSIOL-GASTR L, V276, pG599, DOI 10.1152/ajpgi.1999.276.3.G599; ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Del Bino G, 1999, CELL PROLIFERAT, V32, P25, DOI 10.1046/j.1365-2184.1999.00130.x; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dumont JE, 2002, AM J PHYSIOL-CELL PH, V283, pC2, DOI 10.1152/ajpcell.00581.2001; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; JANES KA, UNPUB; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Vanden Berghe Tom, 2004, Methods Mol Med, V98, P101; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yadav D, 2003, CURR OPIN IMMUNOL, V15, P697, DOI 10.1016/j.coi.2003.09.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	31	396	409	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1646	1653		10.1126/science.1116598	http://dx.doi.org/10.1126/science.1116598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339439				2022-12-28	WOS:000233961700036
J	Siridechadilok, B; Fraser, CS; Hall, RJ; Doudna, JA; Nogales, E				Siridechadilok, B; Fraser, CS; Hall, RJ; Doudna, JA; Nogales, E			Structural roles for human translation factor eIF3 in initiation of protein synthesis	SCIENCE			English	Article							HEPATITIS-C VIRUS; MESSENGER-RNA; EUKARYOTIC RIBOSOME; SUBUNIT; IDENTIFICATION; RECRUITMENT; BINDING; CODON	Protein synthesis in mammalian cells requires initiation factor eIF3, a similar to 750-kilodalton complex that controls assembly of 40S ribosomal subunits on messenger RNAs (mRNAs) bearing either a 5'-cap or an internal ribosome entry site (IRES). Cryo-electron microscopy reconstructions show that eIF3, a five-lobed particle, interacts with the hepatitis C virus (HCV) IRES RNA and the S'-cap binding complex eIF4F via the same domain. Detailed modeling of eIF3 and eIF4F onto the 40S ribosomal subunit reveals that eIF3 uses eIF4F or the HCV IRES in structurally similar ways to position the mRNA strand near the exit site of 40S, promoting initiation complex assembly.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu; enogales@lbl.gov	Fraser, Christopher/H-9186-2013					Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HALL RJ, UNPUB; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; HERSHEY JWB, COMMUNICATION; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maivali U, 2004, RNA, V10, P600, DOI 10.1261/rna.5220504; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	30	226	241	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1513	1515		10.1126/science.1118977	http://dx.doi.org/10.1126/science.1118977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322461				2022-12-28	WOS:000233756500049
J	Hornstein, E; Mansfield, JH; Yekta, S; Hu, JKH; Harfe, BD; McManus, MT; Baskerville, S; Bartel, DP; Tabin, CJ				Hornstein, E; Mansfield, JH; Yekta, S; Hu, JKH; Harfe, BD; McManus, MT; Baskerville, S; Bartel, DP; Tabin, CJ			The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development	NATURE			English	Article							RETINOIC ACID; MESSENGER-RNA; EXPRESSION; TARGETS; BUD; GENES; ZPA; MORPHOGENESIS; CLEAVAGE; FORELIMB	MicroRNAs ( miRNAs) are an abundant class of gene regulatory molecules ( reviewed in refs 1, 2). Although computational work indicates that miRNAs repress more than a third of human genes(3), their roles in vertebrate development are only now beginning to be determined. Here we show that miR- 196 acts upstream of Hoxb8 and Sonic hedgehog ( Shh) in vivo in the context of limb development, thereby identifying a previously observed but uncharacterized inhibitory activity that operates specifically in the hindlimb. Our data indicate that miR- 196 functions in a fail- safe mechanism to assure the fidelity of expression domains that are primarily regulated at the transcriptional level, supporting the idea that many vertebrate miRNAs may function as a secondary level of gene regulation.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Calif San Francisco, Ctr Diabet, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University System of Florida; University of Florida; University of California System; University of California San Francisco	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	HORNSTEIN, ERAN/K-1340-2012; mcmanus, michael/AAB-1239-2020	HORNSTEIN, ERAN/0000-0002-5534-1924; mcmanus, michael/0000-0003-3013-6569; Hu, Jimmy/0000-0003-1035-0779				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helms JA, 1996, DEVELOPMENT, V122, P1385; Kim MH, 2002, INT J DEV BIOL, V46, P325; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu HC, 1997, DEVELOPMENT, V124, P1643; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Min WG, 1998, DNA CELL BIOL, V17, P293, DOI 10.1089/dna.1998.17.293; Nelson CE, 1996, DEVELOPMENT, V122, P1449; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Stratford T, 1999, MECH DEVELOP, V81, P115, DOI 10.1016/S0925-4773(98)00231-7; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Stratford TH, 1997, DEVELOPMENT, V124, P4225; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	28	319	369	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					671	674		10.1038/nature04138	http://dx.doi.org/10.1038/nature04138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319892				2022-12-28	WOS:000233593100051
J	Kannus, P; Sievanen, H; Palvanen, M; Jarvinen, T; Parkkari, J				Kannus, P; Sievanen, H; Palvanen, M; Jarvinen, T; Parkkari, J			Prevention of falls and consequent injuries in elderly people	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION; BONE-MINERAL DENSITY; SEVERE HEAD-INJURIES; HOME-BASED EXERCISE; HIP FRACTURE RISK; OLDER-PEOPLE; PHYSICAL-ACTIVITY; MULTIFACTORIAL INTERVENTION; RESIDENTIAL CARE	Injuries resulting from falls in elderly people are a major public-health concern, representing one of the main causes of longstanding pain, functional impairment, disability, and death in this population. The problem is going to worsen, since the rates of such injuries seem to be rising in many areas, as is the number of elderly people in both the developed and developing world. Many methods and programmes to prevent such injuries already exist, including regular exercise, vitamin D and calcium supplementation, withdrawal of psychotropic medication, cataract surgery, professional environment hazard assessment and modification, hip protectors, and multifactorial preventive programmes for simultaneous assessment and reduction of many of the predisposing and situational risk factors. To receive broader-scale effectiveness, these programmes will need systematic implementation. Care must be taken, however, to rigorously select the right actions for those people most likely to benefit, such as vitamin D and calcium supplementation and hip protectors for elderly people living in institutions.	UKK Inst Hlth Promot Res, Accid & Trauma Res Ctr, FIN-33501 Tampere, Finland; Tampere Univ, Sch Med, Dept Surg, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland	UKK Institute; Tampere University; Tampere University; Tampere University Hospital; UKK Institute	Kannus, P (corresponding author), UKK Inst Hlth Promot Res, Accid & Trauma Res Ctr, POB 30, FIN-33501 Tampere, Finland.		Järvinen, Teppo/B-8189-2013	Järvinen, Teppo/0000-0003-3713-956X				Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Anderson FH, 2004, J BONE MINER RES, V19, pS57; Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Becker C, 2003, J AM GERIATR SOC, V51, P306, DOI 10.1046/j.1532-5415.2003.51103.x; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, pS57; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Blair SN, 2000, AM J HEALTH PROMOT, V15, P1; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; BRIGNOLE M, 2004, INT S PREV FALLS FRA; BUTLER RN, 1998, GERIATRICS, V53, P49; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Carroll Norman V, 2005, J Manag Care Pharm, V11, P307; Carter ND, 2001, SPORTS MED, V31, P427, DOI 10.2165/00007256-200131060-00003; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Close JCT, 2005, AGE AGEING, V34, P98, DOI 10.1093/ageing/afi052; CRANNEY A, 2003, COCHRANE DB SYST REV, V4; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359/jbmr.1997.12.9.1321; Cumming RG, 2002, CLIN GERIATR MED, V18, P175, DOI 10.1016/S0749-0690(02)00004-6; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; de Boer MR, 2004, J BONE MINER RES, V19, P1539, DOI 10.1359/JBMR.040504; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; Dyer CAE, 2004, AGE AGEING, V33, P596, DOI 10.1093/ageing/afh204; Feder G, 2000, BRIT MED J, V321, P1007, DOI 10.1136/bmj.321.7267.1007; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Gallagher B, 2001, Home Care Provid, V6, P157, DOI 10.1067/mhc.2001.119263; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gillespie L, 2004, BMJ-BRIT MED J, V328, P653, DOI 10.1136/bmj.328.7441.653; Gillespie LD, 2003, COCHRANE DATABASE SY; GILLESPIE WJ, 2001, COCHRANE DB SYST REV, V1; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Haines TP, 2004, BMJ-BRIT MED J, V328, P676, DOI 10.1136/bmj.328.7441.676; Hansen K S, 2004, Scand J Surg, V93, P198; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; HAYES WC, 1993, CALCIFIED TISSUE INT, V52, P192, DOI 10.1007/BF00298717; Healey F, 2004, AGE AGEING, V33, P390, DOI 10.1093/ageing/afh130; Heinonen A, 1996, LANCET, V348, P1343, DOI 10.1016/S0140-6736(96)04214-6; Hill-Westmoreland EE, 2002, NURS RES, V51, P1, DOI 10.1097/00006199-200201000-00002; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; Hoidrup S, 2001, AM J EPIDEMIOL, V154, P60, DOI 10.1093/aje/154.1.60; Honkanen LA, 2005, J AM GERIATR SOC, V53, P190, DOI 10.1111/j.1532-5415.2005.53102.x; Howe TE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000333.pub2; Jensen J, 2003, J AM GERIATR SOC, V51, P627, DOI 10.1034/j.1600-0579.2003.00206.x; Jensen J, 2002, ANN INTERN MED, V136, P733, DOI 10.7326/0003-4819-136-10-200205210-00008; Joakimsen RM, 1997, OSTEOPOROSIS INT, V7, P503, DOI 10.1007/BF02652555; Johnell O, 2001, ACTA ORTHOP SCAND, V72, P325, DOI 10.1080/000164701753541952; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 1999, LANCET, V353, P802, DOI 10.1016/S0140-6736(98)04235-4; Kannus P, 2005, AM J PUBLIC HEALTH, V95, P422, DOI 10.2105/AJPH.2004.047779; Kannus P, 2003, LANCET, V362, P1168, DOI 10.1016/S0140-6736(03)14554-0; Kannus P, 1999, BMJ-BRIT MED J, V318, P205; Kannus P, 2002, J BONE MINER RES, V17, P1363, DOI 10.1359/jbmr.2002.17.8.1363; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Kenny RAM, 2001, J AM COLL CARDIOL, V38, P1491, DOI 10.1016/S0735-1097(01)01537-6; Kerse N, 2004, J AM GERIATR SOC, V52, P524, DOI 10.1111/j.1532-5415.2004.52157.x; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Korpelainen R, 2006, OSTEOPOROSIS INT, V17, P109, DOI 10.1007/s00198-005-1924-2; Kujala UM, 2000, ARCH INTERN MED, V160, P705, DOI 10.1001/archinte.160.5.705; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Latham NK, 2003, J AM GERIATR SOC, V51, P1219, DOI 10.1046/j.1532-5415.2003.51405.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Li FZ, 2004, MED SCI SPORT EXER, V36, P2046, DOI 10.1249/01.MSS.0000147590.54632.E7; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Liu-Ambrose T, 2004, J AM GERIATR SOC, V52, P657, DOI 10.1111/j.1532-5415.2004.52200.x; LORD S, 2004, INT S PREV FALLS FRA; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; Lord SR, 2003, J AM GERIATR SOC, V51, P1685, DOI 10.1046/j.1532-5415.2003.51551.x; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Mack KA, 2004, J WOMENS HEALTH, V13, P754, DOI 10.1089/jwh.2004.13.754; Marigold DS, 2005, J AM GERIATR SOC, V53, P416, DOI 10.1111/j.1532-5415.2005.53158.x; McClure R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004441.pub2; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McMurdo MET, 2000, GERONTOLOGY, V46, P83, DOI 10.1159/000022139; Means KM, 2005, AM J PHYS MED REHAB, V84, P238, DOI 10.1097/01.PHM.0000151944.22116.5A; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Moreland J, 2003, GERONTOLOGY, V49, P93, DOI 10.1159/000067948; *NAT I CLIN EXC, 2004, CLIN GUID, V21; Nordstrom A, 2005, J BONE MINER RES, V20, P202, DOI 10.1359/JBMR.041012; Oliver D, 2004, AGE AGEING, V33, P532, DOI 10.1093/ageing/afh239; Oliver D, 2004, AGE AGEING, V33, P328, DOI 10.1093/ageing/afh145; Palvanen M, 2000, OSTEOPOROSIS INT, V11, P822, DOI 10.1007/s001980070040; PARKER MJ, 2004, COCHRANE DB SYST REV, V3, P1255; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Reginster JY, 2005, BMJ-BRIT MED J, V330, P859, DOI 10.1136/bmj.330.7496.859; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Schwartz AV, 1998, OSTEOPOROSIS INT, V8, P240, DOI 10.1007/s001980050060; Schwartz S, 2005, INVEST OPHTH VIS SCI, V46, P920, DOI 10.1167/iovs.04-0543; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Shea B, 2004, COCHRANE DB SYST REV, V1; Sherrington C, 2004, J Sci Med Sport, V7, P43, DOI 10.1016/S1440-2440(04)80277-9; Sinaki M, 2002, BONE, V30, P836, DOI 10.1016/S8756-3282(02)00739-1; Skelton D, 2004, J BONE MINER RES, V19, pS493; Skelton D., 2004, WHAT ARE MAIN RISK F; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Stevens M, 2001, J AM GERIATR SOC, V49, P1448, DOI 10.1046/j.1532-5415.2001.4911236.x; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; VANWEEL C, 1995, LANCET, V345, P1549, DOI 10.1016/S0140-6736(95)91091-3; Venning G, 2005, BRIT MED J, V330, P524, DOI 10.1136/bmj.330.7490.524; Vu Man Quang, 2004, J Am Med Dir Assoc, V5, P401, DOI 10.1016/S1525-8610(04)70009-2; Weatherall M, 2004, INTERN MED J, V34, P102, DOI 10.1111/j.1444-0903.2004.t01-15-.x; Wei TS, 2001, OSTEOPOROSIS INT, V12, P1050, DOI 10.1007/PL00004184; Weir E, 2004, CAN MED ASSOC J, V171, P724, DOI 10.1503/cmaj.1041381; Wolf SL, 2003, J AM GERIATR SOC, V51, P1693, DOI 10.1046/j.1532-5415.2003.51552.x; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89	141	726	750	2	119	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1885	1893		10.1016/S0140-6736(05)67604-0	http://dx.doi.org/10.1016/S0140-6736(05)67604-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310556				2022-12-28	WOS:000233643200028
J	Micchelli, CA; Perrimon, N				Micchelli, CA; Perrimon, N			Evidence that stem cells reside in the adult Drosophila midgut epithelium	NATURE			English	Article							SELF-RENEWAL; NOTCH	Adult stem cells maintain organ systems throughout the course of life and facilitate repair after injury or disease(1). A fundamental property of stem and progenitor cell division is the capacity to retain a proliferative state or generate differentiated daughter cells(2); however, little is currently known about signals that regulate the balance between these processes. Here, we characterize a proliferating cellular compartment in the adult Drosophila midgut. Using genetic mosaic analysis we demonstrate that differentiated cells in the epithelium arise from a common lineage. Furthermore, we show that reduction of Notch signalling leads to an increase in the number of midgut progenitor cells, whereas activation of the Notch pathway leads to a decrease in proliferation. Thus, the midgut progenitor's default state is proliferation, which is inhibited through the Notch signalling pathway. The ability to identify, manipulate and genetically trace cell lineages in the midgut should lead to the discovery of additional genes that regulate stem and progenitor cell biology in the gastrointestinal tract.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Micchelli, CA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cmicchel@genetics.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				BOZCUK AN, 1972, EXP GERONTOL, V7, P147, DOI 10.1016/0531-5565(72)90022-8; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, COLD SPRING HARBOR M, P149; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li L, 2000, GENE DEV, V14, P147; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller A., 1950, BIOL DROSOPHILA, P420; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; OHLSTEIN B, 2005, NATURE          1207, DOI DOI 10.1038/NATURE04333; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Strasburger M, 1932, Z WISS ZOOL ABT A, V140, P539; Torii MA, 1999, DEVELOPMENT, V126, P443; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH; Xie T, 2001, COLD SPRING HARBOR M, P129; XU T, 1993, DEVELOPMENT, V117, P1223	19	761	778	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					475	479		10.1038/nature04371	http://dx.doi.org/10.1038/nature04371			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16340959				2022-12-28	WOS:000234859200047
J	Heath, I; Sweeney, K				Heath, I; Sweeney, K			The NHS revolution: health care in the market place - Medical generalists: connecting the map and the territory	BRITISH MEDICAL JOURNAL			English	Editorial Material									Caversham Grp Practice, London NW5 2UP, England; Royal Devon & Exeter Hosp, Peninsula Med Sch, Exeter EX2 5DW, Devon, England	University of Exeter	Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com						AHLBOM A, 1984, INTRO MODERN EPIDEMI; De Maeseneer J, 2000, BRIT MED J, V320, P1616, DOI 10.1136/bmj.320.7250.1616; Forrest CB, 2003, BRIT MED J, V326, P692, DOI 10.1136/bmj.326.7391.692; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Heath I, 1999, BRIT J GEN PRACT, V49, P651; Korzybski A., 1933, SCI SANITY INTRO NON; *ROYAL COLL GEN PR, 2003, HARD LIV IMPR HLTH P; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Towell D, 1996, POLICY POLIT, V24, P287, DOI 10.1332/030557396782148507; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7	11	20	20	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1462	1464		10.1136/bmj.331.7530.1462	http://dx.doi.org/10.1136/bmj.331.7530.1462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356984	Green Published			2022-12-28	WOS:000234156400029
J	Calais, E; Mattioli, G; DeMets, C; Nocquet, JM; Stein, S; Newman, A; Rydelek, P				Calais, E; Mattioli, G; DeMets, C; Nocquet, JM; Stein, S; Newman, A; Rydelek, P			Tectonic strain in plate interiors?	NATURE			English	Article							MADRID SEISMIC ZONE; EARTHQUAKES		Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; Univ Arkansas, Dept Geol, Fayetteville, AR 72701 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; CNRS, Geosci Azur, F-06560 Valbonne, France; Northwestern Univ, Dept Geol Sci, Evanston, IL 60208 USA; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Univ Memphis, Ctr Earthquake Res, Memphis, TN 38152 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arkansas System; University of Arkansas Fayetteville; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Northwestern University; University System of Georgia; Georgia Institute of Technology; University of Memphis	Calais, E (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA.	ecalais@purdue.edu	Mattioli, Glen S/C-6619-2011; Mattioli, Glen/AAC-3410-2020; Calais, Eric/K-8219-2012; Newman, Andrew V/E-7682-2012	Mattioli, Glen/0000-0002-9117-7471; Calais, Eric/0000-0002-5935-8117; Newman, Andrew V/0000-0001-7414-1197; Nocquet, Jean-Mathieu/0000-0002-3436-9354				Beavan J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000282; Kenner SJ, 2000, SCIENCE, V289, P2329, DOI 10.1126/science.289.5488.2329; Newman A, 1999, SCIENCE, V284, P619, DOI 10.1126/science.284.5414.619; Nocquet JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022174; RYDELEK PA, 1994, GEOPHYSICAL RES LETT, V21, P2302; Smalley R, 2005, NATURE, V435, P1088, DOI 10.1038/nature03642; TUTTLE MP, 1995, GEOLOGY, V23, P253, DOI 10.1130/0091-7613(1995)023<0253:AAPEFL>2.3.CO;2	7	40	40	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					E9	E10		10.1038/nature04428	http://dx.doi.org/10.1038/nature04428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355163				2022-12-28	WOS:000233934600048
J	Simantirakis, EN; Schiza, SE; Chrysostomakis, SI; Chlouverakis, GI; Klapsinos, NC; Siafakas, NM; Vardas, PE				Simantirakis, EN; Schiza, SE; Chrysostomakis, SI; Chlouverakis, GI; Klapsinos, NC; Siafakas, NM; Vardas, PE			Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; HEART-FAILURE; BLOOD-PRESSURE; THERAPY; CPAP; DISTURBANCES; MECHANISMS	BACKGROUND: The role of atrial overdrive pacing (AOP) in sleep apnea remains uncertain. We prospectively evaluated the effect of AOP after 24 hours and after one month in patients with the obstructive sleep apnea-hypopnea syndrome and compared it with the use of nasal continuous positive airway pressure (n-CPAP). METHODS: We studied 16 patients with a moderate or severe case of the obstructive sleep apnea-hypopnea syndrome (baseline mean apnea-hypopnea index, 49) and normal left ventricular systolic function in whom a dual-chamber pacemaker had been implanted. After 48 hours, the patients were randomly assigned to AOP (pacing at 15 bpm above the spontaneous mean nocturnal heart rate) or backup atrial pacing (pacing at a heart rate below 40 bpm); the latter group began n-CPAP therapy one day later. After one month, the two groups switched therapies and were followed for an additional month. Polysomnographic studies were performed at baseline, on the first night after randomization, at crossover, and at the end of the study. RESULTS: During AOP, no significant changes were observed in any of the respiratory variables measured. The change in the apnea-hypopnea index at one month with AOP was +0.2 (95 percent confidence interval, -2.7 to +2.3; P=0.87). In contrast, all variables improved significantly after one month of n-CPAP (change in the apnea-hypopnea index, -46.3; 95 percent confidence interval, -56.2 to -36.5; P<0.001). CONCLUSIONS: Nasal continuous positive airway pressure therapy is highly effective for the treatment of the obstructive sleep apnea-hypopnea syndrome, whereas AOP has no significant effect.	Heraklion Univ Hosp, Dept Cardiol, Iraklion, Crete, Greece; Heraklion Univ Hosp, Dept Pneumol, Iraklion, Crete, Greece	University Hospital of Heraklion; University Hospital of Heraklion	Vardas, PE (corresponding author), Heraklion Univ Hosp, Dept Cardiol, POB 1352, Iraklion, Crete, Greece.	cardio@med.uoc.gr	Siafakas, Nikolas/AAI-3324-2020; Chrysostomakis, Stavros/AAV-3536-2020; vardas, panos/ABF-7144-2020; Vardas, Panos/AAP-5694-2021; Vardas, Panos/AAD-5219-2022	Chrysostomakis, Stavros/0000-0001-6956-2878				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Dimsdale JE, 2000, HYPERTENSION, V35, P144, DOI 10.1161/01.HYP.35.1.144; Garrigue S, 2002, NEW ENGL J MED, V346, P404, DOI 10.1056/NEJMoa011919; GARRIGUE S, 2002, NEW ENGL J MED, V346, P872; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Harbison J, 2000, CHEST, V118, P591, DOI 10.1378/chest.118.3.591; HUDGEL DW, 1992, CHEST, V101, P541, DOI 10.1378/chest.101.2.541; Javaheri S, 2000, CIRCULATION, V101, P392, DOI 10.1161/01.CIR.101.4.392; Kato I, 2001, PSYCHIAT CLIN NEUROS, V55, P257, DOI 10.1046/j.1440-1819.2001.00849.x; Lacasse Y, 2002, EUR RESPIR J, V19, P499, DOI 10.1183/09031936.02.00216902; Luthje L, 2005, AM J RESP CRIT CARE, V172, P118, DOI 10.1164/rccm.200409-1258OC; Narkiewicz K, 1999, CIRCULATION, V100, P2332, DOI 10.1161/01.CIR.100.23.2332; Pepin JL, 1999, AM J RESP CRIT CARE, V160, P1124, DOI 10.1164/ajrccm.160.4.9802027; Pepin JL, 2005, EUR RESPIR J, V25, P343, DOI 10.1183/09031936.05.00132703; Redline S, 1998, AM J RESP CRIT CARE, V157, P858, DOI 10.1164/ajrccm.157.3.9709042; ROLFE I, 1991, AM REV RESPIR DIS, V144, P1130, DOI 10.1164/ajrccm/144.5.1130; Ryan CM, 2005, CHEST, V127, P536, DOI 10.1378/chest.127.2.536; Schulz R, 2000, THORAX, V55, P1046, DOI 10.1136/thorax.55.12.1046; Simantirakis EN, 2004, EUR HEART J, V25, P1070, DOI 10.1016/j.ehj.2004.04.017; Sinha AM, 2004, J AM COLL CARDIOL, V44, P68, DOI 10.1016/j.jacc.2004.03.040; SMITH PL, 1994, AM J RESP CRIT CARE, V150, P1738; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SULLIVAN CE, 1981, LANCET, V1, P862; Tkacova R, 2000, J HYPERTENS, V18, P1257, DOI 10.1097/00004872-200018090-00012; Vgontzas AN, 2003, J INTERN MED, V254, P32, DOI 10.1046/j.1365-2796.2003.01177.x; WILCOX I, 1993, SLEEP, V16, P539, DOI 10.1093/sleep/16.6.539; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Ziegler MG, 2001, CHEST, V120, P887, DOI 10.1378/chest.120.3.887; 1995, AM J RESP CRIT CARE, V151, P578	29	67	70	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2568	2577		10.1056/NEJMoa050610	http://dx.doi.org/10.1056/NEJMoa050610			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354893				2022-12-28	WOS:000233926500006
J	Bryant, J; Powell, J				Bryant, J; Powell, J			Payment to healthcare professionals for patient recruitment to trials: a systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton, Hants, England; Univ Warwick, Warwick Med Sch, Sect Publ Hlth & Epidemiol, Coventry CV4 7AL, W Midlands, England	University of Southampton; University of Warwick	Bryant, J (corresponding author), Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton, Hants, England.	J.S.Bryant@soton.ac.uk		Powell, John/0000-0002-1456-4857				de Wit N J, 2001, J Fam Pract, V50, P976; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hjorth M, 1996, CONTROL CLIN TRIALS, V17, P372, DOI 10.1016/S0197-2456(96)00022-0; Pearl A, 2003, NZ MED J, V116, P681; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200	5	23	23	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1377	1378		10.1136/bmj.331.7529.1377	http://dx.doi.org/10.1136/bmj.331.7529.1377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339248	Bronze, Green Published			2022-12-28	WOS:000233999300020
J	Horton, R				Horton, R			Medicine: the prosperity of virtue	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							HATTERSLEY R, 2005, GUARDIAN        1114, P31; Horton R, 2005, LANCET, V366, P277, DOI 10.1016/S0140-6736(05)66965-6; *LOND COMM HEALTHC, 2005, HEALTHC COMM STAT HE; *OXF PICK I EUR, 2005, PICK I EUR IS NHS GE; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; 2005, LANCET, V366, P1239	6	27	27	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 10	2005	366	9502					1985	1987		10.1016/S0140-6736(05)67792-6	http://dx.doi.org/10.1016/S0140-6736(05)67792-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338437				2022-12-28	WOS:000233826900004
J	Rutten, FH; Moons, KGM; Cramer, MJM; Grobbee, DE; Zuithoff, NPA; Lammers, JWJ; Hoes, AW				Rutten, FH; Moons, KGM; Cramer, MJM; Grobbee, DE; Zuithoff, NPA; Lammers, JWJ; Hoes, AW			Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BRAIN NATRIURETIC PEPTIDE; VENTRICULAR SYSTOLIC DYSFUNCTION; EJECTION FRACTION; DIASTOLIC FUNCTION; GENERAL-PRACTICE; ACCURACY; COMMUNITY; ECHOCARDIOGRAPHY; POPULATION; REGRESSION	Objective To determine which clinical variables provide diagnostic information in recognising heart failure in primary care patients with stable chronic obstructive pulmonary disease (COPD) and whether easily available tests provide added diagnostic information. Design Cross sectional diagnostic study. Setting 51 primary care practices. Participants 1186 patients aged >= 65 years with COPD diagnosed by their general practitioner who did not have a diagnosis of heart failure confirmed by a cardiologist. Main outcome measures Independent diagnostic variables for concomitant heart failure in primary care patients with stable COPD. Results 405 patients (34% of eligible patients) underwent a systematic diagnostic investigation, which resulted in 83 (20.5%) receiving a new diagnosis of concomitant heart failure. Independent clinical variables for concomitant heart failure were a history of ischaemic heart disease, high body mass index, laterally displaced apex beat, and raised heart rate (area under the receiver operating characteristic curve (ROC area) 0.70,95% confidence interval 0.64 to 0.76). Addition of measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) to die reduced "clinical model" had the largest added diagnostic value, with a significant increase of the ROC area to 0.77 (0.71 to 0.83), followed by electrocardiography (0.75, 0.69 to 0.81). C reactive protein and chest radiography had limited added value. A simplified diagnostic model consisting of the four independent clinical variables plus NT-proBNP and electrocardiography was developed. Conclusions A limited number of items easily available from history and physical examination, with addition of NT-proBNP and electrocardiography, cart help general practitioners to identify concomitant heart failure in individual patients with stable COPD.	Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr, Heart Lung Ctr Utrecht, Dept Cardiol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Rutten, FH (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands.	FH.Rutten@umcutrecht.nl	Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468				Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; *CLASS COMM WONCA, 1983, INT CLASS PRIM CAR; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Cowie MR, 2003, EUR HEART J, V24, P1710, DOI 10.1016/S0195-668X(03)00476-7; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HECKERLING PS, 1993, JAMA-J AM MED ASSOC, V270, P1943, DOI 10.1001/jama.270.16.1943; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Landray MJ, 2000, BRIT MED J, V320, P985, DOI 10.1136/bmj.320.7240.985; LANG CC, 1992, CLIN SCI, V83, P529, DOI 10.1042/cs0830529; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Lloyd-Jones DM, 2003, NEW ENGL J MED, V348, P1059; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McCullough PA, 2003, ACAD EMERG MED, V10, P198, DOI 10.1197/aemj.10.3.198; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Moon YJ, 2001, COMPUT FLUIDS, V30, P473, DOI 10.1016/S0045-7930(00)00026-8; Moons KGM, 1999, EPIDEMIOLOGY, V10, P276, DOI 10.1097/00001648-199905000-00015; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P633, DOI 10.1016/S0895-4356(02)00408-0; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Nielsen OW, 2000, BRIT MED J, V320, P220, DOI 10.1136/bmj.320.7229.220; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Oh JK, 1997, J AM SOC ECHOCARDIOG, V10, P246, DOI 10.1016/S0894-7317(97)70062-2; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Rose G, 1982, CARDIOVASCULAR SURVE; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Smith H, 2000, BMJ-BRIT MED J, V320, P906, DOI 10.1136/bmj.320.7239.906; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vasan RS, 1996, ARCH INTERN MED, V156, P146, DOI 10.1001/archinte.156.2.146; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Whitehand JWR, 2004, URBAN MORPHOL, V8, P1; Wright SP, 2003, J AM COLL CARDIOL, V42, P1793, DOI 10.1016/j.jacc.2003.05.011; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226; Zile MR, 2003, J AM COLL CARDIOL, V41, P1519, DOI 10.1016/S0735-1097(03)00186-4	52	157	162	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1379	1382B		10.1136/bmj.38664.661181.55	http://dx.doi.org/10.1136/bmj.38664.661181.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16321994	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000233999300021
J	Shaw, RJ; Lamia, KA; Vasquez, D; Koo, SH; Bardeesy, N; DePinho, RA; Montminy, M; Cantley, LC				Shaw, RJ; Lamia, KA; Vasquez, D; Koo, SH; Bardeesy, N; DePinho, RA; Montminy, M; Cantley, LC			The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR TORC2; HEPATIC GLUCONEOGENESIS; FOOD-INTAKE; SNF1-ACTIVATING KINASES; INSULIN-RESISTANCE; UPSTREAM KINASES; RAT-TISSUES; AMP; PGC-1	The Peutz-Jegher syndrome tumor-suppressor gene encodes a protein-threonine kinase, LKB1, which phosphorylates and activates AMPK [adenosine monophosphate (AMP)-activated protein kinase]. The deletion of LKB1 in the liver of adult mice resulted in a nearly complete loss of AMPK activity. Loss of LKB1 function resulted in hyperglycemia with increased gluconeogenic and lipogenic gene expression. In LKB1-deficient livers, TORC2, a transcriptional coactivator of CREB (cAMP response element-binding protein), was dephosphorylated and entered the nucleus, driving the expression of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha), which in turn drives gluconeogenesis. Adenoviral small hairpin RNA (shRNA) for TORC2 reduced PGC-1 alpha expression and normalized blood glucose levels in mice with deleted liver LKB1, indicating that TORC2 is a critical target of LKB1/AMPK signals in the regulation of gluconeogenesis. Finally, we show that metformin, one of the most widely prescribed type 2 diabetes therapeutics, requires LKB1 in the liver to lower blood glucose levels.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Salk Institute; Sungkyunkwan University (SKKU); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Cantley, Lewis C/D-1800-2014; Tsai, Yu-Chen/B-5852-2008; Koo, Seung-Hoi/E-2763-2015	Cantley, Lewis C/0000-0002-1298-7653; Koo, Seung-Hoi/0000-0001-8769-2879; DePinho, Ronald/0000-0002-5625-577X	NCI NIH HHS [CA84313, U01 CA084313] Funding Source: Medline; NIGMS NIH HHS [GM056203, R01 GM056203-09, R01 GM056203, R37 GM037828, GM37828] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037828, R01GM037828, R01GM056203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Cleasby ME, 2004, DIABETES, V53, P3258, DOI 10.2337/diabetes.53.12.3258; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; HUARD J, 1995, GENE THER, V2, P107; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	47	1466	1564	7	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1642	1646		10.1126/science.1120781	http://dx.doi.org/10.1126/science.1120781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16308421	Green Accepted			2022-12-28	WOS:000233961700035
J	Eisaman, MD; Andre, A; Massou, F; Fleischhauer, M; Zibrov, AS; Lukin, MD				Eisaman, MD; Andre, A; Massou, F; Fleischhauer, M; Zibrov, AS; Lukin, MD			Electromagnetically induced transparency with tunable single-photon pulses	NATURE			English	Article							QUANTUM COMMUNICATION; LIGHT; GENERATION; STORAGE; MEMORY; PAIRS	Techniques to facilitate controlled interactions between single photons and atoms are now being actively explored(1-7). These techniques are important for the practical realization of quantum networks, in which multiple memory nodes that utilize atoms for generation, storage and processing of quantum states are connected by single-photon transmission in optical fibres(1,2). One promising avenue for the realization of quantum networks involves the manipulation of quantum pulses of light in optically dense atomic ensembles using electromagnetically induced transparency (EIT, refs 8, 9). EIT is a coherent control technique that is widely used for controlling the propagation of classical, multi-photon light pulses(10-14) in applications such as efficient nonlinear optics(15). Here we demonstrate the use of EIT for the controllable generation, transmission and storage of single photons with tunable frequency, timing and bandwidth. We study the interaction of single photons produced in a 'source' ensemble of Rb-87 atoms at room temperature with another 'target' ensemble. This allows us to simultaneously probe the spectral and quantum statistical properties of narrow-bandwidth single-photon pulses, revealing that their quantum nature is preserved under EIT propagation and storage. We measure the time delay associated with the reduced group velocity of the single-photon pulses and report observations of their storage and retrieval.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; PN Lebedev Phys Inst, Moscow 117924, Russia	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Kaiserslautern; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Eisaman, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	eisaman@fas.harvard.edu	Fleischhauer, Michael/G-6716-2011; Eisaman, Matthew/E-8006-2011; Fleischhauer, Michael/ABC-1472-2021; Zibrov, Alexander S/G-7419-2014	Eisaman, Matthew/0000-0002-3814-6430; Fleischhauer, Michael/0000-0003-4059-7289; 				Akamatsu D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203602; Andre A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.063902; ANDRE A, 2005, THESIS HARVARD U; Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; Black AT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.133601; Braje DA, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.041801; Briegel HJ, 2000, PHYSICS OF QUANTUM INFORMATION, P261; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, P SOC PHOTO-OPT INS, V5846, P105, DOI 10.1117/12.609460; Eisaman MD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233602; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Jiang W, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043819; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Mandel L, 1995, OPTICAL COHERENCE QU; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Scully MO, 2004, J OPT B-QUANTUM S O, V6, pS816, DOI 10.1088/1464-4266/6/8/030; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946	30	603	623	6	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					837	841		10.1038/nature04327	http://dx.doi.org/10.1038/nature04327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341010				2022-12-28	WOS:000233777800047
J	Leff, B; Burton, L; Mader, SL; Naughton, B; Burl, J; Inouye, SK; Greenough, WB; Guido, S; Langston, C; Frick, KD; Steinwachs, D; Burton, JR				Leff, B; Burton, L; Mader, SL; Naughton, B; Burl, J; Inouye, SK; Greenough, WB; Guido, S; Langston, C; Frick, KD; Steinwachs, D; Burton, JR			Hospital at home: Feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients	ANNALS OF INTERNAL MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; MINI-MENTAL STATE; ACUTE EXACERBATIONS; MANAGEMENT; HEALTH; ADULTS; GUIDELINES; CONFUSION; SEVERITY	Background: Acutely ill older persons often experience adverse events when cared for in the acute care hospital. Objective: To assess the clinical feasibility and efficacy of providing acute hospital-level care in a patient's home in a hospital at home. Design: Prospective quasi-experiment. Setting: 3 medicare-managed care (Medicare + Choice) health systems at 2 sites and a Veterans Administration medical center. Participants: 455 community-dwelling elderly patients who required admission to an acute care hospital for community-cquired pneumonia, exacerbation of chronic heart failure, exacerbation of chronic obstructive pulmonary disease, or cellulitis. Intervention: Treatment in a hospital-at-home model of care that substitutes for treatment in an acute care hospital. Measurements: Clinical process measures, standards of care, clinical complications, satisfaction with care, functional status, and costs of care. Intervention: Treatment in a hospital-at-home model of care that substitutes for treatment in an acute care hospital. Measurements: Clinical process measures, standards of care, clinical complications, satisfaction with care, functional status, and costs of care. Results: Hospital-at-home care was feasible and efficacious in delivering hospital-level care to patients at home. In 2 of 3 sites studied, 69% of patients who were offered hospital-at-home care chose it over acute hospital care; in the third site, 29% of patients chose hospital-at-home care. Although less procedurally oriented than acute hospital care, hospital-at-home care met quality standards at rates similar to those of acute hospital care. On an intention-to-treat basis, patients treated in hospital-at-home had a shorter length of stay (3.2 vs. 4.9 days) (P = 0.004), and there was some evidence that they also had fewer complications. The mean cost was lower for hospital-at-home care than for acute hospital care ($5081 vs. $7480) (P < 0.001). Limitations: Possible selection bias because of the quasi-experimental design and missing data, modest sample size, and study site differences. Conclusions: The hospital-at-home care model is feasible, safe, and efficacious for certain older patients with selected acute medical illnesses who require acute hospital-level care.	Johns Hopkins Univ, Sch Med, John Hopkins Bayview Med Ctr, John Hopkins Care Ctr, Baltimore, MD 21224 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Portland VA Med Ctr, Portland, OR USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; SUNY Buffalo, Independent Hlth, Buffalo, NY 14260 USA; SUNY Buffalo, Univera Hlth, Buffalo, NY 14260 USA; Fallon Community Hlth Plant & Fallon Clin, Worcester, MA USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; John A Hartford Fdn, New York, NY USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Leff, B (corresponding author), Johns Hopkins Univ, Sch Med, John Hopkins Bayview Med Ctr, John Hopkins Care Ctr, John R Burton Pavil,5505 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	bleff@jhmi.edu	Inouye, Sharon/R-7216-2019	Frick, Kevin/0000-0002-0178-5319	NIA NIH HHS [K24AG00949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG000949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bach PB, 2001, ANN INTERN MED, V134, P600, DOI 10.7326/0003-4819-134-7-200104030-00016; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; Caplan GA, 1999, MED J AUSTRALIA, V170, P156, DOI 10.5694/j.1326-5377.1999.tb127711.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; CUMMINGS J, 1985, CLINNEUROPSYCHIATRY, V9; Davies L, 2000, BRIT MED J, V321, P1265, DOI 10.1136/bmj.321.7271.1265; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried TR, 1999, AM J MED, V107, P317, DOI 10.1016/S0002-9343(99)00236-3; Fried TR, 2000, ARCH INTERN MED, V160, P1501, DOI 10.1001/archinte.160.10.1501; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leff B, 2004, J AM GERIATR SOC, V52, P2141, DOI 10.1111/j.1532-5415.2004.52579_1.x; Leff B, 1997, J AM GERIATR SOC, V45, P1066, DOI 10.1111/j.1532-5415.1997.tb05968.x; Leff B, 1999, J AM GERIATR SOC, V47, P697, DOI 10.1111/j.1532-5415.1999.tb01592.x; Leff B, 2001, J AM GERIATR SOC, V49, P1123, DOI 10.1046/j.1532-5415.2001.49219.x; Leff B, 1996, J AM GERIATR SOC, V44, P603, DOI 10.1111/j.1532-5415.1996.tb01452.x; Montalto M, 1997, AUST NZ J MED, V27, P19, DOI 10.1111/j.1445-5994.1997.tb00908.x; MONTALTO M, 2002, HOSP HOME PRINCIPLES; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; *PICK I HOSP, 1996, PICK I HOSP SAT QUES; Ram FSF, 2004, BMJ-BRIT MED J, V329, P315, DOI 10.1136/bmj.38159.650347.55; Ricauda NA, 2004, J AM GERIATR SOC, V52, P278, DOI 10.1111/j.1532-5415.2004.52069.x; Shepperd S, 1998, BRIT MED J, V316, P1786, DOI 10.1136/bmj.316.7147.1786; Shepperd S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000356.pub2; Stessman J, 1996, J AM GERIATR SOC, V44, P591; UHLMANN RF, 1987, J GERONTOL, V42, P33, DOI 10.1093/geronj/42.1.33; Wilson A, 1999, BRIT MED J, V319, P1542, DOI 10.1136/bmj.319.7224.1542; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	37	264	270	0	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					798	808		10.7326/0003-4819-143-11-200512060-00008	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992LH	16330791	Green Published			2022-12-28	WOS:000233884900004
J	Witt, BJ; Brown, RD; Jacobsen, SJ; Weston, SA; Yawn, BP; Roger, VL				Witt, BJ; Brown, RD; Jacobsen, SJ; Weston, SA; Yawn, BP; Roger, VL			A community-based study of stroke incidence after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LONG-TERM; ISCHEMIC-STROKE; THROMBOLYTIC THERAPY; FIBRINOLYTIC THERAPY; CEREBRAL INFARCTION; PRIMARY ANGIOPLASTY; SECULAR TRENDS; MEDICAL-CARE; RISK-FACTORS	Background: The rate of stroke after myocardial infarction (MI) remains unclear. Objectives: To examine the rate of stroke after incident MI; compare it with that observed in the population of Rochester, Minnesota; determine how the rate of stroke after MI has changed over time; and examine the impact of stroke on survival after incident MI. Design: Community-based cohort. Setting: Olmsted County, Minnesota. Participants: Persons with incident (first-ever) MI between 1979 and 1998. Measurements: Ischemic or hemorrhagic stroke in hospitalized and nonhospitalized patients that was identified by screening of the medical record for stroke diagnostic codes and subsequent stroke confirmation by physician review of the recorded event. Medical record review was used to ascertain baseline characteristics and death. Results: A total of 2160 persons with incident MI were hospitalized between 1979 and 1998 and followed for a median of 5.6 years (range, 0 to 22.2 years). The rate of stroke was 22.6 per 1000 person-months (95% CI, 16.3 to 30.6 per 1000 person-months) during the first 30 days after Mi, corresponding to a 44-fold increase (standardized morbidity ratio, 44 [95% CI, 32 to 59]) risk for stroke in the population of Rochester, Minnesota. The risk for stroke remained 2 to 3 times higher than expected during the first 3 years after Mi. Older age, previous stroke, and diabetes increased the risk for stroke, which did not decline over the study period. Strokes were associated with a large Increase in the risk for death after MI (hazard ratio, 2.89 [CI, 2.44 -to 3.43]). Limitations: Findings may not be generalizable to different populations. The authors measured outcomes by reviewing medical records. Conclusions: in the community, the risk for stroke is markedly increased after MI, particularly early after MI, compared with the expected risk in population without Mi. Stroke is associated with a large increase in the risk for death after Nil.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Olmsted Med Ctr, Rochester, MN USA	Mayo Clinic; Olmsted Medical Center	Roger, VL (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.		Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [HL68765, HL59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL068765, R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; *AM HEART ASS AM C, 2004, HEART STRK STAT UPD; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Azar AJ, 1996, ANN NEUROL, V39, P301, DOI 10.1002/ana.410390306; BODENHEIMER MM, 1994, J AM COLL CARDIOL, V24, P61, DOI 10.1016/0735-1097(94)90542-8; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Braunwald E, 2000, EUR HEART J, V21, P2005; Brodie BR, 2002, AM J CARDIOL, V89, P1243, DOI 10.1016/S0002-9149(02)02319-6; Brown RD, 1996, STROKE, V27, P373; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; GILES WH, 1995, ARCH INTERN MED, V155, P1319, DOI 10.1001/archinte.155.12.1319; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Goldstein LB, 2001, CIRCULATION, V103, P163; GORE JM, 1991, CIRCULATION, V83, P448, DOI 10.1161/01.CIR.83.2.448; GORE JM, 1995, CIRCULATION, V92, P2811, DOI 10.1161/01.CIR.92.10.2811; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Heidenreich PA, 2001, AM J MED, V110, P165, DOI 10.1016/S0002-9343(00)00712-9; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; Herlitz J, 2005, J INTERN MED, V257, P201, DOI 10.1111/j.1365-2796.2004.01433.x; HUNT D, 1992, LANCET, V339, P753; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Kandzari DE, 2004, AM J CARDIOL, V93, P458, DOI 10.1016/j.amjcard.2003.10.043; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; Lichtman JH, 2002, CIRCULATION, V105, P1082, DOI 10.1161/hc0902.104708; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; LONGSTRETH WT, 1993, STROKE, V24, P587, DOI 10.1161/01.STR.24.4.587; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Minai K, 2002, AM HEART J, V143, P497, DOI 10.1067/mhj.2002.120778; Mooe T, 1997, STROKE, V28, P762, DOI 10.1161/01.STR.28.4.762; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; O'Connor CM, 2001, AM J CARDIOL, V88, P541, DOI 10.1016/S0002-9149(01)01735-0; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; Perschbacher JM, 2004, MAYO CLIN PROC, V79, P983, DOI 10.4065/79.8.983; Prineas R., 1982, MINNESOTA CODE MANUA; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Spencer FA, 2003, AM J CARDIOL, V92, P383, DOI 10.1016/S0002-9149(03)00654-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Sutton AGC, 2004, J AM COLL CARDIOL, V44, P287, DOI 10.1016/j.jacc.2003.12.059; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; TANNE D, 1995, AM J CARDIOL, V76, P825, DOI 10.1016/S0002-9149(99)80236-7; THOMPSON PL, 1978, BRIT MED J, V2, P457, DOI 10.1136/bmj.2.6135.457; VAITKUS PT, 1992, ARCH INTERN MED, V152, P2020, DOI 10.1001/archinte.152.10.2020; Wannamethee SG, 2004, HEART, V90, P1398, DOI 10.1136/hrt.2003.026104; WHISNANT JP, 1990, J CLIN EPIDEMIOL, V43, P791, DOI 10.1016/0895-4356(90)90239-L; Wienbergen H, 2001, AM J CARDIOL, V87, P782, DOI 10.1016/S0002-9149(00)01505-8	58	130	131	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					785	792		10.7326/0003-4819-143-11-200512060-00006	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330789				2022-12-28	WOS:000233884900002
J	Tosoni, D; Puri, C; Confalonieri, S; Salcini, AE; De Camilli, P; Tacchetti, C; Di Fiore, PP				Tosoni, D; Puri, C; Confalonieri, S; Salcini, AE; De Camilli, P; Tacchetti, C; Di Fiore, PP			TTP specifically regulates the internalization of the transferrin receptor	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; COATED VESICLE FORMATION; TYROSINE PHOSPHORYLATION; ALPHA-ADAPTIN; DYNAMIN; BINDING; DROSOPHILA; CELLS; REQUIREMENTS	Different plasma membrane receptors are internalized through saturable/noncompetitive pathways, suggesting cargo-specific regulation. Here, we report that TTP (SH3BP4), a SH3-containing protein, specifically regulates the internalization of the transferrin receptor (TfR). TTP interacts with endocytic proteins, including clathrin, dynamin, and the TfR, and localizes selectively to TfR-containing coated-pits (CCP) and -vesicles (CCV). Overexpression of TTP specifically inhibits TfR internalization, and causes the formation of morphologically aberrant CCP, which are probably fission impaired. This effect is mediated by the SH3 of TTP, which can bind to dynamin, and it is rescued by overexpression of dynamin. Functional ablation of TTP causes a reduction in TfR internalization, and reduced cargo loading and size of TfR-CCV. Tyrosine phosphorylation of either TTP or dynamin prevents their interaction, pointing to a possible mechanism of exclusion of TTP from some CCP. Thus, TTP might represent one of the long sought for molecules that allow cargo-specific control of clathrin endocytosis.	IFOM, Ist FIRC Oncol Mol, I-20139 Milan, Italy; Univ Genoa, Dept Expt Med, MicroScoBio Res Ctr, I-16132 Genoa, Italy; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med, New Haven, CT 06536 USA; Ist Europeo Oncol, I-20141 Milan, Italy; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Yale University; Howard Hughes Medical Institute; Yale University; IRCCS European Institute of Oncology (IEO); University of Milan	Di Fiore, PP (corresponding author), IFOM, Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it	Salcini, Anna Elisabetta/G-4472-2017; Tosoni, Daniela/K-4524-2014; Confalonieri, Stefano/AAQ-6786-2020; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; TACCHETTI, CARLO/0000-0003-4602-000X; Salcini, Anna Elisabetta/0000-0001-5828-2512	NCI NIH HHS [CA46128] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dunlevy JR, 1999, GENOMICS, V62, P519, DOI 10.1006/geno.1999.5994; FAZIOLI F, 1992, J BIOL CHEM, V267, P5155; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; LAMAZE C, 1993, MOL BIOL CELL, V4, P715, DOI 10.1091/mbc.4.7.715; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rabouille C, 1999, METH MOL B, V117, P125; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	38	81	92	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					875	888		10.1016/j.cell.2005.10.021	http://dx.doi.org/10.1016/j.cell.2005.10.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325581	Bronze			2022-12-28	WOS:000233814100020
J	Yu, DH; Keene, AC; Srivatsan, A; Waddell, S; Davis, RL				Yu, DH; Keene, AC; Srivatsan, A; Waddell, S; Davis, RL			Drosophila DPM neurons form a delayed and branch-specific memory trace after olfactory classical conditioning	CELL			English	Article							MUTANT DROSOPHILA; MUSHROOM BODY; ANTENNAL LOBE; GENE; MAP; REPRESENTATION; EXPRESSION; RECEPTORS; BRAIN	Formation of normal olfactory memory requires the expression of the wild-type amnesiac gene in the dorsal paired medial (DPM) neurons. Imaging the activity in the processes of DPM neurons revealed that the neurons respond when the fly is stimulated with electric shock or with any odor that was tested. Pairing odor and electric-shock stimulation increases odor-evoked calcium signals and synaptic release from DPM neurons. These memory traces form in only one of the two branches of the DPM neuron process. Moreover, trace formation requires the expression of the wildtype amnesiac gene in the DPM neurons. The cellular memory traces first appear at 30 min after conditioning and persist for at least 1 hr, a time window during which DPM neuron synaptic transmission is required for normal memory. DPM neurons are therefore "odor generalists" and form a delayed, branch-specific, and amnesiac-dependent memory trace that may guide behavior after acquisition.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Srivatsan, Anjana/Q-6312-2017; Srivatsan, Anjana/S-1518-2017; Davis, Ronald/J-4998-2013	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Davis, Ronald/0000-0002-5986-7608; Waddell, Scott/0000-0003-4503-6229	NIMH NIH HHS [F31 MH073311-02, MH069883, F31 MH073311] Funding Source: Medline; NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073311, R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS019904, R01NS019904] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beck CDO, 2000, J NEUROSCI, V20, P2944; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Laissue PP, 1999, J COMP NEUROL, V405, P543; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mcguire S.E., 2001, SCIENCE, V10, P1126; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pavlov I.P., 1927, CONDITIONED REFLEXES; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	34	105	106	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					945	957		10.1016/j.cell.2005.09.037	http://dx.doi.org/10.1016/j.cell.2005.09.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325586	Bronze			2022-12-28	WOS:000233814100025
J	Bryden, HL; Longworth, HR; Cunningham, SA				Bryden, HL; Longworth, HR; Cunningham, SA			Slowing of the Atlantic meridional overturning circulation at 25 degrees N	NATURE			English	Article							FLORIDA CURRENT; HEAT-FLUX; SEASONAL VARIABILITY; NORDIC SEAS; OCEAN; TRANSPORT	The Atlantic meridional overturning circulation carries warm upper waters into far- northern latitudes and returns cold deep waters southward across the Equator(1). Its heat transport makes a substantial contribution to the moderate climate of maritime and continental Europe, and any slowdown in the overturning circulation would have profound implications for climate change. A transatlantic section along latitude 25 degrees N has been used as a baseline for estimating the overturning circulation and associated heat transport(2 - 4). Here we analyse a new 25 degrees N transatlantic section and compare it with four previous sections taken over the past five decades. The comparison suggests that the Atlantic meridional overturning circulation has slowed by about 30 per cent between 1957 and 2004. Whereas the northward transport in the Gulf Stream across 25 degrees N has remained nearly constant, the slowing is evident both in a 50 per cent larger southward- moving mid- ocean recirculation of thermocline waters, and also in a 50 per cent decrease in the southward transport of lower North Atlantic Deep Water between 3,000 and 5,000 m in depth. In 2004, more of the northward Gulf Stream flow was recirculating back southward in the thermocline within the subtropical gyre, and less was returning southward at depth.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre	Bryden, HL (corresponding author), Natl Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.	h.bryden@noc.soton.ac.uk		Bryden, Harry/0000-0002-8216-6359	Natural Environment Research Council [NER/T/S/2002/00449, NER/T/S/2002/00481] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baringer MO, 2001, GEOPHYS RES LETT, V28, P3179, DOI 10.1029/2001GL013246; Baringer MO, 1999, GEOPHYS RES LETT, V26, P353, DOI 10.1029/1998GL900323; Bryden H.L., 2001, INT GEOPHYS SERIES, VVol. 77, P455, DOI DOI 10.1016/S0074-6142(01)80134-0; Bryden HL, 2005, J MAR RES, V63, P35, DOI 10.1357/0022240053693806; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Cunningham-Williams RM, 1999, DRUG ALCOHOL DEPEN, V54, P1, DOI 10.1016/S0376-8716(98)00149-5; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; FUGLISTER FC, 1960, WOODS HOLE OCEANOGRA, V1, P1; Ganachaud A, 2003, J ATMOS OCEAN TECH, V20, P1641, DOI 10.1175/1520-0426(2003)020<1641:EBOIBM>2.0.CO;2; GILL AE, 1973, DEEP-SEA RES, V20, P141, DOI 10.1016/0011-7471(73)90049-1; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; Jayne SR, 2001, REV GEOPHYS, V39, P385, DOI 10.1029/2000RG000084; JOSEY S, 2005, NOC FORMERLY SOC AIR; LARSEN JC, 1992, PHILOS T R SOC A, V338, P169, DOI 10.1098/rsta.1992.0007; Lavin A., 1998, GLOBAL ATMOS OCEAN S, V6, P269; LEAMAN KD, 1995, J GEOPHYS RES-OCEANS, V100, P8561, DOI 10.1029/94JC01436; MEINEN CS, 2005, FLORIDA CURRENT TRAN; NIILER PP, 1973, J MAR RES, V31, P144; Osterhus S, 1999, J CLIMATE, V12, P3297, DOI 10.1175/1520-0442(1999)012<3297:TAOTNS>2.0.CO;2; PARRILLA G, 1994, NATURE, V369, P48, DOI 10.1038/369048a0; RICHARDSIN WS, 1969, DEEP SEA RES       S, V16, P225; ROEMMICH D, 1985, DEEP-SEA RES, V32, P619, DOI 10.1016/0198-0149(85)90070-6; SCHMITZ WJ, 1968, DEEP-SEA RES, V15, P679, DOI 10.1016/0011-7471(68)90081-8; Srokosz M., 2004, EOS T AGU, V85, P78, DOI DOI 10.1029/2004EO080003; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; WIJFFELS SE, 1992, J PHYS OCEANOGR, V22, P155, DOI 10.1175/1520-0485(1992)022<0155:TOFBTO>2.0.CO;2; WOODRUFF S, 2005, NCEP REAL TIME MARIN	30	467	486	3	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					655	657		10.1038/nature04385	http://dx.doi.org/10.1038/nature04385			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319889				2022-12-28	WOS:000233593100047
J	Gallop, JL; Butler, PJG; McMahon, HT				Gallop, JL; Butler, PJG; McMahon, HT			Endophilin and CtBP/BARS are not acyl transferases in endocytosis or Golgi fission	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN; CURVATURE; ACID; MEMBRANES; RIBEYE; DRIVEN; ROLES; CTBP	Endophilins have been proposed to have an enzymatic activity ( a lysophosphatidic acid acyl transferase or LPAAT activity) that can make phosphatidic acid in membranes(1-3). This activity is thought to change the bilayer asymmetry in such a way that negative membrane curvature at the neck of a budding vesicle will be stabilized. An LPAAT activity has also been proposed for CtBP/ BARS ( carboxy- terminal binding protein/ brefeldin A- ribosylated substrate), a transcription co- repressor that is implicated in dynamin- independent endocytosis and fission of the Golgi in mitosis(4-6). Here we show that the LPAAT activity associated with endophilin is a contaminant of the purification procedure and can be also found associated with the pleckstrin homology domain of dynamin. Likewise, the LPAAT activity associated with CtBP/ BARS is also a co- purification artefact. The proposed locus of activity in endophilins includes the BAR domain, which has no catalytic site but instead senses positive membrane curvature. These data will prompt a re- evaluation of the molecular details of membrane budding.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ac.uk		Gallop, Jennifer Louise/0000-0002-9978-1382				Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; BROWN AP, 1994, PLANT MOL BIOL, V26, P211, DOI 10.1007/BF00039533; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chinnadurai G, 2003, BIOESSAYS, V25, P9, DOI 10.1002/bies.10212; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Umezu-Goto M, 2004, J CELL BIOCHEM, V92, P1115, DOI 10.1002/jcb.20113; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zhang QH, 2002, SCIENCE, V295, P1895	26	69	75	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					675	678		10.1038/nature04136	http://dx.doi.org/10.1038/nature04136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319893				2022-12-28	WOS:000233593100052
J	Renne, PR; Feinberg, JM; Waters, MR; Arroyo-Cabrales, J; Ochoa-Castillo, P; Perez-Campa, M; Knight, KB				Renne, PR; Feinberg, JM; Waters, MR; Arroyo-Cabrales, J; Ochoa-Castillo, P; Perez-Campa, M; Knight, KB			Age of Mexican ash with alleged 'footprints'	NATURE			English	Editorial Material									Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; Texas A&M Univ, Dept Geog, College Stn, TX 77843 USA; Texas A&M Univ, Ctr Study 1st Amer, College Stn, TX 77843 USA; Inst Nacl Antropol & Hist, Subdirecc Labs & Apoyo Acad, Lab Arqueozool, Mexico City 06060, DF, Mexico; Museo Nacl Antropol, Subdirecc Arqueol, Mexico City 11560, DF, Mexico; Inst Nacl Antropol & Hist, Proyecto Cuicuilco, Mexico City 06700, DF, Mexico	Berkeley Geochronolgy Center; University of California System; University of California Berkeley; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Renne, PR (corresponding author), Berkeley Geochronol Ctr, Berkeley, CA 94709 USA.	prenne@bgc.org	Waters, Michael R/A-9430-2009; Arroyo-Cabrales, Joaquin/S-8752-2019; Waters, Michael/ABI-2377-2020	Arroyo-Cabrales, Joaquin/0000-0002-9095-489X; Waters, Michael/0000-0003-2660-3355; Feinberg, Joshua/0000-0002-5845-9848; Renne, Paul/0000-0003-1769-5235	Natural Environment Research Council [NE/C518422/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Coe RS, 2004, EARTH PLANET SC LETT, V222, P667, DOI 10.1016/j.epsl.2004.03.003; DALTON R, 2005, NATURE, DOI DOI 10.1038/NEWS050704-4; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Nomade S, 2005, CHEM GEOL, V218, P315, DOI 10.1016/j.chemgeo.2005.01.005	8	32	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					E7	E8		10.1038/nature04425	http://dx.doi.org/10.1038/nature04425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319838				2022-12-28	WOS:000233593100032
J	Lagendijk, A				Lagendijk, A			Pushing for power	NATURE			English	Editorial Material									FOM, Inst Atom & Mol Phys, Amsterdam, Netherlands; Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; Univ Twente, NL-7500 AE Enschede, Netherlands	AMOLF; University of Amsterdam; University of Twente	Lagendijk, A (corresponding author), FOM, Inst Atom & Mol Phys, Amsterdam, Netherlands.		Lagendijk, Ad/I-5409-2013						0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					429	429		10.1038/438429a	http://dx.doi.org/10.1038/438429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306972	Bronze			2022-12-28	WOS:000233458200027
J	Wang, LD; Kong, LZ; Wu, F; Bai, YM; Burton, R				Wang, LD; Kong, LZ; Wu, F; Bai, YM; Burton, R			Chronic diseases 4 - Preventing chronic diseases in China	LANCET			English	Article								Chronic diseases now account for an estimated 80% of deaths and 70% of disability-adjusted life-years lost in China. Cardiovascular diseases and cancer are the leading causes of both death and the burden of disease, and exposure to risk factors is high: more than 300 million men smoke cigarettes and 160 million adults are hypertensive, most of whom are not being treated. An obesity epidemic is imminent, with more than 20% of children aged 7-17 years in big cities now overweight or obese. The government of the People's Republic of China must confront these major challenges. The national cancer prevention and control plan (2004-10) is being implemented, and a national chronic disease prevention and control plan is due to be completed this year. Encouraging progress has been made in some areas, with current smoking prevalence in men declining at about 1% per year for a decade, and even better results in large demonstration programmes. Much remains to be done, and resources and sustainability are major issues. However, the surveillance and intervention mechanisms needed to ameliorate the increasing burden of chronic diseases are developing rapidly, taking account of the lessons learned over the past two decades.	WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan; Minist Hlth Peoples Republ China, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; World Hlth Org, Off Representat, Beijing, Peoples R China	World Health Organization; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization	Burton, R (corresponding author), WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan.	BurtonR@chn.wpro.who.int						[Anonymous], 2005, PREV CHRON DIS VIT I; ARMSTRONG T, 2003, ETHNIC DIS, V13, pS2; *CTR HLTH STAT INF, 2004, AN REP CHIN NAT HLTH; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; LEEDER S, 2005, RACE TIME CHALLENGE; Ministries of Health and Science and Technology and the National Bureau of Statistics of the Peoples Republic of China, 2004, NUTR HLTH STAT CHIN; *NAT BUR CENS CHIN, 2000, 5 NAT POP CENS; STRONG K, 2005, LANCET          1005, DOI DOI 10.1016/S0140-6736(05)67341-2; WANG WZ, 2002, CHIN J CHRON NONCOMM, V4, P49; WANG WZ, 2002, CHIN J GERIATR CARDI, V4, P30; Wang Y, 2000, CHIN J SCH HLTH, V21, P456; Wen CH, 2005, LANCET ONCOL, V6, P139, DOI 10.1016/S1470-2045(05)01761-4; *WORLD BANK LOAN C, 2004, HLTH PROM COMP EXT E; *WORLD BANK OFF, 2005, 3 WORLD BANK OFF; Yang GH, 2005, CHIN J EPIDEMIOL, V26, P78; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813	16	326	353	3	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1821	1824		10.1016/S0140-6736(05)67344-8	http://dx.doi.org/10.1016/S0140-6736(05)67344-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298221				2022-12-28	WOS:000233517200028
J	Cleland, J; Sinding, S				Cleland, J; Sinding, S			What would Malthus say about AIDS in Africa?	LANCET			English	Editorial Material									London Sch Hyg & Trop Med, London WC1B 3DP, England; Int Planned Parenthood Federat, London SE1 3UZ, England	University of London; London School of Hygiene & Tropical Medicine	Cleland, J (corresponding author), London Sch Hyg & Trop Med, 49-50 Bedford Sq, London WC1B 3DP, England.	john.Cleland@lshtm.ac.uk						Alexandratos N, 2005, POPUL DEV REV, V31, P237, DOI 10.1111/j.1728-4457.2005.00064.x; [Anonymous], 2004, 2004 REP GLOB AIDS E; BIRDSALL N, 2000, POPULATION MATTERS D; BLACKER J, 1997, HLTH T REV S2, V7, P45; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Commission for Africa, 2005, OUR COMMON INTEREST; *J SNOW INC DELIVE, 2003, FUT PROJ POLICY PROJ; KINGDON G, 2005, AFRICA REGION EMPLOY; MAULDIN WP, 1965, STUD FAMILY PLANN, V1, P1; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; Piotrow P. T., 1997, HLTH COMMUNICATION L; REYNOLDS HW, 2004, 15 INT AIDS C JUL 13; *UK DEP INT DEV, 2003, CALL ACT HIV AIDS; *UN DEP EC SOC AFF, 2002, WORLD POP PROSP 2000, V3; UN Department of Economic and Social Affairs Population Division, 2005, WORLD POP PROSP 2004; *UN MILL PROJ, 2005, INV DEV PRACT GUID A; *UN POP FUND, 2004, FIN RES FLOWS POP AC; *WHO REG OFF AFR, 2003, HIV AIDS EP SURV UPD	18	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1899	1901		10.1016/S0140-6736(05)67603-9	http://dx.doi.org/10.1016/S0140-6736(05)67603-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310558				2022-12-28	WOS:000233643200030
J	Wood, E; Montaner, J; Kerr, T				Wood, E; Montaner, J; Kerr, T			HIV risks in incarcerated injection-drug users	LANCET			English	Editorial Material							PRISON; TRANSMISSION; INFECTION; INMATES		St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Wood, E (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	ewood@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					[Anonymous], 2001, LANCET, V357, P971; Ball A, 1995, MULTICENTRE STUDY DR; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; McCoy CB, 2005, LANCET, V365, P1008; *OFF HIGH COMM HUM, 1990, BAS PRINC TREATM PRI; Small W, 2005, SUBST USE MISUSE, V40, P831, DOI 10.1081/JA-200030795; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; 2005, LANCET, V365, P629	12	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1834	1835		10.1016/S0140-6736(05)67737-9	http://dx.doi.org/10.1016/S0140-6736(05)67737-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310539				2022-12-28	WOS:000233643200007
J	Gurnett, DA; Kirchner, DL; Huff, RL; Morgan, DD; Persoon, AM; Averkamp, TF; Duru, F; Nielsen, E; Safaeinili, A; Plalut, JJ; Picardi, G				Gurnett, DA; Kirchner, DL; Huff, RL; Morgan, DD; Persoon, AM; Averkamp, TF; Duru, F; Nielsen, E; Safaeinili, A; Plalut, JJ; Picardi, G			Radar soundings of the ionosphere of Mars	SCIENCE			English	Article							MAGNETIC-FIELD; GLOBAL SURVEYOR; CRUSTAL MAGNETIZATION; TOPSIDE SOUNDERS; ABSORPTION	We report the first radar soundings of the ionosphere of Mars with the MARSIS (Mars Advanced Radar for Subsurface and Ionosphere Sounding) instrument on board the orbiting Mars Express spacecraft. Several types of ionospheric echoes are observed, ranging from vertical echoes caused by specular reflection from the horizontally stratified ionosphere to a wide variety of oblique and diffuse echoes. The oblique echoes are believed to arise mainly from ionospheric structures associated with the complex crustal magnetic fields of Mars. Echoes at the electron plasma frequency and the cyclotron period also provide measurements of the local electron density and magnetic field strength.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy	University of Iowa; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	donald-gurnett@uiowa.edu						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Brace L. H., 1983, Venus, P779; CAIN J, 2003, J GEOPHYS RES, V108; CALVERT W, 1969, P IEEE, V57, P1019, DOI 10.1109/PROC.1969.7146; Chapman S, 1931, P PHYS SOC, V43, P483, DOI 10.1088/0959-5309/43/5/302; CHICARO A, 2004, EUROPEAN SPACE AGENC; Connerney JEP, 2001, GEOPHYS RES LETT, V28, P4015, DOI 10.1029/2001GL013619; FRANKLIN CA, 1969, P IEEE, V57, P897, DOI 10.1109/PROC.1969.7135; GURNETT DA, 2005, INTRO PLASMA PHYS, P114; HAGG EL, 1969, P IEEE, V57, P949, DOI 10.1109/PROC.1969.7139; Hanson W. B., 1977, Journal of Geophysical Research, V82, P4351, DOI 10.1029/JS082i028p04351; Hinson DP, 2001, J GEOPHYS RES-PLANET, V106, P1463, DOI 10.1029/2000JE001291; Krymskii AM, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010420; Krymskii AM, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009662; Krymskii AM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000239; LUHMANN JG, 1991, REV GEOPHYS, V29, P121, DOI 10.1029/91RG00066; Mitchell DL, 2001, J GEOPHYS RES-PLANET, V106, P23419, DOI 10.1029/2000JE001435; Ness NF, 2000, J GEOPHYS RES-SPACE, V105, P15991, DOI 10.1029/1999JA000212; Patterson JD, 2001, J GEOPHYS RES-SPACE, V106, P149, DOI 10.1029/2000JA002006; Patzold M, 2005, SCIENCE, V310, P837, DOI 10.1126/science.1117755; PICARDI G, 2004, EUROPEAN SPACE AGENC; WILKES MV, 1954, P PHYS SOC LOND B, V67, P304, DOI 10.1088/0370-1301/67/4/304; ZHANG MHG, 1990, J GEOPHYS RES-SPACE, V95, P17095, DOI 10.1029/JA095iA10p17095	24	207	212	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2005	310	5756					1929	1933		10.1126/science.1121868	http://dx.doi.org/10.1126/science.1121868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16319123				2022-12-28	WOS:000234275400035
J	Crepaz-Keay, D				Crepaz-Keay, D			Mental health legislation should respect decision making capacity - Commentary: Who benefits from the new act?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Mental Hlth Fdn, London SE1 9QB, England		Crepaz-Keay, D (corresponding author), Mental Hlth Fdn, London SE1 9QB, England.	dcrepaz-keay@mhf.org.uk	Crepaz-Keay, David/J-1916-2014	Crepaz-Keay, David/0000-0003-3845-4721				*DEP HLTH, 2005, IMPR MENT HLTH LAW N; Doyal L, 2005, BMJ-BRIT MED J, V331, P1467, DOI 10.1136/bmj.331.7530.1467; Kisely S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004101.pub2, 10.1002/14651858.CD004408.pub2]	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1470	1471		10.1136/bmj.331.7530.1470	http://dx.doi.org/10.1136/bmj.331.7530.1470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356988	Green Published			2022-12-28	WOS:000234156400033
J	Barthelmy, SD; Chincarini, G; Burrows, DN; Gehrels, N; Covino, S; Moretti, A; Romano, P; O'Brien, PT; Sarazin, CL; Kouveliotou, C; Goad, M; Vaughan, S; Tagliaferri, G; Zhang, B; Antonelli, LA; Campana, S; Cummings, JR; D'Avanzo, P; Davies, MB; Giommi, P; Grupe, D; Kaneko, Y; Kennea, JA; King, A; Kobayashi, S; Melandri, A; Meszaros, P; Nousek, JA; Patel, S; Sakamoto, T; Wijers, RAMJ				Barthelmy, SD; Chincarini, G; Burrows, DN; Gehrels, N; Covino, S; Moretti, A; Romano, P; O'Brien, PT; Sarazin, CL; Kouveliotou, C; Goad, M; Vaughan, S; Tagliaferri, G; Zhang, B; Antonelli, LA; Campana, S; Cummings, JR; D'Avanzo, P; Davies, MB; Giommi, P; Grupe, D; Kaneko, Y; Kennea, JA; King, A; Kobayashi, S; Melandri, A; Meszaros, P; Nousek, JA; Patel, S; Sakamoto, T; Wijers, RAMJ			An origin for short gamma-ray bursts unassociated with current star formation	NATURE			English	Article							GRB-050709; AFTERGLOW; SGR-1806-20; GALAXY; FLARE	Two short (< 2 s) gamma-ray bursts (GRBs) have recently been localized(1-4) and fading afterglow counterparts detected(2-4). The combination of these two results left unclear the nature of the host galaxies of the bursts, because one was a star-forming dwarf, while the other was probably an elliptical galaxy. Here we report the X-ray localization of a short burst (GRB 050724) with unusual gamma-ray and X-ray properties. The X-ray afterglow lies off the centre of an elliptical galaxy at a redshift of z = 0.258 (ref. 5), coincident with the position determined by ground-based optical and radio observations(6-8). The low level of star formation typical for elliptical galaxies makes it unlikely that the burst originated in a supernova explosion. A supernova origin was also ruled out for GRB 050709 ( refs 3, 31), even though that burst took place in a galaxy with current star formation. The isotropic energy for the short bursts is 2 - 3 orders of magnitude lower than that for the long bursts. Our results therefore suggest that an alternative source of bursts - the coalescence of binary systems of neutron stars or a neutron star-black hole pair - are the progenitors of short bursts.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; INAF, Osservatorio Astron Brera, I-23807 Merate, Italy; Univ Studi Milano Bicocca, I-20126 Milan, Italy; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; NASA, George C Marshall Space Flight Ctr, NSSTC, Huntsville, AL 35805 USA; Univ Nevada, Dept Phys, Las Vegas, NV 89154 USA; Osserv Astron Roma, I-00040 Monte Porzio Catone, Italy; CNR, Washington, DC 20418 USA; Univ Studi Insubria, Dipartimento Matemat & Fis, I-22100 Como, Italy; Lund Observ, SE-22100 Lund, Sweden; ASI Sci Data Ctr, I-00044 Frascati, Italy; NASA, George C Marshall Space Flight Ctr, Univ Space Res Assoc, NSSTC, Huntsville, AL 35805 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale Astrofisica (INAF); University of Milano-Bicocca; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Leicester; University of Virginia; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Istituto Nazionale Astrofisica (INAF); University of Insubria; Lund University; Agenzia Spaziale Italiana (ASI); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Universities Space Research Association (USRA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Amsterdam	Barthelmy, SD (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	scott@lheamail.gsfc.nasa.gov	Kennea, Jamie/AAF-2090-2019; Gehrels, Neil/D-2971-2012; Barthelmy, Scott D/D-2943-2012; Covino, Stefano/AAQ-5188-2021; Tagliaferri, Gianpiero/ABD-7556-2021; Campana, Sergio/AAL-6012-2020; Kaneko, Yuki/V-2908-2019; giommi, paolo/L-1006-2018	Kennea, Jamie/0000-0002-6745-4790; Covino, Stefano/0000-0001-9078-5507; Tagliaferri, Gianpiero/0000-0003-0121-0723; Campana, Sergio/0000-0001-6278-1576; Kaneko, Yuki/0000-0002-1861-5703; giommi, paolo/0000-0002-2265-5003; Melandri, Andrea/0000-0002-2810-2143; Wijers, Ralph/0000-0002-3101-1808; Goad, Michael/0000-0002-2908-7360; Romano, Patrizia/0000-0003-0258-7469				ANTONELLI LA, 2005, 3678 GCN; BLOOM JS, 2005, 3672 GCN; BOER M, 2005, 3653 GCN; Burrows DN, 2005, SCIENCE, V309, P1833, DOI 10.1126/science.1116168; BURROWS DN, 2005, 3697 GCN; CASTROTIRADO AJ, 2005, 3673 GCN; Connaughton V, 2002, ASTROPHYS J, V567, P1028, DOI 10.1086/338695; COVINO S, 2005, 3665 GCN; COVINO S, UNPUB ASTRON ASTROPH; DAVANZO P, 2005, 3690 GCN; Davies MB, 2005, MON NOT R ASTRON SOC, V356, P54, DOI 10.1111/j.1365-2966.2004.08423.x; Fox DB, 2005, NATURE, V437, P845, DOI 10.1038/nature04189; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; GALYAM A, 2005, 3681 GCN; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kochanek CS, 2001, ASTROPHYS J, V560, P566, DOI 10.1086/322488; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; KRIMM H, 2005, 3667 GCN; Kumar P, 2000, ASTROPHYS J, V541, pL51, DOI 10.1086/312905; Lazzati D, 2001, ASTRON ASTROPHYS, V379, pL39, DOI 10.1051/0004-6361:20011485; Le Floc'h E, 2003, ASTRON ASTROPHYS, V400, P499, DOI 10.1051/0004-6361:20030001; LEE WH, 2005, ARXIVORGASTROPH05041; Palmer DM, 2005, NATURE, V434, P1107, DOI 10.1038/nature03525; PROCHASKA JX, 2005, 3700 GRB; Rosswog S, 2003, MON NOT R ASTRON SOC, V345, P1077, DOI 10.1046/j.1365-2966.2003.07032.x; Villasenor JS, 2005, NATURE, V437, P855, DOI 10.1038/nature04213; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359	30	306	309	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					994	996		10.1038/nature04392	http://dx.doi.org/10.1038/nature04392			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355219	Green Submitted			2022-12-28	WOS:000233934600061
J	Jeffcoate, WJ; Game, F; Cavanagh, PR				Jeffcoate, WJ; Game, F; Cavanagh, PR			The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes	LANCET			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; BONE-MINERAL DENSITY; RECEPTOR ACTIVATOR; ENDOTHELIAL-CELLS; BLOOD-FLOW; MELLITUS; EXPRESSION; NEUROARTHROPATHY; OSTEOPROTEGERIN	The pathogenesis of the acute Charcot foot of diabetes remains unclear. All patients with this condition have evidence of peripheral neuropathy, with loss of protective sensation and abnormal foot biomechanics. However, the acute Charcot foot is also characterised by a pronounced inflammatory reaction and the pathogenic significance of this inflammation has received little attention. We suggest that an initial insult-which may or may not be detected-is sufficient to trigger an inflammatory cascade through increased expression of proinflammatory cytokines, including TNF alpha and interleukin 1 beta. This cascade then leads to increased expression of the nuclear transcription factor, NF-kappa B, which results in increased osteoclastogenesis. Osteoclasts cause progressive bone lysis, leading to further fracture, which in turn potentiates the inflammatory process. The potential role of proinflammatory cytokines suggests the possibility of new treatments for this sometimes devastating complication of diabetes.	City Hosp, Dept Endocrinol & Diabet, Foot Ulcer Trials Unit, Nottingham NG5 1PB, England; Cleveland Clin Fdn, Lerner Res Inst, Orthopaed Res Ctr, Dept Orthopaed Surg,Dept Biomed Engn, Cleveland, OH 44195 USA	University of Nottingham; Cleveland Clinic Foundation	Jeffcoate, WJ (corresponding author), City Hosp, Dept Endocrinol & Diabet, Foot Ulcer Trials Unit, Nottingham NG5 1PB, England.	wjeffcoate@futu.co.uk		Game, Frances/0000-0002-5294-4789				Aljada A, 2001, J CLIN ENDOCR METAB, V86, P450, DOI 10.1210/jc.86.1.450; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Celec P, 2004, BIOMED PHARMACOTHER, V58, P365, DOI 10.1016/j.biopha.2003.12.015; Charcot JM, 1868, ARCH PHYSIOL NORM P, V1, P161; DEMER L, 2002, J AM COLL CARDIOL, V44, P1977; EDELMAN SV, 1987, ARCH INTERN MED, V147, P1504, DOI 10.1001/archinte.147.8.1504; Fleischli JE, 1999, FOOT ANKLE INT, V20, P80, DOI 10.1177/107110079902000203; Fujita T, 2004, CELL BIOL INT, V28, P281, DOI 10.1016/j.cellbi.2003.12.007; Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893; Herbst SA, 2004, J BONE JOINT SURG BR, V86B, P378, DOI 10.1302/0301-620X.86B3.14593; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hofbauer LC, 2000, J CLIN ENDOCR METAB, V85, P2355, DOI 10.1210/jc.85.7.2355; Jeffcoate W, 2000, DIABETIC MED, V17, P253, DOI 10.1046/j.1464-5491.2000.00233.x; Jeffcoate W, 2004, DIABETOLOGIA, V47, P1488, DOI 10.1007/s00125-004-1477-5; Jeffcoate WJ, 2004, CLIN INFECT DIS, V39, pS115, DOI 10.1086/383272; Jiang MZ, 2004, LIFE SCI, V75, P1159, DOI 10.1016/j.lfs.2004.01.031; Jordan WR, 1936, ARCH INTERN MED, V57, P307, DOI 10.1001/archinte.1936.00170060069004; Kermanac'h NS, 2002, EUR CYTOKINE NETW, V13, P144; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lam J, 2002, ANN RHEUM DIS, V61, P82; LERICHE MR, 1927, SEANCE          0706, P1022; Mitchell JK, 1831, AM J MED SCI, V8, P55; Mitchell S.W., 1878, AM J MED SCI, V151, P17, DOI DOI 10.1097/00000441-187815100-00001; Petrova NL, 2005, DIABETIC MED, V22, P756, DOI 10.1111/j.1464-5491.2005.01510.x; Rajbhandari SM, 2002, DIABETOLOGIA, V45, P1085, DOI 10.1007/s00125-002-0885-7; Rix M, 1999, DIABETES CARE, V22, P827, DOI 10.2337/diacare.22.5.827; SELBY PL, 1994, DIABETIC MED, V11, P28, DOI 10.1111/j.1464-5491.1994.tb00225.x; Shapiro SA, 1998, J DIABETES COMPLICAT, V12, P147, DOI 10.1016/S1056-8727(97)00080-9; SINHA S, 1972, MEDICINE, V51, P191, DOI 10.1097/00005792-197205000-00006; Sugawara J, 2004, MED SCI SPORT EXER, V36, P1689, DOI 10.1249/01.MSS.0000142410.45142.28; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; YEMENI KK, 1999, DIABETES, V48, P855	34	183	195	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2058	2061		10.1016/S0140-6736(05)67029-8	http://dx.doi.org/10.1016/S0140-6736(05)67029-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338454				2022-12-28	WOS:000233826900025
J	Majeed, A; Aylin, P				Majeed, A; Aylin, P			The ageing population of the United Kingdom and cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Article								The number of people aged 65 and over is predicted to increase by about 53% between 2001 and 2031, but the number of people aged under 65 will change little during this period (table). The increase in the number of older people will likely lead to an increase in the number of people who have chronic diseases, including cardiovascular disease. This will impose further workload and financial pressures on the NHS. We examined the possible impact of the ageing population on the expected number of people with three cardiovascular disorders: coronary heart disease, heart failure, and atrial fibrillation.					Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Majeed, Azeem/0000-0002-2357-9858				*OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; PETERSEN R, 2000, CORONARY HEART DIS S; Salomon JA, 2004, BMJ-BRIT MED J, V329, P733, DOI 10.1136/bmj.329.7468.733; Wanless, 2002, SECURING OUR FUTURE	4	20	20	2	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1362	1362A		10.1136/bmj.331.7529.1362	http://dx.doi.org/10.1136/bmj.331.7529.1362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339247	Green Published			2022-12-28	WOS:000233999300015
J	Chaneliere, T; Matsukevich, DN; Jenkins, SD; Lan, SY; Kennedy, TAB; Kuzmich, A				Chaneliere, T; Matsukevich, DN; Jenkins, SD; Lan, SY; Kennedy, TAB; Kuzmich, A			Storage and retrieval of single photons transmitted between remote quantum memories	NATURE			English	Article							LIGHT; STATE; COMMUNICATION	An elementary quantum network operation involves storing a qubit state in an atomic quantum memory node, and then retrieving and transporting the information through a single photon excitation to a remote quantum memory node for further storage or analysis. Implementations of quantum network operations are thus conditioned on the ability to realize matter-to-light and/or light-to-matter quantum state mappings. Here we report the generation, transmission, storage and retrieval of single quanta using two remote atomic ensembles. A single photon is generated from a cold atomic ensemble at one site 1, and is directed to another site through 100 metres of optical fibre. The photon is then converted into a single collective atomic excitation using a dark-state polariton approach(2). After a programmable storage time, the atomic excitation is converted back into a single photon. This is demonstrated experimentally, for a storage time of 0.5 microseconds, by measurement of an anti-correlation parameter. Storage times exceeding ten microseconds are observed by intensity cross-correlation measurements. This storage period is two orders of magnitude longer than the time required to achieve conversion between photonic and atomic quanta. The controlled transfer of single quanta between remote quantum memories constitutes an important step towards distributed quantum networks.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kuzmich, A (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	alex.kuzmich@physics.gatech.edu	Lan, Shau-Yu/AAB-9094-2022; Matsukevich, Dzmitry/C-9134-2009; Lan, Shau-Yu/B-5567-2014	Lan, Shau-Yu/0000-0003-2608-9472; Matsukevich, Dzmitry/0000-0002-7679-0569; Lan, Shau-Yu/0000-0003-2608-9472; CHANELIERE, Thierry/0000-0003-1715-9520				Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; CLAUSER JF, 1974, PHYS REV D, V9, P853, DOI 10.1103/PhysRevD.9.853; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233602; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; JENKINS SD, 2005, UNPUB PHYS REV A; Jiang W, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043819; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Kuzmich A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.030407; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; RAYMER MG, 1990, PROG OPTICS, V28, P181, DOI 10.1016/S0079-6638(08)70290-7; Scully M.O., 1997, QUANTUM OPT; U'Ren AB, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.021802; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946	28	612	621	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					833	836		10.1038/nature04315	http://dx.doi.org/10.1038/nature04315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341009	Green Submitted			2022-12-28	WOS:000233777800046
J	Merion, RM; Ashby, VB; Wolfe, RA; Distant, DA; Hulbert-Shearon, TE; Metzger, RA; Ojo, AO; Port, FK				Merion, RM; Ashby, VB; Wolfe, RA; Distant, DA; Hulbert-Shearon, TE; Metzger, RA; Ojo, AO; Port, FK			Deceased-donor characteristics and the survival benefit of kidney transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	American Transplant Congress 2004	MAY 14-19, 2004	Boston, MA	Amer Soc Transplant Surg, Amer Soc Transplantat			QUALITY-OF-LIFE; CADAVERIC RENAL-TRANSPLANTATION; DIALYSIS PATIENTS; UNITED-STATES; RECIPIENTS; ACCESS; MORTALITY	Context Transplantation using kidneys from deceased donors who meet the expanded criteria donor (ECD) definition (age >= 60 years or 50 to 59 years with at least 2 of the following: history of hypertension, serum creatinine level >1.5 mg/dL [132.6 mu mol/L], and cerebrovascular cause of death) is associated with 70% higher risk of graft failure compared with non-ECD transplants. However, if ECD transplants offer improved overall patient survival, inferior graft outcome may represent an acceptable trade-off. Objective To compare mortality after ECD kidney transplantation vs that in a combined standard-therapy group of non-ECD recipients and those still receiving dialysis. Design, Setting, and Patients Retrospective cohort study using data from a US national registry of mortality and graft outcomes among kidney transplant candidates and recipients. The cohort included 109 127 patients receiving dialysis and added to the kidney waiting list between January 1, 1995, and December 31, 2002, and followed up through July 31, 2004. Main Outcome Measure Long-term (3-year) relative risk of mortality for ECD kidney recipients vs those receiving standard therapy, estimated using time-dependent Cox regression models. Results By end of follow-up, 7790 ECD kidney transplants were performed. Because of excess ECD recipient mortality in the perioperative period, cumulative survival did not equal that of standard-therapy patients until 3.5 years posttransplantation. Long-term relative mortality risk was 17% lower for ECD recipients (relative risk, 0.83; 95% confidence interval, 0.77-0.90-, P<.001). Subgroups with significant ECD survival benefit included patients older than 40 years, both sexes, non-Hispanics, all races, unsensitized patients, and those with diabetes or hypertension. In organ procurement organizations (OPOs) with long median waiting times (>1350 days), ECD recipients had a 27% lower risk of death (relative risk, 0.73; 95% confidence interval, 0..64-0.83; P<.001). In areas with shorter waiting times, only recipients with diabetes demonstrated an ECD survival benefit. Conclusions ECD kidney transplants should be offered principally to candidates older than 40 years in OPOs with long waiting times. In OPOs with shorter waiting times, in which non-ECD kidney transplant availability is higher, candidates should be counseled that ECD survival benefit is observed only for patients with diabetes.	Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI 48109 USA; Sci Registry Transplant Recipients, Ann Arbor, MI USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; SUNY Hlth Sci Ctr, Dept Surg, Brooklyn, NY 11203 USA; TransLife Florida Hosp Med Ctr, Orlando, FL USA; Univ Renal Res & Educ Assoc, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Merion, RM (corresponding author), Univ Michigan Hlth Syst, Dept Surg, 2926 Taubman Ctr,Box 0331, Ann Arbor, MI 48109 USA.	merionb@umich.edu		Ashby, Valarie/0000-0002-1593-985X	PHS HHS [231-00-0116] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Cox D. R., 1984, ANAL SURVIVAL DATA; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Fiebiger Wolfgang, 2004, Health Qual Life Outcomes, V2, P2, DOI 10.1186/1477-7525-2-2; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; *HLTH RES SERV ADM, 2003, 2003 OPTN SRTR ANN R; Lazzaretti CT, 2004, TRANSPL P, V36, P872, DOI 10.1016/j.transproceed.2004.03.094; MAUGER EA, 1995, STAT MED, V14, P1553, DOI 10.1002/sim.4780141406; Muehrer RJ, 2005, SEMIN DIALYSIS, V18, P124, DOI 10.1111/j.1525-139X.2005.18214.x; OJO AO, 1994, AM J KIDNEY DIS, V24, P59, DOI 10.1016/S0272-6386(12)80160-0; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; *ORG PROC TRANSPL, POL 3 5 ALL DEC DON; Persson MO, 2002, NEPHROL DIAL TRANSPL, V17, P1497, DOI 10.1093/ndt/17.8.1497; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; RUSSELL JD, 1992, TRANSPLANTATION, V54, P656, DOI 10.1097/00007890-199210000-00018; Schnitzler MA, 2003, TRANSPLANTATION, V75, P1940, DOI 10.1097/01.TP.0000076381.16276.1B; *SCI REG TRANSPL R, ORG PROC ORG SPEC RE; *SOC SEC ADM, 2004, DEATH MAST FIL; Sung RS, 2005, TRANSPLANTATION, V79, P1257, DOI 10.1097/01.TP.0000161225.89368.81; *US REN DAT SYST, 2004, USRDS 2004 ANN DAT R; *US REN DAT SYST, 1993, USRDS 2002 ANN DAT R; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	24	512	527	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2726	2733		10.1001/jama.294.21.2726	http://dx.doi.org/10.1001/jama.294.21.2726			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333008	Bronze			2022-12-28	WOS:000233726900021
J	Barr, DA				Barr, DA			The practitioner's dilemma: Can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment?	ANNALS OF INTERNAL MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; CONVERTING-ENZYME-INHIBITION; ISOSORBIDE DINITRATE; BLOOD-PRESSURE; HEART-FAILURE; HYPERTENSIVE PATIENTS; ENDOTHELIAL FUNCTION; AFRICAN-AMERICANS; HYDRALAZINE; BLACKS	Recent research has identified genetic traits that can be used in a laboratory setting to distinguish among global population groups. In some genetic analyses, the population groups identified resemble groups that are historically categorized as "races." On the basis of these associations, some researchers have argued that a patient's race can be used to predict underlying genetic traits and from these traits, the expected outcomes of treatment. Others have questioned the use of race in this way, arguing that racially defined groups are so heterogeneous that predictions of individual characteristics derived from group averages are bound to be problematic. Practitioners today face the dilemma of translating this scientific debate into clinical decisions made 1 patient at a time. Is it or is it not appropriate to use a patient's self-identified "race" to help decide treatment? In contrast to the global population groups identified by genetic studies, the U.S. population has experienced substantial genetic admixture over time, weakening our ability to distinguish groups on the basis of meaningful genetic differences. Nonetheless, many researchers have suggested that these differences are still sufficient to identify racially specific uses for pharmaceutical and other treatments. A review of recent research on the treatment of hypertension and congestive heart failure finds that race-specific treatments of this type carry a substantial risk for treating patients-black or white-inappropriately, either by withholding a treatment that may be effective or by using a treatment that may be ineffective. Only by moving beyond historical concepts of "race" to examining a patient's individual socioeconomic, cultural, behavioral, and ancestral circumstances can a practitioner select the treatment that is most likely to be effective and in doing so, can best serve that patient's needs.	Stanford Univ, Dept Sociol, Stanford, CA 94305 USA	Stanford University	Barr, DA (corresponding author), Stanford Univ, Dept Sociol, Bldg 120,MC 2047, Stanford, CA 94305 USA.	barr@stanford.edu						Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Brands MW, 2004, HYPERTENSION, V43, P57, DOI 10.1161/01.HYP.0000104524.25807.EE; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Dixon LJ, 2005, AM J HYPERTENS, V18, P839, DOI 10.1016/j.amjhyper.2005.01.004; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Endemann DH, 2004, CURR HYPERTENS REP, V6, P85, DOI 10.1007/s11906-004-0081-x; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; *FDA ADV COMM, 2005, BID IS DIN HYDR HYDR; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Grieco EM, 2001, OVERVIEW RACE HISPAN; Gunnett CA, 2003, STROKE, V34, P2970, DOI 10.1161/01.STR.0000099123.55171.3F; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hostetter TH, 2004, NEW ENGL J MED, V351, P1344, DOI 10.1056/NEJMe048211; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; LEMTOUNI S, CLIN REV; LEROI AM, 2005, NY TIMES        0314, pA21; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; Mokwe E, 2004, HYPERTENSION, V43, P1202, DOI 10.1161/01.HYP.0000127924.67353.86; MOOR, 2005, OXFORD ENGLISH DICT; Moran AE, 2005, NEW ENGL J MED, V352, P1041; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rotimi Charles N, 2003, Dev World Bioeth, V3, P151, DOI 10.1046/j.1471-8731.2003.00071.x; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; SATEL S, 2002, NY TIMES MAGAZI 0505, P56; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Triggle CR, 2004, MOL CELL BIOCHEM, V263, P21, DOI 10.1023/B:MCBI.0000041845.62061.c9; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811; WOODMAN RJ, 2005, DIABETES RES CLIN PR; Xiong Y, 2005, LIFE SCI, V77, P149, DOI 10.1016/j.lfs.2004.10.062; XU B, 2005, CLIN SCI LOND; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; Zachary AA, 2001, HUM IMMUNOL, V62, P1127, DOI 10.1016/S0198-8859(01)00305-6	53	30	30	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					809	815		10.7326/0003-4819-143-11-200512060-00009	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330792				2022-12-28	WOS:000233884900005
J	Bronnert, J; Malhotra, C; Suavansri, K; Hanvesakul, R; Kulwichit, W; Wilde, H				Bronnert, J; Malhotra, C; Suavansri, K; Hanvesakul, R; Kulwichit, W; Wilde, H			Complete ptosis caused by dengue fever	LANCET			English	Editorial Material									German Naval Med Inst, Kronshagen Kiel, Germany; BNH Hosp, Bangkok, Thailand; Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; Thai Red Cross Soc, Queen Saovabha Mem Inst, Bangkok, Thailand	Chulalongkorn University; Thai Red Cross Society	Bronnert, J (corresponding author), German Naval Med Inst, Kronshagen Kiel, Germany.	janbronnert@gmx.net						Gaultier C, 2000, REV NEUROL, V156, P169; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Haritoglou C, 2002, LANCET, V360, P1070, DOI 10.1016/S0140-6736(02)11145-7; Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025; *WHO, 2002, WHO FACT SHEET, V117, P1	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1982	1982		10.1016/S0140-6736(05)67791-4	http://dx.doi.org/10.1016/S0140-6736(05)67791-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325703				2022-12-28	WOS:000233777900029
J	Leibfried, D; Knill, E; Seidelin, S; Britton, J; Blakestad, RB; Chiaverini, J; Hume, DB; Itano, WM; Jost, JD; Langer, C; Ozeri, R; Reichle, R; Wineland, DJ				Leibfried, D; Knill, E; Seidelin, S; Britton, J; Blakestad, RB; Chiaverini, J; Hume, DB; Itano, WM; Jost, JD; Langer, C; Ozeri, R; Reichle, R; Wineland, DJ			Creation of a six-atom 'Schrodinger cat' state	NATURE			English	Article							TRAPPED IONS; QUANTUM COMPUTATION; ENTANGLEMENT; TELEPORTATION; OPERATIONS	Among the classes of highly entangled states of multiple quantum systems, the so- called 'Schrodinger cat' states are particularly useful. Cat states are equal superpositions of two maximally different quantum states. They are a fundamental resource in fault- tolerant quantum computing(1-3) and quantum communication, where they can enable protocols such as open- destination teleportation(4) and secret sharing(5). They play a role in fundamental tests of quantum mechanics(6) and enable improved signal- to- noise ratios in interferometry(7). Cat states are very sensitive to decoherence, and as a result their preparation is challenging and can serve as a demonstration of good quantum control. Here we report the creation of cat states of up to six atomic qubits. Each qubit's state space is defined by two hyperfine ground states of a beryllium ion; the cat state corresponds to an entangled equal superposition of all the atoms in one hyperfine state and all atoms in the other hyperfine state. In our experiments, the cat states are prepared in a three- step process, irrespective of the number of entangled atoms. Together with entangled states of a different class created in Innsbruck(8), this work represents the current state- of- the- art for large entangled states in any qubit system.	Natl Inst Stand & Technol, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Leibfried, D (corresponding author), Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80305 USA.	dil@boulder.nist.gov	Itano, Wayne/AAV-8781-2020; Jost, John D/F-4701-2010	Britton, Joe/0000-0001-8103-7347; jost, john/0000-0002-1698-8602				BACON DM, 2001, THESIS U CALIF, pCH10; Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Dur W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107903; Dur W, 2001, J PHYS A-MATH GEN, V34, P6837, DOI 10.1088/0305-4470/34/35/310; Efron B., 1994, MONOGRAPHS STAT APPL; Freeman R., 1998, SPIN CHOREOGRAPHY; Hillery M, 1999, PHYS REV A, V59, P1829, DOI 10.1103/PhysRevA.59.1829; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Lewenstein M, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052310; Ozeri R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030403; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; STEANE AM, 2003, QUANTPH0311014; Zhao Z, 2004, NATURE, V430, P54, DOI 10.1038/nature02643; [No title captured]	30	692	706	6	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					639	642		10.1038/nature04251	http://dx.doi.org/10.1038/nature04251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319885				2022-12-28	WOS:000233593100043
J	Baugh, J; Moussa, O; Ryan, CA; Nayak, A; Laflamme, R				Baugh, J; Moussa, O; Ryan, CA; Nayak, A; Laflamme, R			Experimental implementation of heat-bath algorithmic cooling using solid-state nuclear magnetic resonance	NATURE			English	Article							QUANTUM COMPUTATION; COMPUTERS	The counter-intuitive properties of quantum mechanics have the potential to revolutionize information processing by enabling the development of efficient algorithms with no known classical counterparts(1,2). Harnessing this power requires the development of a set of building blocks(3), one of which is a method to initialize the set of quantum bits (qubits) to a known state. Additionally, fresh ancillary qubits must be available during the course of computation to achieve fault tolerance(4-7). In any physical system used to implement quantum computation, one must therefore be able to selectively and dynamically remove entropy from the part of the system that is to be mapped to qubits. One such method is an 'open-system' cooling protocol in which a subset of qubits can be brought into contact with an external system of large heat capacity. Theoretical efforts(8-10) have led to an implementation-independent cooling procedure, namely heat-bath algorithmic cooling. These efforts have culminated with the proposal of an optimal algorithm, the partner-pairing algorithm, which was used to compute the physical limits of heat-bath algorithmic cooling(11). Here we report the experimental realization of multi-step cooling of a quantum system via heat-bath algorithmic cooling. The experiment was carried out using nuclear magnetic resonance of a solid-state ensemble three-qubit system. We demonstrate the repeated repolarization of a particular qubit to an effective spin-bath temperature, and alternating logical operations within the three-qubit subspace to ultimately cool a second qubit below this temperature. Demonstration of the control necessary for these operations represents an important step forward in the manipulation of solid-state nuclear magnetic resonance qubits.	Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON N2L 3G1, Canada; Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada	University of Waterloo; University of Waterloo; Perimeter Institute for Theoretical Physics	Baugh, J (corresponding author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	baugh@iqc.ca	Baugh, Jonathan/F-3879-2011; Baugh, Jonathan/S-9973-2019	Baugh, Jonathan/0000-0002-9300-7134				ABRAGAM A, 1982, NUCL MAGNETISM ORDER, P339; Boykin PO, 2002, P NATL ACAD SCI USA, V99, P3388, DOI 10.1073/pnas.241641898; CORY DG, 1990, J MAGN RESON, V90, P205, DOI 10.1016/0022-2364(90)90380-R; Cory DG, 1998, PHYSICA D, V120, P82, DOI 10.1016/S0167-2789(98)00046-3; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Everitt H, 2004, QUANTUM INF PROCESS, V3, P1, DOI 10.1007/s11128-004-9416-4; Fernandez JM, 2004, INT J QUANTUM INF, V2, P461, DOI 10.1142/S0219749904000419; Fortunato EM, 2002, J CHEM PHYS, V116, P7599, DOI 10.1063/1.1465412; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; HAEBERLEN U, 1976, ADV MAGNETIC RESO S1, P64; JAGANNATHAN NR, 1994, J CHEM CRYSTALLOGR, V24, P75, DOI 10.1007/BF01665349; Kitaev AY, 1997, QUANTUM COMMUNICATION, COMPUTING, AND MEASUREMENT, P181; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; Leskowitz GM, 2003, J CHEM PHYS, V119, P1643, DOI 10.1063/1.1582171; MOUSSA O, 2005, THESIS U WATERLOO, P20; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Schulman L. J., 1999, Proceedings of the Thirty-First Annual ACM Symposium on Theory of Computing, P322, DOI 10.1145/301250.301332; Schulman LJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120501	22	87	87	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					470	473		10.1038/nature04272	http://dx.doi.org/10.1038/nature04272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306986	Green Submitted			2022-12-28	WOS:000233458200043
J	Ginzler, EM; Dooley, MA; Aranow, C; Kim, MY; Buyon, J; Merrill, JT; Petri, M; Gilkeson, GS; Wallace, DJ; Weisman, MH; Appel, GB				Ginzler, EM; Dooley, MA; Aranow, C; Kim, MY; Buyon, J; Merrill, JT; Petri, M; Gilkeson, GS; Wallace, DJ; Weisman, MH; Appel, GB			Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POOR RENAL SURVIVAL; TERM-FOLLOW-UP; LONG-TERM; IMMUNOSUPPRESSIVE THERAPY; PULSE CYCLOPHOSPHAMIDE; AFRICAN-AMERICAN; CONTROLLED-TRIAL; ERYTHEMATOSUS; PREDICTORS; EFFICACY	BACKGROUND Since anecdotal series and small, prospective, controlled trials suggest that mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are desirable. METHODS We conducted a 24-week randomized, open-label, noninferiority trial comparing oral mycophenolate mofetil (initial dose, 1000 mg per day, increased to 3000 mg per day) with monthly intravenous cyclophosphamide (0.5 g per square meter of body-surface area, increased to 1.0 g per square meter) as induction therapy for active lupus nephritis. A change to the alternative regimen was allowed at 12 weeks in patients who did not have an early response. The study protocol specified adjunctive care and the use and tapering of corticosteroids. The primary end point was complete remission at 24 weeks (normalization of abnormal renal measurements and maintenance of baseline normal measurements). A secondary end point was partial remission at 24 weeks. RESULTS Of 140 patients recruited, 71 were randomly assigned to receive mycophenolate mofetil and 69 were randomly assigned to receive cyclophosphamide. At 12 weeks, 56 patients receiving mycophenolate mofetil and 42 receiving cyclophosphamide had satisfactory early responses. In the intention-to-treat analysis, 16 of the 71 patients (22.5 percent) receiving mycophenolate mofetil and 4 of the 69 patients receiving cyclophosphamide (5.8 percent) had complete remission, for an absolute difference of 16.7 percentage points (95 percent confidence interval, 5.6 to 27.9 percentage points; P=0.005), meeting the prespecified criteria for noninferiority and demonstrating the superiority of mycophenolate mofetil to cyclophosphamide. Partial remission occurred in 21 of the 71 patients (29.6 percent) and 17 of the 69 patients (24.6 percent), respectively (P=0.51). Three patients assigned to cyclophosphamide died, two during protocol therapy. Fewer severe infections and hospitalizations but more diarrhea occurred among those receiving mycophenolate. CONCLUSIONS In this 24-week trial, mycophenolate mofetil was more effective than intravenous cyclophosphamide in inducing remission of lupus nephritis and had a more favorable safety profile.	Suny Downstate Med Ctr, Div Rheumatol, Brooklyn, NY 11203 USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Div Biostat, Bronx, NY 10467 USA; NYU, Hosp Joint Dis, Sch Med, New York, NY 10003 USA; Oklahoma Med Res Fdn, Dept Clin Pharmacol, Oklahoma City, OK 73104 USA; Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; Med Univ S Carolina, Charleston, SC 29425 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Columbia Univ, Med Ctr, Div Nephrol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Oklahoma Medical Research Foundation; Johns Hopkins University; Johns Hopkins Medicine; Medical University of South Carolina; Cedars Sinai Medical Center; Columbia University	Ginzler, EM (corresponding author), Suny Downstate Med Ctr, Div Rheumatol, 450 Clarkson Ave,Box 42, Brooklyn, NY 11203 USA.	ellen.ginzler@downstate.edu		Buyon, Jill/0000-0002-3852-7129				Al Salloum AA, 2003, PEDIATR NEPHROL, V18, P357, DOI 10.1007/s00467-003-1110-8; Alarcon, 2001, ARTHRIT RHEUM-ARTHR, V45, P306; Alarcon GS, 2001, ARTHRIT RHEUM-ARTHR, V45, P191, DOI 10.1002/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Barr RG, 2003, NEPHROL DIAL TRANSPL, V18, P2039, DOI 10.1093/ndt/gfg345; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; BOUMPAS DT, 1995, ANN INTERN MED, V122, P940, DOI 10.7326/0003-4819-122-12-199506150-00009; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Chan TM, 2005, J AM SOC NEPHROL, V16, P1076, DOI 10.1681/ASN.2004080686; CHAN TM, 2001, J AM SOC NEPHROL, V12, P195; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Cortes-Hernandez J, 2003, LUPUS, V12, P287, DOI 10.1191/0961203303lu340oa; Dooley MA, 1999, J AM SOC NEPHROL, V10, P833; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; Gaubitz M, 1999, LUPUS, V8, P731, DOI 10.1191/096120399678840927; Gourley MF, 1996, ANN INTERN MED, V125, P549, DOI 10.7326/0003-4819-125-7-199610010-00003; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Houssiau FA, 2004, ARTHRITIS RHEUM-US, V50, P3934, DOI 10.1002/art.20666; Hu WX, 2002, CHINESE MED J-PEKING, V115, P705; Illei GG, 2002, ARTHRITIS RHEUM, V46, P995, DOI 10.1002/art.10142; Ioannidis JPA, 2000, KIDNEY INT, V57, P258, DOI 10.1046/j.1523-1755.2000.00832.x; Karim MY, 2002, RHEUMATOLOGY, V41, P876, DOI 10.1093/rheumatology/41.8.876; Kim MY, 1999, LUPUS, V8, P620, DOI 10.1191/096120399680411308; Kingdon EJ, 2001, LUPUS, V10, P606, DOI 10.1191/096120301682430186; Korbet SM, 2000, AM J KIDNEY DIS, V35, P904, DOI 10.1016/S0272-6386(00)70262-9; LEHMAN TJA, 1989, J PEDIATR-US, V114, P1055, DOI 10.1016/S0022-3476(89)80463-9; Mok CC, 2004, ARTHRITIS RHEUM, V50, P2559, DOI 10.1002/art.20364; Mok CC, 2002, AM J KIDNEY DIS, V40, P447, DOI 10.1053/ajkd.2002.34882; Neylan JF, 1997, TRANSPLANTATION, V64, P1277, DOI 10.1097/00007890-199711150-00008; Schweitzer EJ, 1998, TRANSPLANTATION, V65, P242; STEINBERG AD, 1991, ARTHRITIS RHEUM-US, V34, P945, DOI 10.1002/art.1780340803; VALERI A, 1994, CLIN NEPHROL, V42, P71; Velasquez X, 2003, JCR-J CLIN RHEUMATOL, V9, P7	33	765	827	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2219	2228		10.1056/NEJMoa043731	http://dx.doi.org/10.1056/NEJMoa043731			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306519	Bronze			2022-12-28	WOS:000233434500005
J	Wilson, DB				Wilson, DB			Immunology - Insulin auto-antigenicity in type 1 diabetes	NATURE			English	Editorial Material							T-CELLS; EPITOPE; PEPTIDE; MOUSE		Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Torrey Pines Institute for Molecular Studies, California	Wilson, DB (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA.	dbwilson@tpims.org		Ricordi, Camillo/0000-0001-8092-7153				Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KUMAR V, 1995, P NATL ACAD SCI USA, V92, P9510, DOI 10.1073/pnas.92.21.9510; Muraro PA, 2000, J IMMUNOL, V164, P5474, DOI 10.4049/jimmunol.164.10.5474; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299	7	13	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2005	438	7067					E5	E5		10.1038/nature04423	http://dx.doi.org/10.1038/nature04423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306940	Bronze			2022-12-28	WOS:000233458200036
J	Mahaffey, KW; Cohen, M; Garg, J; Antman, E; Kleiman, NS; Goodman, SG; Berdan, LG; Reist, CJ; Langer, A; White, HD; Aylward, PE; Col, JJ; Ferguson, JJ; Califf, RM				Mahaffey, KW; Cohen, M; Garg, J; Antman, E; Kleiman, NS; Goodman, SG; Berdan, LG; Reist, CJ; Langer, A; White, HD; Aylward, PE; Col, JJ; Ferguson, JJ; Califf, RM		SYNERGY Trial Investigators	High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin - Outcomes at 6 months and 1 year in the SYNERGY trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ST-SEGMENT ELEVATION; GLYCOPROTEIN IIB/IIIA; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; UNSTABLE ANGINA; ENOXAPARIN; THERAPY; MANAGEMENT; COMMITTEE; MORTALITY	Context The SYNERGY trial comparing enoxaparin and unfractionated heparin in high-risk patients with acute coronary syndromes (ACS) showed that enoxaparin was not inferior to unfractionated heparin in reducing death or nonfatal myocardial infarction (MI) at 30 days. Objective To evaluate continued risk in this patient cohort through 6-month and 1-year follow-up. Design, Setting, and Patients Overall, 9978 patients were randomized from August 2001 through December 2003 in 487 hospitals in 12 countries. Patients were followed up for 6 months and for 1 year. Main Outcome Measures Six-month outcomes were death, nonfatal MI, revascularization procedures, stroke, and site-investigator-reported need for rehospitalization; 1-year outcome was all-cause death. Results Six-month and 1-year follow-up data were available for 9957 (99.8%) and 9608 (96.3%) of 9978 patients, respectively; 541 patients (5.4%) had died at 6 months and 739 (7.4%) at 1 year. Death or nonfatal MI at 6 months occurred in 872 patients receiving enoxaparin (17.6%) vs 884 receiving unfractionated heparin (17.8%) (hazard ratio [HR], 0.98; 95% confidence interval [CI], 0.89-1.07; P = .65). In the subgroup of patients receiving consistent therapy, ie, only enoxaparin or unfractionated heparin during the index hospitalization (n = 6138), a reduction in death or nonfatal MI with enoxaparin was maintained at 180 days (HR, 0.85; 95% CI, 0.75-0.95; P = .006). Rehospitalization within 180 days occurred in 858 patients receiving enoxaparin (17.9%) and 911 receiving unfractionated heparin (19.0%) (HR, 0.94; 95% CI, 0.85-1.03; P = .17). One-year all-cause death rates were similar in the 2 treatment groups (380/4974 [7.6%] for enoxaparin vs 359/4948 [7.3%] for unfractionated heparin; HR, 1.06; 95% CI, 0.92-1.22; P = .44). One-year death rates in patients receiving consistent therapy were also similar (251/3386 [7.4%] for enoxaparin vs 213/2720 [7.8%] for unfractionated heparin; HR, 0.95; 95% CI, 0.79-1.14; P = .55). Conclusions In the SYNERGY trial, patients continued to experience adverse cardiac events through long-term follow-up. The effect of enoxaparin on death or MI compared with that of unfractionated heparin at 6 months was similar to that observed at 30 days in the overall trial and in the consistent-therapy group. One-year death rates were also similar in both groups. High-risk. patients with ACS remain susceptible to continued cardiac events despite aggressive therapies. ClinicalTrials.gov Identifier: NCT00043784.	Duke Clin Res Inst, Durham, NC 27715 USA; Newark Beth Israel Med Ctr, Heart Hosp New Jersey, Newark, NJ USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; Flinders Med Ctr, Bedford Pk, SA, Australia; Clin Univ St Luc, B-1200 Brussels, Belgium	Duke University; Newark Beth Israel Medical Center; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Auckland City Hospital; Flinders Medical Centre; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Mahaffey, KW (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	mahaf002@mc.duke.edu		Aylward, Philip/0000-0002-5358-8552				Allen LA, 2004, AM J CARDIOL, V93, P1218, DOI 10.1016/j.amjcard.2004.01.063; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Antman EM, 2002, EUR HEART J, V23, P308, DOI 10.1053/euhj.2001.2779; Bavry AA, 2004, AM J CARDIOL, V93, P830, DOI 10.1016/j.amjcard.2003.12.019; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Cohen M, 2005, J AM COLL CARDIOL, V45, p202A; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Ferguson JJ, 2002, AM HEART J, V143, P952, DOI 10.1067/mhj.2002.122120; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; Topol E, 1998, NEW ENGL J MED, V339, P436	12	45	51	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2594	2600		10.1001/jama.294.20.2594	http://dx.doi.org/10.1001/jama.294.20.2594			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304073				2022-12-28	WOS:000233436200024
J	Walker, SP; Chang, SM; Powell, CA; Grantham-McGregor, SM				Walker, SP; Chang, SM; Powell, CA; Grantham-McGregor, SM			Effects of early childhood psychosocial stimulation and nutritional supplementation on cognition and education in growth-stunted Jamaican children: prospective cohort study	LANCET			English	Article							SCHOOL	Growth retardation affects about a third of children younger than age 5 years in developing countries and is associated with poor development. Previously, we did a trial of nutritional supplementation and psychosocial stimulation in stunted children aged 9-24 months. Non-stunted children were also assessed. Both types of intervention improved development. We now present the effects of early interventions on cognition and education in 103 of the 129 stunted children and compare them with 64 of the 84 non-stunted children now aged 17-18 years. We recorded no significant effects of nutritional supplementation. Compared with no intervention, stimulation resulted in higher full scale IQ scores (coefficient 0.38, 95% C1 0.06-0.71, p=0.02) and higher scores on the verbal subscale (0.3, 0.07-0.68, p=0.02), Peabody picture vocabulary test (7.84, 0.73-14.95, p=0.03), verbal analogies (0.26, 0.03-0.49, p=0.03), and reading tests (4.73, 1.31-8.14, p=0.007, and 2.7, 1.12.4.37, p=0.001). Overall, stunted non-stimulated participants had significantly poorer scores than the non-stunted group on 11 of 12 cognitive and educational tests. Stunting in early childhood is associated with cognitive and educational deficits in late adolescence, which are reduced by stimulation at a young age.	Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Mona, Jamaica; Inst Child Hlth, London, England	University West Indies Mona Jamaica; University of London; University College London	Walker, SP (corresponding author), Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Mona, Jamaica.	susan.walker@uwimona.edu.jm			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; FRANCE N, 1997, GROUP READING TEST, V2; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; POWELL C, 2004, BMJ             0624; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227	9	243	247	1	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1804	1807		10.1016/S0140-6736(05)67574-5	http://dx.doi.org/10.1016/S0140-6736(05)67574-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	987KQ	16298218				2022-12-28	WOS:000233517200025
J	Wang, XQ; Rickert, M; Garcia, KC				Wang, XQ; Rickert, M; Garcia, KC			Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma(c) receptors	SCIENCE			English	Article							PROTEIN-PROTEIN INTERFACE; COMMON GAMMA-CHAIN; IL-2 RECEPTOR; BETA-CHAIN; CYTOPLASMIC DOMAINS; MOLECULAR-CLONING; C-CHAIN; CYTOKINE; BINDING; GP130	Interleukin-2 (IL-2) is an immunoregulatory cytokine that acts through a quaternary receptor signaling complex containing alpha (IL-2R alpha), beta (IL-2R beta), and common gamma chain (gamma(c)) receptors. In the structure of the quaternary ectodomain complex as visualized at a resolution of 2.3 angstroms, the binding of IL-2R alpha to IL-2 stabilizes a secondary binding site for presentation to IL-2R beta. gamma(c) is then recruited to the composite surface formed by the IL-2/IL-2R beta complex. Consistent with its role as a shared receptor for IL-4, IL-7, IL-9, IL-15, and IL-21, gamma(c) forms degenerate contacts with IL-2. The structure of gamma(c) provides a rationale for loss-of-function mutations found in patients with X-linked severe combined immunodeficiency diseases (X-SCID). This complex structure provides a framework for other gamma(c)-dependent cytokine-receptor interactions and for the engineering of improved IL-2 therapeutics..	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D319, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51321] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Church AC, 2003, QJM-INT J MED, V96, P91, DOI 10.1093/qjmed/hcg014; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; DeLano W.L, PYMOL MOL GRAPHICS S; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; MCKAY DB, 1992, SCIENCE, V257, P412, DOI 10.1126/science.257.5068.412; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Puck JM, 1996, IMMUNOL TODAY, V17, P507, DOI 10.1016/0167-5699(96)30062-5; Raskin N, 1998, J IMMUNOL, V161, P3474; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; SMITH KA, 1993, BLOOD, V81, P1414; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Smith Kendall A, 2003, AIDS Read, V13, P365; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x	43	319	360	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1159	1163		10.1126/science.1117893	http://dx.doi.org/10.1126/science.1117893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293754				2022-12-28	WOS:000233437300038
J	Tornroth-Horsefield, S; Wang, Y; Hedfalk, K; Johanson, U; Karlsson, M; Tajkhorshid, E; Neutze, R; Kjellbom, P				Tornroth-Horsefield, S; Wang, Y; Hedfalk, K; Johanson, U; Karlsson, M; Tajkhorshid, E; Neutze, R; Kjellbom, P			Structural mechanism of plant aquaporin gating	NATURE			English	Article							WATER CHANNEL; PROTON EXCLUSION; MOLECULAR-MECHANISMS; GLYCEROL CONDUCTION; MEMBRANE AQUAPORIN; PERMEATION; TRANSPORT; PERMEABILITY; DYNAMICS; SELECTIVITY	Plants counteract fluctuations in water supply by regulating all aquaporins in the cell plasma membrane. Channel closure results either from the dephosphorylation of two conserved serine residues under conditions of drought stress, or from the protonation of a conserved histidine residue following a drop in cytoplasmic pH due to anoxia during flooding. Here we report the X-ray structure of the spinach plasma membrane aquaporin SoPIP2; 1 in its closed conformation at 2.1 angstrom resolution and in its open conformation at 3.9 angstrom resolution, and molecular dynamics simulations of the initial events governing gating. In the closed conformation loop D caps the channel from the cytoplasm and thereby occludes the pore. In the open conformation loop D is displaced up to 16 angstrom and this movement opens a hydrophobic gate blocking the channel entrance from the cytoplasm. These results reveal a molecular gating mechanism which appears conserved throughout all plant plasma membrane aquaporins.	Chalmers Univ Technol, Dept Chem & Biosci, SE-40530 Gothenburg, Sweden; Univ Illinois, Beckman Inst, Theoret & Computat Biophys Grp, Urbana, IL 61801 USA; Lund Univ, Dept Plant Biochem, SE-22100 Lund, Sweden	Chalmers University of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Lund University	Neutze, R (corresponding author), Chalmers Univ Technol, Dept Chem & Biosci, POB 462, SE-40530 Gothenburg, Sweden.	emad@ks.uiuc.edu; richard.neutze@chembio.chalmers.se; per.kjellbom@plantbio.lu.se	Johanson, Urban/D-4344-2015; Tajkhorshid, Emad/A-1249-2010; Neutze, Richard/A-7573-2010; Tajkhorshid, Emad/AAN-8323-2021; Johanson, Urban/AHE-8231-2022; Wang, Yi/P-9069-2017; Hedfalk, Kristina/A-8244-2010; Törnroth-Horsefield, Susanna/B-2702-2010	Johanson, Urban/0000-0001-8862-128X; Neutze, Richard/0000-0003-0986-6153; Johanson, Urban/0000-0001-8862-128X; Wang, Yi/0000-0002-4174-8790; Tajkhorshid, Emad/0000-0001-8434-1010; Tornroth-Horsefield, Susanna/0000-0002-9435-8243				Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borstlap AC, 2002, TRENDS PLANT SCI, V7, P529, DOI 10.1016/S1360-1385(02)02365-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilan B, 2004, PROTEINS, V55, P223, DOI 10.1002/prot.20038; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jensen MO, 2003, BIOPHYS J, V85, P2884, DOI 10.1016/S0006-3495(03)74711-0; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madsen D, 2002, J APPL CRYSTALLOGR, V35, P137, DOI 10.1107/S0021889802000602; Morishita Y, 2004, J PHARMACOL SCI, V96, P276, DOI 10.1254/jphs.FMJ04004X7; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schlenkrich Michael, 1996, P31; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200	47	603	649	13	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					688	694		10.1038/nature04316	http://dx.doi.org/10.1038/nature04316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16340961				2022-12-28	WOS:000235193100036
J	Coull, JAM; Beggs, S; Boudreau, D; Boivin, D; Tsuda, M; Inoue, K; Gravel, C; Salter, MW; De Koninck, Y				Coull, JAM; Beggs, S; Boudreau, D; Boivin, D; Tsuda, M; Inoue, K; Gravel, C; Salter, MW; De Koninck, Y			BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain	NATURE			English	Article							NEUROTROPHIC FACTOR; TACTILE ALLODYNIA; DORSAL-HORN; LAMINA-I; PLASTICITY; RELEASE	Neuropathic pain that occurs after peripheral nerve injury depends on the hyperexcitability of neurons in the dorsal horn of the spinal cord(1-3). Spinal microglia stimulated by ATP contribute to tactile allodynia, a highly debilitating symptom of pain induced by nerve injury(4). Signalling between microglia and neurons is therefore an essential link in neuropathic pain transmission, but how this signalling occurs is unknown. Here we show that ATP-stimulated microglia cause a depolarizing shift in the anion reversal potential (E-anion) in spinal lamina I neurons. This shift inverts the polarity of currents activated by GABA (gamma-amino butyric acid), as has been shown to occur after peripheral nerve injury(5). Applying brain-derived neurotrophic factor ( BDNF) mimics the alteration in Eanion. Blocking signalling between BDNF and the receptor TrkB reverses the allodynia and the E-anion shift that follows both nerve injury and administration of ATP-stimulated microglia. ATP stimulation evokes the release of BDNF from microglia. Preventing BDNF release from microglia by pretreating them with interfering RNA directed against BDNF before ATP stimulation also inhibits the effects of these cells on the withdrawal threshold and E-anion. Our results show that ATP-stimulated microglia signal to lamina I neurons, causing a collapse of their transmembrane anion gradient, and that BDNF is a crucial signalling molecule between microglia and neurons. Blocking this microglia-neuron signalling pathway may represent a therapeutic strategy for treating neuropathic pain.	Univ Laval, Ctr Rech, Div Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; Univ Laval, Ctr Rech, Div Neurobiol Syst, Quebec City, PQ G1J 2G3, Canada; Univ Laval, Dept Psychiat, Quebec City, PQ G1K 7P4, Canada	Laval University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kyushu University; Laval University; Laval University	De Koninck, Y (corresponding author), Univ Laval, Ctr Rech, Div Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada.	mike.salter@utoronto.ca; Yves.DeKoninck@crulrg.ulaval.ca	Bourinet, Emmanuel/S-4396-2017; De Koninck, Yves/C-2659-2008; Boudreau, Dominic/I-8144-2012; Tsuda, Makoto/AAE-7256-2020; Beggs, Simon/AAI-4438-2021	Bourinet, Emmanuel/0000-0001-8021-0419; De Koninck, Yves/0000-0002-5779-9330; Beggs, Simon/0000-0002-1582-8391				Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chery N, 2000, J NEUROSCI METH, V96, P133, DOI 10.1016/S0165-0270(99)00195-8; CODERRE TJ, 1994, PAIN, V59, P345, DOI 10.1016/0304-3959(94)90020-5; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Jiang B, 2003, J NEUROSCI, V23, P3761; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; Lewin GR, 2004, CURR OPIN NEUROBIOL, V14, P443, DOI 10.1016/j.conb.2004.07.009; Malcangio M, 2003, TRENDS PHARMACOL SCI, V24, P116, DOI 10.1016/S0165-6147(03)00025-7; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nakajima K, 2002, J NEUROCHEM, V80, P697, DOI 10.1046/j.0022-3042.2001.00752.x; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Thompson SWN, 1999, P NATL ACAD SCI USA, V96, P7714, DOI 10.1073/pnas.96.14.7714; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0	29	1367	1444	9	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1017	1021		10.1038/nature04223	http://dx.doi.org/10.1038/nature04223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355225				2022-12-28	WOS:000233934600067
J	Jeganathan, KB; Malureanu, L; van Deursen, JM				Jeganathan, KB; Malureanu, L; van Deursen, JM			The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation	NATURE			English	Article							RNA EXPORT FACTOR; SPINDLE-CHECKPOINT; HUMAN-CELLS; CDC20; PROTEINS; BUB3; CDH1; PROTEOLYSIS; APC/C; RAE1	Cdc20 and Cdh1 are the activating subunits of the anaphase-promoting complex (APC), an E3 ubiquitin ligase that drives cells into anaphase by inducing degradation of cyclin B and the anaphase inhibitor securin(1). To prevent chromosome missegregation, APC activity directed against these mitotic regulators must be inhibited until all chromosomes are properly attached to the mitotic spindle(2). Here we show that in mitosis timely destruction of securin by APC is regulated by the nucleocytoplasmic transport factors Rae1 and Nup98. We show that combined Rae1 and Nup98 haploinsufficiency in mice results in premature separation of sister chromatids, severe aneuploidy and untimely degradation of securin. We find that Rae1 and Nup98 form a complex with Cdh1-activated APC (APC(Cdh1)) in early mitosis and specifically inhibit APC(Cdh1)-mediated ubiquitination of securin. Dissociation of Rae1 and Nup98 from APC(Cdh1) coincides with the release of the mitotic checkpoint protein BubR1 from Cdc20-activated APC (APC(Cdc20)) at the metaphase to anaphase transition. Together, our results suggest that Rae1 and Nup98 are temporal regulators of APC(Cdh1) that maintain euploidy by preventing unscheduled degradation of securin.	Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu	Holt, Janet E/B-2415-2013	Jeganathan, KARTHIK/0000-0001-5587-1266				Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Matsuoka Y, 1999, BIOCHEM BIOPH RES CO, V254, P417, DOI 10.1006/bbrc.1998.9953; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	22	148	150	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1036	1039		10.1038/nature04221	http://dx.doi.org/10.1038/nature04221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355229				2022-12-28	WOS:000233934600071
J	Sanchez-Guerrero, J; Uribe, AG; Jimenez-Santana, L; Mestanza-Peralta, M; Lara-Reyes, P; Seuc, AH; Cravioto, MD				Sanchez-Guerrero, J; Uribe, AG; Jimenez-Santana, L; Mestanza-Peralta, M; Lara-Reyes, P; Seuc, AH; Cravioto, MD			A trial of contraceptive methods in women with systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals	OCT 16-21, 2004	San Antonio, TX	Amer Coll Rheumatol, Assoc Rheumatol Hlth Profess			VENOUS THROMBOEMBOLIC DISEASE; COMBINED ORAL-CONTRACEPTIVES; HORMONE REPLACEMENT THERAPY; ACTIVITY INDEX; PREGNANCY; GLOMERULONEPHRITIS; ANTIBODIES; ANDROGEN; SURVIVAL; COHORT	BACKGROUND: The effects of estrogen-containing contraceptives on disease activity in women with systemic lupus erythematosus have not been determined. METHODS: We conducted a single-blind clinical trial involving 162 women with systemic lupus erythematosus who were randomly assigned to combined oral contraceptives, a progestin-only pill, or a copper intrauterine device (IUD). Disease activity was assessed at 0, 1, 2, 3, 6, 9, and 12 months according to the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). The primary outcome was global disease activity, which we estimated by measuring the area under the SLEDAI curve. Secondary outcomes included the maximum SLEDAI score, change in SLEDAI score, incidence of lupus flares, median time to first flare, systemic lupus erythematosus treatment, and adverse events. The results were analyzed by the intention-to-treat method. RESULTS: At baseline, all demographic features and disease characteristics were similar in the three groups. The mean (+/-SD) SLEDAI score was 6.1+/-5.6 in the group assigned to combined oral contraceptives, 6.4+/-4.6 in the group assigned to the progestin-only pill, and 5.0+/-5.3 in the group assigned to the IUD (54 patients in each group) (P=0.36). Disease activity remained mild and stable in all groups throughout the trial. There were no significant differences among the groups during the trial in global or maximum disease activity, incidence or probability of flares, or medication use. The median time to the first flare was three months in all groups. Thromboses occurred in four patients (two in each of the two groups receiving hormones), and severe infections were more frequent in the IUD group. One patient receiving combined oral contraceptives died from amoxicillin-related severe neutropenia. CONCLUSIONS: Global disease activity, maximum SLEDAI score, incidence of flares, time to first flare, and incidence of adverse events were similar among women with systemic lupus erythematosus, irrespective of the type of contraceptive they were using.	Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City 14000, DF, Mexico; WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; World Health Organization	Sanchez-Guerrero, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Vasco Quiroga 15, Mexico City 14000, DF, Mexico.	jsanchez@innsz.mx						ALARCONSEGOVIA D, 1984, J RHEUMATOL, V11, P588; BARRETT C, 1986, BRIT J RHEUMATOL, V25, P300; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Buyon J P, 1995, J Clin Rheumatol, V1, P205, DOI 10.1097/00124743-199508000-00002; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; CHAPEL TA, 1971, AM J OBSTET GYNECOL, V110, P366, DOI 10.1016/0002-9378(71)90730-7; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; DUBOIS EL, 1968, LANCET, V2, P679; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; GAROVICH M, 1980, ARTHRITIS RHEUM, V23, P1396, DOI 10.1002/art.1780231213; GILL D, 1968, J CHRON DIS, V21, P435, DOI 10.1016/0021-9681(68)90006-4; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gladman DD, 2000, J RHEUMATOL, V27, P377; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; GUERREROSANCHEZ J, 1997, ARTHRITIS RHEUM, V40, P804; JUNGERS P, 1982, ARTHRITIS RHEUM, V25, P618, DOI 10.1002/art.1780250603; KELLEY VE, 1980, CLIN IMMUNOL IMMUNOP, V16, P142, DOI 10.1016/0090-1229(80)90198-1; Kreidstein S, 1997, J RHEUMATOL, V24, P2149; MINTZ G, 1984, CONTRACEPTION, V30, P29, DOI 10.1016/0010-7824(84)90076-3; Mok CC, 1999, ARTHRITIS RHEUM, V42, P1274, DOI 10.1002/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B; MUND A, 1963, JAMA-J AM MED ASSOC, V183, P917; Parkar M, 1998, CYTOKINE, V10, P613, DOI 10.1006/cyto.1998.0336; Petri M, 2004, ARTHRITIS RHEUM, V50, pS239; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; POULTER NR, 1995, LANCET, V346, P1575; RAMSEYGOLDMAN R, 1988, RHEUM DIS CLIN N AM, V14, P169; Rose E, 1944, ANN INTERN MED, V21, P1022, DOI 10.7326/0003-4819-21-6-1022; ROUBINIAN JR, 1979, J CLIN INVEST, V63, P902, DOI 10.1172/JCI109390; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Sanchez-Guerrero J, 2001, AM J MED, V111, P464, DOI 10.1016/S0002-9343(01)00885-3; SANCHEZGUERRERO J, 1995, ANN INTERN MED, V122, P430, DOI 10.7326/0003-4819-122-6-199503150-00005; SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x; Silman AJ, 1993, EPIDEMIOLOGY RHEUMAT, P163; Somers E, 2002, J RHEUMATOL, V29, P2531; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TARZY BJ, 1972, LANCET, V2, P501; TRAVERS RL, 1978, J RHEUMATOL, V5, P448; WHO, 2004, MED EL CRIT CONTR US, V3	40	177	190	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2539	2549		10.1056/NEJMoa050817	http://dx.doi.org/10.1056/NEJMoa050817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	993BA	16354890				2022-12-28	WOS:000233926500003
J	Declercq, G				Declercq, G			Comment on "How science survived: Medieval manuscripts' 'demography' and classic texts' extinction"	SCIENCE			English	Editorial Material								Exciting though it may seem, the mathematical model developed by Cisne (Reports, 25 February 2005, p. 1305) to analyze the transmission of texts and manuscripts from Antiquity and the Middle Ages does not hold up to scrutiny. It seriously underestimates the losses, thus leading to conclusions that are unwarranted.	Vrije Univ Brussels, Dept Hist, B-1050 Brussels, Belgium	Vrije Universiteit Brussel	Declercq, G (corresponding author), Vrije Univ Brussels, Dept Hist, Pleinlaan 2, B-1050 Brussels, Belgium.	georges.declercq@vub.ac.be	Declercq, Georges/F-5410-2013	Declercq, Georges/0000-0001-9844-0618				BEDE, 1975, SER LAT, V123, pR7; Cisne JL, 2005, SCIENCE, V307, P1305, DOI 10.1126/science.1104718; Contreni John, 1995, NEW CAMBRIDGE MEDIEV, V2, P709; Declercq Georges, 2000, ANNO DOMINI ORIGINS; DEROLEZ A, 1997, MEDIEVAL BOOKLISTS S, V1, P164; Gilman SL, 2005, SCIENCE, V307, P1208, DOI 10.1126/science.1109679; GUMBERT JP, 1997, SPOOR EGBERT AARTSBI, P151; JONES CW, 1994, BEDE SCH COMPUTUS, pCH5; KER NR, 1964, MEDIEVAL LIB GREAT B, pR11; Stevens W. M., 1995, CYCLES TIME SCI LEAR; WALLIS F, 1999, BEDE RECKONING TIME, pR85; WERNER KF, 1990, CHARLEMAGNES HEIR NE, P82	12	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754								10.1126/science.1117462	http://dx.doi.org/10.1126/science.1117462			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339431				2022-12-28	WOS:000233961700023
J	Lindblad-Toh, K; Wade, CM; Mikkelsen, TS; Karlsson, EK; Jaffe, DB; Kamal, M; Clamp, M; Chang, JL; Kulbokas, EJ; Zody, MC; Mauceli, E; Xie, XH; Breen, M; Wayne, RK; Ostrander, EA; Ponting, CP; Galibert, F; Smith, DR; deJong, PJ; Kirkness, E; Alvarez, P; Biagi, T; Brockman, W; Butler, J; Chin, CW; Cook, A; Cuff, J; Daly, MJ; DeCaprio, D; Gnerre, S; Grabherr, M; Kellis, M; Kleber, M; Bardeleben, C; Goodstadt, L; Heger, A; Hitte, C; Kim, L; Koepfli, KP; Parker, HG; Pollinger, JP; Searle, SMJ; Sutter, NB; Thomas, R; Webber, C; Lander, ES				Lindblad-Toh, K; Wade, CM; Mikkelsen, TS; Karlsson, EK; Jaffe, DB; Kamal, M; Clamp, M; Chang, JL; Kulbokas, EJ; Zody, MC; Mauceli, E; Xie, XH; Breen, M; Wayne, RK; Ostrander, EA; Ponting, CP; Galibert, F; Smith, DR; deJong, PJ; Kirkness, E; Alvarez, P; Biagi, T; Brockman, W; Butler, J; Chin, CW; Cook, A; Cuff, J; Daly, MJ; DeCaprio, D; Gnerre, S; Grabherr, M; Kellis, M; Kleber, M; Bardeleben, C; Goodstadt, L; Heger, A; Hitte, C; Kim, L; Koepfli, KP; Parker, HG; Pollinger, JP; Searle, SMJ; Sutter, NB; Thomas, R; Webber, C; Lander, ES		Broad Inst Genome Sequencing Plat	Genome sequence, comparative analysis and haplotype structure of the domestic dog	NATURE			English	Review							MOLECULAR EVOLUTION; LINKAGE DISEQUILIBRIUM; ACCELERATED EVOLUTION; BODY-SIZE; GENES; DNA; VERTEBRATE; MAP; ELEMENTS; REVEALS	Here we report a high-quality draft genome sequence of the domestic dog ( Canis familiaris), together with a dense map of single nucleotide polymorphisms ( SNPs) across breeds. The dog is of particular interest because it provides important evolutionary information and because existing breeds show great phenotypic diversity for morphological, physiological and behavioural traits. We use sequence comparison with the primate and rodent lineages to shed light on the structure and evolution of genomes and genes. Notably, the majority of the most highly conserved non-coding sequences in mammalian genomes are clustered near a small subset of genes with important roles in development. Analysis of SNPs reveals long-range haplotypes across the entire dog genome, and defines the nature of genetic diversity within and across breeds. The current SNP map now makes it possible for genome-wide association studies to identify genes responsible for diseases and traits, with important consequences for human and companion animal health.	Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Boston Univ, Program Bioinformat, Boston, MA 02215 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Oxford, Dept Human Anat & Genet, MRC Funct Genet, Oxford OX1 3QX, England; Univ Rennes 1, Fac Med, CNRS, UMR Genet & Dev 6061, F-35043 Rennes, France; Agencourt Biosci Corp, Beverly, MA 01915 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Inst Genom Res, Rockville, MD 20850 USA; Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Boston University; University of North Carolina; North Carolina State University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; J. Craig Venter Institute; Wellcome Trust Sanger Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindblad-Toh, K (corresponding author), Harvard Univ, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	lander@broad.mit.edu	Ponting, Chris/AAV-2621-2021; Mikkelsen, Tarjei S/A-1306-2007; Fiumefreddo, Andrea/T-2977-2019; Daly, Mark J/B-2453-2017; Kellis, Manolis/ABE-7385-2020; Parker, Heidi/C-6954-2008; Koepfli, Klaus-Peter/AAT-9320-2020; OBRIEN, STEPHEN/ABD-1346-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Daly, Mark J/0000-0002-0949-8752; Kellis, Manolis/0000-0001-7113-9630; Breen, Matthew/0000-0002-8901-4155; Ostrander, Elaine/0000-0001-6075-9738; Thomas, Rachael/0000-0002-3029-8798; Sykes, Sean/0000-0001-8344-5176; Cuff, James/0000-0003-0570-4106; Parker, Heidi G./0000-0002-9707-6380; Wade, Claire/0000-0003-3413-4771; Ponting, Chris/0000-0003-0202-7816; Karlsson, Elinor/0000-0002-4343-3776; Xie, Xiaohui/0000-0002-5479-6345; Heger, Andreas/0000-0001-7720-0447; Webber, Caleb/0000-0001-8063-7674; DeCaprio, Dave/0000-0001-8931-9461; Grabherr, Manfred/0000-0001-8792-6508; Hitte, Christophe/0000-0003-1714-437X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, Z01HG200325] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andelfinger G, 2004, GENOMICS, V83, P1053, DOI 10.1016/j.ygeno.2003.12.009; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Bardeleben C, 2005, MOL BIOL EVOL, V22, P347, DOI 10.1093/molbev/msi022; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Breen M, 1999, CHROMOSOME RES, V7, P401, DOI 10.1023/A:1009224232134; Breen M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-65; Breen M, 2001, GENOME RES, V11, P1784, DOI 10.1101/gr.189401; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; CROWLEY J, 1998, COMPLETE DOG BOOK; Daly MJ, 2002, CELL, V109, P283, DOI 10.1016/S0092-8674(02)00742-0; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Demetrius L, 2000, P ROY SOC B-BIOL SCI, V267, P2385, DOI 10.1098/rspb.2000.1295; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Fogel B, 1995, ENCY DOG; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galibert F, 2004, M S-MED SCI, V20, P761, DOI 10.1051/medsci/2004208-9761; Galtier N, 1998, GENETICS, V150, P1577; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hitte C, 2005, NAT REV GENET, V6, P643, DOI 10.1038/nrg1658; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUGHES AL, 1995, J MOL EVOL, V41, P539, DOI 10.1007/BF00175811; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Hyun CB, 2003, MAMM GENOME, V14, P640, DOI 10.1007/s00335-003-3006-0; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; KAJIWARA N, 1998, AKITA, P1; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; LAIRD CD, 1969, NATURE, V224, P149, DOI 10.1038/224149a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li R, 1999, GENOMICS, V58, P9, DOI 10.1006/geno.1999.5772; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lou XY, 2003, MAMM GENOME, V14, P555, DOI 10.1007/s00335-003-2272-1; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Macdonald DW, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P3; Mamedov IZ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni018; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Marques-Bonet T, 2005, GENE, V353, P147, DOI 10.1016/j.gene.2005.05.007; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Ostrander EA, 2000, GENOME RES, V10, P1271, DOI 10.1101/gr.155900; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson M, 2000, NAT REV GENET, V1, P9, DOI 10.1038/35049530; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Sargan DR, 2004, MAMM GENOME, V15, P503, DOI 10.1007/s00335-004-3047-z; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SMITH AFA, REPEATMASKER; Smith NGC, 2004, GENOMICS, V84, P806, DOI 10.1016/j.ygeno.2004.07.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Todhunter RJ, 2003, AM J VET RES, V64, P418, DOI 10.2460/ajvr.2003.64.418; Tsui C, 2003, NUCLEIC ACIDS RES, V31, P4910, DOI 10.1093/nar/gkg664; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Walter K, 2005, TRENDS GENET, V21, P436, DOI 10.1016/j.tig.2005.06.003; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WAYNE RK, 1986, J MORPHOL, V187, P301, DOI 10.1002/jmor.1051870304; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Werner P, 1997, GENOMICS, V42, P74, DOI 10.1006/geno.1997.4723; Wilcox B, 1995, ATLAS DOG BREEDS WOR; Wolfe KH, 2003, NAT GENET, V33, P255, DOI 10.1038/ng1088; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Zeh JA, 2005, TRENDS GENET, V21, P281, DOI 10.1016/j.tig.2005.03.006	119	1730	1884	4	465	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					803	819		10.1038/nature04338	http://dx.doi.org/10.1038/nature04338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341006	Bronze			2022-12-28	WOS:000233777800043
J	McDonald, LC; Killgore, GE; Thompson, A; Owens, RC; Kazakova, SV; Sambol, SP; Johnson, S; Gerding, DN				McDonald, LC; Killgore, GE; Thompson, A; Owens, RC; Kazakova, SV; Sambol, SP; Johnson, S; Gerding, DN			An epidemic, toxin gene-variant strain of Clostridium difficile	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			BINARY TOXIN; ADP-RIBOSYLTRANSFERASE; OUTBREAK; DIARRHEA; DISEASE; TOXINOTYPES; COLITIS	BACKGROUND: Recent reports suggest that the rate and severity of Clostridium difficile-associated disease in the United States are increasing and that the increase may be associated with the emergence of a new strain of C. difficile with increased virulence, resistance, or both. METHODS: A total of 187 C. difficile isolates were collected from eight health care facilities in six states (Georgia, Illinois, Maine, New Jersey, Oregon, and Pennsylvania) in which outbreaks of C. difficile-associated disease had occurred between 2000 and 2003. The isolates were characterized by restriction-endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE), and toxinotyping, and the results were compared with those from a database of more than 6000 isolates obtained before 2001. The polymerase chain reaction was used to detect the recently described binary toxin CDT and a deletion in the pathogenicity locus gene, tcdC, that might result in increased production of toxins A and B. RESULTS: Isolates that belonged to one REA group (BI) and had the same PFGE type (NAP1) were identified in specimens collected from patients at all eight facilities and accounted for at least half of the isolates from five facilities. REA group BI, which was first identified in 1984, was uncommon among isolates from the historic database (14 cases). Both historic and current (obtained since 2001) BI/NAP1 isolates were of toxinotype III, were positive for the binary toxin CDT, and contained an 18-bp tcdC deletion. Resistance to gatifloxacin and moxifloxacin was more common in current BI/NAP1 isolates than in non-BI/NAP1 isolates (100 percent vs. 42 percent, P<0.001), whereas the rate of resistance to clindamycin was the same in the two groups (79 percent). All of the current but none of the historic BI/NAP1 isolates were resistant to gatifloxacin and moxifloxacin (P<0.001). CONCLUSIONS: A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geographically dispersed outbreaks of C. difficile-associated disease.	Ctr Dis Control & Prevent, Epidemiol & Lab Branch, Div Healthcare Qual Promot, Atlanta, GA USA; Maine Med Ctr, Dept Pharm, Portland, ME 04102 USA; Maine Med Ctr, Dept Infect Dis, Portland, ME 04102 USA; Univ Vermont, Coll Med, Burlington, VT USA; Vet Affairs Edward Hines Jr Hosp, Infect Dis Sect, Hines, IL USA; Vet Affairs Edward Hines Jr Hosp, Res Serv, Hines, IL USA; Loyola Univ, Stritch Sch Med, Hines, IL USA	Centers for Disease Control & Prevention - USA; Maine Medical Center; Maine Medical Center; University of Vermont; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	McDonald, LC (corresponding author), 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	cmcdonald1@cdc.gov		McDonald, L. Clifford/0000-0003-3044-5572; Johnson, Stuart/0000-0001-9548-229X				Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BARTLETT JG, 1979, REV INFECT DIS, V1, P370; BILLER P, 2005, P 2005 ANN C ASS PRO; BOYCE JM, 2005, P 15 ANN SCI M SOC H; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gaynes R, 2004, CLIN INFECT DIS, V38, P640, DOI 10.1086/381551; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Johal SS, 2004, GUT, V53, P673, DOI 10.1136/gut.2003.028803; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Klaassen CHW, 2002, J CLIN MICROBIOL, V40, P101, DOI 10.1128/JCM.40.1.101-104.2002; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; LAYTON BA, 2005, P 15 ANN SCI M SOC H; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MCDONALD LC, 2004, P 14 ANN SCI M SOC H; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; *NAT COMM CLIN LAB, 2004, M11A6 NCCLS; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PATEL S, 2005, P 15 ANN SCI M SOC H; RUBIN MS, 1995, DIS COLON RECTUM, V38, P350, DOI 10.1007/BF02054220; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Samore M, 1997, J INFECT DIS, V176, P1233, DOI 10.1086/514117; SEHULSTER L, 2003, MMWR RECOMM REP, V55, P1; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; TAYLOR NS, 1979, REV INFECT DIS, V1, P379; TAYLOR NS, 1981, INFECT IMMUN, V34, P1036, DOI 10.1128/IAI.34.3.1036-1043.1981; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	36	1547	1631	1	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2433	2441		10.1056/NEJMoa051590	http://dx.doi.org/10.1056/NEJMoa051590			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	990OZ	16322603	Bronze			2022-12-28	WOS:000233754400005
J	Fowler, RA; Gupta, S				Fowler, RA; Gupta, S			Subacute and acute infective endocarditis	LANCET			English	Editorial Material									Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Fowler, RA (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, 2075 Bayview Ave,Room D478, Toronto, ON M4N 3M5, Canada.	rob.fowler@sw.ca							0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1964	1964		10.1016/S0140-6736(05)67788-4	http://dx.doi.org/10.1016/S0140-6736(05)67788-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325699				2022-12-28	WOS:000233777900025
J	Kumar, A; Soares, H; Wells, R; Clarke, M; Hozo, L; Bleyer, A; Reaman, G; Chalmers, I; Djulbegovic, B				Kumar, A; Soares, H; Wells, R; Clarke, M; Hozo, L; Bleyer, A; Reaman, G; Chalmers, I; Djulbegovic, B			Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; CLINICAL-TRIALS; UNCERTAINTY PRINCIPLE; THERAPY; CHEMOTHERAPY; EQUIPOISE	Objectives To assess how often new treatments for childhood cancer assessed in phase III randomised trials are superior or inferior to standard treatments and whether the pattern of successes and failures in new treatments is consistent with uncertainty being the ethical basis for enrolling patients in such trials. Design Observational study. Setting Phase III randomised controlled trials carried out under the aegis of the Children's Oncology Group between 1955 and 1997, regardless of whether they were published. Main outcome measures Overall survival, event free survival, and treatment related mortality. Results 126 trials were included, involving 152 comparisons and 36 567 patients. The odds ratio for overall survival with experimental treatments was 0.96 (99% confidence interval 0.89 to 1.03), indicating that new treatments are as likely to be inferior as they are to be superior to standard treatments. This result was not affected by publication bias, methodological quality, treatment type, disease, or comparator. Conclusions New treatments in childhood cancer tested in randomised controlled trials are, on average, as likely to be inferior as they are to be superior to standard treatments, confirming that the uncertainty principle has been operating.	Univ S Florida, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Indiana Univ NW, Gary, IN USA; UK Cochrane Ctr, Oxford, England; James Lind Lib, Oxford, England	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University Northwest; Cochrane Centre	Djulbegovic, B (corresponding author), Univ S Florida, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	djulbebm@moffitt.usf.edu	Djulbegovic, Benjamin/I-3661-2012; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/I-4940-2012; Kumar, Ambuj/U-5268-2019; Hozo, ihozo@iun.edu/R-3498-2016	Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622; Hozo, ihozo@iun.edu/0000-0003-2349-5707	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044417, R01NS052956] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS044417-01, R01 NS052956] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ALUNAN DG, 2001, ANN INTERN MED, V134, P663; Bleyer WA, 1997, J ADOLESCENT HEALTH, V21, P366, DOI 10.1016/S1054-139X(97)00110-9; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; CHLEBOWSKI RT, 1994, J CLIN ONCOL, V12, P1789, DOI 10.1200/JCO.1994.12.9.1789; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; DANGIO GJ, 1976, CANCER-AM CANCER SOC, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO;2-S; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 2001, Curr Oncol Rep, V3, P389, DOI 10.1007/s11912-001-0024-5; Djulbegovic B, 2000, LANCET, V356, P2194, DOI 10.1016/S0140-6736(05)67271-6; Djulbegovic Benjamin, 2003, Account Res, V10, P301; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; Egger M, 2001, SYSTEMATIC REV HLTH; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; GAYNON PS, 1993, J CLIN ONCOL, V11, P2234, DOI 10.1200/JCO.1993.11.11.2234; Gilbert J, 1977, COSTS RISKS BENEFITS, P124; GOTZSCHE PC, 1993, SCAND J RHEUMATOL, V22, P255, DOI 10.3109/03009749309095135; HILL AB, 1963, BMJ-BRIT MED J, P1043, DOI 10.1136/bmj.1.5337.1043; Joffe S, 2004, BMJ-BRIT MED J, V328, P1463, DOI 10.1136/bmj.38118.685289.55; Juni P, 2001, SYSTEMATIC REV HLTH, P87; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lilford RJ, 2001, BMJ-BRIT MED J, V322, P795; Lipton P, 2005, SCIENCE, V307, P219, DOI 10.1126/science.1103024; Machin D, 1997, Clin Oncol (R Coll Radiol), V9, P100; MANN H, 2005, WHY COMP MUST ADDRES; Mann Howard, 2003, BMC Med Res Methodol, V3, P7, DOI 10.1186/1471-2288-3-7; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MOSTELLER F, 1981, SCIENCE, V211, P881, DOI 10.1126/science.6781066; *NAT CANC I, CANC TRIALS; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Ross JA, 1996, CANCER, V77, P201, DOI 10.1002/(SICI)1097-0142(19960101)77:1<201::AID-CNCR32>3.0.CO;2-7; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Rothschild BB, 2005, NEW ENGL J MED, V352, P2451; Simone JV, 2003, NEW ENGL J MED, V349, P627, DOI 10.1056/NEJMp030094; Soares HP, 2005, JAMA-J AM MED ASSOC, V293, P970, DOI 10.1001/jama.293.8.970; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Stephenson T, 1996, BRIT MED J, V313, P362, DOI 10.1136/bmj.313.7053.362b; WELLS RJ, 1994, J CLIN ONCOL, V12, P2367, DOI 10.1200/JCO.1994.12.11.2367; WILLIAMSON G, 1996, BMJ-BRIT MED J, V312, P1479; Wittes RE, 2003, NEW ENGL J MED, V348, P747, DOI 10.1056/NEJMe020181; Woods WG, 2001, BLOOD, V97, P56, DOI 10.1182/blood.V97.1.56	45	55	55	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1295	1298B		10.1136/bmj.38628.561123.7C	http://dx.doi.org/10.1136/bmj.38628.561123.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990YE	16299015	Green Published, Bronze			2022-12-28	WOS:000233778500014
J	Mulleman, D; Goupille, P				Mulleman, D; Goupille, P			A medical mystery - Extensive ecchymosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Tours, F-37032 Tours, France	Universite de Tours	Mulleman, D (corresponding author), Univ Tours, F-37032 Tours, France.		Mulleman, Denis/K-5822-2012; Mulleman, Denis/O-3221-2019	Mulleman, Denis/0000-0003-4089-7513					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2384	2384		10.1056/NEJMicm040655	http://dx.doi.org/10.1056/NEJMicm040655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319387				2022-12-28	WOS:000233574600010
J	Warrell, DA				Warrell, DA			Treatment of bites by adders and exotic venomous snakes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VIPERA-BERUS; HEMOSTATIC DISTURBANCES; ANTIVENOM; FAILURE; PROPHYLAXIS; TRIAL		Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford	Warrell, DA (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	david.warrell@ndm.oxford.ac.uk						CEDERHOLM I, 1987, ACTA PAEDIATR SCAND, V76, P682, DOI 10.1111/j.1651-2227.1987.tb10547.x; Fan HW, 1999, BRIT MED J, V318, P1451, DOI 10.1136/bmj.318.7196.1451; GERRARD M, 1982, PRACTITIONER, V226, P527; GILLISSEN A, 1994, TOXICON, V32, P937, DOI 10.1016/0041-0101(94)90372-7; HOWARTH DM, 1994, MED J AUSTRALIA, V161, P695, DOI 10.5694/j.1326-5377.1994.tb126923.x; Jorge MT, 2004, T ROY SOC TROP MED H, V98, P529, DOI 10.1016/j.trstmh.2003.12.009; KARLSONSTIBER C, 1994, J INTERN MED, V235, P57, DOI 10.1111/j.1365-2796.1994.tb01032.x; KarlsonStiber C, 1997, J INTERN MED, V241, P53, DOI 10.1046/j.1365-2796.1997.80896000.x; MALASIT P, 1986, BRIT MED J, V292, P17, DOI 10.1136/bmj.292.6512.17; Matsen FA, 1980, COMPARTMENTAL SYNDRO, P162; MCNALLY T, 1993, T ROY SOC TROP MED H, V87, P66, DOI 10.1016/0035-9203(93)90427-R; Meier J., 1995, TOXICON; PERSSON H, 1981, ACTA MED SCAND, V210, P433; Persson H, 2001, Przegl Lek, V58, P223; Premawardhena AP, 1999, BRIT MED J, V318, P1041, DOI 10.1136/bmj.318.7190.1041; REID HA, 1978, BMJ-BRIT MED J, V1, P1598, DOI 10.1136/bmj.1.6127.1598; REID HA, 1976, BMJ-BRIT MED J, V2, P153, DOI 10.1136/bmj.2.6028.153; Schneemann M, 2004, QJM-INT J MED, V97, P717, DOI 10.1093/qjmed/hch118; Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129; STAHEL E, 1985, SCHWEIZ MED WSCHR, V115, P890; SUTHERLAND SK, 1979, LANCET, V1, P183, DOI 10.1016/S0140-6736(79)90580-4; THEAKSTON RDG, 1976, LANCET, V2, P121; Warrell D.A., 1999, SE ASIAN J TROP MED, V30, P1; Warrell D.A., 2004, VENOMOUS REPTILES W, P709; WATT G, 1986, NEW ENGL J MED, V315, P1444, DOI 10.1056/NEJM198612043152303	25	74	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1244	1247		10.1136/bmj.331.7527.1244	http://dx.doi.org/10.1136/bmj.331.7527.1244			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308385	Bronze, Green Published			2022-12-28	WOS:000233606800021
J	Yang, C; Zhong, ZH; Lieber, CM				Yang, C; Zhong, ZH; Lieber, CM			Encoding electronic properties by synthesis of axial modulation-doped silicon nanowires	SCIENCE			English	Article							CARBON NANOTUBES; QUANTUM DOTS; GROWTH; HETEROSTRUCTURES; TRANSPORT	We describe the successful synthesis of modulation-doped silicon nanowires by achieving pure axial elongation without radial overcoating during the growth process. Scanning gate microscopy shows that the key properties of the modulated structures-including the number, size, and period of the differentially doped regions-are defined in a controllable manner during synthesis, and moreover, that feature sizes to less than 50 nanometers are possible. Electronic devices fabricated with designed modulation-doped nanowire structures demonstrate their potential for lithography-independent address decoders and tunable, coupled quantum dots in which changes in electronic properties are encoded by synthesis rather than created by conventional lithography-based techniques.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu						Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bjork MT, 2004, NANO LETT, V4, P1621, DOI 10.1021/nl049230s; Bjork MT, 2002, APPL PHYS LETT, V80, P1058, DOI 10.1063/1.1447312; Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640; DeHon A, 2003, IEEE T NANOTECHNOL, V2, P165, DOI 10.1109/TNANO.2003.816658; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; FAHEY PM, 1989, REV MOD PHYS, V61, P289, DOI 10.1103/RevModPhys.61.289; Fasth C, 2005, NANO LETT, V5, P1487, DOI 10.1021/nl050850i; Greytak AB, 2004, APPL PHYS LETT, V84, P4176, DOI 10.1063/1.1755846; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; JASINSKI JM, 1991, ACCOUNTS CHEM RES, V24, P9, DOI 10.1021/ar00001a002; KOUWENHOVEN L, 1997, P ADV STUD I MES EL; Lauhon LJ, 2002, NATURE, V420, P57, DOI 10.1038/nature01141; Lieber CM, 2003, MRS BULL, V28, P486, DOI 10.1557/mrs2003.144; Mason N, 2004, SCIENCE, V303, P655, DOI 10.1126/science.1093605; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Samuelson L, 2004, PHYSICA E, V25, P313, DOI 10.1016/j.physe.2004.06.030; Waugh FR, 1996, PHYS REV B, V53, P1413, DOI 10.1103/PhysRevB.53.1413; WHITE RT, 1985, INT J CHEM KINET, V17, P1029, DOI 10.1002/kin.550171003; Wu Y, 2004, NANO LETT, V4, P433, DOI 10.1021/nl035162i; Zhong ZH, 2003, SCIENCE, V302, P1377, DOI 10.1126/science.1090899; Zhou CW, 2000, SCIENCE, V290, P1552, DOI 10.1126/science.290.5496.1552	23	288	306	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2005	310	5752					1304	1307		10.1126/science.1118798	http://dx.doi.org/10.1126/science.1118798			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311329				2022-12-28	WOS:000233600200034
J	Stuebe, AM; Rich-Edwards, JW; Willett, WC; Manson, JE; Michels, KB				Stuebe, AM; Rich-Edwards, JW; Willett, WC; Manson, JE; Michels, KB			Duration of lactation and incidence of type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL OBESITY; PHYSICAL-ACTIVITY; BODY-COMPOSITION; DELAYED-ONSET; RISK-FACTORS; WEIGHT; WOMEN; METABOLISM; PREGNANCY; MELLITUS	Context Lactation is associated with improved glucose and insulin homeostasis, independent of weight change. Objective To evaluate the association between lactation history and incidence of type 2 diabetes. Design, Setting, and Participants Prospective observational cohort study of 83 585 parous women in the Nurses' Health Study (NHS) and retrospective observational cohort study of 73 418 parous women in the Nurses' Health Study II (NHS II). Main Outcome Measure Incident cases of type 2 diabetes mellitus. Results In the NHS, 5145 cases of type 2 diabetes were diagnosed during 1239709 person-years of follow-up between 1986 and 2002, and in the NHS II, 1132 cases were diagnosed during 778876 person-years of follow-up between 1989 and 2001. Among parous women, increasing duration of lactation was associated with a reduced risk of type 2 diabetes. For each additional year of lactation, women with a birth in the prior 15 years had a decrease in the risk of diabetes of 15% (95% confidence interval, 1%-27%) among NHS participants and of 14% (95% confidence interval, 7%-21%) among NHS II participants, controlling for current body mass index and other relevant risk factors for type 2 diabetes. Conclusions Longer duration of breastfeeding was associated with reduced incidence of type 2 diabetes in 2 large US cohorts of women. Lactation may reduce risk of type 2 diabetes in young and middle-aged women by improving glucose homeostasis.	Harvard Univ, Sch Med,Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Wellesley, MA USA; Harvard Univ, Sch Publ Hlth, Channing Lab, Dept Nutr, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Channing Lab, Dept Epidemiol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Michels, KB (corresponding author), Harvard Univ, Sch Med,Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, 221 Longwood Ave, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu			NCI NIH HHS [CA50385, CA87969] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM DIAB ASS, 2002, NAT DIAB FACT SHEET; American Diabetes Association, 1998, DIABETES CARE S1, V12, pS20, DOI DOI 10.2337/DIACARE.21.1.S20; BREWER MM, 1989, AM J CLIN NUTR, V49, P259, DOI 10.1093/ajcn/49.2.259; BURNOL AF, 1986, AM J PHYSIOL, V251, pE537, DOI 10.1152/ajpendo.1986.251.5.E537; Butte NF, 1999, AM J CLIN NUTR, V69, P299; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; Butte NF, 2001, J NUTR, V131, P53, DOI 10.1093/jn/131.1.53; *CDCP, 2003 NAT IMM SURV AN; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; de Zegher F, 1998, J CLIN ENDOCR METAB, V83, P103, DOI 10.1210/jc.83.1.103; Denis RGP, 2003, J ENDOCRINOL, V176, P193, DOI 10.1677/joe.0.1760193; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; DEWEY KG, 1993, AM J CLIN NUTR, V58, P162, DOI 10.1093/ajcn/58.2.162; Donath SM, 2000, J PAEDIATR CHILD H, V36, P482, DOI 10.1046/j.1440-1754.2000.00562.x; DUGDALE AE, 1989, BRIT J NUTR, V61, P149, DOI 10.1079/BJN19890105; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Gigante DP, 2001, J NUTR, V131, P78, DOI 10.1093/jn/131.1.78; HARRIS M, 1979, DIABETES, V28, P1039; Health, 2005, MED BENEFITS, V22, P12; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; JONES RG, 1984, BIOCHEM J, V220, P455, DOI 10.1042/bj2200455; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; Lankarani-Fard A, 2001, J WOMEN HEALTH GEN-B, V10, P681, DOI 10.1089/15246090152563560; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McManus RM, 2001, METABOLISM, V50, P715, DOI 10.1053/meta.2001.23304; Neville MC, 2001, J NUTR, V131, p3005S, DOI 10.1093/jn/131.11.3005S; Petersen M, 2003, DIABETES CARE, V26, P917; Rasmussen KM, 2001, J NUTR, V131, p3009S, DOI 10.1093/jn/131.11.3009S; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sichieri R, 2003, INT J OBESITY, V27, P815, DOI 10.1038/sj.ijo.0802285; Solomon CG, 1996, DIABETES CARE, V19, P12, DOI 10.2337/diacare.19.1.12; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	36	299	303	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2601	2610		10.1001/jama.294.20.2601	http://dx.doi.org/10.1001/jama.294.20.2601			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304074	Bronze			2022-12-28	WOS:000233436200025
J	Aylin, P; Williams, S; Bottle, A				Aylin, P; Williams, S; Bottle, A			Dr Foster's case notes - Obesity and type 2 diabetes in children, 1996-7 to 2003-4	BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS						Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743				Ehtisham S, 2004, ARCH DIS CHILD, V89, P526, DOI 10.1136/adc.2003.027821; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; JOTANGIA D, 2005, OBESITY CHILDREN 11; *NHS HLTH SOC CAR, CLIN COD DEC IMPR; *OFF NAT STAT, 2004, POP EST CURR REL; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Skidmore PML, 2004, QJM-INT J MED, V97, P817, DOI 10.1093/qjmed/hch136	7	10	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1167	+						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293839				2022-12-28	WOS:000233571000015
J	Stevens, MM; George, JH				Stevens, MM; George, JH			Exploring and engineering the cell surface interface	SCIENCE			English	Review							EXTRACELLULAR-MATRIX; OSTEOBLAST ADHESION; MATERIALS SCIENCE; INTEGRIN; BIOMATERIALS; MORPHOLOGY; RECEPTORS; POLYMER; ARCHITECTURE; FABRICATION	Cells are inherently sensitive to local mesoscale, microscale, and nanoscale patterns of chemistry and topography. We review current approaches to control cell behavior through the nanoscale engineering of materials surfaces. Far-reaching implications are emerging for applications including medical implants, cell supports, and materials that can be used as instructive three-dimensional environments for tissue regeneration.	Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England; Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2BP, England	Imperial College London; Imperial College London	Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.	m.stevens@imperial.ac.uk	Sano, Michael/E-1715-2011	George, Julian/0000-0002-0701-5040	Engineering and Physical Sciences Research Council [EP/C520742/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987; Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002; Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curtis A, 2004, IEEE T NANOBIOSCI, V3, P293, DOI 10.1109/TNB.2004.837898; Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15; Curtis A, 2002, NATURE, V416, P274, DOI 10.1038/416274a; Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a; Gullberg D, 1995, INT J DEV BIOL, V39, P845; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Maheshwari G, 2000, J CELL SCI, V113, P1677; Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Murphy WL, 2004, LANGMUIR, V20, P1026, DOI 10.1021/la035733m; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073; Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885; Santini JT, 1999, NATURE, V397, P335, DOI 10.1038/16898; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; SCOTT JE, 1995, J ANAT, V187, P259; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; Tran KT, 2004, WOUND REPAIR REGEN, V12, P262, DOI 10.1111/j.1067-1927.2004.012302.x; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g; Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467; Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602; Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098; Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Zagris N, 2001, MICRON, V32, P427, DOI 10.1016/S0968-4328(00)00011-1; Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035	64	2090	2180	28	1156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1135	1138		10.1126/science.1106587	http://dx.doi.org/10.1126/science.1106587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293749				2022-12-28	WOS:000233437300032
J	Bobat, R; Coovadia, H; Stephen, C; Naidoo, KL; McKerrow, N; Black, RE; Moss, W				Bobat, R; Coovadia, H; Stephen, C; Naidoo, KL; McKerrow, N; Black, RE; Moss, W			Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial	LANCET			English	Article							HIV-1-INFECTED WOMEN; NUCLEOCAPSID PROTEIN; POOLED ANALYSIS; MORTALITY; PNEUMONIA; COMMUNITY; DIARRHEA; DISEASE; FINGER; BORN	Background Zinc deficiency is associated with impaired immune function and an increased risk of infection. Supplementation can decrease the incidence of diarrhoea and pneumonia in children in resource-poor countries. However, in children with HIV-1 infection, the safety of zinc supplementation is uncertain. We aimed to assess the role of zinc in HIV-1 replication before mass zinc supplementation is recommended in regions of high HIV-1 prevalence. Methods We did a randomised double-blind placebo-controlled equivalence trial of zinc supplementation at Grey's Hospital in Pietermaritzburg, South Africa. 96 children with HIV-1 infection were randomly assigned to receive 10 mg of elemental zinc as sulphate or placebo daily for 6 months. Baseline measurements of plasma HIV-1 viral load and the percentage of CD4+ T lymphocytes were established at two study visits before randomisation, and measurements were repeated 3, 6, and 9 months after the start of supplementation. The primary outcome measure was plasma HIV-1 viral load. Analysis was per protocol. Findings The mean log,, HIV-1 viral load was 5.4 (SD 0.61) for the placebo group and 5.4 (SD 0.66) for the zinc-supplemented group 6 months after supplementation began (difference 0.0002, 95% CI -0.27 to 0.27). 3 months after supplementation ended, the corresponding values were 5.5 (SD 0.77) and 5.4 (SD 0 - 61), a difference of 0.05 (-0.24 to 0.35). The mean percentage of CD4+ T lymphocytes and median haemoglobin concentrations were also similar between the two groups after zinc supplementation. Two deaths occurred in the zinc supplementation group and seven in the placebo group (p=0.1). Children given zinc supplementation were less likely to get watery diarrhoea than those given placebo. Watery diarrhoea was diagnosed at 30 (7.4%) of 407 clinic visits in the zinc-supplemented group versus 65 (14.5%) of 447 visits in the placebo group (p=0.001). Interpretation Zinc supplementation of HIV-1-infected children does not result in an increase in plasma HIV-1 viral load and could reduce morbidity caused by diarrhoea.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Durban, South Africa; Greys Hosp, Dept Paediat, Pietermaritzburg, South Africa; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Kwazulu Natal; University of Kwazulu Natal; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moss, W (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	wmoss@jhsph.edu	Naidoo, Kimesh/ABH-3206-2021	McKerrow, Neil/0000-0001-8891-6176; Black, Robert/0000-0001-9926-7984; naidoo, kimesh/0000-0003-4940-0534				[Anonymous], ZINC TRAC EL HUM NUT; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bobat R, 1999, S AFR MED J, V89, P646; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Coovadia HM, 2002, NUTR RES, V22, P179, DOI 10.1016/S0271-5317(01)00386-4; Faber M, 2001, INT J FOOD SCI NUTR, V52, P401, DOI 10.1080/09637480120078285; Fawzi W, 2003, CLIN INFECT DIS, V37, pS112, DOI 10.1086/375882; Fawzi WW, 2005, AM J CLIN NUTR, V81, P161; Gorelick RJ, 1999, VIROLOGY, V256, P92, DOI 10.1006/viro.1999.9629; HARRER T, 1992, CLIN EXP IMMUNOL, V89, P285; HOTZ C, 2004, FOOD NUTR B, pS91; Kupka R, 2002, NUTR REV, V60, P69, DOI 10.1301/00296640260042739; MOCCHEGIANI E, 1995, INT J IMMUNOPHARMACO, V17, P719, DOI 10.1016/0192-0561(95)00060-F; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Siberry GK, 2002, NUTR RES, V22, P527, DOI 10.1016/S0271-5317(02)00364-0; Tanchou V, 1998, J VIROL, V72, P4442, DOI 10.1128/JVI.72.5.4442-4447.1998; Tang AM, 1996, AM J EPIDEMIOL, V143, P1244, DOI 10.1093/oxfordjournals.aje.a008712; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054	22	109	111	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1862	1867		10.1016/S0140-6736(05)67756-2	http://dx.doi.org/10.1016/S0140-6736(05)67756-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310552				2022-12-28	WOS:000233643200024
